CDISC SDTM Controlled Terminology

CDISC SDTM Controlled Terminology, 2014-12-19
Legend:
CodeList
CodeListItem
NCI attributes
C66767Action Taken with Study Treatment
C101865Acute Coronary Syndrome Presentation Category
C66781Age Unit
C74456Anatomical Location
C101842Canadian Cardiovascular Society Classification
C101859Cardiac Procedure Indication
C101866Cardiac Rhythm Device Failure Manifestation
C101853Cardiac Valvular Regurgitation Severity
C101854Cardiac Valvular Stenosis Severity
C119016Cardiovascular Findings About Results
C119015Cardiovascular Findings About Test Code
C119014Cardiovascular Findings About Test Name
C101847Cardiovascular Test Code
C101846Cardiovascular Test Name
C74558Category for Disposition Event
C66797Category for Inclusion/Exclusion
C66784Common Terminology Criteria for Adverse Events V3.0
C87162Common Terminology Criteria for Adverse Events V4.0
C66727Completion/Reason for Non-Completion
C101838Consensus Cardiac Classification System Test Code
C101837Consensus Cardiac Classification System Test Name
C102575Contact Case Investigation Contact Type
C102588Contact Setting
C66785Control Type
C101843Coronary Artery Disease Presentation
C101849Coronary Artery Disease Risk
C101844Coronary Artery Disease Symptoms
C119018Coronary Artery Dissection NHLBI Grade Responses
C101860Coronary Artery Dominance
C119017Coronary Thrombus TIMI Grade Responses
C101850Coronary Vessel Disease Extent
C66786Country
C116108Death Details Test Code
C116107Death Details Test Name
C111110Device Events Action Taken with Device
C111109Device Events Category
C106480Device Identifier Long Name
C106481Device Identifier Short Name
C111111Device Properties Test Code
C111112Device Properties Test Name
C112037Device Tracking and Disposition Event Dictionary Derived Term
C106483Device-In-Use Test Code
C106482Device-In-Use Test Name
C101857Diabetes Therapy
C66787Diagnosis Group
C66788Dictionary Name
C99074Directionality
C102576Directly Observed Therapy Location
C101863Discharge Disposition
C102578Disease Outcome
C78732Drug Accountability Test Code
C78731Drug Accountability Test Name
C102577Drug Resistance Status
C90013ECG Lead
C71150ECG Result
C71153ECG Test Code
C71151ECG Test Method
C71152ECG Test Name
C111108Employment Status
C99079Epoch
C66790Ethnic Group
C78735Evaluator
C101832Findings About Test Code
C101833Findings About Test Name
C71113Frequency
C103329General Observation Class
C111114Genetic Sample Type
C117737Graft Type
C117739Hepatic Findings About Test Code
C117738Hepatic Findings About Test Name
C99076Intervention Model
C99078Intervention Type
C101840Killip Class Responses
C65047Laboratory Test Code
C67154Laboratory Test Name
C102580Laboratory Test Standard Character Result
C99073Laterality
C101862Lead Abnormality
C101867Lead Status
C101868Left Ventricular Ejection Fraction Measurement Result
C101861Lesion Complexity
C101851Location of Most Severe Stenosis Within a Graft
C76348Marital Status
C101845Mechanical Circulatory Support Placement Timing
C96777Medical Evaluator
C85492Method
C102581Microbial Identification Certainty
C85495Microbiology Susceptibility Testing Result Category
C85491Microorganism
C89974Microscopic Findings Test Code
C89973Microscopic Findings Test Name
C114117Morphology Test Code
C114116Morphology Test Name
C117741Multiple Sclerosis Findings About Test Code
C117740Multiple Sclerosis Findings About Test Name
C88025Neoplasm Type
C116104Nervous System Physiology Test Code
C116103Nervous System Physiology Test Name
C78738Never/Current/Former Classification
C101839New York Heart Association Classification
C66742No Yes Response
C101855Non-system Reason for PCI Delay
C101834Normal Abnormal Response
C66789Not Done
C117743Ophthalmic Exam Test Code
C117742Ophthalmic Exam Test Name
C119013Ophthalmic Focus of Study Specific Interest
C66768Outcome of Event
C66726Pharmaceutical Dosage Form
C114119Pharmacogenomics Biomarker Medical Statement
C116106Pharmacogenomics Findings Test Code
C116105Pharmacogenomics Findings Test Name
C95121Physical Properties Test Code
C95120Physical Properties Test Name
C85493PK Parameters
C85839PK Parameters Code
C85494PK Units of Measure
C99075Portion/Totality
C71148Position
C102582Priority of Tuberculosis Contact
C101858Procedure
C101856Procedure Urgency Status
C114118Protocol Milestone
C74457Race
C101864Reason CS/LV Lead Not Implanted
C102584Reason For Treatment
C102583Reason for Treatment Interruption
C102586Reason Treatment Not Administered
C78736Reference Range Indicator
C66728Relation to Reference Period
C100130Relationship to Subject
C78737Relationship Type
C106479Reproductive System Findings Test Code
C106478Reproductive System Findings Test Name
C111106Respiratory Test Code
C111107Respiratory Test Name
C101848Risk Assessment
C66729Route of Administration
C66734SDTM Domain Abbreviation
C116111SDTM Species
C66769Severity/Intensity Scale for Adverse Events
C66731Sex
C66732Sex of Participants
C66733Size
C76351Skin Classification
C112024Skin Response Test Code
C112023Skin Response Test Name
C74561Skin Type
C102587Social Risk Factor
C78733Specimen Condition
C78734Specimen Type
C119020Stent Thrombosis, Coronary ARC Grade Responses
C119019Stent Thrombosis, Coronary, ARC Timing Responses
C99077Study Type
C74559Subject Characteristic Test Code
C103330Subject Characteristic Test Name
C101852Sudden Death Syndrome Type
C102579Supporting Evidence for Re-Treatment
C101841TIMI Flow Responses
C102589Treatment Episode
C102585Treatment Failure Reason
C66735Trial Blinding Schema
C66736Trial Indication Type
C66737Trial Phase
C66738Trial Summary Parameter Test Code
C67152Trial Summary Parameter Test Name
C66739Trial Type
C96780Tumor and Lesion Identification Results
C96784Tumor Identification Test Code
C96783Tumor Identification Test Name
C96779Tumor or Lesion Properties Test Code
C96778Tumor or Lesion Properties Test Name
C96782Tumor Response Assessment Test Code
C96781Tumor Response Assessment Test Name
C96785Tumor Response Result
C71620Unit
C66770Units for Vital Signs Results
C102590Vaccination Evidence Source
C116110Viral Resistance Findings Test Code
C116109Viral Resistance Findings Test Name
C66741Vital Signs Test Code
C67153Vital Signs Test Name
C117746West Haven Hepatic Encephalopathy Grade

Codelist Definitions

OIDName
(CDISC Submission Value)
DataType
Extensible
NCI CodeCDISC SynonymCDISC DefinitionPreferred Term
CDISC Submission Value [ODM:CodedValue]
CL.C66767.ACNAction Taken with Study Treatment
(ACN)
text
Extensible: No
C66767Action Taken with Study TreatmentTerminology specifying changes to the study treatment as a result of an adverse event.CDISC SDTM Action Taken with Study Treatment Terminology
DOSE INCREASEDC49503An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)Dose Increased
DOSE NOT CHANGEDC49504An indication that a medication schedule was maintained. (NCI)Dose Not Changed
DOSE REDUCEDC49505An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)Dose Reduced
DRUG INTERRUPTEDC49501An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)Drug Interrupted
DRUG WITHDRAWNC49502An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)Drug Withdrawn
NOT APPLICABLEC48660NA;Not ApplicableDetermination of a value is not relevant in the current context. (NCI)Not Applicable
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C101865.ACSPCATAcute Coronary Syndrome Presentation Category
(ACSPCAT)
text
Extensible: No
C101865Acute Coronary Syndrome Presentation CategoryA classification of the presentation of acute coronary syndrome.CDISC SDTM Acute Coronary Syndrome Presentation Category Terminology
NON-ST ELEVATION MYOCARDIAL INFARCTIONC80383NON-STEMI;NSTEMIA myocardial infarction that does not produce elevation in the ST segments of the ECG.Non-ST Elevation Myocardial Infarction by ECG Finding
OTHERC17649OtherDifferent than the one(s) previously specified or mentioned. (NCI)Other
ST ELEVATION MYOCARDIAL INFARCTIONC101888STEMIA myocardial infarction that produces elevation in the ST segments of the ECG.ST Elevation Myocardial Infarction by ECG Finding
STABLE ANGINAC66914Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration of oral, sublingual or transdermal antianginal medications.Stable Angina
UNSTABLE ANGINAC66911Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest.Unstable Angina
Back to top
CL.C66781.AGEUAge Unit
(AGEU)
text
Extensible: No
C66781Age UnitThose units of time that are routinely used to express the age of a subject.CDISC SDTM Age Unit Terminology
DAYSC25301DayThe time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI)Day
HOURSC25529Hour;hrA unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)Hour
MONTHSC29846MonthOne of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)Month
WEEKSC29844WeekAny period of seven consecutive days. (NCI)Week
YEARSC29848YearThe period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)Year
Back to top
CL.C74456.LOCAnatomical Location
(LOC)
text
Extensible: Yes
C74456Anatomical LocationTerminology codelist used for anatomical location within CDISC.CDISC SDTM Anatomical Location Terminology
5TH LUMBAR SPINOUS PROCESSC116163The spinous process of the 5th lumbar vertebra.Fifth Lumbar Spinous Process
ABDOMINAL AORTAC32038The portion of the descending aorta that lies within the abdomen, beginning below the diaphragm and ending at its division into the right and left common iliac arteries. (NCI)Abdominal Aorta
ABDOMINAL CAVITYC12664Abdomen;Abdominal CavityThe portion of the body that lies between the thorax and the pelvis. (NCI)Abdomen
ABDOMINAL LYMPH NODEC12360Any lymph node within the abdomen.Intra-Abdominal Lymph Node
ABDOMINAL SKINC52758Abdominal SkinThe skin or integument surrounding the abdomen. (NCI)Abdominal Skin
ABDOMINAL WALLC77608The tissues that surround the organs that are present within the abdominal cavity. The abdominal wall tissue is composed of layers of fat, parietal peritoneum, fascia, and muscles. (NCI)Abdominal Wall
ABDUCENS NERVEC12665The sixth cranial nerve.Abducens Nerve
ACCESSORY RENAL ARTERYC116183An additional renal vessel originating from the aorta and entering the kidney at the proximal or distal end of the organ. Accessory renal arteries are found in 26-30% of humans.Accessory Renal Artery
ACETABULUMC32042AcetabulumTwo cup shaped areas, one each on the lateral side of the lower pelvis that house the head of the femur to form the ball and socket joint of the hip. (NCI)Acetabulum
ACHILLES TENDONC32043Calcaneal TendonThe tendon that connects the heel bone to the calf muscles at the back of the lower leg. (NCI)Achilles Tendon
ACROMIOCLAVICULAR JOINTC32047Acromioclavicular JointThe junction of the upper distal end of the scapula to the distal edge of the collarbone, also known as the acromion and the clavicle. (NCI)Acromioclavicular Joint
ACROMIONC32048AcromionThe upper distal process of the scapula. (NCI)Acromion
ACUTE MARGINAL ARTERYC102285ACUTE MARGINAL ARTERY SEGMENT(S);AMARGThe arteries that arise at the junction of the proximal and mid-right coronary artery conduit segments.Acute Marginal Artery
ADRENAL GLANDC12666Adrenal GlandSuprarenal gland. A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex). (NCI)Adrenal Gland
AMYGDALAC12440Amygdaloid NucleusAn almond-shaped group of basal nuclei anterior to the inferior horn of the lateral ventricle of the brain, within the temporal lobe. The amygdala is part of the limbic system. (MESH)Amygdala
ANASTOMOSISC15609AnastomosisA natural or surgically-induced connection between tubular structures in the body. (NCI)Anastomosis
ANKLE JOINTC32078Ankle;Ankle JointA gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus. (NCI)Ankle Joint
ANKLE MORTISEC117868Talar MortiseA rectangular socket or bony arch that connects the ends of the tibia and fibula to the talus.Ankle Mortise
ANTERIOR TIBIAL ARTERYC12825An artery of the lower extremity that supplies blood to the anterior part of the leg and the foot.Anterior Tibial Artery
ANTRUM PYLORIC12259Antrum PyloriThe initial part of the pyloric canal of the stomach. This site contains endocrine cells that produce gastrin and somatostatin. (NCI)Antrum Pylori
ANUSC43362AnusThe lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded. (NCI)Anus
AORTAC12669AortaThe major arterial trunk that carries oxygenated blood from the left ventricle into the ascending aorta behind the heart, the aortic arch, through the thorax as the descending aorta and through the abdomen as the abdominal aorta; it bifurcates into the left and right common iliac arteries. (NCI)Aorta
AORTIC ARCHC32123Aortic ArchThe curved segment of the aorta between the ascending and the descending segments.Aortic Arch
AORTIC VALVEC12670A valve that is located between and controls the flow of blood from the left ventricle of the heart and the aorta. (NCI)Aortic Valve
AORTO-ILIAC PERIPHERAL ARTERYC116166The segment of the blood vessels that includes the iliac artery and its origin from the aorta.Aortoiliac Artery Segment
AORTOPULMONARY WINDOW LYMPH NODEC116165A lymph node located in the aortopulmonary window.Aortopulmonary Window Lymph Node
APPENDICEAL TIPC83470The distal end of the appendix. (NCI)Appendiceal Tip
APPENDICULAR SKELETONC49477The part of the skeleton that includes the bones of the upper and lower limbs, including the shoulder and pelvic girdlesAppendicular Skeleton
APPENDIXC12380AppendixSmall tissue projection existing as a cecal diverticulum with a questionable history of vestigial versus specialized organ. (NCI)Appendix
ARMC32141ArmThe portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb. (NCI)Arm
ARM SKINC52754Arm SkinThe skin or integument covering the arm. (NCI)Arm Skin
ARTERYC12372ArteryA blood vessel that carries blood away from the heart. (NCI)Artery
AXIAL SKELETONC32172The part of the skeleton that includes the skull and spinal column and sternum and ribs. (NCI)Axial Skeleton
AXILLAC12674AxillaThe underside concavity where the arm and the shoulder are joined. (NCI)Axilla
AXILLARY ARTERYC32169An artery that originates from the subclavian artery at the lateral margin of the first rib. It supplies the brachial artery.Axillary Artery
AXILLARY LYMPH NODEC12904Axillary Lymph NodeOne of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle. (NCI)Axillary Lymph Node
AXILLARY VEINC32171A large blood vessel which returns blood to the heart from the lateral thorax, axilla and upper limb. Each side of the body contains one axillary vein.Axillary Vein
BACKC13062BackThe dorsal area between the base of the neck and the sacrum. (NCI)Back
BASAL GANGLIAC12447Basal GangliaClusters of neurons comprising the globus pallidus, putamen, caudate, nucleus accumbens, substantia nigra and subthalamic nucleus. They are involved with high level aspects of inhibitory motor activity in coordination with the excitation commands issued from the cerebellum. (NCI)Basal Ganglia
BASILIC VEINC32197Basilic VeinOne of the moderately large superficial veins of the forearm that transports blood from the hand and the medial aspect of the forearm to the axillary vein. (NCI)Basilic Vein
BICEPS FEMORIS MUSCLEC53147A muscle in the back of the thigh. Its action involves the knee flexion and hip extension. (NCI)Biceps Femoris
BILE DUCTC12376Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct.Bile Duct
BILIARY TRACTC12678Biliary TractThe duct system that transports bile from its origination by hepatocytes in the liver to the small intestine. It is comprised of the common bile duct that connects the liver and gall bladder to the small intestine and the cystic duct that connects the gall bladder to the common bile duct. (NCI)Biliary Tract
BLADDERC12414BladderThe distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (NCI)Bladder
BLADDER, DOMEC12332Dome of the BladderThe upper, convex surface of the bladder. (NCI)Dome of the Bladder
BLADDER, FUNDUSC48939Fundus of the BladderThe portion of the bladder that is formed by the posterior wall and is located opposite to the bladder opening. (NCI)Bladder Fundus
BLADDER, NECKC12336Neck of the BladderThe inferior portion of the urinary bladder which is formed as the walls of the bladder converge and become contiguous with the proximal urethra. (NCI)Bladder Neck
BLADDER, TRIGONEC12331Trigone of the BladderThe triangular area in the bladder mucosa that is formed by the two ureteral orifices and the urethral orifice. (NCI)Bladder Trigone
BLOODC12434Blood;Peripheral BloodA liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.Blood
BLOOD VESSELC12679Blood VesselA tubular structure through which the blood circulates in the body. Blood vessels constitute a network composed of arteries, arterioles, capillaries, venules, and veins. (NCI)Blood Vessel
BODYC13041BodyThe entire physical structure of an organism. It is composed of anatomic systems, regions, cavities, and spaces. (NCI)Body
BODY OF STOMACHC12258Body of StomachThe main section of the digestive tube that connects the esophagus to the small intestine. The body proper excludes the upper and lower sections of the fundus and pyloric portion respectively. (NCI)Body of Stomach
BONEC12366BoneCalcified connective tissue that forms the skeletal components of the body. (NCI)Bone
BONE MARROWC12431Bone MarrowThe tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. (NCI)Bone Marrow
BRACHIAL ARTERYC12681Brachial ArteryAn artery originating at the axillary artery and branching into the radial and ulnar arteries. (NCI)Brachial Artery
BRACHIAL LYMPH NODEC92221An axillary lymph node along the brachial vein. (NCI)Brachial Lymph Node
BRACHIAL PLEXUSC12682Brachial PlexusA nerve network originating from C5 to T1 that supplies cutaneous and muscular innervation to the arm and hand. (NCI)Brachial Plexus
BRAINC12439Brain;Nervous System, BrainAn organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium. (NCI)Brain
BRAIN STEMC12441Brain StemThe part of the brain that connects the cerebral hemispheres with the spinal cord. It consists of the mesencephalon, pons, and medulla oblongata. (NCI)Brain Stem
BRAIN VENTRICLEC12356Brain VentricleThe four connected cavities (hollow spaces) centrally located within the brain that connect posteriorly with the central canal of the spinal cord. (NCI)Brain Ventricle
BREASTC12971BreastOne of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest. (NCI)Breast
BRONCHUSC12683Bronchi;BronchusTubular structure in continuation with the trachea, serving as air passage. It terminates in the lung (terminal bronchiole). (NCI)Bronchus
BUTTOCKC89806ButtockEither of the fleshy mounds in the rear pelvic area of the human body formed by the gluteal muscles.Buttock
C1 VERTEBRAC32239C1 VertebraThe first of the seven cervical vertebrae. (NCI)C1 Vertebra
C2 VERTEBRAC32240C2 VertebraThe second of the seven cervical vertebrae. (NCI)C2 Vertebra
C3 VERTEBRAC32241C3 VertebraThe third of the seven cervical vertebrae. (NCI)C3 Vertebra
C4 VERTEBRAC32242C4 VertebraThe fourth of the seven cervical vertebrae. (NCI)C4 Vertebra
C5 VERTEBRAC32243C5 VertebraThe fifth of the seven cervical vertebrae. (NCI)C5 Vertebra
C6 VERTEBRAC32244C6 VertebraThe sixth of the seven cervical vertebrae. (NCI)C6 Vertebra
C7 VERTEBRAC32245C7 VertebraThe seventh of the seven cervical vertebrae. (NCI)C7 Vertebra
CALCARINE SULCUSC32252A cerebral fissure that originates near the occipital lobe and terminates below the corpus callosum. (NCI)Calcarine Sulcus
CALFC93027The posterior aspect of the lower extremity that extends from the knee to the foot. (NCI)Calf
CANINE TOOTHC32258Canine ToothA single-cusped (pointed) and usually single-rooted tooth located between the incisors and premolars. (NCI)Canine Tooth
CAPITATE BONEC12856Capitate BoneThe largest of eight carpal bones, located in the center of the hand. (NCI)Capitate Bone
CAROTID ARTERYC12687Carotid ArteryOne of two arteries that supply oxygenated blood to the head and neck; the left common carotid branches from the aorta and the right common carotid from the innominate (brachiocephalic artery). (NCI)Carotid Artery
CARPAL BONEC12688Any of the small bones of the wrist joint, located between the radius and the ulna and the metacarpus. (NCI)Carpal Bone
CARPOMETACARPAL JOINT 1C103912CMC1A saddle-shaped synovial joint between the metacarpal of the thumb and the trapezium. (NCI)Carpometacarpal Joint 1
CARPOMETACARPAL JOINT 2C103913CMC2A plane joint primarily between the second metacarpal and the trapezoid, which also connects with the trapezium and capitate. (NCI)Carpometacarpal Joint 2
CARPOMETACARPAL JOINT 3C103914CMC3A plane joint between the third metacarpal and the capitate. (NCI)Carpometacarpal Joint 3
CARPOMETACARPAL JOINT 4C103915CMC4A plane joint between the fourth metacarpal and the hamate. (NCI)Carpometacarpal Joint 4
CARPOMETACARPAL JOINT 5C103916CMC5A plane joint between the fifth metacarpal and the pisiform. (NCI)Carpometacarpal Joint 5
CAUDATE NUCLEUSC12451An elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. (MeSH)Caudate Nucleus
CECUMC12381Cecal;CecumA blind pouch-like commencement of the colon in the right lower quadrant of the abdomen at the end of the small intestine and the start of the large intestine. (OMD)Cecum
CELIAC LYMPH NODEC65166Celiac Axis Lymph Node;Celiac Lymph NodeA lymph node at the base of the celiac artery. (NCI)Celiac Lymph Node
CENTRAL NERVOUS SYSTEMC12438The part of the nervous system that consists of the brain, spinal cord, and meninges. (NCI)Central Nervous System
CEPHALIC VEINC32286Cephalic Vein;Vena CephalicaOne of five superficial veins of the upper extremity, beginning at the radial aspect of the wrist area, wrapping around the forearm and emptying into the axillary vein. (NCI)Cephalic Vein
CEREBELLUMC12445The portion of the brain located at the base of the skull that is responsible for balance, equilibrium and movement. (NCI)Cerebellum
CEREBRAL CORTEXC12443Cerebral CortexThe outer layer of the cerebrum composed of neurons and unmyelinated nerve fibers. It is responsible for memory, attention, consciousness and other higher levels of mental function.Cerebral Cortex
CEREBRAL HEMISPHERE, LEFTC32955The left half of the cerebrum.Left Cerebral Hemisphere
CEREBRAL HEMISPHERE, RIGHTC33472The right half of the cerebrum.Right Cerebral Hemisphere
CEREBRAL SUBCORTEXC98712Cerebral SubcortexThe layer located below the cerebral cortex that includes the forebrain, midbrain and hindbrain. (NCI)Cerebral Subcortex
CEREBRUMC12351Cerebral HemisphereOne half of the cerebrum, the part of the brain that controls muscle functions and also controls speech, thought, emotions, reading, writing, and learning. The right hemisphere controls the muscles on the left side of the body, and the left hemisphere controls the muscles on the right side of the body. (NCI)Cerebral Hemisphere
CERVICAL LYMPH NODEC32298Cervical Lymph NodeAny of the lymph nodes located in the neck. (NCI)Cervical Lymph Node
CERVICAL VERTEBRAC12693Cervical VertebraAny one of the seven vertebrae that start with C1, connecting the skull to the spine, and ends with C7, which joins the cervical with the thoracic spine. (NCI)Cervical Vertebra
CERVIX UTERIC12311Cervix Uteri;Uterine CervixThe lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions. (NCI)Cervix Uteri
CHEEKC13070The fleshy part of the face bounded by the eyes, nose, ear, and jaw line. (NCI)Cheek
CHESTC25389ChestThe anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction. (NCI)Chest
CHEST WALLC62484Chest WallThe total system of structures outside the lungs that move as a part of breathing; it includes all structures from the skin to the parietal pleura. (NCI)Chest Wall
CHOROID PLEXUSC12694Choroid PlexusBlood vessels forming villous structures in the third, fourth, and lateral ventricles of the brain. (NCI)Choroid Plexus
CINGULATE CORTEXC52713Part of the medial aspect of the cerebral cortex. (NCI)Cingulate Cortex
CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERYC102287CIRC AV;CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY SEGMENTThe segment of the left circumflex artery that is distal to the third marginal branch, located in the atrioventricular groove.Circumflex Artery AV Groove Continuation Artery
CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLETERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHESC102286The left circumflex coronary artery and all of its branches.Circumflex Artery and its Branches
CLAVICLEC12695ClavicleA bone linking the scapula and the sternum. The clavicle is part of the pectoral girdle.Clavicle
CLITORISC12308The erectile tissue in the vulva. It is composed of the corpora cavernosa and the glans clitoris.Clitoris
COCCYGEAL VERTEBRAC32334Coccygeal VertebraFour vertebral segments positioned at the base of the spine that are fused. (NCI)Coccygeal Vertebra
COCCYXC12696CoccyxA small bone located at the bottom of the spine. The coccyx is a result of 3-5 fused rudimentary vertebrae. (NCI)Coccyx
COLONC12382ColonThe part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion. (NCI)Colon
COLON, ASCENDINGC12265Ascending ColonThe first part of the colon (large intestine) that starts in the right lower quadrant of the abdomen and ends at the transverse colon in the right upper quadrant of the abdomen. (NCI)Ascending Colon
COLON, DESCENDINGC12268Descending ColonThe fourth portion of the large intestine (colon) that communicates with the transverse colon in the left-upper quadrant of the abdomen and the rectum below. (NCI)Descending Colon
COLON, LEFTC33929Left ColonThe portion of the large intestine that includes the descending and sigmoid colon. (NCI)Left Colon
COLON, RECTOSIGMOIDC103438A portion of the large intestine that includes the descending colon, sigmoid colon and rectum.Rectosigmoid Colon
COLON, RIGHTC12383Right ColonThe proximal segment of the large intestine that is located in the right side of the abdominal cavity. It includes the cecum (with the attached appendix) and the ascending colon. (NCI)Right Colon
COLON, SIGMOIDC12384Sigmoid ColonThe portion of the colon that connects to the descending colon above and the rectum below. (NCI)Sigmoid Colon
COLON, TRANSVERSEC12385Transverse ColonThe third division of the colon (large intestine). It communicates with the ascending colon in the upper right-hand quadrant of the abdomen and the descending colon in the upper left-hand quadrant. (NCI)Transverse Colon
COMMON FEMORAL ARTERYC32354An artery arising from the external iliac artery at the inguinal ligament which bifurcates forming the deep and superficial femoral arteries.Common Femoral Artery
COMMON ILIAC ARTERYC32357An artery arising from the bifurcation of the abdominal aorta which then bifurcates forming the internal and external iliac arteries.Common Iliac Artery
COMMON ILIAC LYMPH NODEC103384A lymph node located adjacent to the common iliac artery. (NCI)Common Iliac Lymph Node
CONJUNCTIVAC12341ConjunctivaA thin, transparent tissue divided into the palpebral conjunctiva (covering the inner side of the eye lid) and the bulbar conjunctiva (covering the eyeball). (NCI)Conjunctiva
CORNEAC12342CorneaA dome-shaped, transparent, avascular tissue covering the front of the eye. It is composed of five layers: squamous epithelium, Bowman's membrane, stroma, Descemet's membrane, and endothelium. Refraction of light contributing to eye's focusing ability is its characteristic function. It contains unmyelinated nerve endings which are responsible for the high sensitivity of the tissue. (NCI)Cornea
CORONARY ARTERYC12843Coronary ArteryA principal artery that originates in the aorta. It supplies blood to the muscular tissue of the heart. (NCI)Coronary Artery
CORONARY ARTERY, ANTERIOR DESCENDINGC32089Anterior Descending Coronary Artery;Left Anterior Descending Coronary ArteryA left coronary artery branch that descends on the anterior portion of the heart through the anterior interventricular groove. (NCI)Anterior Descending Coronary Artery
CORONARY ARTERY, LEFTC12872LM;Left Coronary Artery;Left Main Coronary Artery;Left Main Coronary Artery SegmentA coronary artery that arises from the aorta and bifurcates into the left anterior descending artery and the left circumflex artery. (NCI)Left Coronary Artery
CORONARY ARTERY, RIGHTC12875Right Coronary ArteryA coronary artery that originates above the right coronary cusp and supplies blood predominantly to the right side of the heart. (NCI)Right Coronary Artery
CORONARY SINUSC32378The coronary vein that terminates in the right atrium and transports deoxygenated blood from the coronary circulation.Coronary Sinus
CORONARY VEINC12882A blood vessel in the heart which returns coronary blood to the right atrium.Coronary Vein
CORPUS CALLOSUMC12446A white matter structure within the cleft that separates the left and right cerebral hemispheres in the mammalian brain. It is composed of a wide, flat bundle of 200-250 million axonal projections. (NCI)Corpus Callosum
CORPUS LUTEUMC26465Corpus LuteumA group of cells that remain of the Graafian follicle following ovulation. This structure is composed of endocrine tissue and produces progesterone. This is needed to prepare the uterine lining for implantation by the fertilized egg. (NCI)Corpus Luteum
CORPUS STRIATUMC12448The portion of the brain consisting of the neostriatum and globus pallidus.Corpus Striatum
COSTAL CARTILAGEC32391Costal CartilageThe cartilage positioned between the anterior end of the rib and the sternum. Its elasticity allows the ribcage to expand while breathing. (NCI)Costal Cartilage
COSTOCHONDRAL JOINT 1C102288The first hyaline cartilaginous joint between the ribs and costal cartilage.Costochondral Joint 1
COSTOCHONDRAL JOINT 7C102289The seventh hyaline cartilaginous joint between the ribs and costal cartilage.Costochondral Joint 7
CRANIAL NERVEC12700Any of the 12 paired nerves that originate in the brain stem. (NCI)Cranial Nerve
CUBOID BONEC32414Cuboid BoneA bone on the lateral side of the tarsus between the calcaneus and the fourth and fifth metatarsal bones. (NCI)Cuboid Bone
DIAPHRAGMC12702Fibromuscular tissue that separates the thoracic from the abdominal cavity. It increases the volume of the thoracic cavity through contractions, thus facilitating respiration.Diaphragm
DISTAL CIRCUMFLEX ARTERYC102290DCIRC;DISTAL CIRCUMFLEX ARTERY SEGMENTThe segment of the left circumflex artery that is between the second and third obtuse marginal branches.Distal Circumflex Artery
DISTAL INTERPHALANGEAL JOINT 2C102291DIP2A condyloid synovial joint within the second digit of the hand or foot connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 2
DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOTC114198DIP2 of the FootA ginglymoid (hinge) synovial joint within the second digit of the foot connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 2 of the Foot
DISTAL INTERPHALANGEAL JOINT 2 OF THE HANDC114188DIP2 of the HandA ginglymoid (hinge) synovial joint within the second digit of the hand connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 2 of the Hand
DISTAL INTERPHALANGEAL JOINT 3C102292DIP3A condyloid synovial joint within the third digit of the hand or foot connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 3
DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOTC114199DIP3 of the FootA ginglymoid (hinge) synovial joint within the third digit of the foot connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 3 of the Foot
DISTAL INTERPHALANGEAL JOINT 3 OF THE HANDC114189DIP3 of the HandA ginglymoid (hinge) synovial joint within the third digit of the hand connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 3 of the Hand
DISTAL INTERPHALANGEAL JOINT 4C102293DIP4A condyloid synovial joint within the fourth digit of the hand or foot connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 4
DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOTC114275DIP4 of the FootA ginglymoid (hinge) synovial joint within the fourth digit of the foot connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 4 of the Foot
DISTAL INTERPHALANGEAL JOINT 4 OF THE HANDC114273DIP4 of the HandA ginglymoid (hinge) synovial joint within the fourth digit of the hand connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 4 of the Hand
DISTAL INTERPHALANGEAL JOINT 5C102294DIP5A condyloid synovial joint within the fifth digit of the hand or foot connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 5
DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOTC114276DIP5 of the FootA ginglymoid (hinge) synovial joint within the fifth digit of the foot connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 5 of the Foot
DISTAL INTERPHALANGEAL JOINT 5 OF THE HANDC114274DIP5 of the HandA ginglymoid (hinge) synovial joint within the fifth digit of the hand connecting the middle and distal phalanges. (NCI)Distal Interphalangeal Joint 5 of the Hand
DISTAL LAD ARTERYC102295DISTAL LAD ARTERY SEGMENT;DLADThe segment of the left anterior descending (LAD) artery that is distal to the third diagonal branch.Distal Left Anterior Descending Artery
DISTAL RIGHT CORONARY ARTERY CONDUITC102296DISTAL RIGHT CORONARY ARTERY CONDUIT SEGMENT;DRCAThe section of the right coronary artery distal to the origin of the acute marginal artery.Distal Right Coronary Artery Conduit
DORSAL MOTOR NUCLEUSC12934A brain nucleus located in the medulla oblongata. (NCI)Dorsal Motor Nucleus
DORSALIS PEDIS ARTERYC32478Dorsalis Pedis ArteryAn artery of the dorsal surface of the foot, originating from the anterior tibial artery of the lower leg. The following arterial branches originate from the dorsalis pedis artery: the arcuate artery of the foot and deep plantar artery. (NCI)Dorsalis Pedis Artery
DUODENUMC12263A jointed tube 25-30 cm long that connects the stomach to the jejunum. (NCI)Duodenum
DURAL VENOUS SINUSC102627Venous channels within the dura mater of the brain which receives both blood from blood vessels within the brain as well as cerebrospinal fluid then drains into the internal jugular vein. Unlike other blood vessels, dural venous sinuses lack valves and other vessel associated layers.Dural Venous Sinus
EARC12394EarA sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance. (NCI)Ear
EAR, INNERC12499Cochlea;Internal Ear;LabyrinthThe portion of the ear located within the temporal bone that is involved in both hearing and balance and includes the semicircular canals, vestibule, and cochlea. (from American Heritage Dictionary online)Inner Ear
EAR, OUTERC12292Auricle;External EarThe external part of the ear. (NCI)External Ear
ELBOW JOINTC32497Elbow JointA joint involving the humerus, radius and ulna bones.Elbow Joint
ENDOCARDIUMC13004The layer of endothelial cells and connective tissue lining the chambers of the heart. (NCI)Endocardium
ENDOCERVIXC12309The portion of the cervix which is lined by single columnar epithelium (mucosa). (NCI)Endocervix
ENDOMETRIAL CAVITYC32514Endometrial CavityA space inside the uterus lined by a layer of mucus membranes called the endometrium. (NCI)Endometrial Cavity
ENTORHINAL CORTEXC97338A brain region in the medial temporal lobe near the hippocampus. (NCI)Entorhinal Cortex
EPICARDIUMC13164The outer membranous connective tissue layer of the heart tissue. (NCI)Epicardium
EPICONDYLEC69300EpicondyleA bone prominence to which ligaments and tendons of the joints are attached. (NCI)Epicondyle
EPIDIDYMISC12328A crescent-like structure located in the upper and posterior surfaces of the testis. It consists of the efferent ductules and the duct of the epididymis. It facilitates the maturation of sperm that is produced in the testis. (NCI)Epididymis
EPIGLOTTISC12709EpiglottisA small cartilagenous flap-like valve that closes over the larynx during swallowing to prevent food entering the lungs. (NCI)Epiglottis
EPITROCHLEAR LYMPH NODEC98182A lymph node located above and adjacent to the elbow. (NCI)Epitrochlear Lymph Node
ESOPHAGUSC12389EsophagusThe portion of the digestive canal between the pharynx and stomach. It consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach.Esophagus
ESOPHAGUS, ABDOMINALC12252Abdominal EsophagusClinical esophageal segment composed of smooth muscle. It corresponds to the inferior part of the lower third topographic segment of the esophagus. (NCI)Abdominal Esophagus
ESOPHAGUS, CERVICALC12250Cervical EsophagusClinical esophageal segment composed of skeletal muscle. It corresponds to the superior part of the upper third topographic segment of the esophagus. (NCI)Cervical Esophagus
ESOPHAGUS, LOWER THIRDC12255Lower Third of the EsophagusThe lower one third of the esophagus in which the muscle layer is composed of muscle cells predominantly of the smooth type. (NCI)Lower Third of the Esophagus
ESOPHAGUS, MIDDLE THIRDC12254Middle Third of the EsophagusThe middle one third of the esophagus in which the muscle layer is composed of muscle cells of the striated and smooth types.Middle Third of the Esophagus
ESOPHAGUS, THORACICC12251Thoracic EsophagusClinical esophageal segment composed of smooth muscle. It includes the middle third topographic segment, as well as parts of the upper and lower thirds. (NCI)Thoracic Esophagus
ESOPHAGUS, UPPER THIRDC12253Upper Third of the EsophagusThe upper one third of esophagus in which the muscle layer is composed of muscle cells of the striated type. (NCI)Upper Third of the Esophagus
ETHMOID BONEC12711Ethmoid BoneA light and spongy bone that is cubical in shape. This bone is positioned at the anterior part of the cranium, sitting between the two orbits, at the roof of the nose. It consists of four parts: a horizontal or cribriform plate; a perpendicular plate; and two lateral masses or labyrinths. (NCI)Ethmoid Bone
ETHMOID SINUSC12276Ethmoid SinusA sinus of the meatuses of the nasal cavity. (NCI)Ethmoid Sinus
EXTERNAL ILIAC ARTERYC32558An artery arising from the bifurcation of the common iliac artery in the lower torso. The external iliac artery becomes the femoral artery and is the main blood supply for the leg.External Iliac Artery
EXTERNAL ILIAC LYMPH NODEC88143A lymph node located along the external iliac artery. (NCI)External Iliac Lymph Node
EXTRAHEPATIC BILE DUCTC32573The portion of the biliary tract outside the liver; the common hepatic duct joins the cystic duct to form the common bile duct. (NCI)Extrahepatic Bile Duct
EYEC12401Eye;EyeballThe organ of sight or vision. (NCI)Eye
EYE, ANTERIOR CHAMBERC12667The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (Cline et al., Dictionary of Visual Science, 4th ed, p109) (NCI)Anterior Chamber of the Eye
EYE, VITREOUS CHAMBERC33885Postremal ChamberThe largest space within the eye which is bounded by the lens and the retina and filled with the gelatinous vitreous humor. (NCI)Vitreous Chamber
EYELASHC32576Anyone of the short hairs that grow on the edge of the eyelid. (NCI)Eyelash
EYELIDC12713Eyelid;PalpebraA thin membrane of skin with the purpose of covering and protecting an eye. (NCI)Eyelid
FACEC13071Face;FacialThe anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws. (NCI)Face
FACET JOINTC32577Facet JointA synovial joint between two adjacent vertebrae. The facet joint links the articular process of one vertebra and the inferior articular process of the adjacent vertebra. (NCI)Facet Joint
FACIAL BONEC63706Facial BoneAny bone that contributes to the facial structures, except those bones that are part of the braincase. (NCI)Facial Bone
FACIAL NERVEC12714Seventh Cranial NerveThe 7th cranial nerve. The facial nerve has two parts, the larger motor root which may be called the facial nerve proper, and the smaller intermediate or sensory root. Together they provide efferent innervation to the muscles of facial expression and to the lacrimal and salivary glands, and convey afferent information for taste from the anterior two-thirds of the tongue and for touch from the external ear. (MeSH)Facial Nerve
FALLOPIAN TUBEC12403Fallopian TubeOne of a pair of tubes that extend from the uterus to each of the ovaries. Following ovulation the egg travels down the fallopian tube to the uterus where fertilization may or may not occur. (NCI)Fallopian Tube
FASCIAC13108A sheet or band of fibrous connective tissue enveloping, separating, or binding together muscles, organs and other soft structures of the body.Fascia
FEMALE GENITALIAC61600Female GenitaliaFemale internal and external organs of reproduction.Female Genitalia
FEMALE REPRODUCTIVE SYSTEMC12402The sex organs of the female.Female Reproductive System
FEMORAL ARTERYC12715Femoral ArteryAn artery that starts within the inguinal region and extends to the lower extremities. (NCI)Femoral Artery
FEMORAL CONDYLEC114186The rounded bony projection at the distal end of the femur.Femoral Condyle
FEMORAL HEADC32718Femur HeadThe highest portion of the femoral bone that articulates with the acetabulum. (NCI)Head of the Femur
FEMORAL LYMPH NODEC98183A lymph node located in the upper inner portion of the thigh. (NCI)Femoral Lymph Node
FEMORAL NECKC61563Femoral NeckThe short, constricted portion of the thigh bone between the femur head and the trochanter. (NCI)Femoral Neck
FEMORAL VEINC12716Femoral VeinA vein that starts within the inguinal region and extends to the lower extremities. (NCI)Femoral Vein
FEMORO-POPLITEAL PERIPHERAL ARTERYC116167The segment of the blood vessels that includes the popliteal artery and its origin from the femoral artery.Femoropopliteal Artery Segment
FEMURC12717Bone, Femoral;FemurThe upper leg bone positioned between the pelvis and the knee. (NCI)Femur
FEMUR SHAFTC96209The cylindrical body of the femur. (NCI)Femoral Shaft
FIBULAC12718FibulaThe small, lateral calf bone extending from the knee to the ankle. (NCI)Fibula
FINGERC32608FingerAny of the digits of the hand. (NCI)Finger
FINGERNAILC32609FingernailThe nail at the end of a finger. (NCI)Fingernail
FIRST DIAGONAL BRANCH ARTERYC1022971ST DIAG;FIRST DIAGONAL BRANCH ARTERY SEGMENTThe first artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal.First Diagonal Branch Artery
FIRST LEFT POSTEROLATERAL BRANCH ARTERYC1022981ST LPL;FIRST LEFT POSTEROLATERAL BRANCH ARTERY SEGMENTIn an individual with a left-dominant heart, this is the first branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall.First Left Posterolateral Branch Artery
FIRST OBTUSE MARGINAL BRANCH ARTERYC1022991ST OM;FIRST OBTUSE MARGINAL BRANCH ARTERY SEGMENTThe first artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal.First Obtuse Marginal Branch Artery
FIRST RIGHT POSTEROLATERAL ARTERYC1023001ST RPL;FIRST RIGHT POSTEROLATERAL ARTERY SEGMENTIn an individual with a right-dominant heart, this is the first branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal.First Right Posterolateral Artery
FLOOR OF MOUTHC54187The area of the mouth under the ventral surface of the tongue.Floor of Mouth
FOOTC32622Feet;FootThe structure found below the ankle joint required for locomotion. (NCI)Foot
FOOT DIGIT 1C52839Big ToeThe largest and most medial toe of the foot. (NCI)Foot Digit 1
FOOT DIGIT 2C52840Index ToeThe second toe from the medial side of the foot. (NCI)Foot Digit 2
FOOT DIGIT 3C52841Middle ToeThe middle or third toe from the medial side of the foot. (NCI)Foot Digit 3
FOOT DIGIT 4C52842Fourth ToeThe fourth toe from the medial side of the foot. (NCI)Foot Digit 4
FOOT DIGIT 5C52843Little ToeThe smallest and most lateral toe of the foot. (NCI)Foot Digit 5
FOOT PHALANXC52772Foot PhalanxA bone of the foot. (NCI)Foot Phalanx
FOREARMC32628ForearmThe structure on the upper limb, between the elbow and the wrist. (NCI)Forearm
FOREBRAINC40185The largest part of the brain composed of the cerebral hemispheres, thalamus, hypothalamus, and the limbic system. (NCI)Forebrain
FOREHEADC89803ForeheadThe part of the face between the eyebrows and the normal hairline.Forehead
FRONTAL LOBEC12352Frontal LobeThe part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. (NCI)Frontal Lobe
FRONTAL SINUSC12277Frontal SinusThe paired, mucosal lined air spaces located above the orbit and communicating with the nasal passages. (NCI)Frontal Sinus
FUNDUS OF THE STOMACHC12257Fundus of the StomachThe portion of the stomach that lies above the cardiac notch. It allows for the accumulation of gases produced by chemical digestion. (NCI)Fundus of the Stomach
GALLBLADDERC12377GallbladderA pear-shaped organ located under the liver that stores and concentrates bile secreted by the liver. From the gallbladder the bile is delivered through the bile ducts into the intestine thereby aiding the digestion of fat-containing foods. (NCI)Gallbladder
GANGLIONC12719Ganglia;Ganglion;Neural GanglionA cluster of nervous tissue principally composed of neuronal cell bodies external to the central nervous system (CNS). (NCI)Ganglion
GASTRIC CARDIAC12256Gastric CardiaThe area around the esophagogastric mucosal junction where the esophageal mucosa transitions into the gastric mucosa. (NCI)Gastric Cardia
GASTROESOPHAGEAL JUNCTIONC32668Gastroesophageal JunctionThe anatomical location where the esophagus joins to the stomach. (NCI)Gastroesophageal Junction
GASTROINTESTINAL SYSTEMC12378Gastrointestinal SystemThe system that includes the esophagus, stomach, small and large intestine, anus, liver, biliary tract, and pancreas. (NCI)Gastrointestinal System
GASTROINTESTINAL TRACTC34082Gastrointestinal TractThe upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff. (NCI)Gastrointestinal Tract
GASTROINTESTINAL TRACT, LOWERC33010Lower Gastrointestinal TractThe lower part of the gastrointestinal tract that includes the jejunum and ileum of the small intestine and the large intestine. (NCI)Lower Gastrointestinal Tract
GASTROINTESTINAL TRACT, UPPERC33837Upper Gastrointestinal TractThe upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum. (NCI)Upper Gastrointestinal Tract
GENITALIAC25177The external sex organs. (NCI)Genitalia
GINGIVAC32677Gingiva;GumThe soft tissue surrounding the neck of individual teeth as well as covering the alveolar bone. The tissue is fibrous and continuous with the periodontal ligament and mucosal covering. (NCI)Gingiva
GLENOID FOSSAC32682Glenoid FossaThe trough in the head of the scapula that receives the head of the humerus to form the shoulder joint. (NCI)Glenoid Fossa
GLOSSOPHARYNGEAL NERVEC12723The ninth cranial nerve.Glossopharyngeal Nerve
GLOTTISC12724GlottisThe space in which the vocal cords are located. (NCI)Glottis
GLUTEUS MAXIMUSC52560The outermost and largest muscle of the buttocks. (NCI)Gluteus Maximus
GREAT TROCHANTERC32698Great TrochanterA large, irregular, quadrilateral area of bone found at the neck of the femur. (NCI)Great Trochanter
GREATER CURVATURE OF THE STOMACHC12262Greater Curvature of the StomachThe lateral and inferior border of the stomach. Attached to it is the greater omentum. (NCI)Greater Curvature of the Stomach
HAIRC32705HairThe filamentous outgrowth of the epidermis. (NCI)Hair
HAIR BULBC32706The lower segment of the hair that circles the dermal papilla and the hair matrix. (NCI)Hair Bulb
HAIR FOLLICLEC13317A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (NCI)Hair Follicle
HAIR ROOTC32711The portion of the hair that is enclosed within the hair follicle. (NCI)Hair Root
HAIR SHAFTC33543Shaft of the HairThe segment of the hair that projects above the skin surface. (NCI)Shaft of the Hair
HAMATE BONEC12860Hamate BoneThe medial bone in the distal row of carpal bones. (NCI)Hamate Bone
HANDC32712HandThe distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits. (NCI)Hand
HAND DIGIT 1C52834ThumbThe thick and short hand digit which is next to the index finger in humans. (NCI)Hand Digit 1
HAND DIGIT 2C52835Index FingerThe second finger from the radial side of the hand, next to the thumb. (NCI)Hand Digit 2
HAND DIGIT 3C52836Middle FingerThe middle or third finger from the radial side of the hand. (NCI)Hand Digit 3
HAND DIGIT 4C52837Ring FingerThe fourth finger from the radial side of the hand. (NCI)Hand Digit 4
HAND DIGIT 5C52838Little FingerThe fifth and smallest finger from the radial side of the hand. (NCI)Hand Digit 5
HAND PHALANXC52771Hand PhalanxA bone of the hand. (NCI)Hand Phalanx
HARD PALATEC12230Hard PalateThe bony anterior part of the roof of the mouth separating the nose from the mouth. (NCI)Hard Palate
HEADC12419HeadThe anterior and superior part of a human or animal bearing the mouth, the brain and sensory organs.Head
HEAD AND NECKC12418The area of the body comprising the skull, facial bones and the cervical vertebrae, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature, soft tissue and lymph nodes draining these areas.Head and Neck
HEAD OF THE HUMERUSC32720Head of the HumerusThe upper rounded part of the humerus that fits into the glenoid cavity of the scapula. (NCI)Head of the Humerus
HEARTC12727Cardiac;HeartA hollow muscular organ which receives the blood from the veins and propels it into the arteries. It is divided by a musculomembranous septum into two halves -- right or venous and left or arterial -- each of which consists of a receiving chamber (atrium) and an ejecting chamber (ventricle). (NCI)Heart
HEART, APEXC32126Apex of the HeartThe most outer superficial part of the heart which is situated on the left 5th intercostal space. (NCI)Apex of the Heart
HEART, ATRIUMC12728Cardiac AtriumThe paired upper chambers of the heart. The left atrium receives oxygenated blood from the pulmonary vein and pumps blood into the left ventricle. The right atrium receives venous deoxygenated blood from the entire body via the superior and inferior vena cavae and pumps blood into the right ventricle. (NCI)Cardiac Atrium
HEART, BASEC48589Base of the HeartThe superior portion of the heart located opposite to the apical portion. It is formed mainly by the left atrium. (NCI)Base of the Heart
HEART, LEFT VENTRICLEC12871Left VentricleThe left lower chamber of the heart that receives blood from the left atrium and pumps it through the aorta to the body. (NCI)Left Ventricle
HEART, RIGHT VENTRICLEC12870Right VentricleThe lower chamber of the heart located in the right side. It receives blood from the right atrium that is no longer oxygenated and it pumps it to the pulmonary artery. (NCI)Right Ventricle
HEART, SEPTUMC49485Cardiac SeptumThe tissue in the heart that separates the two atria (atrial septum) and the two ventricles (ventricular septum). (NCI)Heart Septum
HEART, VENTRICLEC12730Cardiac VentricleThe lower right and left chambers of the heart. The right pumps venous blood into the lungs and the left pumps oxygenated blood into the systemic arterial circulation. (MeSH)Cardiac Ventricle
HEART, VENTRICULAR WALLC119295The tissue layers that form the cardiac ventricle. They include myocardium, endocardium, and pericardium. (NCI)Ventricular Wall of the Heart
HEPATIC LYMPH NODEC77640Any of the lymph nodes adjacent to the stomach and duodenum. (NCI)Hepatic Lymph Node
HILARC25724HilarRefers to the area associated with the hilum. (NCI)Hilar
HILAR LYMPH NODEC98187A lymph node located in the hilum of the lung within the mediastinum.Pulmonary Hilar Lymph Node
HIPC64193HipThe lateral prominence of the pelvis from the waist to the thigh. (NCI)Hip
HIP JOINTC32742Coxofemoral Joint;Hip JointA ball-and-socket joint between the head of the femur and the acetabulum. (NCI)Hip Joint
HIPPOCAMPUSC12444HippocampusA curved gray matter structure of the temporal lobe lying on the floor of the lateral ventricle of the brain. (NCI)Hippocampus
HUMERAL EPICONDYLEC114187The bone prominence at the distal end of the humerus to which ligaments and tendons of the joints are attached.Humeral Epicondyle
HUMERUSC12731Bone, Humeral;HumerusThe upper arm bone between the shoulder and elbow. (NCI)Humerus
HYOID BONEC32752Hyoid BoneA U-shaped bone supporting the tongue. This bone is located at the base of the tongue and is suspended from the tips of the styloid processes of the temporal bones by the stylohyoid ligaments. (NCI)Hyoid Bone
HYPOGLOSSAL NERVEC12732The twelfth cranial nerve.Hypoglossal Nerve
HYPOPHARYNXC12246HypopharynxThe lower part of the pharynx that connects to the esophagus. (NCI)Hypopharynx
HYPOTHALAMUSC12458HypothalamusThe supervisory center in the brain, rich in ganglia, nerve fibers, and synaptic connections. It is composed of several sections called nuclei, each of which controls a specific function.Hypothalamus
ILEUMC12387IleumThe final section of the small intestine. (NCI)Ileum
ILEUM, TERMINALC33757Terminal IleumThe most distal section of the ileum that is continuous with the cecum. (NCI)Terminal Ileum
ILIAC CRESTC103818A predominate bone structure which borders the ilium wing stretching from the anterior superior iliac spine to the posterior superior iliac spine.Iliac Crest
ILIAC FOSSAC103454The large smooth and concave surface of the ilium. (NCI)Iliac Fossa
ILIAC LYMPH NODEC32761Iliac Lymph NodeOne of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral. (NCI)Iliac Lymph Node
ILIUMC32765IliumThe broad, dorsal, upper, and widest of the three principal bones composing either half of the pelvis. (NCI)Ilium
INCISORC32769IncisorOne of the teeth in front of the canines in either jaw designed for cutting or gnawing. (NCI)Incisor
INCUSC32770IncusOne of the three bones comprising the middle ear. This anvil-shaped bone is positioned between the malleus and the stapes. (NCI)Incus
INFRACLAVICULAR LYMPH NODEC63705Infraclavicular Lymph NodeA lymph node located in the area below the clavicle. (NCI)Infraclavicular Lymph Node
INFRARENAL AORTAC116179The portion of the abdominal aorta that lies below the kidneys.Infrarenal Aortic Segment
INFRATENTORIAL BRAINC12509The part of the brain below the tentorium cerebellum. (NCI)Infratentorial Brain
INGUINAL LYMPH NODEC32801Inguinal Lymph NodeA superficial or deep lymph node located in the inguinal area. (NCI)Inguinal Lymph Node
INGUINAL REGIONC12726GroinThe lower region of the anterior abdominal wall located laterally to the pubic region. (NCI)Inguinal Region
INTERNAL ILIAC ARTERYC32845A short thick blood vessel arising from the bifurcation of the common iliac artery with numerous branches that supply the organs, walls and viscera of the pelvis as well as the inner thigh.Internal Iliac Artery
INTERNAL ILIAC LYMPH NODEC88142A lymph node located along the internal iliac artery. (NCI)Internal Iliac Lymph Node
INTERNAL MAMMARY ARTERYC52941The blood vessel that supplies the breast and the anterior chest wall with arterial blood. It is located in the chest wall. (NCI)Internal Mammary Artery
INTERNAL MAMMARY LYMPH NODEC32853Any of the lymph nodes of the breast located under the ribcage, near the sternum. (NCI)Internal Mammary Lymph Node
INTERPHALANGEAL JOINT 1C102301IP1A ginglymoid (hinge) synovial joint within the first digit of the hand or foot connecting the proximal and distal phalanges. (NCI)Interphalangeal Joint 1
INTERPHALANGEAL JOINT 1 OF THE FOOTC114200IP1 of the FootA ginglymoid (hinge) synovial joint within the first digit of the foot connecting the proximal and distal phalanges. (NCI)Interphalangeal Joint 1 of the Foot
INTERPHALANGEAL JOINT 2C102302IP2A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the hand or foot. (NCI)Interphalangeal Joint 2
INTERPHALANGEAL JOINT 2 OF THE FOOTC114201IP2 of the FootA ginglymoid (hinge) synovial joint between the phalanges of the second digit of the foot. (NCI)Interphalangeal Joint 2 of the Foot
INTERPHALANGEAL JOINT 2 OF THE HANDC114190IP2 of the HandA ginglymoid (hinge) synovial joint between the phalanges of the second digit of the hand. (NCI)Interphalangeal Joint 2 of the Hand
INTERPHALANGEAL JOINT 3C102303IP3A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the hand or foot. (NCI)Interphalangeal Joint 3
INTERPHALANGEAL JOINT 3 OF THE FOOTC114202IP3 of the FootA ginglymoid (hinge) synovial joint between the phalanges of the third digit of the foot. (NCI)Interphalangeal Joint 3 of the Foot
INTERPHALANGEAL JOINT 3 OF THE HANDC114191IP3 of the HandA ginglymoid (hinge) synovial joint between the phalanges of the third digit of the hand. (NCI)Interphalangeal Joint 3 of the Hand
INTERPHALANGEAL JOINT 4C102304IP4A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the hand or foot. (NCI)Interphalangeal Joint 4
INTERPHALANGEAL JOINT 4 OF THE FOOTC114203IP4 of the FootA ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the foot. (NCI)Interphalangeal Joint 4 of the Foot
INTERPHALANGEAL JOINT 4 OF THE HANDC114192IP4 of the HandA ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the hand. (NCI)Interphalangeal Joint 4 of the Hand
INTERPHALANGEAL JOINT 5C102305IP5A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the hand or foot. (NCI)Interphalangeal Joint 5
INTERPHALANGEAL JOINT 5 OF THE FOOTC114204IP5 of the FootA ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the foot. (NCI)Interphalangeal Joint 5 of the Foot
INTERPHALANGEAL JOINT 5 OF THE HANDC114193IP5 of the HandA ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the hand. (NCI)Interphalangeal Joint 5 of the Hand
INTERPHALANGEAL JOINT OF THE HANDC32868Interphalangeal Joint of the HandThe hinge synovial joints between the phalanges of the fingers. (NCI)Interphalangeal Joint of the Hand
INTERPHALANGEAL OF THE FOOTC32867IP of the FootThe hinge synovial joints between the bones of the toes. (NCI)Interphalangeal Joint of the Foot
INTERPHALANGEAL THUMB JOINTC102306IP THUMB;IP1 of the Hand;Interphalangeal Joint 1 of the HandA condyloid synovial joint within the thumb connecting the proximal and distal phalanges.Interphalangeal Thumb Joint
INTERVENTRICULAR SEPTUMC32874The wall that separates the left and right ventricles of the heart. (NCI)Interventricular Septum
INTESTINEC12736IntestineThe portion of the gastrointestinal tract between the stomach and the anus. It includes the small intestine and large intestine. (NCI)Intestine
INTRAHEPATIC BILE DUCTC12677The bile ducts that pass through and drain bile from the liver. (NCI)Intrahepatic Bile Duct
INTRATHORACIC LYMPH NODEC12359Any lymph node within the thoracic cavity.Intrathoracic Lymph Node
ISCHIAL TUBEROSITYC105446The bony prominence of the lower part of the ischium. (NCI)Ischial Tuberosity
ISCHIORECTAL FOSSAC103455A tetrahedral region of adipose tissue located in the ischiorectal region with its base between the tuberosity of the ischium and the lower end of the rectum and its apex at the point where the obturator fascia and the Levator ani membrane divide.Ischiorectal Fossa
ISCHIUMC32884IschiumThe most posterior and ventral bone making up the pelvis. (NCI)Ischium
JEJUNUMC12388JejunumThe portion of the small intestine that extends from the duodenum to the ileum. (NCI)Jejunum
JOINTC13044Articulation;JointThe connection point between two bones or skeletal elements. The joint may be fixed or movable. (NCI)Joint
JUGULAR VEINC12738Vena JugularisVeins in the neck which drain the brain, face, and neck into the brachiocephalic or subclavian veins. (NCI)Jugular Vein
KIDNEYC12415KidneyOne of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blood, thus maintaining the homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat. (NCI)Kidney
KIDNEY, CORTEXC12739Renal CortexThe outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL. (MSH2001)Renal Cortex
KIDNEY, HILUMC32740Hilar Area of the KidneyThe concave area of the kidney through which the renal artery enters and the renal vein and ureter exit the organ. (NCI)Hilar Area of the Kidney
KIDNEY, LOWER LOBEC93180Lower Lobe of the KidneyThe lobe of the kidney located in the lowest portion of the kidney. (NCI)Lower Lobe of Kidney
KIDNEY, MEDULLAC12740Renal MedullaThe internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces. (MSH2001)Renal Medulla
KIDNEY, UPPER LOBEC93179Upper Lobe of the KidneyThe lobe of the kidney located in the uppermost region of the kidney. (NCI)Upper Lobe of Kidney
KNEE JOINTC32898Knee Joint;Tibiofemoral JointA joint connecting the lower part of the femur with the upper part of the tibia. The lower part of the femur and the upper part of the tibia are attached to each other by ligaments. Other structures of the knee joint include the upper part of the fibula, located below and parallel to the tibia, and the patella which moves as the knee bends. (NCI)Knee Joint
L1 VERTEBRAC32899L1 VertebraThe first lumbar vertebra counting from the top down. (NCI)L1 Vertebra
L2 VERTEBRAC32900L2 VertebraThe second lumbar vertebra counting from the top down. (NCI)L2 Vertebra
L2-L3 INTERVERTEBRAL SPACEC112327The space between the L2 and L3 vertebrae.L2-L3 Intervertebral Space
L3 VERTEBRAC32901L3 VertebraThe third lumbar vertebra counting from the top down. (NCI)L3 Vertebra
L3-L4 INTERVERTEBRAL SPACEC112328The space between the L3 and L4 vertebrae.L3-L4 Intervertebral Space
L4 VERTEBRAC32902L4 VertebraThe fourth lumbar vertebra counting from the top down. (NCI)L4 Vertebra
L5 VERTEBRAC32903L5 VertebraThe fifth lumbar vertebra counting from the top down. (NCI)L5 Vertebra
LACRIMAL BONEC32906Lacrimal BoneA small rectangular thin plate forming part of the medial orbit wall. It is located posterior to the frontal process of the maxilla and articulates with the inferior nasal concha, ethmoid, frontal, and maxillary bones. (NCI)Lacrimal Bone
LACRIMAL GLANDC12346Paired, almond-shaped exocrine glands situated superior and posterior to each orbit of the eye that produce and secrete the watery serous component of tears. (NCI)Lacrimal Gland
LAD SEPTAL PERFORATOR ARTERYC102313LAD SEPTAL PERFORATOR ARTERY SEGMENTS;LAD SPThe arteries that arise from the left anterior descending (LAD) artery that supply the interventricular septum.Left Anterior Descending Septal Perforator Artery
LARGE INTESTINEC12379Large IntestineA muscular tube that extends from the end of the small intestine to the anus. (NCI)Large Intestine
LARYNXC12420LarynxThe cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production. (NCI)Larynx
LATERAL FIRST DIAGONAL BRANCH ARTERYC102307LAT 1ST DIAG;LATERAL FIRST DIAGONAL BRANCH ARTERY SEGMENTThe lateral branch distal to a bifurcation of the first diagonal artery.Lateral First Diagonal Branch Artery
LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERYC102308First Obtuse Marginal Lateral Branch;LAT 1ST OM;LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY SEGMENTThe lateral branch distal to a bifurcation of the first obtuse marginal artery.Lateral First Obtuse Marginal Branch Artery
LATERAL RAMUS INTERMEDIUS ARTERYC102309LAT RAMUS;LATERAL RAMUS INTERMEDIUS ARTERY SEGMENTThe lateral branch distal to a bifurcation of the ramus intermedius artery.Lateral Ramus Intermedius Artery
LATERAL SECOND DIAGONAL BRANCH ARTERYC102310LAT 2ND DIAG;LATERAL SECOND DIAGONAL BRANCH ARTERY SEGMENTThe lateral branch distal to a bifurcation of the second diagonal artery.Lateral Second Diagonal Branch Artery
LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERYC102311LAT 2ND OM;LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY SEGMENT;Second Obtuse Marginal Lateral BranchThe lateral branch distal to a bifurcation of the second obtuse marginal artery.Lateral Second Obtuse Marginal Branch Artery
LATERAL THIRD DIAGONAL BRANCH ARTERYC102312LAT 3RD DIAG;LATERAL THIRD DIAGONAL BRANCH ARTERY SEGMENTThe lateral branch distal to a bifurcation of the third diagonal artery.Lateral Third Diagonal Branch Artery
LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERYC102425LAT 3RD OM;LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY SEGMENT;Third Obtuse Marginal Lateral BranchThe lateral branch distal to a bifurcation of the third obtuse marginal artery.Lateral Third Obtuse Marginal Branch Artery
LEFT ANTERIOR DESCENDING ARTERY OSTIUMC116175The opening of the left anterior descending coronary artery at its origin.Left Anterior Descending Artery Ostium
LEFT ATRIOVENTRICULAR ARTERYC116177The first posterolateral branch originating from the posterior atrioventricular left circumflex artery in left dominant and mixed circulations.Left Atrioventricular Artery
LEFT CIRCUMFLEX ARTERY OSTIUMC116176The opening of the left circumflex artery at its origin.Left Circumflex Artery Ostium
LEFT CIRCUMFLEX CORONARY ARTERYC12874An artery arising from the bifurcation of the left coronary artery that runs along the coronary groove.Circumflex Branch of the Left Coronary Artery
LEFT MAIN CORONARY ARTERY BIFURCATIONC116174The portion of the distal end of the left main coronary artery that branches into the left anterior descending artery and the left circumflex artery.Left Main Coronary Artery Bifurcation
LEFT MAIN CORONARY ARTERY BODYC116173The segment of the left main coronary artery that is bounded by its ostium and bifurcation.Left Main Coronary Artery Body
LEFT MAIN CORONARY ARTERY OSTIUMC116172The opening of the left coronary artery at its origin.Left Main Coronary Artery Ostium
LEFT POSTERIOR DESCENDING ARTERYC116178The second posterolateral branch originating from the posterior atrioventricular left circumflex artery in left dominant and mixed circulations.Left Posterior Descending Artery
LEFT POSTEROLATERAL DESCENDING ARTERYC102314LEFT POSTEROLATERAL DESCENDING ARTERY SEGMENT;LPDAIn an individual with a left-dominant heart, this branch arises from the circumflex artery atrioventricular groove continuation and supplies the inferior apex of the heart.Left Posterolateral Descending Artery
LEFT VENTRICULAR EPICARDIUMC102315The outermost layer of cardiac tissue lining of the left ventricle.Left Ventricular Epicardium
LEGC32974LegOne of the two lower extremities in humans used for locomotion and support. (NCI)Leg
LEG SKINC52749Leg SkinThe skin or integument surrounding the leg. (NCI)Leg Skin
LENSC12743Crystalline Lens;Lens;Lens Of Eye;Ocular LensA biconvex transparent structure of the eye through which light is focused on the retina. The lens sits behind the iris and is supported by the zonule, which connects it to the ciliary body. The lens is an avascular structure. (NCI)Lens
LESSER TROCHANTERC32982A cone-shaped projection in the shaft of the femur in which the iliopsoas muscle is attached. (NCI)Lesser Trochanter
LIGAMENTC13046LigamentBand of fibrous tissue connecting bone to bone or cartilage to bone thereby supporting or strengthening a joint. (NCI)Ligament
LIMBC12429Extremities;LimbA body region referring to an upper or lower extremity. (NCI)Limb
LIMB, LOWERC12742Lower ExtremityThe limb that is composed of the hip, thigh, leg and foot. (NCI)Lower Extremity
LIMB, UPPERC12671Upper ExtremityThe region of the body that includes the arm, the forearm, and hand. (NCI)Upper Extremity
LINGULA OF THE LUNGC40373A small tongue-like projection from the lower portion of the upper lobe of the left lung.Lingula of the Lung
LIPC12220LipFleshy fold which surrounds the opening of the mouth. (NCI)Lip
LIP, LOWERC12222External Lower LipThe external surface of the lower lip. (NCI)External Lower Lip
LIP, UPPERC12221External Upper LipThe external surface of the upper lip. (NCI)External Upper Lip
LIVERC12392LiverA triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate. (NCI)Liver
LIVER FISSUREC32996Liver FissureA groove on the surface of the liver.Liver Fissure
LIVER, CAUDATE LOBEC33000The lobe of the liver situated posteriorly located between the left lobe and the inferior vena cava.Caudate Lobe
LIVER, LEFT LOBEC32965The smaller lobe of the liver extending into the left side of the body.Left Lobe of the Liver
LIVER, QUADRATE LOBEC112404An oblong shaped area of the liver that is situated inferior to the right lobe, bounded by the anterior margin of the liver and the porta hepatis.Quadrate Lobe of Liver
LIVER, RIGHT LOBEC33481The larger lobe of the liver extending into the right side of the body.Right Lobe of the Liver
LOCUS CERULEUSC97333A brainstem nucleus. It is the major brain site for the synthesis and secretion of norepinephrine. (NCI)Locus Coeruleus
LUMBAR REGIONC34004The area of the body below the ribs and above the hipbones. (NCI)Lumbar Region
LUMBAR SPINEC69314The vertebrae located below the thoracic and above the sacral vertebrae.Lumbar Spine
LUMBAR VERTEBRAC12744Lumbar VertebraAny of the vertebrae situated between the thoracic vertebrae and the sacrum in the lower part of the spine.Lumbar Vertebra
LUNATE BONEC12786Lunate BoneThe bone in the proximal row of carpal bones that lies between the scaphoid and triquetral bones. (NCI)Lunate Bone
LUNGC12468LungOne of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. (NCI)Lung
LUNG, HILUMC49282Hilar Area of the LungThe wedge-shaped area at the central portion of the lung through which the bronchi, vessels and nerves enter or exit the organ. (NCI)Hilar Area of the Lung
LUNG, LEFTC32967Left LungThe 2-lobed lung located on the left side of the body. (NCI)Left Lung
LUNG, LEFT LOWER LOBEC33020Lower Lobe of the Left LungThe larger lobe of the left lung, situated below and behind the oblique fissure. (NCI)Lower Lobe of the Left Lung
LUNG, LEFT UPPER LOBEC33021Upper Lobe of the Left LungThe smaller lobe of the left lung, situated above and in front the oblique fissure, which includes the apex. (NCI)Upper Lobe of the Left Lung
LUNG, RIGHTC33483Right LungThe 3-lobed lung located on the right side of the body. (NCI)Right Lung
LUNG, RIGHT LOWER LOBEC33022Lower Lobe of the Right LungThe lobe of the right lung situated below the oblique fissure. (NCI)Lower Lobe of the Right Lung
LUNG, RIGHT MIDDLE LOBEC12286Middle Lobe of the Right LungThe smallest lobe of the right lung, situated above the oblique fissure and below the horizontal fissure. (NCI)Middle Lobe of the Right Lung
LUNG, RIGHT UPPER LOBEC33023Upper Lobe of the Right LungThe lobe of the right lung, situated above the horizontal fissure, which includes the apex. (NCI)Upper Lobe of the Right Lung
LYMPH NODEC12745Lymph Node;Lymphatic GlandA bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found through out the body. It is composed predominantly of lymphocytes and its main function is immune protection. (NCI)Lymph Node
LYMPH NODE HILUMC33031Lymph Node HilumThe concave side of the lymph node. (NCI)Lymph Node Hilum
MAIN BRONCHUS, LEFTC32968Left Main BronchusOne of the two main bronchi. It is narrower but longer than the right main bronchus and connects to the left lung. (NCI)Left Main Bronchus
MAIN BRONCHUS, RIGHTC33486Right Main BronchusOne of the two main bronchi. It is wider but shorter than the left main bronchus and connects to the right lung. (NCI)Right Main Bronchus
MALE GENITALIAC61599Male GenitaliaMale internal and external organs of reproduction.Male Genitalia
MALE REPRODUCTIVE SYSTEMC12722The sex organs of the male.Male Reproductive System
MALLEUSC33051MalleusA hammer-shaped bone, part of three interconnected small bones located in the middle ear. It is attached to the inner surface of the tympanic membrane and its function is to transmit sound vibrations. (NCI)Malleus
MAMMARY GLANDC12367Lactiferous glands consisting of fibrous tissue connecting the lobes and fatty tissue in between the lobes.Mammary Gland
MANDIBLEC12290Bone, Mandibular;Inferior Maxillary Bone;Lower Jaw;MandibleThe lower jaw bone holding the lower teeth. (NCI)Mandible
MASTOID PROCESSC12503Mastoid ProcessA honeycombed section of bone located near the base of the skull, protruding behind the outer ear. It is connected to the middle ear. (NCI)Mastoid Process
MAXILLAC26470MaxillaThe upper jawbone in vertebrates: it is fused to the cranium. (NCI)Maxilla
MAXILLARY SINUSC12275Maxillary SinusA pyramidal-shaped, thin-walled, air-filled cavity located in the maxilla. It is lined by mucus membrane and periosteum (mucoperiosteum) which contains cilia. It is adjacent to the nasal cavity and communicates with the middle meatus of the nose. It is the largest paranasal sinus and is composed of three recesses: alveolar, zygomatic, and infraorbital. (NCI)Maxillary Sinus
MEDIAN OR LOWER CERVICAL LYMPH NODEC103417A lymph node located in the median or lower region of the neck. (NCI)Median Or Lower Cervical Lymph Node
MEDIASTINAL LYMPH NODEC33073Mediastinal Lymph NodeA lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent. (NCI)Mediastinal Lymph Node
MEDIASTINUMC12748MediastinumA group of organs surrounded by loose connective tissue, separating the two pleural sacs, between the sternum anteriorly and the vertebral column posteriorly as well as from the thoracic inlet superiorly to the diaphragm inferiorly. The mediastinum contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues. (NCI)Mediastinum
MEDIASTINUM, ANTERIORC32098Anterior MediastinumThe area between the lungs; it contains the thymus, some lymph nodes, and vessels and branches of the internal thoracic artery. (NCI)Anterior Mediastinum
MEDIASTINUM, MIDDLEC33123Middle MediastinumThe broadest part of the lower portion of the mediastinum. It contains the heart and the great vessels. (NCI)Middle Mediastinum
MEDIASTINUM, POSTERIORC33368Posterior MediastinumThe part of the lower portion of the mediastinum that is located behind the pericardium. (NCI)Posterior Mediastinum
MEDIASTINUM, SUPERIORC33684Superior MediastinumThe part of the mediastinum that is located between the upper part of the sternum in the front and the upper thoracic vertebrae in the back. (NCI)Superior Mediastinum
MEDULLA OBLONGATAC12442Medulla OblongataThe lower portion of the brainstem located between the pons and brainstem. This structure contains several descending and ascending tracts, lower cranial nerve nuclei, a significant proportion of the reticular system of the brainstem and other structures. (NCI)Medulla Oblongata
MESENTERIC LYMPH NODEC77641A lymph node located in the mesentery. (NCI)Mesenteric Lymph Node
MESENTERYC33103A double layer of peritoneum that attaches to the back wall of the abdominal cavity and supports the small intestines. (NCI)Mesentery
METACARPAL BONEC12751Any of the five bones between the wrist and the fingers that form the skeleton of the palm. (NCI)Metacarpal Bone
METACARPOPHALANGEAL JOINT 1C102316MCP1A condyloid synovial joint within the first digit of the hand connecting the metacarpal to the proximal phalanx.Metacarpophalangeal Joint 1
METACARPOPHALANGEAL JOINT 2C102317MCP2A condyloid synovial joint within the second digit of the hand connecting the metacarpal to the proximal phalanx.Metacarpophalangeal Joint 2
METACARPOPHALANGEAL JOINT 3C102318MCP3A condyloid synovial joint within the third digit of the hand connecting the metacarpal to the proximal phalanx.Metacarpophalangeal Joint 3
METACARPOPHALANGEAL JOINT 4C102319MCP4A condyloid synovial joint within the fourth digit of the hand connecting the metacarpal to the proximal phalanx.Metacarpophalangeal Joint 4
METACARPOPHALANGEAL JOINT 5C102320MCP5A condyloid synovial joint within the fifth digit of the hand connecting the metacarpal to the proximal phalanx.Metacarpophalangeal Joint 5
METATARSAL BONEC12752Metatarsal BoneA bone belonging to the middle part of the foot located between toes and ankle. There are 5 metatarsal bones and they are numbered from the medial side. (NCI)Metatarsal Bone
METATARSOPHALANGEAL JOINTC33108Metatarsophalangeal JointA spheroid joint located between the heads of the metatarsal bone and the base of the proximal phalanx of the toe. (NCI)Metatarsophalangeal Joint
METATARSOPHALANGEAL JOINT 1C102321MTP1A condyloid synovial joint within the first digit of the foot connecting metatarsal with the proximal phalanx.Metatarsophalangeal Joint 1
METATARSOPHALANGEAL JOINT 2C102322MTP2A condyloid synovial joint within the second digit of the foot connecting metatarsal with the proximal phalanx.Metatarsophalangeal Joint 2
METATARSOPHALANGEAL JOINT 3C102323MTP3A condyloid synovial joint within the third digit of the foot connecting metatarsal with the proximal phalanx.Metatarsophalangeal Joint 3
METATARSOPHALANGEAL JOINT 4C102324MTP4A condyloid synovial joint within the fourth digit of the foot connecting metatarsal with the proximal phalanx.Metatarsophalangeal Joint 4
METATARSOPHALANGEAL JOINT 5C102325MTP5A condyloid synovial joint within the fifth digit of the foot connecting metatarsal with the proximal phalanx.Metatarsophalangeal Joint 5
MID-CIRCUMFLEX ARTERYC102326MCIRC;MID-CIRCUMFLEX ARTERY SEGMENTThe segment of the left circumflex artery between the first and second marginal branches.Mid-Circumflex Artery
MID-LAD ARTERYC102328MID-LAD ARTERY SEGMENT;MLADThe segment of the left anterior descending (LAD) artery between the first and third diagonal branches.Mid-Left Anterior Descending Artery
MID-RIGHT CORONARY ARTERY CONDUITC102329MID-RIGHT CORONARY ARTERY CONDUIT SEGMENT;MRCA;Mid-right Coronary ArteryThe section of the right coronary artery between the right ventricular artery and the acute marginal artery.Mid-Right Coronary Artery Conduit
MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHESC102327All of the arterial branches distal to the proximal left anterior descending coronary artery.Mid-Distal Left Anterior Descending Coronary Artery and All Diagonal Coronary Branches
MIDBRAINC12510Mesencephalon;MidbrainThe uppermost portion of the brainstem located between the pons and the diencephalon. The midbrain contains the cerebral peduncles, oculomotor, trochlear and red nuclei, substantia nigra and various other nuclei and tracts. (NCI)Mesencephalon
MIDDLE EARC12274Middle EarThe part of the ear including the eardrum and ossicles. The middle ear leads to the inner ear. (NCI)Middle Ear
MITRAL VALVEC12753A dual-flap valve of the heart that regulates the flow of blood between the left atrium and the left ventricle of the heart. (NCI)Mitral Valve
MOTOR CORTEXC97339A brain region that is located in the dorsal part of the precentral gyrus. (NCI)Primary Motor Cortex
MUCOSAC13166Mucosa;Mucous MembraneThe moist, inner lining of some organs and body cavities (such as the nose, mouth, lungs, and stomach). Glands in the mucosa make mucus (a thick, slippery fluid).Mucosa
MUCOSA OF THE LIPC12226The lining of the fleshy folds surrounding the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae. (NCI)Mucosa of the Lip
MUSCLEC13056A fibrous soft tissue with the ability to contract to produce force and motion.Muscle
MYOMETRIUMC12314MyometriumThe smooth muscle lining the uterus. (NCI)Myometrium
NAILC33156NailThe cutaneous plate on the dorsal surface of the distal end of a finger or toe. (NCI)Nail
NASAL BONEC33157Nasal BoneOne of two small oblong bones placed side by side at the middle and upper part of the face. (NCI)Nasal Bone
NASAL CAVITYC12424Nasal CavityThe proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx. (NCI)Nasal Cavity
NASAL SEPTUMC33160Nasal SeptumThe thin wall between the two nasal cavities. (NCI)Nasal Septum
NASOPHARYNXC12423NasopharynxThe part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages. (NCI)Nasopharynx
NAVICULAR BONEC33162Navicular BoneAn oval-shaped bone of the tarsus found on the medial side of the foot. (NCI)Navicular Bone
NECKC13063NeckThe region that connects the head to the rest of the body. (NCI)Neck
NERVEC12466A bundle of fibers that transmits electrochemical impulses encoding sensory and motor information from one body part to another.Nerve
NIPPLEC12299NippleThe pigmented protuberance on the surface of the breast through which milk is drawn from the breast. (NCI)Nipple
NOSEC12756NoseA structure of special sense serving as an organ of the sense of smell and as an entrance to the respiratory tract. (NCI)Nose
NOSTRILC33178NostrilOne of the two channels of the nose, from the point where they divide to the external opening. (NCI)Nostril
NUCLEUS OF DIAGONAL BANDC97342BASAL NUCLEUS/DIAGONAL BANDA brain structure that is part of the septal nuclear complex. It is connected with the hippocampus, hypothalamus and amygdala.Nucleus of Diagonal Band
OCCIPITAL LOBEC12355The posterior part of the cerebral hemisphere. (MeSH)Occipital Lobe
OCCIPITAL LYMPH NODEC98188A lymph node located in the back of the head adjacent to the trapezius muscle.Occipital Lymph Node
OCCIPITAL SCALPC103456The occipital region of the skin that covers the top of the head. (NCI)Occipital Scalp
OCULOMOTOR NERVEC12758The third cranial nerve.Oculomotor Nerve
ODONTOGENIC TISSUEC33794TeethThe tissue that forms the tooth. It consists of the dental pulp, dentin, enamel, cementum, odontogenic epithelium, and periodontium. (NCI)Odontogenic Tissue
OLECRANONC33200OlecranonA prominence at the proximal end of the ulna. It forms the tip of the elbow. (NCI)Olecranon
OLFACTORY BULBC28401Olfactory BulbAnatomical structure located in the vertebral forebrain that receives neural input regarding odors that have been detected by cells within the nasal cavity. The axons of olfactory receptor cells extend into the olfactory bulb. (NCI)Olfactory Bulb
OLFACTORY MUCOSAC33205Olfactory MucosaThe part of the nasal mucosa composed of neuroepithelial tissue and mucus-producing Bowman's glands. The mucus moistens the epithelium and helps dissolve odor-containing gases. (NCI)Olfactory Mucosa
OLFACTORY NERVEC12759The first cranial nerve.Olfactory Nerve
OMENTUMC33209Omental FatA fold of peritoneum originating at the stomach and supporting the viscera. (NCI)Omentum
OPTIC DISCC12760Optic Nerve Head;Optic Papilla;Second Cranial NerveA portion of the retina at which the axons of the ganglion cells exit the eyeball to form the optic nerve. No light-sensitive photoreceptors are contained within this portion of the retina. (NCI)Optic Disc
OPTIC NERVEC12761Optic NerveThe second cranial nerve. (NCI)Optic Nerve
ORAL CAVITYC12421Mouth;Oral CavityThe cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue. (NCI)Oral Cavity
ORAL MUCOSAC77637Moist tissue lining the oral cavity, containing mucus secreting glands.Oral Mucosa
ORBITC12347Eye Socket;Ocular Orbit;Orbit;Orbital CavityThe bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa. Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones. (NCI)Orbit
OROPHARYNXC12762The part of the pharynx between the soft palate and the upper portion of the epiglottis. (NCI)Oropharynx
OVARYC12404OvaryOne of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova. (NCI)Ovary
PALATINE BONEC52745Palatine BoneAn irregularly shaped bone positioned at the back part of the nasal cavity between the maxilla and the pterygoid process of the sphenoid. It forms the posterior part of the hard palate and the lateral wall of the nasal fossa and helps to form the floor of the orbit as well as several adjoining parts. (NCI)Palatine Bone
PALMC33252The undersurface of the hand. (NCI)Palmar Region
PANCREASC12393PancreasAn organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known. (NCI)Pancreas
PANCREAS, BODYC12270Body of the PancreasThe part of the pancreas from the point where it crosses the portal vein to the point where it enters the lienorenal ligament. (NCI)Body of the Pancreas
PANCREAS, ENDOCRINEC12608Endocrine PancreasThe pancreatic tissue that contains the islets of Langerhans. It is responsible for the production and secretions of the pancreatic hormones. (NCI)Islet of Langerhans
PANCREAS, EXOCRINEC32546Exocrine PancreasAn enzyme producing region of the pancreatic tissue containing the pancreatic acini and exocrine intralobular ducts which collectively secrete the digestive enzymes into the main pancreatic duct to drain into the duodenal part of the small intestine. (NCI)Exocrine Pancreas
PANCREAS, HEADC12269Head of the PancreasThat portion of the pancreas lying in the concavity of the duodenum. (NCI)Head of the Pancreas
PANCREAS, TAILC12271Tail of the PancreasThe left extremity of the pancreas within the lienorenal ligament. (NCI)Tail of the Pancreas
PARA-AORTIC LYMPH NODEC77643Lymph Node, Para-AorticA lymph node located adjacent to the lumbar region of the spine. (NCI)Paraaortic Lymph Node
PARACAVAL LYMPH NODEC117869A lymph node located adjacent to the lumbar region of the spine, along the right lateral aspect of the inferior vena cava. (NCI)Paracaval Lymph Node
PARAMETRIUMC12320ParametriumThe subserous connective tissue of the pelvic floor of the supracervical portion of the uterus. The parametrium extends laterally between the layers of the broad ligament. (NCI)Parametrium
PARANASAL SINUSC12763Accessory Sinuses;Nasal Cavity;Nasal Sinuses;Paranasal SinusAn air-filled cavity adjacent to the nasal cavity lined by a mucous membrane and located in the bones of the skull. There are four paranasal sinuses on each side of the face: ethmoid, frontal, maxillary, and sphenoid sinus. (NCI)Paranasal Sinus
PARASYMPATHETIC GANGLIAC52557A usually small autonomic ganglion of the parasympathetic nervous system. The majority are located near or in the organs that they innervate. (NCI)Parasympathetic Ganglion
PARATHYROID GLANDC12765One of two small paired endocrine glands, superior and inferior, usually found embedded in the connective tissue capsule on the posterior surface of the thyroid gland; these glands secrete parathyroid hormone that regulates the metabolism of calcium and phosphorus. The parenchyma is composed of chief and oxyphilic cells arranged in anastomosing cords. (NCI)Parathyroid Gland
PARATRACHEAL LYMPH NODEC103426A lymph node located adjacent to the trachea within the mediastinum. (NCI)Paratracheal Lymph Node
PARAVERTEBRAL GANGLIAC97925A cluster of neuronal cell bodies and their dendrites located just ventral and lateral to the spinal cord that give rise to the sympathetic nervous system.Para-Spinal Ganglion
PARIETAL LOBEC12354Parietal LobeOne of the lobes of the cerebral hemisphere located superiorly to the occipital lobe and posteriorly to the frontal lobe. Cognition and visuospatial processing are its main function. (NCI)Parietal Lobe
PAROTID GLANDC12427Parotid GlandThe largest of the three paired salivary glands, located in front of the ear. (NCI)Parotid Gland
PAROTID GLAND LYMPH NODEC33278Parotid Gland Lymph NodeA lymph node located close to, on, or within the parotid gland. (NCI)Parotid Gland Lymph Node
PARS COMPACTAC97341A part of the substantia nigra. The pars compacta nerve cells contain melanin and are involved in motor control. (NCI)Pars Compacta
PATELLAC33282PatellaA small flat triangular bone in front of the knee that articulates with the femur and protects the knee joint. (NCI)Patella
PELVIC BONEC33287Pelvic Bone;Pelvis BoneThe caudal portion of the trunk, bounded anteriorly and laterally by the two hip bones incorporating the socket portion of the hip joint for each leg. Posteriorly it is bounded by the sacrum and coccyx. (NCI)Pelvic Bone
PELVIC LYMPH NODEC12363Pelvic Lymph NodeAny lymph node within the pelvic region. (NCI)Pelvic Lymph Node
PELVISC12767Pelvic Cavity;Pelvic Region;PelvisThe bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans. (NCI)Pelvis
PENISC12409PenisThe male organ of urination and copulation. (NCI)Penis
PERIANAL REGIONC99148The skin area around the anus. (NCI)Perianal Region
PERICARDIAL CAVITYC38662Pericardial CavityThe potential body space formed between the parietal and visceral layers of the pericardial sac. (NCI)Pericardial Cavity
PERICARDIAL LYMPH NODEC117870A lymph node located anterior to the pericardium, posterior to the xiphoid process, and in the right and left cardiophrenic fat. (NCI)Pericardial Lymph Node
PERICARDIUMC13005PericardiumA conical membranous sac filled with serous fluid in which the heart as well as the roots of the aorta and other large blood vessels are contained. (NCI)Pericardium
PERIHILAR LYMPH NODEC102330A lymph node located in the area around the hilum.Perihilar Lymph Node
PERINEUMC33301PerineumThe area located between the anus and vulva in females, and anus and scrotum in males. (NCI)Perineum
PERIPANCREATIC LYMPH NODEC77642A lymph node of the pancreas. (NCI)Pancreatic Lymph Node
PERIPHERAL NERVEC12768Peripheral NerveAny nerve outside the brain or spinal cord that connects with peripheral receptors or effectors. (NCI)Peripheral Nerve
PERITONEAL CAVITYC12769Peritoneal CavityThe lower part of the abdomen that contains the intestines (the last part of the digestive tract), the stomach, and the liver. It is bound by thin membranes. (NCI)Peritoneal Cavity
PERITONEUMC12770PeritoneumThe tissue that lines the wall of the abdominal cavity, intestine, and mesentery. It consists of the parietal peritoneum that covers the inside of the abdominal wall and the visceral peritoneum that covers the surface of the intestine and mesentery. (NCI)Peritoneum
PERIURETHRAL REGIONC111287The tissue surrounding the urethra.Periurethral Region
PERONEAL ARTERYC33314An artery arising from the posterior tibial artery that supplies the muscles on the lateral side of the lower leg.Peroneal Artery
PHARYNGEAL TONSILC33318Adenoid;Pharyngeal TonsilA fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx. (NCI)Pharyngeal Tonsil
PHARYNXC12425PharynxA hollow tube that starts posterior to the mouth and nasal cavity and ends superior to the trachea and esophagus. (NCI)Pharynx
PINEAL GLANDC12398A small endocrine gland within the diencephalon of the brain, situated beneath the back part of the corpus callosum, that secretes melatonin.Pineal Gland
PISIFORM BONEC12855Pisiform BoneThe medial bone of the proximal row of carpal bones. (NCI)Pisiform Bone
PITUITARY GLANDC12399Hypophysis;Hypophysis CerebriPea-sized endocrine gland located at the base of the brain in the pituitary fossa. It produces and secretes hormones such as oxytocin and vasopressin, to regulate the activities of the hypothalamus. (NCI)Pituitary Gland
PLEURAC12469Pleural TissueThe tissue that lines the wall of the thoracic cavity and the surface of the lungs. (NCI)Pleura
PLEURAL CAVITYC12840Pleural CavityThe cavity lined by the pleura, located in the thorax and contains heart and lungs. (NCI)Pleural Cavity
PONS VAROLIIC12511Pons VaroliiThe middle portion of the brainstem located between the midbrain and the medulla oblongata.Pons Varolii
POPLITEAL ARTERY ABOVE KNEEC116180The segment of the popliteal artery that is located above the knee.Popliteal Artery Above the Knee
POPLITEAL ARTERY BELOW KNEEC116181The segment of the popliteal artery that is located below the knee.Popliteal Artery Below the Knee
POPLITEAL LYMPH NODEC53146Lymph node located within the fat layer of the knee joint. (NCI)Popliteal Lymph Node
PORTA HEPATIS LYMPH NODEC117871A lymph node located in the transverse fissure of the liver. (NCI)Porta Hepatis Lymph Node
PORTACAVAL LYMPH NODEC117872Portocaval Lymph NodeA lymph node located in the space between the portal vein and inferior vena cava, along the hepatoduodenal ligament. (NCI)Portacaval Lymph Node
PORTAL LYMPH NODEC77645Periportal Lymph NodeLymph nodes surrounding the portal vein. (NCI)Portal Lymph Node
PORTAL VEINC33343Hepatic Portal Vein;Portal VeinA short thick trunk vein that transports blood containing the absorbed products of digestion from the intestine directly to the liver. (NCI)Portal Vein
POSTERIOR CERVICAL LYMPH NODEC103428A lymph node located in the posterior region of the neck. (NCI)Posterior Cervical Lymph Node
POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERYC102348PDSP;POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY SEGMENTThe arteries arising from the right posterior descending artery that supply the interventricular septum.Septal Perforator Artery
POSTERIOR TIBIAL ARTERYC12826A terminal branch of the popliteal artery that runs along the tibia from the lower portion of the popliteus muscle to the lower ankle with numerous branches supplying the lower leg and foot.Posterior Tibial Artery
POSTEROLATERAL SEGMENTAL ARTERYC116170In an individual with a right-dominant heart, the arterial branch that arises from the distal right coronary artery in the posterior atrioventricular groove after the origin of the right posterior descending artery.Posterolateral Coronary Artery
PREAURICULAR LYMPH NODEC103429A lymph node located anterior to the auricle of the ear. (NCI)Preauricular Lymph Node
PRECUNEUSC112399The posteromedial region of the parietal lobe bounded by the marginal branch of the cingulate sulcus anteriorly, by the medial portion of the parieto-occipital fissure posteriorly and by the subparietal sulcus inferiorly.Precuneus
PREPUTIAL GLANDC79432Exocrine glands located at the anterior aspect of the genitals of some mammals, such as mice and rats, that produce and secrete pheromones. (NCI)Preputial Gland
PRIMARY VISUAL CORTEXC97340A brain region in the occipital cortex that receives visual stimuli from the retina. (NCI)Primary Visual Cortex
PROFUNDA FEMORIS ARTERYC32436An artery arising from the common femoral artery just below the inguinal ligament running close to the femur and ending in the lower third of the thigh with branches supplying the thigh muscles.Deep Femoral Artery
PROSTATE GLANDC12410Prostate GlandThe walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen. (NCI)Prostate Gland
PROSTATE GLAND, LATERAL LOBEC13092Lateral Lobe of the ProstateThe prostate gland lobe that is located on the lateral side of the organ. (NCI)Lateral Lobe of the Prostate
PROSTATE GLAND, MIDDLE LOBEC13094Middle Lobe of the ProstateThe upper, smaller part of the prostate between the ejaculatory ducts and the urethra. (NCI)Middle Lobe of the Prostate
PROSTATE GLAND, POSTERIOR LOBEC13093Posterior Lobe of the ProstateThe prostate gland lobe that is located on the posterior side of the organ. (NCI)Posterior Lobe of the Prostate
PROXIMAL CIRCUMFLEX ARTERYC102331PCIRC;PROXIMAL CIRCUMFLEX ARTERY SEGMENTThe section of the left circumflex coronary artery that arises from the left main coronary artery and extends to the first marginal branch.Proximal Circumflex Artery
PROXIMAL INTERPHALANGEAL JOINT 2C102332PIP2A condyloid synovial joint within the second digit of the hand or foot connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 2
PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOTC114205PIP2 of the FootA ginglymoid (hinge) synovial joint within the second digit of the foot connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 2 of the Foot
PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HANDC114194PIP2 of the HandA ginglymoid (hinge) synovial joint within the second digit of the hand connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 2 of the Hand
PROXIMAL INTERPHALANGEAL JOINT 3C102333PIP3A condyloid synovial joint within the third digit of the hand or foot connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 3
PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOTC114206PIP3 of the FootA ginglymoid (hinge) synovial joint within the third digit of the foot connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 3 of the Foot
PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HANDC114195PIP3 of the HandA ginglymoid (hinge) synovial joint within the third digit of the hand connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 3 of the Hand
PROXIMAL INTERPHALANGEAL JOINT 4C102334PIP4A condyloid synovial joint within the fourth digit of the hand or foot connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 4
PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOTC114207PIP4 of the FootA ginglymoid (hinge) synovial joint within the fourth digit of the foot connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 4 of the Foot
PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HANDC114196PIP4 of the HandA ginglymoid (hinge) synovial joint within the fourth digit of the hand connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 4 of the Hand
PROXIMAL INTERPHALANGEAL JOINT 5C102335PIP5A condyloid synovial joint within the fifth digit of the hand or foot connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 5
PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOTC114208PIP5 of the FootA ginglymoid (hinge) synovial joint within the fifth digit of the foot connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 5 of the Foot
PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HANDC114197PIP5 of the HandA ginglymoid (hinge) synovial joint within the fifth digit of the hand connecting the proximal and middle phalanges. (NCI)Proximal Interphalangeal Joint 5 of the Hand
PROXIMAL LAD ARTERYC102336PLAD;PROXIMAL LAD ARTERY SEGMENTThe section of the left anterior descending coronary artery that arises from the left main coronary artery and extends to the first diagonal branch.Proximal Left Anterior Descending Artery
PROXIMAL RIGHT CORONARY ARTERY CONDUITC102337PRCA;PROXIMAL RIGHT CORONARY ARTERY CONDUIT SEGMENTThe section of the right coronary artery proximal to the origin of the right ventricular artery.Proximal Right Coronary Artery Conduit
PUBIC BONEC33423Either of the two bones (left and right) that form the front of the pelvis. (NCI)Pubic Bone
PUTAMENC12452PutamenThe largest and most lateral of the basal ganglia lying between the lateral medullary lamina of the globus pallidus and the external capsule. It is part of the neostriatum and forms part of the lentiform nucleus along with the globus pallidus. (MeSH)Putamen
PYLORIC SPHINCTERC33433Pyloric SphincterThe muscular structure at the distal portion of the stomach, opening into the duodenum. (NCI)Pyloric Sphincter
QUADRICEPS MUSCLEC33441Muscle, Quadriceps;Muscle, ThighA group of four powerful muscles in the front of the thigh. Their actions involve the extension of the knee joint. (NCI)Quadriceps Muscle of the Thigh
RADIAL ARTERYC12838Radial ArteryThe branch of the brachial artery that passes down the forearm. (NCI)Radial Artery
RADIUSC12777Radius;Radius BoneThe long bone that extends from the lateral aspect of the elbow to the medial side of the carpus.Radius Bone
RAMUS INTERMEDIUS ARTERYC102338RAMUS;RAMUS ARTERY;RAMUS INTERMEDIUS ARTERY SEGMENTAn artery that arises from the left main coronary artery and is positioned between the left anterior descending coronary artery and the circumflex artery.Ramus Intermedius Artery
RAPHEC97335A group of nuclei that are located in the midline of the brainstem and release serotonin. (NCI)Raphe Nuclei
RECTOSIGMOID JUNCTIONC54188The area where the sigmoid colon joins the rectum.Rectosigmoid Region
RECTUMC12390The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal. (NCI)Rectum
RECTUS FEMORIS MUSCLEC53175One of the four quadriceps muscles, located in the middle of the front of the thigh. Its actions involve the extension of the knee joint and flexion of the hip. (NCI)Rectus Femoris
REGIONAL LYMPH NODEC49018Regional Lymph NodeA lymph node that drains lymph from a region of interest. (NCI)Regional Lymph Node
RENAL ARTERYC12778Either of two arteries (right or left) that arise from the aorta to supply the kidneys.Renal Artery
RENAL PELVISC12887The funnel-shaped proximal portion of the ureter located within the kidney into which urine is secreted, from the collecting duct system of the kidney. (NCI)Renal Pelvis
RETINAC12343RetinaA light-sensitive membrane that lines the back wall of the eyeball. The retina is continuous with the optic nerve and this way transmits optical images to the brain. (NCI)Retina
RETINAL NERVE FIBER LAYERC32953A retina layer that contains the axons of ganglion cells. It collects the visual impulses. (NCI)Layer of the Ophthalmic Nerve Fibers
RETROCRURAL LYMPH NODEC103439A lymph node located within the most inferior portion of the posterior mediastinum. (NCI)Retrocrural Lymph Node
RETROPERITONEAL LYMPH NODEC98189A lymph node located in the retroperitoneal space. (NCI)Retroperitoneal Lymph Node
RETROPERITONEUMC12298RETROPERITONEAL CAVITYThe back of the abdomen where the kidneys lie and the great blood vessels run. (NCI)Retroperitoneum
RIBC12782RibAny one of the paired bones, 12 on either side, extending from the thoracic vertebrae toward the median line on the ventral aspect of the trunk. The long curved bones which form the rib cage. Generally, ribs 1 to 7 are connected to the sternum by their costal cartilages and are called true ribs, whereas ribs 8 to 12 are termed false ribs. (NCI)Rib
RIB 1C52770Rib 1The first rib counting from the top of the rib cage down. (NCI)Rib 1
RIB 10C52769Rib 10The tenth rib counting from the top of the rib cage down. (NCI)Rib 10
RIB 11C52768Rib 11The eleventh rib counting from the top of the rib cage down. (NCI)Rib 11
RIB 12C52767Rib 12The twelfth rib counting from the top of the rib cage down. (NCI)Rib 12
RIB 2C52766Rib 2The second rib counting from the top of the rib cage down. (NCI)Rib 2
RIB 3C52765Rib 3The third rib counting from the top of the rib cage down. (NCI)Rib 3
RIB 4C52764Rib 4The fourth rib counting from the top of the rib cage down. (NCI)Rib 4
RIB 5C52763Rib 5The fifth rib counting from the top of the rib cage down. (NCI)Rib 5
RIB 6C52762Rib 6The sixth rib counting from the top of the rib cage down. (NCI)Rib 6
RIB 7C52761Rib 7The seventh rib counting from the top of the rib cage down. (NCI)Rib 7
RIB 8C52760Rib 8The eighth rib counting from the top of the rib cage down. (NCI)Rib 8
RIB 9C52759Rib 9The ninth rib counting from the top of the rib cage down. (NCI)Rib 9
RIGHT ATRIAL ENDOCARDIUMC102339The innermost layer of endothelial cells and connective tissue that lines the right atrium.Right Atrial Endocardium
RIGHT CORONARY ARTERY OSTIUMC116169The opening of the right coronary artery at its origin.Right Coronary Artery Ostium
RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHESC102340The right coronary artery and all of its branches.Right Coronary Artery and its Branches
RIGHT POSTERIOR ATRIOVENTRICULAR ARTERYC102341RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY SEGMENT;RPAVThe arterial branch between the right posterior descending artery segment and the first right posterolateral segment.Right Posterior Atrioventricular Artery
RIGHT POSTERIOR DESCENDING ARTERYC102342RIGHT POSTERIOR DESCENDING ARTERY SEGMENT;RPDAIn an individual with a right-dominant heart, the arterial branch that arises from the distal right coronary artery between the acute marginal artery and the first right posterolateral segment. It supplies the inferior apex of the heart.Right Posterior Descending Artery
RIGHT VENTRICULAR BRANCHC116171The branch of the right coronary artery that supplies blood to the right ventricular wall.Right Ventricular Branch of Right Coronary Artery
RIGHT VENTRICULAR ENDOCARDIUMC102343The innermost layer of endothelial cells and connective tissue that lines the right ventricle.Right Ventricular Endocardium
SACRAL TUBEROSITYC105447The prominence on the lateral surface of the sacrum, posterior to the auricular surface of the sacrum. (NCI)Sacral Tuberosity
SACRAL VERTEBRAC12853Sacral VertebraAny of the vertebrae forming the triangular bone just below the lumbar vertebrae.Sacral Vertebra
SACROILIAC JOINTC33507Sacroiliac JointThe joint located between the sacrum and the ilium. (NCI)Sacroiliac Joint
SACRUMC33508SacrumThe triangular bone, made up of 5 fused bones of the spine, located in the lower area of the spine between the fifth lumbar vertebra and the coccyx. (NCI)Sacrum
SALIVARY GLANDC12426An exocrine gland that secretes saliva. Salivary glands are mostly located in and around the oral cavity.Salivary Gland
SAPHENOUS VEINC33511Saphenous VeinOne of two (Greater, Small) superficial veins of the leg and thigh. (NCI)Saphenous Vein
SCALPC89807The skin which covers the top of the head and which is usually covered by hair. (NCI)Scalp
SCAPHOID BONEC12854Scaphoid BoneA nut-shaped bone of the wrist located in the radial site of the hand. It is one of the eight carpal bones. (NCI)Scaphoid Bone
SCAPULAC12783Scapula;Shoulder BladeThe flat triangle-shaped bone that connects the humerus with the clavicle in the back of the shoulder. (NCI)Scapula
SCIATIC NERVEC52810Sciatic NerveThe longest single nerve that is formed by the merging of the ventral rami of the L4, L5, and S1 in the pelvis and passes down the lower limb where it divides into the common peroneal and tibial nerves. (NCI)Sciatic Nerve
SCLERAC12784The white, opaque, fibrous, outer tunic of the eyeball, covering it entirely excepting the segment covered anteriorly by the cornea. It is essentially avascular but contains apertures for vessels, lymphatics, and nerves. It receives the tendons of insertion of the extraocular muscles and at the corneoscleral junction contains the canal of Schlemm. (From Cline et al., Dictionary of Visual Science, 4th ed)Sclera
SCROTUMC12785ScrotumThe musculocutaneous pouch that encloses the testicles. (NCI)Scrotum
SEBACEOUS GLANDC33519Small glands located within the epidermis, and associated with the hair follicle, that produce and secrete an oily substance that lubricates the skin and hair. (NCI)Sebaceous Gland
SECOND DIAGONAL BRANCH ARTERYC1023442ND DIAG;SECOND DIAGONAL BRANCH ARTERY SEGMENTThe second artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal.Second Diagonal Branch Artery
SECOND LEFT POSTEROLATERAL BRANCH ARTERYC1023452ND LPL;SECOND LEFT POSTEROLATERAL BRANCH ARTERY SEGMENTIn an individual with a left-dominant heart, this is the second branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall.Second Left Posterolateral Branch Artery
SECOND OBTUSE MARGINAL BRANCH ARTERYC1023462ND OM;SECOND OBTUSE MARGINAL BRANCH ARTERY SEGMENTThe second artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal.Second Obtuse Marginal Branch Artery
SECOND RIGHT POSTEROLATERAL ARTERYC1023472ND RPL;SECOND RIGHT POSTEROLATERAL ARTERY SEGMENTIn an individual with a right-dominant heart, this is the second branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal.Second Right Posterolateral Artery
SEMINAL VESICLEC12787Seminal SacsOne of the two paired glands in the male genitourinary system, posterior to the bladder and superior to the prostate gland, that produces fructose-rich seminal fluid which is a component of semen. These glands join the ipsilateral ductus deferens to form the ejaculatory duct. (NCI)Seminal Vesicle
SEMITENDINOSUS MUSCLEC53176A muscle located at the posterior and medial aspect of the thigh that extends the hip joint, flexes the knee joint and assists in medially rotating the knee.Semitendinosus
SHOULDERC25203ShoulderThe region of the body between the neck and the upper arm. (NCI)Shoulder
SHOULDER JOINTC33548Shoulder JointA ball-and-socket joint at the upper end of the humerus, located at the junction of humerus and scapula. (NCI)Shoulder Joint
SINUSC33556SinusA recess, cavity, or channel. (NCI)Sinus
SKINC12470Integument;SkinAn organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages. (NCI)Skin
SKIN OF THE AXILLAC116164The skin or integument surrounding the axilla, or underarm.Skin Of The Axilla
SKIN OF THE HEADC52757The skin or integument surrounding the head.Head Skin
SKIN OF THE LIPC12291The skin portion of the lip that contains hair.Skin of the Lip
SKIN OF THE NECKC52756The skin or integument surrounding the neck.Neck Skin
SKIN OF THE TRUNKC12295Skin of the TrunkThe skin or integument surrounding the trunk of the body. (NCI)Skin of the Trunk
SKULLC12789Bone, Cranial;Cranium;SkullThe bones that form the head, made up of the bones of the braincase and face. (NCI)Skull
SMALL INTESTINEC12386Small IntestineThe section of the intestines between the pylorus and cecum. The small intestine is approximately 20 feet long and consists of the duodenum, the jejunum, and the ileum. Its main function is to absorb nutrients from food as the food is transported to the large intestine. (NCI)Small Intestine
SOFT PALATEC12231A movable fold suspended from the posterior border of the hard palate. (MeSH)Soft Palate
SOLEC33326The undersurface of the foot. (NCI)Plantar Region
SPINAL ACCESSORY NERVEC32041ACCESSORY NERVE;CRANIAL ACCESSORY NERVEThe eleventh cranial nerve.Accessory Nerve
SPINAL CORDC12464Medulla SpinalisThe elongated, approximately cylindrical part of the central nervous system of vertebrates that lies in the vertebral canal and from which the spinal nerves emerge. (NCI)Spinal Cord
SPINOUS PROCESSC116112A bony projection arising from the posterior vertebral arch that serves for the attachment of muscles and ligaments.Spinous Process
SPLEENC12432SpleenAn organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. It is located in the left hypochondriac region. Its functions include lymphocyte production, blood cell storage, and blood cell destruction. (NCI)Spleen
SPLEEN, HILUMC33601Splenic HilumThe area of the spleen through which the vessels and nerves enter or exit the organ. (NCI)Splenic Hilum
SPLENIC HILAR LYMPH NODEC33600A lymph node located in the hilar region of the spleen. (NCI)Splenic Hilar Lymph Node
STERNAL MANUBRIUMC52730Sternal ManubriumThe upper segment of the sternum, quadrangular in shape, as well as wider superiorly and narrower inferiorly. The sternal manubrium articulates with the clavicle and first two ribs. (NCI)Sternal Manubrium
STERNOCLAVICULAR JOINTC33615Sternoclavicular JointThe synovial juncture between the medial end of the clavicle and the anterior segment of the sternum. (NCI)Sternoclavicular Joint
STERNUMC12793Sterna;SternumThe long, flat bone connecting with the cartilages of the first seven ribs and the clavicle. (NCI)Sternum
STOMACHC12391StomachAn organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion. (NCI)Stomach
SUBCARINAL LYMPH NODEC117873A lymph node located in the thoracic cavity between the lungs. It is bordered by the carina of the trachea, lower lobe bronchus on the left and the bronchus intermedius on the right. (NCI)Subcarinal Lymph Node
SUBCLAVIAN VEINC12794The vein that drains the axillary vein and joins the internal jugular vein to form the brachiocephalic vein. It runs parallel to the subclavian artery.Subclavian Vein
SUBCUTISC33645Subcutaneous Adipose Tissue;Subcutaneous TissueAdipose tissue located under the dermis. It binds underlying structures with the skin. The subcutis is important in the regulation of temperature of the skin itself and the body. The size of this layer varies throughout the body and from subject to subject.Subcutis
SUBGLOTTISC12280SubglottisThe area of the larynx below the vocal cords down to the trachea. (NCI)Subglottis
SUBLINGUAL REGIONC102349A body region relating to the area under or adjacent to the tongue.Sublingual Region
SUBMANDIBULAR LYMPH NODEC77650Lymph Node, SubmandibularA lymph node located beneath the floor of the oral cavity. (NCI)Submandibular Lymph Node
SUBSTANTIA NIGRAC12453Substantia NigraA large cell mass extending forward, over the dorsal surface of the crus cerebri, from the rostral border of the pons into the subthalamic region. It is composed of a dorsal stratum of closely spaced pigmented cells, the pars compacta, and a larger ventral region of widely scattered cells, the pars reticulata. The pars compacta includes numerous cells that project forward to the striatum (caudate nucleus and putamen) and contain dopamine, which acts as the primary neurotransmitter at the synaptic endings. Other, apparently non-dopaminergic cells project to portions of the ventral nucleus of thalamus, the superior colliculus and reticular formation. The nigrostriatal projection is reciprocated by a striatonigral fiber system with multiple neurotransmitters, chief among which is gamma-aminobutyric acid (GABA). The substantia nigra is involved in the metabolic disturbances associated with Parkinson's disease and Huntington's disease. (NCI)Substantia Nigra
SUBTALAR JOINTC33653Talocalcaneal JointThe plane synovial joint between the talus and calcaneus bones of the foot.Subtalar Joint
SUDORIFEROUS GLANDC33712Sweat GlandThe small coiled tubular glands in the skin that produce and secrete sweat.Sweat Gland
SUPERFICIAL FEMORAL ARTERYC33661The portion of the femoral artery distal to the branching of the deep femoral artery that runs close to the skin.Superficial Femoral Artery
SUPERFICIAL LYMPH NODEC102716A lymph node located in a superficial part of the body.Superficial Lymph Node
SUPERIOR VENA CAVAC12816The large vein that terminates in the right atrium and transports deoxygenated blood from the head, neck, arms, and chest to the heart.Superior Vena Cava
SUPRACLAVICULAR LYMPH NODEC12903Supraclavicular Lymph NodeA lymph node which is located above the clavicle. (NCI)Supraclavicular Lymph Node
SUPRATENTORIAL BRAINC12512The part of the brain above the tentorium cerebellum. (NCI)Supratentorial Brain
SYMPATHETIC GANGLIAC12467A mass containing the cell bodies of sympathetic nerves. Sympathetic ganglia exist as paravertebral ganglia (located bilaterally adjacent to the spinal cord) or prevertebral ganglia (located close to the target organ).Sympathetic Ganglion
SYNOVIAL FLUIDC33718Synovia;Synovial FluidA viscid fluid secreted by the synovial membrane, serving as a lubricant. (NCI)Synovial Fluid
T1 VERTEBRAC33720T1 VertebraThe first thoracic vertebra counting from the top down. (NCI)T1 Vertebra
T10 VERTEBRAC33721T10 VertebraThe tenth thoracic vertebra counting from the top down. (NCI)T10 Vertebra
T11 VERTEBRAC33722T11 VertebraThe eleventh thoracic vertebra counting from the top down. (NCI)T11 Vertebra
T12 VERTEBRAC33723T12 VertebraThe twelfth thoracic vertebra counting from the top down. (NCI)T12 Vertebra
T2 VERTEBRAC33724T2 VertebraThe second thoracic vertebra counting from the top down. (NCI)T2 Vertebra
T3 VERTEBRAC33725T3 VertebraThe third thoracic vertebra counting from the top down. (NCI)T3 Vertebra
T4 VERTEBRAC33726T4 VertebraThe fourth thoracic vertebra counting from the top down. (NCI)T4 Vertebra
T5 VERTEBRAC33727T5 VertebraThe fifth thoracic vertebra counting from the top down. (NCI)T5 Vertebra
T6 VERTEBRAC33728T6 VertebraThe sixth thoracic vertebra counting from the top down. (NCI)T6 Vertebra
T7 VERTEBRAC33729T7 VertebraThe seventh thoracic vertebra counting from the top down. (NCI)T7 Vertebra
T8 VERTEBRAC33730T8 VertebraThe eighth thoracic vertebra counting from the top down. (NCI)T8 Vertebra
T9 VERTEBRAC33731T9 VertebraThe ninth thoracic vertebra counting from the top down. (NCI)T9 Vertebra
TALUSC52799TalusThe bone of the foot that connects with the tibia and fibula to form the ankle joint. (NCI)Talus
TARSUS BONEC12796Bone, Tarsal;Tarsus;Tarsus BoneAny one of the seven bones forming the instep of the foot. (NCI)Tarsal Bone
TEMPORAL BONEC12797Temporal BoneA large irregular bone situated at the base and side of the skull, connected with the mandible via the temporomandibular joint. The temporal bone consists of the squamous, tympanic and petrous parts. The petrous portion of the temporal bone contains the vestibulocochlear organ of the inner ear. (NCI)Temporal Bone
TEMPORAL LOBEC12353Lower lateral part of the cerebral hemisphere. (MSH2001)Temporal Lobe
TEMPOROMANDIBULAR JOINTC32888Jaw Joint;TMJThe joint between the head of the lower mandible and the temporal bone. (NCI)Jaw Joint
TENTORIUM CEREBELLIC33749A laminar extension of the dura mater that lies between, and separates, the cerebrum and the cerebellum. (NCI)Tentorium Cerebelli
TESTISC12412Testicle;TestisEither of the paired male reproductive glands that produce the male germ cells and the male hormones. (NCI)Testis
THALAMUSC12459ThalamusAn ovoid mass composed predominantly of gray substance and associated laminae of white substance. The thalamus is divided into anterior, medial, and lateral parts. The function of the thalamus is to relay sensory impulses and cerebellar and basal ganglia projections to the cerebral cortex. The thalamus is positioned within the posterior part of the diencephalon forming most of each lateral wall of the third ventricle. (NCI)Thalamus
THIGHC33763ThighA part of the lower limb, located between hip and knee. (NCI)Thigh
THIRD DIAGONAL BRANCH ARTERYC1023503RD DIAG;THIRD DIAGONAL BRANCH ARTERY SEGMENTThe third artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal.Third Diagonal Branch Artery
THIRD OBTUSE MARGINAL BRANCH ARTERYC1023513RD OM;THIRD OBTUSE MARGINAL BRANCH ARTERY SEGMENTThe third artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal.Third Obtuse Marginal Branch Artery
THIRD POSTEROLATERAL DESCENDING ARTERYC1023523RD LPL;THIRD POSTEROLATERAL DESCENDING ARTERY SEGMENTIn an individual with a left-dominant heart, this is the third branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall.Third Posterolateral Descending Artery
THIRD RIGHT POSTEROLATERAL ARTERYC1023533RD RPL;THIRD RIGHT POSTEROLATERAL ARTERY SEGMENTIn an individual with a right-dominant heart, this is the third branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal.Third Right Posterolateral Artery
THORACIC AORTAC33766The section of the aorta between the lower border of the fourth dorsal vertebrae and the aortic opening in the diaphragm. (NCI)Thoracic Aorta
THORACIC CAVITYC12905Thoracic CavityThe cavity in the vertebrate body enclosed by the ribs between the diaphragm and the neck and containing the lungs and heart. (NCI)Thoracic Cavity
THORACIC LYMPH NODEC33769Lymph node located in the thoracic cavity. (NCI)Thoracic Lymph Node
THORACIC VERTEBRAC12798Thoracic VertebraAny of the vertebrae situated between the cervical and lumbar vertebrae.Thoracic Vertebra
THORAXC12799ThoraxThe division of the body lying between the neck and the abdomen. (NCI)Thorax
THROATC54272ThroatThe narrow passage from the mouth to the cavity at the back of the mouth. (NCI)Throat
THYMUS GLANDC12433Thymus GlandA bi-lobed organ surrounded by a connective tissue capsule. It is located in the upper anterior portion of the chest, behind the sternum. It is composed predominantly of lymphocytes and fewer epithelial cells. Connective tissue septa separate the lobes into lobules. The lobules contain an outer portion (cortical zone) which is rich in lymphocytes and an inner portion (medullary zone) which is rich in epithelial cells. It is an organ essential for the development of the immune system. Its function is the maturation of the progenitor lymphoid cells to thymocytes and subsequently to mature T-cells. It reaches its greatest weight at puberty and subsequently begins to involute. (NCI)Thymus Gland
THYROID GLANDC12400Thyroid GlandAn endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control. (NCI)Thyroid Gland
THYROID GLAND ISTHMUSC32887The narrow, central portion of the thyroid gland that crosses the trachea anteriorly and connects the two lobes of the gland. (NCI)Thyroid Gland Isthmus
THYROID GLAND, LEFT LOBEC32973Left Thyroid Gland LobeThe cone-like lobe of the thyroid gland that is located in the left side of the trachea. (NCI)Left Thyroid Gland Lobe
THYROID GLAND, RIGHT LOBEC33491Right Thyroid Gland LobeThe cone-like lobe of the thyroid gland that is located in the right side of the trachea. (NCI)Right Thyroid Gland Lobe
TIBIAC12800TibiaA bone located between the femur and the tarsus, being part of the lower leg. (NCI)Tibia
TIBIAL-CRURAL PERIPHERAL ARTERYC116168The blood vessels segment that includes the crural artery and the tibial artery.Tibialcrural Artery
TIBIALIS ANTERIOR MUSCLEC117874A muscle that originates from the lateral condyle of tibia, spans the upper two-thirds of the lateral surface of the tibia, and is attached to the first cuneiform and metatarsal bones of the foot. It is a dorsiflexor of the ankle and invertor of the foot.Tibialis Anterior Muscle
TIBIO-PERONEAL TRUNKC116182An arterial trunk that contains parts of the posterior tibial artery and fibular artery.Tibioperoneal Arterial Trunk
TOEC33788ToeOne of the terminal digits of the foot. (NCI)Toe
TOENAILC33790ToenailA thin, horny translucent plate covering the end of each toe. (NCI)Toenail
TONGUEC12422TongueThe muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech. (NCI)Tongue
TONSILC12802TonsilThe two organs situated in the throat on either side of the narrow passage from the mouth to the pharynx. They are composed of lymphoid tissues. (NCI)Tonsil
TOOTH CANALC66864Tooth CanalThe anatomic space in the root of a tooth that contains nerves, blood vessels, and connective tissue. (NCI)Tooth Canal
TRACHEAC12428Trachea;WindpipeThe fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi. (NCI)Trachea
TRACHEOBRONCHIAL TREEC117875An anatomical structure comprised of trachea, bronchi, and bronchioles that terminate with the alveolar ducts, sacs, and alveoli. (NCI)Tracheobronchial Tree
TRANSVERSE TARSAL JOINTC102354A combination of syndesmosis and synovial joints formed by the articulation of the talus with the navicular and the calcaneus with the cuboid.Transverse Tarsal Joint
TRAPEZIAL BONEC12857Trapezial BoneA carpal bone on the thumb side of the hand that articulates with the 1st and 2nd metacarpals. (NCI)Trapezial Bone
TRAPEZIUS MUSCLEC33809Trapezius MuscleOne of a pair of flat, large, triangular muscles that extend from the external occipital protuberance and the medial third of the superior nuchal line of the occipital bone to the middle of the back. The trapezius muscle is involved in moving the shoulder and arm. (NCI)Trapezius Muscle
TRAPEZOID BONEC12859Trapezoid BoneA carpal bone located between the trapezium and capitate bones. (NCI)Trapezoid Bone
TRIANGULAR BONEC12858Triangular BoneA carpal bone located between the lunate and pisiform bones. (NCI)Triangular Bone
TRICUSPID VALVEC12805A three-cusp valve of the heart that regulates the flow of blood between the right atrium and the right ventricle of the heart. (NCI)Tricuspid Valve
TRIGEMINAL NERVEC12806Fifth Cranial Nerve;Nervus Trigeminus;Trigeminal NerveThe fifth set of paired nerves of the face that emerge from the brain steam. These nerves have sensory and motor functions in the face, oral cavity, and nasal cavity. (NCI)Trigeminal Nerve
TROCHANTERC33814TrochanterA bony protrusion on the femoral bone to which muscles are attached. (NCI)Trochanter
TROCHLEAR NERVEC12808Trochlear NerveThe cranial nerve that controls the superior oblique muscle of the eye. (NCI)Trochlear Nerve
TRUNKC33816TrunkThe body excluding the head and neck and limbs. (NCI)Trunk
TUNICA INTIMAC33820Tunica IntimaThe inner most layer of the blood vessel wall. The consistency of the intima will vary depending on the type of blood vessel, but will always have an endothelial layer with a basal lamina. It may contain collagen and elastic fibers. (NCI)Tunica Intima
TYMPANIC MEMBRANEC12502Tympanic MembraneA thin membrane that separates the external auditory canal from the middle ear. The movement of the tympanic membrane in response to air pressure changes in the external ear facilitates the transmission of sound energy by causing vibration of the ossicular chain. (NCI)Tympanic Membrane
ULNAC12809Ulna BoneThe long bone that extends from the elbow to the lateral side of the carpus.Ulna
UMBILICUSC77533NavelThe depression or scar on the abdomen that marks the former site of attachment of the umbilical cord. (NCI)Umbilicus
UNCINATE PROCESS OF PANCREASC62432Uncinate Process of PancreasA portion of the pancreas that extends behind the superior mesenteric artery and superior mesenteric vein. (NCI)Uncinate Process of Pancreas
UPPER CERVICAL LYMPH NODEC103447A lymph node located in the upper region of the neck. (NCI)Upper Cervical Lymph Node
UPPER RESPIRATORY SYSTEMC33839The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea.Upper Respiratory System
URETERC12416UreterThe thick-walled tube that carries urine from each kidney to the bladder. (NCI)Ureter
URETHRAC12417UrethraThe tube carrying urine from the bladder to outside of the body. (NCI)Urethra
URETHRA, ANTERIORC61125Anterior Portion of the UrethraThe portion of the urethra that extends from the meatus to the membranous urethra. (NCI)Anterior Portion of the Urethra
URETHRA, PENILEC61123Penile Portion of the UrethraThe portion of the urethra that spans the corpus spongiosum. (NCI)Penile Portion of the Urethra
URETHRA, POSTERIORC61126Posterior Portion of the UrethraThe portion of the urethra that is located on the posterior aspect of the urogenital diaphragm. (NCI)Posterior Portion of the Urethra
URETHRA, PROSTATICC13101Prostatic UrethraThat part of the male urethra that passes through the prostate gland. (NCI)Prostatic Urethra
URINARY SYSTEMC12413Urinary SystemThe organs involved in the creation and excretion of urine. (NCI)Urinary System
UTERUSC12405Uterus;WombA hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy. (NCI)Uterus
UVEAC12811UveaThe pigmented layer of the eyeball between the tough, white outer coat of the eye and the retina. (NCI)Uvea
VAGINAC12407VaginaThe female genital canal, extending from the uterus to the vulva. (NCI)Vagina
VAGUS NERVEC12812The 10th cranial nerve. The vagus is a mixed nerve which contains somatic afferents (from skin in back of the ear and the external auditory meatus), visceral afferents (from the pharynx, larynx, thorax, and abdomen), parasympathetic efferents (to the thorax and abdomen), and efferents to striated muscle (of the larynx and pharynx). (MSH2001)Vagus Nerve
VAS DEFERENSC12813Duct carrying spermatozoa. (NCI)Vas Deferens
VASTUS INTERMEDIUS MUSCLEC117876The portion of the quadriceps femoris muscle group that is underneath the Rectus Femoris muscle, spans and covers the upper two-thirds of the anterior and lateral surfaces of the femur, and inserts into the lateral border of the patella.Vastus Intermedius Muscle
VASTUS LATERALIS MUSCLEC53073The largest muscle of the quadriceps femoris muscle group that extends laterally from the intertrochanteric line of the femur to the lateral aspects of the quadriceps femoris tendon and patella.Vastus Lateralis
VASTUS MEDIALIS MUSCLEC117736The portion of the quadriceps femoris muscle group that extends medially from the intertrochanteric line of the femur to the medial aspects of the quadriceps femoris tendon and patella. (NCI)Vastus Medialis Muscle
VEINC12814VeinA blood vessel that carries blood towards the heart.Vein
VENA CAVAC12817Vena CavaA large vein which returns blood from the head, neck and extremities to the heart. (NCI)Vena Cava
VERTEBRAL COLUMNC12998Vertebral ColumnA series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone. The vertebral column forms the axis of the skeleton and encloses as well as protects the spinal cord and the fluid surrounding the spinal cord. (NCI)Vertebral Column
VESTIBULOCOCHLEAR NERVEC12996The eighth cranial nerve.Vestibulocochlear Nerve
VOCAL CORDC12822Vocal CordA pair of small bands of muscle that stretch from the thyroid cartilage in front to the arytenoid cartilage in back of the larynx. The vocal cords help prevent food entering the lungs and produce sound through vibration. (NCI)Vocal Cord
VOMERC33888VomerA thin, paired or unpaired, trapezoidal bone of the skull located in the floor of the nasal cavity. The vomer forms the posterior and inferior parts of the nasal septum. (NCI)Vomer
VULVAC12408External Genitalia;VulvaThe external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia. (NCI)Vulva
WAISTC64192WaistThe abdominal circumference at the navel. (NCI)Waist
WALDEYER'S TONSILLAR RINGC73468The ring of lymphoid tissue located in the pharynx, consisting of the pharyngeal, tubal, palatine, and lingual tonsils. (NCI)Waldeyer's Tonsillar Ring
WRIST JOINTC33894Wrist JointA joint between the distal end of the radius and the proximal row of carpal bones. (NCI)Wrist Joint
XIPHOID PROCESSC33895Xiphoid ProcessThe cartilage just below the sternal body. (NCI)Xiphoid Process
Back to top
CL.C101842.CACRDSCCanadian Cardiovascular Society Classification
(CACRDSC)
text
Extensible: No
C101842Canadian Cardiovascular Society ClassificationThe anginal classifications as measured by the Canadian Cardiovascular Society grading scale.CDISC SDTM Canadian Cardiovascular Society Classification Terminology
CCS CLASS 1C77265Canadian Cardiovascular Society Classification 1Ordinary physical activity, such as walking or climbing stairs, does not cause angina. Angina occurs with strenuous, rapid, or prolonged exertion at work or recreation.Canadian Cardiovascular Society Grading Scale Class I
CCS CLASS 2C77266Canadian Cardiovascular Society Classification 2Slight limitation of ordinary activity. Angina occurs on walking or climbing stairs rapidly, walking uphill, walking or climbing stairs after meals, or in cold, in wind, or under emotional stress, or only during the few hours after awakening. Angina occurs on walking more than 2 blocks on the level and climbing more than 1 flight of ordinary stairs at a normal pace and in normal conditions.Canadian Cardiovascular Society Grading Scale Class II
CCS CLASS 3C77267Canadian Cardiovascular Society Classification 3Marked limitations of ordinary physical activity. Angina occurs on walking 1 to 2 blocks on the level and climbing 1 flight of stairs in normal conditions and at a normal pace.Canadian Cardiovascular Society Grading Scale Class III
CCS CLASS 4C77268Canadian Cardiovascular Society Classification 4Inability to perform any physical activity without discomfort - anginal symptoms may be present at rest.Canadian Cardiovascular Society Grading Scale Class IV
Back to top
CL.C101859.CVPRCINDCardiac Procedure Indication
(CVPRCIND)
text
Extensible: Yes
C101859Cardiac Procedure IndicationThe reason that a subject had a cardiac procedure.CDISC SDTM Cardiac Procedure Indication Terminology
CANDIDATE TO RECEIVE CARDIAC TRANSPLANTC99919The intended recipient of a heart transplant.Candidate to Receive Cardiac Transplant
CARDIAC ARREST/ARRHYTHMIA ETIOLOGY UNKNOWNC100033An episode of cardiac arrest or arrhythmia where the etiology was unknown.Cardiac Arrest/Arrhythmia Etiology Unknown
CARDIOMYOPATHYC34830A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.Cardiomyopathy
CHRONIC TOTAL OCCLUSIONC99938A longstanding, complete blockage of a vessel.Chronic Total Occlusion Vessel
DONOR FOR CARDIAC TRANSPLANTC99947The subject contributing a heart for a cardiac transplant.Donor for Cardiac Transplant
END OF EXPECTED BATTERY LIFEC99949The battery that supplies the device has reached the end of its life.End of Expected Battery Life
FAULTY CONNECTOR/HEADERC100035There is a faulty connector/header in the device.Faulty Device Connector/Header
GENERATOR IS BEING REPLACED AT THE TIME OF LEAD REVISIONC99925A cardiac lead requires revision, at which time the generator to the device will be replaced.Cardiac Device Generator is Being Replaced at Time of Lead Revision
GENERATOR MALFUNCTIONC99943The device has a generator malfunction.Device Generator Malfunction
IMMEDIATE PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI)C99961An immediate percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation.Immediate Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction
INFECTIONC26726A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. (NCI)Infectious Disorder
LEAD EROSIONC99931A cardiac lead has damaged local tissue enough to require treatment.Cardiac Lead Erosion
LEFT VENTRICULAR SYSTOLIC DYSFUNCTIONC64251The degree of impairment of the left cardiac ventricle to contract efficiently.Left Ventricular Systolic Dysfunction
MANUFACTURER RECALLC100045An imperative issued by the manufacturer of a device that the device needs to be returned to a designated source for repair or replacement.Manufacturer Recall
MANUFACTURER RECOGNIZED A RECURRING PERFORMANCE FAILUREC99980The device manufacturer had recognized a recurrent performance failure in the device.Manufacturer Recognized a Recurring Performance Failure
MEDICAL CONDITION OR PROCEDURE AFFECTS IMPLANTATION SITEC99982The medical condition or the procedure affects the device implantation site.Medical Condition or Procedure Affects Implantation Site
MEDICAL OR SURGICAL PROCEDURE REQUIRING RELOCATION OF LEADC99983An intended medical or surgical procedure necessitates the relocation of a cardiac lead.Medical or Surgical Procedure Requiring Relocation of Lead
PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR HIGH RISK NON-ST ELEVATION MYOCARDIAL INFARCTION OR UNSTABLE ANGINAC99999Includes patients with unstable angina or Non-STEMI who have high risk features for short-term risk of death or nonfatal MI. High risk features includes at least one of the following: history of accelerating tempo of ischemic symptoms in preceding 48 hours; character of pain - prolonged ongoing (greater than 20 minutes) rest pain; clinical findings - pulmonary edema, most likely due to ischemia or new or worsening mitral regurgitation murmur; or S3 or new worsening rales or Hypotension, bradycardia, tachycardia or age greater than 75 years; ECG - angina at rest with transient ST-segment changes greater than 0.5 mm or bundle-branch block, new or presumed new or sustained ventricular tachycardia; cardiac markers - NSTEMI patients with elevated cardiac TnT, Tnl, or CK-MB.Percutaneous Coronary Intervention for High Risk Non-ST Elevation Myocardial Infarction or Unstable Angina
PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (STABLE AFTER SUCCESSFUL FULL-DOSE THROMBOLYTICS)C100001A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject does not have recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia after a successful dose of thrombolytic therapy.Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Stable After Successful Full-Dose Thrombolytic Therapy
PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (STABLE, >12 HRS FROM SYMPTOM ONSET)C100000A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject does not have recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia. The presentation is past twelve hours since onset of symptoms.Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Stable-Over 12 Hours From Symptom Onset
PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (UNSTABLE, >12 HRS FROM SYMPTOM ONSET)C100002A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject has recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia. The presentation is past twelve hours since onset of symptoms.Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Unstable-Over 12 Hours From Symptom Onset
POST-CARDIAC TRANSPLANTC100005A procedure to evaluate the health of the an individual after receiving a heart transplant.Post-Cardiac Transplant Evaluation
PRE-OPERATIVE EVALUATION FOR NON-CARDIOVASCULAR SURGERYC100006A procedure to evaluate the health of the cardiac system to determine feasibility of a non-cardiac related surgical procedure.Pre-Operative Evaluation for Non-Cardiovascular Surgery
PRIMARY PREVENTIONC15306A procedure performed to avoid the first occurrence of a disease condition.Primary Prevention
RESCUE PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (AFTER FAILED FULL-DOSE THROMBOLYTICS)C100008A percutaneous coronary intervention is imperative for a myocardial infarction that presents with ST segment elevation after an unsatisfactory response to a full dose of thrombolytic therapy.Rescue Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction After Failed Full-Dose Thrombolytic Therapy
SECONDARY PREVENTIONC15712A procedure performed to avoid a subsequent occurrence of a disease condition.Secondary Prevention
SPONTANEOUS SUSTAINED VENTRICULAR TACHYCARDIAC100014Ventricular tachycardia that occurs without provocation and does not resolve spontaneously.Spontaneous Sustained Ventricular Tachycardia by ECG Finding
STAGED PERCUTANEOUS CORONARY INTERVENTION (PCI)C100015A subsequent Percutaneous Coronary Intervention in a planned series of procedures, where the first PCI could have been during a prior admission, or during this admission.Staged Percutaneous Coronary Intervention
SYNCOPE WITH HIGH RISK CHARACTERISTICSC100018A sudden loss of consciousness with loss of postural tone not related to anesthesia with high risk characteristics. High risk characteristics include non-ischemic dilated cardiomyopathy, or ischemic heart disease with significant ventricular dysfunction, hypertrophic cardiomyopathy, Brugada Syndrome, or Long QT Syndrome.Syncope with High Risk Cardiac Characteristics
SYNCOPE WITH INDUCIBLE VENTRICULAR TACHYCARDIAC100019Sudden loss of consciousness with loss of postural tone not related to anesthesia with ventricular tachycardia (VT) that can be induced during an electrophysiological study.Syncope with Inducible Ventricular Tachycardia by ECG Finding
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
UPGRADE TO A DEVICE WITH ADDITIONAL PACING CAPABILITIESC100030A device with additional pacing capabilities is replacing the current device.Upgrade to Cardiac Device with Additional Pacing Capabilities
VENTRICULAR FIBRILLATIONC50799Ventricular Fibrillation is characterized by rapid, usually more than 300 bpm (cycle length: 180 ms or less), grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude.Ventricular Fibrillation
Back to top
CL.C101866.CRYDFMANCardiac Rhythm Device Failure Manifestation
(CRYDFMAN)
text
Extensible: Yes
C101866Cardiac Rhythm Device Failure ManifestationThe effect that a cardiac rhythm device malfunction had on the ability to stimulate the heart.CDISC SDTM Cardiac Rhythm Device Failure Manifestation Terminology
ATRIAL PACING MALFUNCTIONC99921The cardiac rhythm device malfunction affected atrial pacing.Cardiac Atrial Pacing Malfunction
DEFIBRILLATION MALFUNCTIONC99923The cardiac rhythm device malfunction affected the defibrillator.Cardiac Defibrillator Malfunction
LEFT VENTRICULAR PACING MALFUNCTIONC99973The cardiac rhythm device malfunction affected the left ventricular (LV) pacing.Left Cardiac Ventricular Pacing Malfunction
RIGHT VENTRICULAR PACING MALFUNCTIONC100011The cardiac rhythm device malfunction affected the right ventricular (RV) pacing.Right Cardiac Ventricle Pacing Malfunction
Back to top
CL.C101853.CVLVRSEVCardiac Valvular Regurgitation Severity
(CVLVRSEV)
text
Extensible: No
C101853Cardiac Valvular Regurgitation SeverityA terminology codelist to describe the severity of cardiac valvular regurgitation.CDISC SDTM Cardiac Valvular Regurgitation Severity Terminology
MILD CARDIAC VALVE REGURGITATIONC99985Evidence of mild retrograde blood flow through the valve(s) of the heart.Mild Cardiac Valve Regurgitation
MODERATE CARDIAC VALVE REGURGITATIONC99989Evidence of moderate retrograde blood flow through the valve(s) of the heart.Moderate Cardiac Valve Regurgitation
NO CARDIAC VALVE REGURGITATIONC99991No evidence of any retrograde blood flow through the valve(s) in the heart.No Cardiac Valve Regurgitation
SEVERE CARDIAC VALVE REGURGITATIONC100012Evidence of severe retrograde blood flow through the valve(s) of the heart.Severe Cardiac Valve Regurgitation
Back to top
CL.C101854.CVLSTSEVCardiac Valvular Stenosis Severity
(CVLSTSEV)
text
Extensible: No
C101854Cardiac Valvular Stenosis SeverityA terminology codelist to describe the severity of cardiac valvular stenosis.CDISC SDTM Cardiac Valvular Stenosis Severity Terminology
MILD CARDIAC VALVE STENOSISC99986The cardiac valve orifice is abnormally narrow, to a mild degree.Mild Cardiac Valve Stenosis
MODERATE CARDIAC VALVE STENOSISC99990The cardiac valve orifice is abnormally narrow, to a moderate degree.Moderate Cardiac Valve Stenosis
NO CARDIAC VALVE STENOSISC99992The cardiac valve orifice is not abnormally narrow.No Cardiac Valve Stenosis
SEVERE CARDIAC VALVE STENOSISC100013The cardiac valve orifice is abnormally narrow, to a severe degree.Severe Cardiac Valve Stenosis
Back to top
CL.C119016.CVFARSCardiovascular Findings About Results
(CVFARS)
text
Extensible: No
C119016Cardiovascular Findings About ResultsTerminology responses used for the cardiovascular findings about test codes and names codelist within CDISC.CDISC SDTM Cardiovascular Findings About Results Terminology
ANGIOGRAPHYC20080A method used to create an image of blood vessels.Angiography
AUGMENTATION OF ORAL DIURETIC THERAPYC119199Initiation or intensification of orally administered medication(s) that promote diuresis to treat heart failure.Oral Diuretic Therapy Augmentation for Heart Failure
AUTOPSYC25153A postmortem examination of the body.Autopsy
CLINICALLY SIGNIFICANT OR RAPID WEIGHT GAINC119200Weight gain thought to be related to fluid retention.Weight Gain Due to Fluid Retention
CORONARY LESION ON ANGIOGRAPHYC119201Angiographic evidence of new or worse greater than or equal to 70 percent lesion and/or thrombus in an epicardial coronary artery believed to be responsible for the myocardial ischemic symptoms/signs. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press)Coronary Lesion by Angiographic Finding
CORONARY REVASCULARIZATIONC119202Need for coronary revascularization procedure (PCI or CABG) for the presumed culprit lesion(s). This criterion would be fulfilled if revascularization was undertaken during the unscheduled hospitalization, or subsequent to transfer to another institution without interceding home discharge. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press)Coronary Revascularization Procedure
DECREASED EXERCISE TOLERANCEC119203Reduced ability to withstand or participate in activities that induce physical or mental exertion.Decreased Exercise Tolerance
DYSPNEAC2998Includes dyspnea on exertion, dyspnea at rest, orthopnea, and paroxysmal nocturnal dyspnea.Dyspnea
FATIGUEC3036Unusual tiredness and inability to perform usual activities.Fatigue
HEART FAILURE HOSPITALIZATIONC119204An event where the patient is admitted to the hospital with a primary diagnosis of heart failure (HF), where the length of stay is at least 24 hours (or extends over a calendar date), where the patient exhibits new or worsening symptoms of HF on presentation, has objective evidence of new or worsening HF, and receives initiation or intensification of treatment specifically for HF. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press)Hospitalization Due to Heart Failure
HEMORRHAGIC STROKEC95803An acute episode of focal or global cerebral or spinal dysfunction caused by intraparenchymal, intraventricular, or subarachnoid hemorrhage.Hemorrhagic Cerebrovascular Accident
INCREASE IN HEART FAILURE BIOMARKERC119205Biomarker increase (B-type natriuretic peptide (BNP)/ N-terminal pro-BNP (NT-proBNP)) consistent with decompensation of heart failure (such as BNP greater than 500 pg/mL or NT-proBNP greater than 2,000 pg/mL). In patients with chronically elevated natriuretic peptides, a significant increase above baseline is required. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press)Increase in B-type Natriuretic Peptide or N-terminal pro-B-type Natriuretic Peptide
INCREASED JUGULAR VENOUS PRESSURE OR HEPATOJUGULAR REFLUXC119206Increase in the estimated height of the mean jugular venous waveform above the right atrium in cm.Increase in Jugular Venous Pressure
INCREASING ABDOMINAL DISTENTION OR ASCITESC2885Intra-abdominal fluid accumulation as determined by physical examination (in the absence of primary hepatic disease).Ascites
INDUCIBLE MYOCARDIAL ISCHEMIAC119207Definite evidence of inducible myocardial ischemia believed to be responsible for the myocardial ischemic symptoms/signs, demonstrated by any of the following: a) an early positive exercise stress test, defined as ST elevation of greater than or equal to 2 mm ST depression prior to 5 mets, b) stress echocardiography (reversible wall motion abnormality), c) myocardial scintigraphy (reversible perfusion defect), d) MRI (myocardial perfusion deficit under pharmacologic stress). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press)Inducible Myocardial Ischemia
INTRAVENOUS DIURETIC, INOTROPE, OR VASODILATOR THERAPYC119208Initiation or intensification of medication(s) administered by vein to treat heart failure, to increase the production of urine, increase cardiac performance, and/or reduce cardiac preload or afterload.Intravenous Diuretic, Inotropic or Vasodilator Augmentation for Heart Failure
INVASIVE DIAGNOSTIC EVIDENCE OF HEART FAILUREC119209Invasive diagnostic evidence with right heart catheterization showing a pulmonary capillary wedge pressure (pulmonary artery occlusion pressure) greater than or equal to 18 mmHg, central venous pressure greater than or equal to 12 mmHg, or a cardiac index less than 2.2 L/min/m2. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press)Heart Failure by Invasive Diagnostic Technique
ISCHEMIC STROKEC95802Ischemic stroke is defined as an acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of central nervous system tissue.Ischemic Cerebrovascular Accident
LOSS OF A SIDE BRANCHC119210Angiographic loss of patency of a side branch.Loss of Patency of Side Branch
LOSS OF MAJOR CORONARYC119211Angiographic loss of patency of a major epicardial vessel.Loss of Patency of Major Vessel
MECHANICAL OR SURGICAL INTERVENTIONC119212Mechanical circulatory support (e.g., intra-aortic balloon pump, ventricular assist device, extracorporeal membrane oxygenation, total artificial heart) or mechanical fluid removal (e.g., ultrafiltration, hemofiltration, dialysis). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press)Vasculature Mechanical or Surgical Intervention
NEW LOSS OF VIABLE MYOCARDIUMC119213Non-invasive imaging evidence of a loss of viable myocardium when compared with the most recent previous non-invasive imaging study.New Loss of Viable Myocardium by Non-invasive Imaging Technique
NEW REGIONAL WALL MOTION ABNORMALITYC119214Non-invasive imaging evidence of a decrease in regional wall motion contractility compared with the most recent previous non-invasive imaging study.New Regional Wall Motion Abnormality by Non-invasive Imaging Technique
NON-INVASIVE DIAGNOSTIC EVIDENCE OF HEART FAILUREC119215Non-invasive diagnostic evidence of clinically significant elevated left- or right-sided ventricular filling pressure or low cardiac output. For example, echocardiographic criteria could include: E/e' greater than 15 or D-dominant pulmonary venous inflow pattern, plethoric inferior vena cava with minimal collapse on inspiration, or decreased left ventricular outflow tract (LVOT) minute stroke distance (time velocity integral (TVI)). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press)Heart Failure by Non-invasive Diagnostic Technique
PERIPHERAL EDEMAC78262Increased tissue fluid indicated by perceptible pitting indentation on lower leg, foot or sacrum after palpation.Edema Limbs
PULMONARY RALES/CRACKLES/CREPITATIONSC119216Abnormal breath sounds caused by the accumulation of fluid in the lungs.Rales
RADIOLOGICAL EVIDENCE OF PULMONARY CONGESTIONC119217Imaging findings consistent with increased intravascular blood volume in the lungs.Pulmonary Congestion by Radiological Technique
RESTING ECG CHANGESC119218New or worsening ST or T wave changes on resting ECG (in the absence of confounders, such as LBBB or LVH), defined as either: a) Transient ST elevation (duration less than 20 minutes): new ST elevation at the J point in any two contiguous leads (other than leads V2-V3) of greater than or equal to 0.1 mV. In leads V2-V3, the following cut-points apply: greater than or equal to 0.2 mV in men greater than or equal to 40 years, greater than or equal to 0.25 mV in men less than 40 years, and greater than or equal to 0.15 mV in women, or b) ST depression and T-wave changes: new horizontal or down-sloping ST depression greater than or equal to 0.05 mV in two contiguous leads and/or new T inversion greater than or equal to 0.3 mV in two contiguous leads with prominent R wave or R/S ratio greater than 1.Resting ECG Changes
S3 GALLOPC61455Presence of mid-diastolic heart sound.S3 Gallop
SLOW-FLOW/NO-FLOW/EMBOLIZATIONC119219Angiographic reduction of flow into the coronary microcirculation.Flow Reduced in Coronary Microcirculation
TYPE 1 MYOCARDIAL INFARCTIONC119220Spontaneous clinical syndrome related to atherosclerotic plaque rupture, ulceration, fissuring, erosion, or dissection, with resulting intraluminal thrombus, and leading to decreased myocardial blood flow or distal platelet emboli with ensuing myocyte necrosis. This classification requires a) detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value greater than 99th percentile of the upper reference limit (URL) and b) at least one of the following: symptoms of myocardial ischemia; new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB) on the ECG; development of pathological Q waves on the ECG; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality; identification of an intracoronary thrombus by angiography or autopsy. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.)Joint Task Force Type 1 Myocardial Infarction
TYPE 2 MYOCARDIAL INFARCTIONC119221Ischemic imbalance: Spontaneous clinical syndrome where a condition other than coronary artery disease contributes to an imbalance between myocardial oxygen supply and/or demand, e.g. coronary endothelial dysfunction, coronary artery spasm, coronary embolism, tachy-/brady-arrhythmias, anemia, respiratory failure, hypotension, and hypertension with or without left ventricular hypertrophy. This classification requires detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value greater than 99th percentile of the upper reference limit (URL) and b) at least one of the following: symptoms of myocardial ischemia; new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB) on the ECG; development of pathological Q waves on the ECG; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.)Joint Task Force Type 2 Myocardial Infarction
TYPE 3 MYOCARDIAL INFARCTIONC119222Death, No Biomarkers: Death where symptoms suggestive of myocardial ischemia are present, and with (presumed) new ischemic changes or new LBBB on ECG, but where death occurs before cardiac biomarkers can be obtained, or before cardiac biomarker values could rise. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.)Joint Task Force Type 3 Myocardial Infarction
TYPE 4A MYOCARDIAL INFARCTIONC119223PCI Related: PCI Related Myocardial infarction associated with and occurring within 48h of percutaneous coronary intervention, with elevation of cardiac biomarker values to greater than 5x 99th percentile of the upper reference limit (URL) in patients with normal baseline values (less than or equal to 99th percentile URL), or a rise of cardiac biomarker values greater than or equal to 20% if the baseline values are elevated and are stable or falling. This classification also requires at least one of the following: symptoms of myocardial ischemia; new ischemic ECG changes or new LBBB; angiographic loss of patency of a major coronary artery or a side branch or persistent slow- or no-flow or embolization; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.)Joint Task Force Type 4A Myocardial Infarction
TYPE 4B MYOCARDIAL INFARCTIONC119224Stent Thrombosis: Myocardial infarction associated with stent thrombosis as detected by coronary angiography or at autopsy, where symptoms suggestive of myocardial ischemia are present, and with a rise and/or fall of cardiac biomarkers values, with at least one value greater than 99th percentile of the upper reference limit. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.)Joint Task Force Type 4B Myocardial Infarction
TYPE 4C MYOCARDIAL INFARCTIONC119225Stent Restenosis: Myocardial infarction associated with stent restenosis as detected by coronary angiography or at autopsy, occurring more than 48h after percutaneous coronary intervention, without evidence of stent thrombosis but with symptoms suggestive of myocardial ischemia, and with elevation of cardiac biomarker values to greater than 99th percentile of the upper reference limit (URL). This classification also requires the following: does not meet criteria for any other classification of myocardial infarction; presence of a greater than or equal to 50 percent stenosis at the site of previous successful stent PCI. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.)Joint Task Force Type 4C Myocardial Infarction
TYPE 5 MYOCARDIAL INFARCTIONC119226CABG Related: Myocardial infarction associated with and occurring within 48h of coronary artery bypass graft surgery, with elevation of cardiac biomarker values to greater than 10x 99th percentile of the upper reference limit (URL) in patients with normal baseline cardiac biomarker values (less than or equal to 99th percentile URL). This classification also requires at least one of the following: new pathologic Q waves or new LBBB on ECG; angiographic new graft or new native coronary artery occlusion; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.)Joint Task Force Type 5 Myocardial Infarction
UNDETERMINED STROKEC3390An acute episode of focal or global neurological dysfunction caused by presumed brain, spinal cord, or retinal vascular injury as a result of hemorrhage or infarction but with insufficient information to allow categorization as ischemic or hemorrhagic.Cerebrovascular Accident
URGENT HEART FAILURE VISITC119227An event where the patient has an urgent, unscheduled office/practice or emergency department visit for a primary diagnosis of heart failure (HF) but is not admitted to the hospital, where the patient exhibits new or worsening symptoms of HF on presentation, has objective evidence of new or worsening HF, and receives initiation or intensification of treatment specifically for HF, with the exception that changes to oral diuretic therapy do no qualify as initiation or intensification of treatment. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press)ER or Office Visit Due to Heart Failure
VOLUME OVERLOADC50591Excessive accumulation of intravascular fluid resulting from compromised regulatory mechanisms.Hypervolemia
WORSENED END-ORGAN PERFUSIONC119228Decreased blood supply to the vital organs (kidney, liver, lungs, heart, brain).Worsened End-Organ Perfusion
Back to top
CL.C119015.CVFATSCDCardiovascular Findings About Test Code
(CVFATSCD)
text
Extensible: No
C119015Cardiovascular Findings About Test CodeTerminology relevant to the test codes that describe findings about a cardiovascular event or intervention.CDISC SDTM Cardiovascular Findings About Test Code Terminology
ACMITYPEC118936Acute Myocardial Infarction TypeCategorization of the type of acute myocardial infarction.Acute Myocardial Infarction Type
CATMTHIDC119229Coronary Artery Thrombosis Method IdentThe method by which the coronary artery thrombosis event is determined or diagnosed.Coronary Artery Thrombosis Method of Identification
ENDPTINDC119230Endpoint Event IndicatorAn indication as to whether the event meets the criteria for being a clinical endpoint.Endpoint Event Indicator
HETYPEC119231Healthcare Encounter TypeCategorization of the type of healthcare encounter.Healthcare Encounter Type
HFLBFNWC119232Heart Failure New/Worsening Lab FindingsCategorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation.Lab Findings of New or Worsening Heart Failure
HFPEFNWC119233Heart Failure New/Worsening PE FindingsCategorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation.Physical Examination Findings of New or Worsening Heart Failure
HFTHERINC119234Heart Failure Therapy, IntensificationCategorization of the type(s) of new and/or intensified treatment administered for heart failure management.Heart Failure Therapy Intensification Type
ISCDINDC119235Ischemic Discomfort IndicatorAn indicator as to whether the subject has symptoms of ischemic discomfort.Ischemic Discomfort Indicator
ISCETYPC119236Ischemic Evidence TypeCategorization of the type of objective evidence of new or worsening ischemia.Ischemic Evidence Type
MI12EXCC119237Exclusion of Type 1 and Type 2 MIAn indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis.Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator
NWSYMPC119238New or Worsening SymptomsA description of the new or worsening symptoms related to a clinical event.New or Worsening Symptom
PCIAACC119239PCI Acute Angiographic ComplicationCategorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia.Acute Myocardial Infarction From PCI Complication Type
PRSUCINDC119240Procedure Success IndicatorAn indication as to whether the procedure is considered successful.Procedure Success Indicator
PRUSTATC101230Procedure Urgency Status TypeThe degree of urgency in which a medical procedure must be performed.Triage Status
STROKTYPC119579Stroke TypeCategorization of the type of stroke.Stroke Type
SYMPINDCC119241Symptom IndicatorAn indication as to whether the subject had symptoms related to the clinical event.Symptom Indicator
SYMSTDTCC119242Symptom Onset DateThe date time of the onset of symptoms of the clinical event.Symptom Onset Date
VOC48INDC119243Vessel Occlusion After CABG 48 IndAn indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure.Vessel Occlusion 48 Hours after CABG Indicator
Back to top
CL.C119014.CVFATSCardiovascular Findings About Test Name
(CVFATS)
text
Extensible: No
C119014Cardiovascular Findings About Test NameTerminology relevant to the test names that describe findings about a cardiovascular event or intervention.CDISC SDTM Cardiovascular Findings About Test Name Terminology
Acute Myocardial Infarction TypeC118936Acute Myocardial Infarction TypeCategorization of the type of acute myocardial infarction.Acute Myocardial Infarction Type
Coronary Artery Thrombosis Method IdentC119229Coronary Artery Thrombosis Method IdentThe method by which the coronary artery thrombosis event is determined or diagnosed.Coronary Artery Thrombosis Method of Identification
Endpoint Event IndicatorC119230Endpoint Event IndicatorAn indication as to whether the event meets the criteria for being a clinical endpoint.Endpoint Event Indicator
Exclusion of Type 1 and Type 2 MIC119237Exclusion of Type 1 and Type 2 MIAn indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis.Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator
Healthcare Encounter TypeC119231Healthcare Encounter TypeCategorization of the type of healthcare encounter.Healthcare Encounter Type
Heart Failure New/Worsening Lab FindingsC119232Heart Failure New/Worsening Lab FindingsCategorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation.Lab Findings of New or Worsening Heart Failure
Heart Failure New/Worsening PE FindingsC119233Heart Failure New/Worsening PE FindingsCategorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation.Physical Examination Findings of New or Worsening Heart Failure
Heart Failure Therapy, IntensificationC119234Heart Failure Therapy, IntensificationCategorization of the type(s) of new and/or intensified treatment administered for heart failure management.Heart Failure Therapy Intensification Type
Ischemic Discomfort IndicatorC119235Ischemic Discomfort IndicatorAn indicator as to whether the subject has symptoms of ischemic discomfort.Ischemic Discomfort Indicator
Ischemic Evidence TypeC119236Ischemic Evidence TypeCategorization of the type of objective evidence of new or worsening ischemia.Ischemic Evidence Type
New or Worsening SymptomsC119238New or Worsening SymptomsA description of the new or worsening symptoms related to a clinical event.New or Worsening Symptom
PCI Acute Angiographic ComplicationC119239PCI Acute Angiographic ComplicationCategorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia.Acute Myocardial Infarction From PCI Complication Type
Procedure Success IndicatorC119240Procedure Success IndicatorAn indication as to whether the procedure is considered successful.Procedure Success Indicator
Procedure Urgency Status TypeC101230Procedure Urgency Status TypeThe degree of urgency in which a medical procedure must be performed.Triage Status
Stroke TypeC119579Stroke TypeCategorization of the type of stroke.Stroke Type
Symptom IndicatorC119241Symptom IndicatorAn indication as to whether the subject had symptoms related to the clinical event.Symptom Indicator
Symptom Onset DateC119242Symptom Onset DateThe date time of the onset of symptoms of the clinical event.Symptom Onset Date
Vessel Occlusion After CABG 48 IndC119243Vessel Occlusion After CABG 48 IndAn indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure.Vessel Occlusion 48 Hours after CABG Indicator
Back to top
CL.C101847.CVTESTCDCardiovascular Test Code
(CVTESTCD)
text
Extensible: Yes
C101847Cardiovascular Test CodeA terminology codelist to describe the test code for a physiological examination of the cardiovascular system.CDISC SDTM Cardiovascular Test Code Terminology
CARDIDXC119245Cardiac IndexThe measure of an individual's cardiac output divided by the individual's body surface area (CI= CO/BSA).Cardiac Index
CARDOUTC119246Cardiac OutputThe total volume of blood pumped by the heart over a set period of time, conventionally one minute; it is calculated as heart rate times stroke volume (CO= HR x SV).Cardiac Output
COARTDOMC100086Coronary Artery DominanceThe pattern of the epicardial vessels supplying the posterolateral and posterior descending coronary arteries.Coronary Artery Dominance
CVLREGTSC102244Cardiac Valvular Regurgitation SeverityThe qualitative measurement of the severity of cardiac valvular regurgitation.Cardiac Valvular Regurgitation Severity
CVLSTNSC102245Cardiac Valvular Stenosis SeverityThe qualitative measurement of the severity of cardiac valvular stenosis.Cardiac Valvular Stenosis Severity
ISHMYOPC80494Ischemic Myocardium PercentageThe percentage of myocardial tissue which exhibits characteristics of inadequate blood flow (ischemia).Ischemic Myocardium Percentage
LADMNC99970Left Atrium DimensionThe diameter across the left atrium measured at the end of systole.Left Atrium Dimension
LVDMNEDC99976Left Ventricle Dimension, End-DiastoleThe diameter across the ventricle at the end of diastole, excluding the thickness of the walls.Left Ventricle Dimension at End-Diastole
LVDMNESC99977Left Ventricular Dimension, End-SystoleThe diameter across the ventricle at the end of systole, excluding the thickness of the walls.Left Ventricular Dimension at End-Systole
LVEFC99524Left Ventricular Ejection FractionThe percent or fraction of the left ventricular end diastolic volume ejected in systole. The left ventricular ejection fraction is equal to the left ventricular stroke volume divided by the left ventricular end diastolic volume.Left Ventricular Ejection Fraction
NUMDCAVC99996Number of Diseased Coronary VesselsNumber of major epicardial vessels with greater than or equal to 70% reduction in diameter or greater than or equal to 50% reduction in cross-sectional area.Number of Diseased Coronary Artery Vessels
PVRC119247Pulmonary Vascular ResistanceThe resistance to blood flow through the pulmonary vasculature.Pulmonary Vascular Resistance
SVRC119248Systemic Vascular ResistanceThe resistance to blood flow through the systemic vasculature.Systemic Vascular Resistance
Back to top
CL.C101846.CVTESTCardiovascular Test Name
(CVTEST)
text
Extensible: Yes
C101846Cardiovascular Test NameA terminology codelist to describe the test name for a physiological examination of the cardiovascular system.CDISC SDTM Cardiovascular Test Name Terminology
Cardiac IndexC119245Cardiac IndexThe measure of an individual's cardiac output divided by the individual's body surface area (CI= CO/BSA).Cardiac Index
Cardiac OutputC119246Cardiac OutputThe total volume of blood pumped by the heart over a set period of time, conventionally one minute; it is calculated as heart rate times stroke volume (CO= HR x SV).Cardiac Output
Cardiac Valvular Regurgitation SeverityC102244Cardiac Valvular Regurgitation SeverityThe qualitative measurement of the severity of cardiac valvular regurgitation.Cardiac Valvular Regurgitation Severity
Cardiac Valvular Stenosis SeverityC102245Cardiac Valvular Stenosis SeverityThe qualitative measurement of the severity of cardiac valvular stenosis.Cardiac Valvular Stenosis Severity
Coronary Artery DominanceC100086Coronary Artery DominanceThe pattern of the epicardial vessels supplying the posterolateral and posterior descending coronary arteries.Coronary Artery Dominance
Ischemic Myocardium PercentageC80494Ischemic Myocardium PercentageThe percentage of myocardial tissue which exhibits characteristics of inadequate blood flow (ischemia).Ischemic Myocardium Percentage
Left Atrium DimensionC99970Left Atrium DimensionThe diameter across the left atrium measured at the end of systole.Left Atrium Dimension
Left Ventricle Dimension, End-DiastoleC99976Left Ventricle Dimension, End-DiastoleThe diameter across the ventricle at the end of diastole, excluding the thickness of the walls.Left Ventricle Dimension at End-Diastole
Left Ventricular Dimension, End-SystoleC99977Left Ventricular Dimension, End-SystoleThe diameter across the ventricle at the end of systole, excluding the thickness of the walls.Left Ventricular Dimension at End-Systole
Left Ventricular Ejection FractionC99524Left Ventricular Ejection FractionThe percent or fraction of the left ventricular end diastolic volume ejected in systole. The left ventricular ejection fraction is equal to the left ventricular stroke volume divided by the left ventricular end diastolic volume.Left Ventricular Ejection Fraction
Number of Diseased Coronary VesselsC99996Number of Diseased Coronary VesselsNumber of major epicardial vessels with greater than or equal to 70% reduction in diameter or greater than or equal to 50% reduction in cross-sectional area.Number of Diseased Coronary Artery Vessels
Pulmonary Vascular ResistanceC119247Pulmonary Vascular ResistanceThe resistance to blood flow through the pulmonary vasculature.Pulmonary Vascular Resistance
Systemic Vascular ResistanceC119248Systemic Vascular ResistanceThe resistance to blood flow through the systemic vasculature.Systemic Vascular Resistance
Back to top
CL.C74558.DSCATCategory for Disposition Event
(DSCAT)
text
Extensible: No
C74558Category for Disposition EventClassifications that describe and group pertinent events that occur throughout the conduct of a clinical trial.CDISC SDTM Category For Disposition Event Terminology
DISPOSITION EVENTC74590Disposition EventThe group of incidents that occur during a clinical trial and describe whether a subject completed the study epoch or the reason this event did not occur. The subject's disposition is often described for each phase of the study.Protocol Disposition Event
OTHER EVENTC74589Other EventOther important events that occur during a trial but are not driven by protocol requirements.Protocol Event
PROTOCOL MILESTONEC74588Protocol MilestoneOccurrences within some epochs that are initiated by a protocol-specified event. The most common protocol milestone is "Informed Consent Obtained" which usually documents the start of the study.Protocol Milestone
Back to top
CL.C66797.IECATCategory for Inclusion/Exclusion
(IECAT)
text
Extensible: No
C66797Category for Inclusion/ExclusionA collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI)CDISC SDTM Category for Inclusion And Or Exclusion Terminology
EXCLUSIONC25370List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)Exclusion Criteria
INCLUSIONC25532The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study. NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)Inclusion Criteria
Back to top
CL.C66784.TOXGRV3Common Terminology Criteria for Adverse Events V3.0
(TOXGRV3)
text
Extensible: No
C66784Common Terminology Criteria for Adverse Events V3.0A standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration. The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)CDISC SDTM Common Terminology Criteria for Adverse Event Grade Terminology V3.0
1C413381;Grade 1A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.Mild Adverse Event
2C413392;Grade 2A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.Moderate Adverse Event
3C413403;Grade 3A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention.Severe Adverse Event
4C413374;Grade 4;LIFE THREATENINGAn adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.) See NCI Common Terminology Criteria for Adverse Events.Life Threatening or Disabling Adverse Event
5C482755;FATAL;Grade 5The termination of life as a result of an adverse event. (NCI)Death Related to Adverse Event
Back to top
CL.C87162.TOXGRV4Common Terminology Criteria for Adverse Events V4.0
(TOXGRV4)
text
Extensible: No
C87162Common Terminology Criteria for Adverse Events V4.0The version 4.0 standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE) are used to study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration. The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)CDISC SDTM Common Terminology Criteria for Adverse Event Grade Terminology Version 4.0
0C755330;ABSENT;Grade 0Grade 0 is universally defined as absence of Adverse Events or within normal limits or values.Absent Adverse Event
1C842631;Grade 1;MILDAn adverse event that is asymptomatic; or involves mild or minor symptoms; or is of marginal clinical relevance; or consists of clinical or diagnostic observations alone; or for which intervention is not indicated; or for which only non-prescription intervention is indicated.Mild Adverse Event
2C842642;Grade 2;MODERATEAn adverse event for which only minimal, local, or noninvasive intervention (e.g. packing, cautery) is indicated; or that limits instrumental activities of daily living (ADLs, e.g., shopping, laundry, transportation, or ability to conduct finances).Moderate Adverse Event
3C842653;Grade 3;SEVEREAn adverse event that is medically significant but not life-threatening; or for which inpatient care or prolongation of hospitalization are indicated; or that is an important medical event that does not result in hospitalization, but may jeopardize the patient or may require intervention either to prevent hospitalization, to prevent the AE from becoming life-threatening or causing death; or that is disabling; or that results in persistent or significant disability, incapacity, or limitation of self care activities of daily living (ADLs, e.g., getting in and out of bed, dressing, eating, getting around inside, bathing, or using the toilet).Severe Adverse Event
4C842664;Grade 4;LIFE THREATENINGAn adverse event that has life-threatening consequences; for which urgent intervention is indicated; that puts the patient at risk of death at the time of the event if immediate intervention is not undertaken; or that causes blindness or deafness.Life Threatening Adverse Event
5C482755;FATAL;Grade 5The termination of life as a result of an adverse event. (NCI)Death Related to Adverse Event
Back to top
CL.C66727.NCOMPLTCompletion/Reason for Non-Completion
(NCOMPLT)
text
Extensible: Yes
C66727Completion/Reason for Non-CompletionThe status of the subject's completion of the study or a segment of the study, or the reason the subject discontinued the study or segment of the study.CDISC SDTM Reason for Non-Completion Terminology
ADVERSE EVENTC41331Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. [Modified from ICH E2A] Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience. (CDISC glossary)Adverse Event
COMPLETEDC25250To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)Complete
DEATHC28554DiedThe absence of life or state of being dead. (NCI)Death
DISEASE RELAPSEC38155Recurrent DiseaseThe return of a disease after a period of remission.Recurrent Disease
FAILURE TO MEET RANDOMIZATION CRITERIAC105448An indication that the subject has been unable to fulfill/satisfy the criteria required for assignment into a randomized group.Failure to Meet Randomization Criteria
LACK OF EFFICACYC48226The lack of expected or desired effect related to a therapy. (NCI)Lack of Efficacy
LOST TO FOLLOW-UPC48227The loss or lack of continuation of a subject to follow-up.Lost To Follow-up
NON-COMPLIANCE WITH STUDY DRUGC49631An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI)Non-Compliance With Study Drug
OTHERC17649OtherDifferent than the one(s) previously specified or mentioned. (NCI)Other
PHYSICIAN DECISIONC48250A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI)Physician Decision
PREGNANCYC25742Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI)Pregnancy
PROGRESSIVE DISEASEC35571Progressive DiseaseA disease process that is increasing in scope or severity. (NCI)Progressive Disease
PROTOCOL DEVIATIONC48251An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI)Protocol Violation
RECOVERYC25746A healing process and/or an outcome implying relative health. The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI)Recovery
SCREEN FAILUREC49628The potential subject who does not meet one or more criteria required for participation in a trial.Trial Screen Failure
SITE TERMINATED BY SPONSORC106576An indication that a clinical study was stopped at a particular site by its sponsor. (NCI)Trial Site Terminated by Sponsor
STUDY TERMINATED BY SPONSORC49632An indication that a clinical study was stopped by its sponsor. (NCI)Study Terminated By Sponsor
TECHNICAL PROBLEMSC49633A problem with some technical aspect of a clinical study, usually related to an instrument. (NCI)Technical Problem
WITHDRAWAL BY PARENT/GUARDIANC102355An indication that a study participant has been removed from the study by the parent or legal guardian.Study Subject Withdrawal by Parent or Guardian
WITHDRAWAL BY SUBJECTC49634An indication that a study participant has removed itself from the study. (NCI)Withdrawal by Subject
Back to top
CL.C101838.CCRCLSCDConsensus Cardiac Classification System Test Code
(CCRCLSCD)
text
Extensible: Yes
C101838Consensus Cardiac Classification System Test CodeClassification system test code for cardiac parameters that are authored or endorsed by organizations.CDISC SDTM Consensus Cardiac Classification Systems Test Code Terminology
CCSGRDSC66910Canadian CV Society Grading ScaleA finding associated with a patient based on the functional classification developed by the Canadian Cardiovascular Society (CCS), for categorizing patients with angina. The classification system comprises four classes, which are defined in terms of the level of physical activity associated with the subject's anginal symptoms.Canadian Cardiovascular Society Grading Scale Class
KILLIPCLC66916Killip ClassA finding associated with a patient based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic blood pressure.Killip Class
LSNCPCLSC100032ACC/AHA Lesion Complexity ClassA classification system for coronary stenosis based upon characteristics that influence the difficulty of percutaneous coronary revascularization.American College of Cardiology/American Heart Association Lesion Complexity Class
NYHACLSC66909New York Heart Association ClassA finding associated with a patient based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. The classification system is based on the ability to engage in physical activity. The classification system comprises four classes, though NYHA Class III and Class IV are often aggregated for the purpose of outcomes analysis.New York Heart Association Class
TIMIFLOWC100021TIMI FlowA grading system for coronary blood flow based on the classification developed by the Thrombolysis in Myocardial Infarction Group. It classifies coronary blood flow into four classes based upon the angiographic appearance of the blood vessels.Thrombolysis in Myocardial Infarction Flow
Back to top
CL.C101837.CCRCLSConsensus Cardiac Classification System Test Name
(CCRCLS)
text
Extensible: Yes
C101837Consensus Cardiac Classification System Test NameClassification system test name for cardiac parameters that are authored or endorsed by organizations.CDISC SDTM Consensus Cardiac Classification Systems Test Name Terminology
ACC/AHA Lesion Complexity ClassC100032ACC/AHA Lesion Complexity ClassA classification system for coronary stenosis based upon characteristics that influence the difficulty of percutaneous coronary revascularization.American College of Cardiology/American Heart Association Lesion Complexity Class
Canadian CV Society Grading ScaleC66910Canadian CV Society Grading ScaleA finding associated with a patient based on the functional classification developed by the Canadian Cardiovascular Society (CCS), for categorizing patients with angina. The classification system comprises four classes, which are defined in terms of the level of physical activity associated with the subject's anginal symptoms.Canadian Cardiovascular Society Grading Scale Class
Killip ClassC66916Killip ClassA finding associated with a patient based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic blood pressure.Killip Class
New York Heart Association ClassC66909New York Heart Association ClassA finding associated with a patient based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. The classification system is based on the ability to engage in physical activity. The classification system comprises four classes, though NYHA Class III and Class IV are often aggregated for the purpose of outcomes analysis.New York Heart Association Class
TIMI FlowC100021TIMI FlowA grading system for coronary blood flow based on the classification developed by the Thrombolysis in Myocardial Infarction Group. It classifies coronary blood flow into four classes based upon the angiographic appearance of the blood vessels.Thrombolysis in Myocardial Infarction Flow
Back to top
CL.C102575.CCINVTYPContact Case Investigation Contact Type
(CCINVTYP)
text
Extensible: Yes
C102575Contact Case Investigation Contact TypeTerminology relevant to the identification and clinical investigation of disease contacts.CDISC SDTM Contact Case Investigation Contact Type Terminology
CASUAL CONTACTC102606A way of contracting a disease through everyday interactions (nonsexual) with an infected person.Casual Contact
CONTACT WITH EXPOSURE DURING MEDICAL PROCEDUREC102609A way of contracting a disease by interacting with an individual that has been exposed to the disease while undergoing a medical procedure.Contact With Exposure During Medical Procedure
CONTACT WITH EXPOSURE IN CROWD SETTINGC102610A way of contracting a disease by physically associating with an infected group of individuals.Contact With Exposure In Crowd Setting
CONTACT WITH MEDICAL RISK FACTORC102611A way of contracting a disease by interacting with an individual that is considered at high risk for having the disease.Contact With Medical Risk Factor
HOUSEHOLD CONTACTC102646A way of contracting a disease through interactions with an infected person in the same residence.Household Contact
Back to top
CL.C102588.SETCONContact Setting
(SETCON)
text
Extensible: Yes
C102588Contact SettingTerminology relevant to the environment within which the subject may have come into contact with a disease carrier, or played the role of a disease carrier.CDISC SDTM Contact Setting Terminology
FARMC48953A tract of land cultivated for the purpose of agricultural production or devoted to the raising and breeding of domestic animals.Farm
HOUSEHOLD ENVIRONMENTC102647The area in which an individual lives.Household Environment
NON-HOUSEHOLD ENVIRONMENTC102679An area outside of that in which an individual lives.Non-household Environment
PRISONC85862An institution where persons are confined for punishment and to protect the public.Correctional Institution
SCHOOLC17118An educational institution.School
SOCIAL SETTINGC102712The surroundings or environment in which social activities occur.Social Setting
WORKSITEC17556Place or physical location of work or employment.Worksite
Back to top
CL.C66785.TCNTRLControl Type
(TCNTRL)
text
Extensible: Yes
C66785Control TypeComparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).CDISC SDTM Control Type Terminology
ACTIVEC49649A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10].Active Control
NONEC41132No person or thing, nobody, not any. (NCI)None
PLACEBOC49648Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the drug or treatment under study. The effects of the active drug or treatment are compared to the effects of the placebo. (NCI)Placebo Control
Back to top
CL.C101843.CADPRSNCoronary Artery Disease Presentation
(CADPRSN)
text
Extensible: No
C101843Coronary Artery Disease PresentationA terminology codelist associated with coronary artery disease presentation.CDISC SDTM Coronary Artery Disease Presentation Terminology
NON-ST ELEVATION MYOCARDIAL INFARCTIONC80383NON-STEMI;NSTEMIA myocardial infarction that does not produce elevation in the ST segments of the ECG.Non-ST Elevation Myocardial Infarction by ECG Finding
ST ELEVATION MYOCARDIAL INFARCTIONC101888STEMIA myocardial infarction that produces elevation in the ST segments of the ECG.ST Elevation Myocardial Infarction by ECG Finding
STABLE ANGINAC66914Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration of oral, sublingual or transdermal antianginal medications.Stable Angina
UNSTABLE ANGINAC66911Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest.Unstable Angina
VARIANT ANGINAC66915A variant form of angina pectoris caused by coronary artery vasospasm, usually occurring spontaneously and frequently associated with ST segment elevation.Variant Angina
Back to top
CL.C101849.CADRISKCoronary Artery Disease Risk
(CADRISK)
text
Extensible: No
C101849Coronary Artery Disease RiskA terminology codelist to describe the relative risk of coronary artery disease.CDISC SDTM Coronary Artery Disease Risk Terminology
HIGH CAD RISKC99955High Coronary Artery Disease RiskThe likelihood an individual will develop coronary artery disease is almost certain or greater than 90%. (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.)High Coronary Artery Disease Risk
INTERMEDIATE CAD RISKC99966Intermediate Coronary Artery Disease RiskThe likelihood an individual will develop coronary artery disease (CAD) is moderate or between 10% and 90%. (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.)Intermediate Coronary Artery Disease Risk
KNOWN CADC99968Known Coronary Artery DiseaseThe individual has coronary artery disease (CAD). (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.)Known Coronary Artery Disease
LOW CAD RISKC99978Low Coronary Artery Disease RiskThe likelihood an individual will develop coronary artery disease (CAD) is minimal or less than10%.(Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.)Low Coronary Artery Disease Risk
Back to top
CL.C101844.CADSYMPCoronary Artery Disease Symptoms
(CADSYMP)
text
Extensible: No
C101844Coronary Artery Disease SymptomsA terminology codelist that contains symptoms associated with coronary artery disease.CDISC SDTM Coronary Artery Disease Symptoms Terminology
ATYPICAL CORONARY ARTERY DISEASE SYMPTOMSC99917Sharp stabbing chest pain or reproduction of pain on palpation. Less common isolated presentations, primarily in older adults, include nausea and vomiting, diaphoresis, and unexplained fatigue. J Am Coll Cardiol, 2007; 50:1-157, doi:10.1016/j.jacc.2007.02.013 (Published online 6 August 2007).Atypical Coronary Artery Disease Symptom
NO SYMPTOMSC3833The finding of no indications of a particular disease or injury.Asymptomatic
NON-CARDIAC CHEST PAINC78504A discomfort in the chest area that is not related to the heart.Non-Cardiac Chest Pain
TYPICAL CORONARY ARTERY DISEASE SYMPTOMSC100024Deep, poorly localized chest or arm discomfort that is reproducibly associated with physical exertion or emotional stress and is relieved promptly (ie, in less than 5 minutes) with rest and/or the use of sublingual nitroglycerin. Some patients may have no chest discomfort but present solely with jaw, neck, ear, arm, shoulder, back, or epigastric discomfort or with unexplained dyspnea without discomfort. If these symptoms have a clear relationship to exertion or stress or are relieved promptly with nitrates, they should be considered equivalent to angina. J Am Coll Cardiol, 2007; 50:1-157, doi:10.1016/j.jacc.2007.02.013 (Published online 6 August 2007).Typical Coronary Artery Disease Symptom
Back to top
CL.C119018.CADGRSCoronary Artery Dissection NHLBI Grade Responses
(CADGRS)
text
Extensible: No
C119018Coronary Artery Dissection NHLBI Grade ResponsesA terminology codelist relevant to the National Heart, Lung, and Blood Institute grade for coronary artery dissection and perforation.CDISC SDTM NHLBI Coronary Artery Dissection Grade Responses Terminology
CORONARY DISSECTION NHLBI GRADE AC119588Minor radiolucencies within the lumen during contrast injection with no persistence after dye clearance. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9)NHLBI Coronary Artery Dissection Type A
CORONARY DISSECTION NHLBI GRADE BC119589Parallel tracts or double lumen separated by a radiolucent area during contrast injection with no persistence after dye clearance. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9)NHLBI Coronary Artery Dissection Type B
CORONARY DISSECTION NHLBI GRADE CC119590Extraluminal cap with persistence of contrast after dye clearance from the lumen. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9)NHLBI Coronary Artery Dissection Type C
CORONARY DISSECTION NHLBI GRADE DC119591Spiral luminal filling defect with delayed but complete distal flow. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9)NHLBI Coronary Artery Dissection Type D
CORONARY DISSECTION NHLBI GRADE EC119592New persistent filling defect with delayed antegrade flow. May represent thrombus. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9)NHLBI Coronary Artery Dissection Type E
CORONARY DISSECTION NHLBI GRADE FC119593Non-A-E types with total coronary occlusion and no distal antegrade flow. May represent thrombus. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9)NHLBI Coronary Artery Dissection Type F
Back to top
CL.C101860.CARTDOMCoronary Artery Dominance
(CARTDOM)
text
Extensible: No
C101860Coronary Artery DominanceA codelist to describe the pattern of the epicardial vessels supplying the posterior descending artery and the posterolateral branches.CDISC SDTM Coronary Artery Dominance Terminology
CO-DOMINANTC99941The right coronary artery supplies the posterior descending artery and the circumflex supplies the posterolateral branches.Co-Dominant Artery
LEFT DOMINANTC99971The left circumflex artery supplies the posterior descending artery and the posterolateral branches.Left Cardiac Artery Dominance
RIGHT DOMINANTC99942The right coronary artery supplies the posterior descending artery and the posterolateral branches.Coronary Artery Right Dominance
Back to top
CL.C119017.CTTIMIRSCoronary Thrombus TIMI Grade Responses
(CTTIMIRS)
text
Extensible: No
C119017Coronary Thrombus TIMI Grade ResponsesA terminology codelist relevant to the Thrombolysis in Myocardial Infarction group grade for the description of coronary thrombus as visualized during angiography.CDISC SDTM Coronary Thrombus TIMI Grade Responses Terminology
CORONARY THROMBUS TIMI GRADE 1C119583Possible thrombus present - angiography demonstrates characteristics such as reduced contrast density, haziness, irregular lesion contour or a smooth convex 'meniscus' at the site of total occlusion suggestive but not diagnostic of thrombus. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.)TIMI Coronary Thrombus Grade 1
CORONARY THROMBUS TIMI GRADE 2C119584Small size definite thrombus, with greatest dimensions less than or equal to 1/2 vessel diameter. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.)TIMI Coronary Thrombus Grade 2
CORONARY THROMBUS TIMI GRADE 3C119585Moderate size definite thrombus, with greatest linear dimension greater than 1/2 but less than 2 vessel diameters. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.)TIMI Coronary Thrombus Grade 3
CORONARY THROMBUS TIMI GRADE 4C119586Large size definite thrombus, with the largest dimension greater than or equal to 2 vessel diameters. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.)TIMI Coronary Thrombus Grade 4
CORONARY THROMBUS TIMI GRADE 5C119587Total vessel occlusion. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.)TIMI Coronary Thrombus Grade 5
Back to top
CL.C101850.CVSLDEXTCoronary Vessel Disease Extent
(CVSLDEXT)
text
Extensible: No
C101850Coronary Vessel Disease ExtentA terminology codelist to describe the extent of coronary artery disease.CDISC SDTM Coronary Vessel Disease Extent Terminology
INDETERMINATEC48658InconclusiveCannot distinguish between two or more possible values in the current context. (NCI)Indeterminate
INSIGNIFICANT DISEASEC119244A finding of stenosis of less than 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in a major epicardial vessel, without stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in any major epicardial vessel. (NCI)Insignificant Disease by ECG Finding
NO DISEASEC99993There was no stenosis in any coronary artery or branch vessel.No Evidence of Coronary Artery Disease
ONE VESSEL DISEASEC99997There was stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in one major epicardial vessel or its major branches.One Vessel Coronary Disease
THREE VESSEL DISEASEC100020There was one of the following: Stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in all three major epicardial vessels (anterior descending, posterior descending, circumflex) or their major branches; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main and greater than or equal to 70 percent reduction in diameter, or 50 percent reduction in cross-sectional area of the right coronary artery with a right dominant or co-dominant circulation; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main with a left dominant circulation.Three Vessel Coronary Disease
TWO VESSEL DISEASEC100023There was one of the following: Stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in two major epicardial vessels or their major branches; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main with a right dominant or co-dominant circulation, and no stenosis of greater than or equal to 70 percent reduction in diameter, or 50 percent reduction in cross-sectional area in the right coronary artery.Two Vessel Coronary Disease
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C66786.COUNTRYCountry
(COUNTRY)
text
Extensible: No
C66786CountryA collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI)CDISC SDTM Country Terminology
ABWC17884ARUBAIsland in the Caribbean Sea, north of Venezuela. (NCI)Aruba
AFGC16267AFGHANISTANA country in Southern Asia, north and west of Pakistan, east of Iran. (NCI)Afghanistan
AGOC16292ANGOLAA country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo. (NCI)Angola
AIAC20133ANGUILLAAn island in the Caribbean Sea, east of Puerto Rico. (NCI)Anguilla
ALAC44481ALAND ISLANDSAn archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland. (NCI)Aland Islands
ALBC16271ALBANIAA country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro. (NCI)Albania
ANDC16289ANDORRAA country in Southwestern Europe, between France and Spain. (NCI)Andorra
AREC17232UNITED ARAB EMIRATESA country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia. (NCI)United Arab Emirates
ARGC16305ARGENTINAA country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay. (NCI)Argentina
ARMC16306ARMENIAA country in Southwestern Asia, east of Turkey. (NCI)Armenia
ASMC17739AMERICAN SAMOAA group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand. (NCI)American Samoa
ATAC18007ANTARCTICAThe continent lying mostly south of the Antarctic Circle. (NCI)Antarctica
ATFC20105FRENCH SOUTHERN TERRITORIESIslands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia. (NCI)French Southern and Antarctic Lands
ATGC16303ANTIGUA AND BARBUDAIslands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico. (NCI)Antigua and Barbuda
AUSC16311AUSTRALIAThe continent between the Indian Ocean and the South Pacific Ocean. (NCI)Australia
AUTC16312AUSTRIAA country in Central Europe, north of Italy and Slovenia. (NCI)Austria
AZEC16316AZERBAIJANA country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia. (NCI)Azerbaijan
BDIC16371BURUNDIA country in Central Africa, east of Democratic Republic of the Congo. (NCI)Burundi
BELC16329BELGIUMA country in Western Europe, bordering the North Sea, between France and the Netherlands. (NCI)Belgium
BENC16333BENIN;BENIN REPUBLICA country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo. (NCI)Benin
BESC101224BONAIRE, SINT EUSTATIUS AND SABAThree Caribbean islands that are part of the Lesser Antilles; Bonaire is east of Aruba and Curacao off the coast of Venezuela, Sint Eustatius and Saba are located south of Sint Maarten and northeast of Saint Kitts and Nevis. (NCI)Bonaire, Sint Eustatius and Saba
BFAC16369BURKINA FASOA country in Western Africa, north of Ghana. (NCI)Burkina Faso
BGDC16323BANGLADESHA country in Southern Asia, bordering the Bay of Bengal, between Burma and India. (NCI)Bangladesh
BGRC16368BULGARIAA country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey. (NCI)Bulgaria
BHRC16322BAHRAINAn archipelago in the Persian Gulf, east of Saudi Arabia. (NCI)Bahrain
BHSC16321BAHAMASA chain of islands in the North Atlantic Ocean, southeast of Florida. (NCI)Bahamas
BIHC16361BOSNIA AND HERZEGOVINA;BOSNIA-HERZEGOVINAA country in Southeastern Europe, bordering the Adriatic Sea and Croatia. (NCI)Bosnia and Herzegovina
BLMC83609SAINT BARTHELEMYAn island in the Caribbean sea, between Saint Martin and Saint Kitts and Nevis. (NCI)Saint Barthelemy
BLRC16372BELARUSA country in Eastern Europe, east of Poland. (NCI)Belarus
BLZC16331BELIZEA country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico. (NCI)Belize
BMUC16334BERMUDAA group of islands in the North Atlantic Ocean, east of South Carolina. (NCI)Bermuda
BOLC16359BOLIVIA;BOLIVIA, PLURINATIONAL STATE OFA country in Central South America, southwest of Brazil. (NCI)Bolivia, Plurinational State of
BRAC16364BRAZILA country in Eastern South America, bordering the Atlantic Ocean. (NCI)Brazil
BRBC16324BARBADOSAn island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela. (NCI)Barbados
BRNC16367BRUNEI;BRUNEI DARUSSALAMA country in Southeastern Asia, bordering the South China Sea and Malaysia. (NCI)Brunei Darussalam
BTNC16336BHUTANA country in Southern Asia, between China and India. (NCI)Bhutan
BVTC20104BOUVET ISLANDAn island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa). (NCI)Bouvet Island
BWAC16363BOTSWANAA country in Southern Africa, north of South Africa. (NCI)Botswana
CAFC16409CENTRAL AFRICAN REPUBLICA country in Central Africa, north of Democratic Republic of the Congo. (NCI)Central African Republic
CANC16380CANADAA country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US. (NCI)Canada
CCKC16445COCOS (KEELING) ISLANDSA group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka. (NCI)Cocos (Keeling) Islands
CHEC17181SWITZERLANDA country in Central Europe, east of France, north of Italy. (NCI)Switzerland
CHLC16427CHILEA country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru. (NCI)Chile
CHNC16428CHINAA country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam. (NCI)China
CIVC16762COTE D'IVOIREA country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia. (NCI)Cote d'Ivoire
CMRC16379CAMEROONA country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria. (NCI)Cameroon
CODC17266CONGO, THE DEMOCRATIC REPUBLIC OF;DEMOCRATIC REPUBLIC OF THE CONGOA country in Central Africa, northeast of Angola. (NCI)Congo, the Democratic Republic of the
COGC16467CONGOA country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon. (NCI)Congo
COKC16469COOK ISLANDSA group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI)Cook Islands
COLC16449COLOMBIAA country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama. (NCI)Colombia
COMC16458COMOROSA group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique. (NCI)Comoros
CPVC16382CAPE VERDEA group of islands in the North Atlantic Ocean, west of Senegal. (NCI)Cape Verde
CRIC16470COSTA RICAA country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama. (NCI)Costa Rica
CUBC16477CUBAAn island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida. (NCI)Cuba
CUWC101225CURACAOAn island nation located in the Caribbean Sea off the coast of Venezuela. (NCI)Curacao
CXRC44482CHRISTMAS ISLANDAn Australian-administered island in the eastern Indian Ocean south of Java, Indonesia. (NCI)Christmas Island
CYMC16391CAYMAN ISLANDSAn island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras. (NCI)Cayman Islands
CYPC16480CYPRUSAn island in the Mediterranean Sea, south of Turkey. (NCI)Cyprus
CZEC17668CZECH REPUBLICA country in Central Europe, southeast of Germany. (NCI)Czech Republic
DEUC16636GERMANYA country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. (NCI)Germany
DJIC16506DJIBOUTIA country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia. (NCI)Djibouti
DMAC16519DOMINICAAn island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago. (NCI)Dominica
DNKC16496DENMARKA country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn). (NCI)Denmark
DOMC16520DOMINICAN REPUBLICA country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti. (NCI)Dominican Republic
DZAC16274ALGERIAA country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia. (NCI)Algeria
ECUC16528ECUADORA country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru. (NCI)Ecuador
EGYC16530EGYPTA country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip. (NCI)Egypt
ERIC16558ERITREAA country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan. (NCI)Eritrea
ESHC20113WESTERN SAHARAA country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco. (NCI)Western Sahara
ESPC17152SPAINA country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France. (NCI)Spain
ESTC16562ESTONIAA country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia. (NCI)Estonia
ETHC16563ETHIOPIAA country in Eastern Africa, west of Somalia. (NCI)Ethiopia
FINC16584FINLANDA country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. (NCI)Finland
FJIC16582FIJIAn island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI)Fiji
FLKC17954FALKLAND ISLANDS;FALKLAND ISLANDS (MALVINAS)Islands in the South Atlantic Ocean, east of southern Argentina. (NCI)Falkland Islands (Malvinas)
FRAC16592FRANCEA country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain. (NCI)France
FROC16573FAROE ISLANDSAn island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway. (NCI)Faroe Islands
FSMC17881MICRONESIA, FEDERATED STATES OFAn island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia. (NCI)Micronesia, Federated States of
GABC16596GABONA country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea. (NCI)Gabon
GBRC17233UNITED KINGDOMA country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France. (NCI)United Kingdom
GEOC16634GEORGIAA country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia. (NCI)Georgia (Republic)
GGYC64375GUERNSEYThe island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK. (NCI)Guernsey
GHAC26330GHANAA country in Western Africa, bordering the Gulf of Guinea, between Cote d'Ivoire and Togo. (NCI)Ghana
GIBC16638GIBRALTARA dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain. (NCI)Gibraltar
GINC16655GUINEAA country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone. (NCI)Guinea
GLPC16651GUADELOUPEIslands in the eastern Caribbean Sea, southeast of Puerto Rico. (NCI)Guadeloupe
GMBC16598GAMBIAA country in Western Africa, bordering the North Atlantic Ocean and Senegal. (NCI)The Gambia
GNBC16656GUINEA-BISSAUA country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal. (NCI)Guinea-Bissau
GNQC16557EQUATORIAL GUINEAA country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands. (NCI)Equatorial Guinea
GRCC16645GREECEA country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. (NCI)Greece
GRDC16647GRENADAAn island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago. (NCI)Grenada
GRLC16646GREENLANDAn island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada. (NCI)Greenland
GTMC16654GUATEMALAA country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico. (NCI)Guatemala
GUFC16593FRENCH GUIANAA country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname. (NCI)French Guiana
GUMC16652GUAMIsland in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines. (NCI)Guam
GUYC16657GUYANAA country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela. (NCI)Guyana
HKGC16695HONG KONGA special administrative region of China, bordering the South China Sea and China. (NCI)Hong Kong
HMDC20106HEARD ISLAND AND MCDONALD ISLANDSIslands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica. (NCI)Heard Island and McDonald Islands
HNDC16694HONDURASA country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua. (NCI)Honduras
HRVC16474CROATIAA country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia. (NCI)Croatia
HTIC16660HAITIA country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic. (NCI)Haiti
HUNC16699HUNGARYA country in Central Europe, northwest of Romania. (NCI)Hungary
IDNC16728INDONESIAA country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean. (NCI)Indonesia
IMNC44480ISLE OF MANAn island in the Irish Sea, between Great Britain and Ireland. (NCI)Isle of Man
INDC16727INDIAA country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. (NCI)India
IOTC16365BRITISH INDIAN OCEAN TERRITORYAn archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia. (NCI)British Indian Ocean Territory
IRLC16757IRELANDA country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain. (NCI)Ireland
IRNC16755IRANA country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. (NCI)Iran, Islamic Republic of
IRQC16756IRAQA country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait. (NCI)Iraq
ISLC16704ICELANDA country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK. (NCI)Iceland
ISRC16760ISRAELA country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. (NCI)Israel
ITAC16761ITALYA country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. (NCI)Italy
JAMC16763JAMAICAAn island in the Caribbean Sea, south of Cuba. (NCI)Jamaica
JEYC64374JERSEYJersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK. (NCI)Jersey
JORC16765JORDANA country in the Middle East, northwest of Saudi Arabia. (NCI)Jordan
JPNC16764JAPANA country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. (NCI)Japan
KAZC20107KAZAKHSTANA country in Central Asia, northwest of China. (NCI)Kazakhstan
KENC16769KENYAA country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania. (NCI)Kenya
KGZC16771KYRGYZSTANA country in Central Asia, west of China. (NCI)Kyrgyzstan
KHMC16378CAMBODIAA country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos. (NCI)Cambodia
KIRC16639KIRIBATIA group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia. (NCI)Kiribati
KNAC17885SAINT KITTS AND NEVISIslands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago. (NCI)Saint Kitts and Nevis
KORC16774KOREA, REPUBLIC OF;SOUTH KOREAA country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea. (NCI)Korea, Republic of
KWTC16775KUWAITA country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia. (NCI)Kuwait
LAOC16780LAO PEOPLE'S DEMOCRATIC REPUBLICA country in Southeastern Asia, northeast of Thailand, west of Vietnam. (NCI)Lao People's Democratic Republic
LBNC16784LEBANONA country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria. (NCI)Lebanon
LBRC16791LIBERIAA country in Western Africa, bordering the North Atlantic Ocean, between Cote d'Ivoire and Sierra Leone. (NCI)Liberia
LBYC16793LIBYAA country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia. (NCI)Libya
LCAC17113SAINT LUCIAA country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago. (NCI)Saint Lucia
LIEC16794LIECHTENSTEINA country in Central Europe, between Austria and Switzerland. (NCI)Liechtenstein
LKAC17163SRI LANKAA country in Southern Asia, occupying an island in the Indian Ocean, south of India. (NCI)Sri Lanka
LSOC16787LESOTHOA country in Southern Africa, an enclave of South Africa. (NCI)Lesotho
LTUC16799LITHUANIAA country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia. (NCI)Lithuania
LUXC16803LUXEMBOURGA country in Western Europe, between France, Belgium, and Germany. (NCI)Luxembourg
LVAC16783LATVIAA country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania. (NCI)Latvia
MACC16807MACAOA country in Eastern Asia, bordering the South China Sea and China. (NCI)Macau
MAFC83610SAINT MARTIN (FRENCH PART);SAINT MARTIN, FRENCHAn island in the Caribbean sea, between Anguilla and Saint Barthelemy. (NCI)Saint Martin (French Part)
MARC16878MOROCCOA country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara. (NCI)Morocco
MCOC16874MONACOA country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy. (NCI)Monaco
MDAC16871MOLDOVA, REPUBLIC OFA country in Eastern Europe, northeast of Romania. (NCI)Moldova, Republic of
MDGC16808MADAGASCARA country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique. (NCI)Madagascar
MDVC16815MALDIVESA country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India. (NCI)Maldives
MEXC16850MEXICOA country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US. (NCI)Mexico
MHLC16822MARSHALL ISLANDSA group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia. (NCI)Marshall Islands
MKDC17654MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF;REPUBLIC OF MACEDONIAA country in Southeastern Europe, north of Greece. (NCI)Macedonia, the Former Yugoslav Republic of
MLIC16816MALIA country in Western Africa, southwest of Algeria. (NCI)Mali
MLTC16817MALTAA country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy). (NCI)Malta
MMRC16370MYANMARA country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand. (NCI)Myanmar
MNEC64378MONTENEGROA republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia). (NCI)Montenegro
MNGC16875MONGOLIAA country in Northern Asia, between China and Russia. (NCI)Mongolia
MNPC17882NORTHERN MARIANA ISLANDSA country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines. (NCI)Northern Mariana Islands
MOZC16882MOZAMBIQUEA country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania. (NCI)Mozambique
MRTC16826MAURITANIAA country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara. (NCI)Mauritania
MSRC16876MONTSERRATA country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico. (NCI)Montserrat
MTQC16823MARTINIQUEAn island in the Caribbean Sea, north of Trinidad and Tobago. (NCI)Martinique
MUSC16827MAURITIUSA country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar. (NCI)Mauritius
MWIC16813MALAWIA country in Southern Africa, east of Zambia. (NCI)Malawi
MYSC16814MALAYSIAA country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam. (NCI)Malaysia
MYTC16828MAYOTTEA country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique. (NCI)Mayotte
NAMC16891NAMIBIAA country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa. (NCI)Namibia
NCLC16913NEW CALEDONIAA country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia. (NCI)New Caledonia
NERC16916NIGERA country in Western Africa, southeast of Algeria. (NCI)Niger
NFKC16919NORFOLK ISLANDA country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia. (NCI)Norfolk Island
NGAC16917NIGERIAA country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon. (NCI)Nigeria
NICC16915NICARAGUAA country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras. (NCI)Nicaragua
NIUC16918NIUEA country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga. (NCI)Niue
NLDC16903NETHERLANDSA country in Western Europe, bordering the North Sea, between Belgium and Germany. (NCI)Netherlands
NORC16920NORWAYA country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden. (NCI)Norway
NPLC16901NEPALA country in Southern Asia, between China and India. (NCI)Nepal
NRUC16896NAURUA country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands. (NCI)Nauru
NZLC16914NEW ZEALANDA country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia. (NCI)New Zealand
OMNC16933OMANA country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates. (NCI)Oman
PAKC16949PAKISTANA country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north. (NCI)Pakistan
PANC16951PANAMAA country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica. (NCI)Panama
PCNC16993PITCAIRNA country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand. (NCI)Pitcairn
PERC16972PERUA country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador. (NCI)Peru
PHLC16978PHILIPPINESA country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam. (NCI)Philippines
PLWC17733PALAUA country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines. (NCI)Palau
PNGC16952PAPUA NEW GUINEAA country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia. (NCI)Papua New Guinea
POLC17002POLANDA country in Central Europe, east of Germany. (NCI)Poland
PRIC17043PUERTO RICOAn island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic. (NCI)Puerto Rico
PRKC16773KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF;NORTH KOREAA country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea. (NCI)Korea, Democratic People's Republic of
PRTC17006PORTUGALA country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain. (NCI)Portugal
PRYC16953PARAGUAYA country in Central South America, northeast of Argentina. (NCI)Paraguay
PSEC20110PALESTINIAN TERRITORY, OCCUPIEDA collective name for the West Bank and the Gaza Strip, two territories in Palestine. (NCI)Palestinian Territory, Occupied
PYFC16594FRENCH POLYNESIAAn archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia. (NCI)French Polynesia
QATC17045QATARA country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia. (NCI)Qatar
REUC17095REUNIONA country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar. (NCI)Reunion
ROUC17108ROMANIAA country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine. (NCI)Romania
RUSC17111RUSSIAN FEDERATIONA country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean. (NCI)Russian Federation
RWAC17112RWANDAA country in Central Africa, east of Democratic Republic of the Congo. (NCI)Rwanda
SAUC17117SAUDI ARABIAA country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen. (NCI)Saudi Arabia
SDNC17170SUDANA country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea. (NCI)Sudan
SENC17121SENEGALA country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania. (NCI)Senegal
SGPC17134SINGAPOREA country in Southeastern Asia, comprised of islands between Malaysia and Indonesia. (NCI)Singapore
SGSC20111SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDSA group of islands in the South Atlantic Ocean, east of the tip of South America. (NCI)South Georgia and the South Sandwich Islands
SHNC17164SAINT HELENA;SAINT HELENA, ASCENSION AND TRISTAN DA CUNHAIslands in the South Atlantic Ocean, about midway between South America and Africa. (NCI)Saint Helena, Ascension and Tristan da Cunha
SJMC17178SVALBARD AND JAN MAYENIslands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway. (NCI)Svalbard and Jan Mayen
SLBC17148SOLOMON ISLANDSA group of islands in the South Pacific Ocean, east of Papua New Guinea. (NCI)Solomon Islands
SLEC17130SIERRA LEONEA country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia. (NCI)Sierra Leone
SLVC16532EL SALVADORA country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras. (NCI)El Salvador
SMRC17115SAN MARINOA country in Southern Europe, an enclave in central Italy. (NCI)San Marino
SOMC17149SOMALIAA country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia. (NCI)Somalia
SPMC17165SAINT PIERRE AND MIQUELONA country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada). (NCI)Saint Pierre and Miquelon
SRBC64377SERBIAA republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia). (NCI)Serbia
SSDC97351SOUTH SUDANA northeastern African country located in the Sahel region and bordered by Sudan in the north, Uganda and Kenya in the south and Ethiopia in the west. (NCI)South Sudan
STPC17116SAO TOME AND PRINCIPEA country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon. (NCI)Sao Tome and Principe
SURC17175SURINAMEA country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana. (NCI)Suriname
SVKC17669SLOVAKIAA country in Central Europe, south of Poland. (NCI)Slovakia
SVNC17138SLOVENIAA country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia. (NCI)Slovenia
SWEC17180SWEDENA country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway. (NCI)Sweden
SWZC17179SWAZILANDA country in Southern Africa, between Mozambique and South Africa. (NCI)Swaziland
SXMC101226SINT MAARTEN (DUTCH PART);SINT MAARTEN (DUTCH)The southern portion of an island in the Caribbean sea, between Anguilla and Saint Barthelemy. (NCI)Sint Maarten (Dutch Part)
SYCC17129SEYCHELLESA country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar. (NCI)Seychelles
SYRC17182SYRIAN ARAB REPUBLICA country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey. (NCI)Syrian Arab Republic
TCAC17224TURKS AND CAICOS ISLANDSTwo island groups in the North Atlantic Ocean, southeast of The Bahamas. (NCI)Turks and Caicos Islands
TCDC16412CHADA country in Central Africa, south of Libya. (NCI)Chad
TGOC17202TOGOA country in Western Africa, bordering the Bight of Benin, between Benin and Ghana. (NCI)Togo
THAC17192THAILANDA country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma. (NCI)Thailand
TJKC17183TAJIKISTANA country in Central Asia, west of China. (NCI)Tajikistan
TKLC17704TOKELAUA group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI)Tokelau
TKMC17223TURKMENISTANA country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan. (NCI)Turkmenistan
TLSC17200TIMOR-LESTEA country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco. (NCI)Timor-Leste
TONC17205TONGAAn archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI)Tonga
TTOC17217TRINIDAD AND TOBAGOIslands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela. (NCI)Trinidad and Tobago
TUNC17221TUNISIAA country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya. (NCI)Tunisia
TURC17222TURKEYA country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria. (NCI)Turkey
TUVC17225TUVALUAn island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia. (NCI)Tuvalu
TWNC17184TAIWANA group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China. (NCI)Taiwan, Province of China
TZAC17185TANZANIA, UNITED REPUBLIC OFA country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique. (NCI)Tanzania, United Republic of
UGAC17228UGANDAA country in Eastern Africa, west of Kenya. (NCI)Uganda
UKRC17229UKRAINEA country in Eastern Europe, bordering the Black Sea, between Poland and Russia. (NCI)Ukraine
UMIC20112UNITED STATES MINOR OUTLYING ISLANDSThe U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll). (NCI)United States Minor Outlying Islands
URYC17244URUGUAYA country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil. (NCI)Uruguay
USAC17234UNITED STATESA country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico. (NCI)United States
UZBC17246UZBEKISTANA country in Central Asia, north of Afghanistan. (NCI)Uzbekistan
VATC17249VATICAN CITY STATEAn enclave of Rome (Italy). (NCI)Holy See (Vatican City State)
VCTC17114SAINT VINCENT AND THE GRENADINESA country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago. (NCI)Saint Vincent and the Grenadines
VENC17250VENEZUELA;VENEZUELA, BOLIVARIAN REPUBLIC OFA country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana. (NCI)Venezuela, Bolivian Republic of
VGBC17653VIRGIN ISLANDS, BRITISHIslands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico. (NCI)Virgin Islands, British
VIRC17255VIRGIN ISLANDS, U.S.Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico. (NCI)Virgin Islands, U.S.
VNMC17252VIET NAM;VIETNAMA country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia. (NCI)Viet Nam
VUTC17247VANUATUA group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia. (NCI)Vanuatu
WLFC17259WALLIS AND FUTUNAIslands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI)Wallis and Futuna
WSMC17740SAMOAA group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI)Samoa
YEMC17264YEMENA country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia. (NCI)Yemen
ZAFC17151SOUTH AFRICAA country in Southern Africa, at the southern tip of the continent of Africa. (NCI)South Africa
ZMBC17267ZAMBIAA country in Southern Africa, east of Angola. (NCI)Zambia
ZWEC17268ZIMBABWEA country in Southern Africa, between South Africa and Zambia. (NCI)Zimbabwe
Back to top
CL.C116108.DDTESTCDDeath Details Test Code
(DDTESTCD)
text
Extensible: Yes
C116108Death Details Test CodeTerminology relevant to the death detail assessment short name.CDISC SDTM Death Details Test Code Terminology
PRCDTHC99531Primary Cause of DeathThe primary significant event which ultimately led to death.Primary Cause of Death
SECDTHC116142Secondary Cause of DeathThe secondary significant event which ultimately led to death.Secondary Cause of Death
Back to top
CL.C116107.DDTESTDeath Details Test Name
(DDTEST)
text
Extensible: Yes
C116107Death Details Test NameTerminology relevant to the death detail assessment name.CDISC SDTM Death Details Test Name Terminology
Primary Cause of DeathC99531Primary Cause of DeathThe primary significant event which ultimately led to death.Primary Cause of Death
Secondary Cause of DeathC116142Secondary Cause of DeathThe secondary significant event which ultimately led to death.Secondary Cause of Death
Back to top
CL.C111110.DEACNDEVDevice Events Action Taken with Device
(DEACNDEV)
text
Extensible: Yes
C111110Device Events Action Taken with DeviceA terminology codelist based on the action taken with respect to the device.CDISC SDTM Device Events Action Taken with Device Terminology
CALIBRATIONC69187The act of checking or adjusting (by comparison with a standard) the accuracy of a measuring instrument. (NCI)Calibration
REMOVALC61575The act of taking out, extracting, or withdrawing an entity from a location.Extraction
REPROGRAMMINGC111306The act of rewriting program code or application software. (NCI)Reprogram
Back to top
CL.C111109.DECATDevice Events Category
(DECAT)
text
Extensible: Yes
C111109Device Events CategoryA terminology codelist based on the category of related records for the device event.CDISC SDTM Device Events Category Terminology
CALIBRATION FAILUREC62994Calibrate, Failure To;Failure to CalibrateIssue associated with the failure of the device to perform a self-calibration procedure or process designed to assure the accuracy and proper performance of the device. (FDA)Medical Device Failure to Calibrate
COMPUTER SOFTWARE ISSUEC63269Software MalfunctionIssue associated with written programs, codes, and/or software system that affects device performance or communication with another device. (NCI)Computer Software Problem Associated with Medical Device
DATA STORAGE FAILUREC116121Issue associated with the failure of the software to store collected data.Data Storage Failure
DEVICE OPERATIONAL ISSUEC62954Device Operational MalfunctionIssue associated with any deviations from specifications relating to device operations (e.g. deployment, connection, electrical, computer software, infusion/flow, output, protective-measure, and incompatibility issues).Medical Device Operational Issue
NON-STUDY EQUIPMENT ISSUEC112361Non-Study Equipment MalfunctionIssue associated with any deviations from specifications relating to non-study device or equipment operations.Non-Study Device Issue
SCHEDULED MAINTENANCEC111309An inspection and/or surveillance activity that has been anticipated to occur and was assigned a time or date when that activity is to be performed. (NCI)Scheduled Maintenance
SOFTWARE UPDATEC67227All program coding after initial deployment to correct coding errors, enhance the functionality of the software, and perfect the functioning of the software. (NCI)Software Maintenance
Back to top
CL.C106480.DIPARMDevice Identifier Long Name
(DIPARM)
text
Extensible: Yes
C106480Device Identifier Long NameA terminology codelist for the long name of the identifier characteristic of the device.CDISC SDTM Device Identifier Long Name Terminology
Batch NumberC104504Batch Identifier;Batch NumberA distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product that is produced in a manner that is expected to render it homogeneous.Batch Number
Device TypeC53265Device TypeGeneric category of medical device within the device classification established by a regulatory authority.Type of Device
FDA Unique Device IdentificationC112279FDA Unique Device IdentificationA UDI is a unique numeric or alphanumeric code that includes a device identifier, which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number, the serial number and/or expiration date. (FDA)FDA Unique Device Identifier
Lot NumberC70848Lot Identifier;Lot NumberA distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product within a batch.Lot Number
ManufacturerC25392ManufacturerThe organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG)Manufacturer
Model NumberC99285Model Identifier;Model NumberThe identifier assigned to a particular design of a device, usually an alphanumeric text string.Model Number
Secure Lead TypeC111191Secure Lead TypeThe type of locking device used to securely fasten the electrical leads to the device. (NCI)Electrical Lead Locking Type
Serial NumberC73518Serial NumberA unique identifier assigned to an individual object.Serial Number
Stereotactic Surgery Frame TypeC106570Stereotactic Surgery Frame TypeThe classification of the cage structure used to immobilize the head or other body part in preparation for stereotactic surgery. (NCI)Stereotactic Surgery Frame Type
Back to top
CL.C106481.DIPARMCDDevice Identifier Short Name
(DIPARMCD)
text
Extensible: Yes
C106481Device Identifier Short NameA terminology codelist for the short name of the identifier characteristic of the device.CDISC SDTM Device Identifier Short Name Terminology
BATCHC104504Batch Identifier;Batch NumberA distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product that is produced in a manner that is expected to render it homogeneous.Batch Number
DEVTYPEC53265Device TypeGeneric category of medical device within the device classification established by a regulatory authority.Type of Device
FDAUDIC112279FDA Unique Device IdentificationA UDI is a unique numeric or alphanumeric code that includes a device identifier, which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number, the serial number and/or expiration date. (FDA)FDA Unique Device Identifier
LOTC70848Lot Identifier;Lot NumberA distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product within a batch.Lot Number
MANUFC25392ManufacturerThe organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG)Manufacturer
MODELC99285Model Identifier;Model NumberThe identifier assigned to a particular design of a device, usually an alphanumeric text string.Model Number
SECURLDC111191Secure Lead TypeThe type of locking device used to securely fasten the electrical leads to the device. (NCI)Electrical Lead Locking Type
SERIALC73518Serial NumberA unique identifier assigned to an individual object.Serial Number
SFMTYPC106570Stereotactic Surgery Frame TypeThe classification of the cage structure used to immobilize the head or other body part in preparation for stereotactic surgery. (NCI)Stereotactic Surgery Frame Type
Back to top
CL.C111111.DOTESTCDDevice Properties Test Code
(DOTESTCD)
text
Extensible: Yes
C111111Device Properties Test CodeA terminology codelist based on the test code used to obtain the device property.CDISC SDTM Device Properties Test Code Terminology
COMPOSC53414CompositionThe materials from which something is made.Composition
FDADEVCLC112278FDA Device ClassificationThe class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860).FDA Device Classification
INDCC41184Indication for UseA general description of the disease or condition the product will diagnose, treat, prevent, cure, or mitigate.Indication
MRICTYPEC116119MRI Coil TypeThe classification of the coil that is used in an magnetic resonance imaging procedure. Usually refers to the anatomical location for where the coil is placed such as head, body or breast.MRI Coil Type
MULTPLEXC116118Multiplex Probe ParameterA descriptor referring to the number of unique molecular probes contained in each assay component from which results are obtained, such as each well in a 96-well plate.Multiplex Probe Parameter
PORESIZEC112332Pore SizeA quantitative or qualitative measurement of the physical dimensions of the pores in a material.Material Pore Size
REAGLOTC112406Reagent LotThe lot number of the reagent.Reagent Lot Number
SCRYSTYPC116120Scintillation Crystal TypeThe classification of the crystalline material, which emits light in response to radiation exposure, used in the imaging procedure.Scintillation Crystal Type
SFTWRVERC111093Software VersionA form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI)Software Version
SHLFLIFEC70855Shelf LifeThe period during which a medical product retains its properties and stated performance within specified limits if stored under defined conditions. The stability period is determined from the date the product was manufactured.Medical Product Shelf Life
SIZEC25681SizeThe physical magnitude of something. (NCI)Size
SRGMSHOAC112421Surgical Mesh Open AreaA quantitative or qualitative measurement of the physical dimensions of the open spaces in a loosely woven sheet of inorganic or biological materials, which is used to physically support organs or tissue during a surgical procedure.Surgical Mesh Open Area
TEMPC25206TemperatureThe property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)Temperature
THICKNSSC41145ThicknessThe dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length.Thickness
Back to top
CL.C111112.DOTESTDevice Properties Test Name
(DOTEST)
text
Extensible: Yes
C111112Device Properties Test NameA terminology codelist based on the test name used to obtain the device property.CDISC SDTM Device Properties Test Name Terminology
CompositionC53414CompositionThe materials from which something is made.Composition
FDA Device ClassificationC112278FDA Device ClassificationThe class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860).FDA Device Classification
Indication for UseC41184Indication for UseA general description of the disease or condition the product will diagnose, treat, prevent, cure, or mitigate.Indication
MRI Coil TypeC116119MRI Coil TypeThe classification of the coil that is used in an magnetic resonance imaging procedure. Usually refers to the anatomical location for where the coil is placed such as head, body or breast.MRI Coil Type
Multiplex Probe ParameterC116118Multiplex Probe ParameterA descriptor referring to the number of unique molecular probes contained in each assay component from which results are obtained, such as each well in a 96-well plate.Multiplex Probe Parameter
Pore SizeC112332Pore SizeA quantitative or qualitative measurement of the physical dimensions of the pores in a material.Material Pore Size
Reagent LotC112406Reagent LotThe lot number of the reagent.Reagent Lot Number
Scintillation Crystal TypeC116120Scintillation Crystal TypeThe classification of the crystalline material, which emits light in response to radiation exposure, used in the imaging procedure.Scintillation Crystal Type
Shelf LifeC70855Shelf LifeThe period during which a medical product retains its properties and stated performance within specified limits if stored under defined conditions. The stability period is determined from the date the product was manufactured.Medical Product Shelf Life
SizeC25681SizeThe physical magnitude of something. (NCI)Size
Software VersionC111093Software VersionA form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI)Software Version
Surgical Mesh Open AreaC112421Surgical Mesh Open AreaA quantitative or qualitative measurement of the physical dimensions of the open spaces in a loosely woven sheet of inorganic or biological materials, which is used to physically support organs or tissue during a surgical procedure.Surgical Mesh Open Area
TemperatureC25206TemperatureThe property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)Temperature
ThicknessC41145ThicknessThe dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length.Thickness
Back to top
CL.C112037.DTDECODDevice Tracking and Disposition Event Dictionary Derived Term
(DTDECOD)
text
Extensible: Yes
C112037Device Tracking and Disposition Event Dictionary Derived TermA terminology codelist based on the verbatim or preprinted term for the device tracking and disposition event that occurs.CDISC SDTM Device Tracking and Disposition Event Dictionary Derived Term Terminology
DEPLOYEDC101231The act of instantiating, positioning or activating a medical device inside of the body.Medical Device Deployment
DESTROYEDC112270A finding referring to a product that has been demolished.Destroyed Medical Device
EXPLANTEDC114146A status indicating that a device is removed from a surgically or naturally formed cavity of the human body.Explanted Medical Device
IMPLANTEDC80457A status indicating that a device is placed into a surgically or naturally formed cavity of the human body.Implanted Medical Device
INTENDED BUT NOT USEDC117758A status indicating that a device was introduced to the subject for use but did not meet its intended goal and was removed. (NCI)Device Intended But Not Used
LOSTC112329A finding referring to a product that is no longer held or possessed; incapable of being recovered or regained.Lost Medical Device
RECEIVEDC25639The status of coming into possession of or acting as the receptacle or recipient of an item conveyed by an intermediary to the intended destination, from a sender.Receive
SHIPPEDC40353The status of being transported or conveyed by an intermediary to a destination, from the sender to the intended receiver.Shipping
Back to top
CL.C106483.DUTESTCDDevice-In-Use Test Code
(DUTESTCD)
text
Extensible: Yes
C106483Device-In-Use Test CodeA terminology codelist for the test code of the test or examination used to obtain the measurement or finding of the device in use.CDISC SDTM Device-In-Use Test Code Terminology
ANTPLANEC102516Anatomical PlaneThe position and orientation of the image slice relative to the patient-based coordinate system. (NCI)Image Plane
AQMTRXSZC106533Image Acquisition Matrix SizeA measurement of the number of data fields, pixels or data points assigned to each linear dimension in a digital image. (NCI)Image Acquisition Matrix Size
ATTCRCTC94862Attenuation Correction TypeThe adjustment for the effect of tissue thicknesses through which gamma's travel from an activity concentration origin to the scanner's detectors. The count rates of a detector are adjusted to values as if there were no attenuation along the gamma's path. This makes possible accurate quantitation in image analysis. (NCI)Attenuation Correction
CHCKSIZEC117759Checkerboard Square SizeA visual stimulus that uses a checkerboard pattern which reverses every half-second (or other specified frequency). The check size can be changed to allow for testing of specific segments of the visual pathway.Checkerboard Square Size
COILNUMC112364Number of Coil ChannelsThe number of channels, or elements, in the coil component of the device.Number of Coil Channels
COILSTRC106510Coil StrengthThe maximum voltage allowable to pass through an electromagnetic coil. (NCI)Coil Strength
DECCORRC116127Decay Correction IndicatorAn indication as to whether the image reconstruction took into account the time-activity curve during which the radiolabeled tracer decayed as it spread through the body during the image acquisition.Decay Correction Indicator
ECHOTIMEC82331Echo TimeThe time in milliseconds between the application of the excitation pulse and the recording of the peak echo signal. (NCI)Echo Time
FLDVIEWC74298Field of ViewThe extent of an area that is visible. (NCI)Field of View
FLIPANGLC73792Flip AngleIn magnetic resonance imaging, the rotation of the average axis of the protons, relative to the main magnetic field direction, induced by radiofrequency signals. (NCI)Flip Angle
IMAQDIMC116126Image Acquisition DimensionalityThe number of dimensions that the acquired image(s) are presented in.Image Acquisition Dimensionality
IMWGTTYPC116122Image Weighting TypeA classification of the technique used to enhance image contrast based on differences in magnetic resonance tissue properties. This can be achieved by changing the echo time or repetition time after the tissue has returned to its equilibrium state.Image Weighting Type
INTDISTMC116123Interslice DistanceA measurement of the distance between slices within an image sequence, calculated by subtracting the nominal slice thickness from the couch increment.Interslice Distance Measurement
INVRTIMEC116124Inversion TimeThe time between the inversion and excitation pulses in an inversion recovery pulse sequence.Inversion Time
NUMSLICEC116125Number of SlicesThe number of planar cross-sections in an imaging sequence; each slice corresponds to a single image.Number of Slices
PIXSPCXC69201X-axis Pixel SpacingA measurement of the distance between the centers of two adjacent pixels located along the X-axis.Horizontal Pixel Spacing
PIXSPCYC69210Y-axis Pixel SpacingA measurement of the distance between the centers of two adjacent pixels located along the Y-axis.Vertical Pixel Spacing
PULSSEQC106562Pulse SequenceA serially recurrent arrangement of radiofrequency pulses that are applied to the sample. (NCI)Pulse Sequence
RANDCORRC116128Randoms Correction IndicatorAn indication as to whether the device was set to correct for random noise generated by deflected positrons.Randoms Correction Indicator
RCBDWDTHC106563Receiver BandwidthThe range between the minimum and maximum cut-off frequencies for a particular receiver, commonly measured in Hertz. (NCI)Receiver Bandwidth
RCFLTRTPC106564Reconstruction Filter TypeA classification of the reconstruction filter used to suppress noise, enhance edges, resolution recovery and smooth an image.Reconstruction Filter Type
RECONDATC111303Reconstruction of Raw Data TypeThe type of mathematical process used to produce the displayed image from the raw k-space data obtained from the receiver circuitry. (NCI)Reconstruction of Raw Data Type
REPTIMEC82330Repetition TimeThe amount of time in milliseconds between successive pulse sequences applied to the same slice.Repetition Time
SFTWRVERC111093Software VersionA form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI)Software Version
SIGAMPC112416Signal AmplitudeA measurement of the height of the signal.Signal Amplitude
SIGFREQC112417Signal FrequencyA measurement of the number of cycles of a periodic wave or pulse per unit of time.Signal Frequency
SIGWC112418Signal WidthA measurement of the range of values seen in the time interval between the beginning and end of the pulse wave.Signal Width
SLICNUMC111314Slice NumberThe numeric identifier used to identify an image slice. (NCI)Slice Number
STHICKC106534Slice ThicknessThe dimension between two surfaces of an imaging plane. (NCI)Image Slice Thickness
STIMPARMC114145Stimulation ParameterThe type of electrode (monopolar or bipolar) used on the subject during electrical stimulation of the body or organ.Electrical Stimulation Electrode Type
Back to top
CL.C106482.DUTESTDevice-In-Use Test Name
(DUTEST)
text
Extensible: Yes
C106482Device-In-Use Test NameA terminology codelist for the test name of the test or examination used to obtain the measurement or finding of the device in use.CDISC SDTM Device-In-Use Test Name Terminology
Anatomical PlaneC102516Anatomical PlaneThe position and orientation of the image slice relative to the patient-based coordinate system. (NCI)Image Plane
Attenuation Correction TypeC94862Attenuation Correction TypeThe adjustment for the effect of tissue thicknesses through which gamma's travel from an activity concentration origin to the scanner's detectors. The count rates of a detector are adjusted to values as if there were no attenuation along the gamma's path. This makes possible accurate quantitation in image analysis. (NCI)Attenuation Correction
Checkerboard Square SizeC117759Checkerboard Square SizeA visual stimulus that uses a checkerboard pattern which reverses every half-second (or other specified frequency). The check size can be changed to allow for testing of specific segments of the visual pathway.Checkerboard Square Size
Coil StrengthC106510Coil StrengthThe maximum voltage allowable to pass through an electromagnetic coil. (NCI)Coil Strength
Decay Correction IndicatorC116127Decay Correction IndicatorAn indication as to whether the image reconstruction took into account the time-activity curve during which the radiolabeled tracer decayed as it spread through the body during the image acquisition.Decay Correction Indicator
Echo TimeC82331Echo TimeThe time in milliseconds between the application of the excitation pulse and the recording of the peak echo signal. (NCI)Echo Time
Field of ViewC74298Field of ViewThe extent of an area that is visible. (NCI)Field of View
Flip AngleC73792Flip AngleIn magnetic resonance imaging, the rotation of the average axis of the protons, relative to the main magnetic field direction, induced by radiofrequency signals. (NCI)Flip Angle
Image Acquisition DimensionalityC116126Image Acquisition DimensionalityThe number of dimensions that the acquired image(s) are presented in.Image Acquisition Dimensionality
Image Acquisition Matrix SizeC106533Image Acquisition Matrix SizeA measurement of the number of data fields, pixels or data points assigned to each linear dimension in a digital image. (NCI)Image Acquisition Matrix Size
Image Weighting TypeC116122Image Weighting TypeA classification of the technique used to enhance image contrast based on differences in magnetic resonance tissue properties. This can be achieved by changing the echo time or repetition time after the tissue has returned to its equilibrium state.Image Weighting Type
Interslice DistanceC116123Interslice DistanceA measurement of the distance between slices within an image sequence, calculated by subtracting the nominal slice thickness from the couch increment.Interslice Distance Measurement
Inversion TimeC116124Inversion TimeThe time between the inversion and excitation pulses in an inversion recovery pulse sequence.Inversion Time
Number of Coil ChannelsC112364Number of Coil ChannelsThe number of channels, or elements, in the coil component of the device.Number of Coil Channels
Number of SlicesC116125Number of SlicesThe number of planar cross-sections in an imaging sequence; each slice corresponds to a single image.Number of Slices
Pulse SequenceC106562Pulse SequenceA serially recurrent arrangement of radiofrequency pulses that are applied to the sample. (NCI)Pulse Sequence
Randoms Correction IndicatorC116128Randoms Correction IndicatorAn indication as to whether the device was set to correct for random noise generated by deflected positrons.Randoms Correction Indicator
Receiver BandwidthC106563Receiver BandwidthThe range between the minimum and maximum cut-off frequencies for a particular receiver, commonly measured in Hertz. (NCI)Receiver Bandwidth
Reconstruction Filter TypeC106564Reconstruction Filter TypeA classification of the reconstruction filter used to suppress noise, enhance edges, resolution recovery and smooth an image.Reconstruction Filter Type
Reconstruction of Raw Data TypeC111303Reconstruction of Raw Data TypeThe type of mathematical process used to produce the displayed image from the raw k-space data obtained from the receiver circuitry. (NCI)Reconstruction of Raw Data Type
Repetition TimeC82330Repetition TimeThe amount of time in milliseconds between successive pulse sequences applied to the same slice.Repetition Time
Signal AmplitudeC112416Signal AmplitudeA measurement of the height of the signal.Signal Amplitude
Signal FrequencyC112417Signal FrequencyA measurement of the number of cycles of a periodic wave or pulse per unit of time.Signal Frequency
Signal WidthC112418Signal WidthA measurement of the range of values seen in the time interval between the beginning and end of the pulse wave.Signal Width
Slice NumberC111314Slice NumberThe numeric identifier used to identify an image slice. (NCI)Slice Number
Slice ThicknessC106534Slice ThicknessThe dimension between two surfaces of an imaging plane. (NCI)Image Slice Thickness
Software VersionC111093Software VersionA form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI)Software Version
Stimulation ParameterC114145Stimulation ParameterThe type of electrode (monopolar or bipolar) used on the subject during electrical stimulation of the body or organ.Electrical Stimulation Electrode Type
X-axis Pixel SpacingC69201X-axis Pixel SpacingA measurement of the distance between the centers of two adjacent pixels located along the X-axis.Horizontal Pixel Spacing
Y-axis Pixel SpacingC69210Y-axis Pixel SpacingA measurement of the distance between the centers of two adjacent pixels located along the Y-axis.Vertical Pixel Spacing
Back to top
CL.C101857.DIABTHPYDiabetes Therapy
(DIABTHPY)
text
Extensible: Yes
C101857Diabetes TherapyA terminology codelist that describes the treatment method for diabetes.CDISC SDTM Diabetes Therapy Terminology
DIETC15383A form of therapy which includes dietary approaches and special diets.Special Diet Therapy
INSULINC581A synthetic or animal-derived form of insulin used in the treatment of diabetes mellitus.Therapeutic Insulin
NO TREATMENTC99994No treatment for diabetes.No Treatment for Diabetes
ORAL MEDICATIONC102246A pharmacological medication intended for administration through the mouth.Oral Medication
Back to top
CL.C66787.TDIGRPDiagnosis Group
(TDIGRP)
text
Extensible: Yes
C66787Diagnosis GroupA grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)CDISC SDTM Diagnosis Group Terminology
HEALTHY SUBJECTSC49651An individual who is or becomes a participant in a research study and has no significant health-related issues. (NCI)Healthy Subject
Back to top
CL.C66788.DICTNAMDictionary Name
(DICTNAM)
text
Extensible: Yes
C66788Dictionary NameA name given to a reference source that lists words and gives their meaning. (NCI)CDISC SDTM Dictionary Name Terminology
COSTARTC49471Coding Symbols for a Thesaurus of Adverse Reaction TermsA terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)Thesaurus of Adverse Reaction Term Coding Symbols
ICDC49474International Classification of DiseasesA system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)International Classification of Diseases
LOINCC49476Logical Observation Identifiers Names and CodesPublished by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)Logical Observation Identifiers Names and Codes
MedDRAC43820Medical Dictionary for Regulatory ActivitiesMedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)MedDRA
SNOMEDC53489Systematized Nomenclature of MedicineA multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)Systematized Nomenclature of Medicine
WHOARTC49468World Health Organization Adverse Reaction TermsA terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)World Health Organization Adverse Reaction Terminology
WHODDC49475World Health Organization Drug DictionaryA reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)World Health Organization Drug Dictionary
Back to top
CL.C99074.DIRDirectionality
(DIR)
text
Extensible: Yes
C99074DirectionalityCDISC terminology for anatomical location or specimen further detailing directionality.CDISC SDTM Directionality Terminology
ANTERIORC25231Denoting the front portion of the body or a structure.Anterior
APICALC25423Relating to or located at the apex.Apical
BASALC90067Relating to or located at the lowest portion of a structure.Basal
CAUDALC73851Toward the tail in a body.Caudal
CENTRALC25445A point or area that is approximately central within some larger region or structure. (NCI)Center
CRANIALC37936Toward the head in a body.Cranial
DEEPC25240Extending relatively far inward. (NCI)Deep
DISTALC25237Situated farthest from a point of reference.Distal
DORSALC45874Pertaining to the back or upper surface of the body.Dorsal
DORSOLATERALC90376Toward the back and side of a body.Dorsolateral
FOREC90386Of or involving the front of a main body. (NCI)Fore
HINDC90393Of or involving the back of a main body. (NCI)Hind
INFERIORC25353Pertaining to a point below a given reference point.Inferior
INNERC37980Inside or closer to the inside of the body or object. (NCI)Inner
INTERMEDIATEC73705Located between two points or extremes.Intermediate
LOWERC25309The bottom one of two. (NCI)Lower
MEDIALC25232Toward the middle or in a limb toward the median plane.Medial
MIDLINEC81170A medial line, especially the medial line or medial plane of the body (or some part of the body).Midline
NASALC27958Of, or related to, or in the direction of the nose.Nasal
OUTERC38166Being on or toward the outside of the body or object. (NCI)Outer
PERIPHERALC25233On or near an edge or constituting an outer boundary; the outer area. (NCI)Peripheral
POSTERIORC25622Denoting the back portion of the body or a structure.Posterior
PROXIMALC25236Situated nearest to a point of reference.Proximal
ROSTRALC94393Toward the muzzle in the head.Rostral
SUPERFICIALC25239Of or pertaining to the exterior surface. (NCI)Superficial
SUPERIORC25235Pertaining to a point above a given reference point.Superior
SURFACEC25245The extended two-dimensional outer layer or area of a three-dimensional object. (NCI)Surface
TEMPORALC117754Of, or related to, anatomic sites that are located in the cranium, brain, and eye.Temporal Anatomic Qualifier
TIPC90069The pointed end of a structure.Tip
UPPERC25355The top one of two.Upper
VENTRALC45875Pertaining to the front or lower surface of the body.Ventral
VENTROLATERALC98798Of or pertaining to the front and side of a main body. (NCI)Ventrolateral
Back to top
CL.C102576.DOBSTLOCDirectly Observed Therapy Location
(DOBSTLOC)
text
Extensible: No
C102576Directly Observed Therapy LocationTerminology relevant to the physical location at which the medication or therapy was observed, by the healthcare provider, as being taken by the subject.CDISC SDTM Directly Observed Therapy Location Terminology
FIELDC102650A setting outside the clinic or a comparable health care facility, e.g. a doctor's office, the subject's home or workplace, a school, a public park, or a restaurant.In the Field
HEALTH FACILITYC21541The buildings and organizations where healthcare services are provided.Healthcare Facility
Back to top
CL.C101863.DISCHDXDischarge Disposition
(DISCHDX)
text
Extensible: Yes
C101863Discharge DispositionThe destination or circumstance at the time of discharge.CDISC SDTM Discharge Disposition Terminology
EXPIREDC28554DiedThe absence of life or state of being dead. (NCI)Death
EXPIRED IN A MEDICAL FACILITYC99944The patient died while in a medical center such as a hospital, skilled nursing facility (SNF), intermediate care facility (ICF), or a freestanding hospice center.Died in a Medical Facility
FEDERAL HEALTH CARE FACILITYC99909The patient will be admitted to a medical center that is funded by the federal government (e.g. Veterans Affairs Hospital).Federal Health Care Facility
HOME UNDER CARE OF ORGANIZED HOME HEALTH SERVICE ORGANIZATION IN ANTICIPATION OF COVERED SKILLED CAREC99959The patient will return home but personal health maintenance will be administered and monitored by a member of a healthcare organization that is eligible to receive Medicare funding.Home Under Care of Organized Home Health Service Organization in Anticipation of Covered Skilled Care
HOME, HOSPICEC99958The patient will receive end-of-life care which will be administered in the patient's home.Home Hospice
HOME, SELF CAREC99957A routine discharge where personal health maintenance will be administered and monitored by the patient from their home.Home Care
HOSPICE - MEDICAL FACILITYC99910The patient will receive end-of-life care which will be administered in a medical center.Hospice Care at Medical Facility
HOSPITAL-BASED MEDICARE-APPROVED SWING BEDC99960The patient will be admitted into a medical center and receive a type of hospital bed that will be paid for my Medicare.Hospital with Medicare Approved Swing Bed
INPATIENT REHABILITATION FACILITY (IRF) INCLUDING REHABILITATION DISTINCT PART UNITS OF A HOSPITALC99911The patient will be admitted full time into a free standing rehabilitation center or a rehabilitation center within a general medical facility.Inpatient Rehabilitation Facility Including Rehabilitation distinct Part Units of a Hospital
INSTITUTION NOT DEFINEDC102247The patient will be admitted into an alternative facility not listed.Institution Not Defined
INTERMEDIATE CARE FACILITYC99912The patient will be admitted into a medical center that provides care 24 hours per day.Intermediate Care Facility
LEFT AGAINST MEDICAL ADVICE OR DISCONTINUED CAREC99969The patient vacated the medical center or ceased medical care contrary to the recommendation of a trained healthcare provider.Left Against Medical Advice
MEDICARE-CERTIFIED LONG TERM CARE HOSPITAL (LTCH)C99984The patient will be admitted into a Medicare funded medical center for a considerable length of time.Medicare Certified Long Term Care Hospital
NURSING FACILITY CERTIFIED UNDER MEDICAID BUT NOT CERTIFIED UNDER MEDICAREC99913The patient will be admitted into a medical center which is eligible to receive funding from Medicaid but not Medicare.Nursing Facility Certified Under Medicaid but Not Certified Under Medicare
PSYCHIATRIC HOSPITAL OR A PSYCHIATRIC-DISTINCT PART UNIT OF A HOSPITALC53536The patient will be admitted into a free standing medical facility or a unit within a general medical facility used for the treatment of mental health disorders.Psychiatric Facility
SHORT TERM GENERAL HOSPITALC102248The patient will remain in a basic hospital environment for a brief time.Short Term General Hospital
SKILLED NURSING FACILITY (SNF) WITH MEDICARE CERTIFICATION IN ANTICIPATION OF COVERED SKILLED CAREC99914The patient will be admitted into a medical center equipped with a trained nursing staff that is eligible to receive Medicare funding.Skilled Nursing Facility with Medicare Certification in Anticipation of Covered Skilled Care
Back to top
CL.C102578.DSSOUTDisease Outcome
(DSSOUT)
text
Extensible: Yes
C102578Disease OutcomeTerminology relevant to the measurable result or effect of treatment on a disease.CDISC SDTM Disease Outcome Terminology
BACTERIOLOGICAL CUREC102600There are no indicators of bacterial infection in an individual who previously had an infection.Bacteriological Cure
BACTERIOLOGICAL FAILUREC102601There are indicators of bacterial infection in the individual who previously had an infection.Bacteriological Failure
CLINICAL CUREC102607There are no signs or symptoms of disease in the individual who previously had a disease.Clinical Cure
CLINICAL FAILUREC102608There are still signs or symptoms of disease in the individual who previously had an infection.Clinical Failure
RECURRENT DISEASEC38155Recurrent DiseaseThe return of a disease after a period of remission.Recurrent Disease
Back to top
CL.C78732.DATESTCDDrug Accountability Test Code
(DATESTCD)
text
Extensible: Yes
C78732Drug Accountability Test CodeThe short name, or code, of the test for the drug accountability assessment.CDISC SDTM Drug Accountability Test Terminology by Code
DISPAMTC78721Dispensed AmountThe quantity of a product that has been dispensed. (NCI)Dispensed Amount
RETAMTC78722Returned AmountThe quantity of a product that has been returned. (NCI)Returned Amount
Back to top
CL.C78731.DATESTDrug Accountability Test Name
(DATEST)
text
Extensible: Yes
C78731Drug Accountability Test NameThe name of the test for the drug accountability assessment.CDISC SDTM Drug Accountability Test Terminology by Name
Dispensed AmountC78721Dispensed AmountThe quantity of a product that has been dispensed. (NCI)Dispensed Amount
Returned AmountC78722Returned AmountThe quantity of a product that has been returned. (NCI)Returned Amount
Back to top
CL.C102577.DRSTATDrug Resistance Status
(DRSTAT)
text
Extensible: Yes
C102577Drug Resistance StatusTerminology relevant to the state or condition of the microbe or lesion to indicate whether it is resistant to drugs normally used in treatment.CDISC SDTM Drug Resistance Status Terminology
EXTENSIVE DRUG RESISTANCEC102633XDRResistance to nearly all known drugs, particularly the most efficacious or non-first line drugs, used in the treatment of a particular disease.Extensively Drug Resistance Process
MULTIPLE DRUG RESISTANCEC17745MDRSimultaneous resistance to a spectrum of unrelated drugs following exposure to a single agent. Mechanisms involve expression of multidrug efflux pumps (p-glycoprotein), altered glutathione metabolism, decreased topoisomerase II activity, and changes in various cellular proteins.Multidrug Resistance Process
SUSCEPTIBLEC85563SusceptibleThe growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection.Antimicrobial Susceptibility Result
Back to top
CL.C90013.EGLEADECG Lead
(EGLEAD)
text
Extensible: Yes
C90013ECG LeadTerminology related to electrocardiogram lead names.CDISC SDTM Electrocardiogram Lead Terminology
LEAD aV6C90403An augmented unipolar lead placed at the sixth intercostal space on the midaxillary line. (NCI)Lead Site aV6
LEAD aVFC90360An augmented unipolar electrocardiogram limb lead in which the positive (red) electrode is situated on the left pelvic limb and the negative electrode is a combination of the right thoracic limb (white) electrode and the left thoracic limb (black) electrode. Measures the electrical activity of the electrode on the left pelvic limb.Augmented Vector Foot
LEAD aVLC90361An augmented unipolar electrocardiogram limb lead in which the positive (black) electrode is situated on the left thoracic limb and the negative electrode is a combination of the right thoracic limb (white) electrode and the left pelvic limb (red) electrode. Measures the electrical activity of the electrode on the left thoracic limb. (NCI)Augmented Vector Left
LEAD aVRC90362An augmented unipolar electrocardiogram limb lead in which the positive (white) electrode is situated on the right thoracic limb and the negative electrode is a combination of the left thoracic limb (black) electrode and the left pelvic limb (red) electrode. Measures the electrical activity of the electrode on the right thoracic limb. (NCI)Augmented Vector Right
LEAD CM5C90404A bipolar EKG lead with the right thoracic limb electrode placed on the manubrium and left thoracic limb electrode placed at the surface marking of the V5 position (just above the 5th interspace in the anterior axillary line). The left pelvic limb lead acts as a neutral and may be placed anywhere. The C refers to 'clavicle' where it is often placed. (NCI)Lead Site CM5
LEAD CV5RLC90405A unipolar chest lead used mostly in large animals. Placed on the sixth ICS on the right side of the thorax along a line parallel to the level of the point of the humeralradial joint.Lead Site CV5RL
LEAD CV6LLC90406V1 electrode (+) placed in the 6th intercostal space on the left side of the thorax along a line parallel to the level of the point of the humeralradial joint.Lead Site CV6LL
LEAD CV6LUC90407V2 electrode (+) placed in the 6th intercostal space on the left side of the thorax along a line parallel to the level of the point of the shoulder. (NCI)Lead Site CV6LU
LEAD IC90408A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the right thoracic limb and the positive electrode on the left thoracic limb. (NCI)Lead Site I
LEAD IIC90409A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the right thoracic limb and the positive electrode on the left pelvic limb. (NCI)Lead Site II
LEAD IIIC90410A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the left thoracic limb and the positive electrode on the left pelvic limb. (NCI)Lead Site III
LEAD rV2C90411A unipolar precordial lead placed at the second intercostal space to the left of the sternum. (NCI)Lead Site rV2
LEAD V1C90412A unipolar electrocardiogram lead site; the electrode is placed at the fourth intercostal space on the anterior chest wall (between ribs 4 and 5) to the right of the sternal border. In small animals, it is placed at the right fifth intercostal space near the sternum. (NCI)Lead Site V1
LEAD V10C90413A unipolar chest lead at which the electrode is placed over the dorsal spinous process of 7th thoracic vertebra. (NCI)Lead Site V10
LEAD V2C90414A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall at the fourth intercostal space (between ribs 4 and 5) to the left of the sternal border. In small animals it corresponds to V2-V3 where it is placed at the 6th left intercostal space near the sternum. In large animals it is placed over the 6th rib at the level of the costochondral junction on the left side of the thorax.Lead Site V2
LEAD V3C90415A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall midway between leads V2 and V4. In large and small animals, it is placed over the dorsal spinous process of the 7th thoracic vertebra. (NCI)Lead Site V3
LEAD V4C90416A unipolar electrocardiogram lead site; the electrode is placed at the fifth intercostal space on the anterior chest wall (between ribs 5 and 6) at the left midclavicular line. In small animals it corresponds to V4-V6 where it is placed at the 6th left intercostal space near the costochondral junction. In large animals it is placed over the 6th rib at the level of a horizontal line drawn through the scapulohumeral articulation on the left side of the thorax. (NCI)Lead Site V4
LEAD V5C90417A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall level with lead V4 at the left anterior axillary line. In large animals it is placed on the sixth ICS on the right side of the thorax along a line parallel to the level of the point of the shoulder corresponding to the electrical center of the heart (central terminal). (NCI)Lead Site V5
LEAD V6C90418A unipolar electrocardiogram lead site at which the electrode is placed on the anterior chest wall level with lead V5 at the left midaxillary line .Lead Site V6
SMLC117760Global Median Beat;Superimposition of Multiple LeadsMeasurement methodology using multiple leads for the determination of an ECG parameter. This is often visually represented as a superimposition of the median beats from multiple leads.Superimposition of Multiple Leads
Back to top
CL.C71150.EGSTRESCECG Result
(EGSTRESC)
text
Extensible: Yes
C71150ECG ResultTerminology codelist used with ECG Findings and Abnormalities within CDISC.CDISC SDTM ECG Finding Terminology
1ST DEGREE AV BLOCKC1110881st degree AV block;PR Prolongation;Prolonged PR intervalAn electrocardiographic finding of prolonged PR interval for a specific population. For adults one common threshold is a PR interval greater than 0.20 seconds. Note that other thresholds may be applicable.AV Block First Degree by ECG Finding
2:1 AV BLOCKC710442:1 AV blockAn electrocardiographic finding of a supraventricular rhythm where the ratio of impulses generated above the atrioventricular node to the number of impulses conducted through to the ventricles is 2:1. This is manifest on the ECG as 2 P waves per QRS complex.2:1 Atrioventricular Block by ECG Finding
2ND DEGREE AV BLOCKC62016Second Degree AV BlockAn electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by regular P waves which intermittently are not followed by QRS complexes.AV Block Second Degree by ECG Finding
3RD DEGREE AV BLOCKC1110913rd Degree Heart Block;AV block, complete (third-degree);Complete Heart BlockAn electrocardiographic finding of complete failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by disassociation of atrial and ventricular rhythms. The atrial rate must be faster than the ventricular rate.AV Block Third Degree by ECG Finding
50 Hz NOISEC11416550 Hz Artifact;50 Hz NoiseAn electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (50 Hz).50 Hertz Noise by ECG Finding
60 Hz NOISEC11416460 Hz Artifact;60 Hz NoiseAn electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (60 Hz).60 Hertz Noise by ECG Finding
ABERRANTLY CONDUCTED COMPLEXESC116132Aberrantly Conducted BeatsAn electrocardiographic finding of abnormal wide QRS complex(es) of supraventricular in origin and wide due to aberrant AV conduction.Aberrantly Conducted Complexes by ECG Finding
AC NOISEC114149AC NoiseAn electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (usually 50 Hz or 60 Hz).Alternating Current Noise by ECG Finding
ACCELERATED IDIOVENTRICULAR RHYTHMC62266Accelerated idioventricular rhythmAn electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute.Accelerated Idioventricular Rhythm by ECG Finding
ACUTE ANTERIOR WALL MYOCARDIAL INFARCTIONC71065Acute Anterior MI;Acute Anterior Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 and V4, which is suggestive of acute myocardial infarction of the anterior wall of the left ventricle.Acute Anterior Myocardial Infarction by ECG Finding
ACUTE ANTEROLATERAL WALL MYOCARDIAL INFARCTIONC102591Acute Anterolateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 through V6, which is suggestive of acute myocardial infarction of the anterolateral wall of the left ventricle.Acute Anterolateral Myocardial Infarction by ECG Finding
ACUTE ANTEROSEPTAL WALL MYOCARDIAL INFARCTIONC102592Acute Anteroseptal Wall Myocardial Infarction;Acute anteroseptal MIAn electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 through V4, which is suggestive of acute myocardial infarction of the anteroseptal wall of the left ventricle.Acute Anteroseptal Myocardial Infarction by ECG Finding
ACUTE EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTIONC106496An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 to V6, I and aVL, which is suggestive of acute myocardial infarction involving the anterior and anterolateral walls of the left ventricle.Acute Extensive Anterior Wall Myocardial Infarction by ECG Finding
ACUTE HIGH LATERAL WALL MYOCARDIAL INFARCTIONC102593Acute High Lateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads I and aVL, which is suggestive of acute myocardial infarction of the high lateral wall of the left ventricle.Acute High Lateral Myocardial Infarction by ECG Finding
ACUTE INFERIOR WALL MYOCARDIAL INFARCTIONC71066Acute Inferior MI;Acute Inferior Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads III, aVF and often II, which is suggestive of acute myocardial infarction of the inferior wall of the left ventricle.Acute Inferior Myocardial Infarction by ECG Finding
ACUTE LATERAL WALL MYOCARDIAL INFARCTIONC71067Acute Lateral MI;Acute Lateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V5, V6, I and aVL, which is suggestive of acute myocardial infarction of the lateral wall of the left ventricle.Acute Lateral Myocardial Infarction by ECG Finding
ACUTE MYOCARDIAL INFARCTIONC101596Acute Myocardial InfarctionAn electrocardiographic finding showing a current of injury with ST elevation. No specification is provided for localization.Acute Myocardial Infarction by ECG Finding
ACUTE POSTERIOR WALL MYOCARDIAL INFARCTIONC71068Acute Posterior MI;Acute Posterior Wall Myocardial InfarctionAn electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present.Acute Posterior Myocardial Infarction by ECG Finding
ACUTE RIGHT VENTRICULAR WALL MYOCARDIAL INFARCTIONC102594Acute Right Ventricular Wall Myocardial Infarction;Acute Right ventricular MIAn electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the ventricular wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. Additional criteria include ST elevation > 100 microvolts in the right precordial leads V4R through V6R.Acute Right Ventricular Myocardial Infarction by ECG Finding
ACUTE SEPTAL WALL MYOCARDIAL INFARCTIONC102595Acute Septal Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1, V2 and often V3, which is suggestive of acute myocardial infarction of the intraventricular septum.Acute Septal Myocardial Infarction by ECG Finding
ADVANCED/HIGH GRADE AV BLOCKC102642Advanced/High Grade AV BlockAn electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by two or more consecutive non-conducted P waves.High Grade Atrioventricular Block by ECG Finding
ALL PRECORDIAL ELECTRODES DISCONNECTEDC114159An electrocardiographic recording in which all precordial electrodes are disconnected resulting in missing waveforms (flat line) of all leads V1 - V6.All Precordial Electrodes Are Disconnected by ECG Finding
ANTERIOR WALL MYOCARDIAL INFARCTIONC71069Anterior MI;Anterior Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle.Anterior Myocardial Infarction by ECG Finding
ANTEROLATERAL WALL MYOCARDIAL INFARCTIONC35303Anterolateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle.Anterolateral Myocardial Infarction by ECG Finding
ANTEROSEPTAL WALL MYOCARDIAL INFARCTIONC35304Anteroseptal MI;Anteroseptal Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle.Anteroseptal Myocardial Infarction by ECG Finding
ARTIFACTC114162An electrocardiographic recording in which one or more leads display extraneous signals which do not represent cardiac electrical activity.Artifact Lead Signal by ECG Finding
ASYSTOLEC116130An electrocardiographic finding showing no cardiac electrical activity on the ECG for the entire duration of the recording.Asystole by ECG Finding
ATRIAL BIGEMINYC102596An electrocardiographic finding of a sinus beat followed by a premature atrial complex for three or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 1-1 ratio.Atrial Bigeminy by ECG Finding
ATRIAL COUPLETSC102597Atrial CoupletsAn electrocardiographic finding in which two premature atrial complexes occur sequentially.Atrial Couplet by ECG Finding
ATRIAL ENLARGEMENTC71039Atrial EnlargementAn electrocardiographic finding which comprises left, right or bilateral atrial enlargement. This is may be characterized by prolonged P wave duration, increased P wave amplitude, or multi-component P waves.Atrial Enlargement by ECG Finding
ATRIAL FIBRILLATIONC111092Atrial fibrillationAn electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response.Atrial Fibrillation by ECG Finding
ATRIAL FLUTTERC111094Atrial flutterAn electrocardiographic finding of an organized, regular atrial rhythm with atrial rate of 240-340 beats per minute. Multiple P waves typically appear in the inferior leads in a saw tooth like pattern between the QRS complexes.Atrial Flutter by ECG Finding
ATRIAL TACHYCARDIAC111105Atrial tachycardiaAn electrocardiographic finding of an organized, regular atrial rhythm with atrial rate between 101 and 240 beats per minute. The P wave morphology must be distinct from the sinus P wave morphology.Atrial Tachycardia by ECG Finding
ATRIAL TACHYCARDIA WITH AV BLOCKC119249An electrocardiographic finding of an atrial tachycardia which does not display 1:1 AV conduction.Atrial Tachycardia With AV Block by ECG Finding
ATRIAL TRIGEMINYC102598Atrial TrigeminyAn electrocardiographic finding of two sinus beats followed by a premature atrial complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 2-1 ratio.Atrial Trigeminy by ECG Finding
ATRIOVENTRICULAR DISSOCIATIONC71045AV Dissociation;Atrioventricular dissociationAn electrocardiographic finding in which the electrical activity of the atria and ventricles are independent of one another.Atrioventricular Dissociation by ECG Finding
AV MOBITZ IC111089AV Mobitz I;Mobitz I Second Degree AV Block;Second degree AV block- Mobitz type I;Second-degree AV block, Mobitz type I (Wenckebach);Type 1 2nd degree AV Block;WenckebachAn electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a progressively lengthening PR interval prior to the block of an atrial impulse.AV Block Second Degree Mobitz Type I by ECG Finding
AV MOBITZ IIC111090Mobitz II AV Block;Mobitz II Second Degree AV Block;Type 2 2nd degree AV BlockAn electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a relatively constant PR interval prior to the block of an atrial impulse.AV Block Second Degree Mobitz Type II by ECG Finding
AV NODE RE-ENTRYC35058AV Node Reentrant Supraventricular TachycardiaAn electrocardiographic finding of a regular supraventricular tachycardia due to reentry within the AV node. It is characterized by P waves which typically occurs nearly simultaneously with the QRS complex, resulting in a P wave which is obscured by the QRS, merged with the QRS or which may follow the QRS.Atrioventricular Nodal Reentry Tachycardia by ECG Finding
AV RE-ENTRANT TACHYCARDIAC62261AV Reentrant Supraventricular TachycardiaAn electrocardiographic finding of a regular supraventricular tachycardia which utilizes an atrioventricular bypass tract as its retrograde limb (orthodromic tachycardia) or as its antegrade limb (antidromic tachycardia). QRS complexes during sinus rhythm may show preexcitation. During orthodromic tachycardia the preexcitation is not present and a retrograde P wave may appear after the QRS complex. During antidromic tachycardia the QRS complex is preexcited.Atrioventricular Reentrant Tachycardia by ECG Finding
BASELINE WANDERC114147An electrocardiographic recording in which the isoelectric line in one or more leads is vertically displaced resulting in low frequency upward and downward movements of the signal with varying amplitudes.Baseline Wander by ECG Finding
BIFASCICULAR BLOCKC71046Bifascicular blockAn electrocardiographic finding comprising right bundle branch block and left anterior fascicular block, or right bundle branch block and left posterior fascicular block. Defects occurring in two of the three divisions of the conduction system of the heart are considered bifascicular blocks. Technically left bundle branch block may be considered a bifascicular block. (NCI)Bifascicular Block by ECG Finding
BIVENTRICULAR HYPERTROPHYC106502An electrocardiographic finding suggestive of enlargement or thickening of both ventricles, with a combination of findings which are related to LVH and RVH, such as voltage criteria for LVH in the presence of marked right axis deviation.Biventricular Hypertrophy by ECG Finding
BORDERLINE QTcBC92228Borderline QTcBAn electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is slightly prolonged. Thresholds for different age, gender, and patient populations exist.Borderline QTcB
BORDERLINE QTcFC92229Borderline QTcFAn electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is slightly prolonged. Thresholds for different age, gender, and patient populations exist.Borderline QTcF
BRADYCARDIAC111120BradycardiaAn electrocardiographic finding of abnormally slow heart rate. Thresholds for different age, gender, and patient populations exist.Bradycardia by ECG Finding
BRUGADA SYNDROME PATTERNC106503An electrocardiographic finding of complete or incomplete right bundle branch block accompanied by ST elevation in leads V1-V3. This may be noted at rest or can be provoked by medication challenge.Brugada Syndrome Pattern by ECG Finding
CV ENDPOINTS ISCHEMIC ECG CHANGESC116138An electrocardiographic finding, in the absence of left ventricular hypertrophy (LVH) and left bundle branch block pattern on ECG, of either a) new (or presumed new) ST elevation at the J point in two contiguous leads with the following cut-points: >=0.1 mV in all leads other than leads V2-V3 where the following cut points apply: >=0.2 mV in men >=40 years; >=0.25 mV in men <40 years, or >=0.15 mV in women; or b) new (or presumed new) horizontal or down-sloping ST depression >=0.05 mV in two contiguous leads and/or T inversion >=0.1 mV in two contiguous leads with prominent R wave or R/S ratio >1. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1-18, 2012)ACC/AHA Ischemic ECG Changes
DELTA WAVEC62258Delta waveAn electrocardiographic finding of initial slurring (delta wave) of the QRS complex due to the presence of an accessory pathway. This characteristic ECG pattern is typically seen in Wolff-Parkinson-White syndrome.Delta Wave by ECG Finding
DEXTROCARDIAC102623DextrocardiaAn electrocardiographic finding suggestive of dextrocardia with situs inversus, characterized by reversal of normal anterior R wave progression and the appearance of reversal of the right and left arm electrodes.Dextrocardia by ECG Finding
EARLY R WAVE TRANSITIONC102628Early R Wave Progression;Early R Wave TransitionAn electrocardiographic finding where the amplitude of the R wave becomes greater than the amplitude of the S wave in the QRS complex at an unusually early point in the precordial leads, usually in leads V1 or V2.Early R Wave Transition by ECG Finding
EARLY REPOLARIZATIONC102629Early RepolarizationAn electrocardiographic finding of J point and ST segment elevation in the absence of other signs of acute ischemia or pericarditis.Early Repolarization
ECG ACQUIRED WITH PRECORDIAL ELECTRODES PLACED ON RIGHT CHESTC114175An electrocardiographic recording in which the precordial electrodes have been placed over the right chest and record a right sided ECG.ECG Acquired with Precordial Electrodes Placed on the Right Chest
ECG EVALUATION NOT PERFORMED DUE TO CORRUPTED DIGITAL ECG FILEC114181A digital electrocardiographic recording which is corrupted (i.e. ECG signal cannot be restored) such that measurements and/or interpretation cannot be performed.ECG Evaluation Not Performed Due to Corrupted Digital ECG File
ECG EVALUATION NOT PERFORMED DUE TO POOR QUALITY OF PRINTED ECGC114180A printed electrocardiographic recording with poor printout quality (e.g. a faded paper ECG tracing or ECG with inconsistent printing speed) such that measurements and/or interpretation cannot be performed.ECG Evaluation Not Performed Due to Poor Quality of Printed ECG
ECG EVALUATION NOT PERFORMED DUE TO UNKNOWN ECG AMPLITUDE GAIN OR RECORDING SPEEDC114178An electrocardiographic recording in which measurements and/or interpretation are not performed because the ECG amplitude gain and/or recording speed are not known.ECG Evaluation Not Performed Due to Unknown ECG Amplitude Gain or Recording Speed
ECTOPIC ATRIAL RHYTHMC62245Ectopic atrial rhythmAn electrocardiographic finding of a regular atrial rhythm with atrial rate of less than 101 beats per minute which does not originate in the sinus node, and which is characterized by P waves whose morphology differs from the P wave morphology during sinus rhythm.Ectopic Atrial Rhythm by ECG Finding
ECTOPIC VENTRICULAR RHYTHMC71042Ectopic ventricular rhythmAn electrocardiographic finding of three or more consecutive complexes of ventricular origin. The QRS complexes are wide and have an abnormal morphology.Ectopic Ventricular Rhythm by ECG Finding
ELECTRICAL ALTERNANSC71035Electrical alternansAn electrocardiographic finding in which there is an alternating pattern of any of the waveform components. (NCI)Electrical Alternans by ECG Finding
EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTIONC106520An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle.Extensive Anterior Wall Myocardial Infarction by ECG Finding
FUSION COMPLEXC102639Fusion Complex;Fusion complex(es)An electrocardiographic finding that occurs when electrical activation of the atria or ventricles occurs from two separate sites. This results in a P wave or QRS complex that displays merged characteristics of beats originating from the two different sites.Fusion Complex
HIGH LATERAL WALL MYOCARDIAL INFARCTIONC102643High Lateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle.High Lateral Myocardial Infarction by ECG Finding
IDIOVENTRICULAR RHYTHMC50599Idioventricular RhythmAn electrocardiographic finding of three or more consecutive complexes of ventricular origin with a rate less than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology.Idioventricular Rhythm
INCOMPLETE ECGC114167An electrocardiographic recording which is limited in duration or which does not display all of the expected leads.Incomplete ECG
INCOMPLETE LEFT BUNDLE BRANCH BLOCKC71047Incomplete left bundle branch blockAn electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex in leads V5, V6, I and aVL and with QRS duration less than 120 ms.Incomplete Left Bundle Branch Block by ECG Finding
INCOMPLETE MEASUREMENTS DUE TO TRUNCATION OF QRS COMPLEXESC114179An electrocardiographic recording in which measurements (particularly of QRS amplitudes) and/or interpretations are not performed because QRS complexes have been truncated.Incomplete ECG Measurements Due to Truncation of QRS Complexes
INCOMPLETE RIGHT BUNDLE BRANCH BLOCKC71048Incomplete right bundle branch block;Incomplete right bundle-branch blockAn electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS in V1 and V2, a widened S wave in V5, V6, I and aVL, and with QRS duration less than 120 ms.Incomplete Right Bundle Branch Block by ECG Finding
INCOMPLETELY DIGITIZED ECG LEAD(S)C114169A digital electrocardiographic recording which was digitized from paper ECG tracings and which does not contain all leads present on the original paper printout.Incompletely Digitized ECG Leads
INCORRECTLY SCALED ECGC114168An electrocardiographic recording in which the ECG signal is not displayed at the indicated recording speed and/or amplitude resolution.Incorrectly Scaled ECG
INDETERMINATE QRS AXISC102701Indeterminate Axis;Indeterminate QRS Axis;QRS Axis IndeterminateAn electrocardiographic finding in which the frontal plane QRS axis cannot be calculated.QRS Axis Indeterminate
INFERIOR WALL MYOCARDIAL INFARCTIONC35398Inferior MI;Inferior Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle.Inferior Myocardial Infarction by ECG Finding
INSUFFICENT NUMBER OF BEATS TO COMPLETELY EVALUATE ECGC114177An electrocardiographic recording in which fewer than the required number of cardiac complexes are available for measurement and/or interpretation due to a shorter than planned recording or due to cardiac complexes which are present but are not suitable for measurement and/or interpretation.Insufficient Number of Beats for Complete ECG Evaluation
INTRAATRIAL CONDUCTION DELAYC71073Intraatrial Conduction DelayAn electrocardiographic finding of a delay in impulse propagation through the atria. This is characterized by broad P waves which are often biphasic in V1.Intra-Atrial Conduction Delay by ECG Finding
INTRAVENTRICULAR CONDUCTION DELAY, NONSPECIFICC62271Intraventricular Conduction Defect;Intraventricular conduction delayAn electrocardiographic finding of a widened QRS duration typically greater than 110 ms which does not meet the morphologic criteria for any of the standard bundle branch or fascicular block patterns.Nonspecific Intraventricular Conduction Delay by ECG Finding
INVALID ECG WAVEFORMSC114171An electrocardiographic recording for which the displayed leads do not represent the individual's true ECG lead information.Invalid ECG Waveforms
ISORHYTHMIC DISSOCIATIONC62248Isorhythmic dissociationAn electrocardiographic finding of a type of atrioventricular dissociation characterized by the atria (P waves) and ventricles (QRS complexes) beating at similar rates, although independently.Isorhythmic Atrioventricular Dissociation
J POINT ELEVATIONC71030J point elevationAn electrocardiographic finding of a significant elevation above the baseline of the J point.J Point Elevation
JUNCTIONAL BRADYCARDIAC71074Junctional bradycardiaAn electrocardiographic finding of a junctional rhythm with a heat rate which is abnormally low.Junctional Bradycardia by ECG Finding
JUNCTIONAL ESCAPE COMPLEXESC116129Junctional Escape BeatsAn electrocardiographic finding of an escape beat following a pause which originates in the AV junction. This is manifest as a QRS complex of supraventricular origin not preceded by a P wave.Junctional Escape Complexes by ECG Finding
JUNCTIONAL PREMATURE COMPLEXC102652Junctional Extra Beat;Junctional Premature Complex;Junctional premature complex(es)An electrocardiographic finding of an ectopic impulse originating in the AV junction presenting as a QRS complex of supraventricular origin which is not preceded by a P wave.Junctional Premature Complex by ECG Finding
JUNCTIONAL RHYTHMC71051Junctional rhythmAn electrocardiographic finding of a rhythm which originates in the AV junction and results in a normal heart rate. It is characterized by retrograde P waves which may be obscured by or may follow the QRS complexes. The QRS complexes may be narrow or may demonstrate aberration.Junctional Rhythm by ECG Finding
JUNCTIONAL TACHYCARDIAC35059Junctional tachycardiaAn electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally elevated.Junctional Tachycardia by ECG Finding
LATE R WAVE TRANSITIONC102653Late R Wave TransitionAn electrocardiographic finding where the amplitude of the R wave does not become greater than the amplitude of the S wave until an unusually late point in the precordial leads, usually in leads V4 to V6.Late R Wave Transition by ECG Finding
LATERAL WALL MYOCARDIAL INFARCTIONC35586Lateral MI;Lateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle.Lateral Myocardial Infarction by ECG Finding
LEFT ANTERIOR FASCICULAR BLOCKC62267Left Anterior Hemiblock;Left anterior fascicular blockAn electrocardiographic finding of a slightly widened QRS duration (typically less than 120 ms) with leftward frontal plane QRS axis and typically small Q waves in leads I and aVL.Left Anterior Fascicular Block by ECG Finding
LEFT ATRIAL ABNORMALITYC71040Left Atrial Enlargement;P-mitraleAn electrocardiographic finding suggesting underlying hypertrophy or dilatation of the left atrium. Electrocardiographic criteria used for the diagnosis of left atrial abnormality may include a bifid p wave, a biphasic p wave and/or a p wave duration of greater than 0.12 seconds. (NCI)P-mitrale by ECG Finding
LEFT BUNDLE BRANCH BLOCKC62269Complete LBBB;Left bundle branch block;Left bundle-branch blockAn electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex in leads V5, V6, I and aVL and with QRS duration greater than or equal to 120 ms.Left Bundle Branch Block by ECG Finding
LEFT POSTERIOR FASCICULAR BLOCKC62268Left Posterior Hemiblock;Left posterior fascicular blockAn electrocardiographic finding of an S1Q3 pattern and QRS axis greater than or equal to 120 degrees. It is usually seen in association with other abnormalities (e.g. RBBB or RVH).Left Posterior Fascicular Block by ECG Finding
LEFT VENTRICULAR CONDUCTION DELAYC92231Left Ventricular Conduction DelayAn electrocardiographic finding in which there is evidence that electrical transmission through the left ventricle is impaired.Left Ventricular Conduction Delay by ECG Finding
LEFT VENTRICULAR HYPERTROPHYC71076Left Ventricular HypertrophyAn electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes and secondary findings of left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion.Left Ventricular Hypertrophy by ECG Finding
LEFT VENTRICULAR HYPERTROPHY WITH STRAINC102655Left Ventricular Hypertrophy With StrainAn electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes, ST depression and T wave inversion.Left Ventricular Hypertrophy with Strain by ECG Finding
LIMB ELECTRODE(S) DISCONNECTEDC114151An electrocardiographic recording in which one or more of the limb electrodes are disconnected resulting in missing waveforms (often flat lines) of the respective leads.Disconnected Limb Electrodes by ECG Finding
LIMB ELECTRODES INTERCHANGEDC114150Limb Lead ReversalAn electrocardiographic recording in which two or more of the limb electrodes are switched resulting in improper representation of the affected leads.Interchanged Limb Electrodes by ECG Finding
LOW AMPLITUDE SIGNALC114166Low Amplitude QRS ComplexAn electrocardiographic recording showing smaller than usual QRS complexes in one or more leads. This may represent a technical issue with the ECG acquisition or characteristics of the individual.Low Amplitude QRS Complex by ECG Finding
LOW QRS VOLTAGEC71078Low QRS voltageAn electrocardiographic finding of a QRS amplitude less than or equal to 0.5 mV in the limb leads or QRS amplitude less than or equal to 1 mV in the precordial leads.Low QRS Voltage by ECG Finding
LOW VOLTAGE - LIMB LEADS ONLYC116133An electrocardiographic finding of small QRS amplitudes (less than 500 microvolts) in all limb leads.Low Voltage in Limb Leads Only by ECG Finding
MULTIFOCAL ATRIAL TACHYCARDIAC71050Multifocal atrial tachycardiaAn electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically 100-150 beats per minute.Multifocal Atrial Tachycardia by ECG Finding
MUSCLE TREMORC114148An electrocardiographic recording with intermittent mid to high frequency artifact in one or more leads due to muscular tremor or movement rather than cardiac activity.Muscle Tremor Artifact
MYOCARDIAL INFARCTIONC101589Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart. No specification is provided for localization.Myocardial Infarction by ECG Finding
NEW ANTERIOR WALL MYOCARDIAL INFARCTIONC102732New Anterior MI;New Anterior Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle and which is new compared to prior ECGs.New Anterior Myocardial Infarction by ECG Finding
NEW ANTEROLATERAL WALL MYOCARDIAL INFARCTIONC102733New Anterolateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle and which is new compared to prior ECGs.New Anterolateral Myocardial Infarction by ECG Finding
NEW ANTEROSEPTAL WALL MYOCARDIAL INFARCTIONC102734New Anteroseptal Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle and which is new compared to prior ECGs.New Anteroseptal Myocardial Infarction by ECG Finding
NEW EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTIONC102735New Extensive Anterior Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle and which is new compared to prior ECGs.New Extensive Anterior Myocardial Infarction by ECG Finding
NEW HIGH LATERAL WALL MYOCARDIAL INFARCTIONC102736New High Lateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle and which is new compared to prior ECGs.New High Lateral Myocardial Infarction by ECG Finding
NEW INFERIOR WALL MYOCARDIAL INFARCTIONC102737New Inferior Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle and which is new compared to prior ECGs.New Inferior Myocardial Infarction by ECG Finding
NEW LATERAL WALL MYOCARDIAL INFARCTIONC102738New Lateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle and which is new compared to prior ECGs.New Lateral Myocardial Infarction by ECG Finding
NEW MYOCARDIAL INFARCTIONC102731New Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart and which is new compared to prior ECGs. No specification is provided for localization.New Myocardial Infarction by ECG Finding
NEW POSTERIOR WALL MYOCARDIAL INFARCTIONC106548An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, and which is new compared to prior ECGs. Evidence of inferior or lateral myocardial infarction is usually also present.New Posterior Wall Myocardial Infarction by ECG Finding
NEW SEPTAL WALL MYOCARDIAL INFARCTIONC102739New Septal Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum and which is new compared to prior ECGs.New Septal Myocardial Infarction by ECG Finding
NO ECG WAVEFORMS PRESENTC114163An electrocardiographic recording that displays flat lines (no waveforms are visible) in all leads present.ECG Waveforms Not Present
NON Q WAVE MYOCARDIAL INFARCTIONC71080Non Q Wave Myocardial InfarctionAn electrocardiographic finding of ST and T wave abnormalities in the absence of pathologic Q waves, which is suggestive of myocardial infarction in one or more regions of the heart.Non Q Wave Myocardial Infarction by ECG Finding
NON-DIAGNOSTIC Q WAVESC116134An electrocardiographic finding of Q waves which are insufficient for the diagnosis of myocardial infarction. In such cases a myocardial infarction may be suspected, even though ECG criteria are not met.Non-Diagnostic Q Waves by ECG Finding
NON-SPECIFIC ST-T CHANGESC71031Non-specific ST-T changesAn electrocardiographic finding of changes in the ST segment and T wave that do not meet criteria for ischemia or infarction. (NCI)Non-Specific ST-T Changes by ECG Finding
NON-SUSTAINED ATRIAL TACHYCARDIAC102680Non-Sustained Atrial TachycardiaAn electrocardiographic finding of an atrial tachycardia which terminates in less than 30 seconds.Non-Sustained Atrial Tachycardia by ECG Finding
NON-SUSTAINED VENTRICULAR TACHYCARDIAC71053Non-sustained ventricular tachycardia;Ventricular tachycardia, unsustainedAn electrocardiographic finding of ventricular tachycardia less than 30 seconds in duration. (NCI)Non-Sustained Ventricular Tachycardia by ECG Finding
NORMAL SINUS RHYTHMC102681Normal Sinus RhythmAn electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population. There are no extra beats or conduction abnormalities.Normal Sinus Rhythm
NORTHWEST AXISC102634Northwest Axis;Right superior axisAn electrocardiographic finding of a frontal plane QRS axis from -90 to +180 degrees.Extreme Right Axis Deviation
NOTCHED T WAVESC71032Notched T WavesAn electrocardiographic finding of an irregular, u or v shaped deflection within the contour of the T wave.T Wave Notched by ECG Finding
OLD OR AGE INDETERMINATE ANTERIOR WALL MYOCARDIAL INFARCTIONC102684Old Or Age Indeterminate Anterior Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle, without evidence of current or ongoing acute infarction.Old or Age Indeterminate Anterior Myocardial Infarction by ECG Finding
OLD OR AGE INDETERMINATE ANTEROLATERAL WALL MYOCARDIAL INFARCTIONC102685Old Or Age Indeterminate Anterolateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle, without evidence of current or ongoing acute infarction.Old or Age Indeterminate Anterolateral Myocardial Infarction by ECG Finding
OLD OR AGE INDETERMINATE ANTEROSEPTAL WALL MYOCARDIAL INFARCTIONC102686Old Or Age Indeterminate Anteroseptal Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle, without evidence of current or ongoing acute infarction.Old or Age Indeterminate Anteroseptal Myocardial Infarction by ECG Finding
OLD OR AGE INDETERMINATE EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTIONC102687Old Or Age Indeterminate Extensive Anterior Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle, without evidence of current or ongoing acute infarction.Old or Age Indeterminate Extensive Anterior Myocardial Infarction by ECG Finding
OLD OR AGE INDETERMINATE HIGH LATERAL WALL MYOCARDIAL INFARCTIONC102688Old Or Age Indeterminate High Lateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle, without evidence of current or ongoing acute infarction.Old or Age Indeterminate High Lateral Myocardial Infarction by ECG Finding
OLD OR AGE INDETERMINATE INFERIOR WALL MYOCARDIAL INFARCTIONC102689Old Or Age Indeterminate Inferior Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle, without evidence of current or ongoing acute infarction.Old or Age Indeterminate Inferior Myocardial Infarction by ECG Finding
OLD OR AGE INDETERMINATE LATERAL WALL MYOCARDIAL INFARCTIONC102690Old Or Age Indeterminate Lateral Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle, without evidence of current or ongoing acute infarction.Old or Age Indeterminate Lateral Myocardial Infarction by ECG Finding
OLD OR AGE INDETERMINATE POSTERIOR WALL MYOCARDIAL INFARCTIONC102691Old Or Age Indeterminate Posterior Wall Myocardial InfarctionAn electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, without evidence of current or ongoing acute infarction. Evidence of inferior or lateral myocardial infarction is usually also present.Old or Age Indeterminate Posterior Myocardial Infarction by ECG Finding
OLD OR AGE INDETERMINATE SEPTAL WALL MYOCARDIAL INFARCTIONC102693Old Or Age Indeterminate Septal Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum, without evidence of current or ongoing acute infarction.Old or Age Indeterminate Septal Myocardial Infarction by ECG Finding
OLD OR AGE INDETERMINATE WALL MYOCARDIAL INFARCTIONC101597Old Or Age Indeterminate Wall Myocardial InfarctionAn electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart, without evidence of current or ongoing acute infarction. No specification is provided for localization.Old Myocardial Infarction by ECG Finding
OLD OR AGE UNDETERMINED RIGHT VENTRICULAR MYOCARDIAL INFARCTIONC102692An electrocardiographic finding, in the presence of an old or age indeterminate inferior wall myocardial infarction, of Q waves greater than or equal to 40 ms in duration in the right ventricular leads V4R through V6R.Old or Age Indeterminate Right Ventricular Myocardial Infarction by ECG Finding
OTHER INCORRECT ELECTRODE PLACEMENTC114176An electrocardiographic recording in which one or more electrodes are incorrectly placed but further details are not provided.Other Incorrect Electrode Placement
P WAVE ABNORMALITYC90430P Wave AbnormalityAn electrocardiographic finding for the P wave that is atypical either for the shape, duration, amplitude, axis or polarity. Abnormality of the P wave signifies aberrant propagation of the electrical impulse through the atria. (NCI)P Wave Abnormality by ECG Finding
P WAVE NOTCHEDC90431P Wave NotchedAn electrocardiographic finding of P waves with two peaks longer in duration than normal and amplitude greater than normal.P Wave Notched by ECG Finding
PACED ATRIAL AND VENTRICULAR RHYTHMC92232AV dual-paced complex(es) or rhythm;Paced Atrial And Ventricular RhythmAn electrocardiographic finding in which both the atrial and ventricular rhythm are controlled by an electrical impulse from an artificial cardiac pacemaker.Paced Atrial And Ventricular Rhythm
PACED ATRIAL RHYTHMC92233Atrial-paced complex(es) or rhythm;Paced Atrial RhythmAn electrocardiographic finding in which the atrial rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker.Paced Atrial Rhythm
PACED RHYTHMC88140Atrial and/or Ventricular Paced Rhythm;Paced RhythmAn electrocardiographic finding in which the cardiac rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker.Paced Rhythm
PACED VENTRICULAR RHYTHMC92234Paced Ventricular Rhythm;Ventricular-paced complex(es) or rhythmAn electrocardiographic finding in which the ventricular rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker.Paced Ventricular Rhythm
PAROXYSMAL AV BLOCKC62250Paroxysmal AV blockAn electrocardiographic finding of the sudden onset of transient AV block, which is often associated with preexisting conduction disorders.Paroxysmal Atrioventricular Block by ECG Finding
PAROXYSMAL VENTRICULAR TACHYCARDIAC34902Paroxysmal Ventricular TachycardiaAn episodic form of ventricular tachycardia, with abrupt onset and termination. (NCI)Paroxysmal Ventricular Tachycardia by ECG Finding
PAUSEC119250An electrocardiographic finding of an RR interval which exceeds a predefined duration threshold, regardless of the underlying rhythm.Pause by ECG Finding
PAUSE GREATER THAN 3.0 SECONDSC119251An electrocardiographic finding of an RR interval with duration greater than 3.0 seconds, regardless of the underlying rhythm.Pause Greater Than Three Seconds by ECG Finding
POOR QUALITY ECGC114172An electrocardiographic recording that does not show proper quality for reasons that are not otherwise described.Poor Quality ECG
POOR R WAVE PROGRESSIONC71033Poor R Wave ProgressionAn electrocardiographic finding of a lack of progression of R wave height across precordial leads.Poor R Wave Progression by ECG Finding
POSTERIOR WALL MYOCARDIAL INFARCTIONC35399Posterior MI;Posterior Wall Myocardial InfarctionAn electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present.Posterior Myocardial Infarction by ECG Finding
PR SEGMENT DEPRESSIONC116135PR DepressionAn electrocardiographic finding of PR segment depression below the iso-electric line in multiple precordial and/or limb leads.PR Segment Depression by ECG Finding
PRE-EXCITATIONC34940Pre-excitation;Ventricular preexcitationAn electrocardiographic finding characterized by a premature activation of the whole or some part of the ventricle. The PR interval is usually shortened and delta waves are frequently present.Pre-Excitation Syndrome
PRECORDIAL ELECTRODE V1 DISCONNECTEDC114153An electrocardiographic recording in which the electrode for lead V1 is disconnected resulting in missing waveforms (flat line) for lead V1.Disconnected Precordial Electrode V1 by ECG Finding
PRECORDIAL ELECTRODE V2 DISCONNECTEDC114154An electrocardiographic recording in which the electrode for lead V2 is disconnected resulting in missing waveforms (flat line) for lead V2.Disconnected Precordial Electrode V2 by ECG Finding
PRECORDIAL ELECTRODE V3 DISCONNECTEDC114155An electrocardiographic recording in which the electrode for lead V3 is disconnected resulting in missing waveforms (flat line) for lead V3.Disconnected Precordial Electrode V3 by ECG Finding
PRECORDIAL ELECTRODE V4 DISCONNECTEDC114156An electrocardiographic recording in which the electrode for lead V4 is disconnected resulting in missing waveforms (flat line) for lead V4.Disconnected Precordial Electrode V4 by ECG Finding
PRECORDIAL ELECTRODE V5 DISCONNECTEDC114157An electrocardiographic recording in which the electrode for lead V5 is disconnected resulting in missing waveforms (flat line) for lead V5.Disconnected Precordial Electrode V5 by ECG Finding
PRECORDIAL ELECTRODE V6 DISCONNECTEDC114158An electrocardiographic recording in which the electrode for lead V6 is disconnected resulting in missing waveforms (flat line) for lead V6.Disconnected Precordial Electrode V6 by ECG Finding
PRECORDIAL ELECTRODE(S) POSITIONED INCORRECTLYC114160An electrocardiographic recording in which one or more precordial electrodes are placed incorrectly with respect to the standard chest electrode positions resulting in improper representation of the affected leads.Incorrectly Positioned Precordial Electrodes by ECG Finding
PRECORDIAL ELECTRODES INTERCHANGEDC114152Precordial Lead ReversalAn electrocardiographic recording in which two or more of the precordial electrodes are switched resulting in improper representation of the affected leads.Interchanged Precordial Electrodes by ECG Finding
PREMATURE ATRIAL COMPLEXESC62257APC;Atrial premature complex(es);PAC;Premature atrial complex;SVE;Supraventricular Extra BeatAn electrocardiographic finding of an ectopic impulse originating in the atria and not specifically in the sinus node. The P wave morphology of these complexes is often different from a sinus P wave and the RR intervals preceding these complexes is also shorter than those of the regular beats.Atrial Premature Complex by ECG Finding
PREMATURE ATRIAL COMPLEXES BLOCKEDC102603Atrial premature complexes, nonconducted;Non-conducted SVE;Premature Atrial Complexes Blocked;Premature Atrial Complexes Non-conductedAn electrocardiographic finding of premature atrial complexes which are not conducted to the ventricle, and which are not followed by a QRS complex.Blocked Atrial Premature Complex by ECG Finding
PREMATURE ATRIAL COMPLEXES MULTIFOCALC102672Multifocal SVE;Multifocal Supraventricular Extra Beats;Premature Atrial Complexes MultiformAn electrocardiographic finding of premature atrial complexes which have 2 or more distinct morphologies, suggesting origin at more than one atrial site.Multifocal Atrial Premature Complex by ECG Finding
PREMATURE ATRIAL COMPLEXES UNIFOCALC102724Premature Atrial Complexes UnifocalAn electrocardiographic finding of premature atrial complexes which have a single distinct morphology, suggesting origin at one atrial site.Unifocal Atrial Premature Complex by ECG Finding
PREMATURE VENTRICULAR COMPLEXC62256PVC;VE;VPC;Ventricular Extra Beat;Ventricular premature complex(es)An electrocardiographic finding of an ectopic impulse originating in the ventricles. The QRS morphology of these complexes is different from those of supraventricular origin. The QRS duration is often longer and the RR interval preceding the complexes is usually shorter than that of supraventricular beats.Ventricular Premature Complex by ECG Finding
PREMATURE VENTRICULAR COMPLEX INTERPOLATEDC107100Interpolated VE;Interpolated VPC;Interpolated Ventricular Extra Beat;Premature Ventricular Complexes InterpolatedAn electrocardiographic finding of a premature ventricular complex which occurs between two normal QRS complexes which have normal timing.Interpolated Premature Ventricular Complex by ECG Finding
PREMATURE VENTRICULAR COMPLEXES MULTIFOCALC102673Multifocal VES;Multifocal VPCS;Multifocal Ventricular Extra Beats;Premature Ventricular Complexes MultifocalAn electrocardiographic finding of premature ventricular complexes which have two or more distinct morphologies, suggesting origin at more than one ventricular site.Multifocal Ventricular Premature Complex by ECG Finding
PREMATURE VENTRICULAR COMPLEXES UNIFOCALC102725Premature Ventricular Complexes Unifocal;Unifocal VES;Unifocal VPCS;Unifocal Ventricular Extra BeatsAn electrocardiographic finding of premature ventricular complexes which have a single distinct morphology, suggesting origin at one ventricular site.Unifocal Ventricular Premature Complex by ECG Finding
PROLONGED QTC71034Prolonged QT;Prolonged QT intervalAn electrocardiographic finding in which the QT interval not corrected for heart rate is prolonged. Thresholds for different age, gender, and patient populations exist.Prolonged QT Interval by ECG Finding
PROLONGED ST SEGMENTC116137An electrocardiographic finding of a prolonged ST segment, resulting in a long QT interval, without lengthening of the T wave duration. This may be observed in hypocalcemia.Prolonged ST Segment by ECG Finding
Q AXIS, LEFT AXIS DEVIATIONC71094Left-axis deviation;Q Axis, Left axis deviation;QRS axis, left axis deviationAn electrocardiographic finding of a frontal plane QRS axis from -30 to -90 degrees.Q Axis Left Axis Deviation
Q AXIS, RIGHT AXIS DEVIATIONC71095Q Axis, Right axis deviation;QRS axis, right axis deviation;Right-axis deviationAn electrocardiographic finding of a frontal plane QRS axis from +90 to +180 degrees.Q Axis Right Axis Deviation
QRS COMPLEX ABNORMALITYC90440QRS Complex AbnormalityAn electrocardiographic finding of a non-specific abnormality of the QRS complex, which is atypical in shape, duration, amplitude, axis or polarity.QRS Complex Abnormality by ECG Finding
QTC PROLONGATIONC83817QTc ProlongationAn electrocardiographic finding in which the QTc interval corrected for heart rate is prolonged. Thresholds for different age, gender, and patient populations exist.Corrected Prolonged QT Interval by ECG Finding
QTCB PROLONGATIONC107098PROLONGED QTcBAn electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is prolonged. Thresholds for different age, gender, and patient populations exist.QTcB Prolongation
QTCF PROLONGATIONC107099PROLONGED QTcFAn electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is prolonged. Thresholds for different age, gender, and patient populations exist.QTcF Prolongation
QUALITY PROBLEM NOT OTHERWISE SPECIFIEDC114161Unknown Quality ProblemAn electrocardiographic artifact or recording error with unknown origin or which is not described otherwise.Quality Problem Not Otherwise Specified by ECG Finding
R ON T PHENOMENONC61395R on T phenomenonAn electrocardiographic finding in which the R wave of a premature ventricular complex occurs on top of the T wave of the preceding beat.R On T Phenomenon by ECG Finding
R WAVE NOTCHEDC90444R Wave NotchedAn electrocardiographic finding of an R wave variant in which there is a small deflection of the R wave, with changing polarity, within the QRS complex. (NCI)R Wave Notched by ECG Finding
REPOLARIZATION ABNORMALITYC102574Repolarization AbnormalityAn electrocardiographic finding of an abnormality of T wave duration or morphology or of early repolarization.Ventricular Repolarization Abnormality
REPOLARIZATION ABNORMALITY SECONDARY TO VENTRICULAR HYPERTROPHYC102706Repolarization Abnormality Secondary To Ventricular Hypertrophy;ST-T change due to ventricular hypertrophyAn electrocardiographic finding of ST depression and T wave inversion in the presence of increased QRS amplitude which are thought to be due to left ventricular hypertrophy.Repolarization Abnormality Secondary To Ventricular Hypertrophy
RIGHT ATRIAL ABNORMALITYC71041P-pulmonale;Right Atrial EnlargementAn electrocardiographic finding suggesting underlying hypertrophy or dilatation of the right atrium. Electrocardiographic criteria used for the diagnosis of right atrial abnormality may include a peaked p wave greater than 2.5 millimeters in amplitude in the inferior leads. (NCI)P-pulmonale by ECG Finding
RIGHT BUNDLE BRANCH BLOCKC62270Complete RBBB;Right bundle branch block;Right bundle-branch blockAn electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS in V1 and V2, a widened S wave in V5, V6, I and aVL, and with QRS duration greater than or equal to 120 ms. An RsR' complex is typically present in leads V1 and V2.Right Bundle Branch Block by ECG Finding
RIGHT VENTRICULAR CONDUCTION DELAYC92235Right Ventricular Conduction Delay;Right Ventricular DelayAn electrocardiographic finding in which there is evidence that electrical transmission through the right ventricle is impaired with a maximal QRS duration of 110 ms and which does not meet the criteria for Incomplete Right Bundle Branch Block.Right Ventricular Conduction Delay by ECG Finding
RIGHT VENTRICULAR HYPERTROPHYC71077Right ventricular HypertrophyAn electrocardiographic finding suggestive of a hypertrophied right ventricle, characterized by large R wave amplitudes in the right precordial leads and secondary findings of right atrial enlargement, right axis deviation, and typical pattern of ST depression and T wave inversion in the right precordial leads.Right Ventricular Hypertrophy by ECG Finding
RSR PRIMEC92227RSR'An electrocardiographic finding in which there are two R waves, which are two deflections above the baseline resulting from a single ventricular depolarization. The first upward deflection in the complex is the R wave. The S is the first downward deflection. A second upward deflection is called the R-prime wave.RSR' by ECG Finding
SEPTAL MYOCARDIAL INFARCTIONC35519Septal myocardial infarctionAn electrocardiographic finding suggesting an infarction in the anatomic location of the cardiac septum. (NCI)Septal Myocardial Infarction by ECG Finding
SHORT PR INTERVALC62246Short PR intervalAn electrocardiographic finding of an abnormally short PR interval. Thresholds for different age, gender, and patient populations exist.Short PR Interval by ECG Finding
SHORT QTC INTERVALC102709Short QTc IntervalAn electrocardiographic finding of a QT interval corrected for heart rate that is shorter than the lower limit of normal. Thresholds for different age, gender, and patient populations exist.Short QTc Interval
SHORT QTCBC112402An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is shortened. Thresholds for different age, gender, and patient populations exist.QTcB Shortened
SHORT QTCFC112403An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is shortened. Thresholds for different age, gender, and patient populations exist.QTcF Shortened
SHORT ST SEGMENTC116136An electrocardiographic finding of a short or absent ST segment, resulting in a short QT interval, without changes in T wave morphology. This may be observed in hypercalcemia.Short ST Segment by ECG Finding
SINOATRIAL EXIT BLOCKC50553SA Block;Sinoatrial Block;Sinoatrial exit blockAn electrocardiographic finding in which impaired conduction or automaticity within the sinus node results in the failure of impulse transmission from the sinoatrial node. This is manifest as dropped P waves during sinus rhythm.Exit Block by ECG Finding
SINUS ARREST/PAUSEC62242Sinus arrest/pause;Sinus pause or arrestAn electrocardiographic finding in which a failure of impulse formation or conduction in the sinus node produces prolongation of the P-P interval or dropped P waves. The threshold for the prolongation of the P-P interval is not well defined.Sinus Arrest by ECG Finding
SINUS ARRHYTHMIAC62239Respiratory Sinus Arrhythmia;Sinus arrhythmiaAn electrocardiographic finding in which the sinus rate fluctuates with the respiratory cycle.Sinus Arrhythmia by ECG Finding
SINUS BRADYCARDIAC111097Sinus bradycardiaAn electrocardiographic finding of abnormally slow heart rate with its origin in the sinus node. Thresholds for different age, gender, and patient populations exist.Sinus Bradycardia by ECG Finding
SINUS RHYTHMC100076Sinus RhythmAn electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population.Sinus Rhythm
SINUS TACHYCARDIAC111104Sinus tachycardiaAn electrocardiographic finding of abnormally rapid heart rate with its origin in the sinus node. Thresholds for different age, gender, and patient populations exist.Sinus Tachycardia by ECG Finding
ST DEPRESSIONC41330ST depressionAn electrocardiographic finding of ST segment depression below the baseline, often described as up sloping, down sloping or horizontal. (NCI)ST Segment Depression by ECG Finding
ST ELEVATIONC50540ST elevationAn electrocardiographic finding of ST segment elevation above the baseline. (NCI)ST Segment Elevation by ECG Finding
ST ELEVATION PERICARDITISC71029ST elevation pericarditisAn electrocardiographic finding of ST elevation which is concave upwards, and which is often accompanied by PR segment depression.ST Elevation Pericarditis by ECG Finding
SUPRAVENTRICULAR COUPLETC119252An electrocardiographic finding in which two premature atrial complexes occur sequentially.Supraventricular Couplet by ECG Finding
SUPRAVENTRICULAR TACHYCARDIAC111100Supraventricular tachycardiaAn electrocardiographic finding of a tachycardia which does not originate in the ventricles or His Purkinje system. There is an abnormally high heart rate and QRS complexes are typically narrow, but aberration or preexcitation may be present.Supraventricular Tachycardia by ECG Finding
SUSPECT LIMB ELECTRODES REVERSED, INTERPRETATION ASSUMES NO REVERSALC114173An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, but for which an interpretation is performed as though the lead placement is correct.Suspicion of Limb Electrodes Reversal But Interpretation Assumes No Reversal by ECG Finding
SUSPECT LIMB ELECTRODES REVERSED, INTERPRETATION ASSUMES REVERSALC114174An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, and for which an interpretation is performed as though the leads have in fact been interchanged.Suspicion of Limb Electrodes Reversal But Interpretation Assumes Reversal by ECG Finding
SUSTAINED VENTRICULAR TACHYCARDIAC71052Sustained ventricular tachycardiaAn electrocardiographic finding of ventricular tachycardia greater than 30 seconds in duration. (NCI)Sustained Ventricular Tachycardia by ECG Finding
T WAVE ALTERNANSC102718T Wave AlternansAn electrocardiographic finding in which there are variations in the shape, amplitude, or direction of the T wave from one beat to the next.T Wave Alternans by ECG Finding
T WAVE INVERSIONC71085T Wave InversionAn electrocardiographic finding of an inversion of the T wave from the expected axis. (NCI)T Wave Inversion by ECG Finding
T WAVE PEAKEDC71086T wave peakedAn electrocardiographic finding in which the T wave appears increased in amplitude and cresting at a point. (NCI)T Wave Peaked by ECG Finding
T WAVES BIPHASICC71087T waves biphasicAn electrocardiographic finding of a T wave with both positive and negative components.T Waves Biphasic by ECG Finding
T WAVES FLATC71088T waves flatAn electrocardiographic finding in which the T wave appears decreased in amplitude. (NCI)T Waves Flat by ECG Finding
TACHYCARDIAC111121TachycardiaAn electrocardiographic finding of abnormally rapid heart rate. Thresholds for different age, gender, and patient populations exist.Tachycardia by ECG Finding
TORSADES DE POINTESC50779Torsades de pointes;Ventricular tachycardia, torsades de pointesAn electrocardiographic finding of an atypical rapid polymorphic ventricular tachycardia with a characteristic rotation of the QRS complex around the isoelectric baseline, occurring in the setting of a prolonged QT interval. In addition, the QRS complex displays a periodic waxing and waning of amplitude on the electrogram.Torsades De Pointes by ECG Finding
U WAVE ABNORMALITYC106579Abnormal U WaveAn electrocardiographic finding of U waves which have increased amplitude, are inverted, or merged with the preceding T wave.U Wave Abnormality by ECG Finding
UNABLE TO DIGITIZE ECG LEADSC114170A statement indicating the inability to digitize a paper ECG.Inability to Digitize ECG Leads
UNDETERMINED RHYTHMC116131An electrocardiographic finding of a cardiac rhythm whose mechanism cannot be determined from the ECG.Undetermined Rhythm by ECG Finding
VENTRICULAR BIGEMINYC71054BigeminyAn electrocardiographic finding of a normal QRS complex followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 1-1 ratio.Ventricular Bigeminy by ECG Finding
VENTRICULAR COUPLETC62259Ventricular Pair;Ventricular coupletAn electrocardiographic finding in which two premature ventricular complexes occur sequentially.Ventricular Couplet by ECG Finding
VENTRICULAR ESCAPE BEATC90483Ventricular Escape Beat;Ventricular escape complex(es)An electrocardiographic finding of a compensatory ventricular complex that occurs following a prolonged RR interval.Ventricular Escape Beat by ECG Finding
VENTRICULAR FIBRILLATIONC111102Ventricular fibrillationAn electrocardiographic finding of a rapid grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. The rate is typically greater than 300 bpm.Ventricular Fibrillation by ECG Finding
VENTRICULAR FLUTTERC111115Ventricular flutterA ventricular tachyarrhythmia characterized by a high ventricular rate (180 to 250 beats per minute) with a regular rhythm. The electrocardiogram shows large oscillating sine wave-like complexes occurring as a result of QRS complexes and T waves being merged. The P wave is not visible. (NCI)Ventricular Flutter by ECG Finding
VENTRICULAR PARASYSTOLEC102728Parasystole;Ventricular ParasystoleAn electrocardiographic finding of normal sinus rhythm coexisting with a regular ectopic ventricular rhythm.Ventricular Parasystole by ECG Finding
VENTRICULAR TACHYCARDIAC111103Ventricular tachycardiaAn electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology.Ventricular Tachycardia by ECG Finding
VENTRICULAR TACHYCARDIA, MONOMORPHICC62234Ventricular tachycardia, monomorphicAn electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a uniform morphology.Monomorphic Ventricular Tachycardia by ECG Finding
VENTRICULAR TACHYCARDIA, POLYMORPHICC62236Ventricular tachycardia, polymorphic;Ventricular tachycardia, polymorphousAn electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a variable morphology and often rate.Polymorphic Ventricular Tachycardia by ECG Finding
VENTRICULAR TRIGEMINYC71055TrigeminyAn electrocardiographic finding of two normal QRS complexes followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio.Ventricular Trigeminy by ECG Finding
WANDERING ATRIAL PACEMAKERC62240Wandering atrial pacemakerAn electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically below 100 beats per minute.Wandering Atrial Pacemaker by ECG Finding
WIDE QRS TACHYCARDIAC71090Wide QRS tachycardia;Wide-QRS tachycardiaAn electrocardiographic finding of three or more consecutive wide QRS complexes of uncertain origin with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used).Wide QRS Tachycardia by ECG Finding
WOLFF-PARKINSON-WHITE SYNDROMEC35132WPW;Wolff-Parkinson-White syndromeAn electrocardiographic finding of ventricular pre-excitation. The syndrome is characterized by a short PR interval and a long QRS interval with a delta wave.Wolff-Parkinson-White Syndrome
Back to top
CL.C71153.EGTESTCDECG Test Code
(EGTESTCD)
text
Extensible: Yes
C71153ECG Test CodeTerminology codelist used with ECG Tests within CDISC.CDISC SDTM ECG Test Terminology by Code
AMIEGCHGC116140Acute Myocardial Ischemia ECG ChangeAn electrocardiographic finding assessment of new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block consistent with acute myocardial ischemia. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1-18, 2012)Acute Myocardial Ischemia by ECG Assessment
AVCONDC111131Atrioventricular ConductionAn electrocardiographic assessment of cardiac atrioventricular conduction.Atrioventricular Conduction ECG Assessment
AXISVOLTC111132Axis and VoltageAn electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage.Axis and Voltage ECG Assessment
CHYPTENLC111155Chamber Hypertrophy or EnlargementAn electrocardiographic assessment of chamber hypertrophy or enlargement.Chamber Hypertrophy or Enlargement ECG Assessment
EGARMAXC119253ECG Maximum Atrial RateAn electrocardiographic measurement of the maximum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute.Maximum Atrial Rate by Electrocardiogram
EGARMEDC119254ECG Median Atrial RateAn electrocardiographic measurement of the median rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute.Median Atrial Rate by Electrocardiogram
EGARMINC119255ECG Minimum Atrial RateAn electrocardiographic measurement of the minimum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute.Minimum Atrial Rate by Electrocardiogram
EGARMNC119256ECG Mean Atrial RateAn electrocardiographic measurement of the average rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute.Mean Atrial Rate by Electrocardiogram
EGCOMPC117761Comparison to a Prior ECGA comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated.Comparison to a Prior ECG
EGHRMAXC119257ECG Maximum Heart RateAn electrocardiographic measurement of the maximum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the maximum ventricular rate.Maximum Heart Rate by Electrocardiogram
EGHRMINC119258ECG Minimum Heart RateAn electrocardiographic measurement of the minimum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the minimum ventricular rate.Minimum Heart Rate by Electrocardiogram
EGHRMNC119259ECG Mean Heart RateAn electrocardiographic measurement of the average rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the mean ventricular rate.Mean Heart Rate by Electrocardiogram
EGVRMAXC119260ECG Maximum Ventricular RateAn electrocardiographic measurement of the maximum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute.Maximum Ventricular Rate by Electrocardiogram
EGVRMEDC119261ECG Median Ventricular RateAn electrocardiographic measurement of the median rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute.Median Ventricular Rate by Electrocardiogram
EGVRMINC119262ECG Minimum Ventricular RateAn electrocardiographic measurement of the minimum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute.Minimum Ventricular Rate by Electrocardiogram
EGVRMNC119263ECG Mean Ventricular RateAn electrocardiographic measurement of the average rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute.Mean Ventricular Rate by Electrocardiogram
HRMEDC102249Summary (Median) Heart RateThe median number of cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate.Median Heart Rate
INTPC41255InterpretationAn act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language.Interpretation
IVTIACDC111238Intraventricular-Intraatrial ConductionAn electrocardiographic assessment of intraventricular and intra-atrial conduction.Intraventricular and Intraatrial Conduction ECG Assessment
JTAGC117762JT Interval, AggregateAn aggregate JT value based on the measurement of JT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate JT Interval
JTCBC62118JTcB - Bazett's Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcB = JT/SqRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)JTcB - Bazett's Correction Formula
JTCBAGC117763JTCB Interval, AggregateA JTAG interval corrected for heart rate using Bazett's formula.Aggregate JTCB Interval
JTCBSBC117764JTCB Interval, Single BeatA JTSB interval corrected for heart rate using Bazett's formula.Single Beat JTCB Interval
JTCFC62119JTcF - Fridericia's Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcF = JT/CubeRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)JTcF - Fridericia's Correction Formula
JTCFAGC117765JTCF Interval, AggregateA JTAG interval corrected for heart rate using Fridericia's formula.Aggregate JTCF Interval
JTCFSBC117766JTCF Interval, Single BeatA JTSB interval corrected for heart rate using Fridericia's formula.Single Beat JTCF Interval
JTCLCC62120JTcLC - Linear Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. Using this method, the corrected JT interval is independent of the ventricular rate. (NCI)JTcLC - Linear Correction Formula
JTMAXC62117Summary (Max) JT IntervalThe maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)Maximum JT Duration
JTMEANC62115Summary (Mean) JT IntervalThe average (mean) duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)Mean JT Duration
JTMINC62116Summary (Min) JT IntervalThe minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)Minimum JT Duration
JTPAGC117767J-Tpeak Interval, AggregateAn aggregate J-Tpeak value based on the measurement of J-Tpeak intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate J-T Peak Interval
JTPSBC117768J-Tpeak Interval, Single BeatAn electrocardiographic interval measured from the J point to the peak of the T wave of a single beat utilizing one or more leads.Single Beat J-T Peak Interval
JTSBC117769JT Interval, Single BeatAn electrocardiographic interval measured from the J point to the offset of the T wave of a single beat utilizing one or more leads.Single Beat JT Interval
MIC111280Myocardial InfarctionAn electrocardiographic assessment of findings suggestive of myocardial infarction.Myocardial Infarction ECG Assessment
NEWQWAVEC117770New Q WaveAn electrocardiographic finding assessment of new or presumed new pathologic Q waves suggestive of myocardial infarction. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1-18, 2012).New Q Wave
P_AXISC118164P Wave AxisA numerical representation of the electrocardiographic vector assessed at maximum deviation of the P wave from the isoelectric baseline, usually reported for the frontal plane.P Wave Axis
PACEMAKRC111285PacemakerAn electrocardiographic assessment of presence of artificial electronic pacing.Pacemaker ECG Assessment
PPAGC117771PP Interval, AggregateAn aggregate PP value based on the measurement of PP intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate PP Interval
PPSMC117772PP Interval, Single MeasurementAn electrocardiographic measurement of the interval between the onsets of two consecutive P waves.Single Measurement PP Interval
PRAGC117773PR Interval, AggregateAn aggregate PR value based on the measurement of PR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate PR Interval
PRMAXC62131Summary (Max) PR DurationThe maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)Maximum PR Duration
PRMEANC62086Summary (Mean) PR DurationThe average (mean) duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)Mean PR Duration
PRMEDC102250Summary (Median) PR DurationThe median duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave.Median PR Duration
PRMINC62125Summary (Min) PR DurationThe minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)Minimum PR Duration
PRSBC117774PR Interval, Single BeatAn electrocardiographic interval measured from the onset of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads.Single Beat PR Interval
PWAVEDURC62123Summary (Mean) P Wave DurationThe average (mean) duration (time) from the onset of atrial depolarization to the completion of atrial depolarization (length of the P wave), obtained from a set of measurements of the time from beginning to end of atrial depolarization. (NCI)Mean P Wave Duration
PWAVEHTC62124Summary (Mean) P Wave HeightThe average (mean) height (usually measured in mm) of the maximum deflection from baseline of the P wave (representing atrial depolarization), obtained from a set of measurements of the P wave, from a single lead or set of leads. Typically this measurement is obtained by analysis of Lead II. (NCI)Mean P Wave Height
PWDURAGC117775P Wave Duration, AggregateAn aggregate P wave duration value based on the measurement of P wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate P Wave Duration
PWDURSBC117776P Wave Duration, Single BeatAn electrocardiographic interval measured from the onset of the P wave to the offset of the P wave of a single beat utilizing one or more leads.Single Beat P Wave Duration
PWHTAGC117777P Wave Amplitude, AggregateAn aggregate P wave amplitude value based on the measurement of P wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate P Wave Amplitude
PWHTSBC117778P Wave Amplitude, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the P wave measured from the isoelectric baseline to the peak of the P wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.Single Beat P Wave Amplitude
QRS_AXISC118165QRS AxisA numerical representation of the electrocardiographic vector assessed at maximum deviation of the QRS complex from the isoelectric baseline, usually reported for the frontal plane.QRS Axis
QRSAGC117779QRS Duration, AggregateAn aggregate QRS value based on the measurement of QRS intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate QRS Duration
QRSDURC62087Summary (Mean) QRS DurationThe average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize. (NCI)Mean QRS Duration
QRSDURVPC100390QRS Duration Ventricular PacedThe average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval while the ventricle rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize.Mean QRS Duration Ventricular Paced
QRSMEDC102251Summary (Median) QRS DurationThe median duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize.Median QRS Duration
QRSSBC117780QRS Duration, Single BeatAn electrocardiographic interval measured from the onset of the QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads.Single Beat QRS Duration
QRVDVPAGC117781QRS Duration, Ventr. Paced, AggregateAn aggregate paced QRS duration value based on the measurement of paced QRS duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Paced Ventricular Aggregate QRS Duration
QRVDVPSBC117782QRS Duration, Ventr. Paced, Single BeatAn electrocardiographic interval measured from the onset of the paced QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads.Paced Ventricular Single Beat QRS Duration
QTAGC117783QT Interval, AggregateAn aggregate QT value based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate QT Interval
QTCC100391QT Interval, CorrectedThe time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula.Corrected QT Interval
QTCBC62112QTcB - Bazett's Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcB = QT/SqRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcB - Bazett's Correction Formula
QTCBAGC117784QTCB Interval, AggregateA QTAG interval corrected for heart rate using Bazett's formula.Aggregate QTCB Interval
QTCBSBC117785QTCB Interval, Single BeatA QTSB interval corrected for heart rate using Bazett's formula.Single Beat QTCB Interval
QTCFC62113QTcF - Fridericia's Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcF = QT/CubeRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcF - Fridericia's Correction Formula
QTCFAGC117786QTCF Interval, AggregateA QTAG interval corrected for heart rate using Fridericia's formula.Aggregate QTCF Interval
QTCFMEDC102253Summary (Median) QTcFThe median duration (time) of the QTc interval, obtained from a set of measurements of the QT interval and corrected using the Fridericia's correction Formula.Median QTcF
QTCFSBC117787QTCF Interval, Single BeatA QTSB interval corrected for heart rate using Fridericia's formula.Single Beat QTCF Interval
QTCLCC62114QTcLC - Linear Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. This method theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcLC - Linear Correction Formula
QTCVC90442QTcV - Van de Water's Correction FormulaA mathematic formula defined as: QTcV = QT-0.087[(60/Heart Rate)-1](seconds). It permits comparison of the QT interval across a range of rates, while accounting for the progressive shortening of the QT interval which occurs as the heart rate increases. (NCI)QTcV - Van de Water's Correction Formula
QTMAXC62135Summary (Max) QT DurationThe maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)Maximum QT Duration
QTMEANC62089Summary (Mean) QT DurationThe average (mean) duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)Mean QT Duration
QTMEDC102252Summary (Median) QT DurationThe median duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave.Median QT Duration
QTMINC62133Summary (Min) QT DurationThe minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)Minimum QT Duration
QTSBC117788QT Interval, Single BeatAn electrocardiographic interval measured from the onset of the QRS complex to the offset of the T wave of a single beat utilizing one or more leads.Single Beat QT Interval
QWAAGC117789Q Wave Amplitude, AggregateAn aggregate Q wave amplitude value based on the measurement of Q wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate Q Wave Amplitude
QWASBC117790Q Wave Amplitude, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the Q wave measured from the isoelectric baseline to the peak of the Q wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.Single Beat Q Wave Amplitude
RHYNOSC111307Rhythm Not Otherwise SpecifiedAn electrocardiographic assessment of cardiac rhythm not otherwise specified.Rhythm Not Otherwise Specified ECG Assessment
RRAGC117791RR Interval, AggregateAn aggregate RR value based on the measurement of RR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate RR Interval
RRMAXC62094Summary (Max) RR DurationThe maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)Maximum RR Duration
RRMEANC62090Summary (Mean) RR DurationThe average (mean) duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate. (NCI)Mean RR Duration
RRMEDC102254Summary (Median) RR DurationThe median duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate.Median RR Duration
RRMINC62093Summary (Min) RR DurationThe minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)Minimum RR Duration
RRSMC117792RR Interval, Single MeasurementAn electrocardiographic measurement of the interval between two consecutive R waves. If R waves are not present, this measurement may utilize the interval between the most easily identified components of the QRS complex within two consecutive beats.RR Interval Single Measurement
RSAAGC117793RS Wave Amplitude, AggregateAn aggregate RS wave amplitude value based on measurements from multiple beats from a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.RS Wave Amplitude Aggregate
RSAMPC62144Summary (Mean) R+S AmplitudeThe average (mean) amplitude (usually in mm) of the summation of the R and S waves, obtained from a set of measurements of the R and S waves, in a particular lead or set of leads. (NCI)Mean R+S Amplitude
RSASBC117794RS Wave Amplitude, Single BeatAn electrocardiographic measurement of the sum of the amplitudes of the R and S waves, obtained from a single beat in one particular lead or set of leads.RS Wave Amplitude Single Beat
RWAAGC117795R Wave Amplitude, AggregateAn aggregate R wave amplitude value based on the measurement of R wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.R Wave Amplitude Aggregate
RWASBC117796R Wave Amplitude, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the R wave measured from the isoelectric baseline to the peak of the R wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.R Wave Amplitude Single Beat
RWAVEAMPC62136Summary (Mean) R Wave AmplitudeThe average (mean) amplitude (usually in mm) of the R wave, obtained from a set of measurements of the R wave, in a particular lead or set of leads. (NCI)Mean R Wave Amplitude
SNRARRYC111312Sinus Node Rhythms and ArrhythmiasAn electrocardiographic assessment of sinus node rhythms and arrhythmias.Sinus Node Rhythm and Arrhythmia ECG Assessment
SPRARRYC111320Supraventricular ArrhythmiasAn electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias.Supraventricular Arrhythmia ECG Assessment
SPRTARRYC111321Supraventricular TachyarrhythmiasAn electrocardiographic assessment of supraventricular tachyarrhythmias.Supraventricular Tachyarrhythmia ECG Assessment
STDAGC117797ST Segment Depression, AggregateAn aggregate ST segment depression value based on the measurement of ST segment depression from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.ST Segment Depression Aggregate
STDPMAXC62163Summary (Max) ST DepressionThe maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)Maximum ST Segment Depression by ECG Finding
STDPMEANC62161Summary (Mean) ST DepressionThe average (mean) depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)Mean ST Segment Depression by ECG Finding
STDPMINC62162Summary (Min) ST DepressionThe minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)Minimum ST Segment Depression by ECG Finding
STDSBC117798ST Segment Depression, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment depression below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.ST Segment Depression Single Beat
STDVAGC117799ST Segment Deviation, AggregateAn aggregate ST segment deviation value based on the measurement of ST segment deviation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.ST Segment Deviation Aggregate
STDVMAXC62157Summary (Max) ST DeviationThe maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)Maximum ST Deviation
STDVMEANC62155Summary (Mean) ST DeviationThe average (mean) deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)Mean ST Deviation
STDVMINC62156Summary (Min) ST DeviationThe minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)Minimum ST Deviation
STDVSBC117800ST Segment Deviation, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment deviation above or below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.ST Segment Deviation Single Beat
STEAGC117801ST Segment Elevation, AggregateAn aggregate ST segment elevation value based on the measurement of ST segment elevation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.ST Segment Elevation Aggregate
STELMAXC62160Summary (Max) ST ElevationThe maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)Maximum ST Segment Elevation
STELMEANC62158Summary (Mean) ST ElevationThe average (mean) elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)Mean ST Segment Elevation
STELMINC62159Summary (Min) ST ElevationThe minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)Minimum ST Segment Elevation
STESBC117802ST Segment Elevation, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment elevation above the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.ST Segment Elevation Single Beat
STSDURAGC117803ST Segment Duration, AggregateAn aggregate ST segment duration value based on the measurement of ST segment duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.ST Segment Duration Aggregate
STSDURSBC117804ST Segment Duration, Single BeatAn electrocardiographic interval measured from the J point to the onset of the T wave of a single beat utilizing one or more leads.ST Segment Duration Single Beat
STSEGDURC62145Summary (Mean) ST Segment DurationThe average (mean) duration (time) of the ST segment, measured from the J point at the end of the QRS complex to the beginning of the T wave.Mean ST Segment Duration
STSTWUWC111363ST Segment, T wave, and U waveAn electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave.ST Segment, T wave, and U wave ECG Assessment
SWAAGC117805S Wave Amplitude, AggregateAn aggregate S wave amplitude value based on the measurement of S wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.S Wave Amplitude Aggregate
SWASBC117806S Wave Amplitude, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the S wave measured from the isoelectric baseline to the peak of the S wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.S Wave Amplitude Single Beat
SWAVEAMPC62137Summary (Mean) S Wave AmplitudeThe average (mean) amplitude (usually in mm) of the S wave, obtained from a set of measurements of the S wave, in a particular lead or set of leads. (NCI)Mean S Wave Amplitude
T_AXISC118166T Wave AxisA numerical representation of the electrocardiographic vector assessed at maximum deviation of the T wave from the isoelectric baseline, usually reported for the frontal plane.T Wave Axis
TECHQUALC117807Technical QualityA statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis.ECG Technical Quality
TPTEAGC117808Tpeak-Tend Interval, AggregateAn aggregate Tpeak-Tend value based on the measurement of Tpeak-Tend from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.T Peak-T End Interval Aggregate
TPTESBC117809Tpeak-Tend Interval, Single BeatAn electrocardiographic interval measured from the peak of the T wave to the offset of the T wave of a single beat utilizing one or more leads.T Peak-T End Interval Single Beat
TWARAGC117810T Wave Area, AggregateAn aggregate T wave area value based on the measurement of T wave areas from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.T Wave Area Aggregate
TWARSBC117811T Wave Area, Single BeatAn electrocardiographic measurement of the area of the T wave of a single beat utilizing one or more leads.T Wave Area Single Beat
TWAVAREAC62148Summary (Mean) T Wave AreaThe average (mean) area under the curve of the deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)Mean T Wave Area
TWAVEDURC62147Summary (Mean) T Wave DurationThe average (mean) duration (time) from the onset of ventricular repolarization to the completion of ventricular repolarization (length of the T wave), obtained from a set of measurements of the time from beginning to end of ventricular repolarization. (NCI)Mean T Wave Duration
TWAVEHTC62149Summary (Mean) T Wave HeightThe average (mean) height (usually measured in mm) of the maximum deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)Mean T Wave Height
TWDURAGC117812T Wave Duration, AggregateAn aggregate T wave duration value based on the measurement of T wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.T Wave Duration Aggregate
TWDURSBC117813T Wave Duration, Single BeatAn electrocardiographic interval measured from the onset of the T wave to the offset of the T wave of a single beat utilizing one or more leads.T Wave Duration Single Beat
TWHAGC117814T Wave Amplitude, AggregateAn aggregate T wave amplitude value based on the measurement of T wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.T Wave Amplitude Aggregate
TWHSBC117815T Wave Amplitude, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the T wave measured from the isoelectric baseline to the peak of the T wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.T Wave Amplitude Single Beat
VTARRYC111330Ventricular ArrhythmiasAn electrocardiographic assessment of ventricular arrhythmias excluding tachycardias.Ventricular Arrhythmia ECG Assessment
VTTARRYC111331Ventricular TachyarrhythmiasAn electrocardiographic assessment of supraventricular tachyarrhythmias.Ventricular Tachyarrhythmia ECG Assessment
Back to top
CL.C71151.EGMETHODECG Test Method
(EGMETHOD)
text
Extensible: Yes
C71151ECG Test MethodTerminology codelist used with ECG Test Methods within CDISC.CDISC SDTM ECG Test Method Terminology
10 LEAD STANDARDC9034910 Lead StandardAn electrocardiogram lead placement on the subject using a ten electrode lead set to synthesize standard 12 lead electrocardiograph data to elicit an electrical view of the heart.10 Lead Standard
12 LEAD 1 LEAD MISSINGC7112512 Lead 1 Lead MissingAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but one standard lead position is missing therefore requiring a Mortara source consistency filter. (NCI)12 Lead Placement 1 Lead Missing
12 LEAD CABRERAC7111612 Lead CabreraAn electrocardiogram (ECG) lead placement whereby the display of the 12 standard ECG leads is in an orderly sequence in a single horizontal display of: aVL, I, -aVR, II, aVF, III, V1 to V6. In the Cabrera display the limb lead aVR is inverted (-aVR) to obtain the same positive leftward orientation as the other 5 limbs. (NCI)12 Lead Placement Cabrera
12 LEAD EASI DOWER TRANSFORMATIONC7112312 Lead EASI Dower TransformationAn electrocardiogram (ECG) lead placement whereby 4 chest electrodes and 1 reference electrode are used to allow for continuous monitoring at the clinical level. This placement creates a 12 lead ECG that allows the acquisition of simultaneous events in the frontal, horizontal and sagittal heart planes with the linear transformation of vectors. This system provides a three-dimensional portrayal of the heart and uses mathematical and fixed coefficients for each lead. (NCI)Lead Placement EASI Dower Transformation
12 LEAD MASON LIKARC7110312 Lead Mason LikarAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified for ECG recording during exercise. Exercise stress testing requires moving the limb electrodes to more central positions on the thorax. The electrodes are placed in bony prominences close to the bases of the respective limbs in order to avoid skeletal muscle artifact, provide stability for recording electrodes and to record waveforms similar to the standard limb sites. (NCI)12 Lead Placement Mason Likar
12 LEAD MODIFIED MASON LIKARC7111012 Lead Modified Mason LikarAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the Mason Likar lead positions have been modified so that V1 to V6 on the chest are part of a single electrode pad. In addition, lead CM5 is substituted for lead aVR. (NCI)12 Lead Placement Mason Likar Modified
12 LEAD NON-STANDARDC7111412 Lead Non-StandardAn electrocardiogram (ECG) lead placement whereby the limb leads are placed on the torso for easier and faster application in emergency situations. (NCI)12 Lead Placement Non-Standard
12 LEAD RIGHT-SIDED PRECORDIAL LEADSC11613912 Lead Right-sided Precordial Leads;Right-sided Chest LeadsAn electrocardiogram (ECG) lead placement whereby the precordial leads are intentionally placed on the right side of the chest.12 Lead Placement Right-sided Precordial Leads
12 LEAD SINGLE PADC7111212 Lead Single PadAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that all leads on the chest are part of a single electrode pad. (NCI)12 Lead Placement Chest
12 LEAD STANDARDC7110212 Lead StandardAn electrocardiogram (ECG) lead placement whereby 12 leads are recorded, with each lead representing an electrical view of the heart. The six leads recorded in the frontal plane are derived from the placement of 3 electrodes (RA or Right Arm, LA, or Left Arm, and LL or Left Leg). These bipolar frontal leads form the basis of Einthoven's triangle, and are represented by leads I, II, and III. Three other derived (or augmented) bipolar frontal vectors are also recorded on a standard 12-lead EKG, aVR, aVF, and aVL. 6 unipolar leads, corresponding to V1 - V6 measure the electrical activity in the horizontal plane. The placement for the V leads is as follows: V1: right 4th intercostal space,V2: left 4th intercostal space, V3: halfway between V2 and V4, V4: left 5th intercostal space, mid-clavicular line, V5: horizontal to V4, anterior axillary line, V6: horizontal to V5, mid-axillary line. (NCI)12 Lead Placement Standard
12 LEAD UNSPECIFIEDC7110112 Lead UnspecifiedAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the position of the leads is unspecified. (NCI)12 Lead Placement Unspecified
6 LEAD STANDARDC903506 Lead StandardAn electrocardiogram lead placement on the subject using a six electrode lead set with three standard leads and three augmented derived leads to elicit an electrical view of the heart.6 Lead Standard
BIPOLAR UNCORRECTED XYZ LEAD SYSTEMC71121Bipolar uncorrected XYZ lead systemAn electrocardiogram (ECG) lead placement whereby the X+ lead is placed at the right mid-axillary line ate the 4th intercostal space, X- at the left mid-axillary line at he 4th intercostal space, Y+ at the proximal left leg, Y- at the superior aspect of the manubrium, Z+ at the direct posterior to Z- and Z- at the 4th intercostal space at the left sternal margin. (NCI)Lead Placement Bipolar Uncorrected XYZ
CUBE LEAD SYSTEMC71120Cube lead systemAn electrocardiogram (ECG) lead placement that is a type of uncorrected vectorcardiograph. This lead system is based on a rectangular body axis. It uses an extra number of electrodes to make it three-dimensional. (NCI)Lead Placement Cube
FRANK LEAD SYSTEMC71118Frank lead systemAn electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (right to left direction), Y (foot to head direction) and Z (back to front direction) of the heart. For this method a minimum of 4 electrodes are needed that represent the right arm, left arm, left leg and back. However, usually 7 electrodes are used to avoid dependence on the dipole location and facilitate interpretation. (NCI)Lead Placement Frank
MCFEE-PARUNGAO LEAD SYSTEMC71119McFee-Parungao lead systemAn electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (back to front), Y (right to left) and Z (foot to head) of the heart. This system places the electrodes closer to the heart to achieve better orthogonality and a homogeneous lead field. (NCI)Lead Placement McFee-Parungao
PSEUDO-ORTHOGONAL XYZ LEAD SYSTEMC71122Pseudo-orthogonal XYZ lead systemAn electrocardiogram (ECG) lead placement that allows monitoring and recording of cardiac electrical activity. A V1-type lead is used whose positive electrode is localized in the 4th intercostal space, 2.5cm from the sternum. Its negative electrode is placed below the left clavicle. An addition of lead V5 and aVF can be made to facilitate interpretation. (NCI)Lead Placement Pseudo Orthogonal XYZ
STANDARD 12-LEAD AND CC5-CM5-MLC71128Standard 12-lead and CC5-CM5-MLAn electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the negative reference is at CM5 and the active electrode is at the left leg position. (NCI)12 Lead Placement Standard And CC5-CM5-ML
STANDARD 12-LEAD AND CM5-CC5-CH5C71126Standard 12-lead and CM5-CC5-CH5An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the bipolar lead groups place the negative of the reference electrode over the manubrium (CM5), the right scapula (CB5), V5R (CC5) or on the forehead (CH5) and the active electrode at V5. (NCI)12 Lead Placement Standard And CC5-CM5-CH5
STANDARD 12-LEAD EXTENDED LEFTC71131Standard 12-lead extended to the left by V7, V8, V9An electrocardiogram (ECG) lead placement whereby the standard lead placement is modified by having leads V7, V8 and V9. (NCI)12 Lead Placement Standard Extended Left
STANDARD 12-LEAD EXTENDED RIGHTC71130Standard 12-lead extended to the right by V5R, V4R, V3RAn electrocardiogram (ECG) lead placement whereby the rightward oriented V leads progress from V1R, placed instead of the standard V2, to V6R. The V3 lead in the standard placement is replaced by V4R. (NCI)12 Lead Placement Standard Extended Right
STANDARD LEADS FOR BICYCLE EXERCISEC71115Standard leads for bicycle exercise. Limb leads on the back (shoulder and on the hips)Limb leads on the back (shoulder and on the hips). (NCI)Lead Placement Bicycle
STANDARD LEADS ONE INTERCOSTAL SPACE HIGHERC71117Standard leads one intercostal space higherAn electrocardiographic lead placement schema in which the V leads are placed one intercostal space cephalad to the position they would have in the standard lead placement schema. (NCI)Lead Placement Standard Intercostal Space Higher
VECTORCARDIOGRAPH CORRECTEDC71092Vectorcardiograph CorrectedA recording of the electrical activity of the heart displayed in the form of a vector loop, corrected for anatomic inconsistencies. (NCI)Vectorcardiograph Corrected
VECTORCARDIOGRAPH UNCORRECTEDC71093Vectorcardiograph UncorrectedA recording of the electrical activity of the heart displayed in the form of a vector loop, uncorrected for anatomic inconsistencies. (NCI)Vectorcardiograph Uncorrected
Back to top
CL.C71152.EGTESTECG Test Name
(EGTEST)
text
Extensible: Yes
C71152ECG Test NameTerminology codelist used with ECG Test Names within CDISC.CDISC SDTM ECG Test Name Terminology
Acute Myocardial Ischemia ECG ChangeC116140Acute Myocardial Ischemia ECG ChangeAn electrocardiographic finding assessment of new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block consistent with acute myocardial ischemia. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1-18, 2012)Acute Myocardial Ischemia by ECG Assessment
Atrioventricular ConductionC111131Atrioventricular ConductionAn electrocardiographic assessment of cardiac atrioventricular conduction.Atrioventricular Conduction ECG Assessment
Axis and VoltageC111132Axis and VoltageAn electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage.Axis and Voltage ECG Assessment
Chamber Hypertrophy or EnlargementC111155Chamber Hypertrophy or EnlargementAn electrocardiographic assessment of chamber hypertrophy or enlargement.Chamber Hypertrophy or Enlargement ECG Assessment
Comparison to a Prior ECGC117761Comparison to a Prior ECGA comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated.Comparison to a Prior ECG
ECG Maximum Atrial RateC119253ECG Maximum Atrial RateAn electrocardiographic measurement of the maximum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute.Maximum Atrial Rate by Electrocardiogram
ECG Maximum Heart RateC119257ECG Maximum Heart RateAn electrocardiographic measurement of the maximum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the maximum ventricular rate.Maximum Heart Rate by Electrocardiogram
ECG Maximum Ventricular RateC119260ECG Maximum Ventricular RateAn electrocardiographic measurement of the maximum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute.Maximum Ventricular Rate by Electrocardiogram
ECG Mean Atrial RateC119256ECG Mean Atrial RateAn electrocardiographic measurement of the average rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute.Mean Atrial Rate by Electrocardiogram
ECG Mean Heart RateC119259ECG Mean Heart RateAn electrocardiographic measurement of the average rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the mean ventricular rate.Mean Heart Rate by Electrocardiogram
ECG Mean Ventricular RateC119263ECG Mean Ventricular RateAn electrocardiographic measurement of the average rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute.Mean Ventricular Rate by Electrocardiogram
ECG Median Atrial RateC119254ECG Median Atrial RateAn electrocardiographic measurement of the median rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute.Median Atrial Rate by Electrocardiogram
ECG Median Ventricular RateC119261ECG Median Ventricular RateAn electrocardiographic measurement of the median rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute.Median Ventricular Rate by Electrocardiogram
ECG Minimum Atrial RateC119255ECG Minimum Atrial RateAn electrocardiographic measurement of the minimum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute.Minimum Atrial Rate by Electrocardiogram
ECG Minimum Heart RateC119258ECG Minimum Heart RateAn electrocardiographic measurement of the minimum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the minimum ventricular rate.Minimum Heart Rate by Electrocardiogram
ECG Minimum Ventricular RateC119262ECG Minimum Ventricular RateAn electrocardiographic measurement of the minimum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute.Minimum Ventricular Rate by Electrocardiogram
InterpretationC41255InterpretationAn act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language.Interpretation
Intraventricular-Intraatrial ConductionC111238Intraventricular-Intraatrial ConductionAn electrocardiographic assessment of intraventricular and intra-atrial conduction.Intraventricular and Intraatrial Conduction ECG Assessment
J-Tpeak Interval, AggregateC117767J-Tpeak Interval, AggregateAn aggregate J-Tpeak value based on the measurement of J-Tpeak intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate J-T Peak Interval
J-Tpeak Interval, Single BeatC117768J-Tpeak Interval, Single BeatAn electrocardiographic interval measured from the J point to the peak of the T wave of a single beat utilizing one or more leads.Single Beat J-T Peak Interval
JT Interval, AggregateC117762JT Interval, AggregateAn aggregate JT value based on the measurement of JT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate JT Interval
JT Interval, Single BeatC117769JT Interval, Single BeatAn electrocardiographic interval measured from the J point to the offset of the T wave of a single beat utilizing one or more leads.Single Beat JT Interval
JTcB - Bazett's Correction FormulaC62118JTcB - Bazett's Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcB = JT/SqRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)JTcB - Bazett's Correction Formula
JTCB Interval, AggregateC117763JTCB Interval, AggregateA JTAG interval corrected for heart rate using Bazett's formula.Aggregate JTCB Interval
JTCB Interval, Single BeatC117764JTCB Interval, Single BeatA JTSB interval corrected for heart rate using Bazett's formula.Single Beat JTCB Interval
JTcF - Fridericia's Correction FormulaC62119JTcF - Fridericia's Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcF = JT/CubeRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)JTcF - Fridericia's Correction Formula
JTCF Interval, AggregateC117765JTCF Interval, AggregateA JTAG interval corrected for heart rate using Fridericia's formula.Aggregate JTCF Interval
JTCF Interval, Single BeatC117766JTCF Interval, Single BeatA JTSB interval corrected for heart rate using Fridericia's formula.Single Beat JTCF Interval
JTcLC - Linear Correction FormulaC62120JTcLC - Linear Correction FormulaA formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. Using this method, the corrected JT interval is independent of the ventricular rate. (NCI)JTcLC - Linear Correction Formula
Myocardial InfarctionC111280Myocardial InfarctionAn electrocardiographic assessment of findings suggestive of myocardial infarction.Myocardial Infarction ECG Assessment
New Q WaveC117770New Q WaveAn electrocardiographic finding assessment of new or presumed new pathologic Q waves suggestive of myocardial infarction. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1-18, 2012).New Q Wave
P Wave Amplitude, AggregateC117777P Wave Amplitude, AggregateAn aggregate P wave amplitude value based on the measurement of P wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate P Wave Amplitude
P Wave Amplitude, Single BeatC117778P Wave Amplitude, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the P wave measured from the isoelectric baseline to the peak of the P wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.Single Beat P Wave Amplitude
P Wave AxisC118164P Wave AxisA numerical representation of the electrocardiographic vector assessed at maximum deviation of the P wave from the isoelectric baseline, usually reported for the frontal plane.P Wave Axis
P Wave Duration, AggregateC117775P Wave Duration, AggregateAn aggregate P wave duration value based on the measurement of P wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate P Wave Duration
P Wave Duration, Single BeatC117776P Wave Duration, Single BeatAn electrocardiographic interval measured from the onset of the P wave to the offset of the P wave of a single beat utilizing one or more leads.Single Beat P Wave Duration
PacemakerC111285PacemakerAn electrocardiographic assessment of presence of artificial electronic pacing.Pacemaker ECG Assessment
PP Interval, AggregateC117771PP Interval, AggregateAn aggregate PP value based on the measurement of PP intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate PP Interval
PP Interval, Single MeasurementC117772PP Interval, Single MeasurementAn electrocardiographic measurement of the interval between the onsets of two consecutive P waves.Single Measurement PP Interval
PR Interval, AggregateC117773PR Interval, AggregateAn aggregate PR value based on the measurement of PR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate PR Interval
PR Interval, Single BeatC117774PR Interval, Single BeatAn electrocardiographic interval measured from the onset of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads.Single Beat PR Interval
Q Wave Amplitude, AggregateC117789Q Wave Amplitude, AggregateAn aggregate Q wave amplitude value based on the measurement of Q wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate Q Wave Amplitude
Q Wave Amplitude, Single BeatC117790Q Wave Amplitude, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the Q wave measured from the isoelectric baseline to the peak of the Q wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.Single Beat Q Wave Amplitude
QRS AxisC118165QRS AxisA numerical representation of the electrocardiographic vector assessed at maximum deviation of the QRS complex from the isoelectric baseline, usually reported for the frontal plane.QRS Axis
QRS Duration Ventricular PacedC100390QRS Duration Ventricular PacedThe average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval while the ventricle rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize.Mean QRS Duration Ventricular Paced
QRS Duration, AggregateC117779QRS Duration, AggregateAn aggregate QRS value based on the measurement of QRS intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate QRS Duration
QRS Duration, Single BeatC117780QRS Duration, Single BeatAn electrocardiographic interval measured from the onset of the QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads.Single Beat QRS Duration
QRS Duration, Ventr. Paced, AggregateC117781QRS Duration, Ventr. Paced, AggregateAn aggregate paced QRS duration value based on the measurement of paced QRS duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Paced Ventricular Aggregate QRS Duration
QRS Duration, Ventr. Paced, Single BeatC117782QRS Duration, Ventr. Paced, Single BeatAn electrocardiographic interval measured from the onset of the paced QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads.Paced Ventricular Single Beat QRS Duration
QT Interval, AggregateC117783QT Interval, AggregateAn aggregate QT value based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate QT Interval
QT Interval, CorrectedC100391QT Interval, CorrectedThe time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula.Corrected QT Interval
QT Interval, Single BeatC117788QT Interval, Single BeatAn electrocardiographic interval measured from the onset of the QRS complex to the offset of the T wave of a single beat utilizing one or more leads.Single Beat QT Interval
QTcB - Bazett's Correction FormulaC62112QTcB - Bazett's Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcB = QT/SqRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcB - Bazett's Correction Formula
QTCB Interval, AggregateC117784QTCB Interval, AggregateA QTAG interval corrected for heart rate using Bazett's formula.Aggregate QTCB Interval
QTCB Interval, Single BeatC117785QTCB Interval, Single BeatA QTSB interval corrected for heart rate using Bazett's formula.Single Beat QTCB Interval
QTcF - Fridericia's Correction FormulaC62113QTcF - Fridericia's Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcF = QT/CubeRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcF - Fridericia's Correction Formula
QTCF Interval, AggregateC117786QTCF Interval, AggregateA QTAG interval corrected for heart rate using Fridericia's formula.Aggregate QTCF Interval
QTCF Interval, Single BeatC117787QTCF Interval, Single BeatA QTSB interval corrected for heart rate using Fridericia's formula.Single Beat QTCF Interval
QTcLC - Linear Correction FormulaC62114QTcLC - Linear Correction FormulaA formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. This method theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI)QTcLC - Linear Correction Formula
QTcV - Van de Water's Correction FormulaC90442QTcV - Van de Water's Correction FormulaA mathematic formula defined as: QTcV = QT-0.087[(60/Heart Rate)-1](seconds). It permits comparison of the QT interval across a range of rates, while accounting for the progressive shortening of the QT interval which occurs as the heart rate increases. (NCI)QTcV - Van de Water's Correction Formula
R Wave Amplitude, AggregateC117795R Wave Amplitude, AggregateAn aggregate R wave amplitude value based on the measurement of R wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.R Wave Amplitude Aggregate
R Wave Amplitude, Single BeatC117796R Wave Amplitude, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the R wave measured from the isoelectric baseline to the peak of the R wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.R Wave Amplitude Single Beat
Rhythm Not Otherwise SpecifiedC111307Rhythm Not Otherwise SpecifiedAn electrocardiographic assessment of cardiac rhythm not otherwise specified.Rhythm Not Otherwise Specified ECG Assessment
RR Interval, AggregateC117791RR Interval, AggregateAn aggregate RR value based on the measurement of RR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.Aggregate RR Interval
RR Interval, Single MeasurementC117792RR Interval, Single MeasurementAn electrocardiographic measurement of the interval between two consecutive R waves. If R waves are not present, this measurement may utilize the interval between the most easily identified components of the QRS complex within two consecutive beats.RR Interval Single Measurement
RS Wave Amplitude, AggregateC117793RS Wave Amplitude, AggregateAn aggregate RS wave amplitude value based on measurements from multiple beats from a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.RS Wave Amplitude Aggregate
RS Wave Amplitude, Single BeatC117794RS Wave Amplitude, Single BeatAn electrocardiographic measurement of the sum of the amplitudes of the R and S waves, obtained from a single beat in one particular lead or set of leads.RS Wave Amplitude Single Beat
S Wave Amplitude, AggregateC117805S Wave Amplitude, AggregateAn aggregate S wave amplitude value based on the measurement of S wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.S Wave Amplitude Aggregate
S Wave Amplitude, Single BeatC117806S Wave Amplitude, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the S wave measured from the isoelectric baseline to the peak of the S wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.S Wave Amplitude Single Beat
Sinus Node Rhythms and ArrhythmiasC111312Sinus Node Rhythms and ArrhythmiasAn electrocardiographic assessment of sinus node rhythms and arrhythmias.Sinus Node Rhythm and Arrhythmia ECG Assessment
ST Segment Depression, AggregateC117797ST Segment Depression, AggregateAn aggregate ST segment depression value based on the measurement of ST segment depression from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.ST Segment Depression Aggregate
ST Segment Depression, Single BeatC117798ST Segment Depression, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment depression below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.ST Segment Depression Single Beat
ST Segment Deviation, AggregateC117799ST Segment Deviation, AggregateAn aggregate ST segment deviation value based on the measurement of ST segment deviation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.ST Segment Deviation Aggregate
ST Segment Deviation, Single BeatC117800ST Segment Deviation, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment deviation above or below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.ST Segment Deviation Single Beat
ST Segment Duration, AggregateC117803ST Segment Duration, AggregateAn aggregate ST segment duration value based on the measurement of ST segment duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.ST Segment Duration Aggregate
ST Segment Duration, Single BeatC117804ST Segment Duration, Single BeatAn electrocardiographic interval measured from the J point to the onset of the T wave of a single beat utilizing one or more leads.ST Segment Duration Single Beat
ST Segment Elevation, AggregateC117801ST Segment Elevation, AggregateAn aggregate ST segment elevation value based on the measurement of ST segment elevation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.ST Segment Elevation Aggregate
ST Segment Elevation, Single BeatC117802ST Segment Elevation, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment elevation above the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.ST Segment Elevation Single Beat
ST Segment, T wave, and U waveC111363ST Segment, T wave, and U waveAn electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave.ST Segment, T wave, and U wave ECG Assessment
Summary (Max) JT IntervalC62117Summary (Max) JT IntervalThe maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)Maximum JT Duration
Summary (Max) PR DurationC62131Summary (Max) PR DurationThe maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)Maximum PR Duration
Summary (Max) QT DurationC62135Summary (Max) QT DurationThe maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)Maximum QT Duration
Summary (Max) RR DurationC62094Summary (Max) RR DurationThe maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)Maximum RR Duration
Summary (Max) ST DepressionC62163Summary (Max) ST DepressionThe maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)Maximum ST Segment Depression by ECG Finding
Summary (Max) ST DeviationC62157Summary (Max) ST DeviationThe maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)Maximum ST Deviation
Summary (Max) ST ElevationC62160Summary (Max) ST ElevationThe maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)Maximum ST Segment Elevation
Summary (Mean) JT IntervalC62115Summary (Mean) JT IntervalThe average (mean) duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)Mean JT Duration
Summary (Mean) P Wave DurationC62123Summary (Mean) P Wave DurationThe average (mean) duration (time) from the onset of atrial depolarization to the completion of atrial depolarization (length of the P wave), obtained from a set of measurements of the time from beginning to end of atrial depolarization. (NCI)Mean P Wave Duration
Summary (Mean) P Wave HeightC62124Summary (Mean) P Wave HeightThe average (mean) height (usually measured in mm) of the maximum deflection from baseline of the P wave (representing atrial depolarization), obtained from a set of measurements of the P wave, from a single lead or set of leads. Typically this measurement is obtained by analysis of Lead II. (NCI)Mean P Wave Height
Summary (Mean) PR DurationC62086Summary (Mean) PR DurationThe average (mean) duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)Mean PR Duration
Summary (Mean) QRS DurationC62087Summary (Mean) QRS DurationThe average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize. (NCI)Mean QRS Duration
Summary (Mean) QT DurationC62089Summary (Mean) QT DurationThe average (mean) duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)Mean QT Duration
Summary (Mean) R Wave AmplitudeC62136Summary (Mean) R Wave AmplitudeThe average (mean) amplitude (usually in mm) of the R wave, obtained from a set of measurements of the R wave, in a particular lead or set of leads. (NCI)Mean R Wave Amplitude
Summary (Mean) R+S AmplitudeC62144Summary (Mean) R+S AmplitudeThe average (mean) amplitude (usually in mm) of the summation of the R and S waves, obtained from a set of measurements of the R and S waves, in a particular lead or set of leads. (NCI)Mean R+S Amplitude
Summary (Mean) RR DurationC62090Summary (Mean) RR DurationThe average (mean) duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate. (NCI)Mean RR Duration
Summary (Mean) S Wave AmplitudeC62137Summary (Mean) S Wave AmplitudeThe average (mean) amplitude (usually in mm) of the S wave, obtained from a set of measurements of the S wave, in a particular lead or set of leads. (NCI)Mean S Wave Amplitude
Summary (Mean) ST DepressionC62161Summary (Mean) ST DepressionThe average (mean) depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)Mean ST Segment Depression by ECG Finding
Summary (Mean) ST DeviationC62155Summary (Mean) ST DeviationThe average (mean) deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)Mean ST Deviation
Summary (Mean) ST ElevationC62158Summary (Mean) ST ElevationThe average (mean) elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)Mean ST Segment Elevation
Summary (Mean) ST Segment DurationC62145Summary (Mean) ST Segment DurationThe average (mean) duration (time) of the ST segment, measured from the J point at the end of the QRS complex to the beginning of the T wave.Mean ST Segment Duration
Summary (Mean) T Wave AreaC62148Summary (Mean) T Wave AreaThe average (mean) area under the curve of the deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)Mean T Wave Area
Summary (Mean) T Wave DurationC62147Summary (Mean) T Wave DurationThe average (mean) duration (time) from the onset of ventricular repolarization to the completion of ventricular repolarization (length of the T wave), obtained from a set of measurements of the time from beginning to end of ventricular repolarization. (NCI)Mean T Wave Duration
Summary (Mean) T Wave HeightC62149Summary (Mean) T Wave HeightThe average (mean) height (usually measured in mm) of the maximum deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI)Mean T Wave Height
Summary (Median) Heart RateC102249Summary (Median) Heart RateThe median number of cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate.Median Heart Rate
Summary (Median) PR DurationC102250Summary (Median) PR DurationThe median duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave.Median PR Duration
Summary (Median) QRS DurationC102251Summary (Median) QRS DurationThe median duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize.Median QRS Duration
Summary (Median) QT DurationC102252Summary (Median) QT DurationThe median duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave.Median QT Duration
Summary (Median) QTcFC102253Summary (Median) QTcFThe median duration (time) of the QTc interval, obtained from a set of measurements of the QT interval and corrected using the Fridericia's correction Formula.Median QTcF
Summary (Median) RR DurationC102254Summary (Median) RR DurationThe median duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate.Median RR Duration
Summary (Min) JT IntervalC62116Summary (Min) JT IntervalThe minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI)Minimum JT Duration
Summary (Min) PR DurationC62125Summary (Min) PR DurationThe minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI)Minimum PR Duration
Summary (Min) QT DurationC62133Summary (Min) QT DurationThe minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI)Minimum QT Duration
Summary (Min) RR DurationC62093Summary (Min) RR DurationThe minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI)Minimum RR Duration
Summary (Min) ST DepressionC62162Summary (Min) ST DepressionThe minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI)Minimum ST Segment Depression by ECG Finding
Summary (Min) ST DeviationC62156Summary (Min) ST DeviationThe minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI)Minimum ST Deviation
Summary (Min) ST ElevationC62159Summary (Min) ST ElevationThe minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI)Minimum ST Segment Elevation
Supraventricular ArrhythmiasC111320Supraventricular ArrhythmiasAn electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias.Supraventricular Arrhythmia ECG Assessment
Supraventricular TachyarrhythmiasC111321Supraventricular TachyarrhythmiasAn electrocardiographic assessment of supraventricular tachyarrhythmias.Supraventricular Tachyarrhythmia ECG Assessment
T Wave Amplitude, AggregateC117814T Wave Amplitude, AggregateAn aggregate T wave amplitude value based on the measurement of T wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.T Wave Amplitude Aggregate
T Wave Amplitude, Single BeatC117815T Wave Amplitude, Single BeatAn electrocardiographic measurement of the mean amplitude (usually measured in mV) of the T wave measured from the isoelectric baseline to the peak of the T wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm.T Wave Amplitude Single Beat
T Wave Area, AggregateC117810T Wave Area, AggregateAn aggregate T wave area value based on the measurement of T wave areas from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.T Wave Area Aggregate
T Wave Area, Single BeatC117811T Wave Area, Single BeatAn electrocardiographic measurement of the area of the T wave of a single beat utilizing one or more leads.T Wave Area Single Beat
T Wave AxisC118166T Wave AxisA numerical representation of the electrocardiographic vector assessed at maximum deviation of the T wave from the isoelectric baseline, usually reported for the frontal plane.T Wave Axis
T Wave Duration, AggregateC117812T Wave Duration, AggregateAn aggregate T wave duration value based on the measurement of T wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.T Wave Duration Aggregate
T Wave Duration, Single BeatC117813T Wave Duration, Single BeatAn electrocardiographic interval measured from the onset of the T wave to the offset of the T wave of a single beat utilizing one or more leads.T Wave Duration Single Beat
Technical QualityC117807Technical QualityA statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis.ECG Technical Quality
Tpeak-Tend Interval, AggregateC117808Tpeak-Tend Interval, AggregateAn aggregate Tpeak-Tend value based on the measurement of Tpeak-Tend from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean.T Peak-T End Interval Aggregate
Tpeak-Tend Interval, Single BeatC117809Tpeak-Tend Interval, Single BeatAn electrocardiographic interval measured from the peak of the T wave to the offset of the T wave of a single beat utilizing one or more leads.T Peak-T End Interval Single Beat
Ventricular ArrhythmiasC111330Ventricular ArrhythmiasAn electrocardiographic assessment of ventricular arrhythmias excluding tachycardias.Ventricular Arrhythmia ECG Assessment
Ventricular TachyarrhythmiasC111331Ventricular TachyarrhythmiasAn electrocardiographic assessment of supraventricular tachyarrhythmias.Ventricular Tachyarrhythmia ECG Assessment
Back to top
CL.C111108.EMPSTATEmployment Status
(EMPSTAT)
text
Extensible: Yes
C111108Employment StatusTerminology relevant to the state of being engaged in an activity or service for wages or salary.CDISC SDTM Employment Status Terminology
FULL-TIMEC52658Employment involving the standard or customary working time.Full Time Employment
NOT EMPLOYEDC75563The state of not having a job.Unemployment
PART-TIMEC75562Employment involving less than the standard or customary working time.Part Time Employment
Back to top
CL.C99079.EPOCHEpoch
(EPOCH)
text
Extensible: Yes
C99079EpochThe name of the EPOCH.CDISC SDTM Epoch Terminology
BLINDED TREATMENTC102255A period in a clinical study during which subjects receive blinded therapeutic treatment.Blinded Treatment Epoch
FOLLOW-UPC99158A period in a clinical study during which information about the health status of an individual is obtained after study procedures and treatments have concluded.Clinical Study Follow-up
LONG-TERM FOLLOW-UPC16032A period in a clinical study during which information about the health status of an individual is obtained long after study procedures and treatments have concluded.Long-term Follow-up
OPEN LABEL TREATMENTC102256A period in a clinical study during which subjects receive open label therapeutic treatment.Open Label Treatment Epoch
RUN-INC98779A period in a clinical study that occurs before the commencement of the primary clinical study investigation, during which subjects may be assessed for suitability in the clinical study, withdrawn from existing therapy, trained in study methodology or evaluated for any other protocol-specified reason.Run-in Period
SCREENINGC48262A period in a clinical study during which subjects are evaluated for participation in the study.Trial Screening
TREATMENTC101526A period in a clinical study during which subjects receive therapeutic treatment.Treatment Epoch
WASHOUTC42872A period of time during a clinical study when a participant is taken off of a study drug or other medication in order to eliminate the effects of the treatment.Washout Period
Back to top
CL.C66790.ETHNICEthnic Group
(ETHNIC)
text
Extensible: No
C66790Ethnic GroupA social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI)CDISC SDTM Ethnic Group Terminology
HISPANIC OR LATINOC17459A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race. (NCI)Hispanic or Latino
NOT HISPANIC OR LATINOC41222A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)Not Hispanic or Latino
NOT REPORTEDC43234Not reportedNot provided or available.Not Stated
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C78735.EVALEvaluator
(EVAL)
text
Extensible: Yes
C78735EvaluatorThe role that the individual or entity plays with respect to a specific situation or person.CDISC SDTM Evaluator Terminology
ADJUDICATION COMMITTEEC78726An external committee whose purpose is to evaluate study data and decide whether a study endpoint or other criterion has been met. (NCI)Adjudication Committee
CAREGIVERC17445CaregiverThe primary person in charge of the care of a patient, usually a family member or a designated health care professional. (NCI)Caregiver
CHILDC42708A son or a daughter.Offspring
CLINICAL RESEARCH ASSOCIATEC25465Research AssociateA person who is employed by a study sponsor or by a contract research organization (CRO), operates independently from the clinical study site and functions as a monitor, and/or auditor, and/or a project director within a particular trial or institution. (NCI)Clinical Research Associate
CLINICAL RESEARCH COORDINATORC51811A person to whom a clinical investigator delegates routine administrative requirements of a protocol. The duties and responsibilities of a clinical research coordinator may vary across different infrastructures. Generally, the coordinator manages the subject's clinical trial participation and provides a vital linkage between the subject, the investigator, and the sponsor. (NCI)Clinical Coordinator
CLINICAL STUDY SPONSORC70793Clinical Study Sponsor;Sponsor;Study SponsorAn entity that is responsible for the initiation, management, and/or financing of a clinical study.Clinical Study Sponsor
DOMESTIC PARTNERC53262Domestic PartnerPerson declares that a domestic partnership relationship exists. (HL7)Domestic Partnership
FRIENDC72884A person whom an individual knows, likes, and trusts. (NCI)Friend
GUARDIANC51828An individual who is authorized under applicable State or local law to consent on behalf of a child or incapable person to general medical care including participation in clinical research. (NCI)Guardian
HEALTH CARE PROFESSIONALC53287A person qualified to be engaged in activity directed at preservation of mental and physical health by diseases prevention and treatment as a source of livelihood. (NCI)Health Care Professional
INDEPENDENT ASSESSORC78720An individual qualified to perform an evaluation who is masked from a subject's data in order to minimize bias or maximize consistency and quality. (NCI)Independent Rater
INTERVIEWERC63759The person who manages an interview and asks the questions.Interviewer
INVESTIGATORC25936A person responsible for the conduct of the clinical trial at a trial site. If a trial is conducted by a team of individuals at the trial site, the investigator is the responsible leader of the team and may be called the principle investigator.Investigator
PARENTC42709A mother or a father.Parent
PROXYC119264A type of directive that gives a person the authority to make decisions for or provide responses on behalf of another individual.Proxy
SIGNIFICANT OTHERC119265A gender-neutral term for a person's partner in an intimate or romantic relationship without disclosing or presuming marital status or sexual orientation.Significant Other
SPOUSEC62649SpouseA person's partner in marriage. (NCI)Spouse
STUDY SUBJECTC41189An individual who is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study.Study Subject
VENDORC68608A person or agency that promotes or exchanges goods or services for money. (NCI)Vendor
Back to top
CL.C101832.FATESTCDFindings About Test Code
(FATESTCD)
text
Extensible: Yes
C101832Findings About Test CodeTerminology relevant to the test codes that describe findings about an event or intervention.CDISC SDTM Findings About Test Code Terminology
DRSTATC102626Drug Resistance StatusThe state or condition of not responding to a pharmacological agent.Drug Resistance Status
Back to top
CL.C101833.FATESTFindings About Test Name
(FATEST)
text
Extensible: Yes
C101833Findings About Test NameTerminology relevant to the test names that describe findings about an event or intervention.CDISC SDTM Findings About Test Name Terminology
Drug Resistance StatusC102626Drug Resistance StatusThe state or condition of not responding to a pharmacological agent.Drug Resistance Status
Back to top
CL.C71113.FREQFrequency
(FREQ)
text
Extensible: Yes
C71113FrequencyThe terminology that includes terms pertaining to frequency within CDISC.CDISC SDTM Frequency Terminology
1 TIME PER WEEKC64526One Time Per WeekOne time per week. (NCI)Once Weekly
2 TIMES PER WEEKC64497BIS;Twice per weekTwo times per week. (NCI)Twice Weekly
2 TIMES PER YEARC988612 Times Per YearTwo times per year. (NCI)Two Times Yearly
3 TIMES PER MONTHC988593 Times Per MonthThree times per month. (NCI)Three Times Monthly
3 TIMES PER WEEKC64528TIS;Three times a weekThree times per week. (NCI)Three Times Weekly
3 TIMES PER YEARC988603 Times Per YearThree times per year. (NCI)Three Times Yearly
4 TIMES PER MONTHC988524 Times Per MonthFour times per month. (NCI)Four Times Monthly
4 TIMES PER WEEKC645314 times per week;QISFour times per week. (NCI)Four Times Weekly
4 TIMES PER YEARC988534 Times Per YearFour times per year. (NCI)Four Times Yearly
5 TIMES PER DAYC988495 Times DailyFive times per day. (NCI)Five Times Daily
5 TIMES PER MONTHC988505 Times Per MonthFive times per month. (NCI)Five Times Monthly
5 TIMES PER WEEKC855525 Times Per WeekFive times per week. (NCI)Five Times Weekly
5 TIMES PER YEARC988515 Times Per YearFive times per year. (NCI)Five Times Yearly
6 TIMES PER DAYC988556 Times DailySix times per day. (NCI)Six Times Daily
6 TIMES PER MONTHC988566 Times Per MonthSix times per month. (NCI)Six Times Monthly
6 TIMES PER WEEKC988576 Times Per WeekSix times per week. (NCI)Six Times Weekly
6 TIMES PER YEARC988586 Times Per YearSix times per year. (NCI)Six Times Yearly
7 TIMES PER WEEKC988547 Times Per WeekSeven times per week. (NCI)Seven Times Weekly
AD LIBITUMC64636Ad LibitumAs much as desired.As Much as Desired
BIDC64496BD;Twice per dayTwo times per day, at unspecified times. (NCI)Twice Daily
BIMC71129Twice per monthTwice per month. (NCI)Twice Per Month
CONTINUOUSC53279ContinuousRemain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI)Continue
EVERY 2 WEEKSC71127Every 2 weeks;Q2SEvery two weeks. (NCI)Every Two Weeks
EVERY 3 WEEKSC64535Every 3 weeks;Q3SEvery three weeks. (NCI)Every Three Weeks
EVERY 4 WEEKSC64529Every 4 weeks;Q4SEvery four weeks. (NCI)Every Four Weeks
EVERY 5 WEEKSC103390Every 5 weeks;Q5SEvery five weeks. (NCI)Every Five Weeks
EVERY 6 WEEKSC89788Every 6 Weeks;Q6SEvery six weeks. (NCI)Every Six Weeks
EVERY 7 WEEKSC116149Every 7 weeks;Q7SEvery seven weeks.Every Seven Weeks
EVERY 8 WEEKSC103389Every 8 weeks;Q8SEvery eight weeks. (NCI)Every Eight Weeks
EVERY WEEKC67069Every week;Per Week;QSEvery week. (NCI)Weekly
INTERMITTENTC71325IntermittentPeriodically stopping and starting. (NCI)Intermittent
OCCASIONALC64954OccasionalNot occurring regularly or at short intervals.Infrequent
ONCEC64576OnceA one time intervention. (NCI)Once
PAC74924/Year;Every Year;Per Annum;Per YearA frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days.Per Year
PRNC64499As neededAs needed. (NCI)As Necessary
Q10HC64500Every 10 hoursEvery ten hours. (NCI)Every Ten Hours
Q11HC64501Every 11 hoursEvery eleven hours. (NCI)Every Eleven Hours
Q12HC64502Every 12 hoursEvery twelve hours. (NCI)Every Twelve Hours
Q13HC64503Every 13 hoursEvery thirteen hours. (NCI)Every Thirteen Hours
Q14HC64504Every 14 hoursEvery fourteen hours. (NCI)Every Fourteen Hours
Q15HC64505Every 15 hoursEvery fifteen hours. (NCI)Every Fifteen Hours
Q16HC64506Every 16 hoursEvery sixteen hours. (NCI)Every Sixteen Hours
Q17HC64507Every 17 hoursEvery seventeen hours. (NCI)Every Seventeen Hours
Q18HC64508Every 18 hoursEvery eighteen hours. (NCI)Every Eighteen Hours
Q19HC64509Every 19 hoursEvery nineteen hours. (NCI)Every Nineteen Hours
Q20HC64511Every 20 hoursEvery twenty hours. (NCI)Every Twenty Hours
Q21HC64512Every 21 hoursEvery twenty-one hours. (NCI)Every Twenty-One Hours
Q22HC64513Every 22 hoursEvery twenty-two hours. (NCI)Every Twenty-Two Hours
Q23HC64514Every 23 hoursEvery twenty-three hours. (NCI)Every Twenty-Three Hours
Q24HC64515Every 24 hoursEvery twenty-four hours. (NCI)Every Twenty-Four Hours
Q2HC64516Every 2 hoursEvery two hours. (NCI)Every Two Hours
Q2MC64536Every two monthsEvery two months. (NCI)Every Two Months
Q3DC64533Every 3 daysEvery three days. (NCI)Every Three Days
Q3HC64517Every 3 hoursEvery three hours. (NCI)Every Three Hours
Q3MC64537Every 3 monthsEvery three months. (NCI)Every Three Months
Q4DC64534Every 4 daysEvery four days. (NCI)Every Four Days
Q4HC64518Every 4 hoursEvery four hours. (NCI)Every Four Hours
Q4MC64538Every 4 monthsEvery four months. (NCI)Every Four Months
Q5DC71124Every 5 daysEvery five days. (NCI)Every Five Days
Q5HC64519Every 5 hoursEvery five hours. (NCI)Every Five Hours
Q6HC64520Every 6 hoursEvery six hours. (NCI)Every Six Hours
Q6MC89789Every 6 MonthsEvery six months. (NCI)Every Six Months
Q7HC64521Every 7 hoursEvery seven hours. (NCI)Every Seven Hours
Q8HC64523Every 8 hoursEvery eight hours. (NCI)Every Eight Hours
Q9HC64524Every 9 hoursEvery nine hours. (NCI)Every Nine Hours
QDC25473Daily;Per DayOccurring or done each day. (NCI)Daily
QHC64510Every hourEvery hour. (NCI)Every Hour
QIDC645304 times per dayFour times per day. (NCI)Four Times Daily
QMC64498Every Month;Per MonthEvery month. (NCI)Monthly
QODC64525Every other dayEvery other day. (NCI)Every Other Day
TIDC645273 times per dayThree times per day. (NCI)Three Times Daily
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C103329.GNRLOBSCGeneral Observation Class
(GNRLOBSC)
text
Extensible: No
C103329General Observation ClassTerminology related to the classification of a CDISC domain.CDISC SDTM General Observation Class Terminology
ADAM OTHERC103375An ADaM analysis dataset that doesn't conform to the ADSL or BDS structure.CDISC Other ADaM Dataset
BASIC DATA STRUCTUREC103371BDSAn ADaM BDS dataset contains one or more records per subject, per analysis parameter, per analysis time point. Variables include the value being analyzed (e.g., AVAL) and the description of the value being analyzed (e.g., PARAM). Other variables in the dataset provide more information about the value being analyzed (e.g., the subject identification) or describe and trace the derivation of it (e.g., DTYPE) or support the analysis of it (e.g., treatment variables, covariates).CDISC Basic Data Structure Dataset
EVENTSC103372This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history).CDISC Events Class
FINDINGSC103373This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires.CDISC Findings Class
INTERVENTIONSC103374This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine).CDISC Interventions Class
RELATIONSHIPC103376This SDTM class provides a means to link related records between datasets. It includes the RELREC and SUPPQUAL datasets.CDISC Relationship Class
SPECIAL PURPOSEC103377This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV.CDISC Special Purpose Class
SUBJECT LEVEL ANALYSIS DATASETC103378ADSLThe Subject-Level Analysis Dataset (ADSL) is a one-record-per-subject dataset which contains variables that describe subject demographic characteristics and group the subjects for analysis. ADSL is the primary source for subject-level variables included in other analysis datasets such as population flags and treatment variables.CDISC Subject Level Analysis Dataset
TRIAL DESIGNC103379This SDTM class describes the plan for the procedures to be followed in a clinical trial, including planned and actual timing of events, control group, method of allocating treatments, blinding methods, assignment of epochs that subjects pass through in the course of a trial.CDISC Trial Design Class
Back to top
CL.C111114.GENSMPGenetic Sample Type
(GENSMP)
text
Extensible: Yes
C111114Genetic Sample TypeTerminology relevant to the type of nucleic acid which was derived from the collected sample.CDISC Genetic Sample Type Terminology
7SK RNAC959517SK Small Nuclear RNA;7SK snRNA7SK small nuclear RNA is encoded by the human RN7SK gene. This oligoribonucleotide may play a role in the regulation of the enzymatic activity of RNA polymerase II.7SK Small Nuclear RNA
cDNAC324Complementary DNASingle-stranded DNA that is complementary to messenger RNA or DNA that has been synthesized from messenger RNA by reverse transcriptase.cDNA
cpDNAC111158Chloroplast DNAThe DNA that is located in the photosynthetic, chlorophyll-containing organelle in the cells of young leaves and stems of higher plants. (NCI)Chloroplast DNA
DNAC449Deoxyribonucleic Acid;Double-stranded DNA;dsDNAA long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone; associated with the transmission of genetic information.DNA
dsRNAC95938Double-stranded RNAAn RNA complex consisting of two base-paired strands of complementary RNA.Double-Stranded RNA
gDNAC95940Genomic DNAThe DNA that is part of the normal chromosomal complement of an organism.Genomic DNA
gRNAC95952Guide RNAA small RNA involved in post-transcriptional mitochondrial RNA modification (RNA editing) in kinetoplastids.Guide RNA
hnRNAC28454Heterogeneous Nuclear RNAA diverse assortment of nascent, immature, unprocessed RNA transcripts synthesized from DNA templates that are found in eukaryotic nuclei before post-transcriptional modifications.hnRNA
miRNAC25966MicroRNAA sequence of single-stranded RNA which is typically 20-25 nucleotides in length and may regulate the expression of other genes. miRNAs are transcribed from DNA, but are not translated into proteins.MicroRNA
mRNAC813Messenger RNAA class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein.Messenger RNA
msDNAC111279Multicopy Single-stranded DNAA DNA/RNA chimera comprised of a single-stranded DNA molecule covalently bound to an internal guanosine of a RNA molecule. (NCI)Multicopy Single-stranded DNA
msdRNAC111278MSRThe RNA portion of the msDNA molecule, which contains two stem-loop stuctures and varies widely in length across bacterial species. (NCI)msdRNA
mtDNAC28512Mitochondrial DNA;mDNATypically small, circular, intronless, and maternally inherited, mitochondrial DNA (mtDNA) is the multicopy deoxyribonucleic acid genome of mitochondria, intracellular organelles responsible for vital respiratory chain and oxidative phosphorylation reactions in higher eukaryotes. Replicated and transcribed by a separate enzymatic machinery from that of nuclear DNA, mtDNA encodes only a subset of mitochondrial functions.Mitochondrial DNA
nDNAC95941Nuclear DNAThe DNA that is normally located in the nucleus of a eukaryotic cell.Nuclear DNA
pDNAC754Plasmid;Plasmid DNAA small cellular inclusion consisting of a ring of DNA that is not in a chromosome but is capable of autonomous replication.Plasmid
piRNAC95953Piwi-Interacting RNASingle-stranded RNA molecules that are expressed in animal cells and form complexes with Piwi proteins. They are involved in transcriptional gene silencing.Piwi-Interacting RNA
pre-mRNAC111298Precursor mRNAA primary RNA transcript synthesized from a DNA template in eukaryotic nuclei which is post-transcriptionally modified and spliced to produce a mature mRNA. (NCI)Precursor mRNA
pri-miRNAC25967Pri-MIR;Pri-miRNA;Pri-microRNA;Primary MicroRNAThe pri-miRNA is a primary transcript derived from a gene whose sole products are miRNA(s). A unique pathway involving the nuclear microprocessor complex participates in the cleavage of such transcripts, which can be substantially longer than the 65-110 nt pre-miRNA.Pri-miRNA
rDNAC95943Ribosomal DNA;Ribosomal RNA GenesThe genomic sequences that code for ribosomal RNA molecules.Ribosomal RNA Gene
RIBOZYMEC1292Catalytic RNA;Ribonucleic EnzymeRNA that contains an intron sequence which has an enzyme-like catalytic activity. This intron sequence can function like an enzyme in reactions with other RNA molecules and thus synthesize new molecules even in the absence of protein.Ribozyme
RNAC812Ribonucleic AcidSingle-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.Ribonucleic Acid
rRNAC814Ribosomal RNAAn RNA molecule that does not contain protein-coding sequence information and constitutes the majority of the cellular RNA (~80%). This nucleic acid associates with multiple proteins to form ribosomes, which are the organelles that drive mRNA-directed protein synthesis.Ribosomal RNA
siRNAC2191Small Interfering RNAA 20 to 25-nucleotide double-stranded RNA which is involved in a sequence-specific messenger RNA degradation process known as RNA interference.Small Interfering RNA
snoRNAC111316Small Nucleolar RNASmall RNA molecules that are present in the nucleolus. They associate with proteins to form small nucleolar ribonucleoprotein particles that are involved in modification of other RNAs. (NCI)Small Nucleolar RNA
snRNAC815Small Nuclear RNA;Small Nuclear Ribonucleic Acid;U-RNAA small RNA molecule (100-300 nucleotides) located in the cell nucleus. This nucleic acid plays a role in RNA splicing, transcriptional regulation, telomere maintenance and rRNA modification.Small Nuclear RNA
SRP RNAC959507SL RNA;SRP RNA;Signal Recognition Particle RNA;srpRNAA non-coding RNA that is part of the signal recognition particle. It is involved in the co-translational targeting of proteins to membranes.Signal Recognition Particle RNA
ssDNAC111311Single-stranded DNAA long linear single-stranded polymer formed from nucleotides attached to a deoxyribose backbone. (NCI)Single-stranded DNA
tmRNAC9595410Sa RNA;SsrA;Transfer-Messenger RNAAn RNA encoded by the bacterial ssrA gene. It is involved in the recycling of stalled ribosomes and the targeting of both defective mRNA molecules and incomplete nascent proteins for degradation.Transfer-Messenger RNA
TRANSPOSONC95942Jumping Gene;Jumping Genes;Transposable ElementA class of mobile genetic elements that can move from one genomic position to another.Transposon
tRNAC816Transfer RNA;Triplet Codon-Amino Acid AdaptorA class of short adaptor RNAs that transfers a specific amino acid to a growing polypeptide chain at the ribosomal site of protein synthesis during translation. Each transfer RNA comprises a three-nucleotide sequence that is complementary to the triplet nucleotide coding sequence of an mRNA, conferring specificity to the amino acid being incorporated into the assembling protein.Transfer RNA
Back to top
CL.C117737.GRAFTTYPGraft Type
(GRAFTTYP)
text
Extensible: Yes
C117737Graft TypeA terminology codelist relevant to the type of graft implanted in the subject.CDISC SDTM Graft Type Terminology
ARTERIAL GRAFT, FREEC117816A vessel graft comprised of an artery that has been completely detached from its original location. (NCI)Free Arterial Graft
ARTERIAL GRAFT, IN-SITUC117817A vessel graft comprised of an artery whose origin remains intact.In Situ Arterial Graft
AUTOLOGOUS VEIN GRAFTC117818A vessel graft comprised of a vein harvested from a different anatomical location.Autologous Vein Graft
CADAVERIC GRAFT, ARTERIALC117819An arterial graft harvested from a cadaver. (NCI)Cadaveric Arterial Graft
CADAVERIC GRAFT, VENOUSC117820A venous graft harvested from a cadaver. (NCI)Cadaveric Venous Graft
COMPOSITE GRAFTC117821A vessel graft comprised of two or more conduit materials.Composite Vessel Graft
SAPHENOUS VEIN GRAFTC117822SVGA vessel graft comprised of the saphenous vein.Saphenous Vein Graft
SYNTHETIC GRAFTC117823A vessel graft comprised of non-biological material.Synthetic Vessel Graft
Back to top
CL.C117739.HEFATSCDHepatic Findings About Test Code
(HEFATSCD)
text
Extensible: Yes
C117739Hepatic Findings About Test CodeTerminology relevant to the test codes that describe hepatic findings.CDISC SDTM Hepatic Findings About Test Code Terminology
WHHEGRC117747West Haven Hepatic Encephalopathy GradeA grading system to describe the severity of hepatic encephalopathy based on the level of mental status, per the West Haven Criteria. (NCI)West Haven Hepatic Encephalopathy Grade
Back to top
CL.C117738.HEFATSHepatic Findings About Test Name
(HEFATS)
text
Extensible: Yes
C117738Hepatic Findings About Test NameTerminology relevant to the test names that describe hepatic findings.CDISC SDTM Hepatic Findings About Test Name Terminology
West Haven Hepatic Encephalopathy GradeC117747West Haven Hepatic Encephalopathy GradeA grading system to describe the severity of hepatic encephalopathy based on the level of mental status, per the West Haven Criteria. (NCI)West Haven Hepatic Encephalopathy Grade
Back to top
CL.C99076.INTMODELIntervention Model
(INTMODEL)
text
Extensible: Yes
C99076Intervention ModelThe trial design developed to compare treatment groups.CDISC SDTM Intervention Model Terminology
CROSS-OVERC82637Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the study.Crossover Study
FACTORIALC82638Two or more interventions, each alone and in combination, are evaluated in parallel against a control group.Factorial Study
PARALLELC82639Participants are assigned to one of two or more arms in parallel for the duration of the study.Parallel Study
SINGLE GROUPC82640Single arm study.Single Group Study
Back to top
CL.C99078.INTTYPEIntervention Type
(INTTYPE)
text
Extensible: No
C99078Intervention TypeThe kind of product or procedure studied in a trial.CDISC SDTM Intervention Type Terminology
BEHAVIORAL THERAPYC15184A technique used to change subjects' behavior, for example, psychotherapy, lifestyle counseling or hypnosis.Behavioral Intervention
BIOLOGICC307A substance made from living organisms or things they produce, for example: virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product.Biological Agent
DEVICEC16830An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes. (FDA)Medical Device
DIETARY SUPPLEMENTC1505Oral preparations containing dietary ingredient(s) intended to supplement the diet. Dietary ingredients include vitamins, minerals, herbs, amino acids, extracts and metabolites.Dietary Supplement
DRUGC1909An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)).Pharmacologic Substance
GENETICC15238Application of genetic material into cells in order to correct an inherited or acquired disease.Gene Therapy
OTHERC17649OtherDifferent than the one(s) previously specified or mentioned. (NCI)Other
PROCEDUREC98769A treatment procedure performed by manual and/or instrumental means, for example: surgery, lithotripsy, or external manipulation.Physical Medical Procedure
RADIATIONC15313Treatment of a disease by means of exposure of the target or the whole body to radiation.Radiation Therapy
Back to top
CL.C101840.KILLIPCKillip Class Responses
(KILLIPC)
text
Extensible: No
C101840Killip Class ResponsesA terminology codelist based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic blood pressure.CDISC SDTM Killip Class Responses Terminology
KILLIP CLASS IC77269The absence of rales over the lung fields and absence of third heart sound (S3). (ACC/AHA)Killip Class I
KILLIP CLASS IIC77270The presence of rales over 50% or less of the lung fields or the presence of a third heart sound (S3).(ACC/AHA)Killip Class II
KILLIP CLASS IIIC77271The presence of rales over more than 50% of the lung fields. (ACC/AHA)Killip Class III
KILLIP CLASS IVC77272The presence of cardiogenic shock (systolic BP less than 90 mm Hg) for greater than 30 minutes, not responsive to fluid resuscitation alone, and felt to be secondary to cardiac dysfunction. (ACC/AHA)Killip Class IV
Back to top
CL.C65047.LBTESTCDLaboratory Test Code
(LBTESTCD)
text
Extensible: Yes
C65047Laboratory Test CodeTerminology used for laboratory test codes of the CDISC Standard Data Tabulation Model.CDISC SDTM Laboratory Test Terminology by Code
A1AGLPC100429Alpha-1 Acid GlycoproteinA measurement of the alpha-1 acid glycoprotein in a biological specimen.Alpha-1 Acid Glycoprotein Measurement
A1ANTRYPC80167Alpha-1 Antitrypsin;Serum Trypsin InhibitorA measurement of the alpha-1 antitrypsin in a biological specimen.Alpha-1 Antitrypsin Measurement
A1MCREATC100462Alpha-1 Microglobulin/CreatinineA relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen.Alpha-1 Microglobulin to Creatinine Ratio Measurement
A1MICGC100461Alpha-1 Microglobulin;Protein HCA measurement of the alpha-1 microglobulin in a biological specimen.Alpha-1 Microglobulin Measurement
A2MACGC80168Alpha-2 MacroglobulinA measurement of the alpha-2 macroglobulin in a biological specimen.Alpha-2 Macroglobulin Measurement
AAPC100430Alanine AminopeptidaseA measurement of the alanine aminopeptidase in a biological specimen.Alanine Aminopeptidase Measurement
ABNCEC111124Abnormal CellsA measurement of the abnormal cells in a biological specimen.Abnormal Cell Count
ACANTC74699AcanthocytesA measurement of the acanthocytes in a biological specimen.Acanthocyte Count
ACANTRBCC74633Acanthocytes/ErythrocytesA relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen.Acanthocyte to Erythrocyte Ratio Measurement
ACEC80169Angiotensin Converting EnzymeA measurement of the angiotensin converting enzyme in a biological specimen.Angiotensin Converting Enzyme Measurement
ACETOACC92247Acetoacetate;Acetoacetic AcidA measurement of the acetoacetic acid in a biological specimen.Acetoacetic Acid Measurement
ACHC74838AcetylcholineA measurement of the acetylcholine hormone in a biological specimen.Acetylcholine Measurement
ACHEC96560AcetylcholinesteraseA measurement of the acetylcholinesterase in a biological specimen.Acetylcholinesterase Measurement
ACHRABC96559Acetylcholine Receptor AntibodyA measurement of the acetylcholine receptor antibody in a biological specimen.Acetylcholine Receptor Antibody Measurement
ACPHOSC80163Acid PhosphataseA measurement of the acid phosphatase in a biological specimen.Acid Phosphatase Measurement
ACTC103348Activated Clot Time;Activated Clotting Time;Coagulation ActivatedA measurement of the inhibition of blood coagulation in response to anticoagulant therapies.Activated Coagulation Time
ACTHC74780Adrenocorticotropic HormoneA measurement of the adrenocorticotropic hormone in a biological specimen.Adrenocorticotropic Hormone Measurement
ACYLCAOXC92286Acyl CoA Oxidase;Acyl Coenzyme A Oxidase;Fatty Acyl Coenzyme A OxidaseA measurement of the acyl coenzyme A oxidase in a biological specimen.Acyl Coenzyme A Oxidase Measurement
ADENOVABC111125Adenovirus AntibodyA measurement of the adenovirus antibody in a biological specimen.Adenovirus Antibody Measurement
ADHC74847Antidiuretic Hormone;VasopressinA measurement of the antidiuretic hormone in a biological specimen.Antidiuretic Hormone Measurement
ADPC102257Adenosine DiphosphateA measurement of the adenosine diphosphate in a biological specimen.Adenosine Diphosphate Measurement
ADPNCTNC74839AdiponectinA measurement of the adiponectin hormone in a biological specimen.Adiponectin Measurement
ADSDNAC74913Anti-Double Stranded DNAA measurement of the anti-double stranded DNA antibody in a biological specimen.Anti-Double Stranded DNA Measurement
ADVVLDC98705ADV Viral LoadA measurement of the adenovirus viral load in a biological specimen.Adenovirus Viral Load Measurement
AFACTXAAC98706Anti-Factor Xa ActivityA measurement of the anti-activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen.Anti-Factor Xa Activity Measurement
AFPC74732Alpha FetoproteinA measurement of the alpha fetoprotein in a biological specimen.Alpha-fetoprotein Measurement
AFPAC106499Alpha Fetoprotein ActivityA measurement of the alpha fetoprotein activity in a biological specimen.Alpha Fetoprotein Activity Measurement
AFPL1C96562Alpha Fetoprotein L1A measurement of the alpha fetoprotein L1 in a biological specimen.Alpha Fetoprotein L1 Measurement
AFPL2C96563Alpha Fetoprotein L2A measurement of the alpha fetoprotein L2 in a biological specimen.Alpha Fetoprotein L2 Measurement
AFPL3C96564Alpha Fetoprotein L3A measurement of the alpha fetoprotein L3 in a biological specimen.Alpha Fetoprotein L3 Measurement
AFPL3AFPC96565A Fetoprotein L3/A FetoproteinA relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen.Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement
AHBDHC111126Alpha Hydroxybutyrate DehydrogenaseA measurement of the alpha-hydroxybutyrate dehydrogenase in a biological specimen.Alpha Hydroxybutyrate Dehydrogenase Measurement
ALBC64431Albumin;MicroalbuminA measurement of the albumin protein in a biological specimen.Albumin Measurement
ALBCREATC74761Albumin/Creatinine;Microalbumin/Creatinine RatioA relative measurement (ratio or percentage) of the albumin to the creatinine in a biological specimen.Albumin To Creatinine Protein Ratio Measurement
ALBEXRC117829Albumin Excretion RateA measurement of the amount of albumin being excreted in urine over a defined period of time (e.g. one hour).Albumin Urine Excretion Rate
ALBGLOBC74894Albumin/GlobulinThe ratio of albumin to globulin in a biological specimen.Albumin to Globulin Ratio Measurement
ALBPROTC103453Albumin/Total ProteinA relative measurement (ratio or percentage) of the albumin to total protein in a biological specimen.Albumin to Total Protein Ratio Measurement
ALDOLASEC74731AldolaseA measurement of the aldolase enzyme in a biological specimen.Aldolase Measurement
ALDSTRNC74841AldosteroneA measurement of the aldosterone hormone in a biological specimen.Aldosterone Measurement
ALPC64432Alkaline PhosphataseA measurement of the alkaline phosphatase in a biological specimen.Alkaline Phosphatase Measurement
ALPBSC92287Bone Specific Alkaline PhosphataseA measurement of the bone specific alkaline phosphatase isoform in a biological specimen.Bone Specific Alkaline Phosphatase Measurement
ALPCREATC79438Alkaline Phosphatase/CreatinineA relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen.Alkaline Phosphatase to Creatinine Ratio Measurement
ALPISC119266Intestinal Specific Alkaline PhosphataseA measurement of the intestinal specific alkaline phosphatase isoform in a biological specimen.Intestinal Specific Alkaline Phosphatase Measurement
ALPLSC119267Liver Specific Alkaline PhosphataseA measurement of the liver specific alkaline phosphatase isoform in a biological specimen.Liver Specific Alkaline Phosphatase Measurement
ALTC64433Alanine Aminotransferase;SGPTA measurement of the alanine aminotransferase in a biological specimen.Alanine Aminotransferase Measurement
ALTASTC106498ALT/ASTA relative measurement (ratio or percentage) of the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) present in a sample.Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement
ALTCPHRLC103349Alpha TocopherolA measurement of the alpha tocopherol in a biological specimen.Alpha Tocopherol Measurement
ALUMINUMC111127Al;AluminumA measurement of aluminum in a biological specimen.Aluminum Measurement
AMAC81975Antimitochondrial Antibodies;Mitochondrial AntibodyA measurement of the antimitochondrial antibodies in a biological specimen.Antimitochondrial Antibody Measurement
AMMONIAC74799Ammonia;NH3A measurement of the ammonia in a biological specimen.Ammonia Measurement
AMORPHSDC74666Amorphous Debris;Amorphous SedimentA measurement of the amorphous sediment present in a biological specimen.Amorphous Sediment Measurement
AMPHETC74687AmphetamineA measurement of any amphetamine class drug present in a biological specimen.Amphetamine Drug Class Measurement
AMPHETDC102262Dextroamphetamine;d-amphetamineA measurement of the dextroamphetamine in a biological specimen.Dextroamphetamine Measurement
AMYLASEC64434AmylaseA measurement of the total enzyme amylase in a biological specimen.Amylase Measurement
AMYLASEMC111243MacroamylaseA measurement of macroamylase in a biological specimen.Macroamylase Measurement
AMYLASEPC98767Amylase, PancreaticA measurement of the pancreatic enzyme amylase in a biological specimen.Pancreatic Amylase Measurement
AMYLASESC98780Amylase, SalivaryA measurement of the salivary enzyme amylase in a biological specimen.Salivary Amylase Measurement
AMYLB38C103352Amyloid Beta 1-38;Amyloid Beta 38;Amyloid Beta 38 ProteinA measurement of amyloid beta protein which is composed of peptides 1 to 38 in a biological specimen.Amyloid Beta 1-38 Measurement
AMYLB40C103353Amyloid Beta 1-40;Amyloid Beta 40;Amyloid Beta 40 ProteinA measurement of amyloid beta protein which is composed of peptides 1 to 40 in a biological specimen.Amyloid Beta 1-40 Measurement
AMYLB42C84809Amyloid Beta 1-42;Amyloid Beta 42;Amyloid Beta 42 ProteinA measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen.Beta Amyloid 42 Measurement
AMYLOIDBC81999Amyloid, Beta;Beta AmyloidA measurement of the total amyloid beta in a biological specimen.Beta Amyloid Measurement
AMYLOIDPC81998Amyloid PA measurement of the total amyloid P in a biological specimen.Amyloid P Measurement
ANAC74916Antinuclear AntibodiesA measurement of the antinuclear antibodies (antibodies that attack the body's own tissue) in a biological specimen.Antinuclear Antibody Measurement
ANDSTNDLC74842AndrostenediolA measurement of the androstenediol metabolite in a biological specimen.Androstenediol Metabolite Measurement
ANDSTNDNC748434-Androstenedione;AndrostenedioneA measurement of the androstenedione hormone in a biological specimen.Androstenedione Measurement
ANGLBINDC91372Antiglobulin Test, Indirect;Indirect Coombs TestA test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in a biological specimen.Indirect Antiglobulin Test
ANGLOBDRC81974Antiglobulin Test, Direct;Direct Coombs TestA measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo.Direct Antiglobulin Test
ANGPT1C111128Angiopoietin 1A measurement of angiopoietin 1 in a biological specimen.Angiopoietin 1 Measurement
ANGTNS1C74844Angiotensin IA measurement of the angiotensin I hormone in a biological specimen.Angiotensin I Measurement
ANGTNS2C74845Angiotensin IIA measurement of the angiotensin II hormone in a biological specimen.Angiotensin II Measurement
ANGTNSGNC74846Angiotensin Precursor;AngiotensinogenA measurement of the angiotensinogen hormone in a biological specimen.Angiotensinogen Measurement
ANIONGC74685Anion GapA computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen.Anion Gap Measurement
ANISOC74797Anisocytes;AnisocytosisA measurement of the inequality in the size of the red blood cells in a whole blood specimen.Anisocyte Measurement
ANPC74886Atrial Natriuretic Peptide;AtriopeptinA measurement of the atrial natriuretic peptide in a biological specimen.Atrial Natriuretic Peptide Measurement
ANTHRMC81958Antithrombin;Antithrombin Activity;Antithrombin III;Antithrombin III ActivityA measurement of the antithrombin activity in a biological specimen.Antithrombin Activity Measurement
ANTHRMAGC81977Antithrombin Antigen;Antithrombin III AntigenA measurement of the antithrombin antigen in a biological specimen.Antithrombin Antigen Measurement
ANTIDPRSC74691AntidepressantsA measurement of any antidepressant class drug present in a biological specimen.Antidepressant Measurement
APLABC102258Antiphospholipid AntibodiesA measurement of the antiphospholipid antibodies in a biological specimen.Antiphospholipid Antibody Measurement
APLSMA2C103351Alpha-2 Plasmin InhibitorA measurement of the alpha-2 antiplasmin in a biological specimen.Alpha-2 Antiplasmin Measurement
APOA1C74733Apolipoprotein A1A measurement of the apolipoprotein A1 in the high density lipoproteins of a biological specimen.Apolipoprotein A1 Measurement
APOA2C82000Apolipoprotein AIIA measurement of the apolipoprotein AII in a biological specimen.Apolipoprotein AII Measurement
APOA4C103354Apolipoprotein A4A measurement of the apolipoprotein A4 in a biological specimen.Apolipoprotein A4 Measurement
APOA5C103355Apolipoprotein A5A measurement of the apolipoprotein A5 in a biological specimen.Apolipoprotein A5 Measurement
APOBC74734Apolipoprotein BA measurement of the apolipoprotein B in the low density lipoproteins of a biological specimen.Apolipoprotein B Measurement
APOBAPA1C103356Apolipoprotein B/Apolipoprotein A1A relative measurement (ratio or percentage) of the Apolipoprotein B to Apolipoprotein A1 in a biological specimen.Apolipoprotein B to Apolipoprotein A1 Ratio Measurement
APOC2C100427Apolipoprotein C2;Apolipoprotein CIIA measurement of the apolipoprotein C2 in a biological specimen.Apolipoprotein C2 Measurement
APOC3C82001Apolipoprotein CIIIA measurement of the apolipoprotein CIII in a biological specimen.Apolipoprotein CIII Measurement
APOEC82002Apolipoprotein EA measurement of the apolipoprotein E in a biological specimen.Apolipoprotein E Measurement
APOE4C92293Apolipoprotein E4A measurement of the apolipoprotein E4 in a biological specimen.Apolipoprotein E4 Measurement
APOHC82003Apolipoprotein HA measurement of the apolipoprotein H in a biological specimen.Apolipoprotein H Measurement
APOJC100428Apolipoprotein J;ClusterinA measurement of the apolipoprotein J in a biological specimen.Apolipoprotein J Measurement
APOJCRTC111130Apolipoprotein J/Creatinine;Clusterin/CreatinineA relative measurement (ratio or percentage) of the apolipoprotein J to creatinine in a biological specimen.Apolipoprotein J to Creatinine Ratio Measurement
APPAC119268Amyloid Alpha Precursor ProteinA measurement of the amyloid alpha precursor protein present in a biological specimen.Amyloid Alpha Precursor Protein Measurement
APPBC105438Amyloid Beta Precursor;Amyloid Beta Precursor Protein;Amyloid Precursor Beta;Amyloid Precursor ProteinA measurement of the amyloid beta precursor protein present in a biological specimen.Amyloid Beta Precursor Protein Measurement
APPEARC25377Specimen AppearanceThe outward or visible aspect of a specimen.Appearance
APPTC119269Total Amyloid Precursor ProteinA measurement of the total amyloid precursor protein present in a biological specimen.Total Amyloid Precursor Protein Measurement
APRILC111123A Proliferation-Inducing Ligand;CD256;TNFSF13;Tumor Necrosis Factor Ligand Superfamily Member 13A measurement of the a proliferation-inducing ligand in a biological specimen.A Proliferation-Inducing Ligand Measurement
APROTCRSC100471Activated Protein C Resistance;Factor V Leiden ScreenA measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen.Activated Protein C Resistance Measurement
APTTC38462Activated Partial Thromboplastin TimeA measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.Partial Thromboplastin Time
APTTLASC102277APTT-LA;Lupus Anticoagulant Sensitive APTTA measurement of the length of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen.Lupus Anticoagulant Sensitive APTT Measurement
APTTSTNDC98862Activated PTT/Standard;Activated PTT/Standard PTT;Activated Partial Thromboplastin Time/Standard Thromboplastin TimeA relative measurement (ratio or percentage) of the subject's partial thromboplastin time to a standard or control partial thromboplastin time.Activated PTT/Standard Ratio Measurement
ARAC102259Arachidonic AcidA measurement of the arachidonic acid present in a biological specimen.Arachidonic Acid Measurement
ASCABC81976Anti-Saccharomyces cerevisiae AntibodyA measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen.Anti-Saccharomyces cerevisiae Antibody Measurement
ASSDNAC92269Anti-Single Stranded DNA IgGA measurement of the anti-single stranded DNA IgG antibody in a biological specimen.Anti-Single Stranded DNA IgG Measurement
ASTC64467Aspartate Aminotransferase;SGOTA measurement of the aspartate aminotransferase in a biological specimen.Aspartate Aminotransferase Measurement
ASTAGC81978Aspartate Aminotransferase Antigen;SGOT AntigenA measurement of the aspartate aminotransferase antigen in a biological specimen.Aspartate Aminotransferase Antigen Measurement
ASTCREATC117830Aspartate Aminotransferase/CreatinineA relative measurement (ratio or percentage) of the aspartate aminotransferase to creatinine in a biological specimen.Aspartate Aminotransferase to Creatinine Ratio Measurement
ATPVITEC103350Vitamin E Alpha TocopherolA relative measurement (ratio or percentage) of alpha-tocopherol to the total vitamin E in a biological specimen.Alpha Tocopherol to Vitamin E Ratio Measurement
AUERRODSC74657Auer RodsA measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen.Auer Rod Measurement
AZURGRANC116185Azurophilic Granulation;Azurophilic GranulesAn observation of azurophilic granules in a biological specimen.Azurophilic Granule Measurement
B2G1GGABC103358Beta-2 Glycoprotein 1 IgG AntibodyA measurement of the Beta-2 glycoprotein 1 IgG antibodies in a biological specimen.Beta-2 Glycoprotein 1 IgG Antibody Measurement
B2G1GMABC103359Beta-2 Glycoprotein 1 IgM AntibodyA measurement of the Beta-2 glycoprotein 1 IgM antibodies in a biological specimen.Beta-2 Glycoprotein 1 IgM Antibody Measurement
B2GLYABC81979Beta-2 Glycoprotein AntibodyA measurement of the beta-2 glycoprotein antibody in a biological specimen.Beta-2 Glycoprotein Antibody Measurement
B2MICGC81980Beta-2 MicroglobulinA measurement of the beta-2 microglobulin in a biological specimen.Beta-2 Microglobulin Measurement
BACTC64469BacteriaA measurement of the bacteria in a biological specimen.Bacterial Count
BAFFC111135B-Cell Activating FactorA measurement of the B-cell activating factor in a biological specimen.B-Cell Activating Factor Measurement
BARBC74688BarbituratesA measurement of any barbiturate class drug present in a biological specimen.Barbiturate Drug Class Measurement
BASEEXCSC119270Base ExcessA measurement of the amount of acid or alkali required to return a biological specimen to a normal pH under standard conditions.Base Excess Measurement
BASOC64470BasophilsA measurement of the basophils in a biological specimen.Total Basophil Count
BASOCEC98865Basophils/Total CellsA relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen).Basophil to Total Cell Ratio Measurement
BASOIMC96670Immature BasophilsA measurement of the immature basophils in a biological specimen.Immature Basophil Count
BASOIMLEC96671Immature Basophils/LeukocytesA relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen.Immature Basophil to Leukocyte Ratio Measurement
BASOLEC64471Basophils/LeukocytesA relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen.Basophil to Leukocyte Ratio
BDNFC82004Brain-Derived Neurotrophic FactorA measurement of the brain-derived neurotrophic factor in a biological specimen.Brain-Derived Neurotrophic Factor Measurement
BETACRTNC100472Beta Carotene;Beta Carotin;b-CaroteneA measurement of the beta carotene in a biological specimen.Beta Carotene Measurement
BHYXBTRC965683-Hydroxybutyrate;B-Hydroxybutyrate;Beta-HydroxybutyrateA measurement of the total Beta-hydroxybutyrate in a biological specimen.Beta-Hydroxybutyrate Measurement
BICARBC74667Bicarbonate;HCO3A measurement of the bicarbonate in a biological specimen.Bicarbonate Measurement
BILDIRC64481Direct BilirubinA measurement of the conjugated or water-soluble bilirubin in a biological specimen.Direct Bilirubin Measurement
BILEACC74800Bile Acid;Bile Acids;Bile Salt;Bile SaltsA measurement of the total bile acids in a biological specimen.Bile Acid Measurement
BILIC38037Bilirubin;Total BilirubinA measurement of the total bilirubin in a biological specimen.Total Bilirubin Measurement
BILINDC64483Indirect BilirubinA measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.Indirect Bilirubin Measurement
BITECEC74700Bite CellsA measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen.Bite Cell Count
BJPROTC111136Bence-Jones Protein;Immunoglobulin Light ChainsA measurement of the total Bence-Jones protein in a biological specimen.Bence-Jones Protein Measurement
BKVVLDC98710BKV Viral LoadA measurement of the BK virus viral load in a biological specimen.BK Virus Viral Load Measurement
BLASTC74605BlastsA measurement of the blast cells in a biological specimen.Blast Count
BLASTIMMC103407Lymphocytes, ImmunoblasticA measurement of the immunoblasts in a biological specimen.Immunoblast Count
BLASTLEC64487Blasts/LeukocytesA relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen.Blast to Leukocyte Ratio
BLASTLMC74630Leukemic BlastsA measurement of the leukemic blasts (lymphoblasts that remain in an immature state even when outside the bone marrow) in a biological specimen.Leukemic Blast Count
BLSTIMLYC106535Immunoblasts/Lymphocytes;Lymphocytes, Immunoblastic/LymphocytesA relative measurement (ratio or percentage) of immunoblasts to all lymphocytes present in a sample.Immunoblasts to Lymphocytes Ratio Measurement
BLSTLMLYC74641Leukemic Blasts/LymphocytesA relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts) to mature lymphocytes in a biological specimen.Leukemic Blast to Lymphocyte Ratio Measurement
BLSTLYC102278LymphoblastsA measurement of the lymphoblasts (immature cells that differentiate to form lymphocytes) in a biological specimen.Lymphoblast Count
BLSTLYLEC105444Lymphoblasts/LeukocytesA relative measurement (ratio or percentage) of the lymphoblasts to leukocytes in a biological specimen.Lymphoblast to Leukocyte Ratio Measurement
BLSTMBCEC98761Myeloblasts/Total CellsA relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen).Myeloblast to Total Cell Ratio Measurement
BLSTMGKC98752MegakaryoblastsA measurement of the megakaryoblasts in a biological specimen.Megakaryoblast Cell Count
BLSTMKCEC98753Megakaryoblasts/Total CellsA relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen).Megakaryoblast to Total Cell Ratio Measurement
BLSTNMCEC98764Normoblasts/Total CellsA relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen).Normoblast to Total Cell Ratio Measurement
BLSTPNCEC98870Pronormoblasts/Total CellsA relative measurement (ratio or percentage) of the pronormoblasts to total cells in a biological specimen (for example a bone marrow specimen).Pronormoblast to Total Cell Ratio Measurement
BLSTRSIDC100419Ringed SideroblastsA measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen.Ringed Sideroblast Measurement
BLSTSIDC100418SideroblastA measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen.Sideroblast Measurement
BNPC74735B-Type Natriuretic Peptide;Brain Natriuretic PeptideA measurement of the brain (B-type) natriuretic peptide in a biological specimen.Brain Natriuretic Peptide Measurement
BNPPROC82032Pro-Brain Natriuretic Peptide;ProB-type Natriuretic Peptide;proBNPA measurement of the proB-type natriuretic peptide in a biological specimen.ProB-Type Natriuretic Peptide Measurement
BNPPRONTC96610N-Terminal ProB-type Natriuretic Peptide;N-terminal pro-Brain Natriuretic Peptide;NT proBNP IIA measurement of the N-terminal proB-type natriuretic peptide in a biological specimen.N-Terminal ProB-type Natriuretic Peptide Measurement
BNZDZPNC74692BenzodiazepineA measurement of any benzodiazepine class drug present in a biological specimen.Benzodiazepine Measurement
BNZLCGNC75350Benzoylecgonine;Cocaine MetaboliteA measurement of the benzoylecgonine in a biological specimen.Benzoylecgonine Measurement
BTECERBCC74634Bite Cells/ErythrocytesA relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen.Bite Cell to Erythrocyte Ratio Measurement
BTPC100426Beta-Trace ProteinA measurement of the beta-trace protein in a biological specimen.Beta-Trace Protein Measurement
BUCHEC111142Acylcholine Acylhydrolase;Butyrylcholinesterase;Non-neuronal Cholinesterase;Plasma Cholinesterase;PseudocholinesteraseA measurement of the total butyrylcholinesterase in a biological specimen.Butyrylcholinesterase Measurement
BUNC61019Blood Urea NitrogenA measurement of the urea nitrogen in a blood specimen.Blood Urea Nitrogen Measurement
BUNCREATC74753BUN/CreatinineA relative measurement (ratio or percentage) (ratio) of the blood urea nitrogen (BUN) to the creatinine in a biological specimen.Blood Urea Nitrogen To Creatinine Ratio Measurement
BURRCEC74701Burr Cells;KeratocytesA measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen.Burr Cell Count
C1QABC80173Complement C1q AntibodyA measurement of the complement C1q antibody in a biological specimen.Complement C1q Antibody Measurement
C3C80174Complement C3A measurement of the complement C3 in a biological specimen.Complement C3 Measurement
C3AC80175ASP, Complement C3 DesArg, Acetylation-stimulating Protein;Complement C3aA measurement of the complement C3a in a biological specimen.Complement C3a Measurement
C3BC80176Complement C3bA measurement of the complement C3b in a biological specimen.Complement C3b Measurement
C3DABC119271Complement C3d AntibodyA measurement of the complement C3d antibody in a biological specimen.Complement C3d Antibody Measurement
C4C80177Complement C4A measurement of the complement C4 in a biological specimen.Complement C4 Measurement
C4AC80178Complement C4aA measurement of the complement C4a in a biological specimen.Complement C4a Measurement
C5AC80179Complement C5aA measurement of the complement C5a in a biological specimen.Complement C5a Measurement
CAC64488CalciumA measurement of the calcium in a biological specimen.Calcium Measurement
CA125AGC79089Cancer Antigen 125A measurement of the cancer antigen 125 in a biological specimen.CA-125 Measurement
CA15_3AGC103362Cancer Antigen 15-3A measurement of the cancer antigen 15-3 in a biological specimen.Cancer Antigen 15-3 Measurement
CA19_9AGC81982Cancer Antigen 19-9A measurement of the cancer antigen 19-9 in a biological specimen.Cancer Antigen 19-9 Measurement
CA1AGC103361Cancer Antigen 1A measurement of the cancer antigen 1 in a biological specimen.Cancer Antigen 1 Measurement
CA2729AGC111143Cancer Antigen 27-29A measurement of the cancer antigen 27-29 in a biological specimen.Cancer Antigen 27-29 Measurement
CA72_4AGC106505CA 72-4;Cancer Antigen 72-4;Carbohydrate Antigen 72-4A measurement of the cancer antigen 72-4 in a biological specimen.Cancer Antigen 72-4 Measurement
CABOTC74702Cabot RingsA measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen.Cabot Ring Count
CACLRC96589Calcium ClearanceA measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute).Calcium Clearance Measurement
CACRC119272Calcium CorrectedA measurement of calcium, which has been corrected for albumin, in a biological specimen.Calcium Corrected Measurement
CACREATC79439Calcium/CreatinineA relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen.Calcium to Creatinine Ratio Measurement
CAEXRC117831Calcium Excretion RateA measurement of the amount of calcium being excreted in urine over a defined period of time (e.g. one hour).Calcium Urine Excretion Rate
CAFFEINEC75346CaffeineA measurement of the caffeine in a biological specimen.Caffeine Measurement
CAIONC81948Calcium, IonizedA measurement of the ionized calcium in a biological specimen.Ionized Calcium Measurement
CALPROC82005CalprotectinA measurement of the calprotectin in a biological specimen.Calprotectin Measurement
CANNABC74689CannabinoidsA measurement of any cannabinoid class drug present in a biological specimen.Cannabinoid Drug Class Measurement
CAPHOSPDC103360Calcium - Phosphorus ProductA measurement of the product of the calcium and phosphate measurements in a biological specimen.Calcium and Phosphorus Product Measurement
CARBXHGBC96591CarboxyhemoglobinA measurement of the carboxyhemoglobin, carbon monoxide-bound hemoglobin, in a biological specimen.Carboxyhemoglobin Measurement
CARNITC74682CarnitineA measurement of the total carnitine in a biological specimen.Total Carnitine Measurement
CARNITATC92288Carnitine Acetyl TransferaseA measurement of the carnitine acetyl transferase in a biological specimen.Carnitine Acetyl Transferase Measurement
CARNITFC74677Carnitine, FreeA measurement of the free carnitine in a biological specimen.Free Carnitine Measurement
CASTSC74763CastsA statement that indicates casts were looked for in a biological specimen.Cast Present Or Absent
CASULPHC96590Calcium SulphateA measurement of the calcium sulphate in a biological specimen.Calcium Sulphate Measurement
CATNINBC103357Beta CateninA measurement of the beta catenin in a biological specimen.Beta Catenin Measurement
CBBC80172Bb Fragment of Complement Factor B;Bb Fragment of Factor B;Complement BbA measurement of the Bb fragment of complement factor B in a biological specimen.Complement Bb Measurement
CCKC74850Cholecystokinin;PancreozyminA measurement of the cholecystokinin hormone in a biological specimen.Cholecystokinin Measurement
CCL17C112236ABCD-2;Chemokine (C-C Motif) Ligand 17;SCYA17;TARC;Thymus and Activation Regulated ChemokineA measurement of the CCL17, chemokine (C-C motif) ligand 17, in a biological specimen.Chemokine (C-C Motif) Ligand 17 Measurement
CCL18C112237AMAC-1;AMAC1;CKB7;Chemokine (C-C Motif) Ligand 18;DC-CK1;DCCK1;MIP-4;Macrophage inflammatory protein-4;PARC;Pulmonary and Activation-Regulated Chemokine;SCYA18A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen.Chemokine (C-C Motif) Ligand 18 Measurement
CCPABC96595Cyclic Citrullinated Peptide AntibodyA measurement of the cyclic citrullinated peptide antibody in a biological specimen.Cyclic Citrullinated Peptide Antibody Measurement
CD1C103364CD1A count of the CD1 expressing cells per unit of a biological specimen.CD1 Expressing Cell Measurement
CD10C111146CD10A measurement of the CD10 expressing cells per unit in a biological specimen.CD10 Expressing Cell Count
CD11AC105439CD11A;CD11aA count of the CD11a expressing cells per unit of a biological specimen.CD11A Expressing Cell Count
CD11BC105440CD11B;CD11b;Complement Component 3 Receptor 3 Subunit;Complement Receptor Type 3 Alpha Subunit;ITGAM Protein;Integrin Alpha-MA count of the CD11b expressing cells per unit of a biological specimen.CD11B Expressing Cell Count
CD13C111147CD13A measurement of the CD13 expressing cells per unit in a biological specimen.CD13 Expressing Cell Count
CD14C103365CD14A count of the CD14 expressing cells per unit of a biological specimen.CD14 Expressing Cell Measurement
CD19C103808CD19A count of the CD19 expressing cells per unit in a biological specimen.CD19 Expressing Cell Count
CD19LYC103812CD19/LymphocytesA relative measurement (ratio or percentage) of CD19 expressing cells to all lymphocytes in a biological specimen.CD19 Cell to Lymphocyte Ratio Measurement
CD2C103366CD2A count of the CD2 expressing cells per unit of a biological specimen.CD2 Expressing Cell Measurement
CD20C103368CD20A count of the CD20 expressing cells per unit of a biological specimen.CD20 Expressing Cell Measurement
CD22C111148CD22A measurement of the CD22 expressing cells per unit in a biological specimen.CD22 Expressing Cell Count
CD23C111149CD23A measurement of the CD23 expressing cells per unit in a biological specimen.CD23 Expressing Cell Count
CD2LYC103367CD2/LymphocytesA relative measurement (ratio or percentage) of CD2 expressing cells to all lymphocytes in a biological specimen.CD2 Expressing Cell to Lymphocyte Ratio Measurement
CD3C103809CD3A count of the CD3 expressing cells per unit in a biological specimen.CD3 Expressing Cell Count
CD33C111150CD33A measurement of the CD33 expressing cells per unit in a biological specimen.CD33 Expressing Cell Count
CD34C102260CD34A measurement of the CD34 expressing cells per unit in a biological specimen.CD34 Measurement
CD38C111151CD38A measurement of the CD38 expressing cells per unit in a biological specimen.CD38 Expressing Cell Count
CD3LYC103813CD3/LymphocytesA relative measurement (ratio or percentage) of CD3 expressing cells to all lymphocytes in a biological specimen.CD3 Cell to Lymphocyte Ratio Measurement
CD4C103810CD4A count of the CD4 expressing cells per unit in a biological specimen.CD4 Expressing Cell Count
CD40C82006CD40A count of the CD40 cells per unit in a biological specimen.CD40 Measurement
CD40LC82007CD40 LigandA count of the CD40 ligand cells per unit in a biological specimen.CD40 Ligand Measurement
CD4CD8C103814CD4/CD8A relative measurement (ratio or percentage) of CD4 expressing cells to the CD8 expressing cells in a biological specimen.CD4 Cell to CD8 Cell Ratio Measurement
CD4LYC103815CD4/LymphocytesA relative measurement (ratio or percentage) of CD4 expressing cells to all lymphocytes in a biological specimen.CD4 Cell to Lymphocyte Ratio Measurement
CD5C103369CD5A count of the CD5 expressing cells per unit of a biological specimen.CD5 Expressing Cell Measurement
CD56C103370CD56A count of the CD56 expressing cells per unit of a biological specimen.CD56 Expressing Cell Measurement
CD79AC111152CD79AA measurement of the CD79A expressing cells per unit in a biological specimen.CD79A Expressing Cell Count
CD8C103811CD8A count of the CD8 expressing cells per unit in a biological specimen.CD8 Expressing Cell Count
CD8LYC103816CD8/LymphocytesA relative measurement (ratio or percentage) of CD8 expressing cells to all lymphocytes in a biological specimen.CD8 Cell to Lymphocyte Ratio Measurement
CDFTXNC103381Clostridium difficile ToxinA measurement of the Clostridium difficile toxin in a biological specimen.Clostridium difficile Toxin Measurement
CDTC101016Carbohydrate-Deficient TransferrinA measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen.Carbohydrate-Deficient Transferrin Measurement
CEAC81983Carcinoembryonic AntigenA measurement of the carcinoembryonic antigen in a biological specimen.Carcinoembryonic Antigen Measurement
CECC96592Circulating Endothelial CellsA measurement of the circulating endothelial cells in a biological specimen.Circulating Endothelial Cell Count
CEIMCEC111234Immature Cells/Total CellsA relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen.Immature Cell to Total Cell Ratio Measurement
CELLSIMC96672Immature CellsA measurement of the total immature cells in a blood specimen.Immature Cell Count
CELLULARC111153Cellularity;Cellularity GradeA measurement of the degree, quality or condition of cells in a biological specimen.Cellularity Measurement
CENTROABC111154Anti-Centromere B AntibodiesA measurement of centromere B antibodies in a biological specimen.Centromere B Antibody Measurement
CETPAC103380Cholesteryl Ester Transfer Protein ActA measurement of the biological activity of cholesteryl ester transfer protein in a biological specimen.Cholesteryl Ester Transfer Protein Activity Measurement
CGMPC111165Cyclic Guanosine 3,5-MonophosphateA measurement of the cyclic guanosine 3,5-monophosphate in a biological specimen.Cyclic Guanosine Monophosphate Measurement
CH50C100423CH50;Complement CH50;Total Hemolytic ComplementA measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen.CH50 Measurement
CHOLC105586Cholesterol;Total CholesterolA measurement of the cholesterol in a biological specimen.Cholesterol Measurement
CHOLHDLC80171Cholesterol/HDL-CholesterolA relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen.Cholesterol to HDL-Cholesterol Ratio Measurement
CHOLINESC92289CholinesteraseA measurement of the cholinesterase in a biological specimen.Cholinesterase Measurement
CHYTRYPC111159ChymotrypsinA measurement of the total chymotrypsin in a biological specimen.Chymotrypsin Measurement
CITRATEC92248CitrateA measurement of the citrate in a biological specimen.Citrate Measurement
CKC64489Creatine KinaseA measurement of the total creatine kinase in a biological specimen.Creatine Kinase Measurement
CKBBC64490Creatine Kinase BBA measurement of the homozygous B-type creatine kinase in a biological specimen.Creatine Kinase BB Measurement
CKBBCKC79466Creatine Kinase BB/Total Creatine KinaseA relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase BB to Total Creatine Kinase Ratio Measurement
CKMBC64491Creatine Kinase MBA measurement of the heterozygous MB-type creatine kinase in a biological specimen.Creatine Kinase MB Measurement
CKMBCKC79441Creatine Kinase MB/Total Creatine KinaseA relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase MB to Total Creatine Kinase Ratio Measurement
CKMMC64494Creatine Kinase MMA measurement of the homozygous M-type creatine kinase in a biological specimen.Creatine Kinase MM Measurement
CKMMCKC79442Creatine Kinase MM/Total Creatine KinaseA relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase MM to Total Creatine Kinase Ratio Measurement
CLC64495ChlorideA measurement of the chloride in a biological specimen.Chloride Measurement
CLARITYC96594ClarityA measurement of the transparency of a biological specimen.Clarity Measurement
CLCLRC106509Chloride ClearanceA measurement of the volume of serum or plasma that would be cleared of chloride by excretion of urine for a specified unit of time (e.g. one minute).Chloride Clearance Measurement
CLCREATC79440Chloride/CreatinineA relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen.Chloride to Creatinine Ratio Measurement
CLCTONNC74848CalcitoninA measurement of the calcitonin hormone in a biological specimen.Calcitonin Measurement
CLCTRIOLC74849CalcitriolA measurement of the calcitriol hormone in a biological specimen.Calcitriol Measurement
CLEXRC117832Chloride Excretion RateA measurement of the amount of chloride being excreted in urine over a defined period of time (e.g. one hour).Chloride Urine Excretion Rate
CLUECEC102261Clue CellsA measurement of the clue cells in a biological specimen.Clue Cell Count
CMVIGGABC96596Cytomegalovirus IgG AntibodyA measurement of the cytomegalovirus IgG antibody in a biological specimen.Cytomegalovirus IgG Antibody Measurement
CMVIGMABC96597Cytomegalovirus IgM AntibodyA measurement of the cytomegalovirus IgM antibody in a biological specimen.Cytomegalovirus IgM Antibody Measurement
CMVVLDC98716CMV Viral LoadA measurement of the cytomegalovirus viral load in a biological specimen.Cytomegalovirus Viral Load Measurement
CO2C64545Carbon DioxideA measurement of the carbon dioxide gas in a biological specimen.Carbon Dioxide Measurement
COAGIDXC112239CI;Coagulation IndexA measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation.Coagulation Index Measurement
COCAINEC74690CocaineA measurement of the cocaine present in a biological specimen.Cocaine Measurement
COCCABC111160Coccidioides AntibodyA measurement of the coccidioides antibody in a biological specimen.Coccidioides Antibody Measurement
CODEINEC74877CodeineA measurement of the codeine present in a biological specimen.Codeine Measurement
COL4C103383Collagen Type IVA measurement of the collagen type IV in a biological specimen.Collagen Type IV Measurement
COLORC64546ColorA measurement of the color of a biological specimen.Color Assessment
COMPC111145Cartilage Oligomeric Matrix ProteinA measurement of the cartilage oligomeric matrix protein in a biological specimen.Cartilage Oligomeric Matrix Protein Measurement
CONDUCTUC102282Urine ConductivityA measurement of the urine conductivity which is a non-linear function of the electrolyte concentration in the urine.Urine Conductivity
COPPERC111161Copper;CuA measurement of copper in a biological specimen.Copper Measurement
CORCREATC106512Cortisol/CreatinineA relative measurement (ratio or percentage) of the cortisol to creatinine present in a sample.Cortisol to Creatinine Ratio Measurement
CORTFRC88113Cortisol, FreeA measurement of the free, unbound cortisol in a biological specimen.Free Cortisol Measurement
CORTISOLC74781Cortisol;Total CortisolA measurement of the cortisol in a biological specimen.Cortisol Measurement
COTININEC92249CotinineA measurement of the cotinine in a biological specimen.Cotinine Measurement
CPEPTIDEC74736C-peptideA measurement of the C (connecting) peptide of insulin in a biological specimen.C-peptide Measurement
CPNIGAABC92432Chlamydia pneumoniae IgA AntibodyA measurement of the Chlamydia pneumoniae IgA antibody in a biological specimen.Chlamydia pneumoniae IgA Antibody Measurement
CPNIGMABC92433Chlamydia pneumoniae IgM AntibodyA measurement of the Chlamydia pneumoniae IgM in a biological specimen.Chlamydia pneumoniae IgM Antibody Measurement
CRDIGGABC111144Anti-Cardiolipin IgG Antibody;Cardiolipin IgG AntibodyA measurement of the cardiolipin IgG antibody in a biological specimen.Cardiolipin IgG Antibody Measurement
CRDIGMABC103363Cardiolipin IgM AntibodyA measurement of the cardiolipin IgM antibodies in a biological specimen.Cardiolipin IgM Antibody Measurement
CREATC64547CreatinineA measurement of the creatinine in a biological specimen.Creatinine Measurement
CREATCLRC25747Creatinine ClearanceA measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute).Creatinine Clearance
CREATEXRC117833Creatinine Excretion RateA measurement of the amount of creatinine being excreted in urine over a defined amount of time (e.g. one hour).Creatinine Urine Excretion Rate
CRENCEC74703Crenated Cells;EchinocytesA measurement of the Burr cells (erythrocytes characterized by the presence of multiple small, sharp projections evenly distributed across the cell surface) in a biological specimen.Crenated Cell Measurement
CRHC74851Corticotropin Releasing Factor;Corticotropin Releasing HormoneA measurement of the corticotropin releasing hormone in a biological specimen.Corticotropin Releasing Hormone Measurement
CRLPLSMNC100432Caeruloplasmin;CeruloplasminA measurement of ceruloplasmin in a biological specimen.Ceruloplasmin Measurement
CRPC64548C Reactive ProteinA measurement of the C reactive protein in a biological specimen.C-Reactive Protein Measurement
CRTCREATC106511Corticosterone/CreatinineA relative measurement (ratio or percentage) of the corticosterone to creatinine present in a sample.Corticosterone to Creatinine Ratio Measurement
CRTRONEC79434CorticosteroneA measurement of corticosterone in a biological specimen.Corticosterone Measurement
CRYOGLBNC111164CryoglobulinA measurement of cryoglobulin in a biological specimen.Cryoglobulin Measurement
CRYSTALSC74673CrystalsA statement that indicates crystals were looked for in a biological specimen.Crystal Present Or Absent
CSBACTC74762Bacterial CastsA measurement of the bacterial casts present in a biological specimen.Bacterial Cast Measurement
CSBROADC96588Broad CastsA measurement of the broad casts in a biological specimen.Broad Casts Measurement
CSCELLC74764Cellular CastsA measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen.Cellular Cast Measurement
CSEPIC74779Epithelial CastsA measurement of the epithelial cell casts present in a biological specimen.Epithelial-Cast Measurement
CSEPI846C112220846-Epitope;Aggrecan Chondroitin Sulfate Epitope 846;CS846;Chondroitin Sulfate Epitope 846;Chondroitin Sulfate Proteoglycan 1 Epitope 846A measurement of the 846 epitope present on the chondroitin sulfate chains of aggrecan in a biological specimen.Aggrecan Chondroitin Sulfate Epitope 846 Measurement
CSFATC74766Fatty CastsA measurement of the fatty casts present in a biological specimen.Fatty Cast Measurement
CSGRANC74768Granular CastsA measurement of the granular (coarse and fine) casts present in a biological specimen.Granular Cast Measurement
CSGRANCC74765Granular Coarse CastsA measurement of the coarse granular casts present in a biological specimen.Coarse Granular Cast Measurement
CSGRANFC74769Granular Fine CastsA measurement of the fine granular casts present in a biological specimen.Granular Fine Cast Measurement
CSHYALC74770Hyaline CastsA measurement of the hyaline casts present in a biological specimen.Hyaline Cast Measurement
CSMIXC74771Mixed CastsA measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen.Mixed Cast Count
CSRBCC74772RBC CastsA measurement of the red blood cell casts present in a biological specimen.Red Blood Cell Cast Measurement
CSUNCLAC74776Unclassified CastsA measurement of the unclassifiable casts present in a biological specimen.Unclassified Cast Measurement
CSWAXC74777Waxy CastsA measurement of the waxy casts present in a biological specimen.Waxy Cell Cast Measurement
CSWBCC74778WBC CastsA measurement of the white blood cell casts present in a biological specimen.White Blood Cell Cast Measurement
CTBIGGABC116194Cholera Toxin B Subunit IgG AntibodyA measurement of the cholera toxin B subunit IgG antibody in a biological specimen.Cholera Toxin B Subunit IgG Antibody Measurement
CTCC96593Circulating Tumor CellsA measurement of the circulating tumor cells in a biological specimen.Circulating Tumor Cell Count
CTOTC80160Complement TotalA measurement of the total complement in a biological specimen.Complement Measurement
CTRIGAABC100464Chlamydia trachomatis IgA AntibodyA measurement of the Chlamydia trachomatis IgA antibody in a biological specimen.Chlamydia trachomatis IgA Antibody Measurement
CTRIGGABC100466Chlamydia trachomatis IgG AntibodyA measurement of the Chlamydia trachomatis IgG antibody in a biological specimen.Chlamydia trachomatis IgG Antibody Measurement
CTRIGMABC100465Chlamydia trachomatis IgM AntibodyA measurement of the Chlamydia trachomatis IgM antibody in a biological specimen.Chlamydia trachomatis IgM Antibody Measurement
CTTIGGABC103382Clostridium tetani IgG AntibodyA measurement of the Clostridium tetani IgG antibody in a biological specimen.Clostridium tetani IgG Antibody Measurement
CTXIC82038Type I Collagen C-Telopeptides;Type I Collagen X-linked C-telopeptideA measurement of the type I collagen C-telopeptides in a biological specimen.Type I Collagen C-Telopeptide Measurement
CTXIIC82040Type II Collagen C-TelopeptidesA measurement of the type II collagen C-telopeptides in a biological specimen.Type II Collagen C-Telopeptide Measurement
CXCL10C112238Chemokine (C-X-C Motif) Ligand 10;IP-10;Interferon Gamma-induced Protein 10;Small-inducible Cytokine B10A measurement of the CXCL10, chemokine (C-X-C motif) ligand 10, in a biological specimen.Chemokine (C-X-C Motif) Ligand 10 Measurement
CXCR3C100431CD183;CXCR3;Chemokine (C-X-C Motif) Receptor 3;GPR9A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen.Chemokine Receptor CXCR3 Measurement
CYACIDUC74912Acid Urate CrystalsA measurement of the acid urate crystals present in a biological specimen.Acid Urate Crystal Measurement
CYAMMBIUC105590Acid Ammonium Urate Crystals;Ammonium Biurate Crystals;Ammonium Urate CrystalsA measurement of the ammonium biurate crystals present in a biological specimen.Ammonium Biurate Crystals Measurement
CYAMMOXC74759Ammonium Oxalate CrystalsA measurement of the ammonium oxalate crystals present in a urine specimen.Urine Ammonium Oxalate Crystal Measurement
CYAMORPHC74665Amorphous CrystalsA measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen.Amorphous Crystal Measurement
CYAMPPHC92243Amorphous Phosphate CrystalsA measurement of the amorphous phosphate crystals in a biological specimen.Amorphous Phosphate Crystals Measurement
CYAMPURTC92244Amorphous Urate CrystalsA measurement of the amorphous urate crystals in a biological specimen.Amorphous Urate Crystals Measurement
CYBILIC74668Bilirubin CrystalsA measurement of the bilirubin crystals present in a biological specimen.Bilirubin Crystal Measurement
CYCACARC74669Calcium Carbonate CrystalsA measurement of the calcium carbonate crystals present in a biological specimen.Calcium Carbonate Crystal Measurement
CYCAOXAC74670Calcium Oxalate CrystalsA measurement of the calcium oxalate crystals present in a biological specimen.Calcium Oxalate Crystal Measurement
CYCAPHOSC74671Calcium Phosphate CrystalsA measurement of the calcium phosphate crystals present in a biological specimen.Calcium Phosphate Crystal Measurement
CYCHOLC74672Cholesterol CrystalsA measurement of the cholesterol crystals present in a biological specimen.Cholesterol Crystal Measurement
CYCYSTINC74674Cystine CrystalsA measurement of the cystine crystals present in a biological specimen.Cystine Crystal Measurement
CYFRA211C106514CYFRA21-1;Cytokeratin 19 Fragment;Cytokeratin Fragment 21-1A measurement of the cytokeratin 19 fragment 21-1 in a biological specimen.Cytokeratin Fragment 21-1 Measurement
CYHGBCC112288Hemoglobin C CrystalsA measurement of hemoglobin C crystals in a biological specimen.Hemoglobin C Crystals Measurement
CYHIPPACC74754Hippuric Acid CrystalsA measurement of the hippuric acid crystals present in a biological specimen.Hippuric Acid Crystal Measurement
CYLEUCC74680Leucine CrystalsA measurement of the leucine crystals present in a biological specimen.Leucine Crystal Measurement
CYMSUC74681Monosodium Urate CrystalsA measurement of the monosodium urate crystals present in a biological specimen.Monosodium Urate Crystal Measurement
CYSCREATC106513Cystatin C/CreatinineA relative measurement (ratio or percentage) of the cystatin C to creatinine present in a sample.Cystatin C to Creatinine Ratio Measurement
CYSTARCHC81951Starch CrystalsA measurement of the starch crystals in a biological specimen.Starch Crystal Measurement
CYSTATCC92290Cystatin CA measurement of the cystatin C in a biological specimen.Cystatin C Measurement
CYSTINEC105441CystineA measurement of the cystine in a biological specimen.Cystine Measurement
CYSULFAC74755Sulfa CrystalsA measurement of the sulfa crystals present in a biological specimen.Sulfa Crystal Measurement
CYTRPHOSC74756Triple Phosphate CrystalsA measurement of the triple phosphate crystals present in a biological specimen.Triple Phosphate Crystal Measurement
CYTYROC74683Tyrosine CrystalsA measurement of the tyrosine crystals present in a biological specimen.Tyrosine Crystal Measurement
CYUNCLAC74757Unclassified CrystalsA measurement of the unclassifiable crystals present in a biological specimen.Unclassified Crystal Measurement
CYURIACC74684Uric Acid CrystalsA measurement of the uric acid crystals present in a biological specimen.Uric Acid Crystal Measurement
DDIMERC82621D-DimerA measurement of the d-dimers in a biological specimen.D-Dimer Measurement
DENSITYC45781DensityA measurement of the compactness of a biological specimen expressed in mass per unit volume.Density
DGNWBCC111190Degenerated Leukocytes;Degenerated WBC;Degenerated White Blood CellsA measurement of the degenerated leukocytes (leukocytes that show deterioration in form or function) in a biological specimen.Degenerated Leukocyte Count
DHEAC74852Dehydroepiandrosterone;DehydroisoandrosteroneA measurement of the dehydroepiandrosterone hormone in a biological specimen.Dehydroepiandrosterone Measurement
DHEASC96629DHEA Sulfate;DHEA-S;Dehydroepiandrosterone Sulfate;sDHEAA measurement of the sulfated Dehydroepiandrosterone in a biological specimen.Sulfated DHEA Measurement
DHPGC1010173,4-Dihydroxyphenylglycol;3.4 DihydroxyphenylglycolA measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen.3,4-Dihydroxyphenylglycol Measurement
DHTC74853Androstanalone;DihydrotestosteroneA measurement of the dihydrotestosterone hormone in a biological specimen.Dihydrotestosterone Measurement
DIHYDCDNC74878DihydrocodeineA measurement of the dihydrocodeine present in a biological specimen.Dihydrocodeine Measurement
DNAABC81973Anti-DNA Antibodies;Anti-ds-DNA AntibodiesA measurement of the anti-DNA antibodies in a biological specimen.Anti-DNA Antibody Measurement
DNASEBABC100463Anti-Dnase B;DNase-B AntibodyA measurement of Dnase-B antibody in a biological specimen.DNase-B Antibody Measurement
DOHLEC74610Dohle BodiesA measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen.Dohle Body Measurement
DOPACC1033453,4-Dihydroxyphenylacetic AcidA measurement of the 3,4-dihydroxyphenylacetic acid in a biological specimen.3,4-Dihydroxyphenylacetic Acid Measurement
DOPAMINEC74854DopamineA measurement of the dopamine hormone in a biological specimen.Dopamine Measurement
DPDC79443DeoxypyridinolineA measurement of the deoxypyridinoline in a biological specimen.Deoxypyridinoline Measurement
DPDCREATC79444Deoxypyridinoline/CreatinineA relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen.Deoxypyridinoline to Creatinine Ratio Measurement
DPPIVAC103387DPPIV ActivityA measurement of the biological activity of dipeptidyl peptidase-4 in a biological specimen.Dipeptidyl Peptidase-4 Activity Measurement
DPTIGGABC103388Diphtheria IgG AntibodyA measurement of the Diphtheria IgG antibodies in a biological specimen.Diphtheria IgG Antibody Measurement
DRUGSCRC78139Drug ScreenAn indication of the presence or absence of recreational drugs or drugs of abuse in a biological specimen.Drug Test
DRVVTC96696Dilute Russell's Viper Venom Time;Lupus Anticoagulant TestA measurement of the time it takes a plasma sample to clot after adding dilute Russell's viper venom.Dilute Russell's Viper Venom Time Measurement
DRVVTRTC103386Lupus Anticoagulant RatioA relative measurement (ratio or percentage) of the dilute Russell's viper venom time in a subject sample to a control sample.Dilute Russell's Viper Venom Time to Control Ratio Measurement
DTPACLRC100441DTPA ClearanceA measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) through its excretion for a specified unit of time.Diethylene Triamine Pentaacetic Acid Clearance
EBCIGGABC96600Epstein-Barr Capsid IgG AntibodyA measurement of the Epstein-Barr capsid IgG antibody in a biological specimen.Epstein-Barr Capsid IgG Antibody Measurement
EBCIGMABC96601Epstein-Barr Capsid IgM AntibodyA measurement of the Epstein-Barr capsid IgM antibody in a biological specimen.Epstein-Barr Capsid IgM Antibody Measurement
EBEAGC96602Epstein-Barr Early AntigenA measurement of the Epstein-Barr early antigen in a biological specimen.Epstein-Barr Early Antigen Measurement
EBN1IGABC106518Epstein-Barr Nuclear Antigen 1 IgG AbA measurement of the Epstein-Barr nuclear antigen 1 IgG antibody in a biological specimen.Epstein-Barr Nuclear Antigen 1 IgG Ab Measurement
EBNABC96603Epstein-Barr Nuclear Antibody;Epstein-Barr Nuclear Antigen AntibodyA measurement of the Epstein-Barr nuclear antibody in a biological specimen.Epstein-Barr Nuclear Antibody Measurement
EBNAGC96604Epstein-Barr Nuclear AntigenA measurement of the Epstein-Barr nuclear antigen in a biological specimen.Epstein-Barr Nuclear Antigen Measurement
EBVINTPC106519EBV Profile Interpretation;Epstein-Barr Virus Antibody Profile;Epstein-Barr Virus Panel;Epstein-Barr Virus Profile InterpretationAn assessment of Epstein-Barr virus infection based on a panel of EBV antigen antibody tests.Epstein-Barr Virus Profile Interpretation
EBVVLDC98721EBV Viral LoadA measurement of the Epstein-Barr virus viral load in a biological specimen.Epstein-Barr Virus Viral Load Measurement
ECCENTCYC96598EccentrocytesA measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen.Eccentrocyte Count
ECTC100422Ecarin Clotting TimeA measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin.Ecarin Clotting Time Measurement
EDTACLRC100440EDTA ClearanceA measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) through its excretion for a specified unit of time.EDTA Clearance
EGFC82009Epidermal Growth FactorA measurement of the epidermal growth factor in a biological specimen.Epidermal Growth Factor Measurement
EGFRC112273ERBB1;Epidermal Growth Factor Receptor;HER1A measurement of the cells with positive expression of EGFR in a biological specimen.Epidermal Growth Factor Receptor Measurement
ELA1C82028Pancreatic Elastase 1A measurement of the pancreatic elastase 1 in a biological specimen.Pancreatic Elastase Measurement
ELA1PMNC82029Pancreatic Elastase 1, PolymorphonuclearA measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen.Polymorphonuclear Pancreatic Elastase Measurement
ELA2C82026Neutrophil ElastaseA measurement of the neutrophil elastase in a biological specimen.Neutrophil Elastase Measurement
ELA2PMNC82027Neutrophil Elastase, PolymorphonuclearA measurement of the polymorphonuclear neutrophil elastase in a biological specimen.Polymorphonuclear Neutrophil Elastase Measurement
ELLIPCYC64549Elliptocytes;OvalocytesA measurement of the elliptically shaped erythrocytes in a biological specimen.Elliptocyte Count
ENA78C82010Epith Neutrophil-Activating Peptide 78A measurement of the epithelial neutrophil-activating peptide in a biological specimen.Epithelial Neutrophil-Activating Peptide 78 Measurement
ENAABC92270Anti-ENA;Extractable Nuclear Antigen AntibodyA measurement of the extractable nuclear antigen antibody in a biological specimen.Extractable Nuclear Antigen Antibody Measurement
ENDOTH1C82008Endothelin-1A measurement of the endothelin-1 in a biological specimen.Endothelin-1 Measurement
ENRAGEC82011Extracell Newly Ident RAGE Bind Protein;S100 Calcium Binding Protein A12A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen.Extracell Newly Ident RAGE Bind Protein Measurement
EOSC64550EosinophilsA measurement of the eosinophils in a biological specimen.Eosinophil Count
EOSBC114216Eosinophils Band FormA measurement of the banded eosinophils in a biological specimen.Eosinophil Band Form Count
EOSBLEC114217Eosinophils Band Form/LeukocytesA relative measurement (ratio or percentage) of the banded eosinophils to leukocytes in a biological specimen.Eosinophil Band Form to Leukocyte Ratio
EOSCEC98720Eosinophils/Total CellsA relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen).Eosinophils to Total Cell Ratio Measurement
EOSIMC96673Immature EosinophilsA measurement of the immature eosinophils in a biological specimen.Immature Eosinophil Count
EOSIMLEC96674Immature Eosinophils/LeukocytesA relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen.Immature Eosinophil to Leukocyte Ratio Measurement
EOSLEC64604Eosinophils/LeukocytesA relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.Eosinophil to Leukocyte Ratio
EOSMMC84819Eosinophilic MetamyelocytesA measurement of the eosinphilic metamyelocytes in a biological specimen.Eosinophilic Metamyelocyte Count
EOSMYLC84821Eosinophilic MyelocytesA measurement of the eosinophilic myelocytes in a biological specimen.Eosinophilic Myelocyte Count
EOTAXIN1C81952Chemokine Ligand 11;Eotaxin-1A measurement of the eotaxin-1 in a biological specimen.Eotaxin-1 Measurement
EOTAXIN2C81953Chemokine Ligand 24;Eotaxin-2A measurement of the eotaxin-2 in a biological specimen.Eotaxin-2 Measurement
EOTAXIN3C81954CCL26;Chemokine (C-C Motif) Ligand 26;Chemokine Ligand 26;Eotaxin-3A measurement of the eotaxin-3 in a biological specimen.Eotaxin-3 Measurement
EPICC64605Epithelial CellsA measurement of the epithelial cells in a biological specimen.Epithelial Cell Count
EPINC79445Adrenaline;EpinephrineA measurement of the epinephrine hormone in a biological specimen.Epinephrine Measurement
EPIROCEC74698Round Epithelial CellsA measurement of the round epithelial cells present in a biological specimen.Round Epithelial Cell Count
EPISQCEC74773Squamous Epithelial CellsA measurement of the squamous epithelial cells present in a biological specimen.Squamous Epithelial Cell Count
EPISQTCEC74774Epithelial Cells;Squamous Transitional Epithelial CellsA measurement of the squamous transitional epithelial cells present in a biological specimen.Squamous Transitional Epithelial Cell Count
EPITCEC92251Transitional Epithelial CellsA measurement of the transitional epithelial cells present in a biological specimen.Transitional Epithelial Cells Measurement
EPITUCEC74775Renal Tubular Epithelial Cells;Tubular Epithelial CellsA measurement of the tubular epithelial cells present in a biological specimen.Tubular Epithelial Cell Count
EPOC74855Erythropoietin;HematopoietinA measurement of the erythropoietin hormone in a biological specimen.Erythropoietin Measurement
ESELSC119273Soluble E-Selectin;sE-selectinA measurement of the soluble E-Selectin activity in a biological specimen.Soluble E-Selectin Measurement
ESRC74611Biernacki Reaction;Erythrocyte Sedimentation RateThe distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour).Erythrocyte Sedimentation Rate Measurement
ESTRCPTC112274ER;ESR;Estrogen Receptor;Oestrogen ReceptorA measurement of the cells with positive expression of estrogen receptor in a biological specimen.Estrogen Receptor Measurement
ESTRDIOLC74782Estradiol;OestradiolA measurement of the estradiol in a biological specimen.Estradiol Measurement
ESTRIOLC74856Estriol;OestriolA measurement of the estriol hormone in a biological specimen.Estriol Measurement
ESTRIOLFC81963Estriol, FreeA measurement of the free estriol in a biological specimen.Free Estriol Measurement
ESTRONEC74857Estrone;OestroneA measurement of the estrone hormone in a biological specimen.Estrone Measurement
ETHANOLC74693Alcohol;EthanolA measurement of the ethanol present in a biological specimen.Ethanol Measurement
ETPC102266Endogenous Thrombin PotentialA measurement of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample.Endogenous Thrombin Potential Measurement
ETPAUCC102263ETP Area Under Curve;Endogenous Thrombin Potential Area Under CurveA measurement of the area under the thrombin generation curve.Endogenous Thrombin Potential Area Under Curve Measurement
ETPLTC102264ETP Lag Time;Endogenous Thrombin Potential Lag TimeA measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated.Endogenous Thrombin Potential Lag Time Measurement
ETPLTRC102265ETP Lag Time Relative;Endogenous Thrombin Potential Lag Time RelativeA relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated.Endogenous Thrombin Potential Lag Time Relative Measurement
ETPPHC102267ETP Peak Height;Endogenous Thrombin Potential Peak HeightA measurement of the maximum concentration of thrombin generated during a thrombin generation test.Endogenous Thrombin Potential Peak Height Measurement
ETPPHRC102268ETP Peak Height Relative;Endogenous Thrombin Potential Peak Height RelativeA relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test.Endogenous Thrombin Potential Peak Height Relative Measurement
ETPTPC102269ETP Time to Peak;Endogenous Thrombin Potential Time to PeakA measurement of the time it takes to generate the maximum concentration of thrombin.Endogenous Thrombin Potential Time to Peak Measurement
ETPTPRC102270ETP Time to Peak Relative;Endogenous Thrombin Potential Time to Peak RelativeA relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin.Endogenous Thrombin Potential Time to Peak Relative Measurement
FABP1C82012Fatty Acid Binding Protein 1A measurement of the fatty acid binding protein 1 in a biological specimen.Fatty Acid Binding Protein 1 Measurement
FABP3C106521Fatty Acid Binding Protein 3A measurement of the fatty acid binding protein 3 in a biological specimen.Fatty Acid Binding Protein 3 Measurement
FACTIIC96626Factor II;ProthrombinA measurement of the Factor II in a biological specimen.Prothrombin Measurement
FACTIIIC81959Factor III;Tissue Factor, CD142A measurement of the factor III in a biological specimen.Factor III Measurement
FACTIXC98725Christmas Factor;Factor IXA measurement of the factor IX in a biological specimen.Factor IX Measurement
FACTIXAC103395Christmas Factor ActivityA measurement of the biological activity of factor IX in a biological specimen.Factor IX Activity Measurement
FACTVC98726Factor V;Labile FactorA measurement of the factor V in a biological specimen.Factor V Measurement
FACTVAC103396Labile Factor ActivityA measurement of the biological activity of factor V in a biological specimen.Factor V Activity Measurement
FACTVIIC81960Factor VII;Proconvertin;Stable FactorA measurement of the factor VII in a biological specimen.Factor VII Measurement
FACTVIIAC103397Proconvertin Activity;Stable Factor ActivityA measurement of the biological activity of factor VII in a biological specimen.Factor VII Activity Measurement
FACTVIIIC81961Anti-hemophilic Factor;Factor VIIIA measurement of the factor VIII in a biological specimen.Factor VIII Measurement
FACTVLC102271Factor V LeidenA measurement of the Factor V Leiden in a biological specimen.Factor V Leiden Measurement
FACTVWC98799von Willebrand Factor;von Willebrand Factor AntigenA measurement of the von Willebrand factor in a biological specimen.von Willebrand Factor Measurement
FACTXC98727Factor XA measurement of the factor X in a biological specimen.Factor X Measurement
FACTXIIIC112277Factor XIII;Fibrin Stablizing FactorA measurement of the factor XIII in a biological specimen.Factor XIII Measurement
FACTXIVC102272Autoprothrombin IIA;Factor XIV;Protein C;Protein C AntigenA measurement of the factor XIV in a biological specimen.Factor XIV Measurement
FACTXIVAC105442Factor XIV Activity;Protein C Activity;Protein C FunctionA measurement of the factor XIV activity in a biological specimen.Factor XIV Activity Measurement
FATC96648FatA measurement of the fat in a biological specimen.Fat Measurement
FATACFRC80200Free Fatty Acid;Non-Esterified Fatty Acid, FreeA measurement of the total non-esterified fatty acids in a biological specimen.Non-esterified Fatty Acids Measurement
FATACFRSC80206Free Fatty Acid, Saturated;Non-esterified Fatty Acid, SaturatedA measurement of the saturated non-esterified fatty acids in a biological specimen.Saturated Non-esterified Fatty Acids Measurement
FATACFRUC80209Free Fatty Acid, Unsaturated;Non-esterified Fatty Acid, UnsaturatedA measurement of the unsaturated non-esterified fatty acids in a biological specimen.Unsaturated Non-esterified Fatty Acids Measurement
FATBODOVC81947Fat Bodies, OvalA measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen.Oval Fat Body Measurement
FATDROPC98728Fat DropletA measurement of the triglyceride aggregates within a biological specimen.Fat Droplet Measurement
FBRTSTC105443FibroSURE Score;FibroTest ScoreA biomarker test that measures liver pathology through the assessment of a six-parameter blood test (for Alpha-2-macroglobulin, Haptoglobin, Apolipoprotein A1, Gamma-glutamyl transpeptidase (GGT), Total bilirubin, and Alanine aminotransferase (ALT)), taking into account the age and gender of the patient.FibroTest Score Measurement
FCTVIIAAC103398Factor VIIa ActivityA measurement of the biological activity of factor VIIa in a biological specimen.Factor VIIa Activity Measurement
FCTVIIIAC103399Anti-hemophilic Factor ActivityA measurement of the biological activity of factor VIII in a biological specimen.Factor VIII Activity Measurement
FDPC82013Fibrin Degradation ProductsA measurement of the fibrin degradation products in a biological specimen.Fibrin Degradation Products Measurement
FECAC114219Fractional Calcium ExcretionA measurement of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine.Fractional Excretion of Calcium
FECLC114220Fractional Chloride ExcretionA measurement of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine.Fractional Excretion of Chloride
FEKC114222Fractional Potassium ExcretionA measurement of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine.Fractional Excretion of Potassium
FENAC107435Fractional Sodium ExcretionA measurement of the fractional excretion of sodium that is computed based upon the concentrations of sodium and creatinine in both blood and urine.Fractional Excretion of Sodium
FEPIC114221Fractional Inorganic Phosphate Excretion;Fractional Phosphorus ExcretionA measurement of the fractional excretion of phosphorus that is computed based upon the concentrations of phosphorus and creatinine in both blood and urine.Fractional Excretion of Phosphate
FERRITINC74737FerritinA measurement of the ferritin in a biological specimen.Ferritin Measurement
FGF21C112280FGF 21;Fibroblast Growth Factor 21A measurement of the fibroblast growth factor 21 in a biological specimen.Fibroblast Growth Factor 21 Measurement
FGF23C96650Fibroblast Growth Factor 23;PhosphatoninA measurement of the fibroblast growth factor 23 in a biological specimen.Fibroblast Growth Factor 23 Measurement
FGFBFC82014FGF2;Fibroblast Growth Factor Basic FormA measurement of the basic form of fibroblast growth factor in a biological specimen.Fibroblast Growth Factor Basic Form Measurement
FIBRINOC64606FibrinogenA measurement of the fibrinogen in a biological specimen.Fibrinogen Measurement
FRUCTC74678Fructosamine;Glycated Serum ProteinA measurement of the fructosamine in a biological specimen.Fructosamine Measurement
FSHC74783Follicle Stimulating HormoneA measurement of the follicle stimulating hormone (FSH) in a biological specimen.Follicle Stimulating Hormone Measurement
G6PDC80184Glucose-6-Phosphate DehydrogenaseA measurement of the glucose-6-phosphate dehydrogenase in a biological specimen.Glucose-6-Phosphate Dehydrogenase Measurement
GAD1C82015Glutamic Acid Decarboxylase 1;Glutamic Acid Decarboxylase 67A measurement of the glutamic acid decarboxylase 1 in a biological specimen.Glutamic Acid Decarboxylase 1 Measurement
GAD2C82016Glutamic Acid Decarboxylase 2;Glutamic Acid Decarboxylase 65A measurement of the glutamic acid decarboxylase 2 in a biological specimen.Glutamic Acid Decarboxylase 2 Measurement
GAD2ABC82017Glutamic Acid Decarboxylase 2 Antibody;Glutamic Acid Decarboxylase 65 AntibodyA measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen.Glutamic Acid Decarboxylase 2 Antibody Measurement
GADABC96653GAD Antibody;Glutamic Acid Decarboxylase AntibodyA measurement of the glutamic acid decarboxylase antibody in a biological specimen.Glutamic Acid Decarboxylase Antibody Measurement
GALANINC80182GalaninA measurement of the galanin in a biological specimen.Galanin Measurement
GASTRINC74858GastrinA measurement of the gastrin hormone in a biological specimen.Gastrin Measurement
GATCPHRLC116211Gamma TocopherolA measurement of the gamma tocopherol in a biological specimen.Gamma Tocopherol Measurement
GCSFC82018Granulocyte Colony Stimulating FactorA measurement of the granulocyte colony stimulating factor in a biological specimen.Granulocyte Colony Stimulating Factor Measurement
GFRC90505Glomerular Filtration RateA kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time.Glomerular Filtration Rate
GFRBSAC98734Glomerular Filtration Rate Adj for BSAA measurement of the glomerular filtration rate adjusted for body size.Glomerular Filtration Rate Adjusted for BSA
GFRBSB2MC100450GFR from B-2 Microglobulin Adj for BSAA measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area.Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement
GFRBSBTPC100449GFR from Beta-Trace Protein Adj for BSAA measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area.Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement
GFRBSCRTC98735GFR from Creatinine Adjusted for BSAAn estimation of the glomerular filtration rate adjusted for body size based on creatinine.Glomerular Filtration Rate from Creatinine Adjusted for BSA
GFRBSCYCC98736GFR from Cystatin C Adjusted for BSAAn estimation of the glomerular filtration rate adjusted for body size based on cystatin C.Glomerular Filtration Rate from Cystatin C Adjusted for BSA
GGTC64847Gamma Glutamyl TransferaseA measurement of the gamma glutamyl transferase in a biological specimen.Gamma Glutamyl Transpeptidase Measurement
GGTCREATC79446Gamma Glutamyl Transferase/CreatinineA relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen.Gamma Glutamyl Transferase to Creatinine Ratio Measurement
GHRELINC112286Ghrelin;Growth Hormone Secretagogue Receptor Ligand;Motilin-related Peptide;Total GhrelinA measurement of total ghrelin in a biological specimen.Ghrelin Measurement
GHRELINAC112219Active Ghrelin;GhrelinA measurement of active ghrelin in a biological specimen.Active Ghrelin Measurement
GIPIC106537Glucose-dep Insulinotropic Pep, Intact;Intact GIP;Intact Gastric Inhibitory Polypeptide;Intact Glucose-dependent Insulinotropic PeptideA measurement of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide in a biological specimen.Intact Glucose-dependent Insulinotropic Peptide Measurement
GLDHC79448Glutamate DehydrogenaseA measurement of the glutamate dehydrogenase in a biological specimen.Glutamate Dehydrogenase Measurement
GLOBA1C92252A1-Globulin;Alpha-1 GlobulinA measurement of the proteins contributing to the alpha 1 fraction in a biological specimen.Alpha-1 Globulin Measurement
GLOBA1PTC92253Alpha-1 Globulin/Total ProteinA relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen.Alpha-1 Globulin to Total Protein Ratio Measurement
GLOBA2C92254A2-Globulin;Alpha-2 GlobulinA measurement of the proteins contributing to the alpha 2 fraction in a biological specimen.Alpha-2 Globulin Measurement
GLOBA2PTC92255Alpha-2 Globulin/Total ProteinA relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen.Alpha-2 Globulin to Total Protein Ratio Measurement
GLOBBC92256Beta GlobulinA measurement of the proteins contributing to the beta fraction in a biological specimen.Beta Globulin Measurement
GLOBB1C119274Beta-1 GlobulinA measurement of the beta-1 globulin in a biological specimen.Beta-1 Globulin Measurement
GLOBB1PTC119275Beta-1 Globulin/Total ProteinA relative measurement (ratio or percentage) of beta-1-fraction proteins to total proteins in a biological specimen.Beta-1 Globulin to Total Protein Ratio Measurement
GLOBB2C119276Beta-2 GlobulinA measurement of the beta-2 globulin in a biological specimen.Beta-2 Globulin Measurement
GLOBB2PTC119277Beta-2 Globulin/Total ProteinA relative measurement (ratio or percentage) of beta-2-fraction proteins to total proteins in a biological specimen.Beta-2 Globulin to Total Protein Ratio Measurement
GLOBBPTC92294Beta Globulin/Total ProteinA relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen.Beta Globulin to Total Protein Ratio Measurement
GLOBGC92257Gamma GlobulinA measurement of the proteins contributing to the gamma fraction in a biological specimen.Gamma Globulin Measurement
GLOBGPTC92295Gamma Globulin/Total ProteinA relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen.Gamma Globulin to Total Protein Ratio Measurement
GLOBULC74738GlobulinA measurement of the globulin protein in a biological specimen.Globulin Protein Measurement
GLP1C80183Glucagon-Like Peptide-1;Total Glucagon-Like Peptide-1A measurement of the total glucagon-like peptide-1 in a biological specimen.Glucagon-like Peptide-1 Measurement
GLP1ACC80164Glucagon-Like Peptide-1, Active FormA measurement of the active form of glucagon-like peptide-1 in a biological specimen.Active Glucagon-like Peptide-1 Measurement
GLUCC105585GlucoseA measurement of the glucose in a biological specimen.Glucose Measurement
GLUCAGONC74859GlucagonA measurement of the glucagon hormone in a biological specimen.Glucagon Measurement
GLUCCLRC96652Glucose ClearanceA measurement of the volume of serum or plasma that would be cleared of glucose by excretion of urine for a specified unit of time (e.g. one minute).Glucose Clearance Measurement
GLUCCRTC79447Glucose/CreatinineA relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen.Glucose to Creatinine Ratio Measurement
GLUCEXRC117834Glucose Excretion RateA measurement of the amount of glucose being excreted in urine over a defined amount of time (e.g. one hour).Glucose Urine Excretion Rate
GLUTAMC74739Glutamate;Glutamic AcidA measurement of the glutamate in a biological specimen.Glutamate Measurement
GLYCRLFRC100448Free Glycerin;Free GlycerolA measurement of the amount of unbound glycerol in a biological specimen.Free Glycerol Measurement
GMCSFC82019Granulocyte Macrophage Colony Stm FactorA measurement of the granulocyte macrophage colony stimulating factor in a biological specimen.Granulocyte Macrophage Colony Stm Factor Measurement
GNRHC74860Gonadotropin Releasing Hormone;Luteinising Hormone Releasing HormoneA measurement of the gonadotropin releasing hormone in a biological specimen.Gonadotropin Releasing Hormone Measurement
GOLDC80186GoldA measurement of the gold in a biological specimen.Gold Measurement
GRANC96654GranulocytesA measurement of the granulocytes in a biological specimen.Granulocyte Count
GRANCEC98866Granulocytes/Total CellsA relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen).Granulocyte to Total Cell Ratio Measurement
GRANIMC96675Immature GranulocytesA measurement of the total immature granulocytes in a biological specimen.Immature Granulocyte Count
GRANIMLEC100445Immature Granulocytes/LeukocytesA relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen).Immature Granulocytes to Leukocytes Ratio Measurement
GRWHIHC74861Growth Hormone Inhibiting Hormone;SomatostatinA measurement of the growth hormone inhibiting hormone in a biological specimen.Growth Hormone Inhibiting Hormone Measurement
GRWHRHC74862Growth Hormone Releasing Hormone;SomatocrininA measurement of the growth hormone releasing hormone in a biological specimen.Growth Hormone Releasing Hormone Measurement
GSTC80185Glutathione S-Transferase, TotalA measurement of the total glutathione-s-transferase in a biological specimen.Glutathione-S-Transferase Measurement
GSTALC79433Alpha Glutathione-S-TransferaseA measurement of the alpha form of glutathione S-transferase in a biological specimen.Alpha Glutathione-S-Transferase Measurement
GSTALCRTC80166Glutathione S-Transferase, Alpha/CreatA relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen.Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement
GSTALEXRC119278Alpha-GST Excretion RateA measurement of the amount of Alpha Glutathione-S-Transferase being excreted in urine over a defined period of time (e.g. one hour).Alpha-GST Excretion Rate
GSTCREATC79435Glutathione-S-Transferase/CreatinineA relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen.Glutathione-S-Transferase to Creatinine Ratio Measurement
GSTMUC79457Mu Glutathione-S-TransferaseA measurement of the mu form of glutathione S-transferase in a biological specimen.Mu Glutathione-S-Transferase Measurement
GSTMUCRTC79458Mu Glutathione-S-Transferase/CreatinineA relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen.Mu Glutathione-S-Transferase to Creatinine Ratio Measurement
GSTPIC80203Glutathione S-Transferase, PiA measurement of the Pi glutathione-s-transferase in a biological specimen.Pi Glutathione S-Transferase Measurement
GSTPIEXRC119279Pi-GST Excretion RateA measurement of the amount of Pi Glutathione-S-Transferase being excreted in urine over a defined period of time (e.g. one hour).Pi-GST Excretion Rate
GSTTHC80207Glutathione S-Transferase, ThetaA measurement of the theta glutathione-s-transferase in a biological specimen.Theta Glutathione S-Transferase Measurement
GUSAC80165Glucuronidase, AlphaA measurement of the alpha glucuronidase in a biological specimen.Alpha Glucuronidase Measurement
GUSBC80170Glucuronidase, BetaA measurement of the beta glucuronidase in a biological specimen.Beta Glucuronidase Measurement
HAABC92534Hepatitis A Virus AntibodyA measurement of the antibody reaction of a biological specimen to the Hepatitis A virus.Hepatitis A Antibody Measurement
HAABIGMC92271Hepatitis A Virus Antibody IgMA measurement of hepatitis A virus antibody IgM in a biological specimen.Hepatitis A Virus Antibody IgM Measurement
HAIRYCEC74604Hairy CellsA measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen.Hairy Cell Count
HALBABC103405Human Albumin AntibodyA measurement of the human albumin antibody in a biological specimen.Human Albumin Antibody Measurement
HAMABC103406HAMAA measurement of the human anti-mouse antibody in a biological specimen.Human Anti-Mouse Antibody Measurement
HAPTOGC74740HaptoglobinA measurement of the haptoglobin protein in a biological specimen.Haptoglobin Protein Measurement
HASIGEABC98740Human Anti-Sheep IgE AntibodyA measurement of the human anti-sheep IgE antibodies in a biological specimen.Human Anti-Sheep IgE Antibody Measurement
HASIGGABC98741Human Anti-Sheep IgG AntibodyA measurement of the human anti-sheep IgG antibodies in a biological specimen.Human Anti-Sheep IgG Antibody Measurement
HASIGMABC98742Human Anti-Sheep IgM AntibodyA measurement of the human anti-sheep IgM antibodies in a biological specimen.Human Anti-Sheep IgM Antibody Measurement
HAVVLDC92541HAV Viral LoadA measurement of the hepatitis A viral load in a biological specimen.Hepatitis A Viral Load Measurement
HBA1CC64849Glycosylated Hemoglobin;Hemoglobin A1CA measurement of the glycosylated hemoglobin in a biological specimen.Glycosylated Hemoglobin Measurement
HBA1CHGBC111207Hemoglobin A1C/HemoglobinA relative measurement (ratio or percentage) of the glycosylated hemoglobin to total hemoglobin in a biological specimen.Hemoglobin A1C to Hemoglobin Ratio Measurement
HBCABC96660Hepatitis B Virus Core AntibodyA measurement of the hepatitis B virus core antibody in a biological specimen.Hepatitis B Virus Core Antibody Measurement
HBCIGGABC119280Hepatitis B Virus Core IgG AntibodyA measurement of the hepatitis B virus core IgG antibody in a biological specimen.Hepatitis B Virus Core IgG Antibody Measurement
HBCIGMABC96661Hepatitis B Virus Core IgM AntibodyA measurement of the hepatitis B virus core IgM antibody in a biological specimen.Hepatitis B Virus Core IgM Antibody Measurement
HBDNAC103404Hepatitis B DNAA measurement of hepatitis B virus DNA in a biological specimen.Hepatitis B DNA Measurement
HBEABC96662Hepatitis B Virus e AntibodyA measurement of the hepatitis B e antibody in a biological specimen.Hepatitis B Virus e Antibody Measurement
HBEAGC96663Hepatitis B Virus e AntigenA measurement of the hepatitis B e antigen in a biological specimen.Hepatitis B Virus e Antigen Measurement
HBSABC74711Anti-HBs;HBsAb;Hepatitis B Virus Surface AntibodyA measurement of the surface antibody reaction of a biological specimen to the Hepatitis B virus.Hepatitis B Surface Antibody Measurement
HBSAGC64850HBsAg;Hepatitis B Virus Surface AntigenA measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.Hepatitis B Virus Surface Antigen Measurement
HBVVLDC92542HBV Viral LoadA measurement of the hepatitis B viral load in a biological specimen.Hepatitis B Viral Load Measurement
HCABC92535Hepatitis C Virus AntibodyA measurement of the antibody reaction of a biological specimen to the Hepatitis C virus.Hepatitis C Antibody Measurement
HCAGC116196Hepatitis C Virus AntigenA measurement of the hepatitis C virus antigen in a biological specimen.Hepatitis C Virus Antigen Measurement
HCGC64851Choriogonadotropin Beta;Pregnancy TestA measurement of the Choriogonadotropin Beta in a biological specimen.Choriogonadotropin Beta Measurement
HCTC64796EVF;Erythrocyte Volume Fraction;Hematocrit;PCV;Packed Cell VolumeThe percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).Hematocrit Measurement
HCVVLDC92543HCV RNA;HCV Viral Load;Hepatitis C RNAA measurement of the hepatitis C viral load in a biological specimen.Hepatitis C Viral Load Measurement
HDABC96664Hepatitis D Virus Antibody;Hepatitis Delta AntibodyA measurement of the hepatitis D virus antibody in a biological specimen.Hepatitis D Virus Antibody Measurement
HDIGGABC119281Hepatitis D Virus IgG AntibodyA measurement of the hepatitis D virus IgG antibody in a biological specimen.Hepatitis D Virus IgG Antibody Measurement
HDIGMABC119282Hepatitis D Virus IgM AntibodyA measurement of the hepatitis D virus IgM antibody in a biological specimen.Hepatitis D Virus IgM Antibody Measurement
HDLC105587HDL CholesterolA measurement of the high density lipoprotein cholesterol in a biological specimen.High Density Lipoprotein Cholesterol Measurement
HDL2C80187HDL-Cholesterol Subclass 2A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen.HDL-Cholesterol Subclass 2 Measurement
HDL3C80188HDL-Cholesterol Subclass 3A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen.HDL-Cholesterol Subclass 3 Measurement
HDLCLDLCC100425HDL Cholesterol/LDL Cholesterol RatioA relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen.HDL Cholesterol to LDL Cholesterol Ratio Measurement
HDLPSZC103402HDL Particle SizeA measurement of the average particle size of high-density lipoprotein in a biological specimen.HDL Particle Size Measurement
HDWC106525Hemoglobin Distribution WidthA measurement of the distribution of the hemoglobin concentration in red blood cells.Hemoglobin Distribution Width Measurement
HEABC119283Hepatitis E Virus AntibodyA measurement of the antibody reaction of a biological specimen to the Hepatitis E virus.Hepatitis E Virus Antibody Measurement
HEIGGABC106526Hepatitis E Virus IgG AntibodyA measurement of IgG antibody to the hepatitis E virus in a biological specimen.Hepatitis E Virus IgG Antibody Measurement
HEIGMABC96665Hepatitis E Virus IgM AntibodyA measurement of the hepatitis E virus IgM antibody in a biological specimen.Hepatitis E Virus IgM Antibody Measurement
HEINZC74709Heinz Bodies;Heinz-Erhlich BodiesA measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen.Heinz-Ehrlich Body Measurement
HEINZRBCC111206Heinz Bodies/ErythrocytesA relative measurement (ratio or percentage) of the erythrocytes that contain heinz bodies to total erythrocytes in a biological specimen.Heinz Body to Erythrocyte Ratio Measurement
HELMETCEC74658Helmet CellsA measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen.Helmet Cell Count
HEMOLYSIC111208Hemolysis;Hemolytic IndexA measurement of the destruction of red blood cells in a biological specimen.Hemolytic Index
HER2C112312ERBB2;HER2/NEU;Human Epidermal Growth Factor Receptor 2A measurement of the cells with positive expression of HER2 in a biological specimen.Human Epidermal Growth Factor Receptor 2 Measurement
HER2AGC112291HER2 Antigen;HER2/NEU AntigenA measurement of the HER2 antigen in a biological specimen.HER2 Antigen Measurement
HETRPHC116186HeterophilsA measurement of heterophils (granular leukocytes) in a biological specimen from avian species.Heterophil Measurement
HETRPHLEC116187Heterophils/LeukocytesA relative measurement (ratio or percentage) of heterophils to leukocytes in a biological specimen from avian species.Heterophils to Leukocytes Ratio Measurement
HEXKC96668HexokinaseA measurement of the hexokinase in a biological specimen.Hexokinase Measurement
HGBC64848FHGB;Free Hemoglobin;HemoglobinA measurement of the non-cellular hemoglobin in a biological specimen.Hemoglobin Measurement
HGBAC92258Hemoglobin AA measurement of the hemoglobin A in a biological specimen.Hemoglobin A Measurement
HGBA2C92259Hemoglobin A2A measurement of the hemoglobin A2 in a biological specimen.Hemoglobin A2 Measurement
HGBBC92260Hemoglobin BA measurement of the hemoglobin B in a biological specimen.Hemoglobin B Measurement
HGBCC92261Hemoglobin CA measurement of the hemoglobin C in a biological specimen.Hemoglobin C Measurement
HGBFC92262Fetal Hemoglobin;Hemoglobin FA measurement of the hemoglobin F in a biological specimen.Hemoglobin F Measurement
HGBMETC96689MethemoglobinA measurement of the methemoglobin in a biological specimen.Methemoglobin Measurement
HGBOXYC96616OxyhemoglobinA measurement of the oxyhemoglobin, oxygen-bound hemoglobin, in a biological specimen.Oxyhemoglobin Measurement
HGRNAC92272Hepatitis G RNAA measurement of the Hepatitis G RNA in a biological specimen.Hepatitis G RNA Measurement
HIST1ABC112293Histone 1 AntibodyA measurement of the total histone 1 antibodies in a biological specimen.Histone 1 Antibody Measurement
HIST2AABC112294Histone 2A AntibodyA measurement of the total histone 2A antibodies in a biological specimen.Histone 2A Antibody Measurement
HIST2BABC112295Histone 2B AntibodyA measurement of the total histone 2B antibodies in a biological specimen.Histone 2B Antibody Measurement
HIST3ABC112296Histone 3 AntibodyA measurement of the total histone 3 antibodies in a biological specimen.Histone 3 Antibody Measurement
HIST4ABC112297Histone 4 AntibodyA measurement of the total histone 4 antibodies in a biological specimen.Histone 4 Antibody Measurement
HISTABC111209Anti-Histone Antibodies;Histone AntibodiesA measurement of histone antibodies in a biological specimen.Histone Antibody Measurement
HISTAMINC80189HistamineA measurement of the histamine in a biological specimen.Histamine Measurement
HIV124AGC92265HIV-1 p24 AntigenA measurement of the HIV-1 p24 antigen in a biological specimen.HIV-1 p24 Antigen Measurement
HIV12ABC74714HIV-1/2 AntibodyA measurement of the antibody reaction of a biological specimen to the either the HIV-1 or HIV-2 virus.HIV-1 HIV-2 Antibody Measurement
HIV1ABC74713HIV-1 AntibodyA measurement of the antibody reaction of a biological specimen to the HIV-1 virus.HIV-1 Antibody Measurement
HIV1MONAC92263HIV-1 Group M and O Nucleic AcidA measurement of the HIV-1 group M and O nucleic acids in a biological specimen.HIV-1 Group M and O Nucleic Acid Measurement
HIV1OABC92264HIV-1 Group O AntibodyA measurement of the HIV-1 group O antibody in a biological specimen.HIV-1 Group O Antibody Measurement
HIV2ABC74715HIV-2 AntibodyA measurement of the antibody reaction of a biological specimen to the HIV-2 virus.HIV-2 Antibody Measurement
HIV2NUACC92266HIV-2 Nucleic AcidA measurement of the HIV-2 nucleic acids in a biological specimen.HIV-2 Nucleic Acid Measurement
HIVABC106527HIV AntibodyA measurement of the antibody reaction of a biological specimen to the HIV virus.HIV Antibody Measurement
HIVVLDC92544HIV Viral LoadA measurement of the HIV viral load in a biological specimen.HIV Viral Load Measurement
HLAB27AGC100460HLA-B27 Antigen;Human Leukocyte Antigen B27A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen.HLA-B27 Antigen Measurement
HMOSIDRNC96659HemosiderinA measurement of the hemosiderin complex in a biological specimen.Hemosiderin Measurement
HOMAIRC100447Homeostatic Model Assessment of Insulin Resistance;Homostat Model Assess of Insulin RstnAn assessment of beta-cell function and insulin resistance based on fasting blood glucose and insulin concentrations.Homeostatic Model Assessment of Insulin Resistance
HOMOCYC74741HomocysteineA measurement of the homocysteine amino acid in a biological specimen.Homocysteine Acid Measurement
HOWJOLC74704Howell-Jolly BodiesA measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen.Howell-Jolly Body Measurement
HPLIGGABC103403Helicobacter pylori IgG AntibodyA measurement of the Helicobacter pylori IgG antibody in a biological specimen.Helicobacter pylori IgG Antibody Measurement
HPOCROMC64802HypochromiaAn observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.Hypochromia
HRYCELYC74640Hairy Cells/LymphocytesA relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen .Hairy Cell to Lymphocyte Ratio Measurement
HS12GGABC96697HSV-1/2 IgG Ab;Herpes Simplex Virus 1/2 IgG AntibodyA measurement of the herpes simplex virus 1 and 2 IgG antibody in a biological specimen.Herpes Simplex Virus 1/2 IgG Antibody Measurement
HS12GMABC96698HSV-1/2 IgM Ab;Herpes Simplex Virus 1/2 IgM AntibodyA measurement of the herpes simplex virus 1 and 2 IgM antibody in a biological specimen.Herpes Simplex Virus 1/2 IgM Antibody Measurement
HS1IGGABC96666HSV-1 IgG Antibody;Herpes Simplex Virus 1 IgG AntibodyA measurement of the herpes simplex virus 1 IgG antibody in a biological specimen.Herpes Simplex Virus 1 IgG Antibody Measurement
HS1IGMABC98738Herpes Simplex Virus 1 IgM AntibodyA measurement of the Herpes Simplex virus 1 IgM antibodies in a biological specimen.Herpes Simplex Virus 1 IgM Antibody Measurement
HS2IGGABC96667HSV-2 IgG Antibody;Herpes Simplex Virus 2 IgG AntibodyA measurement of the herpes simplex virus 2 IgG antibody in a biological specimen.Herpes Simplex Virus 2 IgG Antibody Measurement
HS2IGMABC98739Herpes Simplex Virus 2 IgM AntibodyA measurement of the Herpes Simplex virus 2 IgM antibodies in a biological specimen.Herpes Simplex Virus 2 IgM Antibody Measurement
HS6ABC112292Herpes Simplex Virus 6 AntibodyA measurement of the herpes simplex virus 6 antibody in a biological specimen.Herpes Simplex Virus 6 Antibody Measurement
HTPHABC81984Heterophile AntibodiesA measurement of the heterophile antibodies in a biological specimen.Heterophile Antibody Measurement
HVAC74863Homovanillic AcidA measurement of the homovanillic acid metabolite in a biological specimen.Homovanillic Acid Measurement
HYALUACC112319Hyaluronic AcidA measurement of hyaluronic acid in a biological specimen.Hyaluronic Acid Measurement
HYDCDNC74879HydrocodoneA measurement of the hydrocodone present in a biological specimen.Hydrocodone Measurement
HYDMRPHNC74880HydromorphoneA measurement of the hydromorphone present in a biological specimen.Hydromorphone Measurement
HYDROGENC102275HydrogenA measurement of the hydrogen in a biological specimen.Hydrogen Measurement
HYPERCHRC96669HyperchromiaA measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration.Hyperchromia Measurement
HYPRLNC80190HydroxyprolineA measurement of the total hydroxyproline in a biological specimen.Hydroxyproline Measurement
HYPSEGCEC74612Hypersegmented CellsA measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen.Hypersegmented Neutrophil Measurement
IA2ABC119284Insulinoma-Associated Protein 2 AntibodyA measurement of the insulinoma-associated protein 2 antibody in a biological specimen.Insulinoma-Associated Protein 2 Antibody Measurement
IAA5OHC1122175-Hydroxyindoleacetic AcidA measurement of 5-hydroxyindoleacetic acid in a biological specimen.5-Hydroxyindoleacetic Acid Measurement
IAH1N1VLC92273Influenza A H1N1 Viral LoadA measurement of the Influenza A H1N1 viral load in a biological specimen.Influenza A H1N1 Viral Load Measurement
IAIGGABC103408Influenza A IgG AntibodyA measurement of the Influenza A IgG antibody in a biological specimen.Influenza A IgG Antibody Measurement
IBCTC74718Total Iron Binding CapacityA measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen.Total Iron Binding Capacity
IBCUC74719Unsaturated Iron Binding CapacityA measurement of the binding capacity of unsaturated iron in a biological specimen.Unsaturated Iron Binding Capacity Measurement
IBIGGABC103409Influenza B IgG AntibodyA measurement of the Influenza B IgG antibody in a biological specimen.Influenza B IgG Antibody Measurement
IC512ABC81985Islet Cell 512 AntibodyA measurement of the islet cell 512 antibody in a biological specimen.Islet Cell 512 Antibody Measurement
IC512AGC81986Islet Cell 512 AntigenA measurement of the islet cell 512 antigen in a biological specimen.Islet Cell 512 Antigen Measurement
ICTERUSIC111232Icteric Index;IcterusA measurement of the yellow color of a biological specimen, due to the presence of bile pigments.Icteric Index
IDLC112325IDL Cholesterol;Intermediate Density LipoproteinA measurement of the intermediate density lipoprotein in a biological specimen.Intermediate Density Lipoprotein Cholesterol Measurement
IDLPC116197IDL Particles;Intermediate Density Lipoproteins ParticlesA measurement of the concentration of IDL particles in a biological specimen.IDL Particles Measurement
IFNAC81994Interferon AlphaA measurement of the interferon alpha in a biological specimen.Interferon Alpha Measurement
IFNBC81995Interferon BetaA measurement of the interferon beta in a biological specimen.Interferon Beta Measurement
IFNGC81996Interferon GammaA measurement of the interferon gamma in a biological specimen.Interferon Gamma Measurement
IGAC81969Immunoglobulin AA measurement of the Immunoglobulin A in a biological specimen.Immunoglobulin A Measurement
IGAGMC111233IgG IgM IgA TotalA measurement of the total IgG, IgM, and IgA in a biological specimen.IgG IgM IgA Total Measurement
IGDC98745Immunoglobulin DA measurement of the Immunoglobulin D in a biological specimen.Immunoglobulin D Measurement
IGEC81970Immunoglobulin EA measurement of the Immunoglobulin E in a biological specimen.Immunoglobulin E Measurement
IGF1C74864Insulin-like Growth Factor-1A measurement of the insulin-like growth factor-1 in a biological specimen.Insulin Like Growth Factor-1 Measurement
IGF2C74865Insulin-like Growth Factor-2A measurement of the insulin-like growth factor-2 in a biological specimen.Insulin Like Growth Factor-2 Measurement
IGFBP3C112322Insulin-Like Growth Factor Binding Prot3;Insulin-Like Growth Factor Binding Protein 3A measurement of the insulin-like growth factor binding protein 3 in a biological specimen.Insulin-Like Growth Factor Binding Protein 3 Measurement
IGGC81971Immunoglobulin GA measurement of the Immunoglobulin G in a biological specimen.Immunoglobulin G Measurement
IGGCREATC119285Immunoglobulin G/CreatinineA relative measurement (ratio or percentage) of the immunoglobulin G to creatinine in a biological specimen.Immunoglobulin G to Creatinine Ratio Measurement
IGMC81972Immunoglobulin MA measurement of the Immunoglobulin M in a biological specimen.Immunoglobulin M Measurement
IGSOLC117835Soluble ImmunoglobulinA measurement of the soluble total immunoglobulin in a biological specimen.Soluble Immunoglobulin Measurement
IL1SR1C117836Soluble Interleukin-1 Receptor Type IA measurement of the soluble interleukin-1 receptor type I in a biological specimen.Soluble Interleukin-1 Receptor Type I Measurement
IL2SRAC102280Soluble Interleukin 2 Receptor ActivityA measurement of the soluble interleukin 2 receptor activity in a biological specimen.Soluble Interleukin 2 Receptor Activity Measurement
IL6SRC117837Soluble Interleukin 6 ReceptorA measurement of the soluble interleukin 6 receptor in a biological specimen.Soluble Interleukin 6 Receptor Measurement
ILEC103410IsoleucineA measurement of the isoleucine in a biological specimen.Isoleucine Measurement
INCLBODC116184Inclusion BodiesA measurement of the inclusion bodies in a biological specimen.Inclusion Body Measurement
INDICANC82044IndicanA measurement of the indican present in a biological specimen.Indican Measurement
INFAVLDC92274Influenza A Viral LoadA measurement of the Influenza A viral load in a biological specimen.Influenza A Viral Load Measurement
INGAPABC81987Islet Neogenesis Assoc Protein AntibodyA measurement of the islet neogenesis associated protein antibody in a biological specimen.Islet Neogenesis Associated Protein Antibody Measurement
INHIBINAC82020Inhibin AA measurement of the inhibin A in a biological specimen.Inhibin A Measurement
INHIBINBC96681Inhibin BA measurement of the inhibin B in a biological specimen.Inhibin B Measurement
INLCLRC98748Inulin ClearanceA measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute).Inulin Clearance
INRC64805Prothrombin Intl. Normalized RatioA ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.International Normalized Ratio of Prothrombin Time
INSAABC119286Insulin AutoantibodyA measurement of the antibody to endogenous insulin in a biological specimen.Insulin Autoantibody Measurement
INSABC119287Insulin AntibodyA measurement of the antibody to therapeutic insulin in a biological specimen.Insulin Antibody Measurement
INSULINC74788InsulinA measurement of the insulin in a biological specimen.Insulin Measurement
INTLK1C74805Interleukin 1A measurement of the interleukin 1 in a biological specimen.Interleukin 1 Measurement
INTLK10C74806Interleukin 10A measurement of the interleukin 10 in a biological specimen.Interleukin 10 Measurement
INTLK11C74807Interleukin 11A measurement of the interleukin 11 in a biological specimen.Interleukin 11 Measurement
INTLK12C74808Interleukin 12A measurement of the interleukin 12 in a biological specimen.Interleukin 12 Measurement
INTLK13C74809Interleukin 13A measurement of the interleukin 13 in a biological specimen.Interleukin 13 Measurement
INTLK14C74810Interleukin 14A measurement of the interleukin 14 in a biological specimen.Interleukin 14 Measurement
INTLK15C74811Interleukin 15A measurement of the interleukin 15 in a biological specimen.Interleukin 15 Measurement
INTLK16C74812Interleukin 16A measurement of the interleukin 16 in a biological specimen.Interleukin 16 Measurement
INTLK17C74813Interleukin 17A measurement of the interleukin 17 in a biological specimen.Interleukin 17 Measurement
INTLK18C74814Interleukin 18A measurement of the interleukin 18 in a biological specimen.Interleukin 18 Measurement
INTLK19C74815Interleukin 19A measurement of the interleukin 19 in a biological specimen.Interleukin 19 Measurement
INTLK1BC112323IL-1B;IL1Beta;Interleukin 1 Beta;Interleukin 1BA measurement of interleukin 1 beta in a biological specimen.Interleukin 1 Beta Measurement
INTLK1RAC112324IL-1RA;Interleukin 1 Receptor AntagonistA measurement of the interleukin 1 receptor antagonist in a biological specimen.Interleukin 1 Receptor Antagonist Measurement
INTLK2C74816Interleukin 2A measurement of the interleukin 2 in a biological specimen.Interleukin 2 Measurement
INTLK20C74817Interleukin 20A measurement of the interleukin 20 in a biological specimen.Interleukin 20 Measurement
INTLK21C74818Interleukin 21A measurement of the interleukin 21 in a biological specimen.Interleukin 21 Measurement
INTLK22C74819Interleukin 22A measurement of the interleukin 22 in a biological specimen.Interleukin 22 Measurement
INTLK23C74820Interleukin 23A measurement of the interleukin 23 in a biological specimen.Interleukin 23 Measurement
INTLK24C74821Interleukin 24A measurement of the interleukin 24 in a biological specimen.Interleukin 24 Measurement
INTLK25C74822Interleukin 25A measurement of the interleukin 25 in a biological specimen.Interleukin 25 Measurement
INTLK26C74823Interleukin 26A measurement of the interleukin 26 in a biological specimen.Interleukin 26 Measurement
INTLK27C74824Interleukin 27A measurement of the interleukin 27 in a biological specimen.Interleukin 27 Measurement
INTLK28C74825Interleukin 28A measurement of the interleukin 28 in a biological specimen.Interleukin 28 Measurement
INTLK29C74826Interleukin 29A measurement of the interleukin 29 in a biological specimen.Interleukin 29 Measurement
INTLK3C74827Interleukin 3A measurement of the interleukin 3 in a biological specimen.Interleukin 3 Measurement
INTLK30C74828Interleukin 30A measurement of the interleukin 30 in a biological specimen.Interleukin 30 Measurement
INTLK31C74829Interleukin 31A measurement of the interleukin 31 in a biological specimen.Interleukin 31 Measurement
INTLK32C74830Interleukin 32A measurement of the interleukin 32 in a biological specimen.Interleukin 32 Measurement
INTLK33C74831Interleukin 33A measurement of the interleukin 33 in a biological specimen.Interleukin 33 Measurement
INTLK4C74832Interleukin 4A measurement of the interleukin 4 in a biological specimen.Interleukin 4 Measurement
INTLK5C74833Interleukin 5A measurement of the interleukin 5 in a biological specimen.Interleukin 5 Measurement
INTLK6C74834Interleukin 6A measurement of the interleukin 6 in a biological specimen.Interleukin 6 Measurement
INTLK7C74835Interleukin 7A measurement of the interleukin 7 in a biological specimen.Interleukin 7 Measurement
INTLK8C74836Interleukin 8A measurement of the interleukin 8 in a biological specimen.Interleukin 8 Measurement
INTLK9C74837Interleukin 9A measurement of the interleukin 9 in a biological specimen.Interleukin 9 Measurement
IOHEXCLRC100439Iohexol ClearanceA measurement of the volume of serum or plasma that would be cleared of Iohexol through excretion for a specified unit of time.Iohexol Clearance
IOTCLRC98749Iothalamate ClearanceA measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute).Iothalamate Clearance
IOTCLRBSC98750Iothalamate Clearance Adjusted for BSAA measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body size.Iothalamate Clearance Adjusted for BSA
IRFC102276Immature Reticulocyte FractionA measurement of the immature reticulocyte fraction present in a biological specimen.Immature Reticulocyte Fraction Measurement
IRONC74679FE;IronA measurement of the iron in a biological specimen.Iron Measurement
IRONEXRC117838Iron Excretion RateA measurement of the amount of iron being excreted in urine over a defined amount of time (e.g. one hour).Iron Urine Excretion Rate
ISOPRF2C80180F2-IsoprostaneA measurement of the F2-isoprostane in a biological specimen.F2 Isoprostane Measurement
JCVABC112326JC Polyomavirus Antibody;JC Virus Antibody;JCV Antibody;John Cunningham Virus AntibodyA measurement of the JC virus antibody in a biological specimen.JC Virus Antibody Measurement
JO1ABC100459Jo-1 AntibodyA measurement of the Jo-1 antibody in a biological specimen.Jo-1 Antibody Measurement
KC64853PotassiumA measurement of the potassium in a biological specimen.Potassium Measurement
KCLRC106560Potassium ClearanceA measurement of the volume of serum or plasma that would be cleared of potassium by excretion of urine for a specified unit of time (e.g. one minute).Potassium Clearance Measurement
KCREATC79462Potassium/CreatinineA relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen.Potassium to Creatinine Ratio Measurement
KETONEBDC111239Ketone BodiesA measurement of the ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) in a biological specimen.Ketone Body Measurement
KETONESC64854KetonesA measurement of the ketones in a biological specimen.Ketone Measurement
KEXRC117839Potassium Excretion RateA measurement of the amount of potassium being excreted in urine over a defined amount of time (e.g. one hour).Potassium Urine Excretion Rate
KIM1C100433Hepatitis A Virus Cellular Receptor 1;KIM-1;Kidney Injury Molecule-1A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen.Kidney Injury Molecule-1 Measurement
KLCFRC98730Kappa Light Chain, FreeA measurement of the free kappa light chain in a biological specimen.Free Kappa Light Chain Measurement
KLCLLCFRC98731Kappa Lt Chain,Free/Lambda Lt Chain,FreeA relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen.Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement
KRCYMGC96688MegakaryocytesA measurement of the megakaryocytes per unit of a biological specimen.Megakaryocyte Count
KRCYMGCEC98867Megakaryocytes/Total CellsA relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen).Megakaryocyte to Total Cell Ratio Measurement
KURLOFCEC96682Kurloff CellsA measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family.Kurloff Cells Measurement
LACTICACC794502-hydroxypropanoic acid;Lactate;Lactic AcidA measurement of the lactic acid in a biological specimen.Lactic Acid Measurement
LCN2C106539Lipocalin-2A measurement of lipocalin-2 in a biological specimen.Lipocalin-2 Measurement
LCN2CREAC106540Lipocalin-2/CreatinineA relative measurement (ratio or percentage) of the lipocalin-2 to creatinine present in a sample.Lipocalin-2 to Creatinine Ratio Measurement
LDHC64855Lactate DehydrogenaseA measurement of the lactate dehydrogenase in a biological specimen.Lactate Dehydrogenase Measurement
LDH1C74887LDH Isoenzyme 1A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen.Lactate Dehydrogenase Isoenzyme 1 Measurement
LDH1LDHC79451LDH Isoenzyme 1/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 1 to LDH Ratio Measurement
LDH2C74888LDH Isoenzyme 2A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen.Lactate Dehydrogenase Isoenzyme 2 Measurement
LDH2LDHC79452LDH Isoenzyme 2/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 2 to LDH Ratio Measurement
LDH3C74889LDH Isoenzyme 3A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen.Lactate Dehydrogenase Isoenzyme 3 Measurement
LDH3LDHC79453LDH Isoenzyme 3/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 3 to LDH Ratio Measurement
LDH4C74890LDH Isoenzyme 4A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen.Lactate Dehydrogenase Isoenzyme 4 Measurement
LDH4LDHC79454LDH Isoenzyme 4/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 4 to LDH Ratio Measurement
LDH5C74891LDH Isoenzyme 5A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen.Lactate Dehydrogenase Isoenzyme 5 Measurement
LDH5LDHC79455LDH Isoenzyme 5/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 5 to LDH Ratio Measurement
LDHCREATC79449Lactate Dehydrogenase/CreatinineA relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen.Lactate Dehydrogenase to Creatinine Ratio Measurement
LDLC105588LDL CholesterolA measurement of the low density lipoprotein cholesterol in a biological specimen.Low Density Lipoprotein Cholesterol Measurement
LDLOXABC119288Oxidized LDL Cholesterol AntibodyA measurement of the total oxidized low density lipoprotein cholesterol antibody in a biological specimen.Oxidized LDL Cholesterol Antibody Measurement
LDLPSZC103412LDL Particle SizeA measurement of the average particle size of low-density lipoprotein in a biological specimen.LDL Particle Size Measurement
LEPTINC74866LeptinA measurement of the leptin hormone in a biological specimen.Leptin Measurement
LEUKASEC64856Leukocyte EsteraseA measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.Leukocyte Esterase Measurement
LEUKCEC116195Leukemic Cells;Residual Leukemic CellsA measurement of the leukemic cells in a biological specimen.Leukemic Cells Measurement
LGLUCLEC79467Large Unstained Cells/LeukocytesA relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen.Large Unstained Cells to Leukocytes Ratio Measurement
LGUNSCEC74659Large Unstained CellsA measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen.Large Unstained Cell Count
LHC74790Luteinizing HormoneA measurement of the luteinizing hormone in a biological specimen.Luteinizing Hormone Measurement
LIPASEGC117840Gastric Triacylglycerol Lipase;LIPF;Lipase, GastricA measurement of the gastric triacylglycerol lipase in a biological specimen.Gastric Lipase Measurement
LIPASEPC117841Lipase, Pancreatic;PNLIP;Pancreatic Triacylglycerol LipaseA measurement of the pancreatic triacylglycerol lipase in a biological specimen.Pancreatic Lipase Measurement
LIPASETC117748Lipase;Total LipaseA measurement of the total lipase in a biological specimen.Lipase Measurement
LIPASLALC117842Acid Cholesteryl Ester Hydrolase;LAL;LIPA;Lipase, Lysosomal Acid;Lysosomal LipaseA measurement of the lysosomal acid lipase in a biological specimen.Lysosomal Acid Lipase Measurement
LIPEMIAIC111242Lipemia;Lipemic IndexA measurement of the abnormally high concentration of lipid in a biological specimen.Lipemic Index
LKM1ABC96683LKM-1;Liver Kidney Microsomal Type 1 AntibodyA measurement of the liver kidney microsomal type 1 antibody in a biological specimen.Liver Kidney Microsomal Type 1 Antibody Measurement
LKM1IAABC100456Liver Kidney Microsomal Type 1 IgA AbA measurement of the liver kidney microsomal type 1 IgA antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgA Antibody Measurement
LKM1IGABC100454Liver Kidney Microsomal Type 1 IgG AbA measurement of the liver kidney microsomal type 1 IgG antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgG Antibody Measurement
LKM1IMABC100455Liver Kidney Microsomal Type 1 IgM AbA measurement of the liver kidney microsomal type 1 IgM antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgM Antibody Measurement
LLCFRC98732Lambda Light Chain, FreeA measurement of the free lambda light chain in a biological specimen.Free Lambda Light Chain Measurement
LPAC82022Lipoprotein-aA measurement of the lipoprotein-a in a biological specimen.Lipoprotein a Measurement
LPNAGC92275Legionella pneumophila AntigenA measurement of the Legionella pneumophila antigen in a biological specimen.Legionella pneumophila Antigen Measurement
LPNGMABC92277Legionella pneumophila IgG IgM AntibodyA measurement of the Legionella pneumophila IgG and IgM in a biological specimen.Legionella pneumophila IgG IgM Antibody Measurement
LPNIGGABC92276Legionella pneumophila IgG AntibodyA measurement of the Legionella pneumophila IgG antibody in a biological specimen.Legionella pneumophila IgG Antibody Measurement
LPNIGMABC92278Legionella pneumophila IgM AntibodyA measurement of the Legionella pneumophila IgM antibody in a biological specimen.Legionella pneumophila IgM Antibody Measurement
LSDC75354Acid;Lysergic Acid DiethylamideA measurement of the lysergic acid diethylamine (LSD) in a biological specimen.Lysergide Measurement
LTB4C103413Leukotriene B4A measurement of the leukotriene B4 in a biological specimen.Leukotriene B4 Measurement
LTD4C103414Leukotriene D4A measurement of the leukotriene D4 in a biological specimen.Leukotriene D4 Measurement
LTE4C103415Leukotriene E4A measurement of the leukotriene E4 in a biological specimen.Leukotriene E4 Measurement
LTFC82021Lactoferrin;LactotransferrinA measurement of the lactoferrin in a biological specimen.Lactoferrin Measurement
LYMC51949LymphocytesA measurement of the lymphocytes in a biological specimen.Lymphocyte Count
LYMAC119289Lymphocytes ActivatedA measurement of the total activated lymphocytes in a biological specimen.Activated Lymphocytes Measurement
LYMATC64818Lymphocytes AtypicalA measurement of the atypical lymphocytes in a biological specimen.Atypical Lymphocyte Count
LYMATLEC64819Lymphocytes Atypical/LeukocytesA relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.Atypical Lymphocyte to Leukocyte Ratio
LYMCEC98751Lymphocytes/Total CellsA relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen).Lymphocyte to Total Cell Ratio Measurement
LYMIMC100444Immature LymphocytesA measurement of the immature lymphocytes in a biological specimen.Immature Lymphocytes Measurement
LYMIMLEC100443Immature Lymphocytes/LeukocytesA relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen.Immature Lymphocytes to Leukocytes Ratio Measurement
LYMLEC64820Lymphocytes/LeukocytesA relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.Lymphocyte to Leukocyte Ratio
LYMMCEC74613Lymphoma CellsA measurement of the malignant lymphocytes in a biological specimen.Lymphoma Cell Count
LYMMCELYC74910Lymphoma Cells/LymphocytesA relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen.Lymphoma Cell to Lymphocyte Ratio Measurement
LYMPHOTCC81955Chemokine Ligand 1;LymphotactinA measurement of the lymphotactin in a biological specimen.Lymphotactin Measurement
LYMPLC74618Plasmacytoid Lymphocytes;PlymphocytesA measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen.Plasmacytoid Lymphocyte Count
LYMPLLYC74648Plasmacytoid Lymphocytes/LymphocytesA relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen.Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement
LYMRCTC74629Reactive LymphocytesA measurement of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) in a biological specimen.Reactive Lymphocyte Count Measurement
LYMRCTLYC74654Reactive Lymphocytes/LymphocytesA relative measurement (ratio or percentage) of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) to all lymphocytes in a biological specimen.Reactive Lymphocyte to Lymphocyte Ratio Measurement
LYMVACC111329Vacuolated LymphocytesA measurement of the vacuolated lymphocytes in a biological specimen.Vacuolated Lymphocyte Count
MACROCYC64821MacrocytesA measurement of the macrocytes in a biological specimen.Macrocyte Count
MASTCEC111246Mast Cells;MastocytesA measurement of the mast cells in a biological specimen.Mast Cell Count
MASTCECEC111247Mast Cells/Total CellsA relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen.Mast Cell to Total Cell Ratio Measurement
MAYHEGC74614May-Hegglin AnomalyA measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes.May-Hegglin Anomaly Measurement
MCHC64797Ery. Mean Corpuscular HemoglobinA quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.Erythrocyte Mean Corpuscular Hemoglobin
MCHCC64798Ery. Mean Corpuscular HGB ConcentrationA quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.Erythrocyte Mean Corpuscular Hemoglobin Concentration
MCP1C82025Monocyte Chemotactic Protein 1A measurement of the monocyte chemotactic protein 1 in a biological specimen.Monocyte Chemotactic Protein 1 Measurement
MCPHGC74798MacrophagesA measurement of the macrophages in a biological specimen.Macrophage Count
MCPHGCEC111244Macrophages/Total CellsA relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen.Macrophage to Total Cell Ratio Measurement
MCPROTC92291Monoclonal Immunoglobulin Protein;ParaproteinA measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen.Monoclonal Protein Measurement
MCSFC80191Macrophage Colony Stimulating FactorA measurement of the macrophage colony stimulating factor in a biological specimen.Macrophage Colony Stimulating Factor Measurement
MCVC64799Ery. Mean Corpuscular Volume;Erythrocytes Mean Corpuscular Volume;RBC Mean Corpuscular VolumeA quantitative measurement of the mean volume of erythrocytes in a biological specimen.Erythrocyte Mean Corpuscular Volume
MCVRETICC114215MCV Reticulocytes;Mean Corpuscular Volume ReticulocytesA measurement of the mean volume of reticulocytes in a biological specimen.Reticulocyte Mean Corpuscular Volume
MDCC81956Chemokine Ligand 22;Macrophage-Derived ChemokineA measurement of the macrophage-derived chemokine in a biological specimen.Macrophage-Derived Chemokine Measurement
MDMAC753593,4-methylenedioxymethamphetamine;EcstasyA measurement of the 3,4-methylenedioxymethamphetamine (MDMA) in a biological specimen.3,4-Methylenedioxymethamphetamine Measurement
MENGLC111250Meningeal CellsA measurement of the mengingeal cells in a biological specimen.Meningeal Cell Count
MENGLCEC111251Meningeal Cells/Total CellsA relative measurement (ratio or percentage) of the meningeal cells to total cells in a biological specimen.Meningeal Cell to Total Cell Ratio Measurement
METAMYC74615MetamyelocytesA measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen.Metamyelocyte Count
METAMYCEC98754Metamyelocytes/Total CellsA relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen).Metamyelocyte to Total Cell Ratio Measurement
METAMYLEC74645Metamyelocytes/LeukocytesA relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen.Metamyelocyte to Leukocyte Ratio Measurement
METANEPHC116198Metadrenaline;MetanephrineA measurement of the metanephrine in a biological specimen.Metanephrine Measurement
METHAMPHC75348MethamphetamineA measurement of the methamphetamine drug present in a biological specimen.Methamphetamine Measurement
METHDNC74881MethadoneA measurement of the methadone present in a biological specimen.Methadone Measurement
METHQLDNC74882MethaqualoneA measurement of the methaqualone present in a biological specimen.Methaqualone Measurement
MFILARIAC117843MicrofilariaPresence of microfilaria stage of filarial nematodes in smears prepared from whole blood or other body fluids.Microfilaria Measurement
MGC64840MagnesiumA measurement of the magnesium in a biological specimen.Magnesium Measurement
MGBC79436MyoglobinA measurement of myoglobin in a biological specimen.Myoglobin Measurement
MGBCREATC106546Myoglobin/CreatinineA relative measurement (ratio or percentage) of the myoglobin to creatinine present in a sample.Myoglobin to Creatinine Ratio Measurement
MGCREATC79456Magnesium/CreatinineA relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen.Magnesium to Creatinine Ratio Measurement
MICROCYC64822MicrocytesA measurement of the microcytes in a biological specimen.Microcyte Count
MIDCEFC116199Mid Cell Fraction;Mid CellsA measurement of the mid cell fraction, including eosinophils, basophils, monocytes and other precursor white blood cells, in a biological specimen.Mid Cell Fraction Measurement
MIP1AC82023Chemokine Ligand 3;Macrophage Inflammatory Protein 1 AlphaA measurement of the macrophage inflammatory protein 1 alpha in a biological specimen.Macrophage Inflammatory Protein 1 Alpha Measurement
MIP1BC82024Chemokine Ligand 4;Macrophage Inflammatory Protein 1 BetaA measurement of the macrophage inflammatory protein 1 beta in a biological specimen.Macrophage Inflammatory Protein 1 Beta Measurement
MLATONINC74867MelatoninA measurement of the melatonin hormone in a biological specimen.Melatonin Measurement
MLIGCEC74660Malignant Cells, NOSA measurement of the malignant cells of all types in a biological specimen.Malignant Cell Count
MLIGCEBCC74643Malignant Cells, NOS/Blood CellsA relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen.Malignant Cell to Blood Cell Ratio Measurement
MLRC16790Mixed Leukocyte Reaction;Mixed Lymphocyte ReactionA measurement of the histocompatibility at the HL-A locus between two populations of lymphocytes taken from two separate individuals.Mixed Lymphocyte Reaction Test
MMAC96690Methylmalonic AcidA measurement of the methylmalonic acid in a biological specimen.Methylmalonic Acid Measurement
MMP1C80192Interstitial Collagenase;Matrix Metalloproteinase 1A measurement of the matrix metalloproteinase 1 in a biological specimen.Matrix Metalloproteinase 1 Measurement
MMP2C80193Gelatinase A;Matrix Metalloproteinase 2A measurement of the matrix metalloproteinase 2 in a biological specimen.Matrix Metalloproteinase 2 Measurement
MMP3C80194Matrix Metalloproteinase 3;Stromelysin 1A measurement of the matrix metalloproteinase 3 in a biological specimen.Matrix Metalloproteinase 3 Measurement
MMP7C80195Matrilysin;Matrix Metalloproteinase 7A measurement of the matrix metalloproteinase 7 in a biological specimen.Matrix Metalloproteinase 7 Measurement
MMP8C80196Matrix Metalloproteinase 8;Neutrophil CollagenaseA measurement of the matrix metalloproteinase 8 in a biological specimen.Matrix Metalloproteinase 8 Measurement
MMP9C80197Gelatinase B;Matrix Metalloproteinase 9A measurement of the matrix metalloproteinase 9 in a biological specimen.Matrix Metalloproteinase 9 Measurement
MOCYCEC111276Monocytoid CellsA measurement of the monocytoid cells in a biological specimen.Monocytoid Cell Count
MOCYCECEC111277Monocytoid Cells/Total CellsA relative measurement (ratio or percentage) of the monocytoid cells to total cells in a biological specimen.Monocytoid Cell to Total Cell Ratio Measurement
MONOC64823MonocytesA measurement of the monocytes in a biological specimen.Monocyte Count
MONOBLC74631MonoblastsA measurement of the monoblast cells in a biological specimen.Monoblast Count
MONOBLLEC74646Monoblasts/LeukocytesA relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen.Monoblast to Leukocyte Ratio Measurement
MONOCEC98872Monocytes/Total CellsA relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen).Monocytes to Total Cell Ratio Measurement
MONOIMC96676Immature MonocytesA measurement of the immature monocytes in a biological specimen.Immature Monocyte Count
MONOIMLEC96677Immature Monocytes/LeukocytesA relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen.Immature Monocyte to Leukocyte Ratio Measurement
MONOLEC64824Monocytes/LeukocytesA relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen.Monocyte to Leukocyte Ratio
MONOMAC106544Monocytes/MacrocytesA relative measurement (ratio or percentage) of the monocytes to macrocytes present in a sample.Monocytes to Macrocytes Ratio Measurement
MORPHINEC74883MorphineA measurement of the morphine present in a biological specimen.Morphine Measurement
MPCC96686Mean Platelet ComponentA measurement of the mean platelet component (platelet activity) in a blood specimen.Mean Platelet Component Measurement
MPMC114214Mean Platelet Dry MassA measurement of the mean platelet dry mass in a biological specimen.Mean Platelet Dry Mass
MPOC80198MyeloperoxidaseA measurement of the myeloperoxidase in a biological specimen.Myeloperoxidase Measurement
MPOABC92280Myeloperoxidase AntibodyA measurement of the myeloperoxidase antibody in a biological specimen.Myeloperoxidase Antibody Measurement
MPVC74730Mean Platelet VolumeA measurement of the average size of the platelets present in a blood sample.Mean Platelet Volume Measurement
MPXIC119290Myeloperoxidase IndexThe mean peroxidase activity index or staining intensity of the neutrophil population relative to the archetype.Neutrophil Myeloperoxidase Index
MSPIKEC117844Monoclonal Protein SpikeA measurement of the monoclonal protein in the region of the electrophoresis field containing a spike (increase) in protein.Monoclonal Protein Spike Measurement
MUCTHRC74721Mucous ThreadsA measurement of the mucous threads present in a biological specimen.Mucous Thread Measurement
MYBLAC74632MyeloblastsA measurement of the myeloblast cells in a biological specimen.Myeloblast Count
MYBLALEC64825Myeloblasts/LeukocytesA relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.Myeloblast to Leukocyte Ratio
MYBLAT1C92283Type I MyeloblastsA measurement of type I myeloblast cells per unit of a biological specimen.Type I Myeloblasts Measurement
MYBLAT2C92284Type II MyeloblastsA measurement of type II myeloblast cells per unit of a biological specimen.Type II Myeloblasts Measurement
MYBLAT3C92285Type III MyeloblastsA measurement of type III myeloblast cells per unit of a biological specimen.Type III Myeloblasts Measurement
MYCYC74662MyelocytesA measurement of the myelocytes in a biological specimen.Myelocyte Count
MYCYCEC98868Myelocytes/Total CellsA relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen).Myelocyte to Total Cell Ratio Measurement
MYCYLEC64826Myelocytes/LeukocytesA relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.Myelocyte to Leukocyte Ratio
MYELINABC103418Myelin AntibodiesA measurement of the myelin antibodies in a biological specimen.Myelin Antibodies Measurement
MYL3C106547Cardiac myosin light chain 1;Myosin Light Chain 3;Myosin light chain 1, slow-twitch muscle B/ventricular isoformA measurement of myosin light chain 3 in a biological specimen.Myosin Light Chain 3 Measurement
MYPCERPCC92242Myeloid/Erythroid RatioA relative measurement (ratio or percentage) of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen.Myeloid to Erythroid Ratio Measurement
MYTBGIRC92241Mycobacterium tuberculosis IFN Gamma ResponseA measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection.Mycobacterium tuberculosis Interferon Gamma Response
MYTBNUACC92279Mycobacterium tuberculosis Nucleic AcidA measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen.Mycobacterium tuberculosis Nucleic Acid Measurement
NACLRC106568Sodium ClearanceA measurement of the volume of serum or plasma that would be cleared of sodium by excretion of urine for a specified unit of time (e.g. one minute).Sodium Clearance Measurement
NACREATC79464Sodium/CreatinineA relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen.Sodium to Creatinine Ratio Measurement
NAGC79459N-Acetyl Glucosamide;N-Acetyl GlucosamineA measurement of N-acetyl glucosamide (sugar derivative) in a biological specimen.N-Acetyl Glucosamide Measurement
NAGASEC103419Beta-N-acetyl-D-glucosaminidaseA measurement of the N-acetyl-beta-D-glucosaminidase (enzyme) in a biological specimen.N-acetyl-beta-D-glucosaminidase Measurement
NAGCREATC79460N-Acetyl Glucosamide/CreatinineA relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen.N-Acetyl Glucosamide to Creatinine Ratio Measurement
NCTD5PC794375 Prime Nucleotidase;5'-Ribonucleotide PhosphohydrolaseA measurement of the 5'-nucleotidase in a biological specimen.5 Prime Nucleotidase Measurement
NEOPTERNC80199NeopterinA measurement of the neopterin in a biological specimen.Neopterin Measurement
NEUTC63321NeutrophilsA measurement of the neutrophils in a biological specimen.Absolute Neutrophil Count
NEUTAGRC116200Agranular NeutrophilsA measurement of the agranular neutrophils in a biological specimen.Agranular Neutrophils Measurement
NEUTBC64830Neutrophils Band FormA measurement of the banded neutrophils in a biological specimen.Neutrophil Band Form Count
NEUTBLEC64831Neutrophils Band Form/LeukocytesA relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.Neutrophil Band Form to Leukocyte Ratio
NEUTCEC98763Neutrophils/Total CellsA relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen).Neutrophil to Total Cell Ratio Measurement
NEUTCYBSC111166Cytoplasmic Basophilia NeutrophilA measurement of the neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content.Cytoplasmic Basophilia Neutrophil Count
NEUTGTC96651Giant NeutrophilsA measurement of the giant neutrophils in a biological specimen.Giant Neutrophil Count
NEUTHYGRC116201Hypogranular NeutrophilsA measurement of the hypogranular neutrophils in a biological specimen.Hypogranular Neutrophil Measurement
NEUTIMC96678Immature NeutrophilsA measurement of the total immature neutrophils in a biological specimen.Immature Neutrophil Count
NEUTIMLEC100442Immature Neutrophils/LeukocytesA relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen.Immature Neutrophils to Leukocytes Ratio Measurement
NEUTLEC64827Neutrophils/LeukocytesA relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen.Neutrophil to Leukocyte Ratio
NEUTLSC116202Left Shift NeutrophilsAn observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen.Left Shift Neutrophil Measurement
NEUTMMC84822Neutrophilic MetamyelocytesA measurement of the neutrophilic metamyelocytes in a biological specimen.Neutrophilic Metamyelocyte Count
NEUTMYC84823Neutrophilic MyelocytesA measurement of the neutrophilic myelocytes in a biological specimen.Neutrophilic Myelocyte Count
NEUTSGC81997Neutrophils, SegmentedA measurement of the segmented neutrophils in a biological specimen.Segmented Neutrophil Count
NEUTSGLEC82045Neutrophils, Segmented/LeukocytesA relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen.Segmented Neutrophil to Leukocyte Ratio Measurement
NEUTVACC74628Vacuolated NeutrophilsA measurement of the neutrophils containing small vacuoles in a biological specimen.Vacuolated Neutrophil Count
NGONC92298Neisseria gonorrhoeae ScreeningExamination of a biological specimen to detect the presence of Neisseria gonorrhoeae.Neisseria gonorrhoeae Screening
NITRICOXC112360NO;Nitric OxideA measurement of the nitric oxide in a biological specimen.Nitric Oxide Measurement
NITRITEC64810NitriteA measurement of the nitrite in a urine specimen.Nitrite Measurement
NKCEC98762Natural Killer CellsA measurement of the total natural killer cells in a biological specimen.Natural Killer Cell Count
NKCEFUNCC116203Natural Killer Cell Activity;Natural Killer Cell FunctionA measurement of the natural killer cell function in a biological specimen.Natural Killer Cell Activity Measurement
NONHDLC116204Non-HDL Cholesterol;Non-High Density LipoproteinA measurement of the non-high density lipoprotein cholesterol in a biological specimen.Non-High Density Lipoprotein Cholesterol Measurement
NOREPINC74868Noradrenaline;NorepinephrineA measurement of the norepinephrine hormone in a biological specimen.Noradrenaline Measurement
NPAPC100434Non-Prostatic Acid PhosphataseA measurement of the non-prostatic acid phosphatase in a biological specimen.Non-Prostatic Acid Phosphatase Measurement
NPYC74892Neuropeptide YA measurement of the neuropeptide Y in a biological specimen.Neuropeptide Y Measurement
NSEC116205Enolase 2;Gamma-enolase;Neuron Specific EnolaseA measurement of the neuron specific enolase in a biological specimen.Neuron Specific Enolase Measurement
NTELOPC74743N-telopeptideA measurement of the N-telopeptide in a biological specimen.N-Telopeptide Measurement
NTXIC82039Type I Collagen N-TelopeptidesA measurement of the type I collagen N-telopeptides in a biological specimen.Type I Collagen N-Telopeptide Measurement
NTXIIC82041Type II Collagen N-TelopeptidesA measurement of the type II collagen N-telopeptides in a biological specimen.Type II Collagen N-Telopeptide Measurement
NUCSWELLC114213Nuclear SwellingA measurement of the expansion of the nucleus of the cells in a biological specimen.Nuclear Swelling Measurement
O2CTC111284Oxygen ContentA measurement of the amount of oxygen content in a biological specimen.Oxygen Measurement
OCCBLDC74686Occult BloodA measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination.Occult Blood Measurement
OPGC116206OCIF;Osteoclastogenesis Inhibitory Factor;Osteoprotegerin;TNFRS11B;Tumor Necrosis Factor Receptor Superfamily Member 11bA measurement of the osteoprotegerin in a biological specimen.Osteoprotegerin Measurement
OPIATEC74796OpiateA measurement of any opiate class drug present in a biological specimen.Opiate Measurement
OSMLTYC74801OsmolalityA measurement of the osmoles of solute per unit of biological specimen.Osmolality Measurement
OSMRTYC74802OsmolarityA measurement of the osmoles of solute per liter of solution.Osmolarity Measurement
OSTEOCC74744OsteocalcinA measurement of the osteocalcin in a biological specimen.Osteocalcin Measurement
OVAPARSC100452Ova and ParasiteA measurement of the parasites and ova in a biological specimen.Ova and Parasite Measurement
OXACREATC117983Oxalate/CreatinineA relative measurement (ratio or percentage) of the oxalate to creatinine in a biological specimen.Oxalate to Creatinine Ratio Measurement
OXALATEC92250Ethanedioate;OxalateA measurement of the oxalate in a biological specimen.Oxalate Measurement
OXYCAPC96614Oxygen CapacityA measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood.Oxygen Capacity Measurement
OXYCDNC74884Oxycodone;OxycontinA measurement of the oxycodone present in a biological specimen.Oxycodone Measurement
OXYSATC60832Oxygen SaturationA measurement of the oxygen-hemoglobin saturation of a volume of blood.Oxygen Saturation Measurement
OXYTOCINC74869Oxytocin;OxytoxinA measurement of the oxytocin hormone in a biological specimen.Oxytocin Measurement
P1NPC96625Amino-terminal propeptide of type 1 procollagen;P1NP Aminoterm Type 1;Procollagen 1 N-Terminal PropeptideA measurement of the procollagen 1 N-terminal propeptide in a biological specimen.Procollagen 1 N-Terminal Propeptide Measurement
P50OXYGNC102279P50 OxygenA measurement of the partial pressure of oxygen when hemoglobin is half saturated in a biological specimen.P50 Oxygen Measurement
PAFC111292Platelet Activating FactorA measurement of the platelet activating factor in a biological specimen.Platelet Activating Factor Measurement
PAI1C82030Plasminogen Activator Inhibitor-1A measurement of the plasminogen activator inhibitor-1 in a biological specimen.Plasminogen Activator Inhibitor-1 Measurement
PAI1AGC81989Plasminogen Activator Inhibitor-1 AGA measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen.Plasminogen Activator Inhibitor-1 Antigen Measurement
PAPC80204Prostatic Acid PhosphataseA measurement of the prostatic acid phosphatase in a biological specimen.Prostatic Acid Phosphatase Measurement
PAPPAC82031Pregnancy-Associated Plasma Protein-AA measurement of the pregnancy-associated plasma protein-A in a biological specimen.Pregnancy-Associated Plasma Protein-A Measurement
PAPPENC74616Pappenheimer BodiesA measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen.Pappenheimer Body Count
PARICEABC116207Anti-Parietal Cell Antibody;Parietal Cell AntibodyA measurement of the parietal cell antibody in a biological specimen.Parietal Cell Antibody Measurement
PB19GGABC96617Parvovirus B19 IgG AntibodyA measurement of the Parvovirus B19 IgG antibody in a biological specimen.Parvovirus B19 IgG Antibody Measurement
PB19GMABC96618Parvovirus B19 IgM AntibodyA measurement of the Parvovirus B19 IgM antibody in a biological specimen.Parvovirus B19 IgM Antibody Measurement
PCDWC111294Platelet Component Distribution WidthA measurement of a marker of platelet shape change in a biological specimen.Platelet Component Distribution Width Measurement
PCO2C82625Partial Pressure Carbon DioxideA measurement of the pressure of carbon dioxide in a biological specimen.Partial Pressure of Carbon Dioxide Measurement
PCPC74694Phencyclidine;PhenylcyclohexylpiperidineA measurement of the phencyclidine present in a biological specimen.Phencyclidine Measurement
PCTC103430ProcalcitoninA measurement of the procalcitonin in a biological specimen.Procalcitonin Measurement
PDGFABC116208PDGF Isoform AB;Platelet Derived Growth Factor Isoform AB;Platelet Derived Growth Factor-AB IsoformA measurement of the platelet derived growth factor isoform AB in a biological specimen.Platelet Derived Growth Factor Isoform AB Measurement
PDWC81962Platelet Distribution WidthA measurement of the range of platelet sizes in a biological specimen.Platelet Distribution Width
PELGERHC74617Pelger Huet AnomalyA measurement of the Pelger Huet Anomaly (nuclei of neutrophils and eosinophils appear rod-like, spherical or dumbbell shaped) in a biological specimen.Pelger Huet Anomaly Measurement
PEMABC81988Pemphigoid AntibodiesA measurement of the pemphigoid antibodies in a biological specimen.Pemphigoid Antibody Measurement
PEPSNGC100122PepsinogenA measurement of the pepsinogen in a biological specimen.Pepsinogen Measurement
PEPSNGAC100469PGA;Pepsinogen AA measurement of the pepsinogen A in a biological specimen.Pepsinogen A Measurement
PEPSNGCC100470PGC;Pepsinogen CA measurement of the pepsinogen C in a biological specimen.Pepsinogen C Measurement
PEPSNGIC100467PGI;Pepsinogen IA measurement of the pepsinogen I in a biological specimen.Pepsinogen I Measurement
PEPSNGIIC100468PGII;Pepsinogen IIA measurement of the pepsinogen II in a biological specimen.Pepsinogen II Measurement
PERIOSTNC112395OSF2;Osteoblast Specific Factor 2;POSTN;PeriostinA measurement of the periostin in a biological specimen.Periostin Measurement
PERTHRBLC100446ProerythroblastA measurement of the proerythroblasts in a biological specimen.Proerythroblast Measurement
PF2AI8CRC1192918-Iso-PGF2alpha/CreatinineA relative measurement (ratio or percentage) of the prostaglandin F2 alpha isoform 8 to creatinine in a biological specimen.8-Iso-Prostaglandin F2 Alpha to Creatinine Ratio Measurement
PFCTC111295PFCT;Platelet Function Closure TimeA measurement of the platelet function closure time in a biological specimen.Platelet Function Closure Time Measurement
PGC103343Total ProstaglandinA measurement of the total prostaglandin in a biological specimen.Prostaglandin Measurement
PGD2C103431Prostaglandin D2A measurement of the prostaglandin D2 in a biological specimen.Prostaglandin D2 Measurement
PGD2SC103432Prostaglandin D2 SynthaseA measurement of the prostaglandin D2 synthase in a biological specimen.Prostaglandin D2 Synthase Measurement
PGE1C103434Prostaglandin E1A measurement of the prostaglandin E1 in a biological specimen.Prostaglandin E1 Measurement
PGE2C103435Prostaglandin E2A measurement of the prostaglandin E2 in a biological specimen.Prostaglandin E2 Measurement
PGESC103433Prostaglandin E SynthaseA measurement of the prostaglandin E synthase in a biological specimen.Prostaglandin E Synthase Measurement
PGF1AC103436Prostaglandin F1 AlphaA measurement of the prostaglandin F1 alpha in a biological specimen.Prostaglandin F1 Alpha Measurement
PGF2AC103437Prostaglandin F2 AlphaA measurement of the prostaglandin F2 alpha in a biological specimen.Prostaglandin F2 Alpha Measurement
PGF2AI8C1192928-Iso-Prostaglandin F2 AlphaA measurement of the prostaglandin F2 alpha isoform 8 in a biological specimen.8-Iso-Prostaglandin F2 Alpha Measurement
PHC45997pHThe negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid.pH
PHENTHZC74695Dibenzothiazine;PhenothiazineA measurement of the phenothiazine present in a biological specimen.Phenothiazine Measurement
PHOSC64857Inorganic Phosphate;Phosphate;PhosphorusA measurement of the phosphate in a biological specimen.Phosphate Measurement
PHOSCLRC106553Phosphate ClearanceA measurement of the volume of serum or plasma that would be cleared of phosphate by excretion of urine for a specified unit of time (e.g. one minute).Phosphate Clearance Measurement
PHOSCRTC79461Phosphate/CreatinineA relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen.Phosphate to Creatinine Ratio Measurement
PHOSEXRC117845Phosphorus Excretion RateA measurement of the amount of phosphorus being excreted in urine over a defined amount of time (e.g. one hour).Phosphorus Urine Excretion Rate
PHOSLPDC96623PhospholipidA measurement of the phospholipids in a biological specimen.Phospholipid Measurement
PICPC82033Procollagen Type I Carboxy Term PeptideA measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen.Procollagen Type I Carboxy Terminal Peptide Measurement
PLAGGCVTC114210Platelet Aggregation Curve TypeThe classification of the curve pattern that is formed as a result of platelet aggregation.Platelet Aggregometry Curve Type
PLAGMAMPC114211Platelet Aggregation Mean AmplitudeAn average of the measurements of the magnitude of the platelet aggregation in a biological specimen.Platelet Aggregometry Mean Amplitude
PLAGMCVTC114212Platelet Aggregation Mean Curve TypeThe classification of the curve pattern that is formed as the average result of the platelet aggregation curve measurements.Platelet Aggregometry Mean Curve Type
PLATC51951PlateletsA measurement of the platelets (non-nucleated thrombocytes) in a biological specimen.Platelet Count
PLATAGGRC103427Platelet Aggregation;Platelet FunctionA measurement of the association of platelets to one another via adhesion molecules in a biological sample.Platelet Aggregation Measurement
PLATCLMPC96624PLT Clumps;Platelet ClumpsA measurement of the platelet clumps in a biological specimen.Platelet Clumps Count
PLATGNTC74728Giant PlateletsA measurement of the giant (larger than 7um in diameter) platelets in a biological specimen.Giant Platelet Count
PLATHCTC100424Platelet Hematocrit;ThrombocytocritA relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets.Platelet Hematocrit Measurement
PLATLRGC74729Large PlateletsA measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen.Large Platelet Count
PLATSATC116209Platelet SatellitismAn examination or assessment of the platelet satellitism (platelet rosetting around cells) in a biological specimen.Platelet Satellitism Assessment
PLSCECEC98869Plasma Cells/Total CellsA relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen).Plasma Cell to Total Cell Ratio Measurement
PLSIMCEC96679Immature Plasma CellsA measurement of the immature plasma cells in a biological specimen.Immature Plasma Cell Count
PLSIMCLYC96680Immature Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen.Immature Plasma Cell to Lymphocyte Ratio Measurement
PLSMCEC74661Mature Plasma Cells;PlasmacytesA measurement of the mature plasma cells (plasmacytes) in a biological specimen.Mature Plasma Cell Count
PLSMCELYC74911Mature Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen.Mature Plasma Cell to Lymphocyte Ratio Measurement
PLSMDMC100453Malaria;PlasmodiumExamination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus.Plasmodium Measurement
PLSPCEC74619Plasmablast;Precursor Plasma CellsA measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen.Precursor Plasma Cell Count
PLSPCELYC74650Precursor Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen.Precursor Plasma Cell to Lymphocyte Ratio Measurement
PLTAGAMPC111293Platelet Aggregation AmplitudeA measurement of the magnitude of the platelet aggregation in a biological specimen.Platelet Aggregation Amplitude Measurement
PLTMORPHC111296Platelet MorphologyAn examination or assessment of the form and structure of platelets.Platelet Morphology Measurement
PNCTPPC80201Pancreatic PolypeptideA measurement of the pancreatic polypeptide in a biological specimen.Pancreatic Polypeptide Measurement
PO2C71251Partial Pressure OxygenA measurement of the pressure of oxygen in a biological specimen.Partial Pressure of Oxygen Measurement
PO2FIO2C119293PAO2/FIO2;PP Arterial O2/Fraction Inspired O2A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses.Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement
POIKILOC79602PoikilocytesA measurement of the odd-shaped erythrocytes in a whole blood specimen.Poikilocyte Measurement
POIKRBCC74649Poikilocytes/ErythrocytesA relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen.Poikilocyte to Erythrocyte Ratio Measurement
POLYCHRC64803PolychromasiaA measurement of the blue-staining characteristic of newly generated erythrocytes.Polychromasia
PRAC116210PRA Score;Panel Reactive Antibody;Percent Panel Reactive Antibody;Percent Reactive AntibodyA measurement of the panel reactive antibody (the reactivity between host immune cells and donor human leukocyte antigen) in a biological specimen.Panel Reactive Antibody Test
PREALBC100435Prealbumin;Thyroxine-binding Prealbumin;TransthyretinA measurement of the prealbumin in a biological specimen.Prealbumin Measurement
PRINSINSC111299Proinsulin/Insulin RatioA relative measurement (ratio or percentage) of the proinsulin to insulin in a biological specimen.Proinsulin to Insulin Ratio Measurement
PRLYMLEC64829Prolymphocytes/LeukocytesA relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.Prolymphocyte to Leukocyte Ratio
PROGESTC74791ProgesteroneA measurement of the progesterone hormone in a biological specimen.Progesterone Measurement
PROGESTRC117846NR3C3;PR;Progesterone ReceptorA measurement of the progesterone receptor in a biological specimen.Progesterone Receptor Measurement
PROINSULC81967ProinsulinA measurement of the proinsulin in a biological specimen.Proinsulin Measurement
PROLCTNC74870ProlactinA measurement of the prolactin hormone in a biological specimen.Prolactin Measurement
PROLYMC74620ProlymphocytesA measurement of the prolymphocytes in a biological specimen.Prolymphocyte Count
PROLYMLYC74651Prolymphocytes/LymphocytesA relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen.Prolymphocyte to Lymphocyte Ratio Measurement
PROMONLEC74652Promonocytes/LeukocytesA relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen.Promonocyte to Lymphocyte Ratio Measurement
PROMONOC74621PromonocytesA measurement of the promonocytes in a biological specimen.Promonocyte Count
PROMYC74622PromyelocytesA measurement of the promyelocytes (immature myelocytes) in a biological specimen.Promyelocyte Count
PROMYBC117847PromyeloblastsA measurement of the promyeloblasts in a biological specimen.Promyeloblasts Measurement
PROMYCEC98773Promyelocytes/Total CellsA relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen).Promyelocyte to Total Cell Ratio Measurement
PROMYLEC74653Promyelocytes/LeukocytesA relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen.Promyelocyte to Lymphocyte Ratio Measurement
PROPOXC74885PropoxypheneA measurement of the propoxyphene present in a biological specimen.Propoxyphene Measurement
PROTC64858ProteinA measurement of the total protein in a biological specimen.Total Protein Measurement
PROTCRTC79463Protein/CreatinineA relative measurement (ratio or percentage) of the protein to creatinine in a biological specimen.Protein to Creatinine Ratio Measurement
PROTEXRC117848Protein Excretion RateA measurement of the amount of total protein being excreted in urine over a defined amount of time (e.g. one hour).Total Protein Urine Excretion Rate
PROTOSMLC92240Protein/Osmolality;Protein/Osmolality RatioA relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen.Protein to Osmolality Ratio Measurement
PROTOZOAC117849ProtozoaExamination of a biological specimen to detect the presence of protozoa in a biological specimen.Protozoa Measurement
PROTSC100436Protein SA measurement of the protein S in a biological specimen.Protein S Measurement
PSAC17634Prostate Specific AntigenA measurement of the prostate specific antigen in a biological specimen.Prostate Specific Antigen Measurement
PSDEPHDC74696PseudoephedrineA measurement of the pseudoephedrine present in a biological specimen.Pseudoephedrine Measurement
PSELECTC117850GMP-140;P-SelectinA measurement of total P-selectin in a biological specimen.P-Selectin Measurement
PTC62656Prothrombin TimeA blood clotting measurement that evaluates the extrinsic pathway of coagulation.Prothrombin Time
PTAC98774Factor II Activity;Prothrombin ActivityA measurement of the biological activity of prothrombin in a biological specimen.Prothrombin Activity Measurement
PTF1_2C82034Prothrombin Fragments 1 + 2A measurement of the prothrombin fragments 1 and 2 in a biological specimen.Prothrombin Fragments 1 and 2 Measurement
PTHCTC81964Parathyroid Hormone, C-TerminalA measurement of the C-terminal fragment of parathyroid hormone in a biological specimen.C-Terminal Parathyroid Hormone Measurement
PTHFGC74784Parathyroid Hormone, FragmentedA measurement of the fragmented parathyroid hormone in a biological specimen.Fragmented Parathyroid Hormone Measurement
PTHIC74789Parathyroid Hormone, IntactA measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen.Intact Parathyroid Hormone Measurement
PTHMMC81965Parathyroid Hormone, Mid-MoleculeA measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen.Mid-Molecule Parathyroid Hormone Measurement
PTHNTC81966Parathyroid Hormone, N-TerminalA measurement of the N-terminal fragment of parathyroid hormone in a biological specimen.N-Terminal Parathyroid Hormone Measurement
PTHRPC117851Parathyroid Hormone-related Peptide;Parathyroid Hormone-related ProteinA measurement of parathyroid hormone-related protein in a biological specimen.Parathyroid Hormone-related Protein Measurement
PTHWC103451Parathyroid Hormone, WholeA measurement of the whole parathyroid hormone (consisting of amino acids 1-84) in a biological specimen.Whole Parathyroid Hormone Measurement
PYRIDNLNC80211PyridinolineA measurement of the pyridinoline in a biological specimen.Pyridinoline Measurement
PYYC80202Peptide Tyrosine Tyrosine;Peptide YYA measurement of the peptide YY in a biological specimen.Peptide YY Measurement
RANKLC117852Receptor Activator Nuclear KappaB Ligand;Receptor Activator of Nuclear Kappa-B LigandA measurement of the receptor activator of nuclear kappa-B ligand in a biological specimen.Receptor Activator Nuclear KappaB Ligand Measurement
RANTESC81957Chemokine Ligand 5;Reg upon Act Normal T-cell Exprd SecrtdA measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen.Reg upon Act Normal T-cell Exprd Secrtd Measurement
RBCC51946Erythrocytes;Red Blood CellsA measurement of the total erythrocytes in a biological specimen.Erythrocyte Count
RBCAGGLUC111197Autoagglutination;Erythrocyte Agglutination;RBC AgglutinationA measurement of the erythrocyte agglutination in a biological specimen.Erythrocyte Agglutination Measurement
RBCCLMPC92245Erythrocyte Cell Clumps;RBC Clumps;Red Blood Cell ClumpsA measurement of red blood cell clumps in a biological specimen.Erythrocyte Cell Clumps Measurement
RBCDIPOPC117853Dimorphic Erythrocyte Population;Dimorphic RBC PopulationExamination of a biological specimen to detect the presence of dimorphic erythrocyte population.Dimorphic Erythrocyte Population
RBCFRAGC116212Erythrocyte Fragment;RBC FragmentA measurement of the red blood cell fragments (red cell fragments that have a reticular-like shape with rounded ends and no spicules, differentiating them from schistocytes and acanthocytes) in a biological specimen.Erythrocyte Fragment Measurement
RBCGHOSTC96605Erythrocyte Ghosts;RBC GhostsA measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen.Erythrocyte Ghost Count
RBCMORPHC92296Erythrocyte Cell Morphology;RBC Morphology;Red Blood Cell MorphologyAn examination or assessment of the form and structure of red blood cells.Erythrocyte Cell Morphology
RBCNUCC74705Nucleated Erythrocytes;Nucleated Red Blood CellsA measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen.Nucleated Red Blood Cell Count
RBCNUCLEC82046Nucleated Erythrocytes/LeukocytesA relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen.Nucleated Erythrocyte to Leukocyte Ratio Measurement
RBCNURBCC74647Nucleated Erythrocytes/Erythrocytes;Nucleated Red Blood Cells/ErythrocytesA relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen.Nucleated Red Blood Cell to Erythrocyte Ratio Measurement
RBOIGGABC112412Measles IgG Antibody;Rubeola IgG AntibodyA measurement of the Measles (Rubeola) virus IgG antibody in a biological specimen.Rubeola IgG Antibody Measurement
RBOIGMABC112413Measles IgM Antibody;Rubeola IgM AntibodyA measurement of the Measles (Rubeola) virus IgM antibody in a biological specimen.Rubeola IgM Antibody Measurement
RBPC100437Retinol Binding ProteinA measurement of the total retinol binding protein in a biological specimen.Retinol Binding Protein Measurement
RDWC64800Erythrocytes Distribution Width;Red Blood Cell Distribution WidthA value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.Erythrocyte Distribution Width Measurement
RENINC74893Active Renin;Angiotensinogenase;Direct Renin;ReninA measurement of the renin in a biological specimen.Renin Measurement
RENINAC111305PRA;Plasma Renin Activity;Renin Activity;URA;Urinary Renin ActivityA measurement of the renin activity in a biological specimen.Renin Activity Measurement
RESISTINC80205ResistinA measurement of the resistin in a biological specimen.Resistin Measurement
RETCRRBCC102274HCT Corrected Reticulocytes/ErythrocytesA relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes in a biological specimen.Hematocrit Corrected Reticulocytes to Erythrocytes Ratio Measurement
RETIC51947ReticulocytesA measurement of the reticulocytes in a biological specimen.Reticulocyte Count
RETICDWC114218Reticulocyte Distribution WidthA measurement of the range of reticulocyte sizes in a biological specimen.Reticulocyte Distribution Width
RETICHC117854CHr;Ret. Corpuscular Hemoglobin ContentA quantitative measurement of the total amount of hemoglobin in the reticulocyte population.Total Reticulocyte Corpuscular Hemoglobin Content Measurement
RETIHC116188High Absorption ReticulocytesA measurement of the high absorption reticulocytes in a biological specimen.High Absorption Reticulocyte Measurement
RETIHCRC102273Hematocrit Corrected ReticulocytesA measurement of the hematocrit corrected reticulocytes in a biological specimen.Hematocrit Corrected Reticulocyte Count
RETIHGBC98776Reticulocyte HemoglobinA measurement of the amount of hemoglobin in reticulocytes.Reticulocyte Hemoglobin Measurement
RETIHRTCC116189High Absorption Retic/ReticulocytesA relative measurement (ratio or percentage) of the high absorption reticulocytes to total reticulocytes in a biological specimen.High Absorption Reticulocytes to Total Reticulocytes Ratio Measurement
RETILC116190Low Absorption ReticulocytesA measurement of the low absorption reticulocytes in a biological specimen.Low Absorption Reticulocyte Measurement
RETILRTCC116191Low Absorption Retic/ReticulocytesA relative measurement (ratio or percentage) of the low absorption reticulocytes to total reticulocytes in a biological specimen.Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement
RETIMC116192Medium Absorption ReticulocytesA measurement of the medium absorption reticulocytes in a biological specimen.Medium Absorption Reticulocyte Measurement
RETIMCHC117855CHCMr;Ret. Mean Corpuscular HemoglobinA quantitative measurement of the mean amount of hemoglobin per reticulocyte in a biological specimen.Reticulocyte Mean Corpuscular Hemoglobin Measurement
RETIMRTCC116193Medium Absorption Retic/ReticulocytesA relative measurement (ratio or percentage) of the medium absorption reticulocytes to total reticulocytes in a biological specimen.Medium Absorption Reticulocytes to Total Reticulocytes Ratio Measurement
RETIRBCC64828Reticulocytes/ErythrocytesA relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.Reticulocyte to Erythrocyte Ratio
RFC74717Rheumatoid FactorA measurement of the rheumatoid factor antibody in a biological specimen.Rheumatoid Factor Measurement
RNPABC100457RNP Antibody;Ribonucleoprotein AntibodyA measurement of the ribonucleoprotein antibody in a biological specimen.Ribonucleoprotein Antibody Measurement
ROULEAUXC74624Rouleaux FormationA measurement of the number of stacking red blood cells within a biological specimen.Rouleaux Formation Count
RPRC74716Rapid Plasma ReaginA measurement of the antibodies produced by cellular damage caused by Treponema pallidum (syphilis) in a biological specimen.Rapid Plasma Reagin Measurement
RPTLTIMEC96628Reptilase TimeA measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase.Reptilase Time Measurement
RT3C81968Triiodothyronine, ReverseA measurement of the reverse triiodothyronine in a biological specimen.Reverse Triiodothyronine Measurement
RUBIGGABC103440Rubella IgG AntibodyA measurement of the Rubella IgG antibody in a biological specimen.Rubella IgG Antibody Measurement
SCFC82035KIT Ligand;Stem Cell FactorA measurement of the stem cell factor in a biological specimen.Stem Cell Factor Measurement
SCHISTOC74706SchistocytesA measurement of the schistocytes (fragmented red blood cells) in a biological specimen.Schistocyte Count
SCKCERBCC74656Sickle Cells/ErythrocytesA relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen.Sickle Cell to Erythrocyte Ratio Measurement
SCKLCEC74626Sickle CellsA measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen.Sickle Cell Count
SCL70ABC100458Scl-70 Antibody;Scleroderma-70 AntibodyA measurement of the Scl-70 antibody in a biological specimen.Scl-70 Antibody Measurement
SDHC79465Sorbitol DehydrogenaseA measurement of the sorbitol dehydrogenase in a biological specimen.Sorbitol Dehydrogenase Measurement
SECRETINC74871SecretinA measurement of the secretin hormone in a biological specimen.Secretin Measurement
SEDEXAMC105744Microscopic Sediment Analysis;Sediment Analysis;Sediment ExaminationAn observation, assessment or examination of the sediment in a biological specimen.Sediment Analysis
SEZCEC74625Sezary CellsA measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen.Sezary Cell Count
SEZCELYC74655Sezary Cells/LymphocytesA relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen.Sezary Cell to Lymphocyte Ratio Measurement
SFTPDC111322SP-D;Surfactant Protein DA measurement of the surfactant protein D in a biological specimen.Surfactant Protein D Measurement
SHBGC74745Sex Hormone Binding Globulin;Sex Hormone Binding ProteinA measurement of the sex hormone binding (globulin) protein in a biological specimen.Sex Hormone Binding Protein Measurement
SIXMAMC748766-MonoacetylmorphineA measurement of the 6-monoacetylmorphine present in a biological specimen.6-Monoacetylmorphine Measurement
SJSSAABC92236Ro Antibody;Sjogrens SS-A AntibodyA measurement of the Sjogrens SS-A antibody in a biological specimen.Sjogren's SS-A Antibody Measurement
SJSSBABC92237La Antibody;Sjogrens SS-B AntibodyA measurement of the Sjogrens SS-B antibody in a biological specimen.Sjogren's SS-B Antibody Measurement
SLTFRNRCC100438Soluble Transferrin ReceptorA measurement of the soluble transferrin receptor in a biological specimen.Soluble Transferrin Receptor Measurement
SLXAGC114223SLeX;Sialyl Lewis X Antigen;Sialyl Lex;Sialyl SSEA-1 Antigen;Sialyl-CD15A measurement of the sialyl stage-specific embryonic antigen-1 in a biological specimen.Sialyl SSEA-1 Antigen Measurement
SMDGCEC74627Basket Cells;Gumprecht Shadow Cells;Shadow Cells;Smudge CellsA measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen.Smudge Cell Count
SMDGCELEC119294Basket Cells/Leukocytes;Gumprecht Shadow Cells/Leukocytes;Shadow Cells/Leukocytes;Smudge Cells/LeukocytesA relative measurement (ratio or percentage) of smudge cells to leukocytes in a biological specimen.Smudge Cells to Leukocytes Ratio Measurement
SMTHABC92281Smith AntibodyA measurement of the Smith antibody in a biological specimen.Smith Antibody Measurement
SMUSCABC111317Actin Antibody;Anti-Smooth Muscle Antibody;Smooth Muscle AntibodyA measurement of the smooth muscle antibody in a biological specimen.Smooth Muscle Antibody Measurement
SO2C114224Sulfur DioxideA measurement of the sulfur dioxide in a biological specimen.Sulfur Dioxide Measurement
SODIUMC64809SodiumA measurement of the sodium in a biological specimen.Sodium Measurement
SODMEXRC117856Sodium Excretion RateA measurement of the amount of sodium being excreted in urine over a defined amount of time (e.g. one hour).Sodium Urine Excretion Rate
SOMATROC80360Growth Hormone;SomatotrophinA measurement of the somatotrophin (growth) hormone in a biological specimen.Somatotrophin Measurement
SOSTC117857SclerostinA measurement of the sclerostin in a biological specimen.Sclerostin Measurement
SPERMC74663SpermatozoaA measurement of the spermatozoa cells present in a biological specimen.Spermatozoa Cell Count
SPERMMTLC102281Sperm MotilityA measurement of the sperm capable of forward, progressive movement in a semen specimen.Sperm Motility Measurement
SPGRAVC64832Specific GravityA ratio of the density of a fluid to the density of water.Specific Gravity
SPHEROC74707SpherocytesA measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen.Spherocyte Count
SPWEIGHTC106569Specimen WeightA measurement of the weight of a biological specimen.Specimen Weight Measurement
SRTONINC74872SerotoninA measurement of the serotonin hormone in a biological specimen.Serotonin Measurement
STIPBASOC96567Basophilic StipplingA measurement of the basophilic stippling in a biological specimen.Basophilic Stippling Measurement
STOMCYC74708StomatocytesA measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen.Stomatocyte Count
STRIGGABC117858Strongyloides IgG AntibodyA measurement of strongyloides IgG antibody in a biological specimen.Strongyloides IgG Antibody Measurement
STRPLOABC92282Antistreptolysin O;Streptolysin O AntibodyA measurement of Streptolysin O Antibody in a biological specimen.Streptolysin O Antibody Measurement
SVCAM1C92533Soluble Vascular Cell Adhesion Molecule 1A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen.Soluble Vascular Cell Adhesion Molecule 1
T3C74747Total T3;TriiodothyronineA measurement of the total (free and bound) triiodothyronine in a biological specimen.Triiodothyronine Measurement
T3FRC74787Free T3;Triiodothyronine, FreeA measurement of the free triiodothyronine in a biological specimen.Free Triiodothyronine Measurement
T3UPC74748Triiodothyronine UptakeA measurement of the binding of triiodothyonine to thyroxine binding globulin protein in a biological specimen.Triiodothyronine Uptake Measurement
T4C74794Thyroxine;Total T4A measurement of the total (free and bound) thyroxine in a biological specimen.Total Thyroxine Measurement
T4FRC74786Free T4;Thyroxine, FreeA measurement of the free thyroxine in a biological specimen.Free Thyroxine Measurement
TATC106574Thrombin/Antithrombin;Thrombin/Antithrombin IIIA relative measurement (ratio or percentage) of the thrombin to antithrombin present in a sample.Thrombin to Antithrombin Ratio Measurement
TBGC74746Thyroxine Binding GlobulinA measurement of the thyroxine binding globulin protein in a biological specimen.Thyroxine Binding Globulin Protein Measurement
TDTAGC117859Terminal Deoxynucleotidyl Transferase Ag;Terminal Deoxynucleotidyl Transferase AntigenA measurement of the terminal deoxynucleotidyl transferase antigen in a biological specimen.Terminal Deoxynucleotidyl Transferase Antigen Measurement
TEARDCYC64801Dacryocytes;Tear Shaped Erythrocytes;Teardrop CellsA measurement of dacryocytes in a biological specimen.Dacryocyte Analysis
TESTOSC74793Testosterone;Total TestosteroneA measurement of the total (free and bound) testosterone in a biological specimen.Total Testosterone Measurement
TESTOSBAC117860Bioavailable TestosteroneA measurement of bioavailable testosterone in a biological specimen.Bioavailable Testosterone Measurement
TESTOSFRC74785Testosterone, FreeA measurement of the free testosterone in a biological specimen.Free Testosterone Measurement
TFERRINC82037TransferrinA measurement of the transferrin in a biological specimen.Transferrin Measurement
TFRRNSATC98792Iron Binding Capacity Saturation;Iron Saturation;Iron Saturation Percent;Serum Iron to TIBC Ratio;Transferrin Iron Saturation;Transferrin SaturationA measurement of the iron bound to transferrin in a biological specimen.Transferrin Saturation Measurement
TGFB1C117861Transforming Growth Factor Beta 1A measurement of the transforming growth factor beta 1 in a biological specimen.Transforming Growth Factor Beta 1 Measurement
TGLOBC103446TG;ThyroglobulinA measurement of the thyroglobulin in a biological specimen.Thyroglobulin Measurement
THEOPHYLC105445TheophyllineA measurement of the Theophylline present in a biological specimen.Theophylline Measurement
THRMPTNC74873ThrombopoietinA measurement of the thrombopoietin hormone in a biological specimen.Thrombopoietin Measurement
THROMNUCC111283Nucleated Thrombocytes;ThrombocytesA measurement of the nucleated platelets, namely thrombocytes, in a biological specimen. This is typically measured in birds and other non-mammalian vertebrates.Nucleated Thrombocyte Count
THYABC81990Thyroid AntibodiesA measurement of the thyroid antibodies in a biological specimen.Thyroid Antibody Measurement
THYAMABC81991Thyroid Antimicrosomal AntibodiesA measurement of the thyroid antimicrosomal antibodies in a biological specimen.Thyroid Antimicrosomal Antibody Measurement
THYATABC81992Thyroid Antithyroglobulin AntibodiesA measurement of the thyroid antithyroglobulin antibodies in a biological specimen.Thyroid Antithyroglobulin Antibody Measurement
THYPXDC96639Thyroid Peroxidase;ThyroperoxidaseA measurement of the thyroperoxidase in a biological specimen.Thyroperoxidase Measurement
THYPXDABC96638Thyroperoxidase AntibodyA measurement of the thyroperoxidase antibody in a biological specimen.Thyroperoxidase Antibody Measurement
TIMP1C82036Tissue Inhibitor of Metalloproteinase 1A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen.Tissue Inhibitor of Metalloproteinase 1 Measurement
TIMP1CREC106575TIMP1/Creatinine;Tissue Inhibitor of Metalloproteinase 1/CreatinineA relative measurement (ratio or percentage) of the tissue inhibitor of metalloproteinase 1 to creatinine present in a sample.Tissue Inhibitor of Metalloproteinase 1 to Creatinine Ratio Measurement
TNFC74751Tumor Necrosis Factor;Tumor Necrosis Factor alphaA measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen.Tumor Necrosis Factor Measurement
TNFAPIAC117862TNF-a Production Inhibitory ActivityA measurement of TNF-a production inhibitory activity in a biological specimen.TNF-a Production Inhibitory Activity Measurement
TNFSRC117749Soluble Tumor Necrosis Factor ReceptorA measurement of the total soluble tumor necrosis factor receptor in a biological specimen.Soluble Tumor Necrosis Factor Receptor Measurement
TNFSR1C117863Soluble TNF Receptor Type IA measurement of the soluble tumor necrosis factor receptor type I in a biological specimen.Soluble Tumor Necrosis Factor Receptor Type I Measurement
TNFSR2C117864Soluble TNF Receptor Type IIA measurement of the soluble tumor necrosis factor receptor type II in a biological specimen.Soluble Tumor Necrosis Factor Receptor Type II Measurement
TOXGRANC96641Toxic GranulationA measurement of the toxic granulation in neutrophilic blood cells.Toxic Granulation Measurement
TPAAGC81993Tissue Plasminogen Activator AntigenA measurement of the tissue plasminogen activator antigen in a biological specimen.Tissue Plasminogen Activator Antigen Measurement
TPRONPC84811Non-Phosphorylated Tau ProteinA measurement of the non-phosphorylated Tau protein in a biological specimen.Nonphosphorylated Tau Protein Measurement
TPROTC84810Tau Protein;Total Tau ProteinA measurement of the total Tau protein in a biological specimen.Tau Protein Measurement
TPROTPC84812Phosphorylated Tau ProteinA measurement of the phosphorylated Tau protein in a biological specimen.Phosphorylated Tau Protein Measurement
TRACP5BC117865TRAP5B;Tartrate-Resistant Acid Phosphatase 5bA measurement of tartrate-resistant acid phosphatase 5b in a biological specimen.Tartrate-Resistant Acid Phosphatase 5b Measurement
TRAPC80208Total Radical-Trap Antioxidant PotentialA measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension.Total Radical-Trap Antioxidant Potential Measurement
TRCYANDPC100420Tricyclic AntidepressantsA measurement of tricyclic antidepressants in a biological specimen.Tricyclic Antidepressant Measurement
TRGTCEC96636Codocytes;Leptocytes;Mexican Hat Cells;Target CellsA measurement of the target cells in a biological specimen.Target Cell Count
TRHC74874Thyrotropin Releasing Factor;Thyrotropin Releasing HormoneA measurement of the thyrotropin releasing hormone in a biological specimen.Thyrotropin Releasing Hormone Measurement
TRICHC92238TrichomonasExamination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus.Trichomonas Screening
TRIGC64812TriglyceridesA measurement of the triglycerides in a biological specimen.Triglyceride Measurement
TROPONIC74749Troponin IA measurement of the actin binding troponin in a biological specimen.Troponin I Measurement
TROPONINC111327TroponinA measurement of the total troponin in a biological specimen.Troponin Measurement
TROPONTC74750Troponin TA measurement of the tropomyosin binding troponin in a biological specimen.Troponin T Measurement
TRYPTASEC92292TryptaseA measurement of the tryptase in a biological specimen.Tryptase Measurement
TSHC64813Thyroid Stimulating Hormone;ThyrotropinA measurement of the thyrotropin in a biological specimen.Thyrotropin Measurement
TTC80365Thrombin TimeA measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI)Thrombin Time
TURBC74723TurbidityA measurement of the opacity of a biological specimen.Turbidity Measurement
TXB2C103445Thromboxane B2A measurement of the thromboxane B2 in a biological specimen.Thromboxane B2 Measurement
TXB2_D11C10334411-Dehydro-Thromboxane B2A measurement of the 11-dehydro-thromboxane B2 in a biological specimen.11-Dehydro-Thromboxane B2 Measurement
UNSPCEC112241Unspecified CellsA measurement of the cells not otherwise identified or specified in a biological specimen.Count of Unspecified Cells
UNSPCECEC114225Unspecified Cells/Total CellsA relative measurement (ratio or percentage) of the cells not otherwise identified or specified to total cells in a biological specimen.Unspecified Cells to Total Cell Ratio Measurement
URATEC64814Urate;Uric AcidA measurement of the urate in a biological specimen.Urate Measurement
URATECRTC117866Urate/CreatinineA relative measurement (ratio or percentage) of the urate to creatinine in a biological specimen.Urate to Creatinine Ratio Measurement
UREAC64815UreaA measurement of the urea in a biological specimen.Urea Measurement
UREACRTC96645Urea/CreatinineA relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen.Urea to Creatinine Ratio Measurement
UROBILC64816UrobilinogenA measurement of the urobilinogen in a biological specimen.Urobilinogen Measurement
VCAM1C82042Vascular Cell Adhesion Molecule 1A measurement of the vascular cell adhesion molecule 1 in a biological specimen.Vascular Cell Adhesion Molecule 1 Measurement
VEGFC92514Vascular Endothelial Growth FactorA measurement of the vascular endothelial growth factor in a biological specimen.Vascular Endothelial Growth Factor Measurement
VISCC75912ViscosityThe resistance of a liquid to sheer forces and flow. (NCI)Viscosity
VITAC74895Retinol;Vitamin AA measurement of the Vitamin A in a biological specimen.Vitamin A Measurement
VITB1C74896Thiamine;Vitamin B1A measurement of the thiamine in a biological specimen.Vitamin B1 Measurement
VITB12C64817Vitamin B12A measurement of the Vitamin B12 in a serum specimen.Vitamin B12 Measurement
VITB17C74897Amygdalin;Vitamin B17A measurement of the Vitamin B17 in a biological specimen.Vitamin B17 Measurement
VITB2C74898Riboflavin;Vitamin B2A measurement of the riboflavin in a biological specimen.Vitamin B2 Measurement
VITB3C74899Niacin;Vitamin B3A measurement of the niacin in a biological specimen.Vitamin B3 Measurement
VITB5C74900Pantothenic Acid;Vitamin B5A measurement of the Vitamin B5 in a biological specimen.Vitamin B5 Measurement
VITB6C74901Pyridoxine;Vitamin B6A measurement of the Vitamin B6 in a biological specimen.Vitamin B6 Measurement
VITB7C74902Biotin;Vitamin B7A measurement of the Vitamin B7 in a biological specimen.Vitamin B7 Measurement
VITB9C74676Folic Acid;Vitamin B9A measurement of the folic acid in a biological specimen.Folic Acid Measurement
VITCC74903Ascorbic Acid;Vitamin CA measurement of the Vitamin C in a biological specimen.Vitamin C Measurement
VITDC84818Total Vitamin D;Vitamin DA measurement of the total Vitamin D in a biological specimen.Vitamin D Measurement
VITD2C74904Ergocalciferol;Vitamin D2A measurement of the Vitamin D2 in a biological specimen.Vitamin D2 Measurement
VITD3C74905Cholecalciferol;Vitamin D3A measurement of the Vitamin D3 in a biological specimen.Vitamin D3 Measurement
VITDATC922671, 25-Dihydroxyvitamin D;Active Vitamin DA measurement of the total active Vitamin D in a biological specimen.1, 25-Dihydroxyvitamin D Measurement
VITDITC9226825-Hydroxyvitamin D;Inactive Vitamin DA measurement of the total inactive Vitamin D in a biological specimen.25-Hydroxyvitamin D Measurement
VITEC74906Vitamin EA measurement of the Vitamin E in a biological specimen.Vitamin E Measurement
VITECHOLC103448Vitamin E/CholesterolA relative measurement (ratio or percentage) of vitamin E to total cholesterol in a biological specimen.Vitamin E to Cholesterol Ratio Measurement
VITKC74907Naphthoquinone;Vitamin KA measurement of the total Vitamin K in a biological specimen.Vitamin K Measurement
VITK1C103449Phylloquinone;PhytomenadioneA measurement of the Vitamin K1 in a biological specimen.Vitamin K1 Measurement
VLDLC105589VLDL CholesterolA measurement of the very low density lipoprotein cholesterol in a biological specimen.Very Low Density Lipoprotein Cholesterol Measurement
VLDLPSZC103450VLDL Particle SizeA measurement of the average particle size of very-low-density lipoprotein in a biological specimen.VLDL Particle Size Measurement
VMAC74875Vanillyl Mandelic Acid;Vanilmandelic AcidA measurement of the vanillyl mandelic acid metabolite in a biological specimen.Vanillyl Mandelic Acid Measurement
VOLUMEC74720VolumeA measurement of the volume of a biological specimen.Volume Measurement
VZVABC117867Varicella Zoster Virus AntibodyA measurement of the total varicella zoster virus antibody in a biological specimen.Varicella Zoster Virus Antibody Measurement
VZVIGAABC98795Varicella Zoster Virus IgA AntibodyA measurement of the Varicella Zoster virus IgA antibodies in a biological specimen.Varicella Zoster Virus IgA Antibody Measurement
VZVIGGABC98796Varicella Zoster Virus IgG AntibodyA measurement of the Varicella Zoster virus IgG antibodies in a biological specimen.Varicella Zoster Virus IgG Antibody Measurement
VZVIGMABC98797Varicella Zoster Virus IgM AntibodyA measurement of the Varicella Zoster virus IgM antibodies in a biological specimen.Varicella Zoster Virus IgM Antibody Measurement
WBCC51948Leukocytes;White Blood CellsA measurement of the leukocytes in a biological specimen.Leukocyte Count
WBCCLMPC92246Leukocyte Cell Clumps;WBC Clumps;White Blood Cell ClumpsA measurement of white blood cell clumps in a biological specimen.Leukocyte Cell Clumps Measurement
WBCMORPHC92297Leukocyte Cell Morphology;WBC Morphology;White Blood Cell MorphologyAn examination or assessment of the form and structure of white blood cells.Leukocyte Cell Morphology
YEASTC74664Yeast CellsA measurement of the yeast cells present in a biological specimen.Yeast Cell Measurement
YEASTBUDC106504Budding Yeast;Yeast BuddingA measurement of the budding yeast present in a biological specimen.Budding Yeast Measurement
YEASTHYPC92239Yeast HyphaeA measurement of the yeast hyphae present in a biological specimen.Yeast Hyphae Screening
ZINCC80210ZincA measurement of the zinc in a biological specimen.Zinc Measurement
Back to top
CL.C67154.LBTESTLaboratory Test Name
(LBTEST)
text
Extensible: Yes
C67154Laboratory Test NameTerminology used for laboratory test names of the CDISC Standard Data Tabulation Model.CDISC SDTM Laboratory Test Terminology by Name
1, 25-Dihydroxyvitamin DC922671, 25-Dihydroxyvitamin D;Active Vitamin DA measurement of the total active Vitamin D in a biological specimen.1, 25-Dihydroxyvitamin D Measurement
11-Dehydro-Thromboxane B2C10334411-Dehydro-Thromboxane B2A measurement of the 11-dehydro-thromboxane B2 in a biological specimen.11-Dehydro-Thromboxane B2 Measurement
25-Hydroxyvitamin DC9226825-Hydroxyvitamin D;Inactive Vitamin DA measurement of the total inactive Vitamin D in a biological specimen.25-Hydroxyvitamin D Measurement
3,4-Dihydroxyphenylacetic AcidC1033453,4-Dihydroxyphenylacetic AcidA measurement of the 3,4-dihydroxyphenylacetic acid in a biological specimen.3,4-Dihydroxyphenylacetic Acid Measurement
3,4-DihydroxyphenylglycolC1010173,4-Dihydroxyphenylglycol;3.4 DihydroxyphenylglycolA measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen.3,4-Dihydroxyphenylglycol Measurement
3,4-methylenedioxymethamphetamineC753593,4-methylenedioxymethamphetamine;EcstasyA measurement of the 3,4-methylenedioxymethamphetamine (MDMA) in a biological specimen.3,4-Methylenedioxymethamphetamine Measurement
5 Prime NucleotidaseC794375 Prime Nucleotidase;5'-Ribonucleotide PhosphohydrolaseA measurement of the 5'-nucleotidase in a biological specimen.5 Prime Nucleotidase Measurement
5-Hydroxyindoleacetic AcidC1122175-Hydroxyindoleacetic AcidA measurement of 5-hydroxyindoleacetic acid in a biological specimen.5-Hydroxyindoleacetic Acid Measurement
6-MonoacetylmorphineC748766-MonoacetylmorphineA measurement of the 6-monoacetylmorphine present in a biological specimen.6-Monoacetylmorphine Measurement
8-Iso-PGF2alpha/CreatinineC1192918-Iso-PGF2alpha/CreatinineA relative measurement (ratio or percentage) of the prostaglandin F2 alpha isoform 8 to creatinine in a biological specimen.8-Iso-Prostaglandin F2 Alpha to Creatinine Ratio Measurement
8-Iso-Prostaglandin F2 AlphaC1192928-Iso-Prostaglandin F2 AlphaA measurement of the prostaglandin F2 alpha isoform 8 in a biological specimen.8-Iso-Prostaglandin F2 Alpha Measurement
A Fetoprotein L3/A FetoproteinC96565A Fetoprotein L3/A FetoproteinA relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen.Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement
A Proliferation-Inducing LigandC111123A Proliferation-Inducing Ligand;CD256;TNFSF13;Tumor Necrosis Factor Ligand Superfamily Member 13A measurement of the a proliferation-inducing ligand in a biological specimen.A Proliferation-Inducing Ligand Measurement
Abnormal CellsC111124Abnormal CellsA measurement of the abnormal cells in a biological specimen.Abnormal Cell Count
AcanthocytesC74699AcanthocytesA measurement of the acanthocytes in a biological specimen.Acanthocyte Count
Acanthocytes/ErythrocytesC74633Acanthocytes/ErythrocytesA relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen.Acanthocyte to Erythrocyte Ratio Measurement
Acetoacetic AcidC92247Acetoacetate;Acetoacetic AcidA measurement of the acetoacetic acid in a biological specimen.Acetoacetic Acid Measurement
AcetylcholineC74838AcetylcholineA measurement of the acetylcholine hormone in a biological specimen.Acetylcholine Measurement
Acetylcholine Receptor AntibodyC96559Acetylcholine Receptor AntibodyA measurement of the acetylcholine receptor antibody in a biological specimen.Acetylcholine Receptor Antibody Measurement
AcetylcholinesteraseC96560AcetylcholinesteraseA measurement of the acetylcholinesterase in a biological specimen.Acetylcholinesterase Measurement
Acid PhosphataseC80163Acid PhosphataseA measurement of the acid phosphatase in a biological specimen.Acid Phosphatase Measurement
Acid Urate CrystalsC74912Acid Urate CrystalsA measurement of the acid urate crystals present in a biological specimen.Acid Urate Crystal Measurement
Activated Coagulation TimeC103348Activated Clot Time;Activated Clotting Time;Coagulation ActivatedA measurement of the inhibition of blood coagulation in response to anticoagulant therapies.Activated Coagulation Time
Activated Partial Thromboplastin TimeC38462Activated Partial Thromboplastin TimeA measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.Partial Thromboplastin Time
Activated Protein C ResistanceC100471Activated Protein C Resistance;Factor V Leiden ScreenA measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen.Activated Protein C Resistance Measurement
Activated PTT/StandardC98862Activated PTT/Standard;Activated PTT/Standard PTT;Activated Partial Thromboplastin Time/Standard Thromboplastin TimeA relative measurement (ratio or percentage) of the subject's partial thromboplastin time to a standard or control partial thromboplastin time.Activated PTT/Standard Ratio Measurement
Active GhrelinC112219Active Ghrelin;GhrelinA measurement of active ghrelin in a biological specimen.Active Ghrelin Measurement
Acyl Coenzyme A OxidaseC92286Acyl CoA Oxidase;Acyl Coenzyme A Oxidase;Fatty Acyl Coenzyme A OxidaseA measurement of the acyl coenzyme A oxidase in a biological specimen.Acyl Coenzyme A Oxidase Measurement
Adenosine DiphosphateC102257Adenosine DiphosphateA measurement of the adenosine diphosphate in a biological specimen.Adenosine Diphosphate Measurement
Adenovirus AntibodyC111125Adenovirus AntibodyA measurement of the adenovirus antibody in a biological specimen.Adenovirus Antibody Measurement
AdiponectinC74839AdiponectinA measurement of the adiponectin hormone in a biological specimen.Adiponectin Measurement
Adrenocorticotropic HormoneC74780Adrenocorticotropic HormoneA measurement of the adrenocorticotropic hormone in a biological specimen.Adrenocorticotropic Hormone Measurement
ADV Viral LoadC98705ADV Viral LoadA measurement of the adenovirus viral load in a biological specimen.Adenovirus Viral Load Measurement
Aggrecan Chondroitin Sulfate Epitope 846C112220846-Epitope;Aggrecan Chondroitin Sulfate Epitope 846;CS846;Chondroitin Sulfate Epitope 846;Chondroitin Sulfate Proteoglycan 1 Epitope 846A measurement of the 846 epitope present on the chondroitin sulfate chains of aggrecan in a biological specimen.Aggrecan Chondroitin Sulfate Epitope 846 Measurement
Agranular NeutrophilsC116200Agranular NeutrophilsA measurement of the agranular neutrophils in a biological specimen.Agranular Neutrophils Measurement
Alanine AminopeptidaseC100430Alanine AminopeptidaseA measurement of the alanine aminopeptidase in a biological specimen.Alanine Aminopeptidase Measurement
Alanine AminotransferaseC64433Alanine Aminotransferase;SGPTA measurement of the alanine aminotransferase in a biological specimen.Alanine Aminotransferase Measurement
AlbuminC64431Albumin;MicroalbuminA measurement of the albumin protein in a biological specimen.Albumin Measurement
Albumin Excretion RateC117829Albumin Excretion RateA measurement of the amount of albumin being excreted in urine over a defined period of time (e.g. one hour).Albumin Urine Excretion Rate
Albumin/CreatinineC74761Albumin/Creatinine;Microalbumin/Creatinine RatioA relative measurement (ratio or percentage) of the albumin to the creatinine in a biological specimen.Albumin To Creatinine Protein Ratio Measurement
Albumin/GlobulinC74894Albumin/GlobulinThe ratio of albumin to globulin in a biological specimen.Albumin to Globulin Ratio Measurement
Albumin/Total ProteinC103453Albumin/Total ProteinA relative measurement (ratio or percentage) of the albumin to total protein in a biological specimen.Albumin to Total Protein Ratio Measurement
AldolaseC74731AldolaseA measurement of the aldolase enzyme in a biological specimen.Aldolase Measurement
AldosteroneC74841AldosteroneA measurement of the aldosterone hormone in a biological specimen.Aldosterone Measurement
Alkaline PhosphataseC64432Alkaline PhosphataseA measurement of the alkaline phosphatase in a biological specimen.Alkaline Phosphatase Measurement
Alkaline Phosphatase/CreatinineC79438Alkaline Phosphatase/CreatinineA relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen.Alkaline Phosphatase to Creatinine Ratio Measurement
Alpha FetoproteinC74732Alpha FetoproteinA measurement of the alpha fetoprotein in a biological specimen.Alpha-fetoprotein Measurement
Alpha Fetoprotein ActivityC106499Alpha Fetoprotein ActivityA measurement of the alpha fetoprotein activity in a biological specimen.Alpha Fetoprotein Activity Measurement
Alpha Fetoprotein L1C96562Alpha Fetoprotein L1A measurement of the alpha fetoprotein L1 in a biological specimen.Alpha Fetoprotein L1 Measurement
Alpha Fetoprotein L2C96563Alpha Fetoprotein L2A measurement of the alpha fetoprotein L2 in a biological specimen.Alpha Fetoprotein L2 Measurement
Alpha Fetoprotein L3C96564Alpha Fetoprotein L3A measurement of the alpha fetoprotein L3 in a biological specimen.Alpha Fetoprotein L3 Measurement
Alpha Glutathione-S-TransferaseC79433Alpha Glutathione-S-TransferaseA measurement of the alpha form of glutathione S-transferase in a biological specimen.Alpha Glutathione-S-Transferase Measurement
Alpha Hydroxybutyrate DehydrogenaseC111126Alpha Hydroxybutyrate DehydrogenaseA measurement of the alpha-hydroxybutyrate dehydrogenase in a biological specimen.Alpha Hydroxybutyrate Dehydrogenase Measurement
Alpha TocopherolC103349Alpha TocopherolA measurement of the alpha tocopherol in a biological specimen.Alpha Tocopherol Measurement
Alpha Tocopherol/Vitamin EC103350Vitamin E Alpha TocopherolA relative measurement (ratio or percentage) of alpha-tocopherol to the total vitamin E in a biological specimen.Alpha Tocopherol to Vitamin E Ratio Measurement
Alpha-1 Acid GlycoproteinC100429Alpha-1 Acid GlycoproteinA measurement of the alpha-1 acid glycoprotein in a biological specimen.Alpha-1 Acid Glycoprotein Measurement
Alpha-1 AntitrypsinC80167Alpha-1 Antitrypsin;Serum Trypsin InhibitorA measurement of the alpha-1 antitrypsin in a biological specimen.Alpha-1 Antitrypsin Measurement
Alpha-1 GlobulinC92252A1-Globulin;Alpha-1 GlobulinA measurement of the proteins contributing to the alpha 1 fraction in a biological specimen.Alpha-1 Globulin Measurement
Alpha-1 Globulin/Total ProteinC92253Alpha-1 Globulin/Total ProteinA relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen.Alpha-1 Globulin to Total Protein Ratio Measurement
Alpha-1 MicroglobulinC100461Alpha-1 Microglobulin;Protein HCA measurement of the alpha-1 microglobulin in a biological specimen.Alpha-1 Microglobulin Measurement
Alpha-1 Microglobulin/CreatinineC100462Alpha-1 Microglobulin/CreatinineA relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen.Alpha-1 Microglobulin to Creatinine Ratio Measurement
Alpha-2 AntiplasminC103351Alpha-2 Plasmin InhibitorA measurement of the alpha-2 antiplasmin in a biological specimen.Alpha-2 Antiplasmin Measurement
Alpha-2 GlobulinC92254A2-Globulin;Alpha-2 GlobulinA measurement of the proteins contributing to the alpha 2 fraction in a biological specimen.Alpha-2 Globulin Measurement
Alpha-2 Globulin/Total ProteinC92255Alpha-2 Globulin/Total ProteinA relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen.Alpha-2 Globulin to Total Protein Ratio Measurement
Alpha-2 MacroglobulinC80168Alpha-2 MacroglobulinA measurement of the alpha-2 macroglobulin in a biological specimen.Alpha-2 Macroglobulin Measurement
Alpha-GST Excretion RateC119278Alpha-GST Excretion RateA measurement of the amount of Alpha Glutathione-S-Transferase being excreted in urine over a defined period of time (e.g. one hour).Alpha-GST Excretion Rate
ALT/ASTC106498ALT/ASTA relative measurement (ratio or percentage) of the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) present in a sample.Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement
AluminumC111127Al;AluminumA measurement of aluminum in a biological specimen.Aluminum Measurement
AmmoniaC74799Ammonia;NH3A measurement of the ammonia in a biological specimen.Ammonia Measurement
Ammonium Biurate CrystalsC105590Acid Ammonium Urate Crystals;Ammonium Biurate Crystals;Ammonium Urate CrystalsA measurement of the ammonium biurate crystals present in a biological specimen.Ammonium Biurate Crystals Measurement
Ammonium Oxalate CrystalsC74759Ammonium Oxalate CrystalsA measurement of the ammonium oxalate crystals present in a urine specimen.Urine Ammonium Oxalate Crystal Measurement
Amorphous CrystalsC74665Amorphous CrystalsA measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen.Amorphous Crystal Measurement
Amorphous Phosphate CrystalsC92243Amorphous Phosphate CrystalsA measurement of the amorphous phosphate crystals in a biological specimen.Amorphous Phosphate Crystals Measurement
Amorphous SedimentC74666Amorphous Debris;Amorphous SedimentA measurement of the amorphous sediment present in a biological specimen.Amorphous Sediment Measurement
Amorphous Urate CrystalsC92244Amorphous Urate CrystalsA measurement of the amorphous urate crystals in a biological specimen.Amorphous Urate Crystals Measurement
AmphetamineC74687AmphetamineA measurement of any amphetamine class drug present in a biological specimen.Amphetamine Drug Class Measurement
AmylaseC64434AmylaseA measurement of the total enzyme amylase in a biological specimen.Amylase Measurement
Amylase, PancreaticC98767Amylase, PancreaticA measurement of the pancreatic enzyme amylase in a biological specimen.Pancreatic Amylase Measurement
Amylase, SalivaryC98780Amylase, SalivaryA measurement of the salivary enzyme amylase in a biological specimen.Salivary Amylase Measurement
Amyloid Alpha Precursor ProteinC119268Amyloid Alpha Precursor ProteinA measurement of the amyloid alpha precursor protein present in a biological specimen.Amyloid Alpha Precursor Protein Measurement
Amyloid Beta 1-38C103352Amyloid Beta 1-38;Amyloid Beta 38;Amyloid Beta 38 ProteinA measurement of amyloid beta protein which is composed of peptides 1 to 38 in a biological specimen.Amyloid Beta 1-38 Measurement
Amyloid Beta 1-40C103353Amyloid Beta 1-40;Amyloid Beta 40;Amyloid Beta 40 ProteinA measurement of amyloid beta protein which is composed of peptides 1 to 40 in a biological specimen.Amyloid Beta 1-40 Measurement
Amyloid Beta 1-42C84809Amyloid Beta 1-42;Amyloid Beta 42;Amyloid Beta 42 ProteinA measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen.Beta Amyloid 42 Measurement
Amyloid Beta Precursor ProteinC105438Amyloid Beta Precursor;Amyloid Beta Precursor Protein;Amyloid Precursor Beta;Amyloid Precursor ProteinA measurement of the amyloid beta precursor protein present in a biological specimen.Amyloid Beta Precursor Protein Measurement
Amyloid PC81998Amyloid PA measurement of the total amyloid P in a biological specimen.Amyloid P Measurement
Amyloid, BetaC81999Amyloid, Beta;Beta AmyloidA measurement of the total amyloid beta in a biological specimen.Beta Amyloid Measurement
AndrostenediolC74842AndrostenediolA measurement of the androstenediol metabolite in a biological specimen.Androstenediol Metabolite Measurement
AndrostenedioneC748434-Androstenedione;AndrostenedioneA measurement of the androstenedione hormone in a biological specimen.Androstenedione Measurement
Angiopoietin 1C111128Angiopoietin 1A measurement of angiopoietin 1 in a biological specimen.Angiopoietin 1 Measurement
Angiotensin Converting EnzymeC80169Angiotensin Converting EnzymeA measurement of the angiotensin converting enzyme in a biological specimen.Angiotensin Converting Enzyme Measurement
Angiotensin IC74844Angiotensin IA measurement of the angiotensin I hormone in a biological specimen.Angiotensin I Measurement
Angiotensin IIC74845Angiotensin IIA measurement of the angiotensin II hormone in a biological specimen.Angiotensin II Measurement
AngiotensinogenC74846Angiotensin Precursor;AngiotensinogenA measurement of the angiotensinogen hormone in a biological specimen.Angiotensinogen Measurement
Anion GapC74685Anion GapA computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen.Anion Gap Measurement
AnisocytesC74797Anisocytes;AnisocytosisA measurement of the inequality in the size of the red blood cells in a whole blood specimen.Anisocyte Measurement
Anti-DNA AntibodiesC81973Anti-DNA Antibodies;Anti-ds-DNA AntibodiesA measurement of the anti-DNA antibodies in a biological specimen.Anti-DNA Antibody Measurement
Anti-Double Stranded DNAC74913Anti-Double Stranded DNAA measurement of the anti-double stranded DNA antibody in a biological specimen.Anti-Double Stranded DNA Measurement
Anti-Factor Xa ActivityC98706Anti-Factor Xa ActivityA measurement of the anti-activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen.Anti-Factor Xa Activity Measurement
Anti-Saccharomyces cerevisiae AntibodyC81976Anti-Saccharomyces cerevisiae AntibodyA measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen.Anti-Saccharomyces cerevisiae Antibody Measurement
Anti-Single Stranded DNA IgGC92269Anti-Single Stranded DNA IgGA measurement of the anti-single stranded DNA IgG antibody in a biological specimen.Anti-Single Stranded DNA IgG Measurement
AntidepressantsC74691AntidepressantsA measurement of any antidepressant class drug present in a biological specimen.Antidepressant Measurement
Antidiuretic HormoneC74847Antidiuretic Hormone;VasopressinA measurement of the antidiuretic hormone in a biological specimen.Antidiuretic Hormone Measurement
Antiglobulin Test, DirectC81974Antiglobulin Test, Direct;Direct Coombs TestA measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo.Direct Antiglobulin Test
Antiglobulin Test, IndirectC91372Antiglobulin Test, Indirect;Indirect Coombs TestA test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in a biological specimen.Indirect Antiglobulin Test
Antimitochondrial AntibodiesC81975Antimitochondrial Antibodies;Mitochondrial AntibodyA measurement of the antimitochondrial antibodies in a biological specimen.Antimitochondrial Antibody Measurement
Antinuclear AntibodiesC74916Antinuclear AntibodiesA measurement of the antinuclear antibodies (antibodies that attack the body's own tissue) in a biological specimen.Antinuclear Antibody Measurement
Antiphospholipid AntibodiesC102258Antiphospholipid AntibodiesA measurement of the antiphospholipid antibodies in a biological specimen.Antiphospholipid Antibody Measurement
AntithrombinC81958Antithrombin;Antithrombin Activity;Antithrombin III;Antithrombin III ActivityA measurement of the antithrombin activity in a biological specimen.Antithrombin Activity Measurement
Antithrombin AntigenC81977Antithrombin Antigen;Antithrombin III AntigenA measurement of the antithrombin antigen in a biological specimen.Antithrombin Antigen Measurement
Apolipoprotein A1C74733Apolipoprotein A1A measurement of the apolipoprotein A1 in the high density lipoproteins of a biological specimen.Apolipoprotein A1 Measurement
Apolipoprotein A4C103354Apolipoprotein A4A measurement of the apolipoprotein A4 in a biological specimen.Apolipoprotein A4 Measurement
Apolipoprotein A5C103355Apolipoprotein A5A measurement of the apolipoprotein A5 in a biological specimen.Apolipoprotein A5 Measurement
Apolipoprotein AIIC82000Apolipoprotein AIIA measurement of the apolipoprotein AII in a biological specimen.Apolipoprotein AII Measurement
Apolipoprotein BC74734Apolipoprotein BA measurement of the apolipoprotein B in the low density lipoproteins of a biological specimen.Apolipoprotein B Measurement
Apolipoprotein B/Apolipoprotein A1C103356Apolipoprotein B/Apolipoprotein A1A relative measurement (ratio or percentage) of the Apolipoprotein B to Apolipoprotein A1 in a biological specimen.Apolipoprotein B to Apolipoprotein A1 Ratio Measurement
Apolipoprotein C2C100427Apolipoprotein C2;Apolipoprotein CIIA measurement of the apolipoprotein C2 in a biological specimen.Apolipoprotein C2 Measurement
Apolipoprotein CIIIC82001Apolipoprotein CIIIA measurement of the apolipoprotein CIII in a biological specimen.Apolipoprotein CIII Measurement
Apolipoprotein EC82002Apolipoprotein EA measurement of the apolipoprotein E in a biological specimen.Apolipoprotein E Measurement
Apolipoprotein E4C92293Apolipoprotein E4A measurement of the apolipoprotein E4 in a biological specimen.Apolipoprotein E4 Measurement
Apolipoprotein HC82003Apolipoprotein HA measurement of the apolipoprotein H in a biological specimen.Apolipoprotein H Measurement
Apolipoprotein JC100428Apolipoprotein J;ClusterinA measurement of the apolipoprotein J in a biological specimen.Apolipoprotein J Measurement
Apolipoprotein J/CreatinineC111130Apolipoprotein J/Creatinine;Clusterin/CreatinineA relative measurement (ratio or percentage) of the apolipoprotein J to creatinine in a biological specimen.Apolipoprotein J to Creatinine Ratio Measurement
Arachidonic AcidC102259Arachidonic AcidA measurement of the arachidonic acid present in a biological specimen.Arachidonic Acid Measurement
Aspartate AminotransferaseC64467Aspartate Aminotransferase;SGOTA measurement of the aspartate aminotransferase in a biological specimen.Aspartate Aminotransferase Measurement
Aspartate Aminotransferase AntigenC81978Aspartate Aminotransferase Antigen;SGOT AntigenA measurement of the aspartate aminotransferase antigen in a biological specimen.Aspartate Aminotransferase Antigen Measurement
Aspartate Aminotransferase/CreatinineC117830Aspartate Aminotransferase/CreatinineA relative measurement (ratio or percentage) of the aspartate aminotransferase to creatinine in a biological specimen.Aspartate Aminotransferase to Creatinine Ratio Measurement
Atrial Natriuretic PeptideC74886Atrial Natriuretic Peptide;AtriopeptinA measurement of the atrial natriuretic peptide in a biological specimen.Atrial Natriuretic Peptide Measurement
Auer RodsC74657Auer RodsA measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen.Auer Rod Measurement
Azurophilic GranulesC116185Azurophilic Granulation;Azurophilic GranulesAn observation of azurophilic granules in a biological specimen.Azurophilic Granule Measurement
B-Cell Activating FactorC111135B-Cell Activating FactorA measurement of the B-cell activating factor in a biological specimen.B-Cell Activating Factor Measurement
BacteriaC64469BacteriaA measurement of the bacteria in a biological specimen.Bacterial Count
Bacterial CastsC74762Bacterial CastsA measurement of the bacterial casts present in a biological specimen.Bacterial Cast Measurement
BarbituratesC74688BarbituratesA measurement of any barbiturate class drug present in a biological specimen.Barbiturate Drug Class Measurement
Base ExcessC119270Base ExcessA measurement of the amount of acid or alkali required to return a biological specimen to a normal pH under standard conditions.Base Excess Measurement
Basophilic StipplingC96567Basophilic StipplingA measurement of the basophilic stippling in a biological specimen.Basophilic Stippling Measurement
BasophilsC64470BasophilsA measurement of the basophils in a biological specimen.Total Basophil Count
Basophils/LeukocytesC64471Basophils/LeukocytesA relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen.Basophil to Leukocyte Ratio
Basophils/Total CellsC98865Basophils/Total CellsA relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen).Basophil to Total Cell Ratio Measurement
Bence-Jones ProteinC111136Bence-Jones Protein;Immunoglobulin Light ChainsA measurement of the total Bence-Jones protein in a biological specimen.Bence-Jones Protein Measurement
BenzodiazepineC74692BenzodiazepineA measurement of any benzodiazepine class drug present in a biological specimen.Benzodiazepine Measurement
BenzoylecgonineC75350Benzoylecgonine;Cocaine MetaboliteA measurement of the benzoylecgonine in a biological specimen.Benzoylecgonine Measurement
Beta CaroteneC100472Beta Carotene;Beta Carotin;b-CaroteneA measurement of the beta carotene in a biological specimen.Beta Carotene Measurement
Beta CateninC103357Beta CateninA measurement of the beta catenin in a biological specimen.Beta Catenin Measurement
Beta GlobulinC92256Beta GlobulinA measurement of the proteins contributing to the beta fraction in a biological specimen.Beta Globulin Measurement
Beta Globulin/Total ProteinC92294Beta Globulin/Total ProteinA relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen.Beta Globulin to Total Protein Ratio Measurement
Beta-1 GlobulinC119274Beta-1 GlobulinA measurement of the beta-1 globulin in a biological specimen.Beta-1 Globulin Measurement
Beta-1 Globulin/Total ProteinC119275Beta-1 Globulin/Total ProteinA relative measurement (ratio or percentage) of beta-1-fraction proteins to total proteins in a biological specimen.Beta-1 Globulin to Total Protein Ratio Measurement
Beta-2 GlobulinC119276Beta-2 GlobulinA measurement of the beta-2 globulin in a biological specimen.Beta-2 Globulin Measurement
Beta-2 Globulin/Total ProteinC119277Beta-2 Globulin/Total ProteinA relative measurement (ratio or percentage) of beta-2-fraction proteins to total proteins in a biological specimen.Beta-2 Globulin to Total Protein Ratio Measurement
Beta-2 Glycoprotein 1 IgG AntibodyC103358Beta-2 Glycoprotein 1 IgG AntibodyA measurement of the Beta-2 glycoprotein 1 IgG antibodies in a biological specimen.Beta-2 Glycoprotein 1 IgG Antibody Measurement
Beta-2 Glycoprotein 1 IgM AntibodyC103359Beta-2 Glycoprotein 1 IgM AntibodyA measurement of the Beta-2 glycoprotein 1 IgM antibodies in a biological specimen.Beta-2 Glycoprotein 1 IgM Antibody Measurement
Beta-2 Glycoprotein AntibodyC81979Beta-2 Glycoprotein AntibodyA measurement of the beta-2 glycoprotein antibody in a biological specimen.Beta-2 Glycoprotein Antibody Measurement
Beta-2 MicroglobulinC81980Beta-2 MicroglobulinA measurement of the beta-2 microglobulin in a biological specimen.Beta-2 Microglobulin Measurement
Beta-HydroxybutyrateC965683-Hydroxybutyrate;B-Hydroxybutyrate;Beta-HydroxybutyrateA measurement of the total Beta-hydroxybutyrate in a biological specimen.Beta-Hydroxybutyrate Measurement
Beta-Trace ProteinC100426Beta-Trace ProteinA measurement of the beta-trace protein in a biological specimen.Beta-Trace Protein Measurement
BicarbonateC74667Bicarbonate;HCO3A measurement of the bicarbonate in a biological specimen.Bicarbonate Measurement
Bile AcidC74800Bile Acid;Bile Acids;Bile Salt;Bile SaltsA measurement of the total bile acids in a biological specimen.Bile Acid Measurement
BilirubinC38037Bilirubin;Total BilirubinA measurement of the total bilirubin in a biological specimen.Total Bilirubin Measurement
Bilirubin CrystalsC74668Bilirubin CrystalsA measurement of the bilirubin crystals present in a biological specimen.Bilirubin Crystal Measurement
Bioavailable TestosteroneC117860Bioavailable TestosteroneA measurement of bioavailable testosterone in a biological specimen.Bioavailable Testosterone Measurement
Bite CellsC74700Bite CellsA measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen.Bite Cell Count
Bite Cells/ErythrocytesC74634Bite Cells/ErythrocytesA relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen.Bite Cell to Erythrocyte Ratio Measurement
BKV Viral LoadC98710BKV Viral LoadA measurement of the BK virus viral load in a biological specimen.BK Virus Viral Load Measurement
BlastsC74605BlastsA measurement of the blast cells in a biological specimen.Blast Count
Blasts/LeukocytesC64487Blasts/LeukocytesA relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen.Blast to Leukocyte Ratio
Blood Urea NitrogenC61019Blood Urea NitrogenA measurement of the urea nitrogen in a blood specimen.Blood Urea Nitrogen Measurement
Bone Specific Alkaline PhosphataseC92287Bone Specific Alkaline PhosphataseA measurement of the bone specific alkaline phosphatase isoform in a biological specimen.Bone Specific Alkaline Phosphatase Measurement
Brain Natriuretic PeptideC74735B-Type Natriuretic Peptide;Brain Natriuretic PeptideA measurement of the brain (B-type) natriuretic peptide in a biological specimen.Brain Natriuretic Peptide Measurement
Brain-Derived Neurotrophic FactorC82004Brain-Derived Neurotrophic FactorA measurement of the brain-derived neurotrophic factor in a biological specimen.Brain-Derived Neurotrophic Factor Measurement
Broad CastsC96588Broad CastsA measurement of the broad casts in a biological specimen.Broad Casts Measurement
BUN/CreatinineC74753BUN/CreatinineA relative measurement (ratio or percentage) (ratio) of the blood urea nitrogen (BUN) to the creatinine in a biological specimen.Blood Urea Nitrogen To Creatinine Ratio Measurement
Burr CellsC74701Burr Cells;KeratocytesA measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen.Burr Cell Count
ButyrylcholinesteraseC111142Acylcholine Acylhydrolase;Butyrylcholinesterase;Non-neuronal Cholinesterase;Plasma Cholinesterase;PseudocholinesteraseA measurement of the total butyrylcholinesterase in a biological specimen.Butyrylcholinesterase Measurement
C Reactive ProteinC64548C Reactive ProteinA measurement of the C reactive protein in a biological specimen.C-Reactive Protein Measurement
C-peptideC74736C-peptideA measurement of the C (connecting) peptide of insulin in a biological specimen.C-peptide Measurement
Cabot RingsC74702Cabot RingsA measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen.Cabot Ring Count
CaffeineC75346CaffeineA measurement of the caffeine in a biological specimen.Caffeine Measurement
CalcitoninC74848CalcitoninA measurement of the calcitonin hormone in a biological specimen.Calcitonin Measurement
CalcitriolC74849CalcitriolA measurement of the calcitriol hormone in a biological specimen.Calcitriol Measurement
CalciumC64488CalciumA measurement of the calcium in a biological specimen.Calcium Measurement
Calcium - Phosphorus ProductC103360Calcium - Phosphorus ProductA measurement of the product of the calcium and phosphate measurements in a biological specimen.Calcium and Phosphorus Product Measurement
Calcium Carbonate CrystalsC74669Calcium Carbonate CrystalsA measurement of the calcium carbonate crystals present in a biological specimen.Calcium Carbonate Crystal Measurement
Calcium ClearanceC96589Calcium ClearanceA measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute).Calcium Clearance Measurement
Calcium CorrectedC119272Calcium CorrectedA measurement of calcium, which has been corrected for albumin, in a biological specimen.Calcium Corrected Measurement
Calcium Excretion RateC117831Calcium Excretion RateA measurement of the amount of calcium being excreted in urine over a defined period of time (e.g. one hour).Calcium Urine Excretion Rate
Calcium Oxalate CrystalsC74670Calcium Oxalate CrystalsA measurement of the calcium oxalate crystals present in a biological specimen.Calcium Oxalate Crystal Measurement
Calcium Phosphate CrystalsC74671Calcium Phosphate CrystalsA measurement of the calcium phosphate crystals present in a biological specimen.Calcium Phosphate Crystal Measurement
Calcium SulphateC96590Calcium SulphateA measurement of the calcium sulphate in a biological specimen.Calcium Sulphate Measurement
Calcium, IonizedC81948Calcium, IonizedA measurement of the ionized calcium in a biological specimen.Ionized Calcium Measurement
Calcium/CreatinineC79439Calcium/CreatinineA relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen.Calcium to Creatinine Ratio Measurement
CalprotectinC82005CalprotectinA measurement of the calprotectin in a biological specimen.Calprotectin Measurement
Cancer Antigen 1C103361Cancer Antigen 1A measurement of the cancer antigen 1 in a biological specimen.Cancer Antigen 1 Measurement
Cancer Antigen 125C79089Cancer Antigen 125A measurement of the cancer antigen 125 in a biological specimen.CA-125 Measurement
Cancer Antigen 15-3C103362Cancer Antigen 15-3A measurement of the cancer antigen 15-3 in a biological specimen.Cancer Antigen 15-3 Measurement
Cancer Antigen 19-9C81982Cancer Antigen 19-9A measurement of the cancer antigen 19-9 in a biological specimen.Cancer Antigen 19-9 Measurement
Cancer Antigen 27-29C111143Cancer Antigen 27-29A measurement of the cancer antigen 27-29 in a biological specimen.Cancer Antigen 27-29 Measurement
Cancer Antigen 72-4C106505CA 72-4;Cancer Antigen 72-4;Carbohydrate Antigen 72-4A measurement of the cancer antigen 72-4 in a biological specimen.Cancer Antigen 72-4 Measurement
CannabinoidsC74689CannabinoidsA measurement of any cannabinoid class drug present in a biological specimen.Cannabinoid Drug Class Measurement
Carbohydrate-Deficient TransferrinC101016Carbohydrate-Deficient TransferrinA measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen.Carbohydrate-Deficient Transferrin Measurement
Carbon DioxideC64545Carbon DioxideA measurement of the carbon dioxide gas in a biological specimen.Carbon Dioxide Measurement
CarboxyhemoglobinC96591CarboxyhemoglobinA measurement of the carboxyhemoglobin, carbon monoxide-bound hemoglobin, in a biological specimen.Carboxyhemoglobin Measurement
Carcinoembryonic AntigenC81983Carcinoembryonic AntigenA measurement of the carcinoembryonic antigen in a biological specimen.Carcinoembryonic Antigen Measurement
Cardiolipin IgG AntibodyC111144Anti-Cardiolipin IgG Antibody;Cardiolipin IgG AntibodyA measurement of the cardiolipin IgG antibody in a biological specimen.Cardiolipin IgG Antibody Measurement
Cardiolipin IgM AntibodyC103363Cardiolipin IgM AntibodyA measurement of the cardiolipin IgM antibodies in a biological specimen.Cardiolipin IgM Antibody Measurement
CarnitineC74682CarnitineA measurement of the total carnitine in a biological specimen.Total Carnitine Measurement
Carnitine Acetyl TransferaseC92288Carnitine Acetyl TransferaseA measurement of the carnitine acetyl transferase in a biological specimen.Carnitine Acetyl Transferase Measurement
Carnitine, FreeC74677Carnitine, FreeA measurement of the free carnitine in a biological specimen.Free Carnitine Measurement
Cartilage Oligomeric Matrix ProteinC111145Cartilage Oligomeric Matrix ProteinA measurement of the cartilage oligomeric matrix protein in a biological specimen.Cartilage Oligomeric Matrix Protein Measurement
CastsC74763CastsA statement that indicates casts were looked for in a biological specimen.Cast Present Or Absent
CD1C103364CD1A count of the CD1 expressing cells per unit of a biological specimen.CD1 Expressing Cell Measurement
CD10C111146CD10A measurement of the CD10 expressing cells per unit in a biological specimen.CD10 Expressing Cell Count
CD11AC105439CD11A;CD11aA count of the CD11a expressing cells per unit of a biological specimen.CD11A Expressing Cell Count
CD11BC105440CD11B;CD11b;Complement Component 3 Receptor 3 Subunit;Complement Receptor Type 3 Alpha Subunit;ITGAM Protein;Integrin Alpha-MA count of the CD11b expressing cells per unit of a biological specimen.CD11B Expressing Cell Count
CD13C111147CD13A measurement of the CD13 expressing cells per unit in a biological specimen.CD13 Expressing Cell Count
CD14C103365CD14A count of the CD14 expressing cells per unit of a biological specimen.CD14 Expressing Cell Measurement
CD19C103808CD19A count of the CD19 expressing cells per unit in a biological specimen.CD19 Expressing Cell Count
CD19/LymphocytesC103812CD19/LymphocytesA relative measurement (ratio or percentage) of CD19 expressing cells to all lymphocytes in a biological specimen.CD19 Cell to Lymphocyte Ratio Measurement
CD2C103366CD2A count of the CD2 expressing cells per unit of a biological specimen.CD2 Expressing Cell Measurement
CD2/LymphocytesC103367CD2/LymphocytesA relative measurement (ratio or percentage) of CD2 expressing cells to all lymphocytes in a biological specimen.CD2 Expressing Cell to Lymphocyte Ratio Measurement
CD20C103368CD20A count of the CD20 expressing cells per unit of a biological specimen.CD20 Expressing Cell Measurement
CD22C111148CD22A measurement of the CD22 expressing cells per unit in a biological specimen.CD22 Expressing Cell Count
CD23C111149CD23A measurement of the CD23 expressing cells per unit in a biological specimen.CD23 Expressing Cell Count
CD3C103809CD3A count of the CD3 expressing cells per unit in a biological specimen.CD3 Expressing Cell Count
CD3/LymphocytesC103813CD3/LymphocytesA relative measurement (ratio or percentage) of CD3 expressing cells to all lymphocytes in a biological specimen.CD3 Cell to Lymphocyte Ratio Measurement
CD33C111150CD33A measurement of the CD33 expressing cells per unit in a biological specimen.CD33 Expressing Cell Count
CD34C102260CD34A measurement of the CD34 expressing cells per unit in a biological specimen.CD34 Measurement
CD38C111151CD38A measurement of the CD38 expressing cells per unit in a biological specimen.CD38 Expressing Cell Count
CD4C103810CD4A count of the CD4 expressing cells per unit in a biological specimen.CD4 Expressing Cell Count
CD4/CD8C103814CD4/CD8A relative measurement (ratio or percentage) of CD4 expressing cells to the CD8 expressing cells in a biological specimen.CD4 Cell to CD8 Cell Ratio Measurement
CD4/LymphocytesC103815CD4/LymphocytesA relative measurement (ratio or percentage) of CD4 expressing cells to all lymphocytes in a biological specimen.CD4 Cell to Lymphocyte Ratio Measurement
CD40C82006CD40A count of the CD40 cells per unit in a biological specimen.CD40 Measurement
CD40 LigandC82007CD40 LigandA count of the CD40 ligand cells per unit in a biological specimen.CD40 Ligand Measurement
CD5C103369CD5A count of the CD5 expressing cells per unit of a biological specimen.CD5 Expressing Cell Measurement
CD56C103370CD56A count of the CD56 expressing cells per unit of a biological specimen.CD56 Expressing Cell Measurement
CD79AC111152CD79AA measurement of the CD79A expressing cells per unit in a biological specimen.CD79A Expressing Cell Count
CD8C103811CD8A count of the CD8 expressing cells per unit in a biological specimen.CD8 Expressing Cell Count
CD8/LymphocytesC103816CD8/LymphocytesA relative measurement (ratio or percentage) of CD8 expressing cells to all lymphocytes in a biological specimen.CD8 Cell to Lymphocyte Ratio Measurement
Cellular CastsC74764Cellular CastsA measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen.Cellular Cast Measurement
CellularityC111153Cellularity;Cellularity GradeA measurement of the degree, quality or condition of cells in a biological specimen.Cellularity Measurement
Centromere B AntibodiesC111154Anti-Centromere B AntibodiesA measurement of centromere B antibodies in a biological specimen.Centromere B Antibody Measurement
CeruloplasminC100432Caeruloplasmin;CeruloplasminA measurement of ceruloplasmin in a biological specimen.Ceruloplasmin Measurement
Chemokine (C-C Motif) Ligand 17C112236ABCD-2;Chemokine (C-C Motif) Ligand 17;SCYA17;TARC;Thymus and Activation Regulated ChemokineA measurement of the CCL17, chemokine (C-C motif) ligand 17, in a biological specimen.Chemokine (C-C Motif) Ligand 17 Measurement
Chemokine (C-C Motif) Ligand 18C112237AMAC-1;AMAC1;CKB7;Chemokine (C-C Motif) Ligand 18;DC-CK1;DCCK1;MIP-4;Macrophage inflammatory protein-4;PARC;Pulmonary and Activation-Regulated Chemokine;SCYA18A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen.Chemokine (C-C Motif) Ligand 18 Measurement
Chemokine (C-X-C Motif) Ligand 10C112238Chemokine (C-X-C Motif) Ligand 10;IP-10;Interferon Gamma-induced Protein 10;Small-inducible Cytokine B10A measurement of the CXCL10, chemokine (C-X-C motif) ligand 10, in a biological specimen.Chemokine (C-X-C Motif) Ligand 10 Measurement
Chemokine (C-X-C Motif) Receptor 3C100431CD183;CXCR3;Chemokine (C-X-C Motif) Receptor 3;GPR9A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen.Chemokine Receptor CXCR3 Measurement
Chlamydia pneumoniae IgA AntibodyC92432Chlamydia pneumoniae IgA AntibodyA measurement of the Chlamydia pneumoniae IgA antibody in a biological specimen.Chlamydia pneumoniae IgA Antibody Measurement
Chlamydia pneumoniae IgM AntibodyC92433Chlamydia pneumoniae IgM AntibodyA measurement of the Chlamydia pneumoniae IgM in a biological specimen.Chlamydia pneumoniae IgM Antibody Measurement
Chlamydia trachomatis IgA AntibodyC100464Chlamydia trachomatis IgA AntibodyA measurement of the Chlamydia trachomatis IgA antibody in a biological specimen.Chlamydia trachomatis IgA Antibody Measurement
Chlamydia trachomatis IgG AntibodyC100466Chlamydia trachomatis IgG AntibodyA measurement of the Chlamydia trachomatis IgG antibody in a biological specimen.Chlamydia trachomatis IgG Antibody Measurement
Chlamydia trachomatis IgM AntibodyC100465Chlamydia trachomatis IgM AntibodyA measurement of the Chlamydia trachomatis IgM antibody in a biological specimen.Chlamydia trachomatis IgM Antibody Measurement
ChlorideC64495ChlorideA measurement of the chloride in a biological specimen.Chloride Measurement
Chloride ClearanceC106509Chloride ClearanceA measurement of the volume of serum or plasma that would be cleared of chloride by excretion of urine for a specified unit of time (e.g. one minute).Chloride Clearance Measurement
Chloride Excretion RateC117832Chloride Excretion RateA measurement of the amount of chloride being excreted in urine over a defined period of time (e.g. one hour).Chloride Urine Excretion Rate
Chloride/CreatinineC79440Chloride/CreatinineA relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen.Chloride to Creatinine Ratio Measurement
CholecystokininC74850Cholecystokinin;PancreozyminA measurement of the cholecystokinin hormone in a biological specimen.Cholecystokinin Measurement
Cholera Toxin B Subunit IgG AntibodyC116194Cholera Toxin B Subunit IgG AntibodyA measurement of the cholera toxin B subunit IgG antibody in a biological specimen.Cholera Toxin B Subunit IgG Antibody Measurement
CholesterolC105586Cholesterol;Total CholesterolA measurement of the cholesterol in a biological specimen.Cholesterol Measurement
Cholesterol CrystalsC74672Cholesterol CrystalsA measurement of the cholesterol crystals present in a biological specimen.Cholesterol Crystal Measurement
Cholesterol/HDL-CholesterolC80171Cholesterol/HDL-CholesterolA relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen.Cholesterol to HDL-Cholesterol Ratio Measurement
Cholesteryl Ester Transfer Protein ActC103380Cholesteryl Ester Transfer Protein ActA measurement of the biological activity of cholesteryl ester transfer protein in a biological specimen.Cholesteryl Ester Transfer Protein Activity Measurement
CholinesteraseC92289CholinesteraseA measurement of the cholinesterase in a biological specimen.Cholinesterase Measurement
Choriogonadotropin BetaC64851Choriogonadotropin Beta;Pregnancy TestA measurement of the Choriogonadotropin Beta in a biological specimen.Choriogonadotropin Beta Measurement
ChymotrypsinC111159ChymotrypsinA measurement of the total chymotrypsin in a biological specimen.Chymotrypsin Measurement
Circulating Endothelial CellsC96592Circulating Endothelial CellsA measurement of the circulating endothelial cells in a biological specimen.Circulating Endothelial Cell Count
Circulating Tumor CellsC96593Circulating Tumor CellsA measurement of the circulating tumor cells in a biological specimen.Circulating Tumor Cell Count
CitrateC92248CitrateA measurement of the citrate in a biological specimen.Citrate Measurement
ClarityC96594ClarityA measurement of the transparency of a biological specimen.Clarity Measurement
Clostridium difficile ToxinC103381Clostridium difficile ToxinA measurement of the Clostridium difficile toxin in a biological specimen.Clostridium difficile Toxin Measurement
Clostridium tetani IgG AntibodyC103382Clostridium tetani IgG AntibodyA measurement of the Clostridium tetani IgG antibody in a biological specimen.Clostridium tetani IgG Antibody Measurement
Clue CellsC102261Clue CellsA measurement of the clue cells in a biological specimen.Clue Cell Count
CMV Viral LoadC98716CMV Viral LoadA measurement of the cytomegalovirus viral load in a biological specimen.Cytomegalovirus Viral Load Measurement
Coagulation IndexC112239CI;Coagulation IndexA measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation.Coagulation Index Measurement
CocaineC74690CocaineA measurement of the cocaine present in a biological specimen.Cocaine Measurement
Coccidioides AntibodyC111160Coccidioides AntibodyA measurement of the coccidioides antibody in a biological specimen.Coccidioides Antibody Measurement
CodeineC74877CodeineA measurement of the codeine present in a biological specimen.Codeine Measurement
Collagen Type IVC103383Collagen Type IVA measurement of the collagen type IV in a biological specimen.Collagen Type IV Measurement
ColorC64546ColorA measurement of the color of a biological specimen.Color Assessment
Complement BbC80172Bb Fragment of Complement Factor B;Bb Fragment of Factor B;Complement BbA measurement of the Bb fragment of complement factor B in a biological specimen.Complement Bb Measurement
Complement C1q AntibodyC80173Complement C1q AntibodyA measurement of the complement C1q antibody in a biological specimen.Complement C1q Antibody Measurement
Complement C3C80174Complement C3A measurement of the complement C3 in a biological specimen.Complement C3 Measurement
Complement C3aC80175ASP, Complement C3 DesArg, Acetylation-stimulating Protein;Complement C3aA measurement of the complement C3a in a biological specimen.Complement C3a Measurement
Complement C3bC80176Complement C3bA measurement of the complement C3b in a biological specimen.Complement C3b Measurement
Complement C3d AntibodyC119271Complement C3d AntibodyA measurement of the complement C3d antibody in a biological specimen.Complement C3d Antibody Measurement
Complement C4C80177Complement C4A measurement of the complement C4 in a biological specimen.Complement C4 Measurement
Complement C4aC80178Complement C4aA measurement of the complement C4a in a biological specimen.Complement C4a Measurement
Complement C5aC80179Complement C5aA measurement of the complement C5a in a biological specimen.Complement C5a Measurement
Complement CH50C100423CH50;Complement CH50;Total Hemolytic ComplementA measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen.CH50 Measurement
Complement TotalC80160Complement TotalA measurement of the total complement in a biological specimen.Complement Measurement
CopperC111161Copper;CuA measurement of copper in a biological specimen.Copper Measurement
CorticosteroneC79434CorticosteroneA measurement of corticosterone in a biological specimen.Corticosterone Measurement
Corticosterone/CreatinineC106511Corticosterone/CreatinineA relative measurement (ratio or percentage) of the corticosterone to creatinine present in a sample.Corticosterone to Creatinine Ratio Measurement
Corticotropin Releasing HormoneC74851Corticotropin Releasing Factor;Corticotropin Releasing HormoneA measurement of the corticotropin releasing hormone in a biological specimen.Corticotropin Releasing Hormone Measurement
CortisolC74781Cortisol;Total CortisolA measurement of the cortisol in a biological specimen.Cortisol Measurement
Cortisol, FreeC88113Cortisol, FreeA measurement of the free, unbound cortisol in a biological specimen.Free Cortisol Measurement
Cortisol/CreatinineC106512Cortisol/CreatinineA relative measurement (ratio or percentage) of the cortisol to creatinine present in a sample.Cortisol to Creatinine Ratio Measurement
CotinineC92249CotinineA measurement of the cotinine in a biological specimen.Cotinine Measurement
Creatine KinaseC64489Creatine KinaseA measurement of the total creatine kinase in a biological specimen.Creatine Kinase Measurement
Creatine Kinase BBC64490Creatine Kinase BBA measurement of the homozygous B-type creatine kinase in a biological specimen.Creatine Kinase BB Measurement
Creatine Kinase BB/Total Creatine KinaseC79466Creatine Kinase BB/Total Creatine KinaseA relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase BB to Total Creatine Kinase Ratio Measurement
Creatine Kinase MBC64491Creatine Kinase MBA measurement of the heterozygous MB-type creatine kinase in a biological specimen.Creatine Kinase MB Measurement
Creatine Kinase MB/Total Creatine KinaseC79441Creatine Kinase MB/Total Creatine KinaseA relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase MB to Total Creatine Kinase Ratio Measurement
Creatine Kinase MMC64494Creatine Kinase MMA measurement of the homozygous M-type creatine kinase in a biological specimen.Creatine Kinase MM Measurement
Creatine Kinase MM/Total Creatine KinaseC79442Creatine Kinase MM/Total Creatine KinaseA relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen.Creatine Kinase MM to Total Creatine Kinase Ratio Measurement
CreatinineC64547CreatinineA measurement of the creatinine in a biological specimen.Creatinine Measurement
Creatinine ClearanceC25747Creatinine ClearanceA measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute).Creatinine Clearance
Creatinine Excretion RateC117833Creatinine Excretion RateA measurement of the amount of creatinine being excreted in urine over a defined amount of time (e.g. one hour).Creatinine Urine Excretion Rate
Crenated CellsC74703Crenated Cells;EchinocytesA measurement of the Burr cells (erythrocytes characterized by the presence of multiple small, sharp projections evenly distributed across the cell surface) in a biological specimen.Crenated Cell Measurement
CryoglobulinC111164CryoglobulinA measurement of cryoglobulin in a biological specimen.Cryoglobulin Measurement
CrystalsC74673CrystalsA statement that indicates crystals were looked for in a biological specimen.Crystal Present Or Absent
Cyclic Citrullinated Peptide AntibodyC96595Cyclic Citrullinated Peptide AntibodyA measurement of the cyclic citrullinated peptide antibody in a biological specimen.Cyclic Citrullinated Peptide Antibody Measurement
Cyclic Guanosine MonophosphateC111165Cyclic Guanosine 3,5-MonophosphateA measurement of the cyclic guanosine 3,5-monophosphate in a biological specimen.Cyclic Guanosine Monophosphate Measurement
Cystatin CC92290Cystatin CA measurement of the cystatin C in a biological specimen.Cystatin C Measurement
Cystatin C/CreatinineC106513Cystatin C/CreatinineA relative measurement (ratio or percentage) of the cystatin C to creatinine present in a sample.Cystatin C to Creatinine Ratio Measurement
CystineC105441CystineA measurement of the cystine in a biological specimen.Cystine Measurement
Cystine CrystalsC74674Cystine CrystalsA measurement of the cystine crystals present in a biological specimen.Cystine Crystal Measurement
Cytokeratin Fragment 21-1C106514CYFRA21-1;Cytokeratin 19 Fragment;Cytokeratin Fragment 21-1A measurement of the cytokeratin 19 fragment 21-1 in a biological specimen.Cytokeratin Fragment 21-1 Measurement
Cytomegalovirus IgG AntibodyC96596Cytomegalovirus IgG AntibodyA measurement of the cytomegalovirus IgG antibody in a biological specimen.Cytomegalovirus IgG Antibody Measurement
Cytomegalovirus IgM AntibodyC96597Cytomegalovirus IgM AntibodyA measurement of the cytomegalovirus IgM antibody in a biological specimen.Cytomegalovirus IgM Antibody Measurement
Cytoplasmic Basophilia NeutrophilC111166Cytoplasmic Basophilia NeutrophilA measurement of the neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content.Cytoplasmic Basophilia Neutrophil Count
D-DimerC82621D-DimerA measurement of the d-dimers in a biological specimen.D-Dimer Measurement
DacryocytesC64801Dacryocytes;Tear Shaped Erythrocytes;Teardrop CellsA measurement of dacryocytes in a biological specimen.Dacryocyte Analysis
Degenerated LeukocytesC111190Degenerated Leukocytes;Degenerated WBC;Degenerated White Blood CellsA measurement of the degenerated leukocytes (leukocytes that show deterioration in form or function) in a biological specimen.Degenerated Leukocyte Count
DehydroepiandrosteroneC74852Dehydroepiandrosterone;DehydroisoandrosteroneA measurement of the dehydroepiandrosterone hormone in a biological specimen.Dehydroepiandrosterone Measurement
Dehydroepiandrosterone SulfateC96629DHEA Sulfate;DHEA-S;Dehydroepiandrosterone Sulfate;sDHEAA measurement of the sulfated Dehydroepiandrosterone in a biological specimen.Sulfated DHEA Measurement
DensityC45781DensityA measurement of the compactness of a biological specimen expressed in mass per unit volume.Density
DeoxypyridinolineC79443DeoxypyridinolineA measurement of the deoxypyridinoline in a biological specimen.Deoxypyridinoline Measurement
Deoxypyridinoline/CreatinineC79444Deoxypyridinoline/CreatinineA relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen.Deoxypyridinoline to Creatinine Ratio Measurement
DextroamphetamineC102262Dextroamphetamine;d-amphetamineA measurement of the dextroamphetamine in a biological specimen.Dextroamphetamine Measurement
DihydrocodeineC74878DihydrocodeineA measurement of the dihydrocodeine present in a biological specimen.Dihydrocodeine Measurement
DihydrotestosteroneC74853Androstanalone;DihydrotestosteroneA measurement of the dihydrotestosterone hormone in a biological specimen.Dihydrotestosterone Measurement
Dilute Russell's Viper Venom TimeC96696Dilute Russell's Viper Venom Time;Lupus Anticoagulant TestA measurement of the time it takes a plasma sample to clot after adding dilute Russell's viper venom.Dilute Russell's Viper Venom Time Measurement
Dilute Russell's Viper Venom Time RatioC103386Lupus Anticoagulant RatioA relative measurement (ratio or percentage) of the dilute Russell's viper venom time in a subject sample to a control sample.Dilute Russell's Viper Venom Time to Control Ratio Measurement
Dimorphic Erythrocyte PopulationC117853Dimorphic Erythrocyte Population;Dimorphic RBC PopulationExamination of a biological specimen to detect the presence of dimorphic erythrocyte population.Dimorphic Erythrocyte Population
Dipeptidyl Peptidase-4 ActivityC103387DPPIV ActivityA measurement of the biological activity of dipeptidyl peptidase-4 in a biological specimen.Dipeptidyl Peptidase-4 Activity Measurement
Diphtheria IgG AntibodyC103388Diphtheria IgG AntibodyA measurement of the Diphtheria IgG antibodies in a biological specimen.Diphtheria IgG Antibody Measurement
Direct BilirubinC64481Direct BilirubinA measurement of the conjugated or water-soluble bilirubin in a biological specimen.Direct Bilirubin Measurement
DNase-B AntibodyC100463Anti-Dnase B;DNase-B AntibodyA measurement of Dnase-B antibody in a biological specimen.DNase-B Antibody Measurement
Dohle BodiesC74610Dohle BodiesA measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen.Dohle Body Measurement
DopamineC74854DopamineA measurement of the dopamine hormone in a biological specimen.Dopamine Measurement
Drug ScreenC78139Drug ScreenAn indication of the presence or absence of recreational drugs or drugs of abuse in a biological specimen.Drug Test
DTPA ClearanceC100441DTPA ClearanceA measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) through its excretion for a specified unit of time.Diethylene Triamine Pentaacetic Acid Clearance
EBV Profile InterpretationC106519EBV Profile Interpretation;Epstein-Barr Virus Antibody Profile;Epstein-Barr Virus Panel;Epstein-Barr Virus Profile InterpretationAn assessment of Epstein-Barr virus infection based on a panel of EBV antigen antibody tests.Epstein-Barr Virus Profile Interpretation
EBV Viral LoadC98721EBV Viral LoadA measurement of the Epstein-Barr virus viral load in a biological specimen.Epstein-Barr Virus Viral Load Measurement
Ecarin Clotting TimeC100422Ecarin Clotting TimeA measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin.Ecarin Clotting Time Measurement
EccentrocytesC96598EccentrocytesA measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen.Eccentrocyte Count
EDTA ClearanceC100440EDTA ClearanceA measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) through its excretion for a specified unit of time.EDTA Clearance
ElliptocytesC64549Elliptocytes;OvalocytesA measurement of the elliptically shaped erythrocytes in a biological specimen.Elliptocyte Count
Endogenous Thrombin PotentialC102266Endogenous Thrombin PotentialA measurement of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample.Endogenous Thrombin Potential Measurement
Endothelin-1C82008Endothelin-1A measurement of the endothelin-1 in a biological specimen.Endothelin-1 Measurement
Eosinophilic MetamyelocytesC84819Eosinophilic MetamyelocytesA measurement of the eosinphilic metamyelocytes in a biological specimen.Eosinophilic Metamyelocyte Count
Eosinophilic MyelocytesC84821Eosinophilic MyelocytesA measurement of the eosinophilic myelocytes in a biological specimen.Eosinophilic Myelocyte Count
EosinophilsC64550EosinophilsA measurement of the eosinophils in a biological specimen.Eosinophil Count
Eosinophils Band FormC114216Eosinophils Band FormA measurement of the banded eosinophils in a biological specimen.Eosinophil Band Form Count
Eosinophils Band Form/LeukocytesC114217Eosinophils Band Form/LeukocytesA relative measurement (ratio or percentage) of the banded eosinophils to leukocytes in a biological specimen.Eosinophil Band Form to Leukocyte Ratio
Eosinophils/LeukocytesC64604Eosinophils/LeukocytesA relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen.Eosinophil to Leukocyte Ratio
Eosinophils/Total CellsC98720Eosinophils/Total CellsA relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen).Eosinophils to Total Cell Ratio Measurement
Eotaxin-1C81952Chemokine Ligand 11;Eotaxin-1A measurement of the eotaxin-1 in a biological specimen.Eotaxin-1 Measurement
Eotaxin-2C81953Chemokine Ligand 24;Eotaxin-2A measurement of the eotaxin-2 in a biological specimen.Eotaxin-2 Measurement
Eotaxin-3C81954CCL26;Chemokine (C-C Motif) Ligand 26;Chemokine Ligand 26;Eotaxin-3A measurement of the eotaxin-3 in a biological specimen.Eotaxin-3 Measurement
Epidermal Growth FactorC82009Epidermal Growth FactorA measurement of the epidermal growth factor in a biological specimen.Epidermal Growth Factor Measurement
Epidermal Growth Factor ReceptorC112273ERBB1;Epidermal Growth Factor Receptor;HER1A measurement of the cells with positive expression of EGFR in a biological specimen.Epidermal Growth Factor Receptor Measurement
EpinephrineC79445Adrenaline;EpinephrineA measurement of the epinephrine hormone in a biological specimen.Epinephrine Measurement
Epith Neutrophil-Activating Peptide 78C82010Epith Neutrophil-Activating Peptide 78A measurement of the epithelial neutrophil-activating peptide in a biological specimen.Epithelial Neutrophil-Activating Peptide 78 Measurement
Epithelial CastsC74779Epithelial CastsA measurement of the epithelial cell casts present in a biological specimen.Epithelial-Cast Measurement
Epithelial CellsC64605Epithelial CellsA measurement of the epithelial cells in a biological specimen.Epithelial Cell Count
Epstein-Barr Capsid IgG AntibodyC96600Epstein-Barr Capsid IgG AntibodyA measurement of the Epstein-Barr capsid IgG antibody in a biological specimen.Epstein-Barr Capsid IgG Antibody Measurement
Epstein-Barr Capsid IgM AntibodyC96601Epstein-Barr Capsid IgM AntibodyA measurement of the Epstein-Barr capsid IgM antibody in a biological specimen.Epstein-Barr Capsid IgM Antibody Measurement
Epstein-Barr Early AntigenC96602Epstein-Barr Early AntigenA measurement of the Epstein-Barr early antigen in a biological specimen.Epstein-Barr Early Antigen Measurement
Epstein-Barr Nuclear AntibodyC96603Epstein-Barr Nuclear Antibody;Epstein-Barr Nuclear Antigen AntibodyA measurement of the Epstein-Barr nuclear antibody in a biological specimen.Epstein-Barr Nuclear Antibody Measurement
Epstein-Barr Nuclear AntigenC96604Epstein-Barr Nuclear AntigenA measurement of the Epstein-Barr nuclear antigen in a biological specimen.Epstein-Barr Nuclear Antigen Measurement
Epstein-Barr Nuclear Antigen 1 IgG AbC106518Epstein-Barr Nuclear Antigen 1 IgG AbA measurement of the Epstein-Barr nuclear antigen 1 IgG antibody in a biological specimen.Epstein-Barr Nuclear Antigen 1 IgG Ab Measurement
Ery. Mean Corpuscular HemoglobinC64797Ery. Mean Corpuscular HemoglobinA quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen.Erythrocyte Mean Corpuscular Hemoglobin
Ery. Mean Corpuscular HGB ConcentrationC64798Ery. Mean Corpuscular HGB ConcentrationA quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen.Erythrocyte Mean Corpuscular Hemoglobin Concentration
Ery. Mean Corpuscular VolumeC64799Ery. Mean Corpuscular Volume;Erythrocytes Mean Corpuscular Volume;RBC Mean Corpuscular VolumeA quantitative measurement of the mean volume of erythrocytes in a biological specimen.Erythrocyte Mean Corpuscular Volume
Erythrocyte AgglutinationC111197Autoagglutination;Erythrocyte Agglutination;RBC AgglutinationA measurement of the erythrocyte agglutination in a biological specimen.Erythrocyte Agglutination Measurement
Erythrocyte Cell ClumpsC92245Erythrocyte Cell Clumps;RBC Clumps;Red Blood Cell ClumpsA measurement of red blood cell clumps in a biological specimen.Erythrocyte Cell Clumps Measurement
Erythrocyte Cell MorphologyC92296Erythrocyte Cell Morphology;RBC Morphology;Red Blood Cell MorphologyAn examination or assessment of the form and structure of red blood cells.Erythrocyte Cell Morphology
Erythrocyte FragmentC116212Erythrocyte Fragment;RBC FragmentA measurement of the red blood cell fragments (red cell fragments that have a reticular-like shape with rounded ends and no spicules, differentiating them from schistocytes and acanthocytes) in a biological specimen.Erythrocyte Fragment Measurement
Erythrocyte GhostsC96605Erythrocyte Ghosts;RBC GhostsA measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen.Erythrocyte Ghost Count
Erythrocyte Sedimentation RateC74611Biernacki Reaction;Erythrocyte Sedimentation RateThe distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour).Erythrocyte Sedimentation Rate Measurement
ErythrocytesC51946Erythrocytes;Red Blood CellsA measurement of the total erythrocytes in a biological specimen.Erythrocyte Count
Erythrocytes Distribution WidthC64800Erythrocytes Distribution Width;Red Blood Cell Distribution WidthA value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen.Erythrocyte Distribution Width Measurement
ErythropoietinC74855Erythropoietin;HematopoietinA measurement of the erythropoietin hormone in a biological specimen.Erythropoietin Measurement
EstradiolC74782Estradiol;OestradiolA measurement of the estradiol in a biological specimen.Estradiol Measurement
EstriolC74856Estriol;OestriolA measurement of the estriol hormone in a biological specimen.Estriol Measurement
Estriol, FreeC81963Estriol, FreeA measurement of the free estriol in a biological specimen.Free Estriol Measurement
Estrogen ReceptorC112274ER;ESR;Estrogen Receptor;Oestrogen ReceptorA measurement of the cells with positive expression of estrogen receptor in a biological specimen.Estrogen Receptor Measurement
EstroneC74857Estrone;OestroneA measurement of the estrone hormone in a biological specimen.Estrone Measurement
EthanolC74693Alcohol;EthanolA measurement of the ethanol present in a biological specimen.Ethanol Measurement
ETP Area Under CurveC102263ETP Area Under Curve;Endogenous Thrombin Potential Area Under CurveA measurement of the area under the thrombin generation curve.Endogenous Thrombin Potential Area Under Curve Measurement
ETP Lag TimeC102264ETP Lag Time;Endogenous Thrombin Potential Lag TimeA measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated.Endogenous Thrombin Potential Lag Time Measurement
ETP Lag Time RelativeC102265ETP Lag Time Relative;Endogenous Thrombin Potential Lag Time RelativeA relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated.Endogenous Thrombin Potential Lag Time Relative Measurement
ETP Peak HeightC102267ETP Peak Height;Endogenous Thrombin Potential Peak HeightA measurement of the maximum concentration of thrombin generated during a thrombin generation test.Endogenous Thrombin Potential Peak Height Measurement
ETP Peak Height RelativeC102268ETP Peak Height Relative;Endogenous Thrombin Potential Peak Height RelativeA relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test.Endogenous Thrombin Potential Peak Height Relative Measurement
ETP Time to PeakC102269ETP Time to Peak;Endogenous Thrombin Potential Time to PeakA measurement of the time it takes to generate the maximum concentration of thrombin.Endogenous Thrombin Potential Time to Peak Measurement
ETP Time to Peak RelativeC102270ETP Time to Peak Relative;Endogenous Thrombin Potential Time to Peak RelativeA relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin.Endogenous Thrombin Potential Time to Peak Relative Measurement
Extracell Newly Ident RAGE Bind ProteinC82011Extracell Newly Ident RAGE Bind Protein;S100 Calcium Binding Protein A12A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen.Extracell Newly Ident RAGE Bind Protein Measurement
Extractable Nuclear Antigen AntibodyC92270Anti-ENA;Extractable Nuclear Antigen AntibodyA measurement of the extractable nuclear antigen antibody in a biological specimen.Extractable Nuclear Antigen Antibody Measurement
F2-IsoprostaneC80180F2-IsoprostaneA measurement of the F2-isoprostane in a biological specimen.F2 Isoprostane Measurement
Factor IIC96626Factor II;ProthrombinA measurement of the Factor II in a biological specimen.Prothrombin Measurement
Factor IIIC81959Factor III;Tissue Factor, CD142A measurement of the factor III in a biological specimen.Factor III Measurement
Factor IXC98725Christmas Factor;Factor IXA measurement of the factor IX in a biological specimen.Factor IX Measurement
Factor IX ActivityC103395Christmas Factor ActivityA measurement of the biological activity of factor IX in a biological specimen.Factor IX Activity Measurement
Factor VC98726Factor V;Labile FactorA measurement of the factor V in a biological specimen.Factor V Measurement
Factor V ActivityC103396Labile Factor ActivityA measurement of the biological activity of factor V in a biological specimen.Factor V Activity Measurement
Factor V LeidenC102271Factor V LeidenA measurement of the Factor V Leiden in a biological specimen.Factor V Leiden Measurement
Factor VIIC81960Factor VII;Proconvertin;Stable FactorA measurement of the factor VII in a biological specimen.Factor VII Measurement
Factor VII ActivityC103397Proconvertin Activity;Stable Factor ActivityA measurement of the biological activity of factor VII in a biological specimen.Factor VII Activity Measurement
Factor VIIa ActivityC103398Factor VIIa ActivityA measurement of the biological activity of factor VIIa in a biological specimen.Factor VIIa Activity Measurement
Factor VIIIC81961Anti-hemophilic Factor;Factor VIIIA measurement of the factor VIII in a biological specimen.Factor VIII Measurement
Factor VIII ActivityC103399Anti-hemophilic Factor ActivityA measurement of the biological activity of factor VIII in a biological specimen.Factor VIII Activity Measurement
Factor XC98727Factor XA measurement of the factor X in a biological specimen.Factor X Measurement
Factor XIIIC112277Factor XIII;Fibrin Stablizing FactorA measurement of the factor XIII in a biological specimen.Factor XIII Measurement
Factor XIVC102272Autoprothrombin IIA;Factor XIV;Protein C;Protein C AntigenA measurement of the factor XIV in a biological specimen.Factor XIV Measurement
Factor XIV ActivityC105442Factor XIV Activity;Protein C Activity;Protein C FunctionA measurement of the factor XIV activity in a biological specimen.Factor XIV Activity Measurement
FatC96648FatA measurement of the fat in a biological specimen.Fat Measurement
Fat Bodies, OvalC81947Fat Bodies, OvalA measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen.Oval Fat Body Measurement
Fat DropletC98728Fat DropletA measurement of the triglyceride aggregates within a biological specimen.Fat Droplet Measurement
Fatty Acid Binding Protein 1C82012Fatty Acid Binding Protein 1A measurement of the fatty acid binding protein 1 in a biological specimen.Fatty Acid Binding Protein 1 Measurement
Fatty Acid Binding Protein 3C106521Fatty Acid Binding Protein 3A measurement of the fatty acid binding protein 3 in a biological specimen.Fatty Acid Binding Protein 3 Measurement
Fatty CastsC74766Fatty CastsA measurement of the fatty casts present in a biological specimen.Fatty Cast Measurement
FerritinC74737FerritinA measurement of the ferritin in a biological specimen.Ferritin Measurement
Fibrin Degradation ProductsC82013Fibrin Degradation ProductsA measurement of the fibrin degradation products in a biological specimen.Fibrin Degradation Products Measurement
FibrinogenC64606FibrinogenA measurement of the fibrinogen in a biological specimen.Fibrinogen Measurement
Fibroblast Growth Factor 21C112280FGF 21;Fibroblast Growth Factor 21A measurement of the fibroblast growth factor 21 in a biological specimen.Fibroblast Growth Factor 21 Measurement
Fibroblast Growth Factor 23C96650Fibroblast Growth Factor 23;PhosphatoninA measurement of the fibroblast growth factor 23 in a biological specimen.Fibroblast Growth Factor 23 Measurement
Fibroblast Growth Factor Basic FormC82014FGF2;Fibroblast Growth Factor Basic FormA measurement of the basic form of fibroblast growth factor in a biological specimen.Fibroblast Growth Factor Basic Form Measurement
FibroTest ScoreC105443FibroSURE Score;FibroTest ScoreA biomarker test that measures liver pathology through the assessment of a six-parameter blood test (for Alpha-2-macroglobulin, Haptoglobin, Apolipoprotein A1, Gamma-glutamyl transpeptidase (GGT), Total bilirubin, and Alanine aminotransferase (ALT)), taking into account the age and gender of the patient.FibroTest Score Measurement
Follicle Stimulating HormoneC74783Follicle Stimulating HormoneA measurement of the follicle stimulating hormone (FSH) in a biological specimen.Follicle Stimulating Hormone Measurement
Fractional Calcium ExcretionC114219Fractional Calcium ExcretionA measurement of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine.Fractional Excretion of Calcium
Fractional Chloride ExcretionC114220Fractional Chloride ExcretionA measurement of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine.Fractional Excretion of Chloride
Fractional Phosphorus ExcretionC114221Fractional Inorganic Phosphate Excretion;Fractional Phosphorus ExcretionA measurement of the fractional excretion of phosphorus that is computed based upon the concentrations of phosphorus and creatinine in both blood and urine.Fractional Excretion of Phosphate
Fractional Potassium ExcretionC114222Fractional Potassium ExcretionA measurement of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine.Fractional Excretion of Potassium
Fractional Sodium ExcretionC107435Fractional Sodium ExcretionA measurement of the fractional excretion of sodium that is computed based upon the concentrations of sodium and creatinine in both blood and urine.Fractional Excretion of Sodium
Free Fatty AcidC80200Free Fatty Acid;Non-Esterified Fatty Acid, FreeA measurement of the total non-esterified fatty acids in a biological specimen.Non-esterified Fatty Acids Measurement
Free Fatty Acid, SaturatedC80206Free Fatty Acid, Saturated;Non-esterified Fatty Acid, SaturatedA measurement of the saturated non-esterified fatty acids in a biological specimen.Saturated Non-esterified Fatty Acids Measurement
Free Fatty Acid, UnsaturatedC80209Free Fatty Acid, Unsaturated;Non-esterified Fatty Acid, UnsaturatedA measurement of the unsaturated non-esterified fatty acids in a biological specimen.Unsaturated Non-esterified Fatty Acids Measurement
Free GlycerolC100448Free Glycerin;Free GlycerolA measurement of the amount of unbound glycerol in a biological specimen.Free Glycerol Measurement
FructosamineC74678Fructosamine;Glycated Serum ProteinA measurement of the fructosamine in a biological specimen.Fructosamine Measurement
GalaninC80182GalaninA measurement of the galanin in a biological specimen.Galanin Measurement
Gamma GlobulinC92257Gamma GlobulinA measurement of the proteins contributing to the gamma fraction in a biological specimen.Gamma Globulin Measurement
Gamma Globulin/Total ProteinC92295Gamma Globulin/Total ProteinA relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen.Gamma Globulin to Total Protein Ratio Measurement
Gamma Glutamyl TransferaseC64847Gamma Glutamyl TransferaseA measurement of the gamma glutamyl transferase in a biological specimen.Gamma Glutamyl Transpeptidase Measurement
Gamma Glutamyl Transferase/CreatinineC79446Gamma Glutamyl Transferase/CreatinineA relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen.Gamma Glutamyl Transferase to Creatinine Ratio Measurement
Gamma TocopherolC116211Gamma TocopherolA measurement of the gamma tocopherol in a biological specimen.Gamma Tocopherol Measurement
GastrinC74858GastrinA measurement of the gastrin hormone in a biological specimen.Gastrin Measurement
GFR from B-2 Microglobulin Adj for BSAC100450GFR from B-2 Microglobulin Adj for BSAA measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area.Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement
GFR from Beta-Trace Protein Adj for BSAC100449GFR from Beta-Trace Protein Adj for BSAA measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area.Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement
GFR from Creatinine Adjusted for BSAC98735GFR from Creatinine Adjusted for BSAAn estimation of the glomerular filtration rate adjusted for body size based on creatinine.Glomerular Filtration Rate from Creatinine Adjusted for BSA
GFR from Cystatin C Adjusted for BSAC98736GFR from Cystatin C Adjusted for BSAAn estimation of the glomerular filtration rate adjusted for body size based on cystatin C.Glomerular Filtration Rate from Cystatin C Adjusted for BSA
GhrelinC112286Ghrelin;Growth Hormone Secretagogue Receptor Ligand;Motilin-related Peptide;Total GhrelinA measurement of total ghrelin in a biological specimen.Ghrelin Measurement
Giant NeutrophilsC96651Giant NeutrophilsA measurement of the giant neutrophils in a biological specimen.Giant Neutrophil Count
Giant PlateletsC74728Giant PlateletsA measurement of the giant (larger than 7um in diameter) platelets in a biological specimen.Giant Platelet Count
GlobulinC74738GlobulinA measurement of the globulin protein in a biological specimen.Globulin Protein Measurement
Glomerular Filtration RateC90505Glomerular Filtration RateA kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time.Glomerular Filtration Rate
Glomerular Filtration Rate Adj for BSAC98734Glomerular Filtration Rate Adj for BSAA measurement of the glomerular filtration rate adjusted for body size.Glomerular Filtration Rate Adjusted for BSA
GlucagonC74859GlucagonA measurement of the glucagon hormone in a biological specimen.Glucagon Measurement
Glucagon-Like Peptide-1C80183Glucagon-Like Peptide-1;Total Glucagon-Like Peptide-1A measurement of the total glucagon-like peptide-1 in a biological specimen.Glucagon-like Peptide-1 Measurement
Glucagon-Like Peptide-1, Active FormC80164Glucagon-Like Peptide-1, Active FormA measurement of the active form of glucagon-like peptide-1 in a biological specimen.Active Glucagon-like Peptide-1 Measurement
GlucoseC105585GlucoseA measurement of the glucose in a biological specimen.Glucose Measurement
Glucose ClearanceC96652Glucose ClearanceA measurement of the volume of serum or plasma that would be cleared of glucose by excretion of urine for a specified unit of time (e.g. one minute).Glucose Clearance Measurement
Glucose Excretion RateC117834Glucose Excretion RateA measurement of the amount of glucose being excreted in urine over a defined amount of time (e.g. one hour).Glucose Urine Excretion Rate
Glucose-6-Phosphate DehydrogenaseC80184Glucose-6-Phosphate DehydrogenaseA measurement of the glucose-6-phosphate dehydrogenase in a biological specimen.Glucose-6-Phosphate Dehydrogenase Measurement
Glucose-dep Insulinotropic Pep, IntactC106537Glucose-dep Insulinotropic Pep, Intact;Intact GIP;Intact Gastric Inhibitory Polypeptide;Intact Glucose-dependent Insulinotropic PeptideA measurement of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide in a biological specimen.Intact Glucose-dependent Insulinotropic Peptide Measurement
Glucose/CreatinineC79447Glucose/CreatinineA relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen.Glucose to Creatinine Ratio Measurement
Glucuronidase, AlphaC80165Glucuronidase, AlphaA measurement of the alpha glucuronidase in a biological specimen.Alpha Glucuronidase Measurement
Glucuronidase, BetaC80170Glucuronidase, BetaA measurement of the beta glucuronidase in a biological specimen.Beta Glucuronidase Measurement
GlutamateC74739Glutamate;Glutamic AcidA measurement of the glutamate in a biological specimen.Glutamate Measurement
Glutamate DehydrogenaseC79448Glutamate DehydrogenaseA measurement of the glutamate dehydrogenase in a biological specimen.Glutamate Dehydrogenase Measurement
Glutamic Acid Decarboxylase 1C82015Glutamic Acid Decarboxylase 1;Glutamic Acid Decarboxylase 67A measurement of the glutamic acid decarboxylase 1 in a biological specimen.Glutamic Acid Decarboxylase 1 Measurement
Glutamic Acid Decarboxylase 2C82016Glutamic Acid Decarboxylase 2;Glutamic Acid Decarboxylase 65A measurement of the glutamic acid decarboxylase 2 in a biological specimen.Glutamic Acid Decarboxylase 2 Measurement
Glutamic Acid Decarboxylase 2 AntibodyC82017Glutamic Acid Decarboxylase 2 Antibody;Glutamic Acid Decarboxylase 65 AntibodyA measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen.Glutamic Acid Decarboxylase 2 Antibody Measurement
Glutamic Acid Decarboxylase AntibodyC96653GAD Antibody;Glutamic Acid Decarboxylase AntibodyA measurement of the glutamic acid decarboxylase antibody in a biological specimen.Glutamic Acid Decarboxylase Antibody Measurement
Glutathione S-Transferase, Alpha/CreatC80166Glutathione S-Transferase, Alpha/CreatA relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen.Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement
Glutathione S-Transferase, PiC80203Glutathione S-Transferase, PiA measurement of the Pi glutathione-s-transferase in a biological specimen.Pi Glutathione S-Transferase Measurement
Glutathione S-Transferase, ThetaC80207Glutathione S-Transferase, ThetaA measurement of the theta glutathione-s-transferase in a biological specimen.Theta Glutathione S-Transferase Measurement
Glutathione S-Transferase, TotalC80185Glutathione S-Transferase, TotalA measurement of the total glutathione-s-transferase in a biological specimen.Glutathione-S-Transferase Measurement
Glutathione-S-Transferase/CreatinineC79435Glutathione-S-Transferase/CreatinineA relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen.Glutathione-S-Transferase to Creatinine Ratio Measurement
GoldC80186GoldA measurement of the gold in a biological specimen.Gold Measurement
Gonadotropin Releasing HormoneC74860Gonadotropin Releasing Hormone;Luteinising Hormone Releasing HormoneA measurement of the gonadotropin releasing hormone in a biological specimen.Gonadotropin Releasing Hormone Measurement
Granular CastsC74768Granular CastsA measurement of the granular (coarse and fine) casts present in a biological specimen.Granular Cast Measurement
Granular Coarse CastsC74765Granular Coarse CastsA measurement of the coarse granular casts present in a biological specimen.Coarse Granular Cast Measurement
Granular Fine CastsC74769Granular Fine CastsA measurement of the fine granular casts present in a biological specimen.Granular Fine Cast Measurement
Granulocyte Colony Stimulating FactorC82018Granulocyte Colony Stimulating FactorA measurement of the granulocyte colony stimulating factor in a biological specimen.Granulocyte Colony Stimulating Factor Measurement
Granulocyte Macrophage Colony Stm FactorC82019Granulocyte Macrophage Colony Stm FactorA measurement of the granulocyte macrophage colony stimulating factor in a biological specimen.Granulocyte Macrophage Colony Stm Factor Measurement
GranulocytesC96654GranulocytesA measurement of the granulocytes in a biological specimen.Granulocyte Count
Granulocytes/Total CellsC98866Granulocytes/Total CellsA relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen).Granulocyte to Total Cell Ratio Measurement
Growth Hormone Inhibiting HormoneC74861Growth Hormone Inhibiting Hormone;SomatostatinA measurement of the growth hormone inhibiting hormone in a biological specimen.Growth Hormone Inhibiting Hormone Measurement
Growth Hormone Releasing HormoneC74862Growth Hormone Releasing Hormone;SomatocrininA measurement of the growth hormone releasing hormone in a biological specimen.Growth Hormone Releasing Hormone Measurement
Hairy CellsC74604Hairy CellsA measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen.Hairy Cell Count
Hairy Cells/LymphocytesC74640Hairy Cells/LymphocytesA relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen .Hairy Cell to Lymphocyte Ratio Measurement
HaptoglobinC74740HaptoglobinA measurement of the haptoglobin protein in a biological specimen.Haptoglobin Protein Measurement
HAV Viral LoadC92541HAV Viral LoadA measurement of the hepatitis A viral load in a biological specimen.Hepatitis A Viral Load Measurement
HBV Viral LoadC92542HBV Viral LoadA measurement of the hepatitis B viral load in a biological specimen.Hepatitis B Viral Load Measurement
HCT Corrected Reticulocytes/ErythrocytesC102274HCT Corrected Reticulocytes/ErythrocytesA relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes in a biological specimen.Hematocrit Corrected Reticulocytes to Erythrocytes Ratio Measurement
HCV Viral LoadC92543HCV RNA;HCV Viral Load;Hepatitis C RNAA measurement of the hepatitis C viral load in a biological specimen.Hepatitis C Viral Load Measurement
HDL CholesterolC105587HDL CholesterolA measurement of the high density lipoprotein cholesterol in a biological specimen.High Density Lipoprotein Cholesterol Measurement
HDL Cholesterol/LDL Cholesterol RatioC100425HDL Cholesterol/LDL Cholesterol RatioA relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen.HDL Cholesterol to LDL Cholesterol Ratio Measurement
HDL Particle SizeC103402HDL Particle SizeA measurement of the average particle size of high-density lipoprotein in a biological specimen.HDL Particle Size Measurement
HDL-Cholesterol Subclass 2C80187HDL-Cholesterol Subclass 2A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen.HDL-Cholesterol Subclass 2 Measurement
HDL-Cholesterol Subclass 3C80188HDL-Cholesterol Subclass 3A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen.HDL-Cholesterol Subclass 3 Measurement
Heinz BodiesC74709Heinz Bodies;Heinz-Erhlich BodiesA measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen.Heinz-Ehrlich Body Measurement
Heinz Bodies/ErythrocytesC111206Heinz Bodies/ErythrocytesA relative measurement (ratio or percentage) of the erythrocytes that contain heinz bodies to total erythrocytes in a biological specimen.Heinz Body to Erythrocyte Ratio Measurement
Helicobacter pylori IgG AntibodyC103403Helicobacter pylori IgG AntibodyA measurement of the Helicobacter pylori IgG antibody in a biological specimen.Helicobacter pylori IgG Antibody Measurement
Helmet CellsC74658Helmet CellsA measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen.Helmet Cell Count
HematocritC64796EVF;Erythrocyte Volume Fraction;Hematocrit;PCV;Packed Cell VolumeThe percentage of a whole blood specimen that is composed of red blood cells (erythrocytes).Hematocrit Measurement
Hematocrit Corrected ReticulocytesC102273Hematocrit Corrected ReticulocytesA measurement of the hematocrit corrected reticulocytes in a biological specimen.Hematocrit Corrected Reticulocyte Count
HemoglobinC64848FHGB;Free Hemoglobin;HemoglobinA measurement of the non-cellular hemoglobin in a biological specimen.Hemoglobin Measurement
Hemoglobin AC92258Hemoglobin AA measurement of the hemoglobin A in a biological specimen.Hemoglobin A Measurement
Hemoglobin A1CC64849Glycosylated Hemoglobin;Hemoglobin A1CA measurement of the glycosylated hemoglobin in a biological specimen.Glycosylated Hemoglobin Measurement
Hemoglobin A1C/HemoglobinC111207Hemoglobin A1C/HemoglobinA relative measurement (ratio or percentage) of the glycosylated hemoglobin to total hemoglobin in a biological specimen.Hemoglobin A1C to Hemoglobin Ratio Measurement
Hemoglobin A2C92259Hemoglobin A2A measurement of the hemoglobin A2 in a biological specimen.Hemoglobin A2 Measurement
Hemoglobin BC92260Hemoglobin BA measurement of the hemoglobin B in a biological specimen.Hemoglobin B Measurement
Hemoglobin CC92261Hemoglobin CA measurement of the hemoglobin C in a biological specimen.Hemoglobin C Measurement
Hemoglobin C CrystalsC112288Hemoglobin C CrystalsA measurement of hemoglobin C crystals in a biological specimen.Hemoglobin C Crystals Measurement
Hemoglobin Distribution WidthC106525Hemoglobin Distribution WidthA measurement of the distribution of the hemoglobin concentration in red blood cells.Hemoglobin Distribution Width Measurement
Hemoglobin FC92262Fetal Hemoglobin;Hemoglobin FA measurement of the hemoglobin F in a biological specimen.Hemoglobin F Measurement
Hemolytic IndexC111208Hemolysis;Hemolytic IndexA measurement of the destruction of red blood cells in a biological specimen.Hemolytic Index
HemosiderinC96659HemosiderinA measurement of the hemosiderin complex in a biological specimen.Hemosiderin Measurement
Hepatitis A Virus AntibodyC92534Hepatitis A Virus AntibodyA measurement of the antibody reaction of a biological specimen to the Hepatitis A virus.Hepatitis A Antibody Measurement
Hepatitis A Virus Antibody IgMC92271Hepatitis A Virus Antibody IgMA measurement of hepatitis A virus antibody IgM in a biological specimen.Hepatitis A Virus Antibody IgM Measurement
Hepatitis B DNAC103404Hepatitis B DNAA measurement of hepatitis B virus DNA in a biological specimen.Hepatitis B DNA Measurement
Hepatitis B Virus Core AntibodyC96660Hepatitis B Virus Core AntibodyA measurement of the hepatitis B virus core antibody in a biological specimen.Hepatitis B Virus Core Antibody Measurement
Hepatitis B Virus Core IgG AntibodyC119280Hepatitis B Virus Core IgG AntibodyA measurement of the hepatitis B virus core IgG antibody in a biological specimen.Hepatitis B Virus Core IgG Antibody Measurement
Hepatitis B Virus Core IgM AntibodyC96661Hepatitis B Virus Core IgM AntibodyA measurement of the hepatitis B virus core IgM antibody in a biological specimen.Hepatitis B Virus Core IgM Antibody Measurement
Hepatitis B Virus e AntibodyC96662Hepatitis B Virus e AntibodyA measurement of the hepatitis B e antibody in a biological specimen.Hepatitis B Virus e Antibody Measurement
Hepatitis B Virus e AntigenC96663Hepatitis B Virus e AntigenA measurement of the hepatitis B e antigen in a biological specimen.Hepatitis B Virus e Antigen Measurement
Hepatitis B Virus Surface AntibodyC74711Anti-HBs;HBsAb;Hepatitis B Virus Surface AntibodyA measurement of the surface antibody reaction of a biological specimen to the Hepatitis B virus.Hepatitis B Surface Antibody Measurement
Hepatitis B Virus Surface AntigenC64850HBsAg;Hepatitis B Virus Surface AntigenA measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus.Hepatitis B Virus Surface Antigen Measurement
Hepatitis C Virus AntibodyC92535Hepatitis C Virus AntibodyA measurement of the antibody reaction of a biological specimen to the Hepatitis C virus.Hepatitis C Antibody Measurement
Hepatitis C Virus AntigenC116196Hepatitis C Virus AntigenA measurement of the hepatitis C virus antigen in a biological specimen.Hepatitis C Virus Antigen Measurement
Hepatitis D Virus AntibodyC96664Hepatitis D Virus Antibody;Hepatitis Delta AntibodyA measurement of the hepatitis D virus antibody in a biological specimen.Hepatitis D Virus Antibody Measurement
Hepatitis D Virus IgG AntibodyC119281Hepatitis D Virus IgG AntibodyA measurement of the hepatitis D virus IgG antibody in a biological specimen.Hepatitis D Virus IgG Antibody Measurement
Hepatitis D Virus IgM AntibodyC119282Hepatitis D Virus IgM AntibodyA measurement of the hepatitis D virus IgM antibody in a biological specimen.Hepatitis D Virus IgM Antibody Measurement
Hepatitis E Virus AntibodyC119283Hepatitis E Virus AntibodyA measurement of the antibody reaction of a biological specimen to the Hepatitis E virus.Hepatitis E Virus Antibody Measurement
Hepatitis E Virus IgG AntibodyC106526Hepatitis E Virus IgG AntibodyA measurement of IgG antibody to the hepatitis E virus in a biological specimen.Hepatitis E Virus IgG Antibody Measurement
Hepatitis E Virus IgM AntibodyC96665Hepatitis E Virus IgM AntibodyA measurement of the hepatitis E virus IgM antibody in a biological specimen.Hepatitis E Virus IgM Antibody Measurement
Hepatitis G RNAC92272Hepatitis G RNAA measurement of the Hepatitis G RNA in a biological specimen.Hepatitis G RNA Measurement
HER2 AntigenC112291HER2 Antigen;HER2/NEU AntigenA measurement of the HER2 antigen in a biological specimen.HER2 Antigen Measurement
Herpes Simplex Virus 1 IgG AntibodyC96666HSV-1 IgG Antibody;Herpes Simplex Virus 1 IgG AntibodyA measurement of the herpes simplex virus 1 IgG antibody in a biological specimen.Herpes Simplex Virus 1 IgG Antibody Measurement
Herpes Simplex Virus 1 IgM AntibodyC98738Herpes Simplex Virus 1 IgM AntibodyA measurement of the Herpes Simplex virus 1 IgM antibodies in a biological specimen.Herpes Simplex Virus 1 IgM Antibody Measurement
Herpes Simplex Virus 1/2 IgG AntibodyC96697HSV-1/2 IgG Ab;Herpes Simplex Virus 1/2 IgG AntibodyA measurement of the herpes simplex virus 1 and 2 IgG antibody in a biological specimen.Herpes Simplex Virus 1/2 IgG Antibody Measurement
Herpes Simplex Virus 1/2 IgM AntibodyC96698HSV-1/2 IgM Ab;Herpes Simplex Virus 1/2 IgM AntibodyA measurement of the herpes simplex virus 1 and 2 IgM antibody in a biological specimen.Herpes Simplex Virus 1/2 IgM Antibody Measurement
Herpes Simplex Virus 2 IgG AntibodyC96667HSV-2 IgG Antibody;Herpes Simplex Virus 2 IgG AntibodyA measurement of the herpes simplex virus 2 IgG antibody in a biological specimen.Herpes Simplex Virus 2 IgG Antibody Measurement
Herpes Simplex Virus 2 IgM AntibodyC98739Herpes Simplex Virus 2 IgM AntibodyA measurement of the Herpes Simplex virus 2 IgM antibodies in a biological specimen.Herpes Simplex Virus 2 IgM Antibody Measurement
Herpes Simplex Virus 6 AntibodyC112292Herpes Simplex Virus 6 AntibodyA measurement of the herpes simplex virus 6 antibody in a biological specimen.Herpes Simplex Virus 6 Antibody Measurement
Heterophile AntibodiesC81984Heterophile AntibodiesA measurement of the heterophile antibodies in a biological specimen.Heterophile Antibody Measurement
HeterophilsC116186HeterophilsA measurement of heterophils (granular leukocytes) in a biological specimen from avian species.Heterophil Measurement
Heterophils/LeukocytesC116187Heterophils/LeukocytesA relative measurement (ratio or percentage) of heterophils to leukocytes in a biological specimen from avian species.Heterophils to Leukocytes Ratio Measurement
HexokinaseC96668HexokinaseA measurement of the hexokinase in a biological specimen.Hexokinase Measurement
High Absorption Retic/ReticulocytesC116189High Absorption Retic/ReticulocytesA relative measurement (ratio or percentage) of the high absorption reticulocytes to total reticulocytes in a biological specimen.High Absorption Reticulocytes to Total Reticulocytes Ratio Measurement
High Absorption ReticulocytesC116188High Absorption ReticulocytesA measurement of the high absorption reticulocytes in a biological specimen.High Absorption Reticulocyte Measurement
Hippuric Acid CrystalsC74754Hippuric Acid CrystalsA measurement of the hippuric acid crystals present in a biological specimen.Hippuric Acid Crystal Measurement
HistamineC80189HistamineA measurement of the histamine in a biological specimen.Histamine Measurement
Histone 1 AntibodyC112293Histone 1 AntibodyA measurement of the total histone 1 antibodies in a biological specimen.Histone 1 Antibody Measurement
Histone 2A AntibodyC112294Histone 2A AntibodyA measurement of the total histone 2A antibodies in a biological specimen.Histone 2A Antibody Measurement
Histone 2B AntibodyC112295Histone 2B AntibodyA measurement of the total histone 2B antibodies in a biological specimen.Histone 2B Antibody Measurement
Histone 3 AntibodyC112296Histone 3 AntibodyA measurement of the total histone 3 antibodies in a biological specimen.Histone 3 Antibody Measurement
Histone 4 AntibodyC112297Histone 4 AntibodyA measurement of the total histone 4 antibodies in a biological specimen.Histone 4 Antibody Measurement
Histone AntibodiesC111209Anti-Histone Antibodies;Histone AntibodiesA measurement of histone antibodies in a biological specimen.Histone Antibody Measurement
HIV AntibodyC106527HIV AntibodyA measurement of the antibody reaction of a biological specimen to the HIV virus.HIV Antibody Measurement
HIV Viral LoadC92544HIV Viral LoadA measurement of the HIV viral load in a biological specimen.HIV Viral Load Measurement
HIV-1 AntibodyC74713HIV-1 AntibodyA measurement of the antibody reaction of a biological specimen to the HIV-1 virus.HIV-1 Antibody Measurement
HIV-1 Group M and O Nucleic AcidC92263HIV-1 Group M and O Nucleic AcidA measurement of the HIV-1 group M and O nucleic acids in a biological specimen.HIV-1 Group M and O Nucleic Acid Measurement
HIV-1 Group O AntibodyC92264HIV-1 Group O AntibodyA measurement of the HIV-1 group O antibody in a biological specimen.HIV-1 Group O Antibody Measurement
HIV-1 p24 AntigenC92265HIV-1 p24 AntigenA measurement of the HIV-1 p24 antigen in a biological specimen.HIV-1 p24 Antigen Measurement
HIV-1/2 AntibodyC74714HIV-1/2 AntibodyA measurement of the antibody reaction of a biological specimen to the either the HIV-1 or HIV-2 virus.HIV-1 HIV-2 Antibody Measurement
HIV-2 AntibodyC74715HIV-2 AntibodyA measurement of the antibody reaction of a biological specimen to the HIV-2 virus.HIV-2 Antibody Measurement
HIV-2 Nucleic AcidC92266HIV-2 Nucleic AcidA measurement of the HIV-2 nucleic acids in a biological specimen.HIV-2 Nucleic Acid Measurement
HLA-B27 AntigenC100460HLA-B27 Antigen;Human Leukocyte Antigen B27A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen.HLA-B27 Antigen Measurement
HomocysteineC74741HomocysteineA measurement of the homocysteine amino acid in a biological specimen.Homocysteine Acid Measurement
Homostat Model Assess of Insulin RstnC100447Homeostatic Model Assessment of Insulin Resistance;Homostat Model Assess of Insulin RstnAn assessment of beta-cell function and insulin resistance based on fasting blood glucose and insulin concentrations.Homeostatic Model Assessment of Insulin Resistance
Homovanillic AcidC74863Homovanillic AcidA measurement of the homovanillic acid metabolite in a biological specimen.Homovanillic Acid Measurement
Howell-Jolly BodiesC74704Howell-Jolly BodiesA measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen.Howell-Jolly Body Measurement
Human Albumin AntibodyC103405Human Albumin AntibodyA measurement of the human albumin antibody in a biological specimen.Human Albumin Antibody Measurement
Human Anti-Mouse AntibodyC103406HAMAA measurement of the human anti-mouse antibody in a biological specimen.Human Anti-Mouse Antibody Measurement
Human Anti-Sheep IgE AntibodyC98740Human Anti-Sheep IgE AntibodyA measurement of the human anti-sheep IgE antibodies in a biological specimen.Human Anti-Sheep IgE Antibody Measurement
Human Anti-Sheep IgG AntibodyC98741Human Anti-Sheep IgG AntibodyA measurement of the human anti-sheep IgG antibodies in a biological specimen.Human Anti-Sheep IgG Antibody Measurement
Human Anti-Sheep IgM AntibodyC98742Human Anti-Sheep IgM AntibodyA measurement of the human anti-sheep IgM antibodies in a biological specimen.Human Anti-Sheep IgM Antibody Measurement
Human Epidermal Growth Factor Receptor 2C112312ERBB2;HER2/NEU;Human Epidermal Growth Factor Receptor 2A measurement of the cells with positive expression of HER2 in a biological specimen.Human Epidermal Growth Factor Receptor 2 Measurement
Hyaline CastsC74770Hyaline CastsA measurement of the hyaline casts present in a biological specimen.Hyaline Cast Measurement
Hyaluronic AcidC112319Hyaluronic AcidA measurement of hyaluronic acid in a biological specimen.Hyaluronic Acid Measurement
HydrocodoneC74879HydrocodoneA measurement of the hydrocodone present in a biological specimen.Hydrocodone Measurement
HydrogenC102275HydrogenA measurement of the hydrogen in a biological specimen.Hydrogen Measurement
HydromorphoneC74880HydromorphoneA measurement of the hydromorphone present in a biological specimen.Hydromorphone Measurement
HydroxyprolineC80190HydroxyprolineA measurement of the total hydroxyproline in a biological specimen.Hydroxyproline Measurement
HyperchromiaC96669HyperchromiaA measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration.Hyperchromia Measurement
Hypersegmented CellsC74612Hypersegmented CellsA measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen.Hypersegmented Neutrophil Measurement
HypochromiaC64802HypochromiaAn observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level.Hypochromia
Hypogranular NeutrophilsC116201Hypogranular NeutrophilsA measurement of the hypogranular neutrophils in a biological specimen.Hypogranular Neutrophil Measurement
Icteric IndexC111232Icteric Index;IcterusA measurement of the yellow color of a biological specimen, due to the presence of bile pigments.Icteric Index
IDL CholesterolC112325IDL Cholesterol;Intermediate Density LipoproteinA measurement of the intermediate density lipoprotein in a biological specimen.Intermediate Density Lipoprotein Cholesterol Measurement
IDL ParticlesC116197IDL Particles;Intermediate Density Lipoproteins ParticlesA measurement of the concentration of IDL particles in a biological specimen.IDL Particles Measurement
IgG IgM IgA TotalC111233IgG IgM IgA TotalA measurement of the total IgG, IgM, and IgA in a biological specimen.IgG IgM IgA Total Measurement
Immature BasophilsC96670Immature BasophilsA measurement of the immature basophils in a biological specimen.Immature Basophil Count
Immature Basophils/LeukocytesC96671Immature Basophils/LeukocytesA relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen.Immature Basophil to Leukocyte Ratio Measurement
Immature CellsC96672Immature CellsA measurement of the total immature cells in a blood specimen.Immature Cell Count
Immature Cells/Total CellsC111234Immature Cells/Total CellsA relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen.Immature Cell to Total Cell Ratio Measurement
Immature EosinophilsC96673Immature EosinophilsA measurement of the immature eosinophils in a biological specimen.Immature Eosinophil Count
Immature Eosinophils/LeukocytesC96674Immature Eosinophils/LeukocytesA relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen.Immature Eosinophil to Leukocyte Ratio Measurement
Immature GranulocytesC96675Immature GranulocytesA measurement of the total immature granulocytes in a biological specimen.Immature Granulocyte Count
Immature Granulocytes/LeukocytesC100445Immature Granulocytes/LeukocytesA relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen).Immature Granulocytes to Leukocytes Ratio Measurement
Immature LymphocytesC100444Immature LymphocytesA measurement of the immature lymphocytes in a biological specimen.Immature Lymphocytes Measurement
Immature Lymphocytes/LeukocytesC100443Immature Lymphocytes/LeukocytesA relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen.Immature Lymphocytes to Leukocytes Ratio Measurement
Immature MonocytesC96676Immature MonocytesA measurement of the immature monocytes in a biological specimen.Immature Monocyte Count
Immature Monocytes/LeukocytesC96677Immature Monocytes/LeukocytesA relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen.Immature Monocyte to Leukocyte Ratio Measurement
Immature NeutrophilsC96678Immature NeutrophilsA measurement of the total immature neutrophils in a biological specimen.Immature Neutrophil Count
Immature Neutrophils/LeukocytesC100442Immature Neutrophils/LeukocytesA relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen.Immature Neutrophils to Leukocytes Ratio Measurement
Immature Plasma CellsC96679Immature Plasma CellsA measurement of the immature plasma cells in a biological specimen.Immature Plasma Cell Count
Immature Plasma Cells/LymphocytesC96680Immature Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen.Immature Plasma Cell to Lymphocyte Ratio Measurement
Immature Reticulocyte FractionC102276Immature Reticulocyte FractionA measurement of the immature reticulocyte fraction present in a biological specimen.Immature Reticulocyte Fraction Measurement
ImmunoblastsC103407Lymphocytes, ImmunoblasticA measurement of the immunoblasts in a biological specimen.Immunoblast Count
Immunoblasts/LymphocytesC106535Immunoblasts/Lymphocytes;Lymphocytes, Immunoblastic/LymphocytesA relative measurement (ratio or percentage) of immunoblasts to all lymphocytes present in a sample.Immunoblasts to Lymphocytes Ratio Measurement
Immunoglobulin AC81969Immunoglobulin AA measurement of the Immunoglobulin A in a biological specimen.Immunoglobulin A Measurement
Immunoglobulin DC98745Immunoglobulin DA measurement of the Immunoglobulin D in a biological specimen.Immunoglobulin D Measurement
Immunoglobulin EC81970Immunoglobulin EA measurement of the Immunoglobulin E in a biological specimen.Immunoglobulin E Measurement
Immunoglobulin GC81971Immunoglobulin GA measurement of the Immunoglobulin G in a biological specimen.Immunoglobulin G Measurement
Immunoglobulin G/CreatinineC119285Immunoglobulin G/CreatinineA relative measurement (ratio or percentage) of the immunoglobulin G to creatinine in a biological specimen.Immunoglobulin G to Creatinine Ratio Measurement
Immunoglobulin MC81972Immunoglobulin MA measurement of the Immunoglobulin M in a biological specimen.Immunoglobulin M Measurement
Inclusion BodiesC116184Inclusion BodiesA measurement of the inclusion bodies in a biological specimen.Inclusion Body Measurement
IndicanC82044IndicanA measurement of the indican present in a biological specimen.Indican Measurement
Indirect BilirubinC64483Indirect BilirubinA measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen.Indirect Bilirubin Measurement
Influenza A H1N1 Viral LoadC92273Influenza A H1N1 Viral LoadA measurement of the Influenza A H1N1 viral load in a biological specimen.Influenza A H1N1 Viral Load Measurement
Influenza A IgG AntibodyC103408Influenza A IgG AntibodyA measurement of the Influenza A IgG antibody in a biological specimen.Influenza A IgG Antibody Measurement
Influenza A Viral LoadC92274Influenza A Viral LoadA measurement of the Influenza A viral load in a biological specimen.Influenza A Viral Load Measurement
Influenza B IgG AntibodyC103409Influenza B IgG AntibodyA measurement of the Influenza B IgG antibody in a biological specimen.Influenza B IgG Antibody Measurement
Inhibin AC82020Inhibin AA measurement of the inhibin A in a biological specimen.Inhibin A Measurement
Inhibin BC96681Inhibin BA measurement of the inhibin B in a biological specimen.Inhibin B Measurement
InsulinC74788InsulinA measurement of the insulin in a biological specimen.Insulin Measurement
Insulin AntibodyC119287Insulin AntibodyA measurement of the antibody to therapeutic insulin in a biological specimen.Insulin Antibody Measurement
Insulin AutoantibodyC119286Insulin AutoantibodyA measurement of the antibody to endogenous insulin in a biological specimen.Insulin Autoantibody Measurement
Insulin-Like Growth Factor Binding Prot3C112322Insulin-Like Growth Factor Binding Prot3;Insulin-Like Growth Factor Binding Protein 3A measurement of the insulin-like growth factor binding protein 3 in a biological specimen.Insulin-Like Growth Factor Binding Protein 3 Measurement
Insulin-like Growth Factor-1C74864Insulin-like Growth Factor-1A measurement of the insulin-like growth factor-1 in a biological specimen.Insulin Like Growth Factor-1 Measurement
Insulin-like Growth Factor-2C74865Insulin-like Growth Factor-2A measurement of the insulin-like growth factor-2 in a biological specimen.Insulin Like Growth Factor-2 Measurement
Insulinoma-Associated Protein 2 AntibodyC119284Insulinoma-Associated Protein 2 AntibodyA measurement of the insulinoma-associated protein 2 antibody in a biological specimen.Insulinoma-Associated Protein 2 Antibody Measurement
Interferon AlphaC81994Interferon AlphaA measurement of the interferon alpha in a biological specimen.Interferon Alpha Measurement
Interferon BetaC81995Interferon BetaA measurement of the interferon beta in a biological specimen.Interferon Beta Measurement
Interferon GammaC81996Interferon GammaA measurement of the interferon gamma in a biological specimen.Interferon Gamma Measurement
Interleukin 1C74805Interleukin 1A measurement of the interleukin 1 in a biological specimen.Interleukin 1 Measurement
Interleukin 1 BetaC112323IL-1B;IL1Beta;Interleukin 1 Beta;Interleukin 1BA measurement of interleukin 1 beta in a biological specimen.Interleukin 1 Beta Measurement
Interleukin 1 Receptor AntagonistC112324IL-1RA;Interleukin 1 Receptor AntagonistA measurement of the interleukin 1 receptor antagonist in a biological specimen.Interleukin 1 Receptor Antagonist Measurement
Interleukin 10C74806Interleukin 10A measurement of the interleukin 10 in a biological specimen.Interleukin 10 Measurement
Interleukin 11C74807Interleukin 11A measurement of the interleukin 11 in a biological specimen.Interleukin 11 Measurement
Interleukin 12C74808Interleukin 12A measurement of the interleukin 12 in a biological specimen.Interleukin 12 Measurement
Interleukin 13C74809Interleukin 13A measurement of the interleukin 13 in a biological specimen.Interleukin 13 Measurement
Interleukin 14C74810Interleukin 14A measurement of the interleukin 14 in a biological specimen.Interleukin 14 Measurement
Interleukin 15C74811Interleukin 15A measurement of the interleukin 15 in a biological specimen.Interleukin 15 Measurement
Interleukin 16C74812Interleukin 16A measurement of the interleukin 16 in a biological specimen.Interleukin 16 Measurement
Interleukin 17C74813Interleukin 17A measurement of the interleukin 17 in a biological specimen.Interleukin 17 Measurement
Interleukin 18C74814Interleukin 18A measurement of the interleukin 18 in a biological specimen.Interleukin 18 Measurement
Interleukin 19C74815Interleukin 19A measurement of the interleukin 19 in a biological specimen.Interleukin 19 Measurement
Interleukin 2C74816Interleukin 2A measurement of the interleukin 2 in a biological specimen.Interleukin 2 Measurement
Interleukin 20C74817Interleukin 20A measurement of the interleukin 20 in a biological specimen.Interleukin 20 Measurement
Interleukin 21C74818Interleukin 21A measurement of the interleukin 21 in a biological specimen.Interleukin 21 Measurement
Interleukin 22C74819Interleukin 22A measurement of the interleukin 22 in a biological specimen.Interleukin 22 Measurement
Interleukin 23C74820Interleukin 23A measurement of the interleukin 23 in a biological specimen.Interleukin 23 Measurement
Interleukin 24C74821Interleukin 24A measurement of the interleukin 24 in a biological specimen.Interleukin 24 Measurement
Interleukin 25C74822Interleukin 25A measurement of the interleukin 25 in a biological specimen.Interleukin 25 Measurement
Interleukin 26C74823Interleukin 26A measurement of the interleukin 26 in a biological specimen.Interleukin 26 Measurement
Interleukin 27C74824Interleukin 27A measurement of the interleukin 27 in a biological specimen.Interleukin 27 Measurement
Interleukin 28C74825Interleukin 28A measurement of the interleukin 28 in a biological specimen.Interleukin 28 Measurement
Interleukin 29C74826Interleukin 29A measurement of the interleukin 29 in a biological specimen.Interleukin 29 Measurement
Interleukin 3C74827Interleukin 3A measurement of the interleukin 3 in a biological specimen.Interleukin 3 Measurement
Interleukin 30C74828Interleukin 30A measurement of the interleukin 30 in a biological specimen.Interleukin 30 Measurement
Interleukin 31C74829Interleukin 31A measurement of the interleukin 31 in a biological specimen.Interleukin 31 Measurement
Interleukin 32C74830Interleukin 32A measurement of the interleukin 32 in a biological specimen.Interleukin 32 Measurement
Interleukin 33C74831Interleukin 33A measurement of the interleukin 33 in a biological specimen.Interleukin 33 Measurement
Interleukin 4C74832Interleukin 4A measurement of the interleukin 4 in a biological specimen.Interleukin 4 Measurement
Interleukin 5C74833Interleukin 5A measurement of the interleukin 5 in a biological specimen.Interleukin 5 Measurement
Interleukin 6C74834Interleukin 6A measurement of the interleukin 6 in a biological specimen.Interleukin 6 Measurement
Interleukin 7C74835Interleukin 7A measurement of the interleukin 7 in a biological specimen.Interleukin 7 Measurement
Interleukin 8C74836Interleukin 8A measurement of the interleukin 8 in a biological specimen.Interleukin 8 Measurement
Interleukin 9C74837Interleukin 9A measurement of the interleukin 9 in a biological specimen.Interleukin 9 Measurement
Intestinal Specific Alkaline PhosphataseC119266Intestinal Specific Alkaline PhosphataseA measurement of the intestinal specific alkaline phosphatase isoform in a biological specimen.Intestinal Specific Alkaline Phosphatase Measurement
Inulin ClearanceC98748Inulin ClearanceA measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute).Inulin Clearance
Iohexol ClearanceC100439Iohexol ClearanceA measurement of the volume of serum or plasma that would be cleared of Iohexol through excretion for a specified unit of time.Iohexol Clearance
Iothalamate ClearanceC98749Iothalamate ClearanceA measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute).Iothalamate Clearance
Iothalamate Clearance Adjusted for BSAC98750Iothalamate Clearance Adjusted for BSAA measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body size.Iothalamate Clearance Adjusted for BSA
IronC74679FE;IronA measurement of the iron in a biological specimen.Iron Measurement
Iron Excretion RateC117838Iron Excretion RateA measurement of the amount of iron being excreted in urine over a defined amount of time (e.g. one hour).Iron Urine Excretion Rate
Islet Cell 512 AntibodyC81985Islet Cell 512 AntibodyA measurement of the islet cell 512 antibody in a biological specimen.Islet Cell 512 Antibody Measurement
Islet Cell 512 AntigenC81986Islet Cell 512 AntigenA measurement of the islet cell 512 antigen in a biological specimen.Islet Cell 512 Antigen Measurement
Islet Neogenesis Assoc Protein AntibodyC81987Islet Neogenesis Assoc Protein AntibodyA measurement of the islet neogenesis associated protein antibody in a biological specimen.Islet Neogenesis Associated Protein Antibody Measurement
IsoleucineC103410IsoleucineA measurement of the isoleucine in a biological specimen.Isoleucine Measurement
JC Virus AntibodyC112326JC Polyomavirus Antibody;JC Virus Antibody;JCV Antibody;John Cunningham Virus AntibodyA measurement of the JC virus antibody in a biological specimen.JC Virus Antibody Measurement
Jo-1 AntibodyC100459Jo-1 AntibodyA measurement of the Jo-1 antibody in a biological specimen.Jo-1 Antibody Measurement
Kappa Light Chain, FreeC98730Kappa Light Chain, FreeA measurement of the free kappa light chain in a biological specimen.Free Kappa Light Chain Measurement
Kappa Lt Chain,Free/Lambda Lt Chain,FreeC98731Kappa Lt Chain,Free/Lambda Lt Chain,FreeA relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen.Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement
Ketone BodiesC111239Ketone BodiesA measurement of the ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) in a biological specimen.Ketone Body Measurement
KetonesC64854KetonesA measurement of the ketones in a biological specimen.Ketone Measurement
Kidney Injury Molecule-1C100433Hepatitis A Virus Cellular Receptor 1;KIM-1;Kidney Injury Molecule-1A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen.Kidney Injury Molecule-1 Measurement
Kurloff CellsC96682Kurloff CellsA measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family.Kurloff Cells Measurement
Lactate DehydrogenaseC64855Lactate DehydrogenaseA measurement of the lactate dehydrogenase in a biological specimen.Lactate Dehydrogenase Measurement
Lactate Dehydrogenase/CreatinineC79449Lactate Dehydrogenase/CreatinineA relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen.Lactate Dehydrogenase to Creatinine Ratio Measurement
Lactic AcidC794502-hydroxypropanoic acid;Lactate;Lactic AcidA measurement of the lactic acid in a biological specimen.Lactic Acid Measurement
LactoferrinC82021Lactoferrin;LactotransferrinA measurement of the lactoferrin in a biological specimen.Lactoferrin Measurement
Lambda Light Chain, FreeC98732Lambda Light Chain, FreeA measurement of the free lambda light chain in a biological specimen.Free Lambda Light Chain Measurement
Large PlateletsC74729Large PlateletsA measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen.Large Platelet Count
Large Unstained CellsC74659Large Unstained CellsA measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen.Large Unstained Cell Count
Large Unstained Cells/LeukocytesC79467Large Unstained Cells/LeukocytesA relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen.Large Unstained Cells to Leukocytes Ratio Measurement
LDH Isoenzyme 1C74887LDH Isoenzyme 1A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen.Lactate Dehydrogenase Isoenzyme 1 Measurement
LDH Isoenzyme 1/LDHC79451LDH Isoenzyme 1/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 1 to LDH Ratio Measurement
LDH Isoenzyme 2C74888LDH Isoenzyme 2A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen.Lactate Dehydrogenase Isoenzyme 2 Measurement
LDH Isoenzyme 2/LDHC79452LDH Isoenzyme 2/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 2 to LDH Ratio Measurement
LDH Isoenzyme 3C74889LDH Isoenzyme 3A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen.Lactate Dehydrogenase Isoenzyme 3 Measurement
LDH Isoenzyme 3/LDHC79453LDH Isoenzyme 3/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 3 to LDH Ratio Measurement
LDH Isoenzyme 4C74890LDH Isoenzyme 4A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen.Lactate Dehydrogenase Isoenzyme 4 Measurement
LDH Isoenzyme 4/LDHC79454LDH Isoenzyme 4/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 4 to LDH Ratio Measurement
LDH Isoenzyme 5C74891LDH Isoenzyme 5A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen.Lactate Dehydrogenase Isoenzyme 5 Measurement
LDH Isoenzyme 5/LDHC79455LDH Isoenzyme 5/LDHA relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen.LDH Isoenzyme 5 to LDH Ratio Measurement
LDL CholesterolC105588LDL CholesterolA measurement of the low density lipoprotein cholesterol in a biological specimen.Low Density Lipoprotein Cholesterol Measurement
LDL Particle SizeC103412LDL Particle SizeA measurement of the average particle size of low-density lipoprotein in a biological specimen.LDL Particle Size Measurement
Left Shift NeutrophilsC116202Left Shift NeutrophilsAn observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen.Left Shift Neutrophil Measurement
Legionella pneumophila AntigenC92275Legionella pneumophila AntigenA measurement of the Legionella pneumophila antigen in a biological specimen.Legionella pneumophila Antigen Measurement
Legionella pneumophila IgG AntibodyC92276Legionella pneumophila IgG AntibodyA measurement of the Legionella pneumophila IgG antibody in a biological specimen.Legionella pneumophila IgG Antibody Measurement
Legionella pneumophila IgG IgM AntibodyC92277Legionella pneumophila IgG IgM AntibodyA measurement of the Legionella pneumophila IgG and IgM in a biological specimen.Legionella pneumophila IgG IgM Antibody Measurement
Legionella pneumophila IgM AntibodyC92278Legionella pneumophila IgM AntibodyA measurement of the Legionella pneumophila IgM antibody in a biological specimen.Legionella pneumophila IgM Antibody Measurement
LeptinC74866LeptinA measurement of the leptin hormone in a biological specimen.Leptin Measurement
Leucine CrystalsC74680Leucine CrystalsA measurement of the leucine crystals present in a biological specimen.Leucine Crystal Measurement
Leukemic BlastsC74630Leukemic BlastsA measurement of the leukemic blasts (lymphoblasts that remain in an immature state even when outside the bone marrow) in a biological specimen.Leukemic Blast Count
Leukemic Blasts/LymphocytesC74641Leukemic Blasts/LymphocytesA relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts) to mature lymphocytes in a biological specimen.Leukemic Blast to Lymphocyte Ratio Measurement
Leukemic CellsC116195Leukemic Cells;Residual Leukemic CellsA measurement of the leukemic cells in a biological specimen.Leukemic Cells Measurement
Leukocyte Cell ClumpsC92246Leukocyte Cell Clumps;WBC Clumps;White Blood Cell ClumpsA measurement of white blood cell clumps in a biological specimen.Leukocyte Cell Clumps Measurement
Leukocyte Cell MorphologyC92297Leukocyte Cell Morphology;WBC Morphology;White Blood Cell MorphologyAn examination or assessment of the form and structure of white blood cells.Leukocyte Cell Morphology
Leukocyte EsteraseC64856Leukocyte EsteraseA measurement of the enzyme which indicates the presence of white blood cells in a biological specimen.Leukocyte Esterase Measurement
LeukocytesC51948Leukocytes;White Blood CellsA measurement of the leukocytes in a biological specimen.Leukocyte Count
Leukotriene B4C103413Leukotriene B4A measurement of the leukotriene B4 in a biological specimen.Leukotriene B4 Measurement
Leukotriene D4C103414Leukotriene D4A measurement of the leukotriene D4 in a biological specimen.Leukotriene D4 Measurement
Leukotriene E4C103415Leukotriene E4A measurement of the leukotriene E4 in a biological specimen.Leukotriene E4 Measurement
LipaseC117748Lipase;Total LipaseA measurement of the total lipase in a biological specimen.Lipase Measurement
Lipase, GastricC117840Gastric Triacylglycerol Lipase;LIPF;Lipase, GastricA measurement of the gastric triacylglycerol lipase in a biological specimen.Gastric Lipase Measurement
Lipase, Lysosomal AcidC117842Acid Cholesteryl Ester Hydrolase;LAL;LIPA;Lipase, Lysosomal Acid;Lysosomal LipaseA measurement of the lysosomal acid lipase in a biological specimen.Lysosomal Acid Lipase Measurement
Lipase, PancreaticC117841Lipase, Pancreatic;PNLIP;Pancreatic Triacylglycerol LipaseA measurement of the pancreatic triacylglycerol lipase in a biological specimen.Pancreatic Lipase Measurement
Lipemic IndexC111242Lipemia;Lipemic IndexA measurement of the abnormally high concentration of lipid in a biological specimen.Lipemic Index
Lipocalin-2C106539Lipocalin-2A measurement of lipocalin-2 in a biological specimen.Lipocalin-2 Measurement
Lipocalin-2/CreatinineC106540Lipocalin-2/CreatinineA relative measurement (ratio or percentage) of the lipocalin-2 to creatinine present in a sample.Lipocalin-2 to Creatinine Ratio Measurement
Lipoprotein-aC82022Lipoprotein-aA measurement of the lipoprotein-a in a biological specimen.Lipoprotein a Measurement
Liver Kidney Microsomal Type 1 AntibodyC96683LKM-1;Liver Kidney Microsomal Type 1 AntibodyA measurement of the liver kidney microsomal type 1 antibody in a biological specimen.Liver Kidney Microsomal Type 1 Antibody Measurement
Liver Kidney Microsomal Type 1 IgA AbC100456Liver Kidney Microsomal Type 1 IgA AbA measurement of the liver kidney microsomal type 1 IgA antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgA Antibody Measurement
Liver Kidney Microsomal Type 1 IgG AbC100454Liver Kidney Microsomal Type 1 IgG AbA measurement of the liver kidney microsomal type 1 IgG antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgG Antibody Measurement
Liver Kidney Microsomal Type 1 IgM AbC100455Liver Kidney Microsomal Type 1 IgM AbA measurement of the liver kidney microsomal type 1 IgM antibodies in a biological specimen.Liver Kidney Microsomal Type 1 IgM Antibody Measurement
Liver Specific Alkaline PhosphataseC119267Liver Specific Alkaline PhosphataseA measurement of the liver specific alkaline phosphatase isoform in a biological specimen.Liver Specific Alkaline Phosphatase Measurement
Low Absorption Retic/ReticulocytesC116191Low Absorption Retic/ReticulocytesA relative measurement (ratio or percentage) of the low absorption reticulocytes to total reticulocytes in a biological specimen.Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement
Low Absorption ReticulocytesC116190Low Absorption ReticulocytesA measurement of the low absorption reticulocytes in a biological specimen.Low Absorption Reticulocyte Measurement
Lupus Anticoagulant Sensitive APTTC102277APTT-LA;Lupus Anticoagulant Sensitive APTTA measurement of the length of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen.Lupus Anticoagulant Sensitive APTT Measurement
Luteinizing HormoneC74790Luteinizing HormoneA measurement of the luteinizing hormone in a biological specimen.Luteinizing Hormone Measurement
LymphoblastsC102278LymphoblastsA measurement of the lymphoblasts (immature cells that differentiate to form lymphocytes) in a biological specimen.Lymphoblast Count
Lymphoblasts/LeukocytesC105444Lymphoblasts/LeukocytesA relative measurement (ratio or percentage) of the lymphoblasts to leukocytes in a biological specimen.Lymphoblast to Leukocyte Ratio Measurement
LymphocytesC51949LymphocytesA measurement of the lymphocytes in a biological specimen.Lymphocyte Count
Lymphocytes ActivatedC119289Lymphocytes ActivatedA measurement of the total activated lymphocytes in a biological specimen.Activated Lymphocytes Measurement
Lymphocytes AtypicalC64818Lymphocytes AtypicalA measurement of the atypical lymphocytes in a biological specimen.Atypical Lymphocyte Count
Lymphocytes Atypical/LeukocytesC64819Lymphocytes Atypical/LeukocytesA relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen.Atypical Lymphocyte to Leukocyte Ratio
Lymphocytes/LeukocytesC64820Lymphocytes/LeukocytesA relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen.Lymphocyte to Leukocyte Ratio
Lymphocytes/Total CellsC98751Lymphocytes/Total CellsA relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen).Lymphocyte to Total Cell Ratio Measurement
Lymphoma CellsC74613Lymphoma CellsA measurement of the malignant lymphocytes in a biological specimen.Lymphoma Cell Count
Lymphoma Cells/LymphocytesC74910Lymphoma Cells/LymphocytesA relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen.Lymphoma Cell to Lymphocyte Ratio Measurement
LymphotactinC81955Chemokine Ligand 1;LymphotactinA measurement of the lymphotactin in a biological specimen.Lymphotactin Measurement
Lysergic Acid DiethylamideC75354Acid;Lysergic Acid DiethylamideA measurement of the lysergic acid diethylamine (LSD) in a biological specimen.Lysergide Measurement
M. tuberculosis IFN Gamma ResponseC92241Mycobacterium tuberculosis IFN Gamma ResponseA measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection.Mycobacterium tuberculosis Interferon Gamma Response
MacroamylaseC111243MacroamylaseA measurement of macroamylase in a biological specimen.Macroamylase Measurement
MacrocytesC64821MacrocytesA measurement of the macrocytes in a biological specimen.Macrocyte Count
Macrophage Colony Stimulating FactorC80191Macrophage Colony Stimulating FactorA measurement of the macrophage colony stimulating factor in a biological specimen.Macrophage Colony Stimulating Factor Measurement
Macrophage Inflammatory Protein 1 AlphaC82023Chemokine Ligand 3;Macrophage Inflammatory Protein 1 AlphaA measurement of the macrophage inflammatory protein 1 alpha in a biological specimen.Macrophage Inflammatory Protein 1 Alpha Measurement
Macrophage Inflammatory Protein 1 BetaC82024Chemokine Ligand 4;Macrophage Inflammatory Protein 1 BetaA measurement of the macrophage inflammatory protein 1 beta in a biological specimen.Macrophage Inflammatory Protein 1 Beta Measurement
Macrophage-Derived ChemokineC81956Chemokine Ligand 22;Macrophage-Derived ChemokineA measurement of the macrophage-derived chemokine in a biological specimen.Macrophage-Derived Chemokine Measurement
MacrophagesC74798MacrophagesA measurement of the macrophages in a biological specimen.Macrophage Count
Macrophages/Total CellsC111244Macrophages/Total CellsA relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen.Macrophage to Total Cell Ratio Measurement
MagnesiumC64840MagnesiumA measurement of the magnesium in a biological specimen.Magnesium Measurement
Magnesium/CreatinineC79456Magnesium/CreatinineA relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen.Magnesium to Creatinine Ratio Measurement
Malignant Cells, NOSC74660Malignant Cells, NOSA measurement of the malignant cells of all types in a biological specimen.Malignant Cell Count
Malignant Cells, NOS/Blood CellsC74643Malignant Cells, NOS/Blood CellsA relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen.Malignant Cell to Blood Cell Ratio Measurement
Mast CellsC111246Mast Cells;MastocytesA measurement of the mast cells in a biological specimen.Mast Cell Count
Mast Cells/Total CellsC111247Mast Cells/Total CellsA relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen.Mast Cell to Total Cell Ratio Measurement
Matrix Metalloproteinase 1C80192Interstitial Collagenase;Matrix Metalloproteinase 1A measurement of the matrix metalloproteinase 1 in a biological specimen.Matrix Metalloproteinase 1 Measurement
Matrix Metalloproteinase 2C80193Gelatinase A;Matrix Metalloproteinase 2A measurement of the matrix metalloproteinase 2 in a biological specimen.Matrix Metalloproteinase 2 Measurement
Matrix Metalloproteinase 3C80194Matrix Metalloproteinase 3;Stromelysin 1A measurement of the matrix metalloproteinase 3 in a biological specimen.Matrix Metalloproteinase 3 Measurement
Matrix Metalloproteinase 7C80195Matrilysin;Matrix Metalloproteinase 7A measurement of the matrix metalloproteinase 7 in a biological specimen.Matrix Metalloproteinase 7 Measurement
Matrix Metalloproteinase 8C80196Matrix Metalloproteinase 8;Neutrophil CollagenaseA measurement of the matrix metalloproteinase 8 in a biological specimen.Matrix Metalloproteinase 8 Measurement
Matrix Metalloproteinase 9C80197Gelatinase B;Matrix Metalloproteinase 9A measurement of the matrix metalloproteinase 9 in a biological specimen.Matrix Metalloproteinase 9 Measurement
Mature Plasma CellsC74661Mature Plasma Cells;PlasmacytesA measurement of the mature plasma cells (plasmacytes) in a biological specimen.Mature Plasma Cell Count
Mature Plasma Cells/LymphocytesC74911Mature Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen.Mature Plasma Cell to Lymphocyte Ratio Measurement
May-Hegglin AnomalyC74614May-Hegglin AnomalyA measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes.May-Hegglin Anomaly Measurement
MCV ReticulocytesC114215MCV Reticulocytes;Mean Corpuscular Volume ReticulocytesA measurement of the mean volume of reticulocytes in a biological specimen.Reticulocyte Mean Corpuscular Volume
Mean Platelet ComponentC96686Mean Platelet ComponentA measurement of the mean platelet component (platelet activity) in a blood specimen.Mean Platelet Component Measurement
Mean Platelet Dry MassC114214Mean Platelet Dry MassA measurement of the mean platelet dry mass in a biological specimen.Mean Platelet Dry Mass
Mean Platelet VolumeC74730Mean Platelet VolumeA measurement of the average size of the platelets present in a blood sample.Mean Platelet Volume Measurement
Medium Absorption Retic/ReticulocytesC116193Medium Absorption Retic/ReticulocytesA relative measurement (ratio or percentage) of the medium absorption reticulocytes to total reticulocytes in a biological specimen.Medium Absorption Reticulocytes to Total Reticulocytes Ratio Measurement
Medium Absorption ReticulocytesC116192Medium Absorption ReticulocytesA measurement of the medium absorption reticulocytes in a biological specimen.Medium Absorption Reticulocyte Measurement
MegakaryoblastsC98752MegakaryoblastsA measurement of the megakaryoblasts in a biological specimen.Megakaryoblast Cell Count
Megakaryoblasts/Total CellsC98753Megakaryoblasts/Total CellsA relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen).Megakaryoblast to Total Cell Ratio Measurement
MegakaryocytesC96688MegakaryocytesA measurement of the megakaryocytes per unit of a biological specimen.Megakaryocyte Count
Megakaryocytes/Total CellsC98867Megakaryocytes/Total CellsA relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen).Megakaryocyte to Total Cell Ratio Measurement
MelatoninC74867MelatoninA measurement of the melatonin hormone in a biological specimen.Melatonin Measurement
Meningeal CellsC111250Meningeal CellsA measurement of the mengingeal cells in a biological specimen.Meningeal Cell Count
Meningeal Cells/Total CellsC111251Meningeal Cells/Total CellsA relative measurement (ratio or percentage) of the meningeal cells to total cells in a biological specimen.Meningeal Cell to Total Cell Ratio Measurement
MetamyelocytesC74615MetamyelocytesA measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen.Metamyelocyte Count
Metamyelocytes/LeukocytesC74645Metamyelocytes/LeukocytesA relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen.Metamyelocyte to Leukocyte Ratio Measurement
Metamyelocytes/Total CellsC98754Metamyelocytes/Total CellsA relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen).Metamyelocyte to Total Cell Ratio Measurement
MetanephrineC116198Metadrenaline;MetanephrineA measurement of the metanephrine in a biological specimen.Metanephrine Measurement
MethadoneC74881MethadoneA measurement of the methadone present in a biological specimen.Methadone Measurement
MethamphetamineC75348MethamphetamineA measurement of the methamphetamine drug present in a biological specimen.Methamphetamine Measurement
MethaqualoneC74882MethaqualoneA measurement of the methaqualone present in a biological specimen.Methaqualone Measurement
MethemoglobinC96689MethemoglobinA measurement of the methemoglobin in a biological specimen.Methemoglobin Measurement
Methylmalonic AcidC96690Methylmalonic AcidA measurement of the methylmalonic acid in a biological specimen.Methylmalonic Acid Measurement
MicrocytesC64822MicrocytesA measurement of the microcytes in a biological specimen.Microcyte Count
MicrofilariaC117843MicrofilariaPresence of microfilaria stage of filarial nematodes in smears prepared from whole blood or other body fluids.Microfilaria Measurement
Mid Cell FractionC116199Mid Cell Fraction;Mid CellsA measurement of the mid cell fraction, including eosinophils, basophils, monocytes and other precursor white blood cells, in a biological specimen.Mid Cell Fraction Measurement
Mixed CastsC74771Mixed CastsA measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen.Mixed Cast Count
Mixed Lymphocyte ReactionC16790Mixed Leukocyte Reaction;Mixed Lymphocyte ReactionA measurement of the histocompatibility at the HL-A locus between two populations of lymphocytes taken from two separate individuals.Mixed Lymphocyte Reaction Test
MonoblastsC74631MonoblastsA measurement of the monoblast cells in a biological specimen.Monoblast Count
Monoblasts/LeukocytesC74646Monoblasts/LeukocytesA relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen.Monoblast to Leukocyte Ratio Measurement
Monoclonal ProteinC92291Monoclonal Immunoglobulin Protein;ParaproteinA measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen.Monoclonal Protein Measurement
Monoclonal Protein SpikeC117844Monoclonal Protein SpikeA measurement of the monoclonal protein in the region of the electrophoresis field containing a spike (increase) in protein.Monoclonal Protein Spike Measurement
Monocyte Chemotactic Protein 1C82025Monocyte Chemotactic Protein 1A measurement of the monocyte chemotactic protein 1 in a biological specimen.Monocyte Chemotactic Protein 1 Measurement
MonocytesC64823MonocytesA measurement of the monocytes in a biological specimen.Monocyte Count
Monocytes/LeukocytesC64824Monocytes/LeukocytesA relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen.Monocyte to Leukocyte Ratio
Monocytes/MacrocytesC106544Monocytes/MacrocytesA relative measurement (ratio or percentage) of the monocytes to macrocytes present in a sample.Monocytes to Macrocytes Ratio Measurement
Monocytes/Total CellsC98872Monocytes/Total CellsA relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen).Monocytes to Total Cell Ratio Measurement
Monocytoid CellsC111276Monocytoid CellsA measurement of the monocytoid cells in a biological specimen.Monocytoid Cell Count
Monocytoid Cells/Total CellsC111277Monocytoid Cells/Total CellsA relative measurement (ratio or percentage) of the monocytoid cells to total cells in a biological specimen.Monocytoid Cell to Total Cell Ratio Measurement
Monosodium Urate CrystalsC74681Monosodium Urate CrystalsA measurement of the monosodium urate crystals present in a biological specimen.Monosodium Urate Crystal Measurement
MorphineC74883MorphineA measurement of the morphine present in a biological specimen.Morphine Measurement
Mu Glutathione-S-TransferaseC79457Mu Glutathione-S-TransferaseA measurement of the mu form of glutathione S-transferase in a biological specimen.Mu Glutathione-S-Transferase Measurement
Mu Glutathione-S-Transferase/CreatinineC79458Mu Glutathione-S-Transferase/CreatinineA relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen.Mu Glutathione-S-Transferase to Creatinine Ratio Measurement
Mucous ThreadsC74721Mucous ThreadsA measurement of the mucous threads present in a biological specimen.Mucous Thread Measurement
Mycobacterium tuberculosis Nucleic AcidC92279Mycobacterium tuberculosis Nucleic AcidA measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen.Mycobacterium tuberculosis Nucleic Acid Measurement
Myelin AntibodiesC103418Myelin AntibodiesA measurement of the myelin antibodies in a biological specimen.Myelin Antibodies Measurement
MyeloblastsC74632MyeloblastsA measurement of the myeloblast cells in a biological specimen.Myeloblast Count
Myeloblasts/LeukocytesC64825Myeloblasts/LeukocytesA relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen.Myeloblast to Leukocyte Ratio
Myeloblasts/Total CellsC98761Myeloblasts/Total CellsA relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen).Myeloblast to Total Cell Ratio Measurement
MyelocytesC74662MyelocytesA measurement of the myelocytes in a biological specimen.Myelocyte Count
Myelocytes/LeukocytesC64826Myelocytes/LeukocytesA relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen.Myelocyte to Leukocyte Ratio
Myelocytes/Total CellsC98868Myelocytes/Total CellsA relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen).Myelocyte to Total Cell Ratio Measurement
Myeloid/Erythroid RatioC92242Myeloid/Erythroid RatioA relative measurement (ratio or percentage) of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen.Myeloid to Erythroid Ratio Measurement
MyeloperoxidaseC80198MyeloperoxidaseA measurement of the myeloperoxidase in a biological specimen.Myeloperoxidase Measurement
Myeloperoxidase AntibodyC92280Myeloperoxidase AntibodyA measurement of the myeloperoxidase antibody in a biological specimen.Myeloperoxidase Antibody Measurement
Myeloperoxidase IndexC119290Myeloperoxidase IndexThe mean peroxidase activity index or staining intensity of the neutrophil population relative to the archetype.Neutrophil Myeloperoxidase Index
MyoglobinC79436MyoglobinA measurement of myoglobin in a biological specimen.Myoglobin Measurement
Myoglobin/CreatinineC106546Myoglobin/CreatinineA relative measurement (ratio or percentage) of the myoglobin to creatinine present in a sample.Myoglobin to Creatinine Ratio Measurement
Myosin Light Chain 3C106547Cardiac myosin light chain 1;Myosin Light Chain 3;Myosin light chain 1, slow-twitch muscle B/ventricular isoformA measurement of myosin light chain 3 in a biological specimen.Myosin Light Chain 3 Measurement
N-Acetyl GlucosamideC79459N-Acetyl Glucosamide;N-Acetyl GlucosamineA measurement of N-acetyl glucosamide (sugar derivative) in a biological specimen.N-Acetyl Glucosamide Measurement
N-Acetyl Glucosamide/CreatinineC79460N-Acetyl Glucosamide/CreatinineA relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen.N-Acetyl Glucosamide to Creatinine Ratio Measurement
N-acetyl-beta-D-glucosaminidaseC103419Beta-N-acetyl-D-glucosaminidaseA measurement of the N-acetyl-beta-D-glucosaminidase (enzyme) in a biological specimen.N-acetyl-beta-D-glucosaminidase Measurement
N-telopeptideC74743N-telopeptideA measurement of the N-telopeptide in a biological specimen.N-Telopeptide Measurement
N-Terminal ProB-type Natriuretic PeptideC96610N-Terminal ProB-type Natriuretic Peptide;N-terminal pro-Brain Natriuretic Peptide;NT proBNP IIA measurement of the N-terminal proB-type natriuretic peptide in a biological specimen.N-Terminal ProB-type Natriuretic Peptide Measurement
Natural Killer Cell FunctionC116203Natural Killer Cell Activity;Natural Killer Cell FunctionA measurement of the natural killer cell function in a biological specimen.Natural Killer Cell Activity Measurement
Natural Killer CellsC98762Natural Killer CellsA measurement of the total natural killer cells in a biological specimen.Natural Killer Cell Count
Neisseria gonorrhoeae ScreeningC92298Neisseria gonorrhoeae ScreeningExamination of a biological specimen to detect the presence of Neisseria gonorrhoeae.Neisseria gonorrhoeae Screening
NeopterinC80199NeopterinA measurement of the neopterin in a biological specimen.Neopterin Measurement
Neuron Specific EnolaseC116205Enolase 2;Gamma-enolase;Neuron Specific EnolaseA measurement of the neuron specific enolase in a biological specimen.Neuron Specific Enolase Measurement
Neuropeptide YC74892Neuropeptide YA measurement of the neuropeptide Y in a biological specimen.Neuropeptide Y Measurement
Neutrophil ElastaseC82026Neutrophil ElastaseA measurement of the neutrophil elastase in a biological specimen.Neutrophil Elastase Measurement
Neutrophil Elastase, PolymorphonuclearC82027Neutrophil Elastase, PolymorphonuclearA measurement of the polymorphonuclear neutrophil elastase in a biological specimen.Polymorphonuclear Neutrophil Elastase Measurement
Neutrophilic MetamyelocytesC84822Neutrophilic MetamyelocytesA measurement of the neutrophilic metamyelocytes in a biological specimen.Neutrophilic Metamyelocyte Count
Neutrophilic MyelocytesC84823Neutrophilic MyelocytesA measurement of the neutrophilic myelocytes in a biological specimen.Neutrophilic Myelocyte Count
NeutrophilsC63321NeutrophilsA measurement of the neutrophils in a biological specimen.Absolute Neutrophil Count
Neutrophils Band FormC64830Neutrophils Band FormA measurement of the banded neutrophils in a biological specimen.Neutrophil Band Form Count
Neutrophils Band Form/LeukocytesC64831Neutrophils Band Form/LeukocytesA relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen.Neutrophil Band Form to Leukocyte Ratio
Neutrophils, SegmentedC81997Neutrophils, SegmentedA measurement of the segmented neutrophils in a biological specimen.Segmented Neutrophil Count
Neutrophils, Segmented/LeukocytesC82045Neutrophils, Segmented/LeukocytesA relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen.Segmented Neutrophil to Leukocyte Ratio Measurement
Neutrophils/LeukocytesC64827Neutrophils/LeukocytesA relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen.Neutrophil to Leukocyte Ratio
Neutrophils/Total CellsC98763Neutrophils/Total CellsA relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen).Neutrophil to Total Cell Ratio Measurement
NiacinC74899Niacin;Vitamin B3A measurement of the niacin in a biological specimen.Vitamin B3 Measurement
Nitric OxideC112360NO;Nitric OxideA measurement of the nitric oxide in a biological specimen.Nitric Oxide Measurement
NitriteC64810NitriteA measurement of the nitrite in a urine specimen.Nitrite Measurement
Non-HDL CholesterolC116204Non-HDL Cholesterol;Non-High Density LipoproteinA measurement of the non-high density lipoprotein cholesterol in a biological specimen.Non-High Density Lipoprotein Cholesterol Measurement
Non-Phosphorylated Tau ProteinC84811Non-Phosphorylated Tau ProteinA measurement of the non-phosphorylated Tau protein in a biological specimen.Nonphosphorylated Tau Protein Measurement
Non-Prostatic Acid PhosphataseC100434Non-Prostatic Acid PhosphataseA measurement of the non-prostatic acid phosphatase in a biological specimen.Non-Prostatic Acid Phosphatase Measurement
NorepinephrineC74868Noradrenaline;NorepinephrineA measurement of the norepinephrine hormone in a biological specimen.Noradrenaline Measurement
Normoblasts/Total CellsC98764Normoblasts/Total CellsA relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen).Normoblast to Total Cell Ratio Measurement
Nuclear SwellingC114213Nuclear SwellingA measurement of the expansion of the nucleus of the cells in a biological specimen.Nuclear Swelling Measurement
Nucleated ErythrocytesC74705Nucleated Erythrocytes;Nucleated Red Blood CellsA measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen.Nucleated Red Blood Cell Count
Nucleated Erythrocytes/ErythrocytesC74647Nucleated Erythrocytes/Erythrocytes;Nucleated Red Blood Cells/ErythrocytesA relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen.Nucleated Red Blood Cell to Erythrocyte Ratio Measurement
Nucleated Erythrocytes/LeukocytesC82046Nucleated Erythrocytes/LeukocytesA relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen.Nucleated Erythrocyte to Leukocyte Ratio Measurement
Occult BloodC74686Occult BloodA measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination.Occult Blood Measurement
OpiateC74796OpiateA measurement of any opiate class drug present in a biological specimen.Opiate Measurement
OsmolalityC74801OsmolalityA measurement of the osmoles of solute per unit of biological specimen.Osmolality Measurement
OsmolarityC74802OsmolarityA measurement of the osmoles of solute per liter of solution.Osmolarity Measurement
OsteocalcinC74744OsteocalcinA measurement of the osteocalcin in a biological specimen.Osteocalcin Measurement
OsteoprotegerinC116206OCIF;Osteoclastogenesis Inhibitory Factor;Osteoprotegerin;TNFRS11B;Tumor Necrosis Factor Receptor Superfamily Member 11bA measurement of the osteoprotegerin in a biological specimen.Osteoprotegerin Measurement
Ova and ParasiteC100452Ova and ParasiteA measurement of the parasites and ova in a biological specimen.Ova and Parasite Measurement
OxalateC92250Ethanedioate;OxalateA measurement of the oxalate in a biological specimen.Oxalate Measurement
Oxalate/CreatinineC117983Oxalate/CreatinineA relative measurement (ratio or percentage) of the oxalate to creatinine in a biological specimen.Oxalate to Creatinine Ratio Measurement
Oxidized LDL Cholesterol AntibodyC119288Oxidized LDL Cholesterol AntibodyA measurement of the total oxidized low density lipoprotein cholesterol antibody in a biological specimen.Oxidized LDL Cholesterol Antibody Measurement
OxycodoneC74884Oxycodone;OxycontinA measurement of the oxycodone present in a biological specimen.Oxycodone Measurement
Oxygen CapacityC96614Oxygen CapacityA measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood.Oxygen Capacity Measurement
Oxygen ContentC111284Oxygen ContentA measurement of the amount of oxygen content in a biological specimen.Oxygen Measurement
Oxygen SaturationC60832Oxygen SaturationA measurement of the oxygen-hemoglobin saturation of a volume of blood.Oxygen Saturation Measurement
OxyhemoglobinC96616OxyhemoglobinA measurement of the oxyhemoglobin, oxygen-bound hemoglobin, in a biological specimen.Oxyhemoglobin Measurement
OxytocinC74869Oxytocin;OxytoxinA measurement of the oxytocin hormone in a biological specimen.Oxytocin Measurement
P-SelectinC117850GMP-140;P-SelectinA measurement of total P-selectin in a biological specimen.P-Selectin Measurement
P50 OxygenC102279P50 OxygenA measurement of the partial pressure of oxygen when hemoglobin is half saturated in a biological specimen.P50 Oxygen Measurement
Pancreatic Elastase 1C82028Pancreatic Elastase 1A measurement of the pancreatic elastase 1 in a biological specimen.Pancreatic Elastase Measurement
Pancreatic Elastase 1, PolymorphonuclearC82029Pancreatic Elastase 1, PolymorphonuclearA measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen.Polymorphonuclear Pancreatic Elastase Measurement
Pancreatic PolypeptideC80201Pancreatic PolypeptideA measurement of the pancreatic polypeptide in a biological specimen.Pancreatic Polypeptide Measurement
Panel Reactive AntibodyC116210PRA Score;Panel Reactive Antibody;Percent Panel Reactive Antibody;Percent Reactive AntibodyA measurement of the panel reactive antibody (the reactivity between host immune cells and donor human leukocyte antigen) in a biological specimen.Panel Reactive Antibody Test
Pappenheimer BodiesC74616Pappenheimer BodiesA measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen.Pappenheimer Body Count
Parathyroid Hormone, C-TerminalC81964Parathyroid Hormone, C-TerminalA measurement of the C-terminal fragment of parathyroid hormone in a biological specimen.C-Terminal Parathyroid Hormone Measurement
Parathyroid Hormone, FragmentedC74784Parathyroid Hormone, FragmentedA measurement of the fragmented parathyroid hormone in a biological specimen.Fragmented Parathyroid Hormone Measurement
Parathyroid Hormone, IntactC74789Parathyroid Hormone, IntactA measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen.Intact Parathyroid Hormone Measurement
Parathyroid Hormone, Mid-MoleculeC81965Parathyroid Hormone, Mid-MoleculeA measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen.Mid-Molecule Parathyroid Hormone Measurement
Parathyroid Hormone, N-TerminalC81966Parathyroid Hormone, N-TerminalA measurement of the N-terminal fragment of parathyroid hormone in a biological specimen.N-Terminal Parathyroid Hormone Measurement
Parathyroid Hormone, WholeC103451Parathyroid Hormone, WholeA measurement of the whole parathyroid hormone (consisting of amino acids 1-84) in a biological specimen.Whole Parathyroid Hormone Measurement
Parathyroid Hormone-related ProteinC117851Parathyroid Hormone-related Peptide;Parathyroid Hormone-related ProteinA measurement of parathyroid hormone-related protein in a biological specimen.Parathyroid Hormone-related Protein Measurement
Parietal Cell AntibodyC116207Anti-Parietal Cell Antibody;Parietal Cell AntibodyA measurement of the parietal cell antibody in a biological specimen.Parietal Cell Antibody Measurement
Partial Pressure Carbon DioxideC82625Partial Pressure Carbon DioxideA measurement of the pressure of carbon dioxide in a biological specimen.Partial Pressure of Carbon Dioxide Measurement
Partial Pressure OxygenC71251Partial Pressure OxygenA measurement of the pressure of oxygen in a biological specimen.Partial Pressure of Oxygen Measurement
Parvovirus B19 IgG AntibodyC96617Parvovirus B19 IgG AntibodyA measurement of the Parvovirus B19 IgG antibody in a biological specimen.Parvovirus B19 IgG Antibody Measurement
Parvovirus B19 IgM AntibodyC96618Parvovirus B19 IgM AntibodyA measurement of the Parvovirus B19 IgM antibody in a biological specimen.Parvovirus B19 IgM Antibody Measurement
Pelger Huet AnomalyC74617Pelger Huet AnomalyA measurement of the Pelger Huet Anomaly (nuclei of neutrophils and eosinophils appear rod-like, spherical or dumbbell shaped) in a biological specimen.Pelger Huet Anomaly Measurement
Pemphigoid AntibodiesC81988Pemphigoid AntibodiesA measurement of the pemphigoid antibodies in a biological specimen.Pemphigoid Antibody Measurement
PepsinogenC100122PepsinogenA measurement of the pepsinogen in a biological specimen.Pepsinogen Measurement
Pepsinogen AC100469PGA;Pepsinogen AA measurement of the pepsinogen A in a biological specimen.Pepsinogen A Measurement
Pepsinogen CC100470PGC;Pepsinogen CA measurement of the pepsinogen C in a biological specimen.Pepsinogen C Measurement
Pepsinogen IC100467PGI;Pepsinogen IA measurement of the pepsinogen I in a biological specimen.Pepsinogen I Measurement
Pepsinogen IIC100468PGII;Pepsinogen IIA measurement of the pepsinogen II in a biological specimen.Pepsinogen II Measurement
Peptide YYC80202Peptide Tyrosine Tyrosine;Peptide YYA measurement of the peptide YY in a biological specimen.Peptide YY Measurement
PeriostinC112395OSF2;Osteoblast Specific Factor 2;POSTN;PeriostinA measurement of the periostin in a biological specimen.Periostin Measurement
pHC45997pHThe negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid.pH
PhencyclidineC74694Phencyclidine;PhenylcyclohexylpiperidineA measurement of the phencyclidine present in a biological specimen.Phencyclidine Measurement
PhenothiazineC74695Dibenzothiazine;PhenothiazineA measurement of the phenothiazine present in a biological specimen.Phenothiazine Measurement
PhosphateC64857Inorganic Phosphate;Phosphate;PhosphorusA measurement of the phosphate in a biological specimen.Phosphate Measurement
Phosphate ClearanceC106553Phosphate ClearanceA measurement of the volume of serum or plasma that would be cleared of phosphate by excretion of urine for a specified unit of time (e.g. one minute).Phosphate Clearance Measurement
Phosphate/CreatinineC79461Phosphate/CreatinineA relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen.Phosphate to Creatinine Ratio Measurement
PhospholipidC96623PhospholipidA measurement of the phospholipids in a biological specimen.Phospholipid Measurement
Phosphorus Excretion RateC117845Phosphorus Excretion RateA measurement of the amount of phosphorus being excreted in urine over a defined amount of time (e.g. one hour).Phosphorus Urine Excretion Rate
Phosphorylated Tau ProteinC84812Phosphorylated Tau ProteinA measurement of the phosphorylated Tau protein in a biological specimen.Phosphorylated Tau Protein Measurement
Pi-GST Excretion RateC119279Pi-GST Excretion RateA measurement of the amount of Pi Glutathione-S-Transferase being excreted in urine over a defined period of time (e.g. one hour).Pi-GST Excretion Rate
Plasma Cells/Total CellsC98869Plasma Cells/Total CellsA relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen).Plasma Cell to Total Cell Ratio Measurement
Plasmacytoid LymphocytesC74618Plasmacytoid Lymphocytes;PlymphocytesA measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen.Plasmacytoid Lymphocyte Count
Plasmacytoid Lymphocytes/LymphocytesC74648Plasmacytoid Lymphocytes/LymphocytesA relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen.Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement
Plasminogen Activator Inhibitor-1C82030Plasminogen Activator Inhibitor-1A measurement of the plasminogen activator inhibitor-1 in a biological specimen.Plasminogen Activator Inhibitor-1 Measurement
Plasminogen Activator Inhibitor-1 AGC81989Plasminogen Activator Inhibitor-1 AGA measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen.Plasminogen Activator Inhibitor-1 Antigen Measurement
PlasmodiumC100453Malaria;PlasmodiumExamination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus.Plasmodium Measurement
Platelet Activating FactorC111292Platelet Activating FactorA measurement of the platelet activating factor in a biological specimen.Platelet Activating Factor Measurement
Platelet AggregationC103427Platelet Aggregation;Platelet FunctionA measurement of the association of platelets to one another via adhesion molecules in a biological sample.Platelet Aggregation Measurement
Platelet Aggregation AmplitudeC111293Platelet Aggregation AmplitudeA measurement of the magnitude of the platelet aggregation in a biological specimen.Platelet Aggregation Amplitude Measurement
Platelet Aggregation Curve TypeC114210Platelet Aggregation Curve TypeThe classification of the curve pattern that is formed as a result of platelet aggregation.Platelet Aggregometry Curve Type
Platelet Aggregation Mean AmplitudeC114211Platelet Aggregation Mean AmplitudeAn average of the measurements of the magnitude of the platelet aggregation in a biological specimen.Platelet Aggregometry Mean Amplitude
Platelet Aggregation Mean Curve TypeC114212Platelet Aggregation Mean Curve TypeThe classification of the curve pattern that is formed as the average result of the platelet aggregation curve measurements.Platelet Aggregometry Mean Curve Type
Platelet ClumpsC96624PLT Clumps;Platelet ClumpsA measurement of the platelet clumps in a biological specimen.Platelet Clumps Count
Platelet Component Distribution WidthC111294Platelet Component Distribution WidthA measurement of a marker of platelet shape change in a biological specimen.Platelet Component Distribution Width Measurement
Platelet Derived Growth Factor Isoform ABC116208PDGF Isoform AB;Platelet Derived Growth Factor Isoform AB;Platelet Derived Growth Factor-AB IsoformA measurement of the platelet derived growth factor isoform AB in a biological specimen.Platelet Derived Growth Factor Isoform AB Measurement
Platelet Distribution WidthC81962Platelet Distribution WidthA measurement of the range of platelet sizes in a biological specimen.Platelet Distribution Width
Platelet Function Closure TimeC111295PFCT;Platelet Function Closure TimeA measurement of the platelet function closure time in a biological specimen.Platelet Function Closure Time Measurement
Platelet HematocritC100424Platelet Hematocrit;ThrombocytocritA relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets.Platelet Hematocrit Measurement
Platelet MorphologyC111296Platelet MorphologyAn examination or assessment of the form and structure of platelets.Platelet Morphology Measurement
Platelet SatellitismC116209Platelet SatellitismAn examination or assessment of the platelet satellitism (platelet rosetting around cells) in a biological specimen.Platelet Satellitism Assessment
PlateletsC51951PlateletsA measurement of the platelets (non-nucleated thrombocytes) in a biological specimen.Platelet Count
PoikilocytesC79602PoikilocytesA measurement of the odd-shaped erythrocytes in a whole blood specimen.Poikilocyte Measurement
Poikilocytes/ErythrocytesC74649Poikilocytes/ErythrocytesA relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen.Poikilocyte to Erythrocyte Ratio Measurement
PolychromasiaC64803PolychromasiaA measurement of the blue-staining characteristic of newly generated erythrocytes.Polychromasia
PotassiumC64853PotassiumA measurement of the potassium in a biological specimen.Potassium Measurement
Potassium ClearanceC106560Potassium ClearanceA measurement of the volume of serum or plasma that would be cleared of potassium by excretion of urine for a specified unit of time (e.g. one minute).Potassium Clearance Measurement
Potassium Excretion RateC117839Potassium Excretion RateA measurement of the amount of potassium being excreted in urine over a defined amount of time (e.g. one hour).Potassium Urine Excretion Rate
Potassium/CreatinineC79462Potassium/CreatinineA relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen.Potassium to Creatinine Ratio Measurement
PP Arterial O2/Fraction Inspired O2C119293PAO2/FIO2;PP Arterial O2/Fraction Inspired O2A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses.Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement
PrealbuminC100435Prealbumin;Thyroxine-binding Prealbumin;TransthyretinA measurement of the prealbumin in a biological specimen.Prealbumin Measurement
Precursor Plasma CellsC74619Plasmablast;Precursor Plasma CellsA measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen.Precursor Plasma Cell Count
Precursor Plasma Cells/LymphocytesC74650Precursor Plasma Cells/LymphocytesA relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen.Precursor Plasma Cell to Lymphocyte Ratio Measurement
Pregnancy-Associated Plasma Protein-AC82031Pregnancy-Associated Plasma Protein-AA measurement of the pregnancy-associated plasma protein-A in a biological specimen.Pregnancy-Associated Plasma Protein-A Measurement
ProB-type Natriuretic PeptideC82032Pro-Brain Natriuretic Peptide;ProB-type Natriuretic Peptide;proBNPA measurement of the proB-type natriuretic peptide in a biological specimen.ProB-Type Natriuretic Peptide Measurement
ProcalcitoninC103430ProcalcitoninA measurement of the procalcitonin in a biological specimen.Procalcitonin Measurement
Procollagen 1 N-Terminal PropeptideC96625Amino-terminal propeptide of type 1 procollagen;P1NP Aminoterm Type 1;Procollagen 1 N-Terminal PropeptideA measurement of the procollagen 1 N-terminal propeptide in a biological specimen.Procollagen 1 N-Terminal Propeptide Measurement
Procollagen Type I Carboxy Term PeptideC82033Procollagen Type I Carboxy Term PeptideA measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen.Procollagen Type I Carboxy Terminal Peptide Measurement
ProerythroblastC100446ProerythroblastA measurement of the proerythroblasts in a biological specimen.Proerythroblast Measurement
ProgesteroneC74791ProgesteroneA measurement of the progesterone hormone in a biological specimen.Progesterone Measurement
Progesterone ReceptorC117846NR3C3;PR;Progesterone ReceptorA measurement of the progesterone receptor in a biological specimen.Progesterone Receptor Measurement
ProinsulinC81967ProinsulinA measurement of the proinsulin in a biological specimen.Proinsulin Measurement
Proinsulin/Insulin RatioC111299Proinsulin/Insulin RatioA relative measurement (ratio or percentage) of the proinsulin to insulin in a biological specimen.Proinsulin to Insulin Ratio Measurement
ProlactinC74870ProlactinA measurement of the prolactin hormone in a biological specimen.Prolactin Measurement
ProlymphocytesC74620ProlymphocytesA measurement of the prolymphocytes in a biological specimen.Prolymphocyte Count
Prolymphocytes/LeukocytesC64829Prolymphocytes/LeukocytesA relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen.Prolymphocyte to Leukocyte Ratio
Prolymphocytes/LymphocytesC74651Prolymphocytes/LymphocytesA relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen.Prolymphocyte to Lymphocyte Ratio Measurement
PromonocytesC74621PromonocytesA measurement of the promonocytes in a biological specimen.Promonocyte Count
Promonocytes/LeukocytesC74652Promonocytes/LeukocytesA relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen.Promonocyte to Lymphocyte Ratio Measurement
PromyeloblastsC117847PromyeloblastsA measurement of the promyeloblasts in a biological specimen.Promyeloblasts Measurement
PromyelocytesC74622PromyelocytesA measurement of the promyelocytes (immature myelocytes) in a biological specimen.Promyelocyte Count
Promyelocytes/LeukocytesC74653Promyelocytes/LeukocytesA relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen.Promyelocyte to Lymphocyte Ratio Measurement
Promyelocytes/Total CellsC98773Promyelocytes/Total CellsA relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen).Promyelocyte to Total Cell Ratio Measurement
Pronormoblasts/Total CellsC98870Pronormoblasts/Total CellsA relative measurement (ratio or percentage) of the pronormoblasts to total cells in a biological specimen (for example a bone marrow specimen).Pronormoblast to Total Cell Ratio Measurement
PropoxypheneC74885PropoxypheneA measurement of the propoxyphene present in a biological specimen.Propoxyphene Measurement
ProstaglandinC103343Total ProstaglandinA measurement of the total prostaglandin in a biological specimen.Prostaglandin Measurement
Prostaglandin D2C103431Prostaglandin D2A measurement of the prostaglandin D2 in a biological specimen.Prostaglandin D2 Measurement
Prostaglandin D2 SynthaseC103432Prostaglandin D2 SynthaseA measurement of the prostaglandin D2 synthase in a biological specimen.Prostaglandin D2 Synthase Measurement
Prostaglandin E SynthaseC103433Prostaglandin E SynthaseA measurement of the prostaglandin E synthase in a biological specimen.Prostaglandin E Synthase Measurement
Prostaglandin E1C103434Prostaglandin E1A measurement of the prostaglandin E1 in a biological specimen.Prostaglandin E1 Measurement
Prostaglandin E2C103435Prostaglandin E2A measurement of the prostaglandin E2 in a biological specimen.Prostaglandin E2 Measurement
Prostaglandin F1 AlphaC103436Prostaglandin F1 AlphaA measurement of the prostaglandin F1 alpha in a biological specimen.Prostaglandin F1 Alpha Measurement
Prostaglandin F2 AlphaC103437Prostaglandin F2 AlphaA measurement of the prostaglandin F2 alpha in a biological specimen.Prostaglandin F2 Alpha Measurement
Prostate Specific AntigenC17634Prostate Specific AntigenA measurement of the prostate specific antigen in a biological specimen.Prostate Specific Antigen Measurement
Prostatic Acid PhosphataseC80204Prostatic Acid PhosphataseA measurement of the prostatic acid phosphatase in a biological specimen.Prostatic Acid Phosphatase Measurement
ProteinC64858ProteinA measurement of the total protein in a biological specimen.Total Protein Measurement
Protein Excretion RateC117848Protein Excretion RateA measurement of the amount of total protein being excreted in urine over a defined amount of time (e.g. one hour).Total Protein Urine Excretion Rate
Protein SC100436Protein SA measurement of the protein S in a biological specimen.Protein S Measurement
Protein/CreatinineC79463Protein/CreatinineA relative measurement (ratio or percentage) of the protein to creatinine in a biological specimen.Protein to Creatinine Ratio Measurement
Protein/OsmolalityC92240Protein/Osmolality;Protein/Osmolality RatioA relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen.Protein to Osmolality Ratio Measurement
Prothrombin ActivityC98774Factor II Activity;Prothrombin ActivityA measurement of the biological activity of prothrombin in a biological specimen.Prothrombin Activity Measurement
Prothrombin Fragments 1 + 2C82034Prothrombin Fragments 1 + 2A measurement of the prothrombin fragments 1 and 2 in a biological specimen.Prothrombin Fragments 1 and 2 Measurement
Prothrombin Intl. Normalized RatioC64805Prothrombin Intl. Normalized RatioA ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test.International Normalized Ratio of Prothrombin Time
Prothrombin TimeC62656Prothrombin TimeA blood clotting measurement that evaluates the extrinsic pathway of coagulation.Prothrombin Time
ProtozoaC117849ProtozoaExamination of a biological specimen to detect the presence of protozoa in a biological specimen.Protozoa Measurement
PseudoephedrineC74696PseudoephedrineA measurement of the pseudoephedrine present in a biological specimen.Pseudoephedrine Measurement
PyridinolineC80211PyridinolineA measurement of the pyridinoline in a biological specimen.Pyridinoline Measurement
Rapid Plasma ReaginC74716Rapid Plasma ReaginA measurement of the antibodies produced by cellular damage caused by Treponema pallidum (syphilis) in a biological specimen.Rapid Plasma Reagin Measurement
RBC CastsC74772RBC CastsA measurement of the red blood cell casts present in a biological specimen.Red Blood Cell Cast Measurement
Reactive LymphocytesC74629Reactive LymphocytesA measurement of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) in a biological specimen.Reactive Lymphocyte Count Measurement
Reactive Lymphocytes/LymphocytesC74654Reactive Lymphocytes/LymphocytesA relative measurement (ratio or percentage) of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) to all lymphocytes in a biological specimen.Reactive Lymphocyte to Lymphocyte Ratio Measurement
Receptor Activator Nuclear KappaB LigandC117852Receptor Activator Nuclear KappaB Ligand;Receptor Activator of Nuclear Kappa-B LigandA measurement of the receptor activator of nuclear kappa-B ligand in a biological specimen.Receptor Activator Nuclear KappaB Ligand Measurement
Reg upon Act Normal T-cell Exprd SecrtdC81957Chemokine Ligand 5;Reg upon Act Normal T-cell Exprd SecrtdA measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen.Reg upon Act Normal T-cell Exprd Secrtd Measurement
ReninC74893Active Renin;Angiotensinogenase;Direct Renin;ReninA measurement of the renin in a biological specimen.Renin Measurement
Renin ActivityC111305PRA;Plasma Renin Activity;Renin Activity;URA;Urinary Renin ActivityA measurement of the renin activity in a biological specimen.Renin Activity Measurement
Reptilase TimeC96628Reptilase TimeA measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase.Reptilase Time Measurement
ResistinC80205ResistinA measurement of the resistin in a biological specimen.Resistin Measurement
Ret. Corpuscular Hemoglobin ContentC117854CHr;Ret. Corpuscular Hemoglobin ContentA quantitative measurement of the total amount of hemoglobin in the reticulocyte population.Total Reticulocyte Corpuscular Hemoglobin Content Measurement
Ret. Mean Corpuscular HemoglobinC117855CHCMr;Ret. Mean Corpuscular HemoglobinA quantitative measurement of the mean amount of hemoglobin per reticulocyte in a biological specimen.Reticulocyte Mean Corpuscular Hemoglobin Measurement
Reticulocyte Distribution WidthC114218Reticulocyte Distribution WidthA measurement of the range of reticulocyte sizes in a biological specimen.Reticulocyte Distribution Width
Reticulocyte HemoglobinC98776Reticulocyte HemoglobinA measurement of the amount of hemoglobin in reticulocytes.Reticulocyte Hemoglobin Measurement
ReticulocytesC51947ReticulocytesA measurement of the reticulocytes in a biological specimen.Reticulocyte Count
Reticulocytes/ErythrocytesC64828Reticulocytes/ErythrocytesA relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen.Reticulocyte to Erythrocyte Ratio
Retinol Binding ProteinC100437Retinol Binding ProteinA measurement of the total retinol binding protein in a biological specimen.Retinol Binding Protein Measurement
Rheumatoid FactorC74717Rheumatoid FactorA measurement of the rheumatoid factor antibody in a biological specimen.Rheumatoid Factor Measurement
RiboflavinC74898Riboflavin;Vitamin B2A measurement of the riboflavin in a biological specimen.Vitamin B2 Measurement
Ribonucleoprotein AntibodyC100457RNP Antibody;Ribonucleoprotein AntibodyA measurement of the ribonucleoprotein antibody in a biological specimen.Ribonucleoprotein Antibody Measurement
Ringed SideroblastsC100419Ringed SideroblastsA measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen.Ringed Sideroblast Measurement
Rouleaux FormationC74624Rouleaux FormationA measurement of the number of stacking red blood cells within a biological specimen.Rouleaux Formation Count
Round Epithelial CellsC74698Round Epithelial CellsA measurement of the round epithelial cells present in a biological specimen.Round Epithelial Cell Count
Rubella IgG AntibodyC103440Rubella IgG AntibodyA measurement of the Rubella IgG antibody in a biological specimen.Rubella IgG Antibody Measurement
Rubeola IgG AntibodyC112412Measles IgG Antibody;Rubeola IgG AntibodyA measurement of the Measles (Rubeola) virus IgG antibody in a biological specimen.Rubeola IgG Antibody Measurement
Rubeola IgM AntibodyC112413Measles IgM Antibody;Rubeola IgM AntibodyA measurement of the Measles (Rubeola) virus IgM antibody in a biological specimen.Rubeola IgM Antibody Measurement
SchistocytesC74706SchistocytesA measurement of the schistocytes (fragmented red blood cells) in a biological specimen.Schistocyte Count
Scl-70 AntibodyC100458Scl-70 Antibody;Scleroderma-70 AntibodyA measurement of the Scl-70 antibody in a biological specimen.Scl-70 Antibody Measurement
SclerostinC117857SclerostinA measurement of the sclerostin in a biological specimen.Sclerostin Measurement
SecretinC74871SecretinA measurement of the secretin hormone in a biological specimen.Secretin Measurement
Sediment ExaminationC105744Microscopic Sediment Analysis;Sediment Analysis;Sediment ExaminationAn observation, assessment or examination of the sediment in a biological specimen.Sediment Analysis
SerotoninC74872SerotoninA measurement of the serotonin hormone in a biological specimen.Serotonin Measurement
Sex Hormone Binding GlobulinC74745Sex Hormone Binding Globulin;Sex Hormone Binding ProteinA measurement of the sex hormone binding (globulin) protein in a biological specimen.Sex Hormone Binding Protein Measurement
Sezary CellsC74625Sezary CellsA measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen.Sezary Cell Count
Sezary Cells/LymphocytesC74655Sezary Cells/LymphocytesA relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen.Sezary Cell to Lymphocyte Ratio Measurement
Sialyl SSEA-1 AntigenC114223SLeX;Sialyl Lewis X Antigen;Sialyl Lex;Sialyl SSEA-1 Antigen;Sialyl-CD15A measurement of the sialyl stage-specific embryonic antigen-1 in a biological specimen.Sialyl SSEA-1 Antigen Measurement
Sickle CellsC74626Sickle CellsA measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen.Sickle Cell Count
Sickle Cells/ErythrocytesC74656Sickle Cells/ErythrocytesA relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen.Sickle Cell to Erythrocyte Ratio Measurement
SideroblastC100418SideroblastA measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen.Sideroblast Measurement
Sjogrens SS-A AntibodyC92236Ro Antibody;Sjogrens SS-A AntibodyA measurement of the Sjogrens SS-A antibody in a biological specimen.Sjogren's SS-A Antibody Measurement
Sjogrens SS-B AntibodyC92237La Antibody;Sjogrens SS-B AntibodyA measurement of the Sjogrens SS-B antibody in a biological specimen.Sjogren's SS-B Antibody Measurement
Smith AntibodyC92281Smith AntibodyA measurement of the Smith antibody in a biological specimen.Smith Antibody Measurement
Smooth Muscle AntibodyC111317Actin Antibody;Anti-Smooth Muscle Antibody;Smooth Muscle AntibodyA measurement of the smooth muscle antibody in a biological specimen.Smooth Muscle Antibody Measurement
Smudge CellsC74627Basket Cells;Gumprecht Shadow Cells;Shadow Cells;Smudge CellsA measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen.Smudge Cell Count
Smudge Cells/LeukocytesC119294Basket Cells/Leukocytes;Gumprecht Shadow Cells/Leukocytes;Shadow Cells/Leukocytes;Smudge Cells/LeukocytesA relative measurement (ratio or percentage) of smudge cells to leukocytes in a biological specimen.Smudge Cells to Leukocytes Ratio Measurement
SodiumC64809SodiumA measurement of the sodium in a biological specimen.Sodium Measurement
Sodium ClearanceC106568Sodium ClearanceA measurement of the volume of serum or plasma that would be cleared of sodium by excretion of urine for a specified unit of time (e.g. one minute).Sodium Clearance Measurement
Sodium Excretion RateC117856Sodium Excretion RateA measurement of the amount of sodium being excreted in urine over a defined amount of time (e.g. one hour).Sodium Urine Excretion Rate
Sodium/CreatinineC79464Sodium/CreatinineA relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen.Sodium to Creatinine Ratio Measurement
Soluble E-SelectinC119273Soluble E-Selectin;sE-selectinA measurement of the soluble E-Selectin activity in a biological specimen.Soluble E-Selectin Measurement
Soluble ImmunoglobulinC117835Soluble ImmunoglobulinA measurement of the soluble total immunoglobulin in a biological specimen.Soluble Immunoglobulin Measurement
Soluble Interleukin 2 Receptor ActivityC102280Soluble Interleukin 2 Receptor ActivityA measurement of the soluble interleukin 2 receptor activity in a biological specimen.Soluble Interleukin 2 Receptor Activity Measurement
Soluble Interleukin 6 ReceptorC117837Soluble Interleukin 6 ReceptorA measurement of the soluble interleukin 6 receptor in a biological specimen.Soluble Interleukin 6 Receptor Measurement
Soluble Interleukin-1 Receptor Type IC117836Soluble Interleukin-1 Receptor Type IA measurement of the soluble interleukin-1 receptor type I in a biological specimen.Soluble Interleukin-1 Receptor Type I Measurement
Soluble TNF Receptor Type IC117863Soluble TNF Receptor Type IA measurement of the soluble tumor necrosis factor receptor type I in a biological specimen.Soluble Tumor Necrosis Factor Receptor Type I Measurement
Soluble TNF Receptor Type IIC117864Soluble TNF Receptor Type IIA measurement of the soluble tumor necrosis factor receptor type II in a biological specimen.Soluble Tumor Necrosis Factor Receptor Type II Measurement
Soluble Transferrin ReceptorC100438Soluble Transferrin ReceptorA measurement of the soluble transferrin receptor in a biological specimen.Soluble Transferrin Receptor Measurement
Soluble Tumor Necrosis Factor ReceptorC117749Soluble Tumor Necrosis Factor ReceptorA measurement of the total soluble tumor necrosis factor receptor in a biological specimen.Soluble Tumor Necrosis Factor Receptor Measurement
Soluble Vasc Cell Adhesion Molecule 1C92533Soluble Vascular Cell Adhesion Molecule 1A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen.Soluble Vascular Cell Adhesion Molecule 1
SomatotrophinC80360Growth Hormone;SomatotrophinA measurement of the somatotrophin (growth) hormone in a biological specimen.Somatotrophin Measurement
Sorbitol DehydrogenaseC79465Sorbitol DehydrogenaseA measurement of the sorbitol dehydrogenase in a biological specimen.Sorbitol Dehydrogenase Measurement
Specific GravityC64832Specific GravityA ratio of the density of a fluid to the density of water.Specific Gravity
Specimen AppearanceC25377Specimen AppearanceThe outward or visible aspect of a specimen.Appearance
Specimen WeightC106569Specimen WeightA measurement of the weight of a biological specimen.Specimen Weight Measurement
Sperm MotilityC102281Sperm MotilityA measurement of the sperm capable of forward, progressive movement in a semen specimen.Sperm Motility Measurement
SpermatozoaC74663SpermatozoaA measurement of the spermatozoa cells present in a biological specimen.Spermatozoa Cell Count
SpherocytesC74707SpherocytesA measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen.Spherocyte Count
Squamous Epithelial CellsC74773Squamous Epithelial CellsA measurement of the squamous epithelial cells present in a biological specimen.Squamous Epithelial Cell Count
Squamous Transitional Epithelial CellsC74774Epithelial Cells;Squamous Transitional Epithelial CellsA measurement of the squamous transitional epithelial cells present in a biological specimen.Squamous Transitional Epithelial Cell Count
Starch CrystalsC81951Starch CrystalsA measurement of the starch crystals in a biological specimen.Starch Crystal Measurement
Stem Cell FactorC82035KIT Ligand;Stem Cell FactorA measurement of the stem cell factor in a biological specimen.Stem Cell Factor Measurement
StomatocytesC74708StomatocytesA measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen.Stomatocyte Count
Streptolysin O AntibodyC92282Antistreptolysin O;Streptolysin O AntibodyA measurement of Streptolysin O Antibody in a biological specimen.Streptolysin O Antibody Measurement
Strongyloides IgG AntibodyC117858Strongyloides IgG AntibodyA measurement of strongyloides IgG antibody in a biological specimen.Strongyloides IgG Antibody Measurement
Sulfa CrystalsC74755Sulfa CrystalsA measurement of the sulfa crystals present in a biological specimen.Sulfa Crystal Measurement
Sulfur DioxideC114224Sulfur DioxideA measurement of the sulfur dioxide in a biological specimen.Sulfur Dioxide Measurement
Surfactant Protein DC111322SP-D;Surfactant Protein DA measurement of the surfactant protein D in a biological specimen.Surfactant Protein D Measurement
Target CellsC96636Codocytes;Leptocytes;Mexican Hat Cells;Target CellsA measurement of the target cells in a biological specimen.Target Cell Count
Tartrate-Resistant Acid Phosphatase 5bC117865TRAP5B;Tartrate-Resistant Acid Phosphatase 5bA measurement of tartrate-resistant acid phosphatase 5b in a biological specimen.Tartrate-Resistant Acid Phosphatase 5b Measurement
Tau ProteinC84810Tau Protein;Total Tau ProteinA measurement of the total Tau protein in a biological specimen.Tau Protein Measurement
Terminal Deoxynucleotidyl Transferase AgC117859Terminal Deoxynucleotidyl Transferase Ag;Terminal Deoxynucleotidyl Transferase AntigenA measurement of the terminal deoxynucleotidyl transferase antigen in a biological specimen.Terminal Deoxynucleotidyl Transferase Antigen Measurement
TestosteroneC74793Testosterone;Total TestosteroneA measurement of the total (free and bound) testosterone in a biological specimen.Total Testosterone Measurement
Testosterone, FreeC74785Testosterone, FreeA measurement of the free testosterone in a biological specimen.Free Testosterone Measurement
TheophyllineC105445TheophyllineA measurement of the Theophylline present in a biological specimen.Theophylline Measurement
ThiamineC74896Thiamine;Vitamin B1A measurement of the thiamine in a biological specimen.Vitamin B1 Measurement
Thrombin TimeC80365Thrombin TimeA measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI)Thrombin Time
Thrombin/AntithrombinC106574Thrombin/Antithrombin;Thrombin/Antithrombin IIIA relative measurement (ratio or percentage) of the thrombin to antithrombin present in a sample.Thrombin to Antithrombin Ratio Measurement
ThrombocytesC111283Nucleated Thrombocytes;ThrombocytesA measurement of the nucleated platelets, namely thrombocytes, in a biological specimen. This is typically measured in birds and other non-mammalian vertebrates.Nucleated Thrombocyte Count
ThrombopoietinC74873ThrombopoietinA measurement of the thrombopoietin hormone in a biological specimen.Thrombopoietin Measurement
Thromboxane B2C103445Thromboxane B2A measurement of the thromboxane B2 in a biological specimen.Thromboxane B2 Measurement
ThyroglobulinC103446TG;ThyroglobulinA measurement of the thyroglobulin in a biological specimen.Thyroglobulin Measurement
Thyroid AntibodiesC81990Thyroid AntibodiesA measurement of the thyroid antibodies in a biological specimen.Thyroid Antibody Measurement
Thyroid Antimicrosomal AntibodiesC81991Thyroid Antimicrosomal AntibodiesA measurement of the thyroid antimicrosomal antibodies in a biological specimen.Thyroid Antimicrosomal Antibody Measurement
Thyroid Antithyroglobulin AntibodiesC81992Thyroid Antithyroglobulin AntibodiesA measurement of the thyroid antithyroglobulin antibodies in a biological specimen.Thyroid Antithyroglobulin Antibody Measurement
ThyroperoxidaseC96639Thyroid Peroxidase;ThyroperoxidaseA measurement of the thyroperoxidase in a biological specimen.Thyroperoxidase Measurement
Thyroperoxidase AntibodyC96638Thyroperoxidase AntibodyA measurement of the thyroperoxidase antibody in a biological specimen.Thyroperoxidase Antibody Measurement
ThyrotropinC64813Thyroid Stimulating Hormone;ThyrotropinA measurement of the thyrotropin in a biological specimen.Thyrotropin Measurement
Thyrotropin Releasing HormoneC74874Thyrotropin Releasing Factor;Thyrotropin Releasing HormoneA measurement of the thyrotropin releasing hormone in a biological specimen.Thyrotropin Releasing Hormone Measurement
ThyroxineC74794Thyroxine;Total T4A measurement of the total (free and bound) thyroxine in a biological specimen.Total Thyroxine Measurement
Thyroxine Binding GlobulinC74746Thyroxine Binding GlobulinA measurement of the thyroxine binding globulin protein in a biological specimen.Thyroxine Binding Globulin Protein Measurement
Thyroxine, FreeC74786Free T4;Thyroxine, FreeA measurement of the free thyroxine in a biological specimen.Free Thyroxine Measurement
TIMP1/CreatinineC106575TIMP1/Creatinine;Tissue Inhibitor of Metalloproteinase 1/CreatinineA relative measurement (ratio or percentage) of the tissue inhibitor of metalloproteinase 1 to creatinine present in a sample.Tissue Inhibitor of Metalloproteinase 1 to Creatinine Ratio Measurement
Tissue Inhibitor of Metalloproteinase 1C82036Tissue Inhibitor of Metalloproteinase 1A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen.Tissue Inhibitor of Metalloproteinase 1 Measurement
Tissue Plasminogen Activator AntigenC81993Tissue Plasminogen Activator AntigenA measurement of the tissue plasminogen activator antigen in a biological specimen.Tissue Plasminogen Activator Antigen Measurement
TNF-a Production Inhibitory ActivityC117862TNF-a Production Inhibitory ActivityA measurement of TNF-a production inhibitory activity in a biological specimen.TNF-a Production Inhibitory Activity Measurement
Total Amyloid Precursor ProteinC119269Total Amyloid Precursor ProteinA measurement of the total amyloid precursor protein present in a biological specimen.Total Amyloid Precursor Protein Measurement
Total Iron Binding CapacityC74718Total Iron Binding CapacityA measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen.Total Iron Binding Capacity
Total Radical-Trap Antioxidant PotentialC80208Total Radical-Trap Antioxidant PotentialA measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension.Total Radical-Trap Antioxidant Potential Measurement
Toxic GranulationC96641Toxic GranulationA measurement of the toxic granulation in neutrophilic blood cells.Toxic Granulation Measurement
TransferrinC82037TransferrinA measurement of the transferrin in a biological specimen.Transferrin Measurement
Transferrin SaturationC98792Iron Binding Capacity Saturation;Iron Saturation;Iron Saturation Percent;Serum Iron to TIBC Ratio;Transferrin Iron Saturation;Transferrin SaturationA measurement of the iron bound to transferrin in a biological specimen.Transferrin Saturation Measurement
Transforming Growth Factor Beta 1C117861Transforming Growth Factor Beta 1A measurement of the transforming growth factor beta 1 in a biological specimen.Transforming Growth Factor Beta 1 Measurement
Transitional Epithelial CellsC92251Transitional Epithelial CellsA measurement of the transitional epithelial cells present in a biological specimen.Transitional Epithelial Cells Measurement
TrichomonasC92238TrichomonasExamination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus.Trichomonas Screening
Tricyclic AntidepressantsC100420Tricyclic AntidepressantsA measurement of tricyclic antidepressants in a biological specimen.Tricyclic Antidepressant Measurement
TriglyceridesC64812TriglyceridesA measurement of the triglycerides in a biological specimen.Triglyceride Measurement
TriiodothyronineC74747Total T3;TriiodothyronineA measurement of the total (free and bound) triiodothyronine in a biological specimen.Triiodothyronine Measurement
Triiodothyronine UptakeC74748Triiodothyronine UptakeA measurement of the binding of triiodothyonine to thyroxine binding globulin protein in a biological specimen.Triiodothyronine Uptake Measurement
Triiodothyronine, FreeC74787Free T3;Triiodothyronine, FreeA measurement of the free triiodothyronine in a biological specimen.Free Triiodothyronine Measurement
Triiodothyronine, ReverseC81968Triiodothyronine, ReverseA measurement of the reverse triiodothyronine in a biological specimen.Reverse Triiodothyronine Measurement
Triple Phosphate CrystalsC74756Triple Phosphate CrystalsA measurement of the triple phosphate crystals present in a biological specimen.Triple Phosphate Crystal Measurement
TroponinC111327TroponinA measurement of the total troponin in a biological specimen.Troponin Measurement
Troponin IC74749Troponin IA measurement of the actin binding troponin in a biological specimen.Troponin I Measurement
Troponin TC74750Troponin TA measurement of the tropomyosin binding troponin in a biological specimen.Troponin T Measurement
TryptaseC92292TryptaseA measurement of the tryptase in a biological specimen.Tryptase Measurement
Tubular Epithelial CellsC74775Renal Tubular Epithelial Cells;Tubular Epithelial CellsA measurement of the tubular epithelial cells present in a biological specimen.Tubular Epithelial Cell Count
Tumor Necrosis FactorC74751Tumor Necrosis Factor;Tumor Necrosis Factor alphaA measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen.Tumor Necrosis Factor Measurement
TurbidityC74723TurbidityA measurement of the opacity of a biological specimen.Turbidity Measurement
Type I Collagen C-TelopeptidesC82038Type I Collagen C-Telopeptides;Type I Collagen X-linked C-telopeptideA measurement of the type I collagen C-telopeptides in a biological specimen.Type I Collagen C-Telopeptide Measurement
Type I Collagen N-TelopeptidesC82039Type I Collagen N-TelopeptidesA measurement of the type I collagen N-telopeptides in a biological specimen.Type I Collagen N-Telopeptide Measurement
Type I MyeloblastsC92283Type I MyeloblastsA measurement of type I myeloblast cells per unit of a biological specimen.Type I Myeloblasts Measurement
Type II Collagen C-TelopeptidesC82040Type II Collagen C-TelopeptidesA measurement of the type II collagen C-telopeptides in a biological specimen.Type II Collagen C-Telopeptide Measurement
Type II Collagen N-TelopeptidesC82041Type II Collagen N-TelopeptidesA measurement of the type II collagen N-telopeptides in a biological specimen.Type II Collagen N-Telopeptide Measurement
Type II MyeloblastsC92284Type II MyeloblastsA measurement of type II myeloblast cells per unit of a biological specimen.Type II Myeloblasts Measurement
Type III MyeloblastsC92285Type III MyeloblastsA measurement of type III myeloblast cells per unit of a biological specimen.Type III Myeloblasts Measurement
Tyrosine CrystalsC74683Tyrosine CrystalsA measurement of the tyrosine crystals present in a biological specimen.Tyrosine Crystal Measurement
Unclassified CastsC74776Unclassified CastsA measurement of the unclassifiable casts present in a biological specimen.Unclassified Cast Measurement
Unclassified CrystalsC74757Unclassified CrystalsA measurement of the unclassifiable crystals present in a biological specimen.Unclassified Crystal Measurement
Unsaturated Iron Binding CapacityC74719Unsaturated Iron Binding CapacityA measurement of the binding capacity of unsaturated iron in a biological specimen.Unsaturated Iron Binding Capacity Measurement
Unspecified CellsC112241Unspecified CellsA measurement of the cells not otherwise identified or specified in a biological specimen.Count of Unspecified Cells
Unspecified Cells/Total CellsC114225Unspecified Cells/Total CellsA relative measurement (ratio or percentage) of the cells not otherwise identified or specified to total cells in a biological specimen.Unspecified Cells to Total Cell Ratio Measurement
UrateC64814Urate;Uric AcidA measurement of the urate in a biological specimen.Urate Measurement
Urate/CreatinineC117866Urate/CreatinineA relative measurement (ratio or percentage) of the urate to creatinine in a biological specimen.Urate to Creatinine Ratio Measurement
UreaC64815UreaA measurement of the urea in a biological specimen.Urea Measurement
Urea/CreatinineC96645Urea/CreatinineA relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen.Urea to Creatinine Ratio Measurement
Uric Acid CrystalsC74684Uric Acid CrystalsA measurement of the uric acid crystals present in a biological specimen.Uric Acid Crystal Measurement
Urine ConductivityC102282Urine ConductivityA measurement of the urine conductivity which is a non-linear function of the electrolyte concentration in the urine.Urine Conductivity
UrobilinogenC64816UrobilinogenA measurement of the urobilinogen in a biological specimen.Urobilinogen Measurement
Vacuolated LymphocytesC111329Vacuolated LymphocytesA measurement of the vacuolated lymphocytes in a biological specimen.Vacuolated Lymphocyte Count
Vacuolated NeutrophilsC74628Vacuolated NeutrophilsA measurement of the neutrophils containing small vacuoles in a biological specimen.Vacuolated Neutrophil Count
Vanillyl Mandelic AcidC74875Vanillyl Mandelic Acid;Vanilmandelic AcidA measurement of the vanillyl mandelic acid metabolite in a biological specimen.Vanillyl Mandelic Acid Measurement
Varicella Zoster Virus AntibodyC117867Varicella Zoster Virus AntibodyA measurement of the total varicella zoster virus antibody in a biological specimen.Varicella Zoster Virus Antibody Measurement
Varicella Zoster Virus IgA AntibodyC98795Varicella Zoster Virus IgA AntibodyA measurement of the Varicella Zoster virus IgA antibodies in a biological specimen.Varicella Zoster Virus IgA Antibody Measurement
Varicella Zoster Virus IgG AntibodyC98796Varicella Zoster Virus IgG AntibodyA measurement of the Varicella Zoster virus IgG antibodies in a biological specimen.Varicella Zoster Virus IgG Antibody Measurement
Varicella Zoster Virus IgM AntibodyC98797Varicella Zoster Virus IgM AntibodyA measurement of the Varicella Zoster virus IgM antibodies in a biological specimen.Varicella Zoster Virus IgM Antibody Measurement
Vascular Cell Adhesion Molecule 1C82042Vascular Cell Adhesion Molecule 1A measurement of the vascular cell adhesion molecule 1 in a biological specimen.Vascular Cell Adhesion Molecule 1 Measurement
Vascular Endothelial Growth FactorC92514Vascular Endothelial Growth FactorA measurement of the vascular endothelial growth factor in a biological specimen.Vascular Endothelial Growth Factor Measurement
ViscosityC75912ViscosityThe resistance of a liquid to sheer forces and flow. (NCI)Viscosity
Vitamin AC74895Retinol;Vitamin AA measurement of the Vitamin A in a biological specimen.Vitamin A Measurement
Vitamin B12C64817Vitamin B12A measurement of the Vitamin B12 in a serum specimen.Vitamin B12 Measurement
Vitamin B17C74897Amygdalin;Vitamin B17A measurement of the Vitamin B17 in a biological specimen.Vitamin B17 Measurement
Vitamin B5C74900Pantothenic Acid;Vitamin B5A measurement of the Vitamin B5 in a biological specimen.Vitamin B5 Measurement
Vitamin B6C74901Pyridoxine;Vitamin B6A measurement of the Vitamin B6 in a biological specimen.Vitamin B6 Measurement
Vitamin B7C74902Biotin;Vitamin B7A measurement of the Vitamin B7 in a biological specimen.Vitamin B7 Measurement
Vitamin B9C74676Folic Acid;Vitamin B9A measurement of the folic acid in a biological specimen.Folic Acid Measurement
Vitamin CC74903Ascorbic Acid;Vitamin CA measurement of the Vitamin C in a biological specimen.Vitamin C Measurement
Vitamin DC84818Total Vitamin D;Vitamin DA measurement of the total Vitamin D in a biological specimen.Vitamin D Measurement
Vitamin D2C74904Ergocalciferol;Vitamin D2A measurement of the Vitamin D2 in a biological specimen.Vitamin D2 Measurement
Vitamin D3C74905Cholecalciferol;Vitamin D3A measurement of the Vitamin D3 in a biological specimen.Vitamin D3 Measurement
Vitamin EC74906Vitamin EA measurement of the Vitamin E in a biological specimen.Vitamin E Measurement
Vitamin E/CholesterolC103448Vitamin E/CholesterolA relative measurement (ratio or percentage) of vitamin E to total cholesterol in a biological specimen.Vitamin E to Cholesterol Ratio Measurement
Vitamin KC74907Naphthoquinone;Vitamin KA measurement of the total Vitamin K in a biological specimen.Vitamin K Measurement
Vitamin K1C103449Phylloquinone;PhytomenadioneA measurement of the Vitamin K1 in a biological specimen.Vitamin K1 Measurement
VLDL CholesterolC105589VLDL CholesterolA measurement of the very low density lipoprotein cholesterol in a biological specimen.Very Low Density Lipoprotein Cholesterol Measurement
VLDL Particle SizeC103450VLDL Particle SizeA measurement of the average particle size of very-low-density lipoprotein in a biological specimen.VLDL Particle Size Measurement
VolumeC74720VolumeA measurement of the volume of a biological specimen.Volume Measurement
von Willebrand FactorC98799von Willebrand Factor;von Willebrand Factor AntigenA measurement of the von Willebrand factor in a biological specimen.von Willebrand Factor Measurement
Waxy CastsC74777Waxy CastsA measurement of the waxy casts present in a biological specimen.Waxy Cell Cast Measurement
WBC CastsC74778WBC CastsA measurement of the white blood cell casts present in a biological specimen.White Blood Cell Cast Measurement
Yeast BuddingC106504Budding Yeast;Yeast BuddingA measurement of the budding yeast present in a biological specimen.Budding Yeast Measurement
Yeast CellsC74664Yeast CellsA measurement of the yeast cells present in a biological specimen.Yeast Cell Measurement
Yeast HyphaeC92239Yeast HyphaeA measurement of the yeast hyphae present in a biological specimen.Yeast Hyphae Screening
ZincC80210ZincA measurement of the zinc in a biological specimen.Zinc Measurement
Back to top
CL.C102580.LBSTRESCLaboratory Test Standard Character Result
(LBSTRESC)
text
Extensible: Yes
C102580Laboratory Test Standard Character ResultTerminology relevant to the standardized results, in character format, for laboratory tests.CDISC SDTM Laboratory Test Standard Character Result Terminology
BORDERLINEC14157Straddling the dividing line between two categories.Borderline
INDETERMINATEC48658InconclusiveCannot distinguish between two or more possible values in the current context. (NCI)Indeterminate
INVALIDC50913Not valid data.Invalid Data
NEGATIVEC38757A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.Negative Finding
POSITIVEC38758An observation confirming something, such as the presence of a disease, condition, or microorganism.Positive Finding
Back to top
CL.C99073.LATLaterality
(LAT)
text
Extensible: Yes
C99073LateralityCDISC terminology for anatomical location or specimen further detailing the side(s) of interest.CDISC SDTM Laterality Terminology
BILATERALC13332Affecting both sides of the body, or a pair of organs.Bilateral
CONTRALATERALC25307Having to do with the opposite side of the body, in relation to a pre-existing reference point.Contralateral
IPSILATERALC25308Having to do with the same side of the body, in relation to a pre-existing reference point.Ipsilateral
LATERALC25230Situated at or extending to the side.Lateral
LEFTC25229Being or located on or directed toward the side of the body to the west when facing north.Left
RIGHTC25228Being or located on or directed toward the side of the body to the east when facing north.Right
UNILATERALC68598Affecting one side of the body or one of a pair of organs.Unilateral
Back to top
CL.C101862.LEADABNLead Abnormality
(LEADABN)
text
Extensible: Yes
C101862Lead AbnormalityTerminology related to the complications of cardiac lead systems.CDISC SDTM Lead Abnormality Terminology
CONDUCTOR FAILUREC99924Conductor failure manifests by high lead impedance either absolutely (above manufacturer's product specifications) or by a significant increase from previously stable chronic values.Cardiac Device Conductor Failure
DEFIBRILLATION ISSUESC99922The cardiac lead is not performing as expected with issues such as oversensing with or without shock or ATP, or failed shocks or inadequate DFT safety margins defibrillation activity.Cardiac Defibrillator Issue
EXTRACARDIAC STIMULATIONC99951This manifests as stimulation by the lead of non-cardiac structures such as the diaphragm, chest wall, or pectoral muscle.Extracardiac Stimulation
FAILED TO SHOCK WITH INADEQUATE DFT SAFETY MARGINC99954The cardiac lead failed to administer a shock and had an inadequate defibrillator threshold safety margin.Failure to Shock with Inadequate Defibrillator Threshold Safety Margin
FAILURE TO CAPTURE WITH ACCEPTABLE SAFETY MARGINC99953Failure to capture manifests as a high pacing threshold that results in either intermittent failure to capture at maximal programmed output or excessive battery drain leading to premature battery exhaustion.Failure to Capture with Acceptable Safety Margin
FAILURE TO PACEC99528Failure to pace manifests as absence of pacemaker stimulation artifacts on electrocardiographic recordings despite rates below pacemaker programmed rate.Failure of Cardiac Pacemaker to Pace
INSULATION FAILUREC99932Insulation failure manifests as low lead impedance either absolutely (below manufacturer's product specifications) or by a significant decrease from previously stable chronic values.Cardiac Lead Insulation Failure
LEAD DISLODGEMENT REQUIRING REPOSITION/REOPERATIONC100034The movement (macroscopic or microscopic) of an existing lead within the heart or vascular tree away from the original implantation site.Cardiac Lead Dislodgement Requiring Reposition/Reoperation
OVERSENSINGC99926Oversensing manifests as sensing of electrical signals not related to cardiac depolarization of the lead chamber that cannot be resolved acceptably by device reprogramming.Cardiac Device Oversensing
OVERSENSING WITH SHOCK OR ATPC99927This manifests as sensing of non-cardiac depolarization signals that met arrhythmia detection criteria and elicited programmed tachyarrhythmia therapy.Cardiac Device Oversensing with Shock or Anti-Tachycardia Pacing
OVERSENSING WITHOUT SHOCK OR ATPC99928This manifests as sensing of non-cardiac depolarization signals that did not meet arrhythmia detection criteria and do not elicit programmed tachyarrhythmia therapy.Cardiac Device Oversensing without Shock or Anti-Tachycardia Pacing
SET SCREW PROBLEMC99929The pacing and/or sensing problem associated with high impedance due to a poor connection between a lead and generator caused by a loose set screw.Cardiac Device Set Screw Problem
UNDERSENSINGC99930Undersensing manifests as failure to sense appropriate cardiac depolarizations that cannot be resolved with reprogramming.Cardiac Device Undersensing
Back to top
CL.C101867.LEADSTATLead Status
(LEADSTAT)
text
Extensible: Yes
C101867Lead StatusThe status of the lead.CDISC SDTM Lead Status Terminology
ABANDONEDC99906The lead has been left in situ but is not in use.Abandoned Lead
EXTRACTEDC102283The lead has been removed from the body.Extracted Lead
REUSEDC102284The lead has been left in situ and reused.Reused Lead
Back to top
CL.C101868.LVEFMRELeft Ventricular Ejection Fraction Measurement Result
(LVEFMRE)
text
Extensible: Yes
C101868Left Ventricular Ejection Fraction Measurement ResultTerminology for results of left ventricular ejection fraction assessments.CDISC SDTM Left Ventricular Ejection Fraction Measurement Result Terminology
HYPERDYNAMICC99512A pathologically high percentage of blood that is forced from the heart ventricle to produce cardiac output. This is often the result of ventricular dilation due to hypertrophic cardiomyopathy. Quantitatively, the ejection fraction is considered higher than 70%.Hyperdynamic Ventricular Ejection Fraction
MILD DYSFUNCTIONC99507Slightly less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 40% to 49%.Mildly Abnormal Ejection Fraction
MODERATE DYSFUNCTIONC99508Moderately less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 30% to 39%.Moderately Abnormal Ejection Fraction
NORMAL EJECTION FRACTIONC99513The usual amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 50% to 70%.Normal Ventricular Ejection Fraction
SEVERE DYSFUNCTIONC99509Severely less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered less than 30%.Severely Abnormal Ventricular Ejection Fraction
Back to top
CL.C101861.LSNCMPXLesion Complexity
(LSNCMPX)
text
Extensible: No
C101861Lesion ComplexityTerminology related to the risk of percutaneous coronary intervention for a particular lesion.CDISC SDTM Lesion Complexity Terminology
ACC/AHA LESION COMPLEXITY SCORE AC100037Low RiskDiscrete (less than 10 mm length) and concentric and readily accessible and non-angulated segment less than 45 degrees and smooth contour and little or no calcification and less than totally occlusive and not ostial in location and no major branch involvement and absence of thrombus.American College of Cardiology/American Heart Association Lesion Complexity Score A
ACC/AHA LESION COMPLEXITY SCORE BC100038Medium RiskTubular (10-20 mm length) or eccentric or moderate tortuosity of proximal segment or moderately angulated segment, 45-90 degrees or irregular contour or moderate to heavy calcification or ostial in location or bifurcation lesions requiring double guidewires or some thrombus present or total occlusion less than3 months old.American College of Cardiology/American Heart Association Lesion Complexity Score B
ACC/AHA LESION COMPLEXITY SCORE CC100039High RiskDiffuse (length greater than 2cm) or excessive tortuosity of proximal segment or extremely angulated segments greater than 90 degrees or total occlusions greater than 3 months old and/or bridging collaterals or inability to protect major side branches or degenerated vein grafts with friable lesions.American College of Cardiology/American Heart Association Lesion Complexity Score C
Back to top
CL.C101851.GRSTNLOCLocation of Most Severe Stenosis Within a Graft
(GRSTNLOC)
text
Extensible: No
C101851Location of Most Severe Stenosis Within a GraftTerminology used to describe the part of the graft that is most severely stenotic.CDISC SDTM Location of Most Severe Stenosis Within a Graft Terminology
AORTIC ANASTOMOSIS OF THE GRAFTC99915The connection where the graft joins the aorta usually less than or equal to 3 mm from insertion point.Aortic Anastomosis of Graft
BODY OF THE GRAFTC99918The portion of the graft that lies between its anastomoses.Body of Graft
CORONARY ANASTOMOSIS OF THE GRAFTC80476Coronary Graft AnastomosesThe connection where the graft joins the coronary artery usually less than or equal to 3 mm from insertion point.Coronary Graft Anastomoses
Back to top
CL.C76348.MARISTATMarital Status
(MARISTAT)
text
Extensible: Yes
C76348Marital StatusA demographic parameter indicating a person's current conjugal status.CDISC SDTM Marital Status Terminology
ANNULLEDC76240Marriage contract has been declared null and to not have existed. (HL7)Annulled
DIVORCEDC51776Marriage contract has been declared dissolved and inactive. (HL7)Divorced
DOMESTIC PARTNERC53262Domestic PartnerPerson declares that a domestic partnership relationship exists. (HL7)Domestic Partnership
INTERLOCUTORYC76241Temporary order issued during the course of litigation. (HL7)Interlocutory Marital Status
LEGALLY SEPARATEDC51777A person living apart from his/her spouse by legal arrangement. (HL7)Separated
MARRIEDC51773A current marriage contract is active. (HL7)Married
NEVER MARRIEDC51774No marriage contract has ever been entered. (HL7)Never Married
POLYGAMOUSC76242More than 1 current spouse. (HL7)Polygamous
WIDOWEDC51775The spouse has died. (HL7)Widowed
Back to top
CL.C101845.MCRCSPTMMechanical Circulatory Support Placement Timing
(MCRCSPTM)
text
Extensible: No
C101845Mechanical Circulatory Support Placement TimingA terminology codelist to describe the timing of mechanical circulatory support placement.CDISC SDTM Mechanical Circulatory Support Placement Timing Terminology
IN PLACE AT START OF PROCEDUREC99981In Place at Start of ProcedureMechanical Circulatory Support was in place at the start of the procedure.Mechanical Circulatory Support in Place at Start of Procedure
INSERTED DURING A NON-PERCUTANEOUS CORONARY INTERVENTION PROCEDUREC99962Inserted during a Non PCI ProcedureMechanical Circulatory Support was inserted during a non-Percutaneous Coronary Intervention (PCI) procedure.Inserted During a Non-Percutaneous Coronary Intervention
INSERTED DURING PROCEDURE AND AFTER PERCUTANEOUS CORONARY INTERVENTION STARTEDC99964Inserted during Procedure and after PCI StartedMechanical Circulatory Support was inserted during the procedure after Percutaneous Coronary Intervention (PCI) started.Inserted During Procedure and After Percutaneous Coronary Intervention Began
INSERTED DURING PROCEDURE BUT PRIOR TO PERCUTANEOUS CORONARY INTERVENTIONC99963Inserted during Procedure but Prior to PCIMechanical Circulatory Support was inserted during the procedure prior to percutaneous coronary intervention (PCI).Inserted During a Procedure but Prior to Percutaneous Coronary Intervention
Back to top
CL.C96777.MEDEVALMedical Evaluator
(MEDEVAL)
text
Extensible: Yes
C96777Medical EvaluatorThe individual responsible for the medical assessment.CDISC SDTM Medical Evaluator Terminology
ADJUDICATORC96561An individual that presides over and arbitrates between individuals or organizations.Adjudicator
NEUROLOGISTC17721A physician who specializes in diagnosing and treating diseases and disorders of the nervous system.Neurologist
NEUROLOGIST 1C96692A neurologist performing the assessment that is given the designation of one.Neurologist 1
NEUROLOGIST 2C96606A neurologist performing the assessment that is given the designation of two.Neurologist 2
ONCOLOGISTC17821A physician who specializes in diagnosing and treating cancer. (NCI)Oncologist
ONCOLOGIST 1C96611An oncologist performing the assessment that is given the designation of one.Oncologist 1
ONCOLOGIST 2C96612An oncologist performing the assessment that is given the designation of two.Oncologist 2
RADIOLOGISTC17824A physician who specializes in the diagnostic and/or therapeutic uses of radiation. (NCI)Radiologist
RADIOLOGIST 1C94530A radiologist performing the assessment that is given the designation of one.Radiologist 1
RADIOLOGIST 2C94531A radiologist performing the assessment that is given the designation of two.Radiologist 2
READERC28747An individual who takes non-quantifiable data and provides quantifiable assessments for that data.Reader
READER 1C94532A reader performing the assessment that is given the designation of one.Reader 1
READER 2C94533A reader performing the assessment that is given the designation of two.Reader 2
Back to top
CL.C85492.METHODMethod
(METHOD)
text
Extensible: Yes
C85492MethodMethod is any technique or procedure (an action) that determines how an observation or clinical finding was made.CDISC SDTM Method Terminology
ACID FAST STAINC23015A microscopy staining method used to examine a specimen for the presence of acid-fast microorganisms, specifically mycobacteria.Acid Fast Bacillae Staining Method
ACRIDINE ORANGE STAINC85554A microscopy staining method that utilizes acridine orange, a fluorescent cationic dye that is selective for nucleic acids, to determine the presence of viable cells or microorganisms in a sample. Acridine orange interacts with RNA and DNA and the lysosomal compartment of cells.Acridine Orange Staining Method
AGAR DILUTIONC85555A method to determine microbial susceptibility to antibiotics in which test bacteria is inoculated onto agar plates with serial dilutions of know quantities of antibiotics. The minimum inhibitory concentration of antibiotic is assessed.Agar Dilution Method
ALCIAN BLUE AND PERIODIC ACID SCHIFF STAINC92304A microscopy staining method that utilizes periodic acid, an oxoacid of iodine, Schiff reagent, the reaction product of fuchsine and sodium bisulfite, and Alcian blue, a water soluble copper phthalocyanine dye. This staining method is used to differentially stain glycoproteins.Alcian Blue and Periodic Acid Schiff Staining Method
ALCIAN BLUE STAINC92299A microscopy staining method that utilizes alcian blue, a cationic, water soluble copper-containing phthalocyanine dye to determine the presence of acid mucopolysaccharides and glycosaminoglycans.Alcian Blue Staining Method
ANGIOGRAPHYC20080A method used to create an image of blood vessels.Angiography
ANTIBIOTIC AGAR SCREENC85557A method used to detect organisms that have resistance to a single concentration of antibiotics in an agar matrix.Antibiotic Agar Screening Method
ANTIMICROBIAL COMBINATION TESTINGC85558A method to determine the microbial susceptibility to two or more antibiotics. Numerical result translated into indifference, antagonism, synergism, or additive.Antimicrobial Combination Testing Method
ATOMIC ABSORPTION SPECTROMETRYC85574A spectrometric method that determines the type and concentration of metal elements in a sample, based upon the principle that each elemental metal absorbs a particular wavelength of ultraviolet light when exposed to heat.Atomic Absorption Spectroscopy
AUDIOMETRYC38036Testing conducted utilizing a manual or microprocessor audiometer to test for hearing loss.Audiometric Test
AURAMINE STAINC102599Auramine OA microscopy acid fast staining method that utilizes auramine O, a bright yellow ketonimine dye, which binds to the mycolic acid in the cell walls of acid fast microorganisms.Auramine Staining Method
AUSCULTATIONC85573Listening with a device, such as a stethoscope, to anatomical locations that produce audible sounds like the heart, lungs and abdomen.Auscultation
BAC ACGHC116157BAC Array-based CGH;Bacterial Artificial Chromosome Array-based CGH;Bacterial Artificial Chromosome Array-based Comparative Genomic HybridizationA molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers, using bacterial artificial chromosome clones containing target DNA fragments for hybridization.Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization
BETA LACTAMASEC85576A test that detects beta lactamase produced by Staphylococcus species, Haemophilus species, Moraxella catarrhalis, and Neisseria gonorrhoeae.Beta Lactamase Screening Method
BIOPSYC15189The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis.Biopsy
CALCOFLUOR WHITE STAINC85577A microscopy staining method that utilizes calcofluor, a fluorescent dye that preferentially stains chitin and cellulose on the cell walls of fungi, parasites, and some cysts of the Pneumocystis genus.Calcofluor White Staining Method
CALCULATIONC54125The procedure or activity of determining a result by mathematical or logical methods. (NCI)Calculation
CELLULOSE TAPEC85578A microbiological technique for specimen collection and mounting for microscopic examination that utilizes a cellulose-based adhesive ribbon.Cellulose Tape Method
CHROMATOGRAPHYC16431A technique for the separation of complex mixtures that relies on the differential affinities of substances for a gas or liquid mobile medium and for a stationary adsorbing medium through which they pass.Chromatography
CISHC40960Chromogenic in Situ HybridizationA laboratory procedure that combines the sequence-specific detection aspects of FISH with the simple detection methods of immunohistochemistry. Briefly, sequence-specific probes are hybridized to cells fixed on slides and the sequestered probe is visualized by a peroxidase reaction. It has the advantage of being a less costly assay that does not require fluorescence microscopy with results that are stable over time.Chromogenic In Situ Hybridization
CLIPC111163Cross-Linking and ImmunoprecipitationA type of immunoprecipitation protocol that employs UV-light induced covalent cross-linking of molecules (for instance protein and RNA) prior to the immunoprecipitation and purification steps.Cross-Linking and Immunoprecipitation
CLIP SEQUENCINGC116152CLIP-Seq;Cross-linking Immunoprecipitation High-throughput Sequencing;HITS-CLIPA molecular biology method combining crosslinking-immunoprecipitation and high-throughput sequencing techniques to detect and map RNA-protein interactions.Cross-linking Immunoprecipitation High-throughput Sequencing
CLOT DETECTIONC111095Any of several methods used to detect the presence of or quantify the formation of a thrombus in a specimen. (NCI)Clot Detection
COLORIMETRYC111096A method to measure the absorbance of visible wavelengths of light using a colorimeter.Colorimetry
CONTRAST ENHANCED MRIC46087A technique that uses radiofrequency waves and a magnet to image the body. The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. (NCI)Contrast-enhanced Magnetic Resonance Imaging
CORONARY ANGIOGRAPHYC100085A procedure in which the catheter is passed into the aortic root or other great vessels for the purpose of angiography of the native coronary arteries or bypass grafts supplying native coronary arteries.Coronary Angiography
CT SCANC17204CT;Computed TomographyA series of detailed pictures of areas inside the body; the pictures are created by a computer linked to an x-ray machine.Computed Tomography
DARK FIELD MICROSCOPYC85837A microscopic technique in which the light that does not come into contact with the structure or details of interest is subtracted from the ocular image. This yields an image in which the structure or details are alight while the areas where the structures or details are absent are dark.Dark Field Microscopy
DIGITAL PCR ARRAYC116158Digital PCR;Digital Polymerase Chain Reaction;dPCRA technique used to deliver high-throughput digital PCR. The digital array partitions a sample premixed with PCR reagents into hundreds of individual PCR reactions, which allows the absolute quantification of target sequences and rare allele detection, as compared to conventional real-time quantitative PCR.Digital Array
DIPSTICKC106516A strip of composite material that is coated or impregnated with reagents designed to detect the presence of an analyte in a liquid by producing a color change.Dipstick
DIRECT SEQUENCINGC116154A technique used to identify the sequence of individual nucleotides in a single strand of DNA fragment template which does not require subcloning and can be a plasmid insert, genomic DNA or a PCR product.Direct Sequencing
DISK DIFFUSIONC85595A method to determine microbial susceptibility to antibiotics in which filter paper disks containing known concentrations of antibiotics are placed on the agar surface that has been previously inoculated with the bacteria of interest. Microbial susceptibility is assessed by measuring the area around the disk that is free of microbial growth.Disk Diffusion Method
DNA MICROARRAYC18158DNA Chip;Gene Chip;Gene Expression ArrayAn orderly array of DNA samples affixed to a support. The chip is used in various types of hybridization experiments. Used when a more specific microarray methodology is not specified.DNA Microarray Chip
DXA SCANC48789A technique for scanning bone and measuring bone mineral density (BMD).Dual X-ray Absorptiometry
DYNAMIC CONTRAST ENHANCED MRIC62665A type of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties.Dynamic Contrast-Enhanced Magnetic Resonance Imaging
DYNAMIC LIGHT SCATTERINGC62329Photon Correlation Spectroscopy;Quasi-elastic Light ScatteringA type of spectroscopy that utilizes a laser beam to irradiate a sample containing particles in suspension, resulting in light scattering.Photon Correlation Spectroscopy
ECHOCARDIOGRAMC16525A procedure that uses high-frequency sound waves (ultrasound) to create an image of the heart.Echocardiography
EEGC38054ELECTROENCEPHALOGRAPHYA technique used to capture and record spontaneous electrical activity of the brain by the application of electrodes to the scalp.Electroencephalography
EIAC17455Enzyme ImmunoassayAny of several immunoassay methods that use an enzyme covalently linked to an antigen or antibody as a label; the most common types are enzyme-linked immunosorbent assay (ELISA) and enzyme-multiplied immunoassay technique (EMIT).Enzyme Immunoassay
ELASTOGRAPHYC106517An ultrasound-based imaging technique used to examine the stiffness or elasticity of a tissue by applying mechanical compression or vibration to the tissue being imaged. (NCI)Elastography
ELECTROCHEMILUMINESCENCEC111193A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution. (NCI)Electrochemiluminescence
ELECTROCHEMILUMINESCENCE IMMUNOASSAYC111194A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution due to the formation of antigen-antibody complexes.Electrochemiluminescence Immunoassay
ELECTROPHORESISC16536The motion of charged particles in a colloid under the influence of an electric field; particles with a positive charge go to the cathode and negative to the anode.Electrophoresis
ELISAC16553Enzyme-linked Immunosorbent AssayAn immunoassay for detecting and measuring antigens or antibodies in a solution; the solution is run over a surface to which immobilized antibodies specific to the substance have been attached, and if the substance is present, it will bind to the antibody layer, and its presence is verified and visualized with an application of antibodies that have been tagged in some way.ELISA
ELISPOTC102632Enzyme-linked Immunosorbent Spot AssayA highly sensitive immunoassay capable of detecting secreted materials from individuals cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way.Enzyme-linked Immunosorbent Spot Assay
ENDOSCOPYC16546An examination of the body using an endoscope.Endoscopic Procedure
ENZYMATIC COLORIMETRYC111195A type of colorimetry that makes use of an enzymatic reaction to induce a color change. (NCI)Enzymatic Colorimetry
ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUEC111196EMITA type of homogenous immunoassay in which sample is applied to a reagent mixture of enzyme-labeled ligand, antibody, and substrate. Substrate binding to enzyme leads to inactivation and unlabeled-ligand in the sample can be quantified by colorimetric analysis.Enzyme Multiplied Immunoassay Technique
EPSILOMETERC85596A method to determine microbial susceptibility to antibiotics in which a plastic strip impregnated with the antibiotic of interest is placed on an agar plate that has been inoculated with bacteria. The antibiotic diffuses from the strip producing a concentration gradient of drug on the agar. The point at which the elliptical shaped area of growth inhibition meets the strip is the minimum inhibitory concentration of the drug of interest.Epsilometry
ETDRS EYE CHARTC117877A diagrammatic method to test visual acuity which incorporates the Bailey-Lovie layout in conjunction with Sloan optotypes.Early Treatment of Diabetic Retinopathy Study Eye Chart
FDGPETC103400FDG-PET ScanAn imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake.FDG-Positron Emission Tomography
FISHC17563Fluorescence in Situ HybridizationA physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.Fluorescence In Situ Hybridization
FLAME PHOTOMETRYC106523A type of atomic spectroscopy that qualitatively or quantitatively measures select cations (particularly Na, K, Rb, Cs, Ca, Ba, Cu) by utilizing a low temperature flame capable of exciting a valence electron to an upper energy state which emits light at a wavelength unique to each cation as the electron returns to its ground state. (NCI)Flame Photometry
FLOW CYTOMETRYC16585A technique for counting, examining or sorting microscopic particles suspended in a stream of fluid.Flow Cytometry
FLOW MICROSCOPYC112284A method of measuring the number of cells in a sample by placing the cells in a fluid and passing them, in a stream, through a special light microscope that can record and analyze images of the cells to determine the presence of foreign particles, cell counts, protein aggregates and morphology information.Flow Microscopy
FLTPETC103401FLT-PET ScanAn imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule fluoro-L-thymidine (FLT). FLT when imaged will give tissue metabolic activity, in terms of cell proliferation.FLT-Positron Emission Tomography
FLUORESCENT IMMUNOASSAYC17370Fluorescent Antibody Assay;Immunofluorescence AssayA bioassay in which fluorescent-coupled antibodies or antigens are used to quantify or qualify a biological response to a stimulus.Fluorescent Antibody Procedure
FLUORESCENT MICROSCOPYC16856Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light.Fluorescence Microscopy
FLUORIMETRYC62322An analytical method that utilizes ultraviolet light to excite the sample and detects the fluorescence emitted during the return of the sample to its ground state. (NCI)Fluorimetry
FUNCTIONAL MRIC17958fMRIA type of MRI that takes a series of images of an organ in quick succession and statistically analyzes the differences between the images.Functional Magnetic Resonance Imaging
GC/MSC111203Gas Chromatography/Mass SpectrometryAn analytical technique where gas chromatography is coupled with mass spectrometry in order to separate, identify, and quantify substances in a sample. (NCI)Gas Chromatography Mass Spectrometry
GEL ELECTROPHORESISC18091A method of separating large molecules (such as DNA fragments or proteins) from a mixture of similar molecules by electrophoretic filtration through a gelatinous matrix. Subject to an electric field, each molecule in the sample mixture migrates through the matrix at a different rate, depending mainly on electrical charge and size, resulting in spatial separation within the matrix of each molecular species in the sample mixture. Agarose and acrylamide in a cylindrical tube or slab gel are commonly used media for electrophoresis of proteins and nucleic acids.Gel Electrophoresis
GIEMSA STAINC85598A microscopy staining method that utilizes Giemsa, a mixture of ethylene blue and eosin, which forms purplish-black crystals when dried. This stain preferentially binds to the phosphate groups of DNA and aggregates at areas with an increase in adenine-thymine binding, thus leading to chromosomal staining patterns that lend themselves to g-banding analysis. Additionally Giemsa can be used as a differential stain to determine microbial cell adherence to human cells as well as in the diagnosis of malaria, spirochete, and protozoal infections.Giemsa Staining Method
GRADIENT DIFFUSIONC85599A method to determine microbial susceptibility to antibiotics in which an agar plate, which has a concentration gradient of the drug within the agar, is streaked with the microorganism of interest. Microbial susceptibility as well as minimum inhibitory concentration of antibiotic is assessed.Gradient Diffusion Method
GRAM STAINC23014A microscopy staining method for staining and identifying bacteria, based on the differential retention of a crystal violet-iodine complex within the cell membrane. Gram-positive organisms will appear blue-black or purple while Gram-negative organisms will appear red.Gram Staining Method
HANSEL STAINC111205A microscopy staining method that uses Hansel reagent to differentiate eosinophils and neutrophils in a specimen. (NCI)Hansel Staining Method
HEMATOXYLIN AND EOSIN STAINC23011H&E StainA microscopy staining method that utilizes two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen.Hematoxylin and Eosin Staining Method
HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAYC95525An assay used to verify the presence of anti-HCV antibodies in a blood sample. Serum is incubated with a membrane strip on which four recombinant viral proteins are attached. The immunoblot is considered positive if two or more proteins react, and indeterminate if only one positive band is detected. (NCI)Hepatitis C Virus Recombinant Immunoblot Assay
HIGH LEVEL AMINOGLYCOSIDE SCREENC85556A method to determine microbial susceptibility to high concentrations of aminoglycoside antibiotics.Aminoglycoside Screening Method
HPLCC16434High Performance Liquid ChromatographyFrequently referred to simply as HPLC, this form of column chromatography is used frequently in biochemistry. The analyte is forced through a column by liquid at high pressure, which decreases the time the separated components remain on the stationary phase. Less time on the column then translates to narrower peaks in the resulting chromatogram and thence to better selectivity and sensitivity.High Performance Liquid Chromatography
HPLC/MSC103513High Performance Liquid Chromatography/Mass SpectrometryAn analytical technique wherein high performance liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample.High Performance Liquid Chromatography Mass Spectrometry
IHCC23020ImmunohistochemistryImmunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.Immunohistochemistry Staining Method
IMMUNOASSAYC16714An immunological procedure involving the usage of enzyme-antibody or enzyme-antigen conjugates, antienzyme antibodies, or enzyme-antienzyme complexes.Immunoenzyme Procedure
IMMUNOBLOTC17638A technique for analyzing or identifying proteins immobilized on a filter by complementary reaction with specific antibodies. (NCI)Immunoblot Analysis
IMMUNOCHEMILUMINOMETRIC ASSAYC111235Chemiluminesence Immunoassay;ICMAAn immunoassay in which the antigen-antibody complex is quantified using light emission, which is generated from a chemical reaction.Immunochemiluminometric Assay
IMMUNOPRECIPITATIONC16724Antigen aggregation with antibody, in the right ratios, to cause precipitation. (NCI)Immunoprecipitation
IMMUNORADIOMETRIC ASSAYC111236IRMAAn antibody-excess, non-competition radioimmunometric assay in which ligand is sandwiched between an immobilized antibody on a solid phase and a radiolabeled antibody raised against a different epitope of the ligand.Immunoradiometric Assay
IMMUNOTURBIDIMETRYC106536A method that measures the absorbance of light from a sample which is used for quantifying an amount of analyte based on the level of turbidity produced by the formation and precipitation of an immune complex containing the analyte. (NCI)Immunoturbidimetry
IN SITU HYBRIDIZATIONC17562Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues. (NCI)In Situ Hybridization
INDIA INK STAINC85642A microscopy staining method that utilizes India Ink, a water soluble carbon-based black ink, to determine the presence of microorganisms that are surrounded by a gelatinous capsule. This is a negative staining method in which background is stained in black and the microbes and microscopic structures of interest remain white.India Ink Staining Method
INFRARED SPECTROMETRYC85643A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that the atoms in a sample will vibrate or rotate at a specific frequency when exposed to infrared light.Infrared Spectrometry
INTRAVASCULAR ULTRASOUNDC99535IVUSAn invasive procedure in which sound waves (called ultrasound) are bounced off of vascular tissues from within the vessel and the echoes produce a picture (sonogram).Intravascular Ultrasound
IODINE STAINC85649A microscopy staining method that utilizes Iodine, an element belonging to the halogen group, which specifically stains polysaccharides such as cellulose, chitin, glycogen, and starch a blue color.Iodine Staining Method
IRON HEMATOXYLIN STAINC85650A microscopy staining method that utilizes a mixture of iron and hematoxylin to visualize intracellular structures in a microscopic sample. In this dye system, iron acts as a mordant to hematoxylin rendering it insoluble, thereby allowing irreversible blue-black colored dyeing to the cell nucleus.Iron Hematoxylin Staining Method
KARYOTYPINGC16768The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell sample.Karyotyping
KINETIC MICROPARTICLE IMMUNOASSAYC111240A type of immunoassay in which the antigen of interest found in a biological specimen competes with a lattice of antigen-antibody complexes. Competing antigen inhibits lattice formation and decreases absorbance in proportion to the amount of antigen present in a biological specimen. (NCI)Kinetic Microparticle Immunoassay
KINYOUN STAINC85651A microscopy acid fast staining method that utilizes kinyoun carbol fuchsin, a dye containing basic fuchsin in solution with ethyl alcohol and aqueous phenol. This acid fast staining technique does not require heating during the primary staining step involving the carbol fuchsin.Kinyoun Staining Method
LASER CAPTURE MICRODISSECTIONC19263LCM;LMD;Laser MicrodissectionA technique used for the highly specific and selective capture and isolation of a cell population from a heterogeneous tissue section, cytological preparation, or live cell culture. This technique uses direct visualization of the cells via microscopy as well as a laser energy source for cutting and extraction of the cells.Laser Capture Microdissection
LC/MSC18475Liquid Chromatography/Mass SpectrometryAn analytical technique wherein liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample.Liquid Chromatography Mass Spectrometry
LEAD CITRATE STAINC92301A microscopy staining method that utilizes lead citrate, a mixture of lead nitrate and sodium citrate, and has applications for electron microscopy staining.Lead Citrate Staining Method
LIGHT MICROSCOPYC17995Light microscopy is a technique for producing visible images of structures or details which are too small to be otherwise seen by the human eye. It involves passing light transmitted through or reflected from the subject through a series of lenses to be detected directly by the eye, imaged on a photographic plate, or captured digitally.Light Microscopy
LIGHT SCATTERING SPECTROSCOPYC20059LiSSPA type of spectroscopy that measures power spectral density of surface morphology by exploiting the tendency of light to disperse into a range of directions as a result of physical interaction.Light-Scattering Spectroscopy
LINE PROBE ASSAYC102656LPA;LiPAA microbial identification technique in which polymerase chain reaction is used to amplify specific nucleic acid sequences in a biospecimen. The product of this reaction is then applied to a nitrocellulose test strip containing complementary DNA probes.Line Probe Assay
LOOP-MEDIATED ISOTHERMAL AMPLIFICATIONC102661LAMPA type of nucleic acid amplification test in which sample DNA is exposed to a single temperature in the presence of multiple sets of primers and a polymerase with replication and high strand displacement activity. This test negates the need for thermal cyclers and may be a low cost alternative to PCR.Loop-mediated Isothermal Amplification
LUXOL FAST BLUE AND CRESYL VIOLET STAINC92300A microscopy staining method that utilizes luxol fast blue, an alcohol soluble copper phthalocyanine dye, and cresyl violet, an organic compound that is commonly used as a counter stain, to determine the presence of myelin as well as helicobacter and campylobacter bacterial species.Luxol Fast Blue and Cresyl Violet Staining Method
MACRO BROTH DILUTIONC85697A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a test tube. Each tube contains a known concentration of drug and is inoculated with a known quantity of bacteria. The tubes are incubated for a specified period of time and each is assessed for bacterial cell growth. The drug concentration in the first tube showing no growth is known as the MIC for that antibiotic.Macro Broth Dilution Method
MALDIC48040Matrix-Assisted Laser Desorption Ionization Mass SpectrometryA mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample- matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis. (CHI)Matrix-Assisted Laser Desorption Ionization Mass Spectrometry
MALDI-TOFC19935Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass SpectrometryIn MALDI-TOF, a laser pulse is fired into a protein or peptide sample contained in a light-absorbing matrix. A small explosion vaporizes and ionizes the sample. In the presence of a high electric field, peptide ions are accelerated down an evacuated flight tube. Because large particles travel more slowly than small ones, the masses of the ionized particles are determined by measuring their arrival time at the end of the tube.Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry
MAMMOGRAPHYC16818A type of radiography used specifically to examine breast tissue. The procedure utilizes a low-dose of x-rays or radiation to generate an image.Mammography
MANUAL CLOT DETECTIONC111245A clot detection method that uses a manual means (visual discernment) to detect the presence and/or quantify the formation of a thrombus in a specimen. (NCI)Manual Clot Detection
MAPHC116159Multiplex Amplifiable Probe HybridizationA screening method used to determine changes in complex genomes. This method uses unique short probes which are quantitatively recovered and amplified after hybridization to genomic DNA.Multiplex Amplifiable Probe Hybridization
MASS SPECTROMETRYC17156MassSpecAn analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.Mass Spectrometry
MECHANICAL CLOT DETECTIONC111249A clot detection method that uses a mechanical means (electromagnetic mechanical or electromechanical) to detect the presence of or quantify the formation of a thrombus in a specimen. (NCI)Mechanical Clot Detection
MICRO BROTH DILUTIONC85701A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a multi-well plate. Each well contains a known concentration of drug which is inoculated with a known quantity of bacteria. The plate is incubated for a specified period of time and each well is assessed for bacterial cell growth. The drug concentration in the first well showing no growth is known as the MIC for that antibiotic.Micro Broth Dilution Method
MICROARRAYC44282A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array. The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.Microarray
MICROBIAL BIOCHEMICAL IDENTIFICATIONC51955Any of a number of biochemical tests performed to identify the genus and/or species of a microorganism. These may include the assessment of gram reaction or metabolic characteristics.Bacterial Typing Procedure
MICROBIAL CONCENTRATIONC85702Any technique in which a sample is condensed in order to afford greater sensitivity for the detection of microorganisms.Microbial Concentration Method
MICROBIAL CULTUREC25300Culture ProcedureAny method for growing microorganisms.Microbial Culture Procedure
MICROBIAL CULTURE, LIQUIDC102668A method for growing microorganisms in liquid culture media.Microbial Liquid Culture
MICROBIAL CULTURE, SOLIDC102669A method for growing microorganisms in solid culture media.Microbial Solid Culture
MICROPARTICLE ENZYME IMMUNOASSAYC111252MEIAAn enzyme immunoassay that uses antigen-coated microparticles as a substrate for antibody binding.Microparticle Enzyme Immunoassay
MICROSCOPYC16853The application of microscope magnification to the study of materials that cannot be properly seen by the unaided eye. (NCI)Microscopy
MODIFIED ACID FAST STAINC85736A microscopy staining method, that does not utilize heat in the slide preparation, used to examine a specimen for the presence of acid-fast microorganisms, specifically nocardia.Modified Acid Fast Staining Method
MRIC16809Magnetic Resonance ImagingImaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.Magnetic Resonance Imaging
MRI WITHOUT CONTRASTC114184A technique that uses radiofrequency waves and a magnet to image the body, in which the images are not enhanced by the addition of contrast agents.MRI Without Contrast
MRSC29934Magnetic Resonance SpectroscopyMagnetic resonance spectroscopy is a noninvasive imaging technique that operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules containing proton groups that resonate in the appropriate frequency range. The technique facilitates observation of the spatial distribution of metabolic patterns over a region of interest and surrounding tissue at a high spatial resolution. (NCI)Magnetic Resonance Spectroscopic Imaging
MUGAC38073A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles. (NCI)Radionuclide Ventriculogram Scan
MULTI-SLICE SPIRAL CTC106545A type of spiral computed tomography that employs multiple rows of detectors, each capable of producing a simultaneous image (slice). (NCI)Multi-slice Spiral Computed Tomography
MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPINGC116160Multiple Complete DigestionA DNA mapping technique based on complete restriction enzyme digestion of a set of overlapping clones that provides highly redundant coverage of the mapping target.Multiple Complete Digest Restriction Fragment Mapping
MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATIONC116161MLPAA type of high-throughput , multiplex PCR method that uses a single pair of PCR primers to amplify multiple targets and to determine changes in complex genomes.Multiplex Ligation-dependent Probe Amplification
NEPHELOMETRYC111281A method to quantify the concentration of particulate matter suspended in a liquid or gas using a nephelometer.Nephelometry
NEXT GENERATION SEQUENCINGC101293Massively Parallel SequencingTechnologies that facilitate the rapid determination of the DNA sequence of large numbers of strands or segments of DNA, using spatially separated, clonally amplified DNA templates or molecules in a flow cell.Next Generation Sequencing
NUCLEIC ACID AMPLIFICATION TESTC20055NAATAny of a number of molecular biological techniques that are used to copy nucleic acid sequences within a specimen, leading to an increase in the number of copies of that sequence of interest. These techniques may be used for detection of a particular gene or microorganism of interest.Nucleic Acid Amplification Test
NUCLEIC ACID HYBRIDIZATIONC16924A method in which single stranded nucleic acids are allowed to interact so that complexes, or hybrids, are formed by molecules with sufficiently similar, complementary sequences. By this means the degree of sequence identity can be assessed and specific sequences detected. (From Biology-online)Nucleic Acid Hybridization
NUCLEIC ACID SEQUENCINGC18881The process of determining the sequence of purines and pyrimidines in nucleic acids and polynucleotides.Nucleic Acid Sequencing
OBSERVATIONC25598Watching something and taking note of what happens.Observation
OLIGO ACGHC116156Oligonucleotide Array-based CGH;Oligonucleotide Array-based Comparative Genomic HybridizationA molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers in the genome, using oligonucleotides as targets for hybridization.Oligonucleotide Array-based Comparative Genomic Hybridization
OPTICAL COHERENCE TOMOGRAPHYC20828Optical Coherence Tomography (OCT) combines the principles of ultrasound with the imaging performance of a microscope. OCT uses infrared light waves that reflect off the internal microstructure within the biological tissues. The frequencies and bandwidths of infrared light are orders of magnitude higher than medical ultrasound signals, resulting in greatly increased image resolution, 8-25 times greater than any existing modality. In addition to providing high-level resolutions for the evaluation of microanatomic structures OCT is also able to provide information regarding tissue composition. (NCI)Optical Coherence Tomography
OPTICAL DENSITY MEASUREMENTC85776A quantification of the amount of light that is absorbed by or transmitted through a substance.Optical Density Measurement
OPTICAL MAPPINGC116162Optical MapA technique used for constructing the ordered and high-resolution genome or chromosome sized restriction enzyme map of an organism from a single, stained DNA molecule, digested by the restriction enzyme and imaged by an optical microscope.Optical Mapping
PALPATIONC16950A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient's body to examine the size, consistency, texture, location and tenderness of an organ or body part.Palpation
PANENDOSCOPYC94528An endoscopic examination of the pharynx, larynx, trachea and esophagus.Panendoscopy
PELLI-ROBSON EYE CHARTC117878A diagrammatic method to test visual acuity and contrast sensitivity, which uses large letters (at a 20/60 acuity) that decrease in contrast from right to left and top to bottom.Pelli-Robson Contrast Sensitivity Eye Chart
PERCUSSIONC62298A diagnostic test performed on a tooth by tapping on the crown with a dental instrument.Dental Percussion
PERIODIC ACID SCHIFF STAINC23019A microscopy staining method that utilizes Schiff's reagent, a solution composed of pararosanilin treated with sulfurous acid, which selectively reacts with and stains aldehydes pink to determine the presence of glycogen, mucin, mucoprotein, glycoprotein, as well as fungi. Periodic Acid Schiff staining is useful for outlining tissue structures such as basement membranes, capsules and blood vessels.Periodic Acid Schiff Staining Method
PERIPHERAL ANGIOGRAPHYC117879A procedure in which the catheter is passed into a peripheral vessel (usually in the groin) for the purpose of angiography of the abdomen, hands, arms, feet and legs.Peripheral Angiography
PET SCANC17007An imaging technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance. A scanner reveals the tissue location of the metabolically-active substance administered.Positron Emission Tomography
PET/CT SCANC103512An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.Positron Emission Tomography and Computed Tomography Scan
PET/MRI SCANC103514An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine.Positron Emission Tomography and Magnetic Resonance Imaging
PET/SPECT SCANC111297An imaging technique that utilizes positron emission tomography and single-photon emission computed tomography in a single machine.Positron Emission Tomography and Single Photon Emission Computed Tomography Scan
PHASE CONTRAST MICROSCOPYC16857A microscopic technique in which the amplitude shift that occurs when light passes through a specimen highlights structures or details within the specimen.Phase-Contrast Microscopy
PHOTOGRAPHYC94527The process by which an image is acquired by recording light emissions.Photography
PHOTOMETRIC CLOT DETECTIONC111291A clot detection method that uses a photometric means (measuring the absorbancy of monochromatic light) to detect the presence and/or quantify the formation of a thrombus in a specimen. (NCI)Photometric Clot Detection
PHOTOMETRYC65109Measurement of the properties of light, especially luminous intensity. (NCI)Photometry
PHYSICAL EXAMINATIONC20989Physical ExamA systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.Physical Examination
POLYMERASE CHAIN REACTIONC17003PCRA method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase. This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.Polymerase Chain Reaction
POLYSOMNOGRAPHYC114185PSGA group of tests taken during sleep to capture and record brain wave changes, eye movements, breathing rate, blood pressure, heart rate, and the electrical activity of the heart and other muscles.Polysomnography
PYROSEQUENCINGC99481A DNA sequencing technique that is based on the detection of released pyrophosphate during DNA synthesis.Pyrosequencing
QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTIONC28408qRT-PCRA modified polymerase chain reaction (PCR) technique in which RNA sequences are reverse transcribed into complementary DNA (cDNA) transcripts by the enzyme reverse transcriptase. The cDNA is then amplified by a PCR reaction and quantified by comparing to a standard, using fluorescent probes.Quantitative Reverse Transcriptase PCR
RADIAL IMMUNODIFFUSIONC119296A quantitative technique used to detect and estimate the concentration of an antigen by measuring the diameter of the ring of precipitation (precipitin ring) which is formed as a result of the interaction of the antigen and an antibody at optimal concentration. (NCI)Radial Immunodiffusion
REAL-TIME POLYMERASE CHAIN REACTION ASSAYC51962Quantitative PCR;Real Time-PCR;qPCRA modified polymerase chain reaction (PCR) technique in which DNA amplification is detected and quantified as the PCR reaction progresses, through the use of fluorescent DNA probes in the reaction mixture.Real Time PCR
REFLECTANCE SPECTROSCOPYC19340The spectroscopic analysis of light reflected from a polished sample.Reflectance or Transmission Spectroscopy
REFRACTOMETRYC111304A method to measure the refractive index (propensity for light to bend) of a sample. (NCI)Refractometry
REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSISC40211ROMAA genomic microarray-based method that analyzes two restriction enzyme digested full genomes to identify regions in the genome that have undergone large scale variation.Representational Oligonucleotide Microarray Analysis
REVERSE TRANSCRIPTASE PCRC18136RT-PCR;Reverse Transcription Polymerase Chain ReactionA molecular biology technique used to recreate and amplify complimentary DNA (cDNA) from total RNA or messenger RNA (mRNA).Reverse Transcriptase-Polymerase Chain Reaction
RIAC17057RadioimmunoassayRadioimmunoassay (RIA) is an immunological technique, which quantitatively determines antigen and antibody concentrations, using a radioactively labeled substance (radioligand), either directly or indirectly.Radioimmunoassay
RYAN BLUE STAINC85801A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. This staining technique substitutes aniline blue for the fast green counterstain of the original trichrome staining method and decreased levels of phosphotungstic acid in the reagent.Ryan Blue Staining Method
SCANNING ELECTRON MICROSCOPYC16855An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through a specimen that has been coated with a heavy metal.Scanning Electron Microscopy
SCINTIGRAPHYC62667An imaging technique that uses a small dose of a radioactive chemical (isotope) called a tracer that can detect sites of cancer growth, trauma, infection or degenerative disorders. The tracer, which is either injected into a vein or swallowed, travels through the bloodstream to the target organ, and emits gamma rays, which are detected by a gamma camera and analyzed by a computer to form an image of the target organ. (NCI)Radionuclide Imaging
SEQUENCINGC116155A process to identify and determine the primary structure of, and the order of constituents in a biopolymer. Used when a more specific sequencing methodology is not specified.Biopolymer Sequencing
SINGLE-SLICE SPIRAL CTC106567A type of spiral computed tomography that employs only one detector and produces one image (slice). (NCI)Single-slice Spiral Computed Tomography
SLIT LAMPC75583Examination of the anterior segment of the eye using a medical instrument called a slit lamp.Slit-lamp Examination
SLOAN LETTER EYE CHART 1.25%C117880A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 1.25% contrast level.Sloan Letter Eye Chart 1.25 Percent
SLOAN LETTER EYE CHART 2.5%C117881A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 2.5% contrast level.Sloan Letter Eye Chart 2.5 Percent
SMEARC65126The action of spreading a thin layer of material across a surface.Smear
SNP ARRAYC116151Genotype Chip;SNP Genotyping;SNP Probe;Single Nucleotide Polymorphism ArrayA genomic microarray-based method able to detect single nucleotide polymorphisms.Single Nucleotide Polymorphism Array
SPIRAL CTC20645Spiral Computed TomographyA method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.Spiral CT
TEST STRIPC50322A piece of chemically treated medium designed to react in the presence of specific amounts of a trigger substance.Test Strip Device Component
THICK SMEARC85819A blood smear technique used to make a thick blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria.Thick Smear Technique
THIN SMEARC85820A blood smear technique used to make a thin blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria.Thin Smear Technique
TOLUIDINE BLUE STAINC92302A microscopy staining method that utilizes toluidine blue, a solution composed of tolonium chloride, to determine the presence of mast cells, lignin, proteoglycans and glycosaminoglycans.Toluidine Blue Staining Method
TOTAL BODY IRRADIATIONC15350A therapeutic procedure that involves the irradiation of the whole body with ionizing or non-ionizing radiation. (NCI)Total-Body Irradiation
TOTAL BODY RADIOGRAPHYC96640A diagnostic radiologic test that involves the examination of the entire body in a single procedure.Total Body Radiography
TRANSMISSION ELECTRON MICROSCOPYC18216An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through the specimen.Transmission Electron Microscopy
TRICHROME STAINC23012A microscopy staining method that utilizes two or more colored, acidic dyes of contrasting colors. Masson trichrome is a mixture of three dyes including aniline blue, Beibrich scarlet and Weigert's iron hematoxylin. Other related, modified trichrome staining methods include Lillie's trichrome, Gomori's trichrome and Mallory's trichrome.Trichrome Staining Method
TURBIDIMETRYC111328A method to quantify the opaqueness of a liquid using a turbidimeter, by measuring the decrease in light intensity due to the scattering effect of suspended particles in the liquid sample.Turbidimetry
TWO-COLOR MICROARRAYC116153Dual-channel Microarray;Two-channel Expression Array;Two-channel Microarray;Two-color Microarray-based Gene ExpressionA genomic microarray-based method using cDNA from two samples, labeled with two separate fluorophores/dyes at different emission wavelengths, and hybridized to a single microarray. The relative fluorescence intensity of each dye is being measured.Two Color Microarray
ULTRASOUNDC17230A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer.Ultrasonography
URANYL ACETATE STAINC92303A microscopy staining method that utilizes uranyl acetate, a water insoluble yellow crystalline solid, which is used as a negative stain in electron microscopy.Uranyl Acetate Staining Method
WEBER GREEN STAINC85828A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. The staining method utilizes chromotrope 2R, a red acidic dye, the counterstain fast green, and phosphotungstic acid.Weber Green Staining Method
WESTERN BLOTC16357A method for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymatically labeled or radiolabeled antibody probes.Western Blotting
WRIGHT STAINC85829A microscopy staining method that utilizes the Romanowsky stains, eosin and methylene blue, solubilized in methanol. In this staining protocol, methanol is also utilized as a fixative agent prior to staining.Wright Staining Method
WRIGHT-GIEMSA STAINC23041A microscopy staining method that is a combination of the Wright and Giemsa staining protocols and utilizes the Romanowsky stains, which are mixtures of eosin and thiazine dyes such as methylene blue. It produces darker blue and magenta shades than the giemsa stain alone, which may provide better contrast in microscopy.Wright-Giemsa Staining Method
X-RAYC38101RadiographyA radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.Radiography
X-RAY FLUORESCENCE SPECTROMETRYC85830A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that each element emits fluorescent light of a particular wavelength when exposed to an X-ray.X-Ray Fluorescence Spectrometry
ZIEHL NEELSEN ACID FAST STAINC85831A microscopy acid fast staining method that utilizes Ziehl-Neelsen carbol fuchsin, acid alcohol and methylene blue, to determine the presence of acid fast microorganisms. This acid fast staining technique requires heating during the primary staining step involving the carbol fuchsin.Ziehl Neelsen Acid Fast Staining Method
Back to top
CL.C102581.MCIDCERTMicrobial Identification Certainty
(MCIDCERT)
text
Extensible: No
C102581Microbial Identification CertaintyTerminology relevant to the degree of certainty of the correctness of a microbial identification test result.CDISC SDTM Microbial Identification Certainty Terminology
DEFINITIVEC62607Supplying or being a final or conclusive settlement or result.Definitive
PRESUMPTIVEC102697Supplying or being a probable or reasonable settlement or result.Presumptive
Back to top
CL.C85495.MSRESCATMicrobiology Susceptibility Testing Result Category
(MSRESCAT)
text
Extensible: No
C85495Microbiology Susceptibility Testing Result CategoryUsed to categorize the result of a finding in a standard format.CDISC SDTM Microbiology Susceptibility Testing Result Category Terminology
INTERMEDIATEC85560IntermediateThe growth of microorganisms may be inhibited by antimicrobials that approach usually attainable blood and tissue concentrations. The response rates may be lower than for susceptible isolates. This category also includes a buffer zone, which should prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations, especially for drugs with narrow pharmacotoxicity margins.Antimicrobial Intermediate Susceptibility Result
NONSUSCEPTIBLEC85561Non SusceptibleA category used for microorganisms that have only a susceptible interpretive criteria, but not an intermediate or resistant interpretive category (i.e., susceptible-only interpretive category). This category may be applied to new antimicrobial agents for which no resistant microorganisms have been encountered at the time the initial interpretive criteria are determined. Microorganisms that test with an MIC above or a zone measurement below the susceptible interpretive criteria are designated as nonsusceptible. A designation of nonsusceptible does not necessarily mean that a resistance mechanism(s) exists in the microorganism.Antimicrobial Nonsusceptibility Result
NOT APPLICABLEC48660NA;Not ApplicableDetermination of a value is not relevant in the current context. (NCI)Not Applicable
RESISTANTC85562ResistantThe growth of microorganisms are not inhibited by the usually achievable concentrations of the antimicrobial agent with normal dosages, and/or microorganisms demonstrate MICs or zone diameters that fall in the range where specific microbial resistance mechanisms (e.g. Beta-lactamases) are likely, and clinical efficacy of the agent against the microorganism has not been reliably shown in treatment studies.Antimicrobial Resistance Result
SUSCEPTIBLEC85563SusceptibleThe growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection.Antimicrobial Susceptibility Result
SUSCEPTIBLE-DOSE DEPENDENTC85559Susceptible-Dose DependentThe growth of microorganisms may be inhibited when higher than normal dosages of an antimicrobial agent are used and maximal possible blood concentration of the antimicrobial agent is achieved.Antimicrobial Dose Dependent Susceptibility Result
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C85491.MICROORGMicroorganism
(MICROORG)
text
Extensible: Yes
C85491MicroorganismMicroorganisms, bacteria, fungi and other organisms.CDISC SDTM Microorganism Terminology
ABIOTROPHIAC86077Any bacteria that is not assigned to the species level but can be assigned to the Abiotrophia genus level.Abiotrophia
ABIOTROPHIA DEFECTIVAC86078Any bacterial organism that can be assigned to the species Abiotrophia defectiva.Abiotrophia defectiva
ABSIDIAC119580Any fungal organism that is not assigned to the species level but can be assigned to the Absidia genus level.Absidia
ACANTHAMOEBAC118934Any amoebic organism that is not assigned to the species level but can be assigned to the Acanthamoeba genus level.Acanthamoeba
ACANTHAMOEBA ASTRONYXISC119297Any amoebic organism that can be assigned to the species Acanthamoeba astronyxis.Acanthamoeba astronyxis
ACANTHAMOEBA CASTELLANIIC119298Any amoebic organism that can be assigned to the species Acanthamoeba castellanii.Acanthamoeba castellanii
ACANTHAMOEBA CULBERTSONIC119299Any amoebic organism that can be assigned to the species Acanthamoeba culbertsoni.Acanthamoeba culbertsoni
ACANTHAMOEBA GRIFFINIC119300Any amoebic organism that can be assigned to the species Acanthamoeba griffini.Acanthamoeba griffini
ACANTHAMOEBA HATCHETTIC119301Any amoebic organism that can be assigned to the species Acanthamoeba hatchetti.Acanthamoeba hatchetti
ACANTHAMOEBA LUGDUNENSISC119302Any amoebic organism that can be assigned to the species Acanthamoeba lugdunensis.Acanthamoeba lugdunensis
ACANTHAMOEBA PALESTINENSISC119303Any amoebic organism that can be assigned to the species Acanthamoeba palestinensis.Acanthamoeba palestinensis
ACANTHAMOEBA POLYPHAGAC119304Any amoebic organism that can be assigned to the species Acanthamoeba polyphaga.Acanthamoeba polyphaga
ACANTHAMOEBA QUINAC119305Any amoebic organism that can be assigned to the species Acanthamoeba quina.Acanthamoeba quina
ACANTHAMOEBA RHYSODESC119306Any amoebic organism that can be assigned to the species Acanthamoeba rhysodes.Acanthamoeba rhysodes
ACHROMOBACTERC86079Any bacteria that is not assigned to the species level but can be assigned to the Achromobacter genus level.Achromobacter
ACHROMOBACTER DENITRIFICANSC86080ALCALIGENES DENITRIFICANSAny bacterial organism that can be assigned to the species Achromobacter denitrificans.Achromobacter denitrificans
ACHROMOBACTER PIECHAUDIIC86081Any bacterial organism that can be assigned to the species Achromobacter piechaudii.Achromobacter piechaudii
ACHROMOBACTER RUHLANDIIC119307Alcaligenes ruhlandii;Hydrogenomonas ruhlandii;Pseudomonas ruhlandiiAny bacterial organism that can be assigned to the species Achromobacter ruhlandii.Achromobacter ruhlandii
ACHROMOBACTER XYLOSOXIDANSC86082ALCALIGENES XYLOSOXIDANSAny bacterial organism that can be assigned to the species Achromobacter xylosoxidans.Achromobacter xylosoxidans
ACIDAMINOCOCCUSC86083Any bacteria that is not assigned to the species level but can be assigned to the Acidaminococcus genus level.Acidaminococcus
ACIDAMINOCOCCUS FERMENTANSC86084Any bacterial organism that can be assigned to the species Acidaminococcus fermentans.Acidaminococcus fermentans
ACIDOVORAXC86085Any bacteria that is not assigned to the species level but can be assigned to the Acidovorax genus level.Acidovorax
ACIDOVORAX DELAFIELDIIC86086Any bacterial organism that can be assigned to the species Acidovorax delafieldii.Acidovorax delafieldii
ACIDOVORAX FACILISC86087Any bacterial organism that can be assigned to the species Acidovorax facilis.Acidovorax facilis
ACIDOVORAX TEMPERANSC86088Any bacterial organism that can be assigned to the species Acidovorax temperans.Acidovorax temperans
ACINETOBACTERC76200Any bacteria that is not assigned to the species level but can be assigned to the Acinetobacter genus level.Acinetobacter
ACINETOBACTER ANITRATUSC86089ACINETOBACTER BAUMANNII;ACINETOBACTER CALCOACETICUS SUBSP. ANITRATUSAny bacterial organism that can be assigned to the species Acinetobacter anitratus.Acinetobacter anitratus
ACINETOBACTER CALCOACETICUSC86090Any bacterial organism that can be assigned to the species Acinetobacter calcoaceticus.Acinetobacter calcoaceticus
ACINETOBACTER CALCOACETICUS-BAUMANNII COMPLEXC86091A non-taxonomic grouping of bacteria assigned to the Acinetobacter genus that include the A. calcoaceticus and A. baumannii species.Acinetobacter calcoaceticus/baumannii Complex
ACINETOBACTER HAEMOLYTICUSC86092Any bacterial organism that can be assigned to the species Acinetobacter haemolyticus.Acinetobacter haemolyticus
ACINETOBACTER JOHNSONIIC86093Any bacterial organism that can be assigned to the species Acinetobacter johnsonii.Acinetobacter johnsonii
ACINETOBACTER JUNIIC86094Any bacterial organism that can be assigned to the species Acinetobacter junii.Acinetobacter junii
ACINETOBACTER LWOFFIIC86095ACINETOBACTER CALCOACETICUS SUBSP. LWOFFIIAny bacterial organism that can be assigned to the species Acinetobacter lwoffii.Acinetobacter lwoffii
ACINETOBACTER PARVUSC119308Acinetobacter sp. phenon 4Any bacterial organism that can be assigned to the species Acinetobacter parvus.Acinetobacter parvus
ACINETOBACTER RADIORESISTENSC86096Any bacterial organism that can be assigned to the species Acinetobacter radioresistens.Acinetobacter radioresistens
ACINETOBACTER URSINGIIC119309Acinetobacter sp. phenon 1Any bacterial organism that can be assigned to the species Acinetobacter ursingii.Acinetobacter ursingii
ACREMONIUMC118935CephalosporiumAny fungal organism that is not assigned to the species level but can be assigned to the Acremonium genus level.Acremonium
ACREMONIUM ATROGRISEUMC119310Gliomastix atrogriseum;Phaeoscopulariopsis atrogriseaAny fungal organism that can be assigned to the species Acremonium atrogriseum.Acremonium atrogriseum
ACTINOBACILLUSC86097Any bacteria that is not assigned to the species level but can be assigned to the Actinobacillus genus level.Actinobacillus
ACTINOBACILLUS ACTINOMYCETEMCOMITANSC86098CDC GROUP HB-3Any bacterial organism that can be assigned to the species Actinobacillus actinomycetemcomitans.Actinobacillus actinomycetemcomitans
ACTINOBACILLUS EQUULIC86099Any bacterial organism that can be assigned to the species Actinobacillus equuli.Actinobacillus equuli
ACTINOBACILLUS LIGNIERESIIC86100Any bacterial organism that can be assigned to the species Actinobacillus ligniersii.Actinobacillus lignieresii
ACTINOBACILLUS PLEUROPNEUMONIAEC86101HAEMOPHILUS PLEUROPNEUMONIAEAny bacterial organism that can be assigned to the species Actinobacillus pleuropneumoniae.Actinobacillus pleuropneumoniae
ACTINOBACILLUS SUISC86102Any bacterial organism that can be assigned to the species Actinobacillus suis.Actinobacillus suis
ACTINOBACILLUS UREAEC86103PASTEURELLA UREAEAny bacterial organism that can be assigned to the species Actinobacillus ureae.Actinobacillus ureae
ACTINOBACULUM SCHAALIIC119311Any bacterial organism that can be assigned to the species Actinobaculum schaalii.Actinobaculum schaalii
ACTINOMADURAC86104Any bacteria that is not assigned to the species level but can be assigned to the Actinomadura genus level.Actinomadura
ACTINOMADURA MADURAEC86105Any bacterial organism that can be assigned to the species Actinomadura madurae.Actinomadura madurae
ACTINOMADURA PELLETIERIC86106Any bacterial organism that can be assigned to the species Actinomadura pelletieri.Actinomadura pelletieri
ACTINOMYCESC76201Any bacteria that is not assigned to the species level but can be assigned to the Actinomyces genus level.Actinomyces
ACTINOMYCES BOVISC86107ACTINOCLADOTHRIX BOVIS;CLADOTHRIX BOVIS;DISCOMYCES BOVIS;NOCARDIA BOVIS;OOSPORA BOVIS;PROACTINOMYCES BOVIS;SARCOMYCES BOVIS;SPHAEROTILUS BOVIS;STREPTOTHRIX BOVISAny bacterial organism that can be assigned to the species Actinomyces bovis.Actinomyces bovis
ACTINOMYCES EUROPAEUSC119312Any bacterial organism that can be assigned to the species Actinomyces europaeus.Actinomyces europaeus
ACTINOMYCES ISRAELIIC86108Any bacterial organism that can be assigned to the species Actinomyces israelii.Actinomyces israelii
ACTINOMYCES MEYERIIC86109Any bacterial organism that can be assigned to the species Actinomyces meyerii.Actinomyces meyerii
ACTINOMYCES NAESLUNDIIC86110Any bacterial organism that can be assigned to the species Actinomyces naseslundii.Actinomyces naeslundii
ACTINOMYCES NEUIIC86111Any bacterial organism that can be assigned to the species Actinomyces neuii.Actinomyces neuii
ACTINOMYCES NEUII SUBSP. NEUIIC119313CDC coryneform group 1Any bacterial organism that can be assigned to the species Actinomyces neuii subspecies neuii.Actinomyces neuii Subspecies neuii
ACTINOMYCES ODONTOLYTICUSC86112Any bacterial organism that can be assigned to the species Actinomyces odontolyticus.Actinomyces odontolyticus
ACTINOMYCES RADINGAEC86113Any bacterial organism that can be assigned to the species Actinomyces radingae.Actinomyces radingae
ACTINOMYCES TURICENSISC86114Any bacterial organism that can be assigned to the species Actinomyces turicensis.Actinomyces turicensis
ACTINOMYCES VISCOSUSC86115Any bacterial organism that can be assigned to the species Actinomyces viscosus.Actinomyces viscosus
ADENOVIRUSC14179AdenoviridaeAny viral organism that can be assigned to the family Adenoviridae.Adenovirus
AEROBIC GRAM-NEGATIVE BACILLUSC86116AEROBIC GRAM-NEGATIVE RODAny rod-shaped bacteria with an oxygen-based metabolism and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.Aerobic Gram Negative Bacillus
AEROBIC GRAM-NEGATIVE COCCUSC86117Any spherical-shaped bacteria with an oxygen-based metabolism and a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.Aerobic Gram Negative Coccus
AEROBIC GRAM-POSITIVE BACILLUSC86118AEROBIC GRAM-POSITIVE RODAny rod-shaped bacteria with an oxygen-based metabolism and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.Aerobic Gram Positive Bacillus
AEROBIC GRAM-POSITIVE COCCUSC86119Any spherical-shaped bacteria with an oxygen-based metabolism and a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.Aerobic Gram Positive Coccus
AEROBIC STREPTOCOCCUSC86120Any bacteria assigned to the genus Streptococcus that requires oxygen to grow or respirate.Aerobic Streptococcus
AEROCOCCUSC86121GAFFKYA SPECIESAny bacteria that is not assigned to the species level but can be assigned to the Aerococcus genus level.Aerococcus
AEROCOCCUS SANGUINICOLAC119314Any bacterial organism that can be assigned to the species Aerococcus sanguinicola.Aerococcus sanguinicola
AEROCOCCUS URINAEC86122Any bacterial organism that can be assigned to the species Aerococcus urinae.Aerococcus urinae
AEROCOCCUS VIRIDANSC86123Any bacterial organism that can be assigned to the species Aerococcus viridans.Aerococcus viridans
AEROMONASC86124Any bacteria that is not assigned to the species level but can be assigned to the Aeromonas genus level.Aeromonas
AEROMONAS HYDROPHILAC86125AEROMONAS HYDROPHILA GROUPAny bacterial organism that can be assigned to the species Aeromonas hydrophila.Aeromonas hydrophila
AEROMONAS JANDAEIC86126Any bacterial organism that can be assigned to the species Aeromonas jandaei.Aeromonas jandaei
AEROMONAS PUNCTATAC86127AEROMONAS CAVIAEAny bacterial organism that can be assigned to the species Aeromonas punctata.Aeromonas punctata
AEROMONAS SALMONICIDAC86128Any bacterial organism that can be assigned to the species Aeromonas salmonicida.Aeromonas salmonicida
AEROMONAS SCHUBERTIIC86129Any bacterial organism that can be assigned to the species Aeromonas schubertii.Aeromonas schubertii
AEROMONAS SOBRIAC86130Any bacterial organism that can be assigned to the species Aeromonas sobria.Aeromonas sobria
AEROMONAS VERONIIC86131Any bacterial organism that can be assigned to the species Aeromonas veronii.Aeromonas veronii
AGGREGATIBACTERC86132Any bacteria that is not assigned to the species level but can be assigned to the Aggregatibacter genus level.Aggregatibacter
AGGREGATIBACTER ACTINOMYCETEMCOMITANSC86133HAEMOPHILUS ACTINOMYCETEMCOMITANSAny bacterial organism that can be assigned to the species Aggregatibacter actinomycetemcomitans.Aggregatibacter actinomycetemcomitans
AGGREGATIBACTER APHROPHILUSC86134BETA-LACTAMASE NEGATIVE HAEMOPHILUS PARAPHROPHILUS;CDC GROUP HB-2;HAEMOPHILUS APHROPHILUS;HAEMOPHILUS PARAPHROPHILUSAny bacterial organism that can be assigned to the species Aggregatibacter aphrophilus.Aggregatibacter aphrophilus
AGGREGATIBACTER APHROPHILUS, BETA-LACTAMASE NEGATIVEC119315Haemophilus Aphrophilus, Beta-Lactamase NegativeAny bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is beta-lactamase negative.Aggregatibacter aphrophilus, Beta-lactamase Negative
AGGREGATIBACTER APHROPHILUS, BETA-LACTAMASE POSITIVEC119316Haemophilus Aphrophilus, Beta-Lactamase PositiveAny bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is beta-lactamase positive.Aggregatibacter aphrophilus, Beta-lactamase Positive
AGGREGATIBACTER APHROPHILUS, PENICILLINASE NEGATIVEC119317Haemophilus Aphrophilus, Penicillinase NegativeAny bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is penicillinase negative.Aggregatibacter aphrophilus, Penicillinase Negative
AGGREGATIBACTER APHROPHILUS, PENICILLINASE POSITIVEC119318Haemophilus Aphrophilus, Penicillinase PositiveAny bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is penicillinase positive.Aggregatibacter aphrophilus, Penicillinase Positive
AGGREGATIBACTER SEGNISC86135HAEMOPHILUS SEGNISAny bacterial organism that can be assigned to the species Aggregatibacter segnis.Aggregatibacter segnis
AGROBACTERIUMC86011Any bacteria that is not assigned to the species level but can be assigned to the Agrobacterium genus level.Agrobacterium
AGROBACTERIUM RADIOBACTERC86137Any bacterial organism that can be assigned to the species Agrobacterium radiobacter.Agrobacterium radiobacter
AGROBACTERIUM TUMEFACIENSC86138CDC GROUP VD-3;RHIZOBIUM RADIOBACTERAny bacterial organism that can be assigned to the species Agrobacterium tumefaciens.Agrobacterium tumefaciens
AJELLOMYCES CAPSULATUSC77186Any fungal organism that can be assigned to the species Ajellomyces capsulatus.Ajellomyces capsulatus
ALCALIGENESC86012Any bacteria that is not assigned to the species level but can be assigned to the Alcaligenes genus level.Alcaligenes
ALCALIGENES FAECALISC86140ALCALIGENES ODORANSAny bacterial organism that can be assigned to the species Alcaligenes faecalis.Alcaligenes faecalis
ALISTIPESC86870Any bacterial organism that is not assigned to the species level but can be assigned to the Alistipes genus level.Alistipes
ALISTIPES PUTREDINISC86871BACTEROIDES PUTREDINISAny bacterial organism that can be assigned to the species Alistipes putredinis.Alistipes putredinis
ALISTIPES SHAHIIC114246Any bacterial organism that can be assigned to the species Alistipes shahii.Alistipes shahii
ALPHACORONAVIRUSC119319Coronavirus Group 1Any viral organism that is not assigned to the species level but can be assigned to the Alphacoronavirus genus level.Alphacoronavirus
ALPHAVIRUSC112030Arboviruses Group AAny viral organism that can be assigned to the genus Alphavirus.Alphavirus
ALTERNARIAC119320Any fungal organism that is not assigned to the species level but can be assigned to the Alternaria genus level.Alternaria
AMOEBAC119581AmebaAny protozoan organism that is not assigned to the species level but can be assigned to the Amoeba genus level.Amoeba
ANAEROBIC BACTERIAC119321AnaerobeAny bacterial organism that does not require oxygen to grow or respirate and cannot be assigned to a specific genus or species.Anaerobic Bacteria
ANAEROBIC COCCUSC119322Any spherical shaped bacterial organism that does not require oxygen to grow or respirate and cannot be assigned to a specific genus or species.Anaerobic Coccus
ANAEROBIC GRAM-NEGATIVE BACILLUSC86142ANAEROBIC GRAM-NEGATIVE RODAny rod-shaped bacteria that does not require oxygen to grow or respirate and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.Anaerobic Gram Negative Bacillus
ANAEROBIC GRAM-NEGATIVE BACTERIAC119323Gram-negative AnaerobeAny bacterial organism that does not require oxygen to grow or respirate, cannot be assigned to a specific genus or species, and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.Anaerobic Gram-negative Bacteria
ANAEROBIC GRAM-NEGATIVE COCCUSC86143Any spherical-shaped bacteria that does not require oxygen to grow or respirate and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.Anaerobic Gram Negative Coccus
ANAEROBIC GRAM-POSITIVE BACILLUSC86144ANAEROBIC GRAM-POSITIVE RODAny rod-shaped bacteria that does not require oxygen to grow or respirate and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.Anaerobic Gram Positive Bacillus
ANAEROBIC GRAM-POSITIVE COCCUSC86145Any spherical-shaped bacteria that does not require oxygen to grow or respirate and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.Anaerobic Gram Positive Coccus
ANAEROBIC STREPTOCOCCUSC86146Any bacteria assigned to the genus Streptococcus that does not require oxygen to grow or respirate.Anaerobic Streptococcus
ANAEROCOCCUSC86872Any bacteria that is not assigned to the species level but can be assigned to the Anaerococcus genus level.Anaerococcus
ANAEROCOCCUS HYDROGENALISC86874PEPTOSTREPTOCOCCUS HYDROGENALISAny bacterial organism that can be assigned to the species Anaerococcus hydrogenalis.Anaerococcus hydrogenalis
ANAEROCOCCUS PREVOTIIC86875Any bacterial organism that can be assigned to the species Anaerococcus prevotii.Anaerococcus prevotii
ANAEROCOCCUS TETRADIUSC86876GAFFKYA ANAEROBIA;PEPTOSTREPTOTOCCUS TETRADIUSAny bacterial organism that can be assigned to the species Anaerococcus tetradius.Anaerococcus tetradius
ANAEROCOCCUS VAGINALISC86877Any bacterial organism that can be assigned to the species Anaerococcus vaginalis.Anaerococcus vaginalis
APHTHOVIRUSC112229Any viral organism that can be assigned to the genus Aphthovirus.Aphthovirus
ARBOVIRUSC112230Arthropod-Borne VirusA non-taxonomic grouping of viruses that are transmitted through an arthropod vector and replicate in a vertebrate host.Arbovirus
ARCANOBACTERIUMC86147Any bacteria that is not assigned to the species level but can be assigned to the Arcanobacterium genus level.Arcanobacterium
ARCANOBACTERIUM BERNARDIAEC86148Any bacterial organism that can be assigned to the species Arcanobacterium bernardiae.Arcanobacterium bernardiae
ARCANOBACTERIUM HAEMOLYTICUMC86149CORYNEBACTERIUM HAEMOLYTICUM;CORYNEBACTERIUM HAEMOLYTICUSAny bacterial organism that can be assigned to the species Arcanobacterium haemolyticum.Arcanobacterium haemolyticum
ARCANOBACTERIUM PYOGENESC86150ACTINOMYCES PYOGENES;CORYNEBACTERIUM PYOGENESAny bacterial organism that can be assigned to the species Arcanobacterium pyogenes.Arcanobacterium pyogenes
ARCOBACTERC86152Any bacteria that is not assigned to the species level but can be assigned to the Arcobacter genus level.Arcobacter
ARCOBACTER BUTZLERIC86153CAMPYLOBACTER BUTZLERIAny bacterial organism that can be assigned to the species Arcobacter butzleri.Arcobacter butzleri
ARCOBACTER CRYAEROPHILUSC86154CAMPYLOBACTER CRYAEROPHILUSAny bacterial organism that can be assigned to the species Arcobacter cryaerophilus.Arcobacter cryaerophilus
ARENAVIRUSC14306Any viral organism that can be assigned to the genus Arenavirus.Arenavirus
ARTHROBACTERC86155Any bacteria that is not assigned to the species level but can be assigned to the Arthrobacter genus level.Arthrobacter
ARTHROBACTER CUMMINSIIC114248Any bacterial organism that can be assigned to the species Arthrobacter cumminsii.Arthrobacter cumminsii
ASTROVIRUSC112231AstroviridaeAny viral organism that can be assigned to the family Astroviridae.Astroviridae
ATOPOBIUM MINUTUMC86156LACTOBACILLUS MINUTIS;LACTOBACILLUS MINUTUSAny bacterial organism that can be assigned to the species Atopobium minutum.Atopobium minutum
ATOPOBIUM PARVULUMC86157STREPTOCOCCUS PARVULUSAny bacterial organism that can be assigned to the species Atopobium parvulum.Atopobium parvulum
ATOPOBIUM RIMAEC114244Lactobacillus rimaeAny bacterial organism that can be assigned to the species Atopobium rimae.Atopobium rimae
AVIBACTERIUM PARAGALLINARUMC86158HAEMOPHILUS PARAGALLINARUMAny bacterial organism that can be assigned to the species Avibacterium paragallinarum.Avibacterium paragallinarum
BACILLUSC76202Any bacteria that is not assigned to the species level but can be assigned to the Bacillus genus level.Bacillus
BACILLUS ALVEIC86159Any bacterial organism that can be assigned to the species Bacillus alvei.Bacillus alvei
BACILLUS ANTHRACISC86160Any bacterial organism that can be assigned to the species Bacillus anthracis.Bacillus anthracis
BACILLUS CEREUSC86161Any bacterial organism that can be assigned to the species Bacillus cereus.Bacillus cereus
BACILLUS LENTUSC86162Any bacterial organism that can be assigned to the species Bacillus lentus.Bacillus lentus
BACILLUS LICHENIFORMISC86163Any bacterial organism that can be assigned to the species Bacillus licheniformis.Bacillus licheniformis
BACILLUS MEGATERIUMC86164Any bacterial organism that can be assigned to the species Bacillus megaterium.Bacillus megaterium
BACILLUS MYCOIDESC86165Any bacterial organism that can be assigned to the species Bacillus mycoides.Bacillus mycoides
BACILLUS POLYMYXAC86166Any bacterial organism that can be assigned to the species Bacillus polymyxa.Bacillus polymyxa
BACILLUS SUBTILISC86167Any bacterial organism that can be assigned to the species Bacillus subtilis.Bacillus subtilis
BACTERIAC14187BACTERIUM;EUBACTERIAAny organism assigned to the kingdom Bacteria.Bacteria
BACTEROIDESC76204Any bacteria that is not assigned to the species level but can be assigned to the Bacteroides genus level.Bacteroides
BACTEROIDES CACCAEC86168BACTEROIDES FRAGILIS GROUP 3452AAny bacterial organism that can be assigned to the species Bacteroides caccae.Bacteroides caccae
BACTEROIDES CAPILLOSUSC86169Any bacterial organism that can be assigned to the species Bacteroides capillosus.Bacteroides capillosus
BACTEROIDES CELLULOSOLVENSC86170Any bacterial organism that can be assigned to the species Bacteroides cellulosolvens.Bacteroides cellulosolvens
BACTEROIDES DOREIC111133Any bacterial organism that can be assigned to the species Bacteroides dorei.Bacteroides dorei
BACTEROIDES EGGERTHIIC86171Any bacterial organism that can be assigned to the species Bacteroides eggerthii.Bacteroides eggerthii
BACTEROIDES FAECISC111134Any bacterial organism that can be assigned to the species Bacteroides faecis.Bacteroides faecis
BACTEROIDES FRAGILISC86172Any bacterial organism that can be assigned to the species Bacteroides fragilis.Bacteroides fragilis
BACTEROIDES FRAGILIS GROUPC86173A bacteria that belongs to the Fragilis group of the genus Bacteroides.Bacteroides fragilis Group
BACTEROIDES INTESTINALISC119324Any bacterial organism that can be assigned to the species Bacteroides intestinalis.Bacteroides intestinalis
BACTEROIDES NORDIIC86174Any bacterial organism that can be assigned to the species Bacteroides nordii.Bacteroides nordii
BACTEROIDES OVATUSC86175Any bacterial organism that can be assigned to the species Bacteroides ovatus.Bacteroides ovatus
BACTEROIDES STERCORISC86177BACTEROIDES FRAGILIS SUBSP. AAny bacterial organism that can be assigned to the species Bacteroides stercoris.Bacteroides stercoris
BACTEROIDES TECTUSC86178BACTEROIDES TECTUMAny bacterial organism that can be assigned to the species Bacteroides tectus.Bacteroides tectus
BACTEROIDES THETAIOTAOMICRONC86179Any bacterial organism that can be assigned to the species Bacteroides thetaiotamicron.Bacteroides thetaiotaomicron
BACTEROIDES UNIFORMISC86180Any bacterial organism that can be assigned to the species Bacteroides uniformis.Bacteroides uniformis
BACTEROIDES UREOLYTICUSC86181BACTEROIDES CORRODENSAny bacterial organism that can be assigned to the species Bacteroides ureolyticus.Bacteroides ureolyticus
BACTEROIDES VULGATUSC86182Any bacterial organism that can be assigned to the species Bacteroides vulgatus.Bacteroides vulgatus
BARMAH FOREST VIRUSC112232Any viral organism that can be assigned to the species Barmah Forest virus.Barmah Forest Virus
BARTONELLAC86184Any bacteria that is not assigned to the species level but can be assigned to the Bartonella genus level.Bartonella
BARTONELLA ELIZABETHAEC86185ROCHALIMAEA ELIZABETHAEAny bacterial organism that can be assigned to the species Bartonella elizabethae.Bartonella elizabethae
BARTONELLA HENSELAEC86186ROCHALIMAEA HENSELAEAny bacterial organism that can be assigned to the species Bartonella henselae.Bartonella henselae
BARTONELLA QUINTANAC86187ROCHALIMAEA QUINTANAAny bacterial organism that can be assigned to the species Bartonella quintana.Bartonella quintana
BERGEYELLAC86188Any bacteria that is not assigned to the species level but can be assigned to the Bergeyella genus level.Bergeyella
BERGEYELLA ZOOHELCUMC86189WEEKSELLA ZOOHELCUMAny bacterial organism that can be assigned to the species Bergeyella zoohelcum.Bergeyella zoohelcum
BETA STREPTOCOCCUS, GROUP CC86191A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the C group.Beta Streptococcus Group C
BETA STREPTOCOCCUS, GROUP FC86192A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the F group.Beta Streptococcus Group F
BETA STREPTOCOCCUS, GROUP GC86193A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the G group.Beta Streptococcus Group G
BIFIDOBACTERIUMC86194Any bacteria that is not assigned to the species level but can be assigned to the Bifidobacterium genus level.Bifidobacterium
BIFIDOBACTERIUM ADOLESCENTISC86195Any bacterial organism that can be assigned to the species Bifidobacterium adolescentis.Bifidobacterium adolescentis
BIFIDOBACTERIUM ANGULATUMC86196Any bacterial organism that can be assigned to the species Bifidobacterium angulatum.Bifidobacterium angulatum
BIFIDOBACTERIUM BIFIDUMC86197Any bacterial organism that can be assigned to the species Bifidobacterium bifidum.Bifidobacterium bifidum
BIFIDOBACTERIUM DENTIUMC86198BIFIDOBACTERIUM APPENDICITISAny bacterial organism that can be assigned to the species Bifidobacterium dentium.Bifidobacterium dentium
BIFIDOBACTERIUM LONGUMC86199Any bacterial organism that can be assigned to the species Bifidobacterium longum.Bifidobacterium longum
BILOPHILAC86200Any bacteria that is not assigned to the species level but can be assigned to the Bilophila genus level.Bilophila
BILOPHILA WADSWORTHIAC86201Any bacterial organism that can be assigned to the species Bilophila wadsworthia.Bilophila wadsworthia
BK POLYOMAVIRUSC89820BK VirusAny viral organism that can be assigned to the species BK polyomavirus.BK Virus
BORDETELLAC86202Any bacteria that is not assigned to the species level but can be assigned to the Bordetella genus level.Bordetella
BORDETELLA AVIUMC86203Any bacterial organism that can be assigned to the species Bordetella avium.Bordetella avium
BORDETELLA BRONCHISEPTICAC86204BORDETELLA BRONCHICANISAny bacterial organism that can be assigned to the species Bordetella bronchiseptica.Bordetella bronchiseptica
BORDETELLA PARAPERTUSSISC86205Any bacterial organism that can be assigned to the species Bordetella parapertussis.Bordetella parapertussis
BORDETELLA PERTUSSISC76205Any bacterial organism that can be assigned to the species Bordetella pertussis.Bordetella pertussis
BORRELIAC86206Any bacteria that is not assigned to the species level but can be assigned to the Borrelia genus level.Borrelia
BORRELIA BURGDORFERIC76208Any bacterial organism that can be assigned to the species Borrelia burgdorferi.Borrelia burgdorferi
BREVIBACILLUSC86207Any bacteria that is not assigned to the species level but can be assigned to the Brevibacillus genus level.Brevibacillus
BREVIBACILLUS LATEROSPORUSC86208Any bacterial organism that can be assigned to the species Brevibacillus laterosporus.Brevibacillus laterosporus
BREVIBACTERIUMC86209Any bacteria that is not assigned to the species level but can be assigned to the Brevibacterium genus level.Brevibacterium
BREVIBACTERIUM CASEIC86210Any bacterial organism that can be assigned to the species Brevibacterium casei.Brevibacterium casei
BREVIBACTERIUM EPIDERMIDISC86211Any bacterial organism that can be assigned to the species Brevibacterium epidermidis.Brevibacterium epidermidis
BREVUNDIMONASC86212Any bacteria that is not assigned to the species level but can be assigned to the Brevundimonas genus level.Brevundimonas
BREVUNDIMONAS DIMINUTAC86213PSEUDOMONAS DIMINUTAAny bacterial organism that can be assigned to the species Brevundimonas diminuta.Brevundimonas diminuta
BREVUNDIMONAS VESICULARISC86214PSEUDOMONAS VESICULARISAny bacterial organism that can be assigned to the species Brevundimonas vesicularis.Brevundimonas vesicularis
BRUCELLAC86215Any bacteria that is not assigned to the species level but can be assigned to the Brucella genus level.Brucella
BRUCELLA ABORTUSC86216Any bacterial organism that can be assigned to the species Brucella abortus.Brucella abortus
BRUCELLA CANISC86217Any bacterial organism that can be assigned to the species Brucella canis.Brucella canis
BRUCELLA MELITENSISC86218Any bacterial organism that can be assigned to the species Brucella melitensis.Brucella melitensis
BRUCELLA SUISC86219Any bacterial organism that can be assigned to the species Brucella suis.Brucella suis
BUDVICIAC86220Any bacteria that is not assigned to the species level but can be assigned to the Budvicia genus level.Budvicia
BUDVICIA AQUATICAC86221Any bacterial organism that can be assigned to the species Budvicia aquatica.Budvicia aquatica
BURKHOLDERIAC86222Any bacteria that is not assigned to the species level but can be assigned to the Burkholderia genus level.Burkholderia
BURKHOLDERIA CENOCEPACIAC86223Any bacterial organism that can be assigned to the species Burkholderia cenocepacia.Burkholderia cenocepacia
BURKHOLDERIA CEPACIAC76376CDC GROUP EO-1;PSEUDOMONAS CEPACIAAny bacterial organism that can be assigned to the species Burkholderia cepacia.Burkholderia cepacia
BURKHOLDERIA CEPACIA COMPLEXC86224A non-taxonomic grouping of bacteria assigned to and including at least nine related species from the Burkholderia genus.Burkholderia cepacia Complex
BURKHOLDERIA GLADIOLIC86225PSEUDOMONAS GLADIOLIAny bacterial organism that can be assigned to the species Burkholderia gladioli.Burkholderia gladioli
BURKHOLDERIA MALLEIC86226ACTINOBACILLUS MALLEIAny bacterial organism that can be assigned to the species Burkholderia mallei.Burkholderia mallei
BURKHOLDERIA PSEUDOMALLEIC86227BURKHOLDERIA PSEUDOMALLE;PSEUDOMONAS PSEUDOMALLEIAny bacterial organism that can be assigned to the species Burkholderia pseudomallei.Burkholderia pseudomallei
BUTTIAUXELLAC86228Any bacteria that is not assigned to the species level but can be assigned to the Buttiauxella genus level.Buttiauxella
BUTTIAUXELLA AGRESTISC86229Any bacterial organism that can be assigned to the species Buttiauxella agrestis.Buttiauxella agrestis
CALICIVIRUSC14304CaliciviridaeAny viral organism that can be assigned to the family Caliciviridae.Calicivirus
CAMPYLOBACTERC76211Any bacteria that is not assigned to the species level but can be assigned to the Campylobacter genus level.Campylobacter
CAMPYLOBACTER COLIC86230Any bacterial organism that can be assigned to the species Campylobacter coli.Campylobacter coli
CAMPYLOBACTER CONCISUSC86231CDC GROUP EF-22Any bacterial organism that can be assigned to the species Campylobacter concisus.Campylobacter concisus
CAMPYLOBACTER CURVUSC86232WOLINELLA CURVAAny bacterial organism that can be assigned to the species Campylobacter curvus.Campylobacter curvus
CAMPYLOBACTER FETUSC86233VIBRIO FETUSAny bacterial organism that can be assigned to the species Campylobacter fetus.Campylobacter fetus
CAMPYLOBACTER GRACILISC86234BACTEROIDES GRACILISAny bacterial organism that can be assigned to the species Campylobacter gracilis.Campylobacter gracilis
CAMPYLOBACTER JEJUNIC86235Any bacterial organism that can be assigned to the species Campylobacter jejuni.Campylobacter jejuni
CAMPYLOBACTER LARIC86236CAMPYLOBACTER LARIDISAny bacterial organism that can be assigned to the species Campylobacter lari.Campylobacter lari
CAMPYLOBACTER RECTUSC86237WOLINELLA RECTAAny bacterial organism that can be assigned to the species Campylobacter rectus.Campylobacter rectus
CAMPYLOBACTER UPSALIENSISC86238Any bacterial organism that can be assigned to the species Campylobacter upsaliensis.Campylobacter upsaliensis
CANDIDA ALBICANSC77170C. albicansAny fungal organism that can be assigned to the species Candida albicans.Candida albicans
CANDIDA DUBLINIENSISC114255C. dubliniensisAny fungal organism that can be assigned to the species Candida dubliniensis.Candida dubliniensis
CANDIDA GLABRATAC77179C. glabrata;Torulopsis glabrataAny fungal organism that can be assigned to the species Candida glabrata.Candida glabrata
CANDIDA ORTHOPSILOSISC114260C. orthopsilosis;Candida parapsilosis group IIAny fungal organism that can be assigned to the species Candida orthopsilosis.Candida orthopsilosis
CANDIDA PARAPSILOSISC77176C. parapsilosisAny fungal organism that can be assigned to the species Candida parapsilosis.Candida parapsilosis
CANDIDA PARARUGOSAC114258C. pararugosaAny fungal organism that can be assigned to the species Candida pararugosa.Candida pararugosa
CANDIDA RUGOSAC114254C. rugosaAny fungal organism that can be assigned to the species Candida rugosa.Candida rugosa
CANDIDA TROPICALISC77177C. tropicalisAny fungal organism that can be assigned to the species Candida tropicalis.Candida tropicalis
CANDIDA ZEYLANOIDESC114261C. krissii;C. zeylanoides;Candida krissiiAny fungal organism that can be assigned to the species Candida zeylanoides.Candida zeylanoides
CAPNOCYTOPHAGAC76269Any bacteria that is not assigned to the species level but can be assigned to the Capnocytophaga genus level.Capnocytophaga
CAPNOCYTOPHAGA CANIMORSUSC86239CDC GROUP DF-2Any bacterial organism that can be assigned to the species Capnocytophaga canimorsus.Capnocytophaga canimorsus
CAPNOCYTOPHAGA GINGIVALISC86240Any bacterial organism that can be assigned to the species Capnocytophaga gingivalis.Capnocytophaga gingivalis
CAPNOCYTOPHAGA OCHRACEAC86241Any bacterial organism that can be assigned to the species Capnocytophaga ochracea.Capnocytophaga ochracea
CAPNOCYTOPHAGA SPUTIGENAC86242Any bacterial organism that can be assigned to the species Capnocytophaga sputigena.Capnocytophaga sputigena
CARDIOBACTERIUMC86243Any bacteria that is not assigned to the species level but can be assigned to the Cardiobacterium genus level.Cardiobacterium
CARDIOBACTERIUM HOMINISC86244CDC GROUP IIDAny bacterial organism that can be assigned to the species Cardiobacterium hominis.Cardiobacterium hominis
CEDECEAC86245Any bacteria that is not assigned to the species level but can be assigned to the Cedecea genus level.Cedecea
CEDECEA DAVISAEC86246CDC ENTERIC GROUP 15Any bacterial organism that can be assigned to the species Cedecea davisae.Cedecea davisae
CEDECEA LAPAGEIC86247Any bacterial organism that can be assigned to the species Cedecea lapagei.Cedecea lapagei
CEDECEA NETERIC86248CEDECEA SPECIES 4Any bacterial organism that can be assigned to the species Cedecea neteri.Cedecea neteri
CELLULOMONASC86249Any bacteria that is not assigned to the species level but can be assigned to the Cellulomonas genus level.Cellulomonas
CELLULOMONAS HOMINISC86250Any bacterial organism that can be assigned to the species Cellulomonas hominis.Cellulomonas hominis
CELLULOSIMICROBIUMC86251Any bacteria that is not assigned to the species level but can be assigned to the Cellulosimicrobium genus level.Cellulosimicrobium
CELLULOSIMICROBIUM CELLULANSC86252ARTHROBACTER LUTEUS;CELLULOMONAS CELLULANS;NOCARDIA CELLULANS;OERSKOVIA XANTHINEOLYTICAAny bacterial organism that can be assigned to the species Cellulosimicrobium cellulans.Cellulosimicrobium cellulans
CHLAMYDIAC76271Any bacteria that is not assigned to the species level but can be assigned to the Chlamydia genus level.Chlamydia
CHLAMYDIA TRACHOMATISC86253Any bacterial organism that can be assigned to the species Chlamydia trachomatis.Chlamydia trachomatis
CHLAMYDOPHILAC86254Any bacteria that is not assigned to the species level but can be assigned to the Chlamydophila genus level.Chlamydophila
CHLAMYDOPHILA PNEUMONIAEC76272CHLAMYDIA PNEUMONIAEAny bacterial organism that can be assigned to the species Chlamydophila pneumoniae.Chlamydophila pneumoniae
CHLAMYDOPHILA PSITTACIC86255CHLAMYDIA PSITTACIAny bacterial organism that can be assigned to the species Chlamydophila psittaci.Chlamydophila psittaci
CHROMOBACTERIUMC86256Any bacteria that is not assigned to the species level but can be assigned to the Chromobacterium genus level.Chromobacterium
CHROMOBACTERIUM VIOLACEUMC86257Any bacterial organism that can be assigned to the species Chromobacterium violaceum.Chromobacterium violaceum
CHRYSEOBACTERIUMC86258Any bacteria that is not assigned to the species level but can be assigned to the Chryseobacterium genus level.Chryseobacterium
CHRYSEOBACTERIUM GLEUMC86259FLAVOBACTERIUM GLEUMAny bacterial organism that can be assigned to the species Chryseobacterium gleum.Chryseobacterium gleum
CHRYSEOBACTERIUM INDOLOGENESC86260FLAVOBACTERIUM INDOLOGENESAny bacterial organism that can be assigned to the species Chryseobacterium indologenes.Chryseobacterium indologenes
CHRYSEOMONASC86261Any bacteria that is not assigned to the species level but can be assigned to the Chryseomonas genus level.Chryseomonas
CITROBACTERC76273Any bacteria that is not assigned to the species level but can be assigned to the Citrobacter genus level.Citrobacter
CITROBACTER AMALONATICUSC86262LEVINEA AMALONATICAAny bacterial organism that can be assigned to the species Citrobacter amalonaticus.Citrobacter amalonaticus
CITROBACTER BRAAKIIC86263Any bacterial organism that can be assigned to the species Citrobacter braakii.Citrobacter braakii
CITROBACTER FARMERIC86264CITROBACTER AMALONATICUS BIOGROUP 1Any bacterial organism that can be assigned to the species Citrobacter farmeri.Citrobacter farmeri
CITROBACTER FREUNDIIC86265COLOBACTRUM FREUNDIIAny bacterial organism that can be assigned to the species Citrobacter freundii.Citrobacter freundii
CITROBACTER FREUNDII COMPLEXC86266A non-taxonomic grouping of bacteria assigned to and including eight related species from the Citrobacter genus.Citrobacter freundii Complex
CITROBACTER KOSERIC86267CITROBACTER DIVERSUSAny bacterial organism that can be assigned to the species Citrobacter koseri.Citrobacter koseri
CITROBACTER YOUNGAEC86268Any bacterial organism that can be assigned to the species Citrobacter youngae.Citrobacter youngae
CLAVISPORA LUSITANIAEC77174C. lusitaniae;Candida lusitaniaeAny fungal organism that can be assigned to the species Clavispora lusitaniae.Clavispora lusitaniae
CLOSTRIDIUMC76275Any bacteria that is not assigned to the species level but can be assigned to the Clostridium genus level.Clostridium
CLOSTRIDIUM ACETOBUTYLICUMC86269Any bacterial organism that can be assigned to the species Clostridium acetobutylicum.Clostridium acetobutylicum
CLOSTRIDIUM BARATIIC86270CLOSTRIDIUM BARATIAny bacterial organism that can be assigned to the species Clostridium baratii.Clostridium baratii
CLOSTRIDIUM BEIJERINCKIIC86271Any bacterial organism that can be assigned to the species Clostridium beijerinckii.Clostridium beijerinckii
CLOSTRIDIUM BIFERMENTANSC86272Any bacterial organism that can be assigned to the species Clostridium bifermentans.Clostridium bifermentans
CLOSTRIDIUM BOLTEAEC114250Any bacterial organism that can be assigned to the species Clostridium bolteae.Clostridium bolteae
CLOSTRIDIUM BUTYRICUMC86273CLOSTRIDIUM PSEUDOTETANICUMAny bacterial organism that can be assigned to the species Clostridium butyricum.Clostridium butyricum
CLOSTRIDIUM CADAVERISC86274Any bacterial organism that can be assigned to the species Clostridium cadaveris.Clostridium cadaveris
CLOSTRIDIUM CELATUMC86275Any bacterial organism that can be assigned to the species Clostridium celatum.Clostridium celatum
CLOSTRIDIUM CLOSTRIDIOFORMEC86276CLOSTRIDIUM CLOSTRIDIIFORMEAny bacterial organism that can be assigned to the species Clostridium clostridioforme.Clostridium clostridioforme
CLOSTRIDIUM COCHLEARIUMC86277Any bacterial organism that can be assigned to the species Clostridium cochlearium.Clostridium cochlearium
CLOSTRIDIUM COCLEATUMC86278Any bacterial organism that can be assigned to the species Clostridium cocleatum.Clostridium cocleatum
CLOSTRIDIUM DIFFICILEC76276CLOSTRIDIUM DIFFICILISAny bacterial organism that can be assigned to the species Clostridium difficile.Clostridium difficile
CLOSTRIDIUM FALLAXC86279CLOSTRIDIUM PSEUDOFALLAXAny bacterial organism that can be assigned to the species Clostridium fallax.Clostridium fallax
CLOSTRIDIUM GLYCOLICUMC86280Any bacterial organism that can be assigned to the species Clostridium glycolicum.Clostridium glycolicum
CLOSTRIDIUM HAEMOLYTICUMC86281Any bacterial organism that can be assigned to the species Clostridium haemolyticum.Clostridium haemolyticum
CLOSTRIDIUM HATHEWAYIC114251Any bacterial organism that can be assigned to the species Clostridium hathewayi.Clostridium hathewayi
CLOSTRIDIUM HISTOLYTICUMC86282Any bacterial organism that can be assigned to the species Clostridium histolyticum.Clostridium histolyticum
CLOSTRIDIUM INNOCUUMC86283Any bacterial organism that can be assigned to the species Clostridium innocuum.Clostridium innocuum
CLOSTRIDIUM LIMOSUMC86284CLOSTRIDIUM SPECIES CDC GROUP P-1Any bacterial organism that can be assigned to the species Clostridium limosum.Clostridium limosum
CLOSTRIDIUM NOVYIC86285Any bacterial organism that can be assigned to the species Clostridium novyi.Clostridium novyi
CLOSTRIDIUM OCEANICUMC86286Any bacterial organism that can be assigned to the species Clostridium oceanicum.Clostridium oceanicum
CLOSTRIDIUM PARAPUTRIFICUMC86287Any bacterial organism that can be assigned to the species Clostridium paraputrificum.Clostridium paraputrificum
CLOSTRIDIUM PERFRINGENSC86288CLOSTRIDIUM WELCHIIAny bacterial organism that can be assigned to the species Clostridium perfringens.Clostridium perfringens
CLOSTRIDIUM PUTRIFICUMC86289CLOSTRIDIUM LENTOPUTRESCENSAny bacterial organism that can be assigned to the species Clostridium putrificum.Clostridium putrificum
CLOSTRIDIUM RAMOSUMC86290ACTINOMYCES RAMOSUSAny bacterial organism that can be assigned to the species Clostridium ramosum.Clostridium ramosum
CLOSTRIDIUM RECTUMC86291Any bacterial organism that can be assigned to the species Clostridium rectum.Clostridium rectum
CLOSTRIDIUM SARTAGOFORMEC119325Any bacterial organism that can be assigned to the species Clostridium sartagoforme.Clostridium sartagoforme
CLOSTRIDIUM SEPTICUMC86292Any bacterial organism that can be assigned to the species Clostridium septicum.Clostridium septicum
CLOSTRIDIUM SORDELLIIC86293Any bacterial organism that can be assigned to the species Clostridium sordellii.Clostridium sordellii
CLOSTRIDIUM SPOROGENESC86294Any bacterial organism that can be assigned to the species Clostridium sporogenes.Clostridium sporogenes
CLOSTRIDIUM SUBTERMINALEC86295Any bacterial organism that can be assigned to the species Clostridium subterminale.Clostridium subterminale
CLOSTRIDIUM SYMBIOSUMC86296BACTEROIDES SYMBIOSUSAny bacterial organism that can be assigned to the species Clostridium symbiosum.Clostridium symbiosum
CLOSTRIDIUM TERTIUMC86297Any bacterial organism that can be assigned to the species Clostridium tertium.Clostridium tertium
CLOSTRIDIUM TETANIC86298Any bacterial organism that can be assigned to the species Clostridium tetani.Clostridium tetani
CLOSTRIDIUM TYROBUTYRICUMC86299Any bacterial organism that can be assigned to the species Clostridium tyrobutyricum.Clostridium tyrobutyricum
COAGULASE NEGATIVE STAPHYLOCOCCUSC62584Any bacteria assigned to the genus Staphylococcus that does not express the enzyme coagulase.Coagulase-Negative Staphylococcus
COAGULASE POSITIVE STAPHYLOCOCCUSC62585Any bacteria assigned to the genus Staphylococcus that expresses the enzyme coagulase.Coagulase-Positive Staphylococcus
COLLINSELLAC86300Any bacteria that is not assigned to the species level but can be assigned to the Collinsella genus level.Collinsella
COLLINSELLA AEROFACIENSC86301EUBACTERIUM AEROFACIENSAny bacterial organism that can be assigned to the species Collinsella aerofaciens.Collinsella aerofaciens
COLLINSELLA INTESTINALISC86302Any bacterial organism that can be assigned to the species Collinsella intestinalis.Collinsella intestinalis
COLORADO TICK FEVER VIRUSC112240CTFVAny viral organism that can be assigned to the species Colorado tick fever virus.Colorado Tick Fever Virus
COMAMONASC86303Any bacteria that is not assigned to the species level but can be assigned to the Comamonas genus level.Comamonas
COMAMONAS TERRIGENAC86304CDC GROUP EF-19Any bacterial organism that can be assigned to the species Comamonas terrigena.Comamonas terrigena
COMAMONAS TESTOSTERONIC86305PSEUDOMONAS TESTOSTERONIAny bacterial organism that can be assigned to the species Comamonas testosteroni.Comamonas testosteroni
CORONAVIRUSC113205CoronaviridaeAny viral organism that can be assigned to the family Coronaviridae.Coronaviridae
CORYNEBACTERIUMC76308Any bacteria that is not assigned to the species level but can be assigned to the Corynebacterium genus level.Corynebacterium
CORYNEBACTERIUM ACCOLENSC86306CORYNEBACTERIUM GROUP G-1Any bacterial organism that can be assigned to the species Corynebacterium accolens.Corynebacterium accolens
CORYNEBACTERIUM AFERMENTANSC86307CORYNEBACTERIUM ANF-1Any bacterial organism that can be assigned to the species Corynebacterium afermentans.Corynebacterium afermentans
CORYNEBACTERIUM AMYCOLATUMC86308Any bacterial organism that can be assigned to the species Corynebacterium amycolatum.Corynebacterium amycolatum
CORYNEBACTERIUM ARGENTORATENSEC86309Any bacterial organism that can be assigned to the species Corynebacterium argentoratense.Corynebacterium argentoratense
CORYNEBACTERIUM AURISC86310Any bacterial organism that can be assigned to the species Corynebacterium auris.Corynebacterium auris
CORYNEBACTERIUM BOVISC86311Any bacterial organism that can be assigned to the species Corynebacterium bovis.Corynebacterium bovis
CORYNEBACTERIUM DIPHTHERIAEC86312Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae.Corynebacterium diphtheriae
CORYNEBACTERIUM GENITALIUMC86313Any bacterial organism that can be assigned to the species Corynebacterium genitalium.Corynebacterium genitalium
CORYNEBACTERIUM GLUCURONOLYTICUMC86955Any bacterial organism that can be assigned to the species Corynebacterium glucuronolyticum.Corynebacterium glucuronolyticum
CORYNEBACTERIUM JEIKEIUMC76307CDC GROUP JK;CORYNEBACTERIUM GROUP JKAny bacterial organism that can be assigned to the species Corynebacterium jeikeium.Corynebacterium jeikeium
CORYNEBACTERIUM KUTSCHERIC86314Any bacterial organism that can be assigned to the species Corynebacterium kutscheri.Corynebacterium kutscheri
CORYNEBACTERIUM MACGINLEYIC86315Any bacterial organism that can be assigned to the species Corynebacterium macginleyi.Corynebacterium macginleyi
CORYNEBACTERIUM MATRUCHOTIIC86316BACTERIONEMA MATRUCHOTIIAny bacterial organism that can be assigned to the species Corynebacterium matruchotii.Corynebacterium matruchotii
CORYNEBACTERIUM MINUTISSIMUMC86317Any bacterial organism that can be assigned to the species Corynebacterium minutissimum.Corynebacterium minutissimum
CORYNEBACTERIUM PILOSUMC86318Any bacterial organism that can be assigned to the species Corynebacterium pilosum.Corynebacterium pilosum
CORYNEBACTERIUM PROPINQUUMC86319Any bacterial organism that can be assigned to the species Corynebacterium propinquum.Corynebacterium propinquum
CORYNEBACTERIUM PSEUDODIPHTHERITICUMC86320CORYNEBACTERIUM HOFMANNIIAny bacterial organism that can be assigned to the species Corynebacterium pseudodiphtheriticum.Corynebacterium pseudodiphtheriticum
CORYNEBACTERIUM PSEUDOTUBERCULOSISC86321Any bacterial organism that can be assigned to the species Corynebacterium pseudotuberculosis.Corynebacterium pseudotuberculosis
CORYNEBACTERIUM RENALEC86322Any bacterial organism that can be assigned to the species Corynebacterium renale.Corynebacterium renale
CORYNEBACTERIUM STRIATUMC86323Any bacterial organism that can be assigned to the species Corynebacterium striatum.Corynebacterium striatum
CORYNEBACTERIUM TUBERCULOSTEARICUMC114249Any bacterial organism that can be assigned to the species Corynebacterium tuberculostearicum.Corynebacterium tuberculostearicum
CORYNEBACTERIUM ULCERANSC86324Any bacterial organism that can be assigned to the species Corynebacterium ulcerans.Corynebacterium ulcerans
CORYNEBACTERIUM UREALYTICUMC86325CDC GROUP D2;CORYNEBACTERIUM GROUP D-2Any bacterial organism that can be assigned to the species Corynebacterium urealyticum.Corynebacterium urealyticum
CORYNEBACTERIUM XEROSISC86326Any bacterial organism that can be assigned to the species Corynebacterium xerosis.Corynebacterium xerosis
CORYNEFORM GRAM-POSITIVE BACILLUSC86327CORYNEFORM GRAM-POSITIVE RODAny bacteria whose shape is similar to those bacteria assigned to the Corynebacterium genus and have a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.Coryneform Gram Positive Bacillus
COXIELLAC76309Any bacteria that is not assigned to the species level but can be assigned to the Coxiella genus level.Coxiella
COXIELLA BURNETIIC86328Any bacterial organism that can be assigned to the species Coxiella burnetii.Coxiella burnetii
COXSACKIE A VIRUSC112242Coxsackie Virus AAny viral organism that can be assigned to the Enterovirus A species subtype Coxsackie A virus.Coxsackie A Virus
COXSACKIE B VIRUSC112243Coxsackie Virus BAny viral organism that can be assigned to the Enterovirus B species subtype Coxsackie B virus.Coxsackie B Virus
CRONOBACTER SAKAZAKIIC86329ENTEROBACTER SAKAZAKIIAny bacterial organism that can be assigned to the species Cronobacter sakazakii.Cronobacter sakazakii
CRYPTOCOCCUS ALBIDUSC114267C. albidus;R. albida;Rhodotorula albida;T. albida;T. nadaensis;T. neoformans var. albida;Torula albida;Torulopsis albida;Torulopsis nadaensis;Torulopsis neoformans var. albidaAny fungal organism that can be assigned to the species Cryptococcus albidus.Cryptococcus albidus
CRYPTOCOCCUS GATTIIC114268C. bacillisporus;C. gattii;Cryptococcus bacillisporusAny fungal organism that can be assigned to the species Cryptococcus gattii.Cryptococcus gattii
CRYPTOCOCCUS LAURENTIIC114269C. laurentiiAny fungal organism that can be assigned to the species Cryptococcus laurentii.Cryptococcus laurentii
CRYPTOCOCCUS NEOFORMANSC14195B. neoformans;Blastomyces neoformans;C. neoformans;D. neoformans;Debaryomyces neoformans;L. neoformans;Lipomyces neoformans;S. neoformans;Saccharomyces neoformans;T. neoformans;Torula neoformans;Torulopsis neoformansAny fungal organism that can be assigned to the species Cryptococcus neoformans.Cryptococcus neoformans
CRYPTOCOCCUS RANDHAWIIC114266C. randhawiiAny fungal organism that can be assigned to the species Cryptococcus randhawii.Cryptococcus randhawii
CUPRIAVIDUSC86330Any bacteria that is not assigned to the species level but can be assigned to the Cupriavidus genus level.Cupriavidus
CUPRIAVIDUS PAUCULUSC86331CDC GROUP IVC-2;RALSTONIA PAUCULA;WAUTERSIA PAUCULAAny bacterial organism that can be assigned to the species Cupriavidus pauculus.Cupriavidus pauculus
CYTOMEGALOVIRUSC14196Any viral organism that can be assigned to the genus Cytomegalovirus.Cytomegalovirus
DELFTIAC86332Any bacteria that is not assigned to the species level but can be assigned to the Delftia genus level.Delftia
DELFTIA ACIDOVORANSC86333COMAMONAS ACIDOVORANS;PSEUDOMONAS ACIDOVORANSAny bacterial organism that can be assigned to the species Delftia acidovorans.Delftia acidovorans
DELTARETROVIRUSC14347Any viral organism that can be assigned to the genus Deltaretrovirus.Deltaretrovirus
DENGUE VIRUSC112036Any viral organism that can be assigned to the species Dengue virus.Dengue Virus
DENGUE VIRUS 1C112266DEN-1;DENV-1;Dengue Virus Type 1Any viral organism that can be assigned to the Dengue virus serotype 1.Dengue Virus 1
DENGUE VIRUS 2C112267DEN-2;DENV-2;Dengue Virus Type 2Any viral organism that can be assigned to the Dengue virus serotype 2.Dengue Virus 2
DENGUE VIRUS 3C112268DEN-3;DENV-3;Dengue Virus Type 3Any viral organism that can be assigned to the Dengue virus serotype 3.Dengue Virus 3
DENGUE VIRUS 4C112269DEN-4;DENV-4;Dengue Virus Type 4Any viral organism that can be assigned to the Dengue virus serotype 4.Dengue Virus 4
DERMABACTERC86334Any bacteria that is not assigned to the species level but can be assigned to the Dermabacter genus level.Dermabacter
DERMABACTER HOMINISC86335Any bacterial organism that can be assigned to the species Dermabacter hominis.Dermabacter hominis
DERMACOCCUS NISHINOMIYAENSISC86336MICROCOCCUS NISHINOMIYAENSISAny bacterial organism that can be assigned to the species Dermacoccus nishinomiyaensis.Dermacoccus nishinomiyaensis
DERMATOPHILUSC86337Any bacteria that is not assigned to the species level but can be assigned to the Dermatophilus genus level.Dermatophilus
DERMATOPHILUS CONGOLENSISC86338Any bacterial organism that can be assigned to the species Dermatophilus congolensis.Dermatophilus congolensis
DESULFOVIBRIOC86339DESULFOMONAS SPECIESAny bacteria that is not assigned to the species level but can be assigned to the Desulfovibrio genus level.Desulfovibrio
DESULFOVIBRIO DESULFURICANSC86340Any bacterial organism that can be assigned to the species Desulfovibrio desulfuricans.Desulfovibrio desulfuricans
DESULFOVIBRIO FAIRFIELDENSISC86341Any bacterial organism that can be assigned to the species Desulfovibrio fairfieldensis.Desulfovibrio fairfieldensis
DESULFOVIBRIO PIGERC86342DESULFOMONAS PIGRAAny bacterial organism that can be assigned to the species Desulfovibrio piger.Desulfovibrio piger
DIPHTHEROID BACILLUSC86343Any of a number of rod-shaped bacteria that resemble Corynebacterium diphtheriae, either in morphology or etiology.Diptheroid Bacillus
EBOLA VIRUSC112271EBOVAny viral organism that can be assigned to the genus Ebola virus.Ebola Virus
ECHOVIRUSC112272Any viral organism that can be assigned to the species Echovirus.Echovirus
EDWARDSIELLAC86344Any bacteria that is not assigned to the species level but can be assigned to the Edwardsiella genus level.Edwardsiella
EDWARDSIELLA HOSHINAEC86345Any bacterial organism that can be assigned to the species Edwardsiella hoshinae.Edwardsiella hoshinae
EDWARDSIELLA ICTALURIC86346Any bacterial organism that can be assigned to the species Edwardsiella ictaluri.Edwardsiella ictaluri
EDWARDSIELLA TARDAC86347Any bacterial organism that can be assigned to the species Edwardsiella tarda.Edwardsiella tarda
EGGERTHELLAC86348Any bacteria that is not assigned to the species level but can be assigned to the Eggerthella genus level.Eggerthella
EGGERTHELLA LENTAC86349EUBACTERIUM LENTUMAny bacterial organism that can be assigned to the species Eggerthella lenta.Eggerthella lenta
EIKENELLAC86350Any bacteria that is not assigned to the species level but can be assigned to the Eikenella genus level.Eikenella
EIKENELLA CORRODENSC86351CDC GROUP HB-1Any bacterial organism that can be assigned to the species Eikenella corrodens.Eikenella corrodens
ELIZABETHKINGIAC86352Any bacteria that is not assigned to the species level but can be assigned to the Elizabethkingia genus level.Elizabethkingia
ELIZABETHKINGIA MENINGOCEPTICAC86353CHRYSEOBACTERIUM MENINGOSEPTICUM;FLAVOBACTERIUM MENINGOSEPTICUMAny bacterial organism that can be assigned to the species Elizabethkingia meningoceptica.Elizabethkingia meningoceptica
EMPEDOBACTERC86354Any bacteria that is not assigned to the species level but can be assigned to the Empedobacter genus level.Empedobacter
EMPEDOBACTER BREVISC86355FLAVOBACTERIUM BREVEAny bacterial organism that can be assigned to the species Empedobacter brevis.Empedobacter brevis
ENTEROBACTERC76310Any bacteria that is not assigned to the species level but can be assigned to the Enterobacter genus level.Enterobacter
ENTEROBACTER AEROGENESC86356AEROBACTER AEROGENESAny bacterial organism that can be assigned to the species Enterobacter aerogenes.Enterobacter aerogenes
ENTEROBACTER AMNIGENUSC86357ENTEROBACTER AMNIGENUS IAny bacterial organism that can be assigned to the species Enterobacter amnigenus.Enterobacter amnigenus
ENTEROBACTER ASBURIAEC86358CDC ENTERIC GROUP 17Any bacterial organism that can be assigned to the species Enterobacter asburiae.Enterobacter asburiae
ENTEROBACTER CANCEROGENUSC86359CDC ENTERIC GROUP 19;ENTEROBACTER TAYLORAEAny bacterial organism that can be assigned to the species Enterobacter cancerogenus.Enterobacter cancerogenus
ENTEROBACTER CLOACAEC86360ENTEROBACTER CLOACAE STRAIN 1Any bacterial organism that can be assigned to the species Enterobacter cloacae.Enterobacter cloacae
ENTEROBACTER GERGOVIAEC86361Any bacterial organism that can be assigned to the species Enterobacter gergoviae.Enterobacter gergoviae
ENTEROBACTER HORMAECHEIC86362CDC ENTERIC GROUP 75Any bacterial organism that can be assigned to the species Enterobacter hormaechei.Enterobacter hormaechei
ENTEROCOCCUSC76311PRESUMPTIVE ENTEROCOCCUSAny bacteria that is not assigned to the species level but can be assigned to the Enterococcus genus level.Enterococcus
ENTEROCOCCUS AVIUMC86364STREPTOCOCCUS AVIUMAny bacterial organism that can be assigned to the species Enterococcus avium.Enterococcus avium
ENTEROCOCCUS CASSELIFLAVUSC86365Any bacterial organism that can be assigned to the species Enterococcus casseliflavus.Enterococcus casseliflavus
ENTEROCOCCUS DISPARC86366Any bacterial organism that can be assigned to the species Enterococcus dispar.Enterococcus dispar
ENTEROCOCCUS DURANSC86367STREPTOCOCCUS DURANSAny bacterial organism that can be assigned to the species Enterococcus durans.Enterococcus durans
ENTEROCOCCUS FAECALISC86368STREPTOCOCCUS FAECALISAny bacterial organism that can be assigned to the species Enterococcus faecalis.Enterococcus faecalis
ENTEROCOCCUS FAECIUMC86369STREPTOCOCCUS FAECIUMAny bacterial organism that can be assigned to the species Enterococcus faecium.Enterococcus faecium
ENTEROCOCCUS GALLINARUMC86370Any bacterial organism that can be assigned to the species Enterococcus gallinarum.Enterococcus gallinarum
ENTEROCOCCUS HIRAEC86371Any bacterial organism that can be assigned to the species Enterococcus hirae.Enterococcus hirae
ENTEROCOCCUS MALODORATUSC86372Any bacterial organism that can be assigned to the species Enterococcus malodoratus.Enterococcus malodoratus
ENTEROCOCCUS MUNDTIIC86373Any bacterial organism that can be assigned to the species Enterococcus mundtii.Enterococcus mundtii
ENTEROCOCCUS PSEUDOAVIUMC86374Any bacterial organism that can be assigned to the species Enterococcus pseudoavium.Enterococcus pseudoavium
ENTEROCOCCUS RAFFINOSUSC86375Any bacterial organism that can be assigned to the species Enterococcus raffinosus.Enterococcus raffinosus
ENTEROCOCCUS THAILANDICUSC114243Enterococcus sanguinicolaAny bacterial organism that can be assigned to the species Enterococcus thailandicus.Enterococcus thailandicus
ENTEROVIRUSC14203Any viral organism that can be assigned to the genus Enterovirus.Enterovirus
ERYSIPELOTHRIXC86376ERYSIPELOTHRIX INSIDIOSAAny bacteria that is not assigned to the species level but can be assigned to the Erysipelothrix genus level.Erysipelothrix
ERYSIPELOTHRIX RHUSIOPATHIAEC86377Any bacterial organism that can be assigned to the species Erysipelothrix rhusiopathiae.Erysipelothrix rhusiopathiae
ESCHERICHIAC77208Any bacteria that is not assigned to the species level but can be assigned to the Escherichia genus level.Escherichia
ESCHERICHIA ALBERTIIC86378Any bacterial organism that can be assigned to the species Escherichia albertii.Escherichia albertii
ESCHERICHIA BLATTAEC86379Any bacterial organism that can be assigned to the species Escherichia blattae.Escherichia blattae
ESCHERICHIA COLIC14206E. COLIAny bacterial organism that can be assigned to the species Escherichia coli.Escherichia coli
ESCHERICHIA COLI O111C86881Any bacterial organism that can be assigned to the species Escherichia coli and strain O111.Escherichia coli strain O111
ESCHERICHIA COLI O157 (NOT H7)C86882Any bacterial organism that can be assigned to the species Escherichia coli and strain O157.Escherichia coli strain O157
ESCHERICHIA COLI O157:H7C86883Any bacterial organism that can be assigned to the species Escherichia coli and strain O157:H7.Escherichia coli strain O157:H7
ESCHERICHIA COLI O26C86884Any bacterial organism that can be assigned to the species Escherichia coli and strain O26.Escherichia coli strain O26
ESCHERICHIA FERGUSONIIC86380CDC ENTERIC GROUP 10Any bacterial organism that can be assigned to the species Escherichia fergusonii.Escherichia fergusonii
ESCHERICHIA HERMANNIIC86381CDC ENTERIC GROUP 11Any bacterial organism that can be assigned to the species Escherichia hermannii.Escherichia hermannii
ESCHERICHIA VULNERISC86382CDC ENTERIC GROUP 1Any bacterial organism that can be assigned to the species Escherichia vulneris.Escherichia vulneris
EUBACTERIUMC86383Any bacteria that is not assigned to the species level but can be assigned to the Eubacterium genus level.Eubacterium
EUBACTERIUM ALACTOLYTICUMC86384Any bacterial organism that can be assigned to the species Eubacterium adactolyticum.Eubacterium alactolyticum
EUBACTERIUM CONTORTUMC86385Any bacterial organism that can be assigned to the species Eubacterium contortum.Eubacterium contortum
EUBACTERIUM LIMOSUMC86386Any bacterial organism that can be assigned to the species Eubacterium limosum.Eubacterium limosum
EUBACTERIUM NODATUMC86387Any bacterial organism that can be assigned to the species Eubacterium nodatum.Eubacterium nodatum
EUBACTERIUM RECTALEC86388Any bacterial organism that can be assigned to the species Eubacterium rectale.Eubacterium rectale
EUBACTERIUM VENTRIOSUMC86389Any bacterial organism that can be assigned to the species Eubacterium ventriosum.Eubacterium ventriosum
EWINGELLAC86390Any bacteria that is not assigned to the species level but can be assigned to the Ewingella genus level.Ewingella
EWINGELLA AMERICANAC86391CDC ENTERIC GROUP 40Any bacterial organism that can be assigned to the species Ewingella americana.Ewingella americana
EXIGUOBACTERIUMC86885Any bacteria that is not assigned to the species level but can be assigned to the Exiguobacterium genus level.Exiguobacterium
EXIGUOBACTERIUM ACETYLICUMC86886BREVIBACTERIUM ACETYLICUMAny bacterial organism that can be assigned to the species Exiguobacterium acetylicum.Exiguobacterium acetylicum
FACKLAMIAC86392Any bacteria that is not assigned to the species level but can be assigned to the Facklamia genus level.Facklamia
FAECALIBACTERIUMC86393Any bacteria that is not assigned to the species level but can be assigned to the Faecalibacterium genus level.Faecalibacterium
FAECALIBACTERIUM PRAUSNITZIIC86394FUSOBACTERIUM PRAUSNITZIIAny bacterial organism that can be assigned to the species Faecalibacterium prausnitzii.Faecalibacterium prausnitzii
FERMENTATIVE GRAM-NEGATIVE BACILLUSC86395FERMENTATIVE GRAM-NEGATIVE RODAny rod-shaped, anaerobic bacteria that can convert carbohydrates into acids and alcohols and has a cell wall contains low levels of peptidoglycan and stains pink with the Gram staining technique.Fermentative Gram Negative Bacillus
FILOBASIDIUM UNIGUTTULATUMC114265C. neoformans var. uniguttulatus;C. uniguttulatus;Cryptococcus neoformans var. uniguttulatus;Cryptococcus uniguttulatus;E. uniguttulata;Eutorulopsis uniguttulata;F. uniguttulatumAny fungal organism that can be assigned to the species Filobasidium uniguttulatum.Filobasidium uniguttulatum
FILOVIRUSC112031FiloviridaeAny viral organism that can be assigned to the family Filoviridae.Filoviridae
FINEGOLDIAC86887Any bacteria that is not assigned to the species level but can be assigned to the Finegoldia genus level.Finegoldia
FINEGOLDIA MAGNAC86888PEPTOSTREPTOCOCCUS MAGNUSAny bacterial organism that can be assigned to the species Finegoldia magna.Finegoldia magna
FLAVIVIRUSC14208Any viral organism that can be assigned to the genus Flavivirus.Flavivirus
FLAVOBACTERIUMC76320Any bacteria that is not assigned to the species level but can be assigned to the Flavobacterium genus level.Flavobacterium
FRANCISELLAC86396Any bacteria that is not assigned to the species level but can be assigned to the Francisella genus level.Francisella
FRANCISELLA TULARENSISC86397PASTEURELLA TULARENSISAny bacterial organism that can be assigned to the species Francisella tularensis.Francisella tularensis
FUSOBACTERIUMC76323Any bacteria that is not assigned to the species level but can be assigned to the Fusobacterium genus level.Fusobacterium
FUSOBACTERIUM GONIDIAFORMANSC86398Any bacterial organism that can be assigned to the species Fusobacterium gonidiaformans.Fusobacterium gonidiaformans
FUSOBACTERIUM MORTIFERUMC86399Any bacterial organism that can be assigned to the species Fusobacterium mortiferum.Fusobacterium mortiferum
FUSOBACTERIUM NAVIFORMEC114252Bacillus naviformis;Fusibacterium naviforme;Pseudobacterium naviformis;Ristella naviformisAny bacterial organism that can be assigned to the species Fusobacterium naviforme.Fusobacterium naviforme
FUSOBACTERIUM NECROGENESC86400Any bacterial organism that can be assigned to the species Fusobacterium necrogenes.Fusobacterium necrogenes
FUSOBACTERIUM NECROPHORUMC86401Any bacterial organism that can be assigned to the species Fusobacterium necrophorum.Fusobacterium necrophorum
FUSOBACTERIUM NUCLEATUMC86404Any bacterial organism that can be assigned to the species Fusobacterium nucleatum.Fusobacterium nucleatum
FUSOBACTERIUM RUSSIIC86405Any bacterial organism that can be assigned to the species Fusobacterium russii.Fusobacterium russii
FUSOBACTERIUM ULCERANSC86406Any bacterial organism that can be assigned to the species Fusobacterium ulcerans.Fusobacterium ulcerans
FUSOBACTERIUM VARIUMC86407FUSOBACTERIUM NECROPHORUM BIOVAR C;FUSOBACTERIUM PSEUDONECROPHORUMAny bacterial organism that can be assigned to the species Fusobacterium varium.Fusobacterium varium
GARDNERELLAC86409Any bacteria that is not assigned to the species level but can be assigned to the Gardnerella genus level.Gardnerella
GARDNERELLA VAGINALISC86410CORYNEBACTERIUM VAGINALISAny bacterial organism that can be assigned to the species Gardnerella vaginalis.Gardnerella vaginalis
GEMELLAC86889Any bacteria that is not assigned to the species level but can be assigned to the Gemella genus level.Gemella
GEMELLA BERGERIC86890Any bacterial organism that can be assigned to the species Gemella bergeri.Gemella bergeri
GEMELLA HAEMOLYSANSC86891NEISSERIA HAEMOLYSANSAny bacterial organism that can be assigned to the species Gemella haemolysans.Gemella haemolysans
GEMELLA MORBILLORUMC86892STREPTOCOCCUS MORBILLORUMAny bacterial organism that can be assigned to the species Gemella morbillorum.Gemella morbillorum
GEMELLA SANGUINISC86893Any bacterial organism that can be assigned to the species Gemella sanguinis.Gemella sanguinis
GLOBICATELLAC86411Any bacteria that is not assigned to the species level but can be assigned to the Globicatella genus level.Globicatella
GLOBICATELLA SANGUINISC86412GLOBICATELLA SANGUISAny bacterial organism that can be assigned to the species Globicatella sanguinis.Globicatella sanguinis
GLOBICATELLA SULFIDIFACIENSC86413Any bacterial organism that can be assigned to the species Globicatella sulfidifaciens.Globicatella sulfidifaciens
GORDONIAC86414Any bacteria that is not assigned to the species level but can be assigned to the Gordonia genus level.Gordonia
GORDONIA AICHIENSISC86415GORDONA AICHIENSIS;TSUKAMURELLA AICHIENSISAny bacterial organism that can be assigned to the species Gordonia aichiensis.Gordonia aichiensis
GORDONIA BRONCHIALISC86416GORDONA BRONCHIALIS;RHODOCOCCUS BRONCHIALISAny bacterial organism that can be assigned to the species Gordonia bronchialis.Gordonia bronchialis
GORDONIA RUBRIPERTINCTAC86417GORDONA RUBROPERTINCTA;RHODOCOCCUS RUBRIPERTINCTAAny bacterial organism that can be assigned to the species Gordonia rubripertincta.Gordonia rubripertincta
GORDONIA SPUTIC86418GORDONA SPUTIAny bacterial organism that can be assigned to the species Gordonia sputi.Gordonia sputi
GORDONIA TERRAEC86419GORDONA TERRAE;RHODOCOCCUS TERRAEAny bacterial organism that can be assigned to the species Gordonia terrae.Gordonia terrae
GRACILIBACILLUSC86420Any bacteria that is not assigned to the species level but can be assigned to the Gracilibacillus genus level.Gracilibacillus
GRAM-NEGATIVE BACILLUSC86421Any rod-shaped bacteria that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique.Gram Negative Bacillus
GRAM-NEGATIVE COCCUSC86422Any spherical-shaped bacteria that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique.Gram Negative Coccus
GRAM-POSITIVE BACILLUSC62589Any rod-shaped bacteria that has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.Gram-Positive Rod
GRAM-POSITIVE COCCUSC86424Any spherical-shaped bacteria that has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique.Gram Positive Coccus
GRANULICATELLAC86425Any bacteria that is not assigned to the species level but can be assigned to the Granulicatella genus level.Granulicatella
GRANULICATELLA ADIACENSC86426ABIOTROPHIA ADJACENS;STREPTOCOCCUS ADJACENSAny bacterial organism that can be assigned to the species Granulicatella adiacens.Granulicatella adiacens
GRANULICATELLA ELEGANSC111204ABIOTROPHIA ELEGANSAny bacterial organism that can be assigned to the species Granulicatella elegans.Granulicatella elegans
GRIMONTIA HOLLISAEC86427VIBRIO HOLLISAEAny bacterial organism that can be assigned to the species Grimontia hollisae.Grimontia hollisae
HAEMOPHILUSC76324Any bacteria that is not assigned to the species level but can be assigned to the Haemophilus genus level.Haemophilus
HAEMOPHILUS AEGYPTIUSC86428Any bacterial organism that can be assigned to the species Haemophilus aegyptius.Haemophilus aegyptius
HAEMOPHILUS HAEMOGLOBINOPHILUSC86429Any bacterial organism that can be assigned to the species Haemophilus haemoglobinophilus.Haemophilus haemoglobinophilus
HAEMOPHILUS HAEMOLYTICUSC86430Any bacterial organism that can be assigned to the species Haemophilus haemolyticus.Haemophilus haemolyticus
HAEMOPHILUS INFLUENZAEC86431H-FLUAny bacterial organism that can be assigned to the species Haemophilus influenzae.Haemophilus influenzae
HAEMOPHILUS PARAHAEMOLYTICUSC86432Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus.Haemophilus parahaemolyticus
HAEMOPHILUS PARAINFLUENZAEC86433HEMOPHILUS PARAINFLUENZAEAny bacterial organism that can be assigned to the species Haemophilus parainfluenzae.Haemophilus parainfluenzae
HAFNIAC86434Any bacteria that is not assigned to the species level but can be assigned to the Hafnia genus level.Hafnia
HAFNIA ALVEIC86435ENTEROBACTER ALVEIAny bacterial organism that can be assigned to the species Hafnia alvei.Hafnia alvei
HALOBACILLUSC86436Any bacteria that is not assigned to the species level but can be assigned to the Halobacillus genus level.Halobacillus
HANTAVIRUSC14213Any viral organism that can be assigned to the genus Hantavirus.Hantavirus
HELCOCOCCUSC86873Any bacteria that is not assigned to the species level but can be assigned to the Helcococcus genus level.Helcococcus
HELCOCOCCUS KUNZIIC86878Any bacterial organism that can be assigned to the species Helcococcus kunzii.Helcococcus kunzii
HELCOCOCCUS PYOGENESC86879Any bacterial organism that can be assigned to the species Helcococcus pyogenes.Helcococcus pyogenes
HELCOCOCCUS SUECIENSISC86880Any bacterial organism that can be assigned to the species Helcococcus sueciensis.Helcococcus sueciensis
HELICOBACTERC14296Any bacteria that is not assigned to the species level but can be assigned to the Helicobacter genus level.Helicobacter
HELICOBACTER CINAEDIC86437CAMPYLOBACTER CINAEDIAny bacterial organism that can be assigned to the species Helicobacter cinaedi.Helicobacter cinaedi
HELICOBACTER FELISC14330H. FELISAny bacterial organism that can be assigned to the species Helicobacter felis.Helicobacter felis
HELICOBACTER FENNELLIAEC86438CAMPYLOBACTER FENNELLIAEAny bacterial organism that can be assigned to the species Helicobacter fennelliae.Helicobacter fennelliae
HELICOBACTER MUSTELAEC86439CAMPYLOBACTER MUSTELAEAny bacterial organism that can be assigned to the species Helicobacter mustelae.Helicobacter mustelae
HELICOBACTER PYLORIC14289CAMPYLOBACTER PYLORI;H. PYLORIAny bacterial organism that can be assigned to the species Helicobacter pylori.Helicobacter pylori
HELICOBACTER RAPPINIC86440FLEXISPIRA RAPPINIAny bacterial organism that can be assigned to the species Helicobacter rappini.Helicobacter rappini
HENDRA VIRUSC112289Any viral organism that can be assigned to the species Hendra virus.Hendra Virus
HENIPAVIRUSC112290Any viral organism that can be assigned to the genus Henipavirus.Henipavirus
HEPATITIS A VIRUSC14325HAVAny viral organism that can be assigned to the species Hepatitis A virus.Hepatitis A Virus
HEPATITIS B VIRUSC14215HBVAny viral organism that can be assigned to the species Hepatitis B virus.Hepatitis B Virus
HEPATITIS C VIRUSC14312HCVAny viral organism that can be assigned to the species Hepatitis C virus.Hepatitis C Virus
HEPATITIS D VIRUSC93324HDVAny viral organism that can be assigned to the species Hepatitis D virus.Hepatitis D Virus
HEPATITIS E VIRUSC14295HEVAny viral organism that can be assigned to the species Hepatitis E virus.Hepatitis E Virus
HEPATITIS G VIRUSC14328GBV-C;HGVAny viral organism that can be assigned to the species Hepatitis G virus.GB virus C
HISTOPHILUS SOMNIC86441HAEMOPHILUS SOMNUSAny bacterial organism that can be assigned to the species Histophilus somni.Histophilus somni
HOLDEMANIAC86442Any bacteria that is not assigned to the species level but can be assigned to the Holdemania genus level.Holdemania
HOLDEMANIA FILIFORMISC86443Any bacterial organism that can be assigned to the species Holdemania filiformis.Holdemania filiformis
HUMAN HERPESVIRUS 1C14311HHV-1;HSV-1;Herpes Simplex Virus type 1Any viral organism that can be assigned to the species Human Herpesvirus 1 within the genus Simplexvirus.Human Herpesvirus 1
HUMAN HERPESVIRUS 2C112313HHV-2;HSV-2;Herpes Simplex Virus type 2Any viral organism that can be assigned to the species Human Herpesvirus 2 within the genus Simplexvirus.Human Herpesvirus 2
HUMAN HERPESVIRUS 3C71091HHV-3;VZV;Varicella Zoster VirusAny viral organism that can be assigned to the species Human Herpesvirus 3.Varicella Zoster Virus
HUMAN HERPESVIRUS 4C14204EBV;Epstein-Barr Virus;HHV-4Any viral organism that can be assigned to the species Human Herpesvirus 4.Epstein-Barr Virus
HUMAN HERPESVIRUS 5C112314HCMV;HHV-5;Human CytomegalovirusAny viral organism that can be assigned to the species Human Herpesvirus 5.Human Herpesvirus 5
HUMAN HERPESVIRUS 6C14218HHV-6Any viral organism that can be assigned to the species Human Herpesvirus 6.Human Herpesvirus 6
HUMAN HERPESVIRUS 7C112315HHV-7Any viral organism that can be assigned to the species Human Herpesvirus 7.Human Herpesvirus 7
HUMAN HERPESVIRUS 8C14327HHV-8;KSHV;Kaposi's sarcoma-associated herpesvirusAny viral organism that can be assigned to the species Human herpesvirus 8.Human Herpesvirus 8
HUMAN IMMUNODEFICIENCY VIRUS 1C14220HIV-1;LAV-1Any viral organism that can be assigned to the species Human Immunodeficiency virus 1.Human Immunodeficiency Virus 1
HUMAN IMMUNODEFICIENCY VIRUS 2C14221HIV-2;LAV-2Any viral organism that can be assigned to the species Human Immunodeficiency virus 2.Human Immunodeficiency Virus 2
HUMAN PAPILLOMAVIRUSC14226HPV;Human Papilloma VirusAny viral organism in humans that can be assigned to the family Papillomaviridae.Human Papillomavirus
HUMAN PARAINFLUENZA VIRUS 1C14254HPIV-1;Human Parainfluenza Virus Type 1;hPIV-1Any viral organism that can be assigned to the Human Parainfluenza virus 1 serotype.Human Parainfluenza Virus 1
HUMAN PARAINFLUENZA VIRUS 2C112316HPIV-2;Human Parainfluenza Virus Type 2;hPIV-2Any viral organism that can be assigned to the Human Parainfluenza virus 2 serotype.Human Parainfluenza Virus 2
HUMAN PARAINFLUENZA VIRUS 3C112317HPIV-3;Human Parainfluenza Virus Type 3;hPIV-3Any viral organism that can be assigned to the Human Parainfluenza virus 3 serotype.Human Parainfluenza Virus 3
HUMAN PARAINFLUENZA VIRUS 4C112318HPIV-4;Human Parainfluenza Virus Type 4;hPIV-4Any viral organism that can be assigned to the Human Parainfluenza virus 4 serotype.Human Parainfluenza Virus 4
HUMAN PARVOVIRUS B19C89772B19 Virus;Human Erythrovirus B19;Parvovirus B19Any viral organism that can be assigned to the species Human Parvovirus B19.Parvovirus B19
HUMAN RESPIRATORY SYNCYTIAL VIRUSC14267Human RSV;RSV;hRSVAny viral organism that can be assigned to the species Human Respiratory Syncitial virus.Human Respiratory Syncytial Virus
HUMAN T-LYMPHOTROPIC VIRUS 1C14223Adult T-cell leukemia lymphoma ATLL;Adult T-cell lymphoma virus type 1;HTLV-1Any viral organism that can be assigned to the Human T-lymphotrophic virus serotype 1.HTLV-1
HUMAN T-LYMPHOTROPIC VIRUS 2C14224HTLV-2;HTLV-IIAny viral organism that can be assigned to the Human T-lymphotrophic virus serotype 2.HTLV-2
INFLUENZA A VIRUSC53454FLUAV;Influenza Virus Type AAny viral organism that can be assigned to the species Influenza A virus.Influenza A Virus
INFLUENZA B VIRUSC53468FLUBV;Influenza Virus Type BAny viral organism that can be assigned to the species Influenza B virus.Influenza B Virus
INFLUENZA C VIRUSC97157FLUCV;Influenza Virus Type CAny viral organism that can be assigned to the species Influenza C virus.Influenza C Virus
INQUILINUSC86444Any bacteria that is not assigned to the species level but can be assigned to the Inquilinus genus level.Inquilinus
INQUILINUS LIMOSUSC86445Any bacterial organism that can be assigned to the species Inquilinus limosus.Inquilinus limosus
JC VIRUSC14229Human polyomavirus (type JC);Polyomavirus hominis 2;polyomavirus JCAny viral organism that can be assigned to the species JC polyomavirus.JC Virus
JEOTGALIBACILLUSC86446Any bacteria that is not assigned to the species level but can be assigned to the Jeotgalibacillus genus level.Jeotgalibacillus
JOHNSONELLAC86447Any bacteria that is not assigned to the species level but can be assigned to the Johnsonella genus level.Johnsonella
JOHNSONELLA IGNAVAC86448Any bacterial organism that can be assigned to the species Johnsonella ignava.Johnsonella ignava
KINGELLAC86449Any bacteria that is not assigned to the species level but can be assigned to the Kingella genus level.Kingella
KINGELLA DENITRIFICANSC86450CDC GROUP TM-1Any bacterial organism that can be assigned to the species Kingella denitrificans.Kingella denitrificans
KINGELLA KINGAEC86451MORAXELLA KINGAEAny bacterial organism that can be assigned to the species Kingella kingae.Kingella kingae
KINGELLA ORALISC86452Any bacterial organism that can be assigned to the species Kingella oralis.Kingella oralis
KINGELLA POTUSC86453Any bacterial organism that can be assigned to the species Kingella potus.Kingella potus
KLEBSIELLAC28165Any bacteria that is not assigned to the species level but can be assigned to the Klebsiella genus level.Klebsiella
KLEBSIELLA GRANULOMATISC86454Any bacterial organism that can be assigned to the species Klebsiella granulomatis.Klebsiella granulomatis
KLEBSIELLA OXYTOCAC86455K. OXYTOCAAny bacterial organism that can be assigned to the species Klebsiella oxytoca.Klebsiella oxytoca
KLEBSIELLA OZAENAEC86456KLEBSIELLA PNEUMONIAE SUBSP. OZAENAEAny bacterial organism that can be assigned to the species Klebsiella ozaenae.Klebsiella ozaenae
KLEBSIELLA PNEUMONIAEC86457K. PNEUMONIAEAny bacterial organism that can be assigned to the species Klebsiella pneumoniae.Klebsiella pneumoniae
KLEBSIELLA RHINOSCLEROMATISC86458KLEBSIELLA PNEUMONIAE SUBSP. RHINOSCLEROMATISAny bacterial organism that can be assigned to the species Klebsiella rhinoscleromatis.Klebsiella rhinoscleromatis
KLEBSIELLA SINGAPORENSISC86459Any bacterial organism that can be assigned to the species Klebsiella singaporensis.Klebsiella singaporensis
KLEBSIELLA VARIICOLAC86460Any bacterial organism that can be assigned to the species Klebsiella variicola.Klebsiella variicola
KLUYVERAC86461Any bacteria that is not assigned to the species level but can be assigned to the Kluyvera genus level.Kluyvera
KLUYVERA ASCORBATAC86462CDC ENTERIC GROUP 8Any bacterial organism that can be assigned to the species Kluyvera ascorbata.Kluyvera ascorbata
KLUYVERA CRYOCRESCENSC86463Any bacterial organism that can be assigned to the species Kluyvera cryocrescens.Kluyvera cryocrescens
KLUYVERA GEORGIANAC86464Any bacterial organism that can be assigned to the species Kluyvera georgiana.Kluyvera georgiana
KLUYVERA INTERMEDIAC86465ENTEROBACTER INTERMEDIUM;ENTEROBACTER INTERMEDIUS;KLUYVERA COCHLEAEAny bacterial organism that can be assigned to the species Kluyvera intermedia.Kluyvera intermedia
KLUYVEROMYCES MARXIANUSC114256C. pseudotropicalis;Candida pseudotropicalis;K. cicerisporus;K. fragilis;Kluyveromyces cicerisporus;Kluyveromyces fragilisAny fungal organism that can be assigned to the species Kluyveromyces marxianus.Kluyveromyces marxianus
KNOELLIAC86466Any bacteria that is not assigned to the species level but can be assigned to the Knoellia genus level.Knoellia
KOCURIAC86467Any bacteria that is not assigned to the species level but can be assigned to the Kocuria genus level.Kocuria
KOCURIA KRISTINAEC86468MICROCOCCUS KRISTINAEAny bacterial organism that can be assigned to the species Kocuria kristinae.Kocuria kristinae
KOCURIA RHIZOPHILAC86513MICROCOCCUS LUTEUS;SARCINA LUTEAAny bacterial organism that can be assigned to the species Kocuria rhizophila.Micrococcus luteus
KOCURIA ROSEAC86469Any bacterial organism that can be assigned to the species Kocuria rosea.Kocuria rosea
KOCURIA VARIANSC86470Any bacterial organism that can be assigned to the species Kocuria varians.Kocuria varians
KURTHIAC86471Any bacteria that is not assigned to the species level but can be assigned to the Kurthia genus level.Kurthia
KYTOCOCCUSC86472Any bacteria that is not assigned to the species level but can be assigned to the Kytococcus genus level.Kytococcus
KYTOCOCCUS SEDENTARIUSC86473Any bacterial organism that can be assigned to the species Kytococcus sedentarius.Kytococcus sedentarius
LACTOBACILLUSC76352Any bacteria that is not assigned to the species level but can be assigned to the Lactobacillus genus level.Lactobacillus
LACTOBACILLUS ACIDOPHILUSC86474Any bacterial organism that can be assigned to the species Lactobacillus acidophilus.Lactobacillus acidophilus
LACTOBACILLUS BREVISC86475Any bacterial organism that can be assigned to the species Lactobacillus brevis.Lactobacillus brevis
LACTOBACILLUS CASEIC86476Any bacterial organism that can be assigned to the species Lactobacillus casei.Lactobacillus casei
LACTOBACILLUS CATENAFORMISC86477LACTOBACILLUS CATENAFORMEAny bacterial organism that can be assigned to the species Lactobacillus catenaformis.Lactobacillus catenaformis
LACTOBACILLUS FERMENTUMC86478Any bacterial organism that can be assigned to the species Lactobacillus fermentum.Lactobacillus fermentum
LACTOBACILLUS GALLINARUMC86479Any bacterial organism that can be assigned to the species Lactobacillus gallinarum.Lactobacillus gallinarum
LACTOBACILLUS JENSENIIC86480Any bacterial organism that can be assigned to the species Lactobacillus jensenii.Lactobacillus jensenii
LACTOBACILLUS JOHNSONIIC86481Any bacterial organism that can be assigned to the species Lactobacillus johnsonii.Lactobacillus johnsonii
LACTOBACILLUS SALIVARIUSC86482Any bacterial organism that can be assigned to the species Lactobacillus salivarius.Lactobacillus salivarius
LACTOCOCCUSC86483DOEDERLEIN BACILLUSAny bacteria that is not assigned to the species level but can be assigned to the Lactococcus genus level.Lactococcus
LACTOCOCCUS GARVIEAEC86484Any bacterial organism that can be assigned to the species Lactococcus garvieae.Lactococcus garvieae
LACTOCOCCUS LACTISC86485Any bacterial organism that can be assigned to the species Lactococcus lactis.Lactococcus lactis
LECLERCIAC86486Any bacteria that is not assigned to the species level but can be assigned to the Leclercia genus level.Leclercia
LECLERCIA ADECARBOXYLATAC86487CDC ENTERIC GROUP 41Any bacterial organism that can be assigned to the species Leclercia adecarboxylata.Leclercia adecarboxylata
LEGIONELLAC76353Any bacteria that is not assigned to the species level but can be assigned to the Legionella genus level.Legionella
LEGIONELLA LONGBEACHAEC86488Any bacterial organism that can be assigned to the species Legionella longbeachae.Legionella longbeachae
LEGIONELLA PNEUMOPHILAC86489Any bacterial organism that can be assigned to the species Legionella pneumophila.Legionella pneumophila
LEIFSONIAC86490Any bacteria that is not assigned to the species level but can be assigned to the Leifsonia genus level.Leifsonia
LEIFSONIA AQUATICAC86491CORYNEBACTERIUM AQUATICUMAny bacterial organism that can be assigned to the species Leifsonia aquatica.Leifsonia aquatica
LEMINORELLAC86492Any bacteria that is not assigned to the species level but can be assigned to the Leminorella genus level.Leminorella
LEMINORELLA GRIMONTIIC86493CDC ENTERIC GROUP 57Any bacterial organism that can be assigned to the species Leminorella grimontii.Leminorella grimontii
LEMINORELLA RICHARDIIC86494Any bacterial organism that can be assigned to the species Leminorella richardii.Leminorella richardii
LENTIVIRUSC14290LentivirinaeAny viral organism that can be assigned to the genus Lentivirus.Lentivirus
LEPTOSPIRAC76355Any bacteria that is not assigned to the species level but can be assigned to the Leptospira genus level.Leptospira
LEUCONOSTOCC76357Any bacteria that is not assigned to the species level but can be assigned to the Leuconostoc genus level.Leuconostoc
LEUCONOSTOC CITREUMC86495Any bacterial organism that can be assigned to the species Leuconostoc citreum.Leuconostoc citreum
LEUCONOSTOC LACTISC86496Any bacterial organism that can be assigned to the species Leuconostoc lactis.Leuconostoc lactis
LEUCONOSTOC MESENTEROIDESC86497Any bacterial organism that can be assigned to the species Leuconostoc mesenteroides.Leuconostoc mesenteroides
LEUCONOSTOC PSEUDOMESENTEROIDESC86498Any bacterial organism that can be assigned to the species Leuconostoc pseudomesenteroides.Leuconostoc pseudomesenteroides
LISTERIAC76359Any bacteria that is not assigned to the species level but can be assigned to the Listeria genus level.Listeria
LISTERIA GRAYIC86499Any bacterial organism that can be assigned to the species Listeria grayi.Listeria grayi
LISTERIA INNOCUAC86500Any bacterial organism that can be assigned to the species Listeria innocua.Listeria innocua
LISTERIA IVANOVIIC86501LISTERIA MONOCYTOGENES SEROVAR 5Any bacterial organism that can be assigned to the species Listeria ivanovii.Listeria ivanovii
LISTERIA MONOCYTOGENESC86502Any bacterial organism that can be assigned to the species Listeria monocytogenes.Listeria monocytogenes
LISTERIA SEELIGERIC86503Any bacterial organism that can be assigned to the species Listeria seeligeri.Listeria seeligeri
LISTERIA WELSHIMERIC86504Any bacterial organism that can be assigned to the species Listeria welshimeri.Listeria welshimeri
LYSSAVIRUSC112330Any viral organism that can be assigned to the genus Lyssavirus.Lyssavirus
MACROCOCCUSC86505Any bacteria that is not assigned to the species level but can be assigned to the Macrococcus genus level.Macrococcus
MACROCOCCUS CASEOLYTICUSC86506STAPHYLOCOCCUS CASEOLYTICUSAny bacterial organism that can be assigned to the species Macrococcus caseolyticus.Macrococcus caseolyticus
MAGNUSIOMYCES CAPITATUSC114263M. capitatusAny fungal organism that can be assigned to the species Magnusiomyces capitatus.Magnusiomyces capitatus
MANNHEIMIAC86507Any bacteria that is not assigned to the species level but can be assigned to the Mannheimia genus level.Mannheimia
MANNHEIMIA HAEMOLYTICAC86508PASTEURELLA HAEMOLYTICAAny bacterial organism that can be assigned to the species Mannheimia haemolytica.Mannheimia haemolytica
MANSONELLA PERSTANSC119326Dipetalonema perstansAny parasitic organism that can be assigned to the species Mansonella perstans.Mansonella perstans
MARBURGVIRUSC112331Marburg VirusAny viral organism that can be assigned to the genus Marburgvirus.Marburgvirus
MEASLES VIRUSC14237Rubeola Virus;SSPEV;rougeole virus;subacute sclerosing panencephalitis virusAny viral organism that can be assigned to the species Measles virus.Measles Virus
MEGAMONAS FUNIFORMISC114247Any bacterial organism that can be assigned to the species Megamonas funiformis.Megamonas funiformis
MEGASPHAERAC86895Any bacteria that is not assigned to the species level but can be assigned to the Megasphaera genus level.Megasphaera
MEGASPHAERA ELSDENIIC86896PEPTOSTREPTOCOCCUS ELSDENIIAny bacterial organism that can be assigned to the species Megasphaera elsdenii.Megasphaera elsdenii
METHYLOBACTERIUMC76361Any bacteria that is not assigned to the species level but can be assigned to the Methylobacterium genus level.Methylobacterium
METHYLOBACTERIUM MESOPHILICUMC86510PSEUDOMONAS MESOPHILICAAny bacterial organism that can be assigned to the species Methylobacterium mesophilicum.Methylobacterium mesophilicum
MEYEROZYMA GUILLIERMONDIIC77172C. guilliermondii;Candida guilliermondii;M. guillliermondiiAny fungal organism that can be assigned to the species Meyerozyma guilliermondii.Pichia guilliermondii
MICROBACTERIUMC85511CDC CORYNEFORM GROUP A-4, A-5Any bacteria that is not assigned to the species level but can be assigned to the Microbacterium genus level.Microbacterium
MICROBACTERIUM PARAOXYDANSC86512Any bacterial organism that can be assigned to the species Microbacterium paraoxydans.Microbacterium paraoxydans
MICROCOCCUSC77086Any bacteria that is not assigned to the species level but can be assigned to the Micrococcus genus level.Micrococcus
MICROCOCCUS LYLAEC86514Any bacterial organism that can be assigned to the species Micrococcus lylae.Micrococcus lylae
MITSUOKELLAC86515Any bacteria that is not assigned to the species level but can be assigned to the Mitsuokella genus level.Mitsuokella
MITSUOKELLA MULTACIDAC86516Any bacterial organism that can be assigned to the species Mitsuokella multacida.Mitsuokella multacida
MOBILUNCUSC86517Any bacteria that is not assigned to the species level but can be assigned to the Mobiluncus genus level.Mobiluncus
MOBILUNCUS CURTISIIC86518Any bacterial organism that can be assigned to the species Mobiluncus curtisii.Mobiluncus curtisii
MOBILUNCUS MULIERISC86519Any bacterial organism that can be assigned to the species Mobiluncus mulieris.Mobiluncus mulieris
MOELLERELLAC86520Any bacteria that is not assigned to the species level but can be assigned to the Moellerella genus level.Moellerella
MOELLERELLA WISCONSENSISC86521CDC ENTERIC GROUP 46Any bacterial organism that can be assigned to the species Moellerella wisconsensis.Moellerella wisconsensis
MOGIBACTERIUMC86898Any bacteria that is not assigned to the species level but can be assigned to the Mogibacterium genus level.Mogibacterium
MOGIBACTERIUM TIMIDUMC86899EUBACTERIUM TIMIDUMAny bacterial organism that can be assigned to the species Mogibacterium timidum.Mogibacterium timidum
MOLLUSCIPOXVIRUSC112356Molluscipox VirusAny viral organism that can be assigned to the genus Molluscipoxvirus.Molluscipoxvirus
MOLLUSCUM CONTAGIOSUM VIRUSC112357MCV;MOCVAny viral organism that can be assigned to the species Molluscum contagiosum virus.Molluscum Contagiosum Virus
MORAXELLAC86009BRANHAMELLA SPECIESAny bacteria that is not assigned to the species level but can be assigned to the Moraxella genus level.Moraxella
MORAXELLA ATLANTAEC86523CDC GROUP M-3Any bacterial organism that can be assigned to the species Moraxella atlantae.Moraxella atlantae
MORAXELLA BOVISC86524Any bacterial organism that can be assigned to the species Moraxella bovis.Moraxella bovis
MORAXELLA CANISC86525Any bacterial organism that can be assigned to the species Moraxella canis.Moraxella canis
MORAXELLA CATARRHALISC76210BRANHAMELLA CATARRHALISAny bacterial organism that can be assigned to the species Moraxella catarrhalis.Moraxella catarrhalis
MORAXELLA LACUNATAC86526MORAXELLA LIQUEFACIENSAny bacterial organism that can be assigned to the species Moraxella lacunata.Moraxella lacunata
MORAXELLA LINCOLNIIC86527Any bacterial organism that can be assigned to the species Moraxella lincolnii.Moraxella lincolnii
MORAXELLA NONLIQUEFACIENSC86528Any bacterial organism that can be assigned to the species Moraxella nonliquefaciens.Moraxella nonliquefaciens
MORAXELLA OBLONGAC86529Any bacterial organism that can be assigned to the species Moraxella oblonga.Moraxella oblonga
MORAXELLA OSLOENSISC86530Any bacterial organism that can be assigned to the species Moraxella osloensis.Moraxella osloensis
MORBILLIVIRUSC14309Any viral organism that can be assigned to the genus Morbillivirus.Morbillivirus
MORGANELLAC86531Any bacteria that is not assigned to the species level but can be assigned to the Morganella genus level.Morganella
MORGANELLA MORGANIIC86015PROTEUS MORGANIIAny bacterial organism that can be assigned to the species Morganella morganii.Morganella morganii
MYCOBACTERIUMC76369Any bacteria that is not assigned to the species level but can be assigned to the Mycobacterium genus level.Mycobacterium
MYCOBACTERIUM ABSCESSUSC86533MYCOBACTERIUM CHELONAE SUBSP. ABSCESSUSAny bacterial organism that can be assigned to the species Mycobacterium abscessus.Mycobacterium abscessus
MYCOBACTERIUM AFRICANUMC85544Any bacterial organism that can be assigned to the species Mycobacterium africanum.Mycobacterium africanum
MYCOBACTERIUM AVIUMC86535Any bacterial organism that can be assigned to the species Mycobacterium avium.Mycobacterium avium
MYCOBACTERIUM AVIUM COMPLEXC76368A non-taxonomic grouping of bacteria assigned to and including at least three related subspecies from the Mycobacterium avium species.Mycobacterium avium complex
MYCOBACTERIUM BOVISC85545Any bacterial organism that can be assigned to the species Mycobacterium bovis.Mycobacterium bovis
MYCOBACTERIUM BOVIS BCGC85546An attenuated form of Mycobacterium bovis that is used to generate the Bacillus Calmette-Guerin vaccine.Mycobacterium bovis BCG
MYCOBACTERIUM CANETTIIC85547Any bacterial organism that can be assigned to the species Mycobacterium canettii.Mycobacterium canetti
MYCOBACTERIUM CHELONAEC86536MYCOBACTERIUM CHELONAE SUBSP. CHELONAEAny bacterial organism that can be assigned to the species Mycobacterium chelonae.Mycobacterium chelonae
MYCOBACTERIUM FLAVESCENSC86537Any bacterial organism that can be assigned to the species Mycobacterium flavescens.Mycobacterium flavescens
MYCOBACTERIUM FORTUITUMC86538Any bacterial organism that can be assigned to the species Mycobacterium fortuitum.Mycobacterium fortuitum
MYCOBACTERIUM FORTUITUM COMPLEXC86539A non-taxonomic grouping of bacteria assigned to the Mycobacterium genus, which includes the related species and subspecies M. chelonei subsp. chelonei, M. chelonei subsp. abscessus, M. fortuitum, and M. peregrinum.Mycobacterium fortuitum Complex
MYCOBACTERIUM GASTRIC86540Any bacterial organism that can be assigned to the species Mycobacterium gastri.Mycobacterium gastri
MYCOBACTERIUM GORDONAEC86541MYCOBACTERIUM AQUAEAny bacterial organism that can be assigned to the species Mycobacterium gordonae.Mycobacterium gordonae
MYCOBACTERIUM HAEMOPHILUMC86542Any bacterial organism that can be assigned to the species Mycobacterium haemophilum.Mycobacterium haemophilum
MYCOBACTERIUM INTRACELLULAREC91843Any bacterial organism that can be assigned to the species Mycobacterium intracellulare.Mycobacterium intracellulare
MYCOBACTERIUM KANSASIIC85543Any bacterial organism that can be assigned to the species Mycobacterium kansasii.Mycobacterium kansasii
MYCOBACTERIUM LEPRAEC86544Any bacterial organism that can be assigned to the species Mycobacterium leprae.Mycobacterium leprae
MYCOBACTERIUM MARINUMC86545MYCOBACTERIUM BALNEIAny bacterial organism that can be assigned to the species Mycobacterium marinum.Mycobacterium marinum
MYCOBACTERIUM MICROTIC85548Any bacterial organism that can be assigned to the species Mycobacterium microti.Mycobacterium microti
MYCOBACTERIUM PEREGRINUMC86546Any bacterial organism that can be assigned to the species Mycobacterium peregrinum.Mycobacterium peregrinum
MYCOBACTERIUM SCROFULACEUMC86547Any bacterial organism that can be assigned to the species Mycobacterium scrofulaceum.Mycobacterium scrofulaceum
MYCOBACTERIUM SIMIAEC86548MYCOBACTERIUM HABANAAny bacterial organism that can be assigned to the species Mycobacterium simiae.Mycobacterium simiae
MYCOBACTERIUM SMEGMATISC86590Any bacterial organism that can be assigned to the species Mycobacterium smegmatis.Mycobacterium smegmatis
MYCOBACTERIUM SZULGAIC86591Any bacterial organism that can be assigned to the species Mycobacterium szulgai.Mycobacterium szulgai
MYCOBACTERIUM TERRAEC86592Any bacterial organism that can be assigned to the species Mycobacterium terrae.Mycobacterium terrae
MYCOBACTERIUM THERMORESISTIBILEC86593Any bacterial organism that can be assigned to the species Mycobacterium thermoresistibile.Mycobacterium thermoresistibile
MYCOBACTERIUM TUBERCULOSISC76370Any bacterial organism that can be assigned to the species Mycobacterium tuberculosis.Mycobacterium tuberculosis
MYCOBACTERIUM TUBERCULOSIS COMPLEXC86594A non-taxonomic grouping of bacteria assigned to the Mycobacterium genus, which includes the related species M. tuberculosis, M. africanum, M. bovis, and M. microti.Mycobacterium tuberculosis Complex
MYCOBACTERIUM ULCERANSC86595MYCOBACTERIUM BURULIAny bacterial organism that can be assigned to the species Mycobacterium ulcerans.Mycobacterium ulcerans
MYCOPLASMAC73540Any bacteria that is not assigned to the species level but can be assigned to the Mycoplasma genus level.Mycoplasma
MYCOPLASMA HOMINISC86597Any bacterial organism that can be assigned to the species Mycoplasma hominis.Mycoplasma hominis
MYCOPLASMA ORALEC86598Any bacterial organism that can be assigned to the species Mycoplasma orale.Mycoplasma orale
MYCOPLASMA PNEUMONIAEC86599Any bacterial organism that can be assigned to the species Mycoplasma pneumoniae.Mycoplasma pneumoniae
MYROIDESC86953Any bacteria that is not assigned to the species level but can be assigned to the Myroides genus level.Myroides
MYROIDES ODORATUSC86954FLAVOBACTERIUM ODORATUMAny bacterial organism that can be assigned to the species Myroides odoratus.Myroides odoratus
NAIROVIRUSC112358Any viral organism that can be assigned to the genus Nairovirus.Nairovirus
NEISSERIAC76371Any bacteria that is not assigned to the species level but can be assigned to the Neisseria genus level.Neisseria
NEISSERIA CANISC86600Any bacterial organism that can be assigned to the species Neisseria canis.Neisseria canis
NEISSERIA CINEREAC86601MICROCOCCUS CINEREUSAny bacterial organism that can be assigned to the species Neisseria cinerea.Neisseria cinerea
NEISSERIA FLAVESCENSC86602Any bacterial organism that can be assigned to the species Neisseria flavescens.Neisseria flavescens
NEISSERIA GONORRHOEAEC86603Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae.Neisseria gonorrhoeae
NEISSERIA LACTAMICAC86604Any bacterial organism that can be assigned to the species Neisseria lactamica.Neisseria lactamica
NEISSERIA MENINGITIDISC86605BETA-LACTAMASE NEGATIVE NEISSERIA MENINGITIDISAny bacterial organism that can be assigned to the species Neisseria meningitidis.Neisseria meningitidis
NEISSERIA MUCOSAC86606Any bacterial organism that can be assigned to the species Neisseria mucosa.Neisseria mucosa
NEISSERIA POLYSACCHAREAC86607Any bacterial organism that can be assigned to the species Neisseria polysaccharea.Neisseria polysaccharea
NEISSERIA SICCAC86608Any bacterial organism that can be assigned to the species Neisseria sicca.Neisseria sicca
NEISSERIA SUBFLAVAC86609Any bacterial organism that can be assigned to the species Neisseria subflava.Neisseria subflava
NEISSERIA WEAVERIIC86610CDC GROUP M-5Any bacterial organism that can be assigned to the species Neisseria weaverii.Neisseria weaverii
NEWCASTLE DISEASE VIRUSC93023Avian Paramyxovirus Type 1;NDVAny viral organism that can be assigned to the species Newcastle disease virus.Newcastle Disease Virus
NIPAH VIRUSC112359NiVAny viral organism that can be assigned to the species Nipah virus.Nipah Virus
NOCARDIAC76372Any bacteria that is not assigned to the species level but can be assigned to the Nocardia genus level.Nocardia
NOCARDIA ASTEROIDESC86611Any bacterial organism that can be assigned to the species Nocardia asteroides.Nocardia asteroides
NOCARDIA ASTEROIDES COMPLEXC86612A non-taxonomic grouping of bacteria assigned to and including at least four related species from the Nocardia genus.Nocardia asteroides Complex
NOCARDIA BRASILIENSISC86613Any bacterial organism that can be assigned to the species Nocardia brasiliensis.Nocardia brasiliensis
NOCARDIA DASSONVILLEIC86614Any bacterial organism that can be assigned to the species Nocardia dassonvillei.Nocardia dassonvillei
NOCARDIA FARCINICAC86615Any bacterial organism that can be assigned to the species Nocardia farcinica.Nocardia farcinica
NOCARDIA NOVAC86616Any bacterial organism that can be assigned to the species Nocardia nova.Nocardia nova
NOCARDIA OTITIDISCAVIARUMC86617NOCARDIA CAVIAEAny bacterial organism that can be assigned to the species Nocardia otitidiscaviarum.Nocardia otitidiscaviarum
NON-FERMENTATIVE GRAM-NEGATIVE BACILLUSC86618NON-FERMENTATIVE GRAM-NEGATIVE RODAny rod-shaped, anaerobic bacteria that cannot convert carbohydrates into acids and alcohols and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique.Non-Fermentative Gram Negative Bacillus
NOROVIRUSC112362NoV;Norwalk-like virusAny viral organism that can be assigned to the genus Norovirus.Norovirus
NORWALK VIRUSC112363NV;Norwalk calicivirusAny viral organism that can be assigned to the species Norwalk virus.Norwalk Virus
OCHROBACTRUMC86619Any bacteria that is not assigned to the species level but can be assigned to the Ochrobactrum genus level.Ochrobactrum
OCHROBACTRUM ANTHROPIC86620ACHROMOBACTER SUBSP. BIOTYPE 1Any bacterial organism that can be assigned to the species Ochrobactrum anthropi.Ochrobactrum anthropi
OCHROBACTRUM INTERMEDIUMC86621Any bacterial organism that can be assigned to the species Ochrobactrum intermedium.Ochrobactrum intermedium
ODORIBACTER SPLANCHNICUSC86176BACTEROIDES SPLANCHNICUSAny bacterial organism that can be assigned to the species Odoribacter splanchnicus.Bacteroides splanchnicus
OERSKOVIAC86622Any bacteria that is not assigned to the species level but can be assigned to the Oerskovia genus level.Oerskovia
OERSKOVIA TURBATAC86623Any bacterial organism that can be assigned to the species Oerskovia turbata.Oerskovia turbata
OLIGELLAC86624Any bacteria that is not assigned to the species level but can be assigned to the Oligella genus level.Oligella
OLIGELLA UREOLYTICAC86625CDC GROUP IVEAny bacterial organism that can be assigned to the species Oligella ureolytica.Oligella ureolytica
OLIGELLA URETHRALISC86626CDC GROUP M-4Any bacterial organism that can be assigned to the species Oligella urethralis.Oligella urethralis
OLSENELLAC86627Any bacteria that is not assigned to the species level but can be assigned to the Olsenella genus level.Olsenella
OLSENELLA ULIC86628LACTOBACILLUS ULIAny bacterial organism that can be assigned to the species Olsenella uli.Olsenella uli
ORBIVIRUSC112365Any viral organism that can be assigned to the genus Orbivirus.Orbivirus
ORTHOBUNYAVIRUSC112366BunyavirusAny viral organism that can be assigned to the genus Orthobunyavirus.Orthobunyavirus
ORTHOPOXVIRUSC96524Any viral organism that can be assigned to the genus Orthopoxvirus.Orthopoxvirus
PANDORAEAC86629Any bacteria that is not assigned to the species level but can be assigned to the Pandoraea genus level.Pandoraea
PANDORAEA PNOMENUSAC86630Any bacterial organism that can be assigned to the species Pandoraea pnomenusa.Pandoraea pnomenusa
PANDORAEA SPUTORUMC119327Any bacterial organism that can be assigned to the species Pandoraea sputorum.Pandoraea sputorum
PANNONIBACTER PHRAGMITETUSC119328Achromobacter group B;Achromobacter group EAny bacterial organism that can be assigned to the species Pannonibacter phragmitetus.Pannonibacter phragmitetus
PANTOEAC86631Any bacteria that is not assigned to the species level but can be assigned to the Pantoea genus level.Pantoea
PANTOEA AGGLOMERANSC86632ENTEROBACTER AGGLOMERANSAny bacterial organism that can be assigned to the species Pantoea agglomerans.Pantoea agglomerans
PARABACTEROIDESC86633Any bacteria that is not assigned to the species level but can be assigned to the Parabacteroides genus level.Parabacteroides
PARABACTEROIDES DISTASONISC86634BACTEROIDES DISTASONISAny bacterial organism that can be assigned to the species Parabacteroides distasonis.Parabacteroides distasonis
PARABACTEROIDES MERDAEC86635BACTEROIDES FRAGILIS T4-1;BACTEROIDES MERDAEAny bacterial organism that can be assigned to the species Parabacteroides merdae.Parabacteroides merdae
PARAPOXVIRUSC112367Any viral organism that can be assigned to the genus Parapoxvirus.Parapoxvirus
PARVIMONASC86900Any bacteria that is not assigned to the species level but can be assigned to the Parvimonas genus level.Parvimonas
PARVIMONAS MICRAC86901MICROMONAS MICROS;PEPTOSTREPTOCOCCUS MICROSAny bacterial organism that can be assigned to the species Parvimonas micra.Parvimonas micra
PASTEURELLAC86636Any bacteria that is not assigned to the species level but can be assigned to the Pasteurella genus level.Pasteurella
PASTEURELLA AEROGENESC86637Any bacterial organism that can be assigned to the species Pasteurella aerogenes.Pasteurella aerogenes
PASTEURELLA BETTYAEC86638CDC GROUP HB-5Any bacterial organism that can be assigned to the species Pasteurella bettyae.Pasteurella bettyae
PASTEURELLA CANISC86639PASTEURELLA MULTOCIDA BIOTYPE 6Any bacterial organism that can be assigned to the species Pasteurella canis.Pasteurella canis
PASTEURELLA MULTOCIDAC76373PASTEURELLA SEPTICAAny bacterial organism that can be assigned to the species Pasteurella multocida.Pasteurella multocida
PASTEURELLA PNEUMOTROPICAC86640Any bacterial organism that can be assigned to the species Pasteurella pneumotropica.Pasteurella pneumotropica
PEDIOCOCCUSC86641Any bacteria that is not assigned to the species level but can be assigned to the Pediococcus genus level.Pediococcus
PEPTOCOCCUSC86642Any bacteria that is not assigned to the species level but can be assigned to the Peptococcus genus level.Peptococcus
PEPTOCOCCUS NIGERC86643MICROCOCCUS NIGERAny bacterial organism that can be assigned to the species Peptococcus niger.Peptococcus niger
PEPTONIPHILUSC86902Any bacteria that is not assigned to the species level but can be assigned to the Peptoniphilus genus level.Peptoniphilus
PEPTONIPHILUS ASACCHAROLYTICUSC86903PEPTOCOCCUS ASACCHAROLYTICUS;PEPTOSTREPTOCOCCUS ASACCHAROLYTICUSAny bacterial organism that can be assigned to the species Peptoniphilus asaccharolyticus.Peptoniphilus asaccharolyticus
PEPTONIPHILUS HAREIC114245Peptostreptococcus harei;Schleiferella hareiAny bacterial organism that can be assigned to the species Peptoniphilus harei.Peptoniphilus harei
PEPTONIPHILUS INDOLICUSC86904PEPTOSTREPTOCOCCUS INDOLICUSAny bacterial organism that can be assigned to the species Peptoniphilus indolicus.Peptoniphilus indolicus
PEPTOSTREPTOCOCCUSC86644Any bacteria that is not assigned to the species level but can be assigned to the Peptostreptococcus genus level.Peptostreptococcus
PEPTOSTREPTOCOCCUS ANAEROBIUSC86645Any bacterial organism that can be assigned to the species Peptostreptococcus anaerobius.Peptostreptococcus anaerobius
PEPTOSTREPTOCOCCUS STOMATISC119329Any bacterial organism that can be assigned to the species Peptostreptococcus stomatis.Peptostreptococcus stomatis
PHLEBOVIRUSC112397Any viral organism that can be assigned to the genus Phlebovirus.Phlebovirus
PHOTOBACTERIUMC86646Any bacteria that is not assigned to the species level but can be assigned to the Photobacterium genus level.Photobacterium
PHOTOBACTERIUM DAMSELAEC86647CDC GROUP EF-5;PHOTOBACTERIUM DAMSELAE SUBSP. DAMSELAE;VIBRIO DAMSELAAny bacterial organism that can be assigned to the species Photobacterium damselae.Photobacterium damselae
PHOTORHABDUSC86648Any bacteria that is not assigned to the species level but can be assigned to the Photorhabdus genus level.Photorhabdus
PHOTORHABDUS LUMINESCENSC86649Any bacterial organism that can be assigned to the species Photorhabdus luminescens.Photorhabdus luminescens
PICHIA KLUYVERIC114270P. kluyveriAny fungal organism that can be assigned to the species Pichia kluyveri.Pichia kluyveri
PICHIA KUDRIAVZEVIIC77173C. krusei;Candida krusei;I. orientalis;Issatchenkia orientalis;P. kudriavzeviiAny fungal organism that can be assigned to the species Pichia kudriavzevii.Candida krusei
PICHIA NORVEGENSISC114259C. mycoderma var. annulata;Candida mycoderma var. annulata;P. norvegensisAny fungal organism that can be assigned to the species Pichia norvegensis.Pichia norvegensis
PLANOCOCCUSC86650Any bacteria that is not assigned to the species level but can be assigned to the Planococcus genus level.Planococcus
PLESIOMONASC86651Any bacteria that is not assigned to the species level but can be assigned to the Plesiomonas genus level.Plesiomonas
PLESIOMONAS SHIGELLOIDESC86652AEROMONAS SHIGELLOIDESAny bacterial organism that can be assigned to the species Plesiomonas shigelloides.Plesiomonas shigelloides
PNEUMOVIRUSC112398Any viral organism that can be assigned to the genus Pneumovirus.Pneumovirus
POLIOVIRUSC14259Enterovirus C;Human enterovirus CAny viral organism that can be assigned to the species Poliovirus.Poliovirus
POLYOMAVIRUSC14260Any viral organism that can be assigned to the genus Polyomavirus.Polyomavirus
PORPHYROMONASC86653Any bacteria that is not assigned to the species level but can be assigned to the Porphyromonas genus level.Porphyromonas
PORPHYROMONAS ASACCHAROLYTICAC86654BACTEROIDES ASACCHAROLYTICUSAny bacterial organism that can be assigned to the species Porphyromonas asaccharolytica.Porphyromonas asaccharolytica
PORPHYROMONAS CATONIAEC86655Any bacterial organism that can be assigned to the species Porphyromonas catoniae.Porphyromonas catoniae
PORPHYROMONAS ENDODONTALISC86656BACTEROIDES ENDODONTALISAny bacterial organism that can be assigned to the species Porphyromonas endodontalis.Porphyromonas endodontalis
PORPHYROMONAS GINGIVALISC86657BACTEROIDES GINGIVALISAny bacterial organism that can be assigned to the species Porphyromonas gingivalis.Porphyromonas gingivalis
PORPHYROMONAS LEVIIC86658BACTEROIDES LEVII;BACTEROIDES MELANINOGENICUS SUBSP. LEVIIAny bacterial organism that can be assigned to the species Porphyromonas levii.Porphyromonas levii
PORPHYROMONAS SOMERAEC86659Any bacterial organism that can be assigned to the species Porphyromonas somerae.Porphyromonas somerae
PREVOTELLAC86660Any bacteria that is not assigned to the species level but can be assigned to the Prevotella genus level.Prevotella
PREVOTELLA BERGENSISC119330Any bacterial organism that can be assigned to the species Prevotella bergensis.Prevotella bergensis
PREVOTELLA BIVIAC86661BACTEROIDES BIVIAAny bacterial organism that can be assigned to the species Prevotella bivia.Prevotella bivia
PREVOTELLA BREVISC86662BACTEROIDES RUMINICOLA SUBSP. BREVIS;BACTEROIDES RUMINICOLA SUBSP. BREVUSAny bacterial organism that can be assigned to the species Prevotella brevis.Prevotella brevis
PREVOTELLA BUCCAEC86663BACTEROIDES BUCCAEAny bacterial organism that can be assigned to the species Prevotella buccae.Prevotella buccae
PREVOTELLA BUCCALISC86664Any bacterial organism that can be assigned to the species Prevotella buccalis.Prevotella buccalis
PREVOTELLA CORPORISC86665Any bacterial organism that can be assigned to the species Prevotella corporis.Prevotella corporis
PREVOTELLA DENTALISC86666Any bacterial organism that can be assigned to the species Prevotella dentalis.Prevotella dentalis
PREVOTELLA DENTICOLAC86667BACTEROIDES DENTICOLAAny bacterial organism that can be assigned to the species Prevotella denticola.Prevotella denticola
PREVOTELLA DISIENSC86668BACTEROIDES DISIENSAny bacterial organism that can be assigned to the species Prevotella disiens.Prevotella disiens
PREVOTELLA HEPARINOLYTICAC86669BACTEROIDES HEPARINOLYTICUSAny bacterial organism that can be assigned to the species Prevotella heparinolytica.Prevotella heparinolytica
PREVOTELLA INTERMEDIAC86670BACTEROIDES INTERMEDIAAny bacterial organism that can be assigned to the species Prevotella intermedia.Prevotella intermedia
PREVOTELLA INTERMEDIA/NIGRESCENS GROUPC86671A non-taxonomic grouping of bacteria assigned to the Prevotella genus that include the P. intermedia and P. nigrescens species.Prevotella intermedia/nigrescens Group
PREVOTELLA LOESCHEIIC86672Any bacterial organism that can be assigned to the species Prevotella loescheii.Prevotella loescheii
PREVOTELLA MELANINOGENICAC86673BACTEROIDES MELANINOGENICUSAny bacterial organism that can be assigned to the species Prevotella melaninogenica.Prevotella melaninogenica
PREVOTELLA NIGRESCENSC86674Any bacterial organism that can be assigned to the species Prevotella nigrescens.Prevotella nigrescens
PREVOTELLA ORALISC86675BACTEROIDES ORALISAny bacterial organism that can be assigned to the species Prevotella oralis.Prevotella oralis
PREVOTELLA ORISC86676BACTEROIDES ORISAny bacterial organism that can be assigned to the species Prevotella oris.Prevotella oris
PREVOTELLA RUMINICOLAC86677BACTEROIDES RUMINICOLAAny bacterial organism that can be assigned to the species Prevotella ruminicola.Prevotella ruminicola
PREVOTELLA TANNERAEC86678Any bacterial organism that can be assigned to the species Prevotella tannerae.Prevotella tannerae
PREVOTELLA VERORALISC86679Any bacterial organism that can be assigned to the species Prevotella veroralis.Prevotella veroralis
PROPIONIBACTERIUMC86013Any bacteria that is not assigned to the species level but can be assigned to the Propionibacterium genus level.Propionibacterium
PROPIONIBACTERIUM ACNESC14378BACILLUS ACNES;C. PARVUM;CORYNEBACTERIUM ACNES;CORYNEBACTERIUM PARVUM;CPARVAny bacterial organism that can be assigned to the species Propionibacterium acnes.Propionibacterium acnes
PROPIONIBACTERIUM AVIDUMC86681Any bacterial organism that can be assigned to the species Propionibacterium avidum.Propionibacterium avidum
PROPIONIBACTERIUM GRANULOSUMC86682CORYNEBACTERIUM GRANULOSUMAny bacterial organism that can be assigned to the species Propionibacterium granulosum.Propionibacterium granulosum
PROPIONIBACTERIUM PROPIONICUMC86683ACTINOMYCES PROPIONICUSAny bacterial organism that can be assigned to the species Propionibacterium propionicum.Propionibacterium propionicum
PROTEUSC76374Any bacteria that is not assigned to the species level but can be assigned to the Proteus genus level.Proteus
PROTEUS HAUSERIC86684Any bacterial organism that can be assigned to the species Proteus hauseri.Proteus hauseri
PROTEUS INCONSTANSC84582PROVIDENCIA INCONSTANSAny bacterial organism that can be assigned to the species Proteus inconstans.Proteus inconstans
PROTEUS MIRABILISC86019Any bacterial organism that can be assigned to the species Proteus mirabilis.Proteus mirabilis
PROTEUS MYXOFACIENSC86687Any bacterial organism that can be assigned to the species Proteus myxofaciens.Proteus myxofaciens
PROTEUS PENNERIC86688INDOLE NEGATIVE PROTEUS VULGARISAny bacterial organism that can be assigned to the species Proteus penneri.Proteus penneri
PROTEUS VULGARISC85250Any bacterial organism that can be assigned to the species Proteus vulgaris.Proteus vulgaris
PROTOTHECA WICKERHAMIIC114271P. wickerhamiiAny algal organism that can be assigned to the species Prototheca wickerhamii.Prototheca wickerhamii
PROVIDENCIAC86690Any bacteria that is not assigned to the species level but can be assigned to the Providencia genus level.Providencia
PROVIDENCIA ALCALIFACIENSC86691Any bacterial organism that can be assigned to the species Providencia alcalifaciens.Providencia alcalifaciens
PROVIDENCIA HEIMBACHAEC86692Any bacterial organism that can be assigned to the species Providencia heimbachae.Providencia heimbachae
PROVIDENCIA RETTGERIC86693Any bacterial organism that can be assigned to the species Providencia rettgeri.Proteus rettgeri
PROVIDENCIA RUSTIGIANIIC86694PROVIDENCIA ALCALIFACIENS BIOGROUP 3Any bacterial organism that can be assigned to the species Providencia rustigianii.Providencia rustigianii
PROVIDENCIA STUARTIIC86695Any bacterial organism that can be assigned to the species Providencia stuartii.Providencia stuartii
PSEUDOCOWPOX VIRUSC112401Paravaccinia virus;PseudocowpoxvirusAny viral organism that can be assigned to the species Pseudocowpox virus.Pseudocowpox Virus
PSEUDOMONASC76375Any bacteria that is not assigned to the species level but can be assigned to the Pseudomonas genus level.Pseudomonas
PSEUDOMONAS AERUGINOSAC86696Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa.Pseudomonas aeruginosa
PSEUDOMONAS ALCALIGENESC86697Any bacterial organism that can be assigned to the species Pseudomonas alcaligenes.Pseudomonas alcaligenes
PSEUDOMONAS CHLORORAPHISC86699Any bacterial organism that can be assigned to the species Pseudomonas chlororaphis.Pseudomonas chlororaphis
PSEUDOMONAS FLUORESCENS/PUTIDA GROUPC86962A non-taxonomic grouping of bacteria assigned to the Pseudomonas genus that include the P. fluorescens and P. putida species.Pseudomonas fluorescens/putida Group
PSEUDOMONAS LUTEOLAC86701CHRYSEOMONAS LUTEOLAAny bacterial organism that can be assigned to the species Pseudomonas luteola.Pseudomonas luteola
PSEUDOMONAS MENDOCINAC86702CDC GROUP VB-2Any bacterial organism that can be assigned to the species Pseudomonas mendocina.Pseudomonas mendocina
PSEUDOMONAS MOSSELIIC86703Any bacterial organism that can be assigned to the species Pseudomonas mosselii.Pseudomonas mosselii
PSEUDOMONAS ORYZIHABITANSC76319FLAVIMONAS ORYZIHABITANSAny bacterial organism that can be assigned to the species Pseudomonas oryzihabitans.Pseudomonas oryzihabitans
PSEUDOMONAS PSEUDOALCALIGENESC86704PSEUDOMONAS ALCALIGENES BIOTYPE BAny bacterial organism that can be assigned to the species Pseudomonas pseudoalcaligenes.Pseudomonas pseudoalcaligenes
PSEUDOMONAS PUTIDAC86705Any bacterial organism that can be assigned to the species Pseudomonas putida.Pseudomonas putida
PSEUDOMONAS STUTZERIC86706PSEUDOMONAS GROUP VB-1Any bacterial organism that can be assigned to the species Pseudomonas stutzeri.Pseudomonas stutzeri
PSYCHROBACTERC86707Any bacteria that is not assigned to the species level but can be assigned to the Psychrobacter genus level.Psychrobacter
PSYCHROBACTER IMMOBILISC86708Any bacterial organism that can be assigned to the species Psychrobacter immobilis.Psychrobacter immobilis
PSYCHROBACTER PHENYLPYRUVICUSC86709CDC GROUP M-2;MORAXELLA PHENYLPYRUVICAAny bacterial organism that can be assigned to the species Psychrobacter phenylpyruvicus.Psychrobacter phenylpyruvicus
RABIES VIRUSC112405Any viral organism that can be assigned to the species Rabies virus.Rabies Virus
RAHNELLAC86710Any bacteria that is not assigned to the species level but can be assigned to the Rahnella genus level.Rahnella
RAHNELLA AQUATILISC86711Any bacterial organism that can be assigned to the species Rahnella aquatilis.Rahnella aquatilis
RALSTONIAC86712Any bacteria that is not assigned to the species level but can be assigned to the Ralstonia genus level.Ralstonia
RALSTONIA MANNITOLILYTICAC111302Any bacterial organism that can be assigned to the species Ralstonia mannitolilytica.Ralstonia mannitolilytica
RALSTONIA PICKETTIIC86713BURKHOLDERIA PICKETTII;PSEUDOMONAS PICKETTIIAny bacterial organism that can be assigned to the species Ralstonia pickettii.Ralstonia pickettii
RAOULTELLAC86714Any bacteria that is not assigned to the species level but can be assigned to the Raoultella genus level.Raoultella
RAOULTELLA ORNITHINOLYTICAC86715KLEBSIELLA ORNITHINOLYTICAAny bacterial organism that can be assigned to the species Raoultella ornithinolytica.Raoultella ornithinolytica
RAOULTELLA PLANTICOLAC86716Any bacterial organism that can be assigned to the species Raoultella planticola.Raoultella planticola
RAOULTELLA TERRIGENAC86717KLEBSIELLA TERRIGENAAny bacterial organism that can be assigned to the species Raoultella terrigena.Raoultella terrigena
RESPIROVIRUSC14310ParamyxovirusAny viral organism that can be assigned to the genus Paramyxovirus.Paramyxovirus
RHINOVIRUS AC112407Human Rhinovirus AAny viral organism that can be assigned to the species Rhinovirus A.Rhinovirus A
RHINOVIRUS BC112408Human Rhinovirus BAny viral organism that can be assigned to the species Rhinovirus B.Rhinovirus B
RHINOVIRUS CC112409Human Rhinovirus CAny viral organism that can be assigned to the species Rhinovirus C.Rhinovirus C
RHIZOBIUMC86718Any bacteria that is not assigned to the species level but can be assigned to the Rhizobium genus level.Rhizobium
RHODOCOCCUSC76378Any bacteria that is not assigned to the species level but can be assigned to the Rhodococcus genus level.Rhodococcus
RHODOCOCCUS EQUIC86719CORYNEBACTERIUM EQUIAny bacterial organism that can be assigned to the species Rhodococcus equi.Rhodococcus equi
RHODOTORULA GLUTINISC114264R. glutinisAny fungal organism that can be assigned to the species Rhodotorula glutinis.Rhodotorula glutinis
RHODOTORULA MUCILAGINOSAC86027R. mucilaginosa;R. pilimanae;R. rubra;Rhodotorula pilimanae;Rhodotorula rubra;S. albo-rubescens;Sporobolomyces albo-rubescensAny fungal organism that can be assigned to the species Rhodotorula mucilaginosa.Rhodotorula mucilaginosa
RICKETTSIAC76379Any bacteria that is not assigned to the species level but can be assigned to the Rickettsia genus level.Rickettsia
RICKETTSIA AFRICAEC86720Any bacterial organism that can be assigned to the species Rickettsia africae.Rickettsia africae
RICKETTSIA FELISC86721Any bacterial organism that can be assigned to the species Rickettsia felis.Rickettsia felis
RICKETTSIA JAPONICAC86722Any bacterial organism that can be assigned to the species Rickettsia japonica.Rickettsia japonica
RICKETTSIA PROWAZEKIIC86723Any bacterial organism that can be assigned to the species Rickettsia prowazekii.Rickettsia prowazekii
RICKETTSIA RICKETTSIIC86724Any bacterial organism that can be assigned to the species Rickettsia rickettsii.Rickettsia rickettsii
RICKETTSIA TYPHIC86725Any bacterial organism that can be assigned to the species Rickettsia typhi.Rickettsia typhi
ROSEOLOVIRUSC112410Any viral organism that can be assigned to the genus Roseolovirus.Roseolovirus
ROSEOMONASC86726Any bacteria that is not assigned to the species level but can be assigned to the Roseomonas genus level.Roseomonas
ROSS RIVER VIRUSC112411RRVAny viral organism that can be assigned to the species Ross River virus.Ross River Virus
ROTAVIRUSC77199Any viral organism that can be assigned to the genus Rotavirus.Rotavirus
ROTHIAC86727Any bacteria that is not assigned to the species level but can be assigned to the Rothia genus level.Rothia
ROTHIA DENTOCARIOSAC86728NOCARDIA DENTOCARIOSAAny bacterial organism that can be assigned to the species Rothia dentocariosa.Rothia dentocariosa
ROTHIA MUCILAGINOSAC76382STOMATOCOCCUS MUCILAGINOSUSAny bacterial organism that can be assigned to the species Rothia mucilaginosa.Rothia mucilaginosa
RUBELLA VIRUSC77198German Measles VirusAny viral organism that can be assigned to the species Rubella virus.Rubella Virus
RUBIVIRUSC112414Any viral organism that can be assigned to the genus Rubivirus.Rubivirus
RUBULAVIRUSC14326Any viral organism that can be assigned to the genus Rubulavirus.Rubulavirus
RUMINOCOCCUSC86729Any bacteria that is not assigned to the species level but can be assigned to the Ruminococcus genus level.Ruminococcus
RUMINOCOCCUS PRODUCTUSC86730PEPTOSTREPTOCOCCUS PRODUCTUSAny bacterial organism that can be assigned to the species Ruminococcus productus.Ruminococcus productus
SACCHAROMYCES CEREVISIAEC14271Bakers Yeast;Brewers Yeast;S. capensis;S. cerevisiae;S. italicus;S. oviformis;S. uvarum var. melibiosus;Saccharomyces capensis;Saccharomyces italicus;Saccharomyces oviformis;Saccharomyces uvarum var. melibiosusAny fungal organism that can be assigned to the species Saccharomyces cerevisiae.Saccharomyces cerevisiae
SALMONELLAC76380SALMONELLA SEROGROUP D (NOT S. TYPHI)Any bacteria that is not assigned to the species level but can be assigned to the Salmonella genus level.Salmonella
SALMONELLA BONGORIC91842Any bacterial organism that can be assigned to the species Salmonella bongori.Salmonella bongori
SALMONELLA ENTERICAC86731Any bacterial organism that can be assigned to the species Salmonella enterica.Salmonella enterica
SALMONELLA ENTERICA SUBSP. ARIZONAEC86910Any bacterial organism that can be assigned to the species Salmonella enterica subspecies arizonae.Salmonella enterica subsp arizonae
SALMONELLA ENTERICA SUBSP. DIARIZONAEC91844Any bacterial organism that can be assigned to the species Salmonella enterica subspecies diarizonae.Salmonella enterica subsp diarizonae
SALMONELLA ENTERICA SUBSP. ENTERICAC86913Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica.Salmonella enterica subsp enterica
SALMONELLA ENTERICA SUBSP. HOUTENAEC91845Any bacterial organism that can be assigned to the species Salmonella enterica subspecies houtenae.Salmonella enterica subsp houtenae
SALMONELLA ENTERICA SUBSP. INDICAC91846Any bacterial organism that can be assigned to the species Salmonella enterica subspecies indica.Salmonella enterica subsp indica
SALMONELLA ENTERICA SUBSP. SALAMAEC91847Any bacterial organism that can be assigned to the species Salmonella enterica subspecies salamae.Salmonella enterica subsp salamae
SALMONELLA SEROTYPE CHOLERAESUISC86915Any bacterial organism that can be assigned to the genus Salmonella with serotype Choleraesuis.Salmonella Serotype Choleraesuis
SALMONELLA SEROTYPE DUBLINC86918Any bacterial organism that can be assigned to the genus Salmonella with serotype Dublin.Salmonella Serotype Dublin
SALMONELLA SEROTYPE ENTERITIDISC86919Any bacterial organism that can be assigned to the genus Salmonella with serotype Enteritidis.Salmonella Serotype Enteritidis
SALMONELLA SEROTYPE NEWPORTC86921Any bacterial organism that can be assigned to the genus Salmonella with serotype Newport.Salmonella Serotype Newport
SALMONELLA SEROTYPE PARATYPHI AC86922Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi A.Salmonella Serotype Paratyphi A
SALMONELLA SEROTYPE PARATYPHI BC86924Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi B.Salmonella Serotype Paratyphi B
SALMONELLA SEROTYPE PARATYPHI CC86925Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi C.Salmonella Serotype Paratyphi C
SALMONELLA SEROTYPE TYPHIC86926Any bacterial organism that can be assigned to the genus Salmonella with serotype Typhi.Salmonella Serotype Typhi
SALMONELLA SEROTYPE TYPHIMURIUMC86927Any bacterial organism that can be assigned to the genus Salmonella with serotype Typhimurium.Salmonella Serotype Typhimurium
SAPOVIRUSC112029Any viral organism that can be assigned to the genus Sapovirus.Sapovirus
SAPPORO VIRUSC112415Human calicivirus SLV;Human calicivirus Sapporo-like VirusAny viral organism that can be assigned to the species Sapporo virus.Sapporo Virus
SARS CORONAVIRUSC112432HCoV-SARS;SARS;Severe Acute Respiratory Syndrome CoronavirusAny viral organism that can be assigned to the species SARS coronavirus.SARS Coronavirus
SELENOMONASC86732Any bacteria that is not assigned to the species level but can be assigned to the Selenomonas genus level.Selenomonas
SELENOMONAS NOXIAC86733Any bacterial organism that can be assigned to the species Selenomonas noxia.Selenomonas noxia
SELENOMONAS SPUTIGENAC86734Any bacterial organism that can be assigned to the species Selenomonas sputigena.Selenomonas sputigena
SERRATIAC86010SERRATIAAny bacteria that is not assigned to the species level but can be assigned to the Serratia genus level.Serratia
SERRATIA FICARIAC86736Any bacterial organism that can be assigned to the species Serratia ficaria.Serratia ficaria
SERRATIA FONTICOLAC86737Any bacterial organism that can be assigned to the species Serratia fonticola.Serratia fonticola
SERRATIA LIQUEFACIENSC86738ENTEROBACTER LIQUEFACIENSAny bacterial organism that can be assigned to the species Serratia liquefaciens.Serratia liquefaciens
SERRATIA MARCESCENSC14272S. MARCESCENSAny bacterial organism that can be assigned to the species Serratia marcescens.Serratia marcescens
SERRATIA ODORIFERAC86739Any bacterial organism that can be assigned to the species Serratia odorifera.Serratia odorifera
SERRATIA PLYMUTHICAC86740Any bacterial organism that can be assigned to the species Serratia plymuthica.Serratia plymuthica
SERRATIA RUBIDAEAC86741SERRATIA MARINORUBRAAny bacterial organism that can be assigned to the species Serratia rubidaea.Serratia rubidaea
SHEWANELLAC86742Any bacteria that is not assigned to the species level but can be assigned to the Shewanella genus level.Shewanella
SHEWANELLA PUTREFACIENSC86743ALTEROMONAS PUTREFACIENS;PSEUDOMONAS PUTREFACIENSAny bacterial organism that can be assigned to the species Shewanella putrefaciens.Shewanella putrefaciens
SHIGELLAC76381Any bacteria that is not assigned to the species level but can be assigned to the Shigella genus level.Shigella
SHIGELLA BOYDIIC86744SHIGELLA BIOGROUP CAny bacterial organism that can be assigned to the species Shigella boydii.Shigella boydii
SHIGELLA DYSENTERIAEC86745SHIGELLA BIOGROUP AAny bacterial organism that can be assigned to the species Shigella dysenteriae.Shigella dysenteriae
SHIGELLA FLEXNERIC86746SHIGELLA BIOGROUP BAny bacterial organism that can be assigned to the species Shigella flexneri.Shigella flexneri
SHIGELLA SONNEIC86747SHIGELLA BIOGROUP DAny bacterial organism that can be assigned to the species Shigella sonnei.Shigella sonnei
SIMPLEXVIRUSC112419Human Herpes Simplex VirusAny viral organism that can be assigned to the genus Simplexvirus.Simplexvirus
SLACKIA EXIGUAC111313EUBACTERIUM EXIGUUMAny bacterial organism that can be assigned to the species Slackia exigua.Slackia exigua
SPHINGOBACTERIUMC86957Any bacteria that is not assigned to the species level but can be assigned to the Sphingobacterium genus level.Sphingobacterium
SPHINGOBACTERIUM MIZUTAIIC86958FLAVOBACTERIUM MIZUTAEAny bacterial organism that can be assigned to the species Sphingobacterium mizutaii.Sphingobacterium mizutaii
SPHINGOBACTERIUM MULTIVORUMC86959CDC GROUP IIK-2Any bacterial organism that can be assigned to the species Sphingobacterium multivorum.Sphingobacterium multivorum
SPHINGOBACTERIUM SPIRITIVORUMC86960CDC GROUP IIK-3Any bacterial organism that can be assigned to the species Sphingobacterium spiritivorum.Sphingobacterium spiritivorum
SPHINGOBACTERIUM THALPOPHILUMC86961FLAVOBACTERIUM THALPOPHILUMAny bacterial organism that can be assigned to the species Sphingobacterium thalpophilum.Sphingobacterium thalpophilum
SPHINGOMONASC86748Any bacteria that is not assigned to the species level but can be assigned to the Sphingomonas genus level.Sphingomonas
SPHINGOMONAS PAUCIMOBILISC86749CDC GROUP IIK-1;PSEUDOMONAS PAUCIMOBILISAny bacterial organism that can be assigned to the species Sphingomonas paucimobilis.Sphingomonas paucimobilis
STAPHYLOCOCCUSC62583Any bacteria that is not assigned to the species level but can be assigned to the Staphylococcus genus level.Staphylococcus
STAPHYLOCOCCUS ARLETTAEC86750Any bacterial organism that can be assigned to the species Staphylococcus arlettae.Staphylococcus arlettae
STAPHYLOCOCCUS AUREUSC50921STAPH. AUREUSAny bacterial organism that can be assigned to the species Staphylococcus aureus.Staphylococcus aureus
STAPHYLOCOCCUS AURICULARISC86751Any bacterial organism that can be assigned to the species Staphylococcus auricularis.Staphylococcus auricularis
STAPHYLOCOCCUS CAPITISC86752Any bacterial organism that can be assigned to the species Staphylococcus capitis.Staphylococcus capitis
STAPHYLOCOCCUS CAPRAEC86753Any bacterial organism that can be assigned to the species Staphylococcus caprae.Staphylococcus caprae
STAPHYLOCOCCUS CARNOSUSC86754Any bacterial organism that can be assigned to the species Staphylococcus carnosus.Staphylococcus carnosus
STAPHYLOCOCCUS CHROMOGENESC86755Any bacterial organism that can be assigned to the species Staphylococcus chromogenes.Staphylococcus chromogenes
STAPHYLOCOCCUS COHNIIC86756Any bacterial organism that can be assigned to the species Staphylococcus cohnii.Staphylococcus cohnii
STAPHYLOCOCCUS EPIDERMIDISC86757STAPHYLOCOCCUS ALBUSAny bacterial organism that can be assigned to the species Staphylococcus epidermidis.Staphylococcus epidermidis
STAPHYLOCOCCUS EQUORUMC86758Any bacterial organism that can be assigned to the species Staphylococcus equorum.Staphylococcus equorum
STAPHYLOCOCCUS FELISC86759Any bacterial organism that can be assigned to the species Staphylococcus felis.Staphylococcus felis
STAPHYLOCOCCUS GALLINARUMC86760Any bacterial organism that can be assigned to the species Staphylococcus gallinarum.Staphylococcus gallinarum
STAPHYLOCOCCUS HAEMOLYTICUSC86761STAPH. HAEMOLYTICUSAny bacterial organism that can be assigned to the species Staphylococcus haemolyticus.Staphylococcus haemolyticus
STAPHYLOCOCCUS HOMINISC86762COAGULASE NEGATIVE STAPHYLOCOCCUS HOMINISAny bacterial organism that can be assigned to the species Staphylococcus hominis.Staphylococcus hominis
STAPHYLOCOCCUS HYICUSC86763Any bacterial organism that can be assigned to the species Staphylococcus hyicus.Staphylococcus hyicus
STAPHYLOCOCCUS INTERMEDIUSC86764Any bacterial organism that can be assigned to the species Staphylococcus intermedius.Staphylococcus intermedius
STAPHYLOCOCCUS KLOOSIIC86765Any bacterial organism that can be assigned to the species Staphylococcus kloosii.Staphylococcus kloosii
STAPHYLOCOCCUS LENTUSC86766Any bacterial organism that can be assigned to the species Staphylococcus lentus.Staphylococcus lentus
STAPHYLOCOCCUS LUGDUNENSISC86767Any bacterial organism that can be assigned to the species Staphylococcus lugdunensis.Staphylococcus lugdunensis
STAPHYLOCOCCUS PASTEURIC86768Any bacterial organism that can be assigned to the species Staphylococcus pasteuri.Staphylococcus pasteuri
STAPHYLOCOCCUS SACCHAROLYTICUSC86769PEPTOCOCCUS SACCHAROLYTICUSAny bacterial organism that can be assigned to the species Staphylococcus saccharolyticus.Staphylococcus saccharolyticus
STAPHYLOCOCCUS SAPROPHYTICUSC86770MICROCOCCUS SUBGROUP 3Any bacterial organism that can be assigned to the species Staphylococcus saprophyticus.Staphylococcus saprophyticus
STAPHYLOCOCCUS SCHLEIFERIC86771Any bacterial organism that can be assigned to the species Staphylococcus schleiferi.Staphylococcus schleiferi
STAPHYLOCOCCUS SCIURIC86772Any bacterial organism that can be assigned to the species Staphylococcus sciuri.Staphylococcus sciuri
STAPHYLOCOCCUS SIMULANSC86773Any bacterial organism that can be assigned to the species Staphylococcus simulans.Staphylococcus simulans
STAPHYLOCOCCUS WARNERIC86774Any bacterial organism that can be assigned to the species Staphylococcus warneri.Staphylococcus warneri
STAPHYLOCOCCUS XYLOSUSC86775Any bacterial organism that can be assigned to the species Staphylococcus xylosus.Staphylococcus xylosus
STENOTROPHOMONASC86776STENOTROPHOMONASAny bacteria that is not assigned to the species level but can be assigned to the Stenotrophomonas genus level.Stenotrophomonas
STENOTROPHOMONAS MALTOPHILIAC76377PSEUDOMONAS MALTOPHILIA;XANTHOMONAS MALTOPHILIAAny bacterial organism that can be assigned to the species Stenotrophomonas maltophilia.Stenotrophomonas maltophilia
STREPTOBACILLUSC86777Any bacteria that is not assigned to the species level but can be assigned to the Streptobacillus genus level.Streptobacillus
STREPTOBACILLUS MONILIFORMISC86778HAVERHILLIA MULTIFORMISAny bacterial organism that can be assigned to the species Streptobacillus moniliformis.Streptobacillus moniliformis
STREPTOCOCCUSC76383STREPTOCOCCI SP.Any bacteria that is not assigned to the species level but can be assigned to the Streptococcus genus level.Streptococcus
STREPTOCOCCUS ACIDOMINIMUSC86779Any bacterial organism that can be assigned to the species Streptococcus acidominimus.Streptococcus acidominimus
STREPTOCOCCUS AGALACTIAEC86780STREPT. GP B(AGALACT)Any bacterial organism that can be assigned to the species Streptococcus agalactiae.Streptococcus agalactiae
STREPTOCOCCUS ALACTOLYTICUSC86781Any bacterial organism that can be assigned to the species Streptococcus alactolyticus.Streptococcus alactolyticus
STREPTOCOCCUS ALPHA-HEMOLYTICC86141ALPHA-HEMOLYTIC STREPTOCOCCUSA bacteria that is assigned to the genus Streptococcus that is able to reduce the iron content in hemoglobin in red blood cells, thus producing green-colored colonies on blood agar plates.Alpha-Hemolytic Streptococcus
STREPTOCOCCUS ANGINOSISC86782Any bacterial organism that can be assigned to the species Streptococcus anginosis.Streptococcus anginosis
STREPTOCOCCUS ANGINOSUS GROUPC86783A bacteria that belongs to the Anginosus group of the genus Streptococcus.Streptococcus anginosus Group
STREPTOCOCCUS BETA-HEMOLYTICC86190BETA-HEMOLYTIC STREPTOCOCCUSA bacteria that is assigned to the genus Streptococcus that is able to facilitate the complete rupturing of red blood cells, thus producing wide, clear, zones around colonies on blood agar plates.Beta-Hemolytic Streptococcus
STREPTOCOCCUS BOVISC86784Any bacterial organism that can be assigned to the species Streptococcus bovis.Streptococcus bovis
STREPTOCOCCUS BOVIS GROUPC86785A bacteria that belongs to the Bovis group of the genus Streptococcus.Streptococcus bovis Group
STREPTOCOCCUS CANISC86786STREPTOCOCCUS DYSGALACTIAEAny bacterial organism that can be assigned to the species Streptococcus canis.Streptococcus canis
STREPTOCOCCUS CONSTELLATUSC86787Any bacterial organism that can be assigned to the species Streptococcus constellatus.Streptococcus constellatus
STREPTOCOCCUS CRISTATUSC86788Any bacterial organism that can be assigned to the species Streptococcus cristatus.Streptococcus cristatus
STREPTOCOCCUS DYSGALACTIAE SUBSP. DYSGALACTIAEC91848Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae subspecies dysgalactiae.Streptococcus dysgalactiae subsp dysgalactiae
STREPTOCOCCUS DYSGALACTIAE SUBSP. EQUISIMILISC86906STREPTOCOCCUS EQUISIMILISAny bacterial organism that can be assigned to the species Streptococcus dysgalactiae subspecies equisimilis.Streptococcus dysgalactiae subsp equisimilis
STREPTOCOCCUS EQUIC86789Any bacterial organism that can be assigned to the species Streptococcus equi.Streptococcus equi
STREPTOCOCCUS EQUINUSC86790Any bacterial organism that can be assigned to the species Streptococcus equinus.Streptococcus equinus
STREPTOCOCCUS GALLOLYTICUSC86791Any bacterial organism that can be assigned to the species Streptococcus gallolyticus.Streptococcus gallolyticus
STREPTOCOCCUS GAMMA-HEMOLYTICC86408GAMMA-HEMOLYTIC STREPTOCOCCUSA bacteria that is assigned to the genus Streptococcus that is unable to facilitate red blood cell lysis.Gamma-Hemolytic Streptococcus
STREPTOCOCCUS GORDONIIC86792Any bacterial organism that can be assigned to the species Streptococcus gordonii.Streptococcus gordonii
STREPTOCOCCUS INFANTARIUSC86793Any bacterial organism that can be assigned to the species Streptococcus infantarius.Streptococcus infantarius
STREPTOCOCCUS INTERMEDIUSC86794Any bacterial organism that can be assigned to the species Streptococcus intermedius.Streptococcus intermedius
STREPTOCOCCUS MILLERIC86795STREPTOCOCCUS MILLERI IAny bacterial organism that can be assigned to the species Streptococcus milleri.Streptococcus milleri
STREPTOCOCCUS MILLERI GROUPC86796A bacteria that belongs to the Milleri group of the genus Streptococcus.Streptococcus milleri Group
STREPTOCOCCUS MITIS GROUPC86797A bacteria that belongs to the Mitis group of the genus Streptococcus.Streptococcus mitis Group
STREPTOCOCCUS MUTANS GROUPC86798A bacteria that belongs to the Mutans group of the genus Streptococcus.Streptococcus mutans Group
STREPTOCOCCUS ORALISC86799Any bacterial organism that can be assigned to the species Streptococcus oralis.Streptococcus oralis
STREPTOCOCCUS PARASANGUINISC86800STREPTOCOCCUS PARASANGUISAny bacterial organism that can be assigned to the species Streptococcus parasanguinis.Streptococcus parasanguinis
STREPTOCOCCUS PNEUMONIAEC76384DIPLOCOCCUS PNEUMONIAEAny bacterial organism that can be assigned to the species Streptococcus pneumoniae.Streptococcus pneumoniae
STREPTOCOCCUS PORCINUSC86802Any bacterial organism that can be assigned to the species Streptococcus porcinus.Streptococcus porcinus
STREPTOCOCCUS PYOGENESC86803GROUP A BETA-HEMOLYTIC STREPTOCOCCUS PYOGENESAny bacterial organism that can be assigned to the species Streptococcus pyogenes.Streptococcus pyogenes
STREPTOCOCCUS SALIVARIUSC86804Any bacterial organism that can be assigned to the species Streptococcus salivarius.Streptococcus salivarius
STREPTOCOCCUS SALIVARIUS GROUPC86805A bacteria that belongs to the Salivarius group of the genus Streptococcus.Streptococcus salivarius Group
STREPTOCOCCUS SANGUINISC86806STREPTOCOCCUS SANGUISAny bacterial organism that can be assigned to the species Streptococcus sanguinis.Streptococcus sanguinis
STREPTOCOCCUS SUISC86807Any bacterial organism that can be assigned to the species Streptococcus suis.Streptococcus suis
STREPTOCOCCUS THERMOPHILUSC86808Any bacterial organism that can be assigned to the species Streptococcus thermophilus.Streptococcus thermophilus
STREPTOCOCCUS UBERISC86809Any bacterial organism that can be assigned to the species Streptococcus uberis.Streptococcus uberis
STREPTOCOCCUS VESTIBULARISC86810Any bacterial organism that can be assigned to the species Streptococcus vestibularis.Streptococcus vestibularis
STREPTOCOCCUS VIRIDANS GROUPC86811STREPTOCOCCUS VIRIDANS;VIRIDANS STREPTOCOCCUSA non-taxonomic grouping of species within the Streptococcus genus that are alpha-hemolytic and do not express Lancefield antigens.Streptococcus viridans Group
STREPTOMYCESC14278Any bacteria that is not assigned to the species level but can be assigned to the Streptomyces genus level.Streptomyces
STREPTOMYCES ALBUSC86812Any bacterial organism that can be assigned to the species Streptomyces albus.Streptomyces albus
STREPTOMYCES GRISEUSC86813Any bacterial organism that can be assigned to the species Streptomyces griseus.Streptomyces griseus
STREPTOMYCES SOMALIENSISC86814Any bacterial organism that can be assigned to the species Streptomyces somaliensis.Streptomyces somaliensis
SUTTERELLAC86956Any bacteria that is not assigned to the species level but can be assigned to the Sutterella genus level.Sutterella
SUTTONELLAC86815Any bacteria that is not assigned to the species level but can be assigned to the Suttonella genus level.Suttonella
SUTTONELLA INDOLOGENESC86816KINGELLA INDOLOGENESAny bacterial organism that can be assigned to the species Suttonella indologenes.Suttonella indologenes
TATLOCKIA MICDADEIC86817LEGIONELLA MICDADEIAny bacterial organism that can be assigned to the species Legionella micdadei.Tatlockia micdadei
TATUMELLAC86818Any bacteria that is not assigned to the species level but can be assigned to the Tatumella genus level.Tatumella
TATUMELLA PTYSEOSC86819CDC GROUP EF-9Any bacterial organism that can be assigned to the species Tatumella ptyseos.Tatumella ptyseos
TETRAGENOCOCCUSC86820Any bacteria that is not assigned to the species level but can be assigned to the Tetragenococcus genus level.Tetragenococcus
TETRAGENOCOCCUS SOLITARIUSC86821ENTEROCOCCUS SOLITARIUSAny bacterial organism that can be assigned to the species Tetragenococcus solitarius.Tetragenococcus solitarius
TICK-BORNE ENCEPHALITIS VIRUSC112422FSME virus;TBEVAny viral organism that can be assigned to the species Tick-borne encephalitis virus.Tick-Borne Encephalitis Virus
TISSIERELLAC86907Any bacteria that is not assigned to the species level but can be assigned to the Tissierella genus level.Tissierella
TISSIERELLA PRAEACUTAC86908Any bacterial organism that can be assigned to the species Tissierella praeacuta.Tissierella praeacuta
TRABULSIELLAC86822Any bacteria that is not assigned to the species level but can be assigned to the Trabulsiella genus level.Trabulsiella
TRABULSIELLA GUAMENSISC86823CDC ENTERIC GROUP 90Any bacterial organism that can be assigned to the species Trabulsiella guamensis.Trabulsiella guamensis
TREPONEMAC76385Any bacteria that is not assigned to the species level but can be assigned to the Treponema genus level.Treponema
TREPONEMA PALLIDUMC86825Any bacterial organism that can be assigned to the species Treponema pallidum.Treponema pallidum
TREPONEMA PALLIDUM SUBSP. ENDEMICUMC91850Any bacterial organism that can be assigned to the species Treponema pallidum subspecies endemicum.Treponema pallidum subsp endemicum
TREPONEMA PALLIDUM SUBSP. PALLIDUMC91849Any bacterial organism that can be assigned to the species Treponema pallidum subspecies pallidum.Treponema pallidum subsp pallidum
TREPONEMA PALLIDUM SUBSP. PERTENUEC86909TREPONEMA PERTENUEAny bacterial organism that can be assigned to the species Treponema pallidum and subspecies pertenue.Treponema pallidum subsp pertenue
TRICHOSPORON ASAHIIC114272T. asahiiAny fungal organism that can be assigned to the species Trichosporon asahii.Trichosporon asahii
TROPHERYMAC86826Any bacteria that is not assigned to the species level but can be assigned to the Tropheryma genus level.Tropheryma
TROPHERYMA WHIPPLEIC86827Any bacterial organism that can be assigned to the species Tropheryma whipplei.Tropheryma whipplei
TSUKAMURELLAC86828Any bacteria that is not assigned to the species level but can be assigned to the Tsukamurella genus level.Tsukamurella
TSUKAMURELLA PAUROMETABOLUMC86829GORDONA AURANTIACAAny bacterial organism that can be assigned to the species Tsukamurella paurometabolum.Tsukamurella paurometabolum
TSUKAMURELLA PULMONISC114253Any bacterial organism that can be assigned to the species Tsukamurella pulmonis.Tsukamurella pulmonis
TURICELLAC86830Any bacteria that is not assigned to the species level but can be assigned to the Turicella genus level.Turicella
TURICELLA OTITIDISC86831RHODOCOCCUS AURANTIAZUSAny bacterial organism that can be assigned to the species Turicella otitidis.Turicella otitidis
UREAPLASMAC86832Any bacteria that is not assigned to the species level but can be assigned to the Ureaplasma genus level.Ureaplasma
UREAPLASMA UREALYTICUMC86833T-MYCOPLASMAAny bacterial organism that can be assigned to the species Ureaplasma urealyticum.Ureaplasma urealyticum
VACCINIA VIRUSC14281VVAny viral organism that can be assigned to the species Vaccinia virus.Vaccinia Virus
VAGOCOCCUSC86834Any bacteria that is not assigned to the species level but can be assigned to the Vagococcus genus level.Vagococcus
VARIBACULUMC86835Any bacteria that is not assigned to the species level but can be assigned to the Varibaculum genus level.Varibaculum
VARIBACULUM CAMBRIENSEC86836Any bacterial organism that can be assigned to the species Varibaculum cambriense.Varibaculum cambriense
VARICELLOVIRUSC112426VaricellavirusAny viral organism that can be assigned to the genus Varicellovirus.Varicellovirus
VARIOLA VIRUSC96527Smallpox Virus;Variola Virus VARAny viral organism that can be assigned to the species Variola virus.Variola Virus
VEILLONELLAC86837Any bacteria that is not assigned to the species level but can be assigned to the Veillonella genus level.Veillonella
VEILLONELLA DISPARC86838Any bacterial organism that can be assigned to the species Veillonella dispar.Veillonella dispar
VEILLONELLA PARVULAC86839Any bacterial organism that can be assigned to the species Veillonella parvula.Veillonella parvula
VIBRIOC76386Any bacteria that is not assigned to the species level but can be assigned to the Vibrio genus level.Vibrio
VIBRIO ALGINOLYTICUSC86840Any bacterial organism that can be assigned to the species Vibrio alginolyticus.Vibrio alginolyticus
VIBRIO CHOLERAEC86841VIBRIO COMMAAny bacterial organism that can be assigned to the species Vibrio cholerae.Vibrio cholerae
VIBRIO FLUVIALISC86842CDC GROUP EF-6Any bacterial organism that can be assigned to the species Vibrio fluvialis.Vibrio fluvialis
VIBRIO FURNISSIIC86843VIBRIO FLUVIALIS BIOGROUP 2Any bacterial organism that can be assigned to the species Vibrio furnissii.Vibrio furnissii
VIBRIO METSCHNIKOVIIC86844CDC ENTERIC GROUP 16Any bacterial organism that can be assigned to the species Vibrio metschnikovii.Vibrio metschnikovii
VIBRIO MIMICUSC86845SUCROSE NEGATIVE VIBRIO CHOLERAEAny bacterial organism that can be assigned to the species Vibrio mimicus.Vibrio mimicus
VIBRIO PARAHAEMOLYTICUSC86846Any bacterial organism that can be assigned to the species Vibrio parahaemolyticus.Vibrio parahaemolyticus
VIBRIO VULNIFICUSC86847BENECKEA VULNIFICAAny bacterial organism that can be assigned to the species Vibrio vulnificus.Vibrio vulnificus
WAUTERSIELLA FALSENIIC111334Any bacterial organism that can be assigned to the species Wautersiella falsenii.Wautersiella falsenii
WEEKSELLAC86848Any bacteria that is not assigned to the species level but can be assigned to the Weeksella genus level.Weeksella
WEEKSELLA VIROSAC86849CDC GROUP IIFAny bacterial organism that can be assigned to the species Weeksella virosa.Weeksella virosa
WEST NILE VIRUSC71877WNVAny viral organism that can be assigned to the species West Nile virus.West Nile Virus
WICKERHAMOMYCES ANOMALUSC114262C. pelliculosa;Candida pelliculosa;H. anomala;Hansenula anomala;P. anomala;Pichia anomala;W. anomalusAny fungal organism that can be assigned to the species Wickerhamomyces anomalus.Wickerhamomyces anomalus
WOLINELLAC86850Any bacteria that is not assigned to the species level but can be assigned to the Wolinella genus level.Wolinella
WOLINELLA SUCCINOGENESC86851Any bacterial organism that can be assigned to the species Wolinella succinogenes.Wolinella succinogenes
YARROWIA LIPOLYTICAC114257M. lipolytica;Mycotorula lipolytica;Y. lipolyticaAny fungal organism that can be assigned to the species Yarrowia lipolytica.Yarrowia lipolytica
YELLOW FEVER VIRUSC97156Flavivirus febricis;YFVAny viral organism that can be assigned to the species Yellow fever virus.Yellow Fever Virus
YERSINIAC86852Any bacteria that is not assigned to the species level but can be assigned to the Yersinia genus level.Yersinia
YERSINIA ALDOVAEC86853Any bacterial organism that can be assigned to the species Yersinia aldovae.Yersinia aldovae
YERSINIA BERCOVIERIC86854YERSINIA ENTEROLITICA BIOGROUP 3BAny bacterial organism that can be assigned to the species Yersinia bercovieri.Yersinia bercovieri
YERSINIA ENTEROCOLITICAC86855PASTEURELLA ENTEROCOLITICAAny bacterial organism that can be assigned to the species Yersinia enterocolitica.Yersinia enterocolitica
YERSINIA FREDERIKSENIIC86856Any bacterial organism that can be assigned to the species Yersinia frederiksenii.Yersinia frederiksenii
YERSINIA INTERMEDIAC86857Any bacterial organism that can be assigned to the species Yersinia intermedia.Yersinia intermedia
YERSINIA KRISTENSENIIC86858Any bacterial organism that can be assigned to the species Yersinia kristensenii.Yersinia kristensenii
YERSINIA MOLLARETIIC86859YERSINIA ENTEROLITICA BIOGROUP 3AAny bacterial organism that can be assigned to the species Yersinia mollaretii.Yersinia mollaretii
YERSINIA PESTISC86860PASTEURELLA PESTISAny bacterial organism that can be assigned to the species Yersinia pestis.Yersinia pestis
YERSINIA PSEUDOTUBERCULOSISC86861PASTEURELLA PSEUDOTUBERCULOSISAny bacterial organism that can be assigned to the species Yersinia pseudotuberculosis.Yersinia pseudotuberculosis
YERSINIA ROHDEIC86862Any bacterial organism that can be assigned to the species Yersinia rohdei.Yersinia rohdei
YERSINIA RUCKERIC86863Any bacterial organism that can be assigned to the species Yersinia ruckeri.Yersinia ruckeri
YOKENELLAC86864Any bacteria that is not assigned to the species level but can be assigned to the Yokenella genus level.Yokenella
YOKENELLA REGENSBURGEIC86865CDC ENTERIC GROUP 45Any bacterial organism that can be assigned to the species Yokenella regensburgei.Yokenella regensburgei
ZIMMERMANNELLAC86866Any bacteria that is not assigned to the species level but can be assigned to the Zimmermannella genus level.Zimmermannella
ZIMMERMANNELLA ALBAC86867Any bacterial organism that can be assigned to the species Zimmermannella alba.Zimmermannella alba
ZIMMERMANNELLA BIFIDAC86868Any bacterial organism that can be assigned to the species Zimmermannella bifida.Zimmermannella bifida
Back to top
CL.C89974.MITESTCDMicroscopic Findings Test Code
(MITESTCD)
text
Extensible: Yes
C89974Microscopic Findings Test CodeTerminology for the test codes concerned with the findings from a specimen that are visible by microscopic analysis.CDISC SEND Microscopic Findings Test Code Terminology
FIBSCBALC119570Batts-Ludwig Fibrosis ScoreThe histopathological evaluation of the liver based on the Batts-Ludwig scoring system.Batts-Ludwig Fibrosis Score
FIBSCISHC95149Ishak Fibrosis ScoreThe histopathological evaluation of the liver based on the Ishak scoring system.Ishak Score
FIBSCKNOC119571Knodell Fibrosis ScoreThe histopathological evaluation of the liver based on the Knodell scoring system.Knodell Fibrosis Score
FIBSCMETC119572Metavir Fibrosis ScoreThe histopathological evaluation of the liver based on the Meta-analysis of Histological Data in Viral Hepatitis (Metavir) scoring system.METAVIR Fibrosis Score
FIBSCSCHC119573Scheuer Fibrosis ScoreThe histopathological evaluation of the liver based on the Scheuer scoring system.Scheuer Fibrosis Score
MIEXAMC90424Microscopic ExaminationAn assessment by microscope (e.g., light, electron, confocal, etc.).Microscopic Examination
Back to top
CL.C89973.MITESTMicroscopic Findings Test Name
(MITEST)
text
Extensible: Yes
C89973Microscopic Findings Test NameTerminology for the test names concerned with the findings from a specimen that are visible by microscopic analysis.CDISC SEND Microscopic Findings Test Name Terminology
Batts-Ludwig Fibrosis ScoreC119570Batts-Ludwig Fibrosis ScoreThe histopathological evaluation of the liver based on the Batts-Ludwig scoring system.Batts-Ludwig Fibrosis Score
Ishak Fibrosis ScoreC95149Ishak Fibrosis ScoreThe histopathological evaluation of the liver based on the Ishak scoring system.Ishak Score
Knodell Fibrosis ScoreC119571Knodell Fibrosis ScoreThe histopathological evaluation of the liver based on the Knodell scoring system.Knodell Fibrosis Score
Metavir Fibrosis ScoreC119572Metavir Fibrosis ScoreThe histopathological evaluation of the liver based on the Meta-analysis of Histological Data in Viral Hepatitis (Metavir) scoring system.METAVIR Fibrosis Score
Microscopic ExaminationC90424Microscopic ExaminationAn assessment by microscope (e.g., light, electron, confocal, etc.).Microscopic Examination
Scheuer Fibrosis ScoreC119573Scheuer Fibrosis ScoreThe histopathological evaluation of the liver based on the Scheuer scoring system.Scheuer Fibrosis Score
Back to top
CL.C114117.MOTESTCDMorphology Test Code
(MOTESTCD)
text
Extensible: Yes
C114117Morphology Test CodeA terminology codelist based on the test codes for macroscopic assessments that are seen by the naked eye or observed via procedures such as imaging modalities, endoscopy, or other technologies.CDISC SDTM Morphology Test Code Terminology
BSIC114183Boundary Shift IntegralA measurement of change in volume of an organ or anatomical feature as determined by a shift in tissue boundary over time.Boundary Shift Integral
CANRFINDC119331Coronary Artery No Reflow IndicatorAn indication as to whether there is a new acute reduction in coronary flow (TIMI grade 0-1) in the absence of dissection, thrombus, spasm, or high-grade residual stenosis at the original PCI lesion site.Coronary No Reflow at PCI Site Indicator
DEPTHC25333DepthThe extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI)Depth
ELASTICC119332ElasticityA quantitative measurement of an organ's ability to deform in response to physiological force and return to its normal shape by passive elastic recoil.Organ Elasticity
INRSTINDC116148In-Stent Restenosis IndicatorAn indication as to whether there is re-narrowing of a stent implanted at a lesion site to treat a prior stenosis, to a diameter stenosis of greater than 50% within the stent.In-Stent Restenosis Indicator
INTPC41255InterpretationAn act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language.Interpretation
LATELOSSC116146Late LossThe difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up angiography.Late Lumen Loss Measurement
LENGTHC25334LengthThe linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI)Length
LRSTINDC116147Lesion Restenosis IndicatorAn indication as to whether there is re-narrowing of a lesion site following treatment of a prior stenosis, to a diameter stenosis of greater than 50% at the previously treated lesion site.Lesion Restenosis Indicator
MASSC43246MassThe amount of matter in an object.Mass
MEANVDIAC116143Mean Vessel DiameterThe mean of the inside diameters of the normal blood vessel segments.Mean Vessel Diameter
MINLDIAMC116144Minimum Vessel Lumen DiameterThe minimum diameter of the inside of a blood vessel (lumen) derived quantitatively in a single view.Minimum Vessel Lumen Diameter
PCTDIASTC116145Percent Diameter StenosisThe value calculated as 100 x (1 - MLD/RVD), using the mean quantitative values for minimum lumen diameter (MLD) and reference vessel diameter (RVD).Percent Diameter Stenosis Measurement
THICKC41145ThicknessThe dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length.Thickness
VOLUMEC25335VolumeThe amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI)Volume
WEIGHTC25208WeightThe vertical force exerted by a mass as a result of gravity. (NCI)Weight
WIDTHC25345WidthThe extent or measurement of something from side to side. (NCI)Width
Back to top
CL.C114116.MOTESTMorphology Test Name
(MOTEST)
text
Extensible: Yes
C114116Morphology Test NameA terminology codelist based on the test names for macroscopic assessments that are seen by the naked eye or observed via procedures such as imaging modalities, endoscopy, or other technologies.CDISC SDTM Morphology Test Name Terminology
Boundary Shift IntegralC114183Boundary Shift IntegralA measurement of change in volume of an organ or anatomical feature as determined by a shift in tissue boundary over time.Boundary Shift Integral
Coronary Artery No Reflow IndicatorC119331Coronary Artery No Reflow IndicatorAn indication as to whether there is a new acute reduction in coronary flow (TIMI grade 0-1) in the absence of dissection, thrombus, spasm, or high-grade residual stenosis at the original PCI lesion site.Coronary No Reflow at PCI Site Indicator
DepthC25333DepthThe extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI)Depth
ElasticityC119332ElasticityA quantitative measurement of an organ's ability to deform in response to physiological force and return to its normal shape by passive elastic recoil.Organ Elasticity
In-Stent Restenosis IndicatorC116148In-Stent Restenosis IndicatorAn indication as to whether there is re-narrowing of a stent implanted at a lesion site to treat a prior stenosis, to a diameter stenosis of greater than 50% within the stent.In-Stent Restenosis Indicator
InterpretationC41255InterpretationAn act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language.Interpretation
Late LossC116146Late LossThe difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up angiography.Late Lumen Loss Measurement
LengthC25334LengthThe linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI)Length
Lesion Restenosis IndicatorC116147Lesion Restenosis IndicatorAn indication as to whether there is re-narrowing of a lesion site following treatment of a prior stenosis, to a diameter stenosis of greater than 50% at the previously treated lesion site.Lesion Restenosis Indicator
MassC43246MassThe amount of matter in an object.Mass
Mean Vessel DiameterC116143Mean Vessel DiameterThe mean of the inside diameters of the normal blood vessel segments.Mean Vessel Diameter
Minimum Vessel Lumen DiameterC116144Minimum Vessel Lumen DiameterThe minimum diameter of the inside of a blood vessel (lumen) derived quantitatively in a single view.Minimum Vessel Lumen Diameter
Percent Diameter StenosisC116145Percent Diameter StenosisThe value calculated as 100 x (1 - MLD/RVD), using the mean quantitative values for minimum lumen diameter (MLD) and reference vessel diameter (RVD).Percent Diameter Stenosis Measurement
ThicknessC41145ThicknessThe dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length.Thickness
VolumeC25335VolumeThe amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI)Volume
WeightC25208WeightThe vertical force exerted by a mass as a result of gravity. (NCI)Weight
WidthC25345WidthThe extent or measurement of something from side to side. (NCI)Width
Back to top
CL.C117741.MSFATSCDMultiple Sclerosis Findings About Test Code
(MSFATSCD)
text
Extensible: Yes
C117741Multiple Sclerosis Findings About Test CodeTerminology relevant to the test codes that describe multiple sclerosis findings.CDISC SDTM Multiple Sclerosis Findings About Test Code Terminology
DXCRITMTC117883Diagnostic Criteria MetA description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis.Which Diagnostic Criteria Met
LOCONSETC117884Localization of OnsetThe anatomical location of the beginning or early stages of a disease.Location of Disease Onset
OUNIMULTC117885Onset Unifocal or MultifocalA categorization of the number of lesions present in the Central Nervous System at the time of diagnosis of a specific disease.Focality of Disease Onset
Back to top
CL.C117740.MSFATSMultiple Sclerosis Findings About Test Name
(MSFATS)
text
Extensible: Yes
C117740Multiple Sclerosis Findings About Test NameTerminology relevant to the test names that describe multiple sclerosis findings.CDISC SDTM Multiple Sclerosis Findings About Test Name Terminology
Diagnostic Criteria MetC117883Diagnostic Criteria MetA description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis.Which Diagnostic Criteria Met
Localization of OnsetC117884Localization of OnsetThe anatomical location of the beginning or early stages of a disease.Location of Disease Onset
Onset Unifocal or MultifocalC117885Onset Unifocal or MultifocalA categorization of the number of lesions present in the Central Nervous System at the time of diagnosis of a specific disease.Focality of Disease Onset
Back to top
CL.C88025.NEOPLASMNeoplasm Type
(NEOPLASM)
text
Extensible: Yes
C88025Neoplasm TypeThe terminology that includes concepts relevant to benign or malignant tissue growth.CDISC SEND Tumor Findings Results Terminology
ACINAR-ISLET CELL TUMOR, BENIGNC116215A benign tumor of the pancreas with morphologic characteristics of endocrine, acinar and ductal cells. (INHAND)Experimental Organism Benign Acinar-islet Cell Tumor
ACINAR-ISLET CELL TUMOR, MALIGNANTC6878A malignant pancreatic neoplasm characterized by the presence of a mixture of acinar and islet cell elements.Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas
ADAMANTINOMA, MALIGNANTC7644AdamantinomaA low-grade malignant neoplasm composed of epithelial cells and a spindle cell osteo-fibrous proliferation.Adamantinoma
ADENOACANTHOMA, MALIGNANTC4200AdenoacanthomaA malignant neoplasm arising from glandular cells that includes focal or extensive areas of squamous metaplasia.Adenocarcinoma with Squamous Metaplasia
ADENOCARCINOMA, CLEAR CELL, MALIGNANTC3766Clear Cell Carcinoma;Mesonephroid Clear Cell Adenocarcinoma;Mesonephroid Clear Cell CarcinomaA malignant neoplasm comprising glandular epithelial clear cells.Clear Cell Adenocarcinoma
ADENOCARCINOMA, ENDOMETRIAL, MALIGNANTC7359Adenocarcinoma of Endometrium;Adenocarcinoma of the EndometriumA malignant glandular neoplasm of the uterine lining.Endometrial Adenocarcinoma
ADENOCARCINOMA, MALIGNANTC2852A malignant neoplasm arising from glandular cells.Adenocarcinoma
ADENOCARCINOMA, MUCINOUS, MALIGNANTC26712Colloid Adenocarcinoma;Colloid Carcinoma;Gelatinous Adenocarcinoma;Gelatinous Carcinoma;Mucinous Carcinoma;Mucoid Adenocarcinoma;Mucoid Carcinoma;Mucous Adenocarcinoma;Mucous CarcinomaAn adenocarcinoma comprising neoplastic glandular cells containing intracytoplasmic mucin.Mucinous Adenocarcinoma
ADENOCARCINOMA, PAPILLARY, MALIGNANTC2853An adenocarcinoma with papillary growth pattern.Papillary Adenocarcinoma
ADENOCARCINOMA, SEBACEOUS, MALIGNANTC40310Carcinoma of Sebaceous Gland;Carcinoma of the Sebaceous Gland;Sebaceous Gland CarcinomaAn adenocarcinoma with sebaceous differentiation.Sebaceous Carcinoma
ADENOFIBROMA, BENIGNC8984Benign Mixed Muellerian TumorBenign mixed neoplasm comprised of epithelial/glandular and mesenchymal structures.Adenofibroma
ADENOLIPOMA, BENIGNC4159Benign mixed neoplasm comprised of epithelial/glandular and lipomatous structures.Lipoadenoma
ADENOMA, ACINAR CELL, BENIGNC4196Acinar Adenoma;Acinic Cell AdenomaA benign glandular epithelial neoplasm comprising secretory cells forming acinar patterns.Acinar Cell Adenoma
ADENOMA, ADNEXAL, BENIGNC7580Adenoma of Adnexa;Adenoma of Skin Appendage;Adnexal AdenomaA benign epithelial neoplasm arising from the sebaceous or sweat glands.Skin Appendage Adenoma
ADENOMA, ADRENOCORTICAL, BENIGNC9003Adenoma of Adrenal Cortex;Adenoma of Adrenal Gland;Adenoma of the Adrenal Cortex;Adenoma of the Adrenal Gland;Adrenal Adenoma;Adrenal Cortical Adenoma;Adrenal Gland Adenoma;Adrenocortical Adenoma;Benign Adenoma of Adrenal Gland;Benign Adenoma of the Adrenal Gland;Benign Adrenal Adenoma;Benign Adrenal Gland Adenoma;Cortical Cell AdenomaA benign neoplasm arising from any of the adrenal cortical layers.Adrenal Cortex Adenoma
ADENOMA, ANTERIOR LOBE PITUITARY GLAND, BENIGNC3329Adenoma of Pituitary;Adenoma of Pituitary Gland;Adenoma of the Pituitary;Adenoma of the Pituitary Gland;Pituitary AdenomaA benign neoplasm of the anterior lobe of the pituitary gland.Pituitary Gland Adenoma
ADENOMA, BENIGNC2855A benign neoplasm arising from epithelium.Adenoma
ADENOMA, BRONCHIAL, BENIGNC3494A benign neoplasia of the lung, arising from bronchial epithelium.Lung Papillary Adenoma
ADENOMA, BRONCHIOLOALVEOLAR, BENIGNC4140Adenoma of Alveoli;Adenoma of the AlveoliA benign lung neoplasm arising from the alveolar/bronchiolar epithelium.Alveolar Adenoma
ADENOMA, C-CELL, BENIGNC46101Parafollicular Cell AdenomaA benign neoplasm arising from C-cells of the thyroid gland.Neoplastic C-Cell Hyperplasia
ADENOMA, CERUMINOUS GLAND, BENIGNC6088Ceruminoma;Ceruminous Adenoma;Ceruminous Adenoma of External Auditory Canal;Ceruminous Adenoma of the External Auditory CanalA benign epithelial neoplasm derived from ceruminous glands in the external auditory canal.External Auditory Canal Ceruminous Adenoma
ADENOMA, CLEAR CELL, BENIGNC4151A benign neoplasm comprising glands containing epithelial clear cells.Clear Cell Adenoma
ADENOMA, FOLLICULAR CELL, BENIGNC3502Adenoma of Thyroid;Adenoma of Thyroid Gland;Adenoma of the Thyroid;Adenoma of the Thyroid Gland;Follicular Adenoma;Follicular Adenoma of Thyroid;Follicular Adenoma of Thyroid Gland;Follicular Adenoma of the Thyroid;Follicular Adenoma of the Thyroid Gland;Thyroid Adenoma;Thyroid Follicular Adenoma;Thyroid Gland AdenomaA benign neoplasm arising from follicular cells of the thyroid gland.Thyroid Gland Follicular Adenoma
ADENOMA, HEPATOCELLULAR, BENIGNC3758Adenoma of Liver Cells;Adenoma of the Liver Cells;HCA;Liver Cell AdenomaA benign epithelial neoplasm arising from hepatocytes.Hepatocellular Adenoma
ADENOMA, HEPATOCHOLANGIOCELLULAR, BENIGNC7126A benign neoplasm arising from the intrahepatic bile duct.Intrahepatic Bile Duct Adenoma
ADENOMA, ISLET CELL, BENIGNC114108Islet Cell AdenomaA benign neoplasm arising from the islet cells of the pancreas.Experimental Organism Islet Cell Adenoma Neoplasm
ADENOMA, LIGHT CELL, BENIGNC46119A benign epithelial neoplasm of the thyroid gland comprising follicular cells with cytoplasmic clearing.Thyroid Gland Clear Cell Follicular Adenoma
ADENOMA, MUCINOUS, BENIGNC2973Mucinous Adenoma;Mucinous Cystoma;Pseudomucinous CystadenomaA benign, cystic epithelial neoplasm comprising cells containing intracytoplasmic mucin.Mucinous Cystadenoma
ADENOMA, PAPILLARY, BENIGNC79951A benign epithelial neoplasm characterized by the presence of papillary epithelial patterns.Papillary Adenoma
ADENOMA, PARS DISTALIS, BENIGNC60490Rat Pars Distalis AdenomaA benign epithelial neoplasm arising from the pars distalis of the anterior pituitary gland.Rat Pars Distalis Adenoma
ADENOMA, PARS INTERMEDIA, BENIGNC60493Rat Pars Intermedia AdenomaA benign epithelial neoplasm arising from the pars intermedia of the anterior pituitary gland.Rat Pars Intermedia Adenoma
ADENOMA, PITUITARY GLAND, BENIGNC98723A benign neoplasm of the pituitary gland.Experimental Organism Pituitary Gland Adenoma
ADENOMA, RENAL CELL, BENIGNC8383Renal Tubule AdenomaA benign neoplasm arising from the renal cortex.Renal Adenoma
ADENOMA, RETE TESTIS, BENIGNC39956A benign epithelial neoplasm arising from the rete testis.Rete Testis Adenoma
ADENOMA, SEBACEOUS, BENIGNC4174Adenoma of Sebaceous Gland;Adenoma of the Sebaceous Gland;Sebaceous Gland Adenoma;Skin Appendage Sebaceous AdenomaA benign neoplasm arising from sebaceous glands.Sebaceous Adenoma
ADENOMA, SERTOLIFORM TUBULAR, BENIGNC92180Rat Sertoliform Tubular AdenomaA benign tubular adenoma with Sertoli cell differentiation.Rat Sertoliform Tubular Adenoma
ADENOMA, SWEAT GLAND, BENIGNC7560Adenoma of Sweat Gland;Adenoma of the Sweat GlandA benign epithelias neoplasm arising from sweat glands.Sweat Gland Adenoma
ADENOMA, TUBULAR CELL, BENIGNC4133A benign neoplasm arising from glandular epithelium, characterized by a tubular architectural pattern.Tubular Adenoma
ADENOMA, TUBULOSTROMAL, BENIGNC79953A benign ovarian epithelial neoplasm characterized by the presence of tubular structures and interstitial stroma.Tubulostromal Adenoma
ADENOMA, ZYMBAL'S GLAND, BENIGNC98800A benign neoplasm of the rodent Zymbal's gland with sebaceous and/or squamous differentiation.Zymbal's Gland Adenoma
ADENOMYOMA, BENIGNC3726A benign neoplasm characterized by the presence of a glandular and a mesenchymal component.Adenomyoma
ADRENAL TUMOR, SUBCAPSULAR, BENIGNC83488Subcapsular Single Cell Adenoma, AdrenalA benign neoplasm located beneath the adrenal capsule.Benign Subcapsular Adrenal Tumor
ADRENAL TUMOR, SUBCAPSULAR, MALIGNANTC83489Subcapsular Single Cell Carcinoma, AdrenalA malignant neoplasm located beneath the adrenal capsule.Malignant Subcapsular Adrenal Tumor
ADRENAL TUMOR, SUBCAPSULAR, UNDETERMINEDC82973Subcapsular Cell Tumor, AdrenalA neoplasm located beneath the adrenal capsule in which the malignancy status has not been established.Subcapsular Adrenal Tumor
ADRENOCORTICAL NEOPLASM, UNDETERMINEDC2858Adrenal Cortex Tumor;Adrenocortical Neoplasm;Adrenocortical TumorA neoplasm of the adrenal cortex in which the malignancy status has not been established.Adrenal Cortex Neoplasm
AMELOBLASTOMA, BENIGNC7111A benign odontogenic neoplasm arising from the epithelial component of the embryonic tooth.Benign Ameloblastoma
AMELOBLASTOMA, MALIGNANTC54297Malignant AmeloblastomaA malignant odontogenic neoplasm arising from the epithelial component of the embryonic tooth.Metastasizing Ameloblastoma
AMELOBLASTOMA, UNDETERMINEDC4313A odontogenic neoplasm arising from the epithelial component of the embryonic tooth of undetermined malignancy status.Ameloblastoma
ANGIOFIBROMA, BENIGNC3799Angiofibromatous Hyperplasia;Fibroangioma, Benign;Fibrous Papule;Telangiectatic FibromaA benign, morphologic variant of fibroma characterized by the presence of numerous dilated vascular channels.Angiofibroma
ANGIOLIPOMA, BENIGNC3733AngiolipomaA lipoma characterized by prominent vascularization.Angiolipoma
ARRHENOBLASTOMA, BENIGNC4209Arrhenoblastoma, BenignA benign Sertoli-Leydig neoplasm of the ovary characterized by the presence of Sertoli cells in tubules without evidence of significant nuclear atypia or mitotic activity.Well Differentiated Ovarian Sertoli-Leydig Cell Tumor
ARRHENOBLASTOMA, MALIGNANTC4210Arrhenoblastoma, MalignantA malignant Sertoli-Leydig neoplasm of the ovary characterized by the presence of a sarcomatoid stroma which contains primitive gonadal stromal cells.Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor
ASTROCYTOMA, ANAPLASTIC, MALIGNANTC9477Grade III Astrocytic Neoplasm;Grade III Astrocytic Tumor;Grade III Astrocytoma;Malignant AstrocytomaA malignant neoplasm of the brain or spinal cord originating from astrocytes, exhibiting poor differentiation (anaplasia).Anaplastic Astrocytoma
ASTROCYTOMA, DIFFUSE, MALIGNANTC7173Astrocytoma, DiffuseA malignant astrocytic neoplasm characterized by a high degree of cellular differentiation, slow growth, and diffuse infiltration of neighboring brain structures.Diffuse Astrocytoma
ASTROCYTOMA, MALIGNANTC119574A malignant neoplasm of the brain or spinal cord originating from astrocytes.Experimental Organism Malignant Astrocytoma
ASTROCYTOMA, PILOCYTIC, BENIGNC4047Astrocytoma, Benign;Grade I Astrocytic Neoplasm;Grade I Astrocytic Tumor;Grade I AstrocytomaA benign neoplasm of the brain or spinal cord arising from astrocytes associated with single or multiple cysts.Pilocytic Astrocytoma
ASTROCYTOMA, UNDETERMINEDC60781A neoplasm of the brain or spinal cord exhibiting astrocytic differentiation, but in which the malignancy status has not been established.Astrocytoma
BASAL CELL TUMOR, BENIGNC111198Adenoma, Basal Cell, BenignA benign epithelial neoplasm with a uniform, monomorphic appearance that is dominated by basal cells.Experimental Organism Basal Cell Adenoma
BASALIOMA, BENIGNC103391BasaliomaA benign epithelial neoplasm arising from primary epithelial germ cells of the piliary complex.Experimental Organism Benign Basalioma
BASOSQUAMOUS TUMOR, BENIGNC4614Cutaneous Papilloma;Papilloma of Skin;Papilloma of the SkinA benign papillary neoplasm of the skin.Skin Papilloma
BASOSQUAMOUS TUMOR, MALIGNANTC2922Basosquamous Carcinoma;Basosquamous Cell Carcinoma;Skin Mixed Basal and Squamous Cell CarcinomaA basal cell carcinoma (skin neoplasm) which displays squamous differentiation.Skin Basosquamous Cell Carcinoma
CARCINOID TUMOR, MALIGNANTC72074Malignant Carcinoid TumorA malignant neuroendocrine neoplasm arising from enterochromaffin cells in the gastrointestinal tract and (less common) in the bronchi.Atypical Carcinoid Tumor
CARCINOID TUMOR, UNDETERMINEDC2915Carcinoid;Carcinoid Neoplasm;Well-differentiated Endocrine NeoplasmA neuroendocrine neoplasm arising from enterochromaffin cells in the gastrointestinal tract and (less common) the bronchi with undetermined malignancy status.Carcinoid Tumor
CARCINOMA, ACIDOPHIL, MALIGNANTC114109Acidophil Adenocarcinoma;Acidophil Carcinoma;Eosinophil Adenocarcinoma;Eosinophil CarcinomaA malignant epithelial neoplasm of the anterior pituitary gland in which the neoplastic cells stain positive with acidic dyes.Experimental Organism Acidophil Carcinoma Neoplasm
CARCINOMA, ACINAR CELL, MALIGNANTC3768Acinar Adenocarcinoma;Acinar Carcinoma;Acinar Cell Adenocarcinoma;Acinic Cell Adenocarcinoma;Acinic Cell CarcinomaA malignant glandular epithelial neoplasm comprising secretory cells forming acinar patterns.Acinar Cell Carcinoma
CARCINOMA, ADENOSQUAMOUS, MALIGNANTC3727Mixed Adenocarcinoma and Epidermoid Carcinoma;Mixed Adenocarcinoma and Epidermoid Cell Carcinoma;Mixed Adenocarcinoma and Squamous Carcinoma;Mixed Adenocarcinoma and Squamous Cell CarcinomaAn epithelial neoplasm composed of malignant glandular and malignant squamous cells.Adenosquamous Carcinoma
CARCINOMA, ADNEXAL, MALIGNANTC3775Carcinoma of Adnexa;Carcinoma of Skin Appendage;Skin Appendage CarcinomaA malignant epithelial neoplasm arising from sebaceous or sweat glands or from hair follicles.Adnexal Carcinoma
CARCINOMA, ADRENOCORTICAL, MALIGNANTC9325Adenocarcinoma, Adrenocortical, Malignant;Adrenal Cortex Adenocarcinoma;Adrenal Cortex Cancer;Adrenal Cortical Adenocarcinoma;Adrenal Cortical Carcinoma;Adrenocortical Carcinoma;Cortical Cell CarcinomaA malignant epithelial neoplasm arising from adrenal cortical cells.Adrenal Cortex Carcinoma
CARCINOMA, BASAL CELL, MALIGNANTC111199BCC;Basal Cell Cancer;Basal Cell Carcinoma;Basal Cell Epithelioma;Basal Cell Skin CarcinomaA malignant epithelial neoplasm arising from basal cells.Experimental Organism Basal Cell Carcinoma
CARCINOMA, BRONCHIAL, MALIGNANTC35875A malignant neoplasia of the lung, arising from bronchial epithelium.Bronchogenic Carcinoma
CARCINOMA, BRONCHIOLOALVEOLAR, MALIGNANTC2923BAC;Bronchioalveolar Adenocarcinoma of Lung;Bronchioalveolar Adenocarcinoma of the Lung;Bronchioalveolar Lung Carcinoma;Bronchiolo-Alveolar Carcinoma of Lung;Bronchiolo-Alveolar Carcinoma of the Lung;Bronchiolo-Alveolar Lung Carcinoma;Bronchioloalveolar Adenocarcinoma of Lung;Bronchioloalveolar Adenocarcinoma of the Lung;Bronchioloalveolar Lung AdenocarcinomaA malignant lung neoplasm originating from the alveolar/bronchiolar epithelium.Bronchioloalveolar Carcinoma
CARCINOMA, C-CELL, MALIGNANTC3879C Cell Carcinoma;MTC;Medullary Carcinoma;Medullary Carcinoma of Thyroid;Medullary Carcinoma of Thyroid Gland;Medullary Carcinoma of the Thyroid;Medullary Carcinoma of the Thyroid Gland;Medullary Thyroid Cancer;Medullary Thyroid Carcinoma;Medullary Thyroid Gland Carcinoma;Parafollicular Cell Carcinoma;Thyroid Gland Neuroendocrine Carcinoma;Thyroid Medullary CarcinomaA neuroendocrine malignant epithelial neoplasm arising from C-cells of the thyroid gland.Thyroid Gland Medullary Carcinoma
CARCINOMA, CERUMINOUS GLAND, MALIGNANTC4176A malignant neoplasm derived from ceruminous glands in the external auditory canal.Ceruminous Adenocarcinoma
CARCINOMA, CHOROID PLEXUS, MALIGNANTC4715Anaplastic Choroid Plexus Papilloma;Cancer of Choroid Plexus;Cancer of the Choroid Plexus;Carcinoma of Choroid Plexus;Carcinoma of the Choroid Plexus;Choroid Plexus CancerA malignant neoplasm arising from the choroid plexus of the brain.Choroid Plexus Carcinoma
CARCINOMA, EMBRYONAL, MALIGNANTC3752Carcinoma, Embryonal, MalignantA non-seminomatous malignant germ cell neoplasm of the testis or ovary.Embryonal Carcinoma
CARCINOMA, ENDOMETRIAL, MALIGNANTC7558Carcinoma of Endometrium;Carcinoma of the EndometriumA malignant epithelial neoplasm arising from the lining of the uterine body cavity.Endometrial Carcinoma
CARCINOMA, FOLLICULAR CELL, MALIGNANTC8054Follicular Adenocarcinoma;Follicular Cancer of Thyroid;Follicular Cancer of Thyroid Gland;Follicular Cancer of the Thyroid;Follicular Cancer of the Thyroid Gland;Follicular Carcinoma;Follicular Carcinoma of Thyroid;Follicular Carcinoma of Thyroid Gland;Follicular Carcinoma of the Thyroid;Follicular Carcinoma of the Thyroid Gland;Follicular Thyroid Cancer;Follicular Thyroid Carcinoma;Follicular Thyroid Gland Carcinoma;Thyroid Follicular Carcinoma;Well-differentiated Follicular Adenocarcinoma;Well-differentiated Follicular CarcinomaA malignant neoplasia arising from follicular cells of the thyroid gland.Thyroid Gland Follicular Carcinoma
CARCINOMA, HEPATOCELLULAR, MALIGNANTC3099Carcinoma of Liver Cells;Carcinoma of the Liver Cells;HCC;Hepatoma;Liver Cell Carcinoma;Primary Carcinoma of Liver Cells;Primary Carcinoma of the Liver CellsA malignant neoplasm arising from hepatocytes.Hepatocellular Carcinoma
CARCINOMA, HEPATOCHOLANGIOCELLULAR, MALIGNANTC103393Hepatocholangiocellular CarcinomaA malignant mixed neoplasm of the liver comprising neoplastic hepatocytes and bile duct epithelial cells; both elements displaying evidence of malignancy.Experimental Organism Malignant Hepatocholangiocellular Carcinoma
CARCINOMA, IN SITU, MALIGNANTC2917CIS;Epithelial Tumor, In situ, Malignant;Intraepithelial Carcinoma;Non-invasive CarcinomaA malignant epithelial neoplasm confined to the epithelial layer and without evidence of further tissue invasion.Carcinoma In Situ
CARCINOMA, ISLET CELL, MALIGNANTC3770Islet Cell Cancer;Islet Cell Carcinoma;Malignant Islet Cell Tumor;Malignant Pancreatic Endocrine Tumor;Pancreatic Neuroendocrine CarcinomaA malignant endocrine neoplasm arising from islets of Langerhans of the pancreas.Pancreatic Neuroendocrine Carcinoma
CARCINOMA, MALIGNANTC2916Epithelial Carcinoma;Epithelioma Malignant;Malignant Epithelial Neoplasm;Malignant Epithelial Tumor;Malignant EpitheliomaA malignant epithelial neoplasm.Carcinoma
CARCINOMA, NEUROENDOCRINE CELL, MALIGNANTC3773Neuroendocrine Carcinoma;Neuroendocrine Cell Carcinoma;Neuroendocrine Tumor, MalignantA malignant neuroendocrine neoplasm comprising cells containing secretory granules.Neuroendocrine Carcinoma
CARCINOMA, PARS DISTALIS, MALIGNANTC60491Rat Pars Distalis CarcinomaA malignant epithelial neoplasm arising from the pars distalis of the pituitary gland.Rat Pars Distalis Carcinoma
CARCINOMA, PARS INTERMEDIA, MALIGNANTC92183Rat Pars Intermedia CarcinomaA malignant epithelial neoplasm arising from the pars intermedia of the pituitary gland.Rat Pars Intermedia Carcinoma
CARCINOMA, RENAL CELL, MALIGNANTC9385Adenocarcinoma of Kidney;Adenocarcinoma of the Kidney;Kidney Adenocarcinoma;RCC;Renal Cell Adenocarcinoma;Renal Cell Cancer;Renal Cell Carcinoma, Stage UnspecifiedA malignant neoplasm arising from renal parenchyma.Renal Cell Carcinoma
CARCINOMA, RENAL, TUBULAR, MALIGNANTC39807Mucinous Tubular and Spindle Cell Carcinoma of the KidneyA malignant neoplasm of the kidney, characterized by the presence of tubules.Mucinous Tubular and Spindle Cell Carcinoma of the Kidney
CARCINOMA, SPINDLE CELL, MALIGNANTC27004Pseudosarcomatous Carcinoma;Spindle Cell CarcinomaA malignant epithelial neoplasm characterized by the presence of spindle cells.Sarcomatoid Carcinoma
CARCINOMA, SQUAMOUS CELL, IN SITU, MALIGNANTC27093Epidermoid Carcinoma In situ;Epidermoid Cell Carcinoma In situ;Grade 3 Squamous Intraepithelial Neoplasia;Grade III Squamous Intraepithelial Neoplasia;Intraepithelial Squamous Cell Carcinoma;Squamous Carcinoma In situ;Squamous Cell Carcinoma In situA malignant epithelial neoplasm confined to the squamous epithelium, without invasion of underlying tissues.Stage 0 Squamous Cell Carcinoma
CARCINOMA, SQUAMOUS CELL, MALIGNANTC2929Epidermoid Carcinoma;Epidermoid Cell Cancer;Malignant Epidermoid Cell Neoplasm;Malignant Epidermoid Cell Tumor;Malignant Squamous Cell Neoplasm;Malignant Squamous Cell Tumor;Squamous Carcinoma;Squamous Cell Cancer;Squamous Cell EpitheliomaA malignant neoplasm arising from squamous epithelial cells.Squamous Cell Carcinoma
CARCINOMA, SWEAT GLAND, MALIGNANTC6938Carcinoma of Sweat Gland;Carcinoma of the Sweat GlandA malignant neoplasm arising from sweat glands.Sweat Gland Carcinoma
CARCINOMA, TRANSITIONAL CELL, MALIGNANTC2930Transitional CarcinomaA malignant neoplasm arising from transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis.Transitional Cell Carcinoma
CARCINOMA, TUBULAR CELL, MALIGNANTC65192A malignant glandular neoplasm exhibiting tubular structures.Tubular Adenocarcinoma
CARCINOMA, TUBULOSTROMAL, MALIGNANTC80356A malignant epithelial neoplasm of the ovary with tubular and stromal neoplastic components.Tubulostromal Adenocarcinoma
CARCINOMA, UNDIFFERENTIATED, MALIGNANTC3692Anaplastic Carcinoma;Carcinoma, UndifferentiatedA malignant epithelial neoplasm exhibiting poor differentiation (anaplasia).Undifferentiated Carcinoma
CARCINOMA, ZYMBAL'S GLANDC98801A malignant neoplasm of the rodent Zymbal's gland with sebaceous and/or squamous differentiation.Zymbal's Gland Carcinoma
CARCINOSARCOMA, MALIGNANTC34448A malignant neoplasm comprising a mixture of carcinomatous and sarcomatous elements.Carcinosarcoma
CARDIAC SCHWANNOMA, BENIGNC5358Schwannoma, Endocardial, BenignA benign peripheral nervous system neoplasm that is composed of well-differentiated Schwann cells and affects the heart.Benign Cardiac Schwannoma
CHEMODECTOMA, BENIGNC79950Benign ChemodectomaA benign neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale).Benign Carotid Body Paraganglioma
CHEMODECTOMA, MALIGNANTC3574Malignant Carotid Body Neoplasm;Malignant Carotid Body Tumor;Malignant Neoplasm of Carotid Body;Malignant Neoplasm of the Carotid Body;Malignant Tumor of Carotid Body;Malignant Tumor of the Carotid BodyA malignant neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale).Malignant Carotid Body Paraganglioma
CHEMODECTOMA, UNDETERMINEDC2932Carotid Body Chemodectoma;Carotid Body Tumor;Chemodectoma;Paraganglioma of Carotid Body;Paraganglioma of the Carotid Body;Tumor of Carotid Body;Tumor of the Carotid BodyA neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale) for which the malignancy status has not be established.Carotid Body Paraganglioma
CHOLANGIOCARCINOMA, INTRAHEPATIC, MALIGNANTC35417Intrahepatic Bile Duct Carcinoma;Intrahepatic Carcinoma of Bile Duct;Intrahepatic Carcinoma of the Bile DuctA malignant neoplasm of the liver arising from/comprising cells resembling those of bile ducts.Intrahepatic Cholangiocarcinoma
CHOLANGIOCARCINOMA, MALIGNANTC4436Cholangiocellular CarcinomaA malignant neoplasm arising from/comprising cells resembling those of bile ducts.Cholangiocarcinoma
CHOLANGIOMA, BENIGNC2942Adenoma of Bile Duct;Adenoma of the Bile Duct;Cholangioadenoma;Cholangioma;Hepatocholangiocellular Adenoma;HepatocholangiomaA benign neoplasm arising from/comprising cells resembling those of bile ducts.Bile Duct Adenoma
CHONDROMA, BENIGNC53459A benign, well circumscribed neoplasm arising from the hyaline cartilage in soft tissue or bone. It is characterized by the presence of chondrocytes.Chondroma
CHONDROSARCOMA, MALIGNANTC2946A malignant mesenchymal neoplasm arising from cartilage-forming tissues.Chondrosarcoma
CHORDOMA, BENIGNC60334A benign bone neoplasm arising from the remnants of the fetal notochord.Rat Benign Chordoma
CHORDOMA, MALIGNANTC2947A malignant bone neoplasm arising from the remnants of the fetal notochord.Chordoma
CHORIOCARCINOMA, MALIGNANTC2948ChorioepitheliomaA malignant neoplasm arising from placental trophoblast cells. They generally arise in the uterus.Choriocarcinoma
CONNECTIVE AND SOFT TISSUE NEOPLASM, BENIGNC53684Benign Connective and Soft Tissue Neoplasm;Benign Connective and Soft Tissue Tumor;Benign Mesenchymal Cell Neoplasm;Benign Neoplasm of the Soft Tissue and Bone;Benign Tumor of the Soft Tissue and BoneA benign neoplasm arising from connective and soft tissues that does not invade adjacent tissues or metastasize to other anatomic sites.Benign Connective and Soft Tissue Neoplasm
CRANIOPHARYNGIOMA, BENIGNC2964Cystoma;Neoplasm of Rathke's Pouch;Rathke Pouch Neoplasm;Rathke Pouch Tumor;Rathke's Pouch Neoplasm;Rathke's Pouch Tumor;Tumor of Rathke's PouchA benign epithelial neoplasm of the sellar region, presumably derived from Rathke pouch epithelium.Craniopharyngioma
CRANIOPHARYNGIOMA, MALIGNANTC79949Carcinoma Arising From CraniopharyngiomaA malignant epithelial neoplasm of the sellar region, presumably derived from Rathke pouch epithelium.Carcinoma Arising from Craniopharyngioma
CYSTADENOCARCINOMA, MALIGNANTC2971A malignant cystic epithelial neoplasm arising from glandular epithelium.Cystadenocarcinoma
CYSTADENOCARCINOMA, PAPILLARY, MALIGNANTC3777A malignant cystic epithelial neoplasm arising from glandular epithelium exhibiting papillary structures.Papillary Cystadenocarcinoma
CYSTADENOMA, BENIGNC2972CystomaA benign cystic epithelial neoplasm arising from glandular epithelium.Cystadenoma
CYSTADENOMA, PAPILLARY, BENIGNC2974A benign cystic epithelial neoplasm arising from glandular epithelium exhibiting papillary structures.Papillary Cystadenoma
DECIDUOMA, MALIGNANTC3555Malignant Neoplasm of Placenta;Malignant Neoplasm of the Placenta;Malignant Placental Neoplasm;Malignant Placental Tumor;Malignant Tumor of Placenta;Malignant Tumor of the PlacentaA malignant neoplasm arising from decidua (placental) cells.Malignant Placental Neoplasm
DECIDUOMA, UNDETERMINEDC4858Neoplasm of Placenta;Neoplasm of the Placenta;Placenta Neoplasm;Placenta Neoplasms;Placenta Tumor;Placenta Tumors;Placental Tumor;Placental Tumors;Tumor Of the Placenta;Tumor of Placenta;Tumor of the PlacentaA neoplasm arising from decidua (placental) cells in which the malignancy status has not been established.Placental Neoplasm
DERMOID CYST, BENIGNC9011Benign Cystic Teratoma;Dermoid;Mature Cystic TeratomaA benign neoplasm comprised of a cyst, lined by mature epidermis-like tissue with dermal appendages.Dermoid Cyst
DYSGERMINOMA, MALIGNANTC2996A malignant germ cell neoplasm characterized by the presence of a monotonous primitive germ cell population, primarily in the ovary.Dysgerminoma
EPENDYMOMA, ANAPLASTIC, MALIGNANTC4049Anaplastic Ependymal Neoplasm;Anaplastic Ependymal Tumor;Malignant Ependymoma;Undifferentiated Ependymal Neoplasm;Undifferentiated Ependymal Tumor;Undifferentiated Ependymoma;Who Grade III Ependymal Neoplasm;Who Grade III Ependymal TumorA malignant neoplasm of ependymal origin with anaplastic cellular morphology.Anaplastic Ependymoma
EPENDYMOMA, BENIGNC3697A benign neoplasm of ependymal origin.Myxopapillary Ependymoma
EPENDYMOMA, MALIGNANTC119575A malignant neoplasm of ependymal origin.Experimental Organism Malignant Ependymoma
EPENDYMOMA, UNDETERMINEDC3017Who Grade II Ependymal Neoplasm;Who Grade II Ependymal TumorA neoplasm of ependymal origin, for which the malignancy status has not been established.Ependymoma
EPITHELIOMA, BENIGNC4092Benign Epithelial Tumor;Benign Epithelioma;Benign Neoplasm of Epithelium;Benign Neoplasm of the Epithelium;Benign Tumor of Epithelium;Benign Tumor of the EpitheliumA benign neoplasm arising from epithelial cells of the skin.Benign Epithelial Neoplasm
EPITHELIOMA, CYSTIC KERATINIZING, BENIGNC80349A benign cystic epithelial neoplasm featuring a central keratin mass surrounded by squamous epithelium.Cystic Keratinizing Epithelioma
EPITHELIOMA, NON-KERATINIZING, BENIGNC84356A benign cystic epithelial neoplasm characterized by the absence of keratin production.Non-Keratinizing Epithelioma
FIBROADENOCARCINOMA, MALIGNANTC2928Adenocarcinoma With Productive Fibrosis;Fibrocarcinoma;Scirrhous CarcinomaA malignant neoplasm originating from glandular cells with a fibrous or fibroblastic component.Scirrhous Adenocarcinoma
FIBROADENOMA, BENIGNC3744Breast Fibroadenoma;Fibroadenoma of Breast;Fibroadenoma of the BreastA benign neoplasm originating from glandular cells with a fibrous or fibroblastic component.Fibroadenoma
FIBROLIPOMA, BENIGNC4249A benign neoplasm comprising mature adipocytes, characterized by areas of abundant fibrous tissue.Fibrolipoma
FIBROMA, BENIGNC3041A benign neoplasm arising from fibrous tissue.Fibroma
FIBROMA, ODONTOGENIC, BENIGNC4314Central Odontogenic FibromaA benign intraosseous neoplasm arising from tooth-forming tissues in the mandible and maxilla, characterized by the presence of islands of odontogenic epithelium.Odontogenic Fibroma
FIBROMA, OSSIFYING, BENIGNC8422Cementifying Fibroma;Cemento-Ossifying Fibroma;Ossifying FibromaA benign fibrous neoplasm characterized by a mineralized component (woven bone, lamellar bone, or cementum-like material).Ossifying Fibroma
FIBROMYXOMA, BENIGNC66760FibromyxomaA benign soft-tissue neoplasm of uncertain lineage, characterized by the presence of neoplastic spindle-shaped to round cells and a fibromyxoid stroma.Fibromyxoid Neoplasm
FIBROPAPILLOMA, BENIGNC3337A benign polypoid tumor comprising fibrous tissue and epithelium.Fibroepithelial Polyp
FIBROSARCOMA, MALIGNANTC3043A malignant mesenchymal neoplasm of the soft tissue and bone.Fibrosarcoma
GANGLIOGLIOMA, BENIGNC119576A benign neoplasm comprised of ganglion and glial cells.Experimental Organism Benign Ganglioglioma
GANGLIOGLIOMA, UNDETERMINEDC3788A neuroepithelial neoplasm comprised of neoplastic ganglion cells and neoplastic glial cells, in which the malignancy status has not been established.Ganglioglioma
GANGLIONEUROBLASTOMA, MALIGNANTC3790A malignant neoplasm characterized by the presence of neuroblastic and ganglion cells and a stroma with Schwannian differentiation.Ganglioneuroblastoma
GANGLIONEUROMA, BENIGNC3049Neural Crest Tumor, BenignA benign neoplasm characterized by the presence of ganglion cells and spindle cell proliferation, located primarily in the brain, ganglia, or adrenal medulla.Ganglioneuroma
GIANT CELL TUMOR, BENIGNC27477Benign Bone Giant Cell Tumor;Osteoclastoma, BenignA benign neoplasm of bone comprised of giant cells (osteoclast-like) and mononuclear cells.Benign Giant Cell Tumor of Bone
GIANT CELL TUMOR, MALIGNANTC4090Malignant Giant Cell TumorA malignant neoplasm of bone comprised of giant cells (osteoclast-like) and mononuclear cells.Malignant Giant Cell Neoplasm
GIANT CELL TUMOR, UNDETERMINEDC3055Tumor of Giant Cell;Tumor of the Giant CellA neoplasm of bone comprised of giant cells (osteoclast-like) and mononuclear cells, for which the malignancy status has not been established.Giant Cell Tumor
GLIOMA, MALIGNANTC4822Malignant Glial Neoplasm;Malignant Glial Tumor;Malignant Neuroglial Neoplasm;Malignant Neuroglial TumorA malignant neuroglial neoplasm. The term can apply to several primary neoplasm of the brain and spinal cord, including astrocytoma and oligodendroglioma in addition to others.Malignant Glioma
GLIOMA, MIXED, MALIGNANTC3903Glioma, Mixed;Mixed Glial Neoplasm;Mixed Glial Tumor;Mixed Neuroglial Neoplasm;Mixed Neuroglial TumorA malignant neoplasm comprising two or more glial cell types (e.g., astrocytes, ependymal cells, oligodendrocytes).Mixed Glioma
GRANULAR CELL TUMOR, BENIGNC3252Benign Granular Cell Myoblastoma;Benign Granular Cell Neoplasm;Benign Granular Cell Tumor;MyoblastomaA benign neoplasm, comprised of large cells with cytoplasmatic granules, occurring in various organs/tissues.Benign Granular Cell Tumor
GRANULAR CELL TUMOR, MALIGNANTC4336Malignant Granular Cell Myoblastoma;Malignant Granular Cell Neoplasm;Myoblastoma, MalignantA malignant neoplasm, comprised of large cells with cytoplasmatic granules, occurring in various organs/tissues.Malignant Granular Cell Tumor
GRANULOSA CELL TUMOR, BENIGNC60340A benign neoplasm of the ovary, originating from granulosa cells.Rat Benign Granulosa Cell Tumor
GRANULOSA CELL TUMOR, MALIGNANTC4205Malignant Granulosa Cell TumorA malignant neoplasm of the ovary, originating from granulosa cells.Malignant Granulosa Cell Tumor
GRANULOSA CELL TUMOR, UNDETERMINEDC3070Granulosa Cell NeoplasmA neoplasm of the ovary (or testis), originating from granulosa cells for which the malignancy status has not been established.Granulosa Cell Tumor
HAIR FOLLICLE NEOPLASM, BENIGNC27520Benign Follicular Neoplasm;Benign Follicular Tumor;Benign Hair Follicle TumorA benign neoplasm that arises from the hair follicle.Benign Hair Follicle Neoplasm
HAIR FOLLICLE NEOPLASM, MALIGNANTC43310Malignant Hair Follicle TumorA malignant neoplasm that arises from the hair follicle.Malignant Hair Follicle Neoplasm
HAIR FOLLICLE NEOPLASM, UNDETERMINEDC7367Hair Follicle Tumor;Hair Matrix Neoplasm;Hair Matrix Tumor;Neoplasm of Hair Follicle;Neoplasm of the Hair FollicleA neoplasm that arises from the hair follicle, for which the malignancy status has not been established.Hair Follicle Neoplasm
HEMANGIOMA, BENIGNC3085Angioma;Benign Angioma;Benign HemangiomaA benign vascular neoplasm characterized by the formation of capillary-sized or cavernous vascular channels.Hemangioma
HEMANGIOPERICYTOMA, BENIGNC4300A benign neoplasm originating from vascular pericytes (cells in the periphery of vessels).Benign Hemangiopericytoma
HEMANGIOPERICYTOMA, MALIGNANTC4301Malignant Hemangiopericytoma NOSA malignant neoplasm originating from vascular pericytes (cells in the periphery of vessels).Malignant Hemangiopericytoma
HEMANGIOPERICYTOMA, UNDETERMINEDC3087A neoplasm originating from vascular pericytes (cells in the periphery of vessels), for which the malignancy status has not been established.Hemangiopericytoma
HEMANGIOSARCOMA, MALIGNANTC3088HemangiosarcomaA malignant vascular neoplasm arising from endothelial cells.Angiosarcoma
HEPATOBLASTOMA, MALIGNANTC3728HBL;Pediatric Embryonal Hepatoma;Pediatric HepatoblastomaA malignant liver neoplasm composed of immature hepatocytic elements.Hepatoblastoma
HIBERNOMA, BENIGNC3702Brown Fat Neoplasm;Brown Fat Tumor;Fetal Fat Cell LipomaA benign neoplasm of the brown adipose tissue.Hibernoma
HIBERNOMA, MALIGNANTC103394Malignant HibernomaA malignant neoplasm arising from the brown adipose tissue in animals, usually in the subcutis and the thoracic cavity.Experimental Organism Malignant Hibernoma
HISTIOCYTOMA, BENIGNC98708A benign dermal neoplasm comprising of round cells, resembling histiocytes. The tumor commonly occurs in young dogs and may regress spontaneously.Benign Histiocytoma
HISTIOCYTOMA, FIBROUS, BENIGNC3739Fibrous HistiocytomaA benign neoplasm composed of a fibroblastic and a histiocytic component.Benign Fibrous Histiocytoma
HISTIOCYTOMA, FIBROUS, MALIGNANTC4247Fibroxanthosarcoma;MFH;Malignant Fibrous Histiocytoma of Soft Tissue and Bone;Malignant Fibrous Histiocytoma of the Soft Tissue and Bone;Malignant FibroxanthomaA malignant neoplasm composed of a fibroblastic and a histiocytic component.Unclassified Pleomorphic Sarcoma
HISTIOCYTOMA, FIBROUS, UNDETERMINEDC8402Fibrohistiocytic TumorA neoplasm composed of a fibroblastic and a histiocytic component, for which the malignancy status has not been established.Fibrohistiocytic Neoplasm
HISTIOCYTOMA, UNDETERMINEDC35765A neoplasm composed of histiocytic cells, for which the malignancy status has not been established.Histiocytoma
ITO CELL TUMOR, BENIGNC80351Benign Spongiotic PericytomaA benign neoplasm of the liver composed of hepatic stellate cells (Ito cells).Benign Ito Cell Tumor
ITO CELL TUMOR, MALIGNANTC80352Malignant Spongiotic PericytomaA malignant neoplasm of the liver composed of hepatic stellate cells (Ito cells).Malignant Ito Cell Tumor
KERATOACANTHOMA, BENIGNC117977A benign neoplasm in the superficial dermis with direct association to the epidermis, composed of well differentiated squamous epithelium and a central cavity filled with concentric layers of keratin; a pore (opening in the epidermis) may be present.Experimental Organism Benign Keratoacanthoma
KERATOACANTHOMA, UNDETERMINEDC3146An epithelial skin neoplasm, composed of squamous cells, for which the malignancy status has not been established.Keratoacanthoma
LEIOMYOBLASTOMA, BENIGNC81854A benign neoplasm of the gastro-intestinal tract, originating from smooth muscle cells.Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor
LEIOMYOBLASTOMA, MALIGNANTC81855A malignant neoplasm of the gastro-intestinal tract, originating from smooth muscle cells.Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor
LEIOMYOBLASTOMA, UNDETERMINEDC3486Epithelioid Cell Type GIST;Leiomyoblastoma;Stout's LeiomyoblastomaA neoplasm of the gastro-intestinal tract, originating from smooth muscle cells, for which the malignancy status has not been established.Epithelioid Cell Type Gastrointestinal Stromal Tumor
LEIOMYOMA, BENIGNC3157Fibroid;Fibroid Neoplasm;Fibroid Tumor;Leiomyomatous Neoplasm;Leiomyomatous TumorA benign neoplasm, originating from smooth muscle cells.Leiomyoma
LEIOMYOSARCOMA, MALIGNANTC3158LeiomyosarcomasA malignant neoplasm, originating from smooth muscle cells.Leiomyosarcoma
LEUKEMIA, ERYTHROID, MALIGNANTC8923Acute Erythroblastic Leukemia;Erythroblastic Leukemia;Fab M6;M6 Acute Myeloid LeukemiaA progressive, proliferative disease of blood cells, originating from immature erythroid cells.Acute Erythroid Leukemia
LEUKEMIA, GRANULOCYTIC, MALIGNANTC3172Leukemia Granulocytic;Leukemia Myeloid;Myelocytic Leukemia;Myelogenous Leukemia;Non-lymphoblastic Leukemia;Non-lymphocytic LeukemiaA progressive, proliferative disease of blood cells, originating from immature granulocytes.Myeloid Leukemia
LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC, MALIGNANTC4664LGLL;Large Cell Granular Lymphogenous Leukemia;Large Cell Granular Lymphoid Leukemia;Large Granular Lymphocytic Leukemia;Large Granular Lymphocytosis;T Gamma Lymphoproliferative Disorder;T-Cell Large Granular Lymphocytic Leukemia;T-Gamma Lymphoproliferative Disorder;Tgamma Large Granular Lymphocyte LeukemiaA progressive, proliferative disease of blood cells which are large and granular, originating from lymphoid cells.T-Cell Large Granular Lymphocyte Leukemia
LEUKEMIA, LYMPHOBLASTIC, MALIGNANTC3167ALL;ALL - Acute Lymphocytic Leukemia;Acute Lymphocytic Leukaemia;Acute Lymphocytic Leukemias;Acute Lymphogenous Leukemia;Acute Lymphoid Leukemia;Lymphoblastic Leukemia;Precursor Cell Lymphoblastic Leukemia;Precursor Lymphoblasic LeukemiaA progressive, proliferative disease of blood cells, originating from immature lymphoid cells.Acute Lymphoblastic Leukemia
LEUKEMIA, LYMPHOCYTIC, MALIGNANTC7539Lymphocytic Leukemia;Lymphogenous LeukemiaA progressive, proliferative disease of blood cells, originating from lymphoid cells.Lymphoid Leukemia
LEUKEMIA, MALIGNANTC3161Blood (Leukemia);Leukemia NOS;Leukemias;Leukemias, GeneralA progressive, proliferative disease of blood cells, originating from myeloid or lymphoid stem cells.Leukemia
LEUKEMIA, MEGAKARYOCYTIC, MALIGNANTC3170Acute M7 Myeloid Leukemia;Acute Megakaryoblastic Leukemia (Fab Type M7);Acute Megakaryocytic Leukemia;Fab M7A progressive, proliferative disease of blood cells, originating from immature megakaryocytes.Acute Megakaryoblastic Leukemia
LEUKEMIA, MONOCYTIC, MALIGNANTC4861Acute Monocytic Leukemia (Fab M5B);Monocytic LeukemiaA progressive, proliferative disease of blood cells, originating from immature monocytes.Acute Monocytic Leukemia
LEYDIG CELL TUMOR, BENIGNC4212Adenoma, Interstitial;Benign Interstitial Cell Neoplasm;Benign Interstitial Cell Tumor;Benign Leydig Cell NeoplasmA benign neoplasm of the testis originating from interstitial (Leydig) cells.Benign Leydig Cell Tumor
LEYDIG CELL TUMOR, MALIGNANTC4213Malignant Interstitial Cell Neoplasm;Malignant Interstitial Cell Tumor;Malignant Leydig Cell NeoplasmA malignant neoplasm of the testis originating from interstitial (Leydig) cells.Malignant Leydig Cell Tumor
LEYDIG CELL TUMOR, UNDETERMINEDC3188Interstitial Cell Neoplasm;Interstitial Cell Tumor;Leydig Cell Neoplasm;Leydig Cell TumorA neoplasm of the testis originating from interstitial (Leydig) cells, for which the malignancy status has not been established.Leydig Cell Tumor
LIPOMA, BENIGNC3192A benign neoplasm composed of adipose tissue.Lipoma
LIPOSARCOMA, MALIGNANTC3194A malignant neoplasm composed of adipose tissue.Liposarcoma
LUTEOMA, BENIGNC3202Luteal Cell Neoplasm;Luteal Cell Tumor;Luteinoma;Luteoma;Ovarian Stroma LuteomaA benign neoplasm of the ovary, composed of leuteinized granulosa-theca cells.Ovarian Stromal Luteoma
LYMPHANGIOMA, BENIGNC8965A benign neoplasm arising from the lymphatics.Lymphangioma
LYMPHANGIOSARCOMA, MALIGNANTC3205Lymphangioendothelial Sarcoma;Malignant LymphangioendotheliomaA malignant neoplasm arising from the endothelial cells of the lymphatic vessels.Lymphangiosarcoma
LYMPHOMA, FOLLICULAR, MALIGNANTC3209Follicle Center Lymphoma;Follicular Centre Cell Lymphoma;Follicular Non-Hodgkin Lymphoma;Follicular Non-Hodgkin's Lymphoma;Lymphoma, Follicular Centre CellA neoplasm of lymphoid cells which has at least a partial follicular pattern.Follicular Lymphoma
LYMPHOMA, HISTIOCYTIC, MALIGNANTC114110Lymphoma, Large Cell, MalignantA malignant neoplasm of large lymphocytes, which resemble histiocytes.Experimental Organism Histiocytic Lymphoma Neoplasm
LYMPHOMA, IMMUNOBLASTIC, MALIGNANTC3461A malignant neoplasm composed of immunoblasts (large B cells).Immunoblastic Lymphoma
LYMPHOMA, LYMPHOBLASTIC, MALIGNANTC9360Precursor Cell Lymphoblastic Lymphoma;Precursor Lymphoblastic LymphomaA malignant neoplasm composed of lymphoblasts (lymphoid precursor cells).Lymphoblastic Lymphoma
LYMPHOMA, LYMPHOPLASMACYTIC, MALIGNANTC3212Immunocytoma, Lymphoplasmacytic Type;Lymphoma, Plasmacytic;Lymphoplasmacytoid LymphomaA malignant neoplasm composed of lymphocytes (B-cells), lymphoplasmacytoid cells, and plasma cells.Lymphoplasmacytic Lymphoma
LYMPHOMA, MALIGNANTC3208Lymphoma (Hodgkin and Non-Hodgkin);Lymphoma (Hodgkin's and Non-Hodgkin's);Malignant LymphomaA malignant neoplasm composed of lymphocytes of B- or T/NK-cell phenotype.Lymphoma
LYMPHOMA, MIXED, MALIGNANTC114111Diffuse Mixed Large and Small Cell LymphomaA malignant neoplasm composed of a mixed lymphocyte population.Experimental Organism Mixed Lymphoma Neoplasm
LYMPHOMA, SMALL LYMPHOCYTIC, MALIGNANTC7540B-Cell Small Lymphocytic Lymphoma;Lymphoma, Lymphocytic, Malignant;SLL;Small B-Cell Lymphocytic LymphomaA malignant neoplasm composed of small lymphocytes.Small Lymphocytic Lymphoma
LYMPHOSARCOMA, MALIGNANTC114112An antiquated term referring to a malignant lymphoma that is diffused and composed of small and large lymphocytes.Experimental Organism Lymphosarcoma Neoplasm
MAST CELL TUMOR, BENIGNC3217A benign neoplasm composed of mast cells.Benign Mastocytoma
MAST CELL TUMOR, MALIGNANTC8991A malignant neoplasm composed of mast cells.Malignant Mastocytosis
MAST CELL TUMOR, UNDETERMINEDC9295Mast Cell Proliferative Disease;Mast Cell Tumor;Neoplasm of Mast Cells;Neoplasm of the Mast Cells;Tumor of Mast Cells;Tumor of the Mast CellsA neoplasm composed of mast cells, for which the malignancy status has not been determined.Mast Cell Neoplasm
MEDULLOBLASTOMA, MALIGNANTC3222MedulloblastomasA malignant, invasive embryonal neoplasm arising from the cerebellum.Medulloblastoma
MELANOMA, AMELANOTIC, MALIGNANTC3802A malignant neoplasm composed of melanocytes, which lack melanin.Amelanotic Melanoma
MELANOMA, BENIGNC98709Benign Melanocytoma;Melanocytoma, BenignA benign neoplasm or hamartoma composed of melanocytes.Benign Melanocytoma
MELANOMA, MALIGNANTC3224Malignant MelanomaA malignant neoplasm composed of melanocytes.Melanoma
MELANOMA, UVEAL, MALIGNANTC7712Intraocular Melanoma;Melanoma of Uvea;Melanoma of the UveaA malignant neoplasm of the uvea composed of melanocytes.Uveal Melanoma
MENINGIOMA, ANAPLASTIC, MALIGNANTC4051Anaplastic Meningioma;Malignant Meningioma;Meningioma, MalignantA malignant neoplasm of the meninges, exhibiting poor differentiation (anaplasia).Anaplastic (Malignant) Meningioma
MENINGIOMA, BENIGNC4055Meningioma, BenignA benign neoplasm of the meninges.Benign Meningioma
MENINGIOMA, MALIGNANTC38938Grade 3 Meningioma;Grade III Meningioma;Who Grade III MeningiomaA malignant neoplasm of the meninges.Grade III Meningioma
MENINGIOMA, UNDETERMINEDC3230A neoplasm of the meninges, for which the status of malignancy has not been determined.Meningioma
MESENCHYMAL TUMOR, BENIGNC4267A benign soft-tissue neoplasm comprising two or more non-fibroblastic mesenchymal lines of differentiation.Benign Mesenchymoma
MESENCHYMAL TUMOR, MALIGNANTC64118A malignant soft-tissue neoplasm comprising two or more non-fibroblastic mesenchymal lines of differentiation.Malignant Mesenchymal Tumor of the Rat Kidney
MESOTHELIOMA, BENIGNC3762Adenomatoid Tumor, Benign;Benign Localized Epithelial Mesothelioma;Benign Mesothelial Neoplasm;Benign Mesothelial Tumor;Benign Mesothelioma;Benign Neoplasm of Mesothelium;Benign Neoplasm of the Mesothelium;Benign Tumor of Mesothelium;Benign Tumor of the Mesothelium;Mesothelioma, BenignA benign neoplasm arising from mesothelial cells.Adenomatoid Tumor
MESOTHELIOMA, MALIGNANTC4456Malignant Mesothelial Neoplasm;Malignant Mesothelial Tumor;Malignant Neoplasm of Mesothelium;Malignant Neoplasm of the Mesothelium;Malignant Tumor of Mesothelium;Malignant Tumor of the MesotheliumA malignant neoplasm originating from mesothelial cells of the pleura or peritoneum.Malignant Mesothelioma
MESOTHELIOMA, UNDETERMINEDC3234A neoplasm originating from mesothelial cells of the pleura or peritoneum, for which the malignancy status has not been established.Mesothelioma
MIXED GLIOMA, BENIGNC4050A benign neoplasm of the central nervous system with an astrocytic and oligodendrocytic component.Oligoastrocytoma
MIXED TUMOR, BENIGNC8602A benign neoplasm composed of epithelial and/or myoepithelial cells and a mesenchymal component.Pleomorphic Adenoma
MIXED TUMOR, MALIGNANTC3729Malignant Mixed TumorA malignant neoplasm composed of epithelial and/or myoepithelial cells and a mesenchymal component. A general term for which the transformed cell types have not been specified.Malignant Mixed Neoplasm
MIXED TUMOR, UNDETERMINEDC6930Mixed Tumor;Tumor, MixedA neoplasm composed of an epithelial component and/or a mesenchymal component, for which the malignancy status has not been established. A general term for which the transformed cell types have not been specified.Mixed Neoplasm
MUELLERIAN TUMOR, MIXED, MALIGNANTC8975Malignant Mixed Mesodermal Tumor;Malignant Mixed Mullerian Tumor;MmmtA malignant neoplasm of the female reproductive system (mostly uterus and ovaries) originating from the Muellerian ducts and composed of carcinomatous and sarcomatous elements.Malignant Mixed Mesodermal (Mullerian) Tumor
MYELOLIPOMA, BENIGNC3736MyelolipomaA benign tumor of the adrenal gland composed of adipocytes and hematopoietic/lymphoid cells.Adrenal Gland Myelolipoma
MYELOMA, PLASMA CELL, MALIGNANTC3242Multiple Myeloma;MyelomaA malignant neoplasm of the bone marrow composed of plasma cells.Plasma Cell Myeloma
MYOEPITHELIOMA, BENIGNC7442A benign neoplasm composed of myoepithelial cells.Benign Myoepithelioma
MYOEPITHELIOMA, MALIGNANTC7596Malignant Myoepithelioma;Myoepithelial CarcinomaA malignant neoplasm composed of myoepithelial cells.Malignant Myoepithelioma
MYXOMA, BENIGNC6577A benign soft tissue neoplasm with a myxoid stroma formation.Myxoma
MYXOSARCOMA, MALIGNANTC3255A malignant soft tissue neoplasm with a myxoid stroma formation.Myxosarcoma
NEOPLASM, BENIGNC3677Benign Tumor;Benign Unclassifiable TumorA general term used to describe autonomous growth of tissue where the originating cell type has not been characterized. The term benign indicates the absence of morphologic features associated with malignancy (for instance severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses).Benign Neoplasm
NEOPLASM, MALIGNANTC9305CA;Cancer;Malignancy;Malignant TumorA general term for autonomous tissue growth exhibiting morphologic features of malignancy (e.g. severe atypia, nuclear pleomorphism, tumor cell necrosis, abnormal mitoses, tissue invasiveness) and for which the transformed cell type has not been specifically identified.Malignant Neoplasm
NEOPLASM, UNDETERMINEDC3262A general term for autonomous tissue growth in which the malignancy status has not been established and for which the transformed cell type has not been specifically identified.Neoplasm
NEPHROBLASTOMA, BENIGNC114235A benign embryonal neoplasm of the kidney.Experimental Organism Benign Nephroblastoma Neoplasm
NEPHROBLASTOMA, MALIGNANTC40407Embryonal Nephroma;Nephroblastoma;Renal Wilms' Tumor;Wilms Tumor of the Kidney;Wilms' Tumor of the KidneyA malignant embryonal neoplasm of the kidney.Nephroblastoma
NEURAL CREST TUMOR, UNDETERMINEDC6963A neoplasm composed of cells of neuroendocrine origin for which the malignancy status has not been established.Neuroblastic Tumor
NEUROBLASTOMA, MALIGNANTC3270Neural Crest Tumor, Malignant;Neuroblastoma (Schwannian Stroma-poor)A malignant neoplasm composed of neuroblastic cells.Neuroblastoma
NEUROBLASTOMA, OLFACTORY, MALIGNANTC3789Esthesioneuroblastoma;Esthesioneuroepithelioma;Olfactory Esthesioneuroblastoma;Olfactory NeuroepitheliomaA malignant neoplasm of the olfactory receptor cells, composed of neuroblastic cells.Olfactory Neuroblastoma
NEUROFIBROMA, BENIGNC3272An intraneural or extraneural neoplasm arising from nerve tissues and neural sheaths, composed of perineurial-like fibroblasts and Schwann cells.Neurofibroma
NEUROGLIAL TUMOR, UNDETERMINEDC3059Glial Neoplasm;Glial Tumor;Glioma;Neoplasm of Neuroglia;Neoplasm of the Neuroglia;Neoplasms of Neuroglia;Neuroglial Neoplasm;Neuroglial Neoplasms;Tumor of Neuroglia;Tumor of the Neuroglia;Tumors of NeurogliaA neoplasm of the central nervous system composed of glial cells (astrocytes, oligodendrocytes, ependymal cells), for which the malignancy status has not been determined.Glioma
NEUROMYOBLASTOMA, MALIGNANTC116214A malignant tumor that arises in the brain stem or adjacent cranial nerves, consisting of variable populations of cells with neuronal and myoblast differentiation. (INHAND)Experimental Organism Malignant Neuromyoblastoma
ODONTOGENIC TUMOR, BENIGNC4306Benign Odontogenic TumorA benign neoplasm arising from tooth-forming tissues.Benign Odontogenic Neoplasm
ODONTOGENIC TUMOR, UNDETERMINEDC3286Odontogenic TumorA neoplasm arising from tooth-forming tissues, for which the malignancy status has not been established.Odontogenic Neoplasm
ODONTOMA, AMELOBLASTIC, BENIGNC3710Ameloblastic Fibroodontoma;Fibroameloblastic OdontomaA benign neoplasm arising from tooth-forming tissues with-enamel organ differentiation (but without enamel formation).Ameloblastic Fibro-Odontoma
ODONTOMA, AMELOBLASTIC, MALIGNANTC7492A malignant neoplasm arising from tooth-forming tissues with-enamel organ differentiation (but without enamel formation).Ameloblastic Carcinoma
ODONTOMA, BENIGNC3287Fibro-Odontoma;FibroodontomaA benign neoplasm of tooth origin.Odontoma
ODONTOMA, MALIGNANTC4812Malignant Odontogenic Tumor;Odontogenic Carcinoma;Odontogenic CarcinosarcomaA malignant neoplasm of tooth origin.Malignant Odontogenic Neoplasm
OLIGODENDROGLIOMA, ANAPLASTIC, MALIGNANTC4326Malignant;Malignant Oligodendroglioma;Oligodendroglioma;Undifferentiated Oligodendroglioma;Who Grade III Oligodendroglial Neoplasm;Who Grade III Oligodendroglial TumorA malignant neoplasm of the central nervous system arising from oligodendrocytes, exhibiting poor differentiation (anaplasia).Anaplastic Oligodendroglioma
OLIGODENDROGLIOMA, MALIGNANTC119577A malignant neoplasm of the brain or spinal cord originating from oligodendrocytes.Experimental Organism Malignant Oligodendroglioma
OLIGODENDROGLIOMA, UNDETERMINEDC3288Well Differentiated Oligodendroglial Tumor;Well Differentiated Oligodendroglioma;Who Grade II Oligodendroglial Neoplasm;Who Grade II Oligodendroglial TumorA neoplasm of the central nervous system arising from oligodendrocytes, for which the malignancy status has not been determined.Oligodendroglioma
ONCOCYTOMA, BENIGNC7072Oncocytic Tumor;OncocytomaA benign neoplasm composed of large cells with abundant eosinophilic granular cytoplasm (oncocytes).Oncocytic Neoplasm
ONCOCYTOMA, MALIGNANTC3679Hurthle Cell Adenocarcinoma;Hurthle Cell Carcinoma;Oncocytic Adenocarcinoma;Oncocytic CarcinomaA malignant neoplasm composed of large epithelial cells with abundant granular eosinophilic cytoplasm (oncocytes).Oxyphilic Adenocarcinoma
OSTEOBLASTOMA, BENIGNC3294Giant Osteoid Osteoma;Ossifying Giant Cell TumorA benign neoplasm of bone, characterized by the formation of osteoid tissue and large osteoblast-like cells.Osteoblastoma
OSTEOCHONDROMA, BENIGNC3295A benign cartiliginous neoplasm arising from the metaphysis of bone.Osteochondroma
OSTEOCHONDROSARCOMA, MALIGNANTC7155Conventional Chondrosarcoma of Bone;Primary Bone Chondrosarcoma;Primary Chondrosarcoma;Primary Chondrosarcoma of Bone;Primary Chondrosarcoma of the BoneA malignant cartiliginous neoplasm of bone.Conventional Chondrosarcoma
OSTEOCLASTOMA, MALIGNANTC4304Dedifferentiated Giant Cell Tumor;Giant Cell Bone Sarcoma;Giant Cell Sarcoma of Bone;Giant Cell Sarcoma of the BoneA malignant neoplasm of bone comprised of osteoclast-like giant cells and mononuclear cells.Malignant Giant Cell Tumor of Bone
OSTEOCLASTOMA, UNDETERMINEDC3738Bone Giant Cell Neoplasm;Bone Giant Cell Tumor;Giant Cell Neoplasm of BoneA neoplasm of bone comprised of osteoclast-like giant cells and mononuclear cells, for which the malignancy status has not been established.Giant Cell Tumor of Bone
OSTEOFIBROMA, BENIGNC3740Desmoid Tumor of Bone;Desmoplastic Fibroma;Desmoplastic Fibroma of Bone;Desmoplastic Fibroma of the Bone;Osseous Desmoplastic FibromaA benign neoplasm characterized by osteolysis and the presence of a rich collagenous stroma and spindle cells.Bone Desmoplastic Fibroma
OSTEOFIBROMA, BONE, BENIGNC103392Osteofibroma, BoneA benign neoplasm, morphologically a fibroma with osseous components.Experimental Organism Benign Bone Osteofibroma
OSTEOMA, BENIGNC3296A benign well-differentiated neoplasm of bone.Osteoma
OSTEOSARCOMA, EXTRASKELETAL, MALIGNANTC8810Extraosseous Osteosarcoma;Extraskeletal Osteogenic Sarcoma;Soft Tissue OsteosarcomaA malignant bone-forming neoplasm, arising in tissue other than bone.Extraskeletal Osteosarcoma
OSTEOSARCOMA, MALIGNANTC9145Osteogenic SarcomaA malignant neoplasm usually arising from bone.Osteosarcoma
OVARIAN SEX CORD-STROMAL TUMOR, BENIGNC6803Benign Ovarian Sex Cord-Stromal Neoplasm;Benign Sex Cord-Stromal Neoplasm of Ovary;Benign Sex Cord-Stromal Neoplasm of the Ovary;Benign Sex Cord-Stromal Tumor of Ovary;Benign Sex Cord-Stromal Tumor of the Ovary;Sex Cord Stromal Tumor, BenignA benign neoplasm of the ovary, originating from the sex-cord stroma.Benign Ovarian Sex Cord-Stromal Tumor
PAPILLOMA, BENIGNC7440A benign epithelial neoplasm that projects above the surrounding epithelial surface.Papilloma
PAPILLOMA, CHOROID PLEXUS, BENIGNC3698Papilloma of Choroid Plexus;Papilloma of the Choroid PlexusA benign neoplasm of the choroid plexus of the central nervous system.Choroid Plexus Papilloma
PAPILLOMA, SQUAMOUS CELL, BENIGNC3712Epidermoid Cell Papilloma;Epidermoid Papilloma;Keratotic Papilloma;Squamous Cell PapillomaA benign epithelial neoplasm characterized by a papillary growth pattern and a proliferation of neoplastic squamous cells.Squamous Papilloma
PAPILLOMA, TRANSITIONAL CELL, BENIGNC4115Transitional PapillomaA benign papillary neoplasm composed of transitional cells.Transitional Cell Papilloma
PARAGANGLIOMA, BENIGNC48314Benign Neuroendocrine Cell Tumor;Benign Paraganglionic NeoplasmA benign neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells.Benign Paraganglioma
PARAGANGLIOMA, MALIGNANTC8559Malignant;Malignant Neoplasm of Paraganglion;Malignant Neoplasm of the Paraganglion;Malignant Paraganglion Neoplasm;Malignant Paraganglion Tumor;Malignant Paraganglionic Neoplasm;Malignant Paraganglionic Tumor;Malignant Tumor of Paraganglion;Malignant Tumor of the Paraganglion;Paraganglion NeoplasmA malignant neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells.Malignant Paraganglioma
PARAGANGLIOMA, UNDETERMINEDC3308Neoplasm of Paraganglion;Neoplasm of the Paraganglion;Paraganglion Neoplasm;Paraganglion Tumor;Paraganglionic Neoplasm;Paraganglionic Tumor;Tumor of Paraganglion;Tumor of the ParaganglionA neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells, for which the malignancy status has not been established.Paraganglioma
PERIPHERAL CHOLANGIOCARCINOMA, MALIGNANTC96805Peripheral CholangiocarcinomaA malignant intrahepatic neoplasm arising from the small interlobular bile ducts.Peripheral Intrahepatic Cholangiocarcinoma
PERIPHERAL NERVE SHEATH TUMOR, MALIGNANTC3798MPNST;Malignant Neoplasm of Peripheral Nerve Sheath;Malignant Neoplasm of the Peripheral Nerve Sheath;Malignant Neurilemmoma;Malignant Neurilemoma;Malignant Peripheral Nerve Sheath Neoplasm;Malignant Peripheral Nerve Sheath Tumour;Malignant Schwannoma;Malignant Tumor of Peripheral Nerve Sheath;Malignant Tumor of the Peripheral Nerve Sheath;Neurofibrosarcoma, MalignantA malignant neoplasm, originating from the sheaths of the peripheral nerve.Malignant Peripheral Nerve Sheath Tumor
PHEOCHROMOCYTOMA, BENIGNC48305A benign neoplasm of the adrenal gland medulla.Benign Adrenal Gland Pheochromocytoma
PHEOCHROMOCYTOMA, COMPLEX, BENIGNC92181A benign neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components.Benign Adrenal Gland Composite Pheochromocytoma
PHEOCHROMOCYTOMA, COMPLEX, MALIGNANTC92184A malignant neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components.Malignant Adrenal Gland Composite Pheochromocytoma
PHEOCHROMOCYTOMA, COMPLEX, UNDETERMINEDC48306A neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components, for which the malignancy status has not been established.Adrenal Gland Composite Pheochromocytoma
PHEOCHROMOCYTOMA, MALIGNANTC4220Malignant Adrenal Gland Chromaffin Neoplasm;Malignant Adrenal Gland Chromaffin Paraganglioma;Malignant Adrenal Gland Chromaffin Tumor;Malignant Adrenal Gland Chromaffinoma;Malignant Adrenal Gland Paraganglioma;Malignant Adrenal Medullary Paraganglioma;Malignant Adrenal Medullary Pheochromocytoma;Malignant Adrenal Pheochromocytoma;Malignant Pheochromocytoma;PheochromoblastomaA malignant neoplasm of the adrenal gland medulla.Malignant Adrenal Gland Pheochromocytoma
PHEOCHROMOCYTOMA, UNDETERMINEDC3326Adrenal Gland Chromaffin Paraganglioma;Adrenal Gland Chromaffinoma;Adrenal Gland Paraganglioma;Adrenal Medullary Paraganglioma;Adrenal Medullary Pheochromocytoma;Adrenal Pheochromocytoma;Chromaffin Paraganglioma of the Adrenal Gland;Intraadrenal Paraganglioma;PCC;Phaeochromocytoma;PheochromocytomaA neoplasm of the adrenal gland medulla, for which the malignancy status has not been established.Adrenal Gland Pheochromocytoma
PILOMATRIXOMA, BENIGNC7368Benign Hair Follicle Neoplasm;Benign Pilomatricoma;Benign Pilomatrixoma;Calcifying Epitherlioma of Malherbe;PilomatrixomaA benign adnexal neoplasm arising from hair-bearing skin surfaces.Pilomatricoma
PINEOBLASTOMA, MALIGNANTC9344PNET of Pineal Gland;PNET of the Pineal Gland;Pineal Gland PNET;Pineal Gland Primitive Neuroectodermal Neoplasm;Pineal Gland Primitive Neuroectodermal Tumor;Pineal PNET;Pineal Primitive Neuroectodermal Neoplasm;Pineal Primitive Neuroectodermal Tumor;Primitive Neuroectodermal Neoplasm of Pineal Gland;Primitive Neuroectodermal Neoplasm of the Pineal Gland;Primitive Neuroectodermal Tumor of Pineal Gland;Primitive Neuroectodermal Tumor of the Pineal GlandA poorly differentiated malignant embryonal neoplasm arising from the pineal region of the brain.Pineoblastoma
PINEOCYTOMA, BENIGNC6966Benign Pinealoma;PinealomaA benign neoplasm of the brain arising from the pineal gland.Pineocytoma
PITUICYTOMA, BENIGNC7157Neurohypophysis Neoplasm;Neurohypophysis Tumor;Posterior Pituitary Gland Tumor;Posterior Pituitary Neoplasm;Posterior Pituitary TumorA neoplasm arising from the posterior lobe of the pituitary gland.Posterior Pituitary Gland Neoplasm
PLASMA CELL TUMOR, MALIGNANTC4665Plasma Cell Dyscrasia;Plasma Cell Tumor;Plasmacytic Neoplasm;Plasmacytic TumorA malignant neoplasm composed of plasma cells.Plasma Cell Neoplasm
POLYP, ADENOMATOUS, UNDETERMINEDC3764Polypoid AdenomaA neoplasm, originating from glandular epithelium, exhibiting polypoid growth, for which the malignancy status has not been determined.Adenomatous Polyp
POLYP, BENIGNC112275A benign polypoid neoplasm of an epithelial lining projecting into a lumen or cavity.Experimental Organism Benign Polyp
POLYP, ENDOMETRIAL STROMAL, BENIGNC6433Adenoma, Endometrial;Endometrial Adenoma;Endometrial Stromal Polyp;Glandular Endometrial Polyp;Polyp of Endometrium;Polyp of the Endometrium;Polyp, StromalA benign polypoid neoplasm of the endometrium projecting into the endometrial cavity.Endometrial Polyp
POLYP, UNDETERMINEDC3340A protruding growth attached to the underlying tissue by a broad base or a thin stalk, which can be either inflammatory, hamartomatous, or neoplastic.Polyp
POLYP, VAGINAL, BENIGNC3664Polyp of Vagina;Polyp of the VaginaA benign polypoid growth arising from the vaginal wall.Vaginal Polyp
RETICULOSIS, MALIGNANTC4684Angiocentric T-Cell LymphomaA malignant lymphoid neoplasm composed of EBV-positive NK/T cells arranged in an angiocentric pattern.Nasal Type Extranodal NK/T-Cell Lymphoma
RETINOBLASTOMA, MALIGNANTC7541RBA malignant neoplasm originating in the nuclear layer of the retina.Retinoblastoma
RHABDOMYOMA, BENIGNC3358A benign neoplasm arising from skeletal muscle, characterized by the presence of rhabdomyoblasts.Rhabdomyoma
RHABDOMYOSARCOMA, MALIGNANTC3359A malignant mesenchymal neoplasm arising from skeletal muscle.Rhabdomyosarcoma
SARCOMA, GRANULOCYTIC, MALIGNANTC35815A malignant neoplasm composed of myeloblasts, neutrophils and neutrophil precursors.Granulocytic Sarcoma
SARCOMA, HISTIOCYTIC, MALIGNANTC27349A malignant neoplasm composed of cells resembling histiocytes.Histiocytic Sarcoma
SARCOMA, LEPTOMENINGEAL, MALIGNANTC8312Sarcoma of Leptomeninges;Sarcoma of the Leptomeninges;Sarcoma, MeningealA malignant mesenchymal neoplasm arising from the leptomeninges.Leptomeningeal Sarcoma
SARCOMA, MALIGNANTC9118Mesenchymal Tumor, Malignant;Sarcoma;Sarcoma of Soft Tissue and Bone;Sarcoma of the Soft Tissue and BoneA malignant mesenchymal neoplasm. A general term for which the transformed cell type has not been specified.Sarcoma
SARCOMA, MYELOID, MALIGNANTC3520Chloroma;Extramedullary Myeloid TumorA malignant neoplasm composed of myeloblasts or immature myeloid cells. It occurs in extramedullary sites or the bone.Myeloid Sarcoma
SARCOMA, SYNOVIAL, MALIGNANTC3400SSA malignant neoplasm that usually arises in the synovial membranes of the joints and the synovial cells of the tendons and bursae.Synovial Sarcoma
SARCOMA, UNDIFFERENTIATED, MALIGNANTC27096Embryonal Sarcoma, UndifferentiatedA rare malignant neoplasm of the liver that is most common in youth.Undifferentiated (Embryonal) Sarcoma
SCHWANNOMA, BENIGNC3269Neurilemmoma;Neurinoma;Schwannoma;Schwannoma (Who Grade I)A benign neoplasm of the peripheral nervous system composed of well-differentiated Schwann cells.Schwannoma
SEMINOMA, BENIGNC112276A benign germ cell neoplasm of the testis.Experimental Organism Benign Seminoma
SEMINOMA, MALIGNANTC9309Seminoma;Seminoma, PureA malignant germ cell neoplasm of the testis.Seminoma
SERTOLI CELL TUMOR, BENIGNC67012Benign AndroblastomaA benign neoplasm of the testis or ovary, originating from Sertoli cells.Benign Sertoli Cell Tumor
SERTOLI CELL TUMOR, MALIGNANTC67006Malignant AndroblastomaA malignant neoplasm of the testis or ovary, originating from Sertoli cells.Malignant Sertoli Cell Tumor
SERTOLI CELL TUMOR, UNDETERMINEDC98794An ovarian neoplasm comprising Sertoli cells in which the malignancy status has not been established.Undetermined Sertoli Cell Tumor
STROMAL NEPHROMA, MALIGNANTC6569Cmn;Mesoblastic NephromaA congenital malignant neoplasm of the kidney characterized by the presence of fibroblastic cells.Congenital Mesoblastic Nephroma
STROMAL SARCOMA, ENDOMETRIAL, MALIGNANTC8973ESSA malignant, mesenchymal tumor of the uterine stroma.Endometrioid Stromal Sarcoma
STROMAL SARCOMA, MALIGNANTC6926Stromal Tumor, MalignantA malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells.Stromal Sarcoma
STROMAL TUMOR, BENIGNC114113A benign neoplasm composed of mesenchymal stromal cells.Experimental Organism Benign Stromal Tumor Neoplasm
STROMAL TUMOR, GONADAL, MALIGNANTC67561Sex Cord Stromal Tumor, MalignantA malignant neoplasm originating from the gonadal sex cord stroma.Malignant Sex Cord-Stromal Tumor
STROMAL TUMOR, GONADAL, UNDETERMINEDC3794Sex Cord-Stromal Neoplasm;Sex Cord-Stromal Tumor, UndeterminedA neoplasm originating from the gonadal sex cord stroma, for which the status of malignancy has not been determined.Sex Cord-Stromal Tumor
SUBEPENDYMOMA, BENIGNC3795Subependymal Glioma;Who Grade I Ependymal Neoplasm;Who Grade I Ependymal TumorA benign neoplasm of the brain localized in the vicinity of a ventricular wall and is composed of glial tumor cell clusters embedded in an abundant fibrillary matrix with frequent microcystic changes.Subependymoma
SYNOVIOMA, BENIGNC3829Benign Neoplasm of Synovium;Benign Neoplasm of the Synovium;Benign Synovial Tumor;Benign Synovioma;Benign Tumor of Synovium;Benign Tumor of the SynoviumA benign neoplasm arising from the synovial membrane.Benign Synovial Neoplasm
TERATOMA, BENIGNC114114A benign germ-cell neoplasm derived from pluripotent cells and consisting of components from one or more of the three germ-cell layers.Experimental Organism Benign Teratoma Neoplasm
TERATOMA, MALIGNANTC4286Immature TeratomaA malignant germ-cell neoplasm derived from pluripotent cells and consisting of components from one or more of the three germ-cell layers.Immature Teratoma
TERATOMA, UNDETERMINEDC3403A germ-cell neoplasm derived from pluripotent cells and consisting of components from one or more of the three germ-cell layers, for which the malignancy status has not been established.Teratoma
THECOMA, BENIGNC5219Benign Ovarian Thecal Cell Neoplasm;Benign Ovarian Thecal Cell Tumor;Benign Thecal Cell Neoplasm of Ovary;Benign Thecal Cell Neoplasm of the Ovary;Benign Thecal Cell Tumor of Ovary;Benign Thecal Cell Tumor of the Ovary;Benign Thecoma of Ovary;Benign Thecoma of the Ovary;Thecal Cell Tumor, BenignA benign sex-cord neoplasm of the ovary, originating from theca cells.Benign Ovarian Thecoma
THECOMA, OVARIAN, MALIGNANTC6929Malignant Ovarian Thecal Cell Neoplasm;Malignant Ovarian Thecal Cell Tumor;Malignant Thecal Cell Neoplasm of Ovary;Malignant Thecal Cell Neoplasm of the Ovary;Malignant Thecal Cell Tumor of Ovary;Malignant Thecal Cell Tumor of the Ovary;Malignant Thecoma of Ovary;Malignant Thecoma of the Ovary;Thecoma, MalignantA malignant sex-cord neoplasm of the ovary, originating from theca cells.Malignant Ovarian Thecoma
THYMOMA, BENIGNC114115A benign neoplasm of the thymus, originating from epithelial thymus cells.Experimental Organism Benign Thymoma Neoplasm
THYMOMA, MALIGNANTC7612A malignant neoplasm of the thymus, originating from epithelial thymus cells.Malignant Thymoma
THYMOMA, UNDETERMINEDC3411A neoplasm of the thymus, originating from epithelial thymus cells, for which the malignancy status has not been established.Thymoma
TRICHOEPITHELIOMA, BENIGNC27132Brooke's Tumor;Trichoepithelioma;Trichogenic Adnexal Tumor;Trichogenic TrichoblastomaA benign hair follicle neoplasm with trichoblastic differentiation.Trichoblastoma
YOLK SAC TUMOR, BENIGNC84357A benign epithelial neoplasm arising from the yolk sac.Yolk Sac Adenoma
YOLK SAC TUMOR, MALIGNANTC3011Endodermal Sinus Neoplasm;Endodermal Sinus Tumor;Yolk Sac Neoplasm;Yolk Sac Tumor Site UnspecifiedA non-seminomatous malignant germ cell tumor composed of primitive germ cells and which produce an eosinophilic substance (alpha-fetoprotein).Yolk Sac Tumor
Back to top
CL.C116104.NVTESTCDNervous System Physiology Test Code
(NVTESTCD)
text
Extensible: Yes
C116104Nervous System Physiology Test CodeTerminology relevant to the test codes that describe nervous system physiology findings.CDISC SDTM Nervous System Physiology Test Code Terminology
N145LATC117886N145 LatencyAn assessment of the latency of the N145 or N2 wave of the visual evoked potential assessment waveform.N145 Latency
P100AMPC117887P100 AmplitudeThe magnitude, or height, of the P100 wave of the visual evoked potential assessment waveform. This assessment calculates the height from the N75 negative peak to the P100 positive peak.N75 to P100 Peak to Peak Amplitude
P100LATC117888P100 LatencyAn assessment of the latency of the P100 or P1 wave of the visual evoked potential assessment waveform.P100 Latency
SUVRC116141Standard Uptake Value RatioThe ratio between the uptake or binding of a radiopharmaceutical agent in an anatomical region of interest and a context-defined reference anatomical region.Standard Uptake Value Ratio
Back to top
CL.C116103.NVTESTNervous System Physiology Test Name
(NVTEST)
text
Extensible: Yes
C116103Nervous System Physiology Test NameTerminology relevant to the test names that describe nervous system physiology findings.CDISC SDTM Nervous System Physiology Test Name Terminology
N145 LatencyC117886N145 LatencyAn assessment of the latency of the N145 or N2 wave of the visual evoked potential assessment waveform.N145 Latency
P100 AmplitudeC117887P100 AmplitudeThe magnitude, or height, of the P100 wave of the visual evoked potential assessment waveform. This assessment calculates the height from the N75 negative peak to the P100 positive peak.N75 to P100 Peak to Peak Amplitude
P100 LatencyC117888P100 LatencyAn assessment of the latency of the P100 or P1 wave of the visual evoked potential assessment waveform.P100 Latency
Standard Uptake Value RatioC116141Standard Uptake Value RatioThe ratio between the uptake or binding of a radiopharmaceutical agent in an anatomical region of interest and a context-defined reference anatomical region.Standard Uptake Value Ratio
Back to top
CL.C78738.NCFNever/Current/Former Classification
(NCF)
text
Extensible: Yes
C78738Never/Current/Former ClassificationA classification of usage or experience that falls into three categories; never, current, or former.CDISC SDTM Never/Current/Former Classification Terminology
CURRENTC25471Occurring in or belonging to the present time. (NCI)Current
FORMERC25627PreviousOccurring prior to something else. (NCI)Previous
NEVERC70543Not ever; at no time in the past.Never
Back to top
CL.C101839.NYHACNew York Heart Association Classification
(NYHAC)
text
Extensible: No
C101839New York Heart Association ClassificationA terminology codelist based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease.CDISC SDTM New York Heart Association Class Responses Terminology
NYHA CLASS IC66904New York Heart Association Class IWithout limitations of physical activity. Ordinary physical activity does not cause undue fatigue, palpitations, or dyspnea.New York Heart Association Class I
NYHA CLASS IIC66905New York Heart Association Class IISlight limitation of physical activity. The patient is comfortable at rest. Ordinary physical activity results in fatigue, palpitations, or dyspnea.New York Heart Association Class II
NYHA CLASS IIIC66907New York Heart Association Class IIIMarked limitation of physical activity. The patient is comfortable at rest. Less than ordinary activity causes fatigue, palpitations, or dyspnea.New York Heart Association Class III
NYHA CLASS IVC66908New York Heart Association Class IVInability to carry on any physical activity without discomfort. Heart failure symptoms are present even at rest or with minimal exertion.New York Heart Association Class IV
Back to top
CL.C66742.NYNo Yes Response
(NY)
text
Extensible: No
C66742No Yes ResponseA term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.CDISC SDTM Yes No Unknown or Not Applicable Response Terminology
NC49487NoThe non-affirmative response to a question. (NCI)No
NAC48660NA;Not ApplicableDetermination of a value is not relevant in the current context. (NCI)Not Applicable
UC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
YC49488YesThe affirmative response to a question. (NCI)Yes
Back to top
CL.C101855.NSYSPCIDNon-system Reason for PCI Delay
(NSYSPCID)
text
Extensible: No
C101855Non-system Reason for PCI DelayA terminology codelist that contains reasons for non-system PCI delay.CDISC SDTM Non-system Reason for PCI Delay Terminology
CARDIAC ARREST BEFORE PCIC99920Cardiac arrest which occurs before a percutaneous coronary intervention can take place.Cardiac Arrest Prior to Percutaneous Coronary Intervention
DIFFICULT VASCULAR ACCESSC99945Access to the subject's vasculature is troublesome or formidable.Difficult Vascular Access
DIFFICULTY CROSSING THE CULPRIT LESION DURING THE PCI PROCEDUREC99946Placement of intracoronary devices across the coronary stenosis is troublesome or formidable.Difficulty Crossing Culprit Lesion During Percutaneous Coronary Intervention
ENDOTRACHEAL INTUBATION BEFORE PCIC99950Intubation before PCIEndotracheal intubation which occurs before a percutaneous coronary intervention can take place.Endotracheal Intubation before Percutaneous Coronary Intervention
OTHERC17649OtherDifferent than the one(s) previously specified or mentioned. (NCI)Other
SUBJECT DELAY IN PROVIDING CONSENTC100016Patient Delay in Providing ConsentThe subject has not provided consent in a timely manner for the procedure to take place.Subject Delay in Providing Consent
Back to top
CL.C101834.NORMABNMNormal Abnormal Response
(NORMABNM)
text
Extensible: No
C101834Normal Abnormal ResponseA terminology codelist to describe a normal or abnormal response.CDISC SDTM Normal Abnormal Response Terminology
ABNORMALC25401Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm. (NCI)Abnormal
INDETERMINATEC48658InconclusiveCannot distinguish between two or more possible values in the current context. (NCI)Indeterminate
NORMALC14165Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI)Normal
NOT EVALUABLEC62222Not EvaluableUnable to be evaluated. (NCI)Unevaluable
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C66789.NDNot Done
(ND)
text
Extensible: No
C66789Not DoneIndicates a task, process or examination that has either not been initiated or completed. (NCI)CDISC SDTM Not Done Terminology
NOT DONEC49484Indicates a task, process or examination that has either not been initiated or completed. (NCI)Not Done
Back to top
CL.C117743.OETESTCDOphthalmic Exam Test Code
(OETESTCD)
text
Extensible: Yes
C117743Ophthalmic Exam Test CodeTerminology relevant to the test codes that describe findings from ophthalmic examinations.CDISC SDTM Ophthalmic Exam Test Code Terminology
ASTAXISC117889Astigmatism AxisA measurement of the location, in degrees, of the flatter principal meridian on a 180-degree scale, where 90 degrees designates the vertical meridian and 180 degrees designates the horizontal meridian.Astigmatism Axis
LOGSCOREC117890Log ScoreA number or range of numeric values on the log scale that measures performance, function, quality, or ability.Log Score
NUMLCORC117891Number of Letters CorrectThe integer that describes the number of letters correctly identified by the subject during an eye chart assessment.Number of Correct Eye Chart Letters
RECYLDRC117892Cylindrical Refraction ErrorA measurement of the extent of defect in vision caused by a mismatch of optical power between the cylindrical and horizontal meridians, resulting in sub-optimal reflection of light onto the retina. (NCI)Cylindrical Refractive Error
RESPHEREC117893Spherical Refractive ErrorA measurement of the extent of defect in vision caused by a mismatch of optimal power between the cornea and/or lens and the length of the eyeball, resulting in sub-optimal reflection of light onto the retina. (NCI)Spherical Refractive Error
Back to top
CL.C117742.OETESTOphthalmic Exam Test Name
(OETEST)
text
Extensible: Yes
C117742Ophthalmic Exam Test NameTerminology relevant to the test names that describe findings from ophthalmic examinations.CDISC SDTM Ophthalmic Exam Test Name Terminology
Astigmatism AxisC117889Astigmatism AxisA measurement of the location, in degrees, of the flatter principal meridian on a 180-degree scale, where 90 degrees designates the vertical meridian and 180 degrees designates the horizontal meridian.Astigmatism Axis
Cylindrical Refraction ErrorC117892Cylindrical Refraction ErrorA measurement of the extent of defect in vision caused by a mismatch of optical power between the cylindrical and horizontal meridians, resulting in sub-optimal reflection of light onto the retina. (NCI)Cylindrical Refractive Error
Log ScoreC117890Log ScoreA number or range of numeric values on the log scale that measures performance, function, quality, or ability.Log Score
Number of Letters CorrectC117891Number of Letters CorrectThe integer that describes the number of letters correctly identified by the subject during an eye chart assessment.Number of Correct Eye Chart Letters
Spherical Refractive ErrorC117893Spherical Refractive ErrorA measurement of the extent of defect in vision caused by a mismatch of optimal power between the cornea and/or lens and the length of the eyeball, resulting in sub-optimal reflection of light onto the retina. (NCI)Spherical Refractive Error
Back to top
CL.C119013.OEFOCUSOphthalmic Focus of Study Specific Interest
(OEFOCUS)
text
Extensible: No
C119013Ophthalmic Focus of Study Specific InterestTerminology relevant to the identification of a focus of ophthalmic observations.CDISC SDTM Ophthalmic Focus of Study Specific Interest Terminology
ODC119333The eye positioned in the right orbit, Oculus Dexter.Right Eye
OSC119334The eye positioned in the left orbit, Oculus Sinister.Left Eye
OUC119335Of or pertaining to both the left and right eyes, Oculus Uterque.Both Eyes
Back to top
CL.C66768.OUTOutcome of Event
(OUT)
text
Extensible: No
C66768Outcome of EventA condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)CDISC SDTM Adverse Event Outcome Terminology
FATALC482755;FATAL;Grade 5The termination of life as a result of an adverse event. (NCI)Death Related to Adverse Event
NOT RECOVERED/NOT RESOLVEDC49494One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)Not Recovered or Not Resolved
RECOVERED/RESOLVEDC49498One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)Recovered or Resolved
RECOVERED/RESOLVED WITH SEQUELAEC49495One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)Recovered or Resolved with Sequelae
RECOVERING/RESOLVINGC49496One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)Recovering or Resolving
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C66726.FRMPharmaceutical Dosage Form
(FRM)
text
Extensible: Yes
C66726Pharmaceutical Dosage FormThe form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug.CDISC SDTM Pharmaceutical Dosage Form Terminology
AEROSOLC42887aerA product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols).Aerosol Dosage Form
AEROSOL, FOAMC42888A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged.Aerosol Foam Dosage Form
AEROSOL, METEREDC42960A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI)Metered Aerosol Dosage Form
AEROSOL, POWDERC42971A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI)Powder Aerosol Dosage Form
AEROSOL, SPRAYC42889An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI)Aerosol Spray Dosage Form
BAR, CHEWABLEC42892A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI)Chewable Bar Dosage Form
BEADC42890A solid dosage form in the shape of a small ball. (NCI)Bead Dosage Form
BEAD, IMPLANT, EXTENDED RELEASEC43451A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)Extended Release Bead Implant Dosage Form
BLOCKC42891Solid dosage form, usually in the shape of a square or rectangle. (NCI)Block Dosage Form
CAPLETC97197A solid dosage form in which a tablet has been compacted into capsule shape.Caplet Dosage Form
CAPSULEC25158capA solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)Capsule Dosage Form
CAPSULE, COATEDC42895A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating.Coated Capsule Dosage Form
CAPSULE, COATED PELLETSC42896A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or 'shell' made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI)Coated Pellet in Capsule Dosage Form
CAPSULE, COATED, EXTENDED RELEASEC42917A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.Extended Release Coated Capsule Dosage Form
CAPSULE, DELAYED RELEASEC42902A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)Delayed Release Capsule Dosage Form
CAPSULE, DELAYED RELEASE PELLETSC42904A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines.Delayed Release Pellet in Capsule Dosage Form
CAPSULE, EXTENDED RELEASEC42916A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)Extended Release Capsule Dosage Form
CAPSULE, FILM COATED, EXTENDED RELEASEC42928A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or 'shell' made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.Extended Release Film Coated Capsule Dosage Form
CAPSULE, GELATIN COATEDC42936A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI)Gelatin Coated Capsule Dosage Form
CAPSULE, LIQUID FILLEDC42954A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI)Liquid Filled Capsule Dosage Form
CEMENTC45414A substance that serves to produce solid union between two surfaces. (NCI)Cement Dosage Form
CIGARETTEC42678A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.Cigarette Dosage Form
CLOTHC60884A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing.Cloth Dosage Form
CONCENTRATEC60891A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI)Concentrated Dosage Form
CONEC42900A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI)Cone Dosage Form
CORE, EXTENDED RELEASEC42919An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI)Extended Release Core Dosage Form
CREAMC28944A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)Cream Dosage Form
CREAM, AUGMENTEDC60897A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented.Augmented Cream Dosage Form
CRYSTALC42901A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.Crystal Dosage Form
CULTUREC45415The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI)Culture Dosage Form
DIAPHRAGMC47890A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI)Vaginal Diaphragm Dosage Form
DISCC43525A circular plate-like organ or structure.Disc Dosage Form
DOUCHEC42679A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI)Douche Dosage Form
DRESSINGC42763The application of various materials for protecting a wound.Dressing Dosage Form
DRUG DELIVERY SYSTEMC17423Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body.Drug Delivery System
ELIXIRC42912A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI)Elixir Dosage Form
EMULSIONC42913A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI)Emulsion Dosage Form
ENEMAC42915A rectal preparation for therapeutic, diagnostic, or nutritive purposes. (NCI)Enema Dosage Form
EXTRACTC42929A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI)Extract Dosage Form
FIBER, EXTENDED RELEASEC60926A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.Extended Release Fiber Dosage Form
FILMC42932A thin layer or coating. (NCI)Film Dosage Form
FILM, EXTENDED RELEASEC42920A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI)Extended Release Film Dosage Form
FILM, SOLUBLEC42984A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI)Soluble Film Dosage Form
FOR SOLUTIONC60927A product, usually a solid, intended for solution prior to administration.Dosage Form for Solution
FOR SUSPENSIONC60928A product, usually a solid, intended for suspension prior to administration.Dosage Form for Suspension
FOR SUSPENSION, EXTENDED RELEASEC60929A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period.Extended Release Dosage Form for Suspension
GASC42933Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI)Gas Dosage Form
GELC42934A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2). A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid.Gel Dosage Form
GEL, DENTIFRICEC42906A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI)Dentifrice Gel Dosage Form
GEL, METEREDC60930A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation.Metered Gel Dosage Form
GENERATORC48193An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI)Generator Dosage Form
GLOBULEC42937Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI)Globule Dosage Form
GRAFTC45416A slip of skin or of other tissue for implantation. (NCI)Graft Dosage Form
GRANULEC42938A small particle or grain. (NCI)Granule Dosage Form
GRANULE, DELAYED RELEASEC42903A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)Delayed Release Granule Dosage Form
GRANULE, EFFERVESCENTC42909A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI)Effervescent Granule Dosage Form
GRANULE, FOR SOLUTIONC42939A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)Granule for Solution Dosage Form
GRANULE, FOR SUSPENSIONC42940A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)Granule for Suspension Dosage Form
GRANULE, FOR SUSPENSION, EXTENDED RELEASEC42921A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI)Extended Release Granule for Suspension Dosage Form
GUMC42941A mucilaginous excretion from various plants. (NCI)Gum Dosage Form
GUM, CHEWINGC42894A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI)Chewing Gum Dosage Form
GUM, RESINC42978Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI)Resin Gum Dosage Form
IMPLANTC42942A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI)Implant Dosage Form
INHALANTC42944A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI)Inhalant Dosage Form
INJECTABLE, LIPOSOMALC60931An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance).Liposomal Injection Dosage Form
INJECTIONC42946A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)Injectable Dosage Form
INJECTION, EMULSIONC42914An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.Emulsion for Injection Dosage Form
INJECTION, LIPID COMPLEXC42950[definition pending]Injectable Lipid Complex Dosage Form
INJECTION, POWDER, FOR SOLUTIONC42974A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI)Powder for Injectable Solution Dosage Form
INJECTION, POWDER, FOR SUSPENSIONC42976A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI)Powder for Injectable Suspension Dosage Form
INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASEC42977A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).Powder for Injectable Extended Release Suspension Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSIONC42959A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI)Lyophilized Powder for Injectable Liposomal Suspension Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONC42957A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI)Lyophilized Powder for Injectable Solution Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSIONC42958A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures.Lyophilized Powder for Injectable Suspension Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASEC42956A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI)Lyophilized Powder for Extended Release Injectable Suspension Dosage Form
INJECTION, SOLUTIONC42945A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI)Injectable Solution Dosage Form
INJECTION, SOLUTION, CONCENTRATEC42899A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI)Concentrated Injectable Solution Dosage Form
INJECTION, SUSPENSIONC42995A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI)Injectable Suspension Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASEC42926A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)Injectable Extended Release Suspension Dosage Form
INJECTION, SUSPENSION, LIPOSOMALC42951A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI)Injectable Liposomal Suspension Dosage Form
INJECTION, SUSPENSION, SONICATEDC42988A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI)Injectable Sonicated Suspension Dosage Form
INSERTC60933A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects.Insert Dosage Form
INSERT, EXTENDED RELEASEC42922A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI)Extended Release Insert Dosage Form
INTRAUTERINE DEVICEC47915A device inserted and left in the uterus to prevent effective conception. (NCI)Intrauterine Device Dosage Form
IRRIGANTC42947A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI)Irrigant Dosage Form
JELLYC42948A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI)Jelly Dosage Form
KITC47916A packaged collection of related material. (NCI)Kit Dosage Form
LINER, DENTALC45413A material applied to the inside of the dental cavity, for protection or insulation of the surface.Dental Liner Dosage Form
LINIMENTC42949A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI)Liniment Dosage Form
LIPSTICKC42952A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI)Lipstick Dosage Form
LIQUIDC42953A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.Liquid Dosage Form
LIQUID, EXTENDED RELEASEC60934A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form.Extended Release Liquid Dosage Form
LOTIONC29167An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion.Lotion Dosage Form
LOTION, AUGMENTEDC60957A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented.Augmented Lotion Dosage Form
LOTION/SHAMPOOC60958A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents.Lotion Shampoo Dosage Form
LOZENGEC42955A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.Lozenge Dosage Form
MOUTHWASHC29269An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI)Mouthwash Dosage Form
NOT APPLICABLEC48624The use of a dosage form term is not relevant or appropriate. (NCI)Dosage Form Not Applicable
OILC42965An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI)Oil Dosage Form
OINTMENTC42966ointA suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved.Ointment Dosage Form
OINTMENT, AUGMENTEDC60984An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented.Augmented Ointment Dosage Form
PACKINGC47887A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.Packing Dosage Form
PASTEC42967A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI)Paste Dosage Form
PASTE, DENTIFRICEC42907A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)Dentifrice Paste Dosage Form
PASTILLEC60985An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth.Pastille Dosage Form
PATCHC42968A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms Extended Release Film and System.Patch Dosage Form
PATCH, EXTENDED RELEASEC42923A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)Extended Release Patch Dosage Form
PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLEDC42911A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)Electrically Controlled Extended Release Patch Dosage Form
PELLETC42969A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI)Pellet Dosage Form
PELLET, IMPLANTABLEC42943A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time.Implantable Pellet Dosage Form
PELLETS, COATED, EXTENDED RELEASEC42918A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)Extended Release Coated Pellet Dosage Form
PILLC25394A dose of medicine in the form of a small pellet. (NCI)Pill Dosage Form
PLASTERC42970Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin.Plaster Dosage Form
POULTICEC47913A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI)Poultice Dosage Form
POWDERC42972An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI)Powder Dosage Form
POWDER, DENTIFRICEC42908A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)Dentifrice Powder Dosage Form
POWDER, FOR SOLUTIONC42973An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI)Powder for Solution Dosage Form
POWDER, FOR SUSPENSIONC42975An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI)Powder for Suspension Dosage Form
POWDER, METEREDC42961A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI)Metered Powder Dosage Form
RINGC60988A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects.Ring Dosage Form
RINSEC42979A liquid used to cleanse by flushing. (NCI)Rinse Dosage Form
SALVEC42980A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI)Salve Dosage Form
SHAMPOOC42981A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)Shampoo Dosage Form
SHAMPOO, SUSPENSIONC42982A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)Shampoo Suspension Dosage Form
SOAPC42983Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI)Soap Dosage Form
SOLUTIONC42986A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.Solution Dosage Form
SOLUTION, CONCENTRATEC42898A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI)Concentrated Solution Dosage Form
SOLUTION, FOR SLUSHC42987A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI)Solution for Slush Dosage Form
SOLUTION, GEL FORMING / DROPSC60994A solution, which after usually being administered in a drop-wise fashion, forms a gel.Gel Forming Drop Solution Dosage Form
SOLUTION, GEL FORMING, EXTENDED RELEASEC42935A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency.Extended Release Gel Forming Solution Dosage Form
SOLUTION/ DROPSC60992A solution which is usually administered in a drop-wise fashion.Drop Solution Dosage Form
SPONGEC47912A porous, interlacing, absorbent material that contains a drug. It is typically used for applying or introducing medication, or for cleansing. A sponge usually retains its shape.Sponge Dosage Form
SPRAYC42989A liquid minutely divided as by a jet of air or steam. (NCI)Spray Dosage Form
SPRAY, METEREDC42962A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI)Metered Spray Dosage Form
SPRAY, SUSPENSIONC42990A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI)Spray Suspension Dosage Form
STICKC42991A dosage form prepared in a relatively long and slender often cylindrical form. (NCI)Stick Dosage Form
STRIPC47914A long narrow piece of material.Strip Dosage Form
SUPPOSITORYC42993suppA solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature.Suppository Dosage Form
SUPPOSITORY, EXTENDED RELEASEC42924A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI)Extended Release Suppository Dosage Form
SUSPENSIONC42994suspA liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.Suspension Dosage Form
SUSPENSION, EXTENDED RELEASEC42925A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)Extended Release Suspension Dosage Form
SUSPENSION/DROPSC60995A suspension which is usually administered in a dropwise fashion.Drop Suspension Dosage Form
SUTUREC47889A strand or fiber used to hold wound edges in apposition during healing. (NCI)Suture Dosage Form
SWABC47898A small piece of relatively flat absorbent material that contains a drug. A swab may also be attached to one end of a small stick. A swab is typically used for applying medication or for cleansing.Swab Dosage Form
SYRUPC42996An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions. (NCI)Syrup Dosage Form
TABLETC42998tabA solid dosage form containing medicinal substances with or without suitable diluents. (NCI)Tablet Dosage Form
TABLET, CHEWABLEC42893A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI)Chewable Tablet Dosage Form
TABLET, COATEDC42897A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI)Coated Tablet Dosage Form
TABLET, COATED PARTICLESC60997A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating.Tablet Coated Particle Dosage Form
TABLET, DELAYED RELEASEC42905A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)Delayed Release Tablet Dosage Form
TABLET, DELAYED RELEASE PARTICLESC42997A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)Delayed Release Particle Tablet Dosage Form
TABLET, EFFERVESCENTC42910A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.Effervescent Tablet Dosage Form
TABLET, EXTENDED RELEASEC42927A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI)Extended Release Tablet Dosage Form
TABLET, FILM COATEDC42931A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI)Film Coated Tablet Dosage Form
TABLET, FILM COATED, EXTENDED RELEASEC42930A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.Film Coated Extended Release Tablet Dosage Form
TABLET, FOR SOLUTIONC61004A tablet that forms a solution when placed in a liquid.Tablet for Solution Dosage Form
TABLET, FOR SUSPENSIONC61005A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).Tablet for Suspension Dosage Form
TABLET, MULTILAYERC42964A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI)Multilayered Tablet Dosage Form
TABLET, MULTILAYER, EXTENDED RELEASEC42963A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)Multilayered Extended Release Tablet Dosage Form
TABLET, ORALLY DISINTEGRATINGC42999A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue. (NCI)Orally Disintegrating Tablet Dosage Form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASEC61006A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration.Orally Disintegrating Delayed Release Tablet Dosage Form
TABLET, SOLUBLEC42985A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI)Soluble Tablet Dosage Form
TABLET, SUGAR COATEDC42992A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI)Sugar Coated Tablet Dosage Form
TAMPONC47892A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI)Tampon Dosage Form
TAPEC47897A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI)Tape Dosage Form
TINCTUREC43000An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances. (NCI)Tincture Dosage Form
TROCHEC43001A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients. (NCI)Troche Dosage Form
UNASSIGNEDC43002A dosage form has yet to be assigned. (NCI)Unassigned Dosage Form
WAFERC43003A thin slice of material containing a medicinal agent. (NCI)Wafer Dosage Form
Back to top
CL.C114119.PBSTMTPharmacogenomics Biomarker Medical Statement
(PBSTMT)
text
Extensible: Yes
C114119Pharmacogenomics Biomarker Medical StatementA terminology codelist relevant to the medical conclusion such as confirmation of a diagnosis or drug resistance based on genetic biological markers.CDISC SDTM Pharmacogenomics Biomarker Medical Statement Terminology
NEGATIVEC38757A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.Negative Finding
POSITIVEC38758An observation confirming something, such as the presence of a disease, condition, or microorganism.Positive Finding
RESISTANTC85562ResistantThe growth of microorganisms are not inhibited by the usually achievable concentrations of the antimicrobial agent with normal dosages, and/or microorganisms demonstrate MICs or zone diameters that fall in the range where specific microbial resistance mechanisms (e.g. Beta-lactamases) are likely, and clinical efficacy of the agent against the microorganism has not been reliably shown in treatment studies.Antimicrobial Resistance Result
SUSCEPTIBLEC85563SusceptibleThe growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection.Antimicrobial Susceptibility Result
Back to top
CL.C116106.PFTESTCDPharmacogenomics Findings Test Code
(PFTESTCD)
text
Extensible: Yes
C116106Pharmacogenomics Findings Test CodeTerminology relevant to the test codes that describe pharmacogenomics findings.CDISC SDTM Pharmacogenomics Findings Test Code Terminology
ALLELEC16277AlleleMutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process. (NCI)Allele
Back to top
CL.C116105.PFTESTPharmacogenomics Findings Test Name
(PFTEST)
text
Extensible: Yes
C116105Pharmacogenomics Findings Test NameTerminology relevant to the test names that describe pharmacogenomics findings.CDISC SDTM Pharmacogenomics Findings Test Name Terminology
AlleleC16277AlleleMutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process. (NCI)Allele
Back to top
CL.C95121.PHSPRPCDPhysical Properties Test Code
(PHSPRPCD)
text
Extensible: Yes
C95121Physical Properties Test CodeTerminology relevant to the test codes that describe the physical characteristics of an entity.CDISC SDTM Physical Properties Test Code Terminology
COLORC37927ColorThe appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI)Color
CONSISTC95110ConsistencyA description about the firmness or make-up of an entity.Consistency
DEPTHC25333DepthThe extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI)Depth
DESCRC25365DescriptionA written or verbal account, representation, statement, or explanation of something. (NCI)Description
DIAMETERC25285DiameterThe length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI)Diameter
HAIRCOVC95109Hair CoverA description of the quantity or quality of the hair or fur covering a biological entity. (NCI)Hair or Fur Cover
LENGTHC25334LengthThe linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI)Length
SHAPEC25677ShapeThe spatial arrangement of something as distinct from its substance. (NCI)Shape
ULCERC25757UlcerationThe formation or development of an ulcer. (NCI)Ulceration
WIDTHC25345WidthThe extent or measurement of something from side to side. (NCI)Width
Back to top
CL.C95120.PHSPRPPhysical Properties Test Name
(PHSPRP)
text
Extensible: Yes
C95120Physical Properties Test NameTerminology relevant to the test names that describe the physical characteristics of an entity.CDISC SDTM Physical Properties Test Name Terminology
ColorC37927ColorThe appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI)Color
ConsistencyC95110ConsistencyA description about the firmness or make-up of an entity.Consistency
DepthC25333DepthThe extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI)Depth
DescriptionC25365DescriptionA written or verbal account, representation, statement, or explanation of something. (NCI)Description
DiameterC25285DiameterThe length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI)Diameter
Hair CoverC95109Hair CoverA description of the quantity or quality of the hair or fur covering a biological entity. (NCI)Hair or Fur Cover
LengthC25334LengthThe linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI)Length
ShapeC25677ShapeThe spatial arrangement of something as distinct from its substance. (NCI)Shape
UlcerationC25757UlcerationThe formation or development of an ulcer. (NCI)Ulceration
WidthC25345WidthThe extent or measurement of something from side to side. (NCI)Width
Back to top
CL.C85493.PKPARMPK Parameters
(PKPARM)
text
Extensible: Yes
C85493PK ParametersParameters used to describe the time-concentration curve.CDISC SDTM Pharmacokinetic Parameter Terminology
Accumulation Index using Lambda zC114234Accumulation Index using Lambda zPredicted accumulation ratio for area under the curve (AUC) calculated using the Lambda z estimated from single dose data.Accumulation Index using Lambda z
Accumulation Ratio AUCC102356Accumulation Ratio AUCThe area under the curve (AUCTAU) at steady state divided by the area under the curve over the initial dosing interval.Accumulation Ratio Area Under the Curve
Accumulation Ratio CmaxC102357Accumulation Ratio CmaxThe maximum concentration at steady state divided by the maximum concentration during the initial dosing interval.Accumulation Ratio Cmax
Accumulation Ratio CminC102358Accumulation Ratio CminThe minimum concentration at steady state divided by the minimum concentration during the initial dosing interval.Accumulation Ratio Cmin
Accumulation Ratio CtroughC102426Accumulation Ratio CtroughThe trough concentration at steady state divided by the trough concentration during the initial dosing interval.Accumulation Ratio Ctrough
Amt Rec from T1 to T2C102359Amt Rec from T1 to T2The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2.Amount Recovered from T1 to T2
Amt Rec from T1 to T2 Norm by BMIC102360Amt Rec from T1 to T2 Norm by BMIThe cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by body mass index.Amount Recovered from T1 to T2 Normalized by Body Mass Index
Amt Rec from T1 to T2 Norm by SAC102361Amt Rec from T1 to T2 Norm by SAThe cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by surface area.Amount Recovered from T1 to T2 Normalized by Surface Area
Amt Rec from T1 to T2 Norm by WTC102362Amt Rec from T1 to T2 Norm by WTThe cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by weight.Amount Recovered from T1 to T2 Normalized by Weight
Amt Rec Infinity ObsC112032Amt Rec Infinity ObsThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration.Amount Recovered Infinity Observed
Amt Rec Infinity Obs Norm by BMIC112223Amt Rec Infinity Obs Norm by BMIThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Amount Recovered Infinity Observed Normalized by Body Mass Index
Amt Rec Infinity Obs Norm by SAC112224Amt Rec Infinity Obs Norm by SAThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.Amount Recovered Infinity Observed Normalized by Surface Area
Amt Rec Infinity Obs Norm by WTC112225Amt Rec Infinity Obs Norm by WTThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.Amount Recovered Infinity Observed Normalized by Weight
Amt Rec Infinity PredC112033Amt Rec Infinity PredThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.Amount Recovered Infinity Predicted
Amt Rec Infinity Pred Norm by BMIC112226Amt Rec Infinity Pred Norm by BMIThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.Amount Recovered Infinity Predicted Normalized by Body Mass Index
Amt Rec Infinity Pred Norm by SAC112227Amt Rec Infinity Pred Norm by SAThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Amount Recovered Infinity Predicted Normalized by Surface Area
Amt Rec Infinity Pred Norm by WTC112228Amt Rec Infinity Pred Norm by WTThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.Amount Recovered Infinity Predicted Normalized by Weight
Amt Rec Over Dosing IntervalC102363Amt Rec Over Dosing IntervalThe cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU).Amount Recovered Over Dosing Interval
Amt Rec Over Dosing Interval Norm by BMIC102364Amt Rec Over Dosing Interval Norm by BMIThe cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by body mass index.Amount Recovered Over Dosing Interval Normalized by Body Mass Index
Amt Rec Over Dosing Interval Norm by SAC102365Amt Rec Over Dosing Interval Norm by SAThe cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by surface area.Amount Recovered Over Dosing Interval Normalized by Surface Area
Amt Rec Over Dosing Interval Norm by WTC102366Amt Rec Over Dosing Interval Norm by WTThe cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by weight.Amount Recovered Over Dosing Interval Normalized by Weight
AUC %Back Extrapolation ObsC85763AUC %Back Extrapolation ObsApplies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the observed value of the last non-zero concentration.Observed Area Under the Curve Percent Back Extrapolation
AUC %Back Extrapolation PredC85787AUC %Back Extrapolation PredApplies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the predicted value of the last non-zero concentration.Predicted Area Under the Curve Percent Back Extrapolation
AUC %Extrapolation ObsC85764AUC %Extrapolation ObsThe area under the curve (AUC) from the last observed non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity.Observed Area Under the Curve Percent Extrapolation
AUC %Extrapolation PredC85788AUC %Extrapolation PredThe area under the curve (AUC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity.Predicted Area Under the Curve Percent Extrapolation
AUC AllC85564AUC AllThe area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not.Area Under the Curve All
AUC All Norm by BMIC92362AUC All Norm by BMIThe area under the curve (AUC) from the time of dosing to the time of the last observation divided by the body mass index, regardless of whether the last concentration is measurable or not.AUC All Normalized by Body Mass Index
AUC All Norm by DoseC92306AUC All Norm by DoseThe area under the curve (AUC) from the time of dosing to the time of the last observation divided by the dose, regardless of whether the last concentration is measurable or not.AUC All Normalized by Dose
AUC All Norm by SAC92307AUC All Norm by SAThe area under the curve (AUC) from the time of dosing to the time of the last observation divided by the surface area, regardless of whether the last concentration is measurable or not.AUC All Normalized by Surface Area
AUC All Norm by WTC92308AUC All Norm by WTThe area under the curve (AUC) from the time of dosing to the time of the last observation divided by the weight, regardless of whether the last concentration is measurable or not.AUC All Normalized by Weight
AUC from T1 to T2C85566AUC from T1 to T2The area under the curve (AUC) over the interval from T1 to T2.Area Under the Curve from T1 to T2
AUC from T1 to T2 Norm by BMIC92312AUC from T1 to T2 Norm by BMIThe area under the curve (AUC) over the interval from T1 to T2 divided by the body mass index.AUC from T1 to T2 Normalized by Body Mass Index
AUC from T1 to T2 Norm by DoseC92313AUC from T1 to T2 Norm by DoseThe area under the curve (AUC) over the interval from T1 to T2 divided by the dose.AUC from T1 to T2 Normalized by Dose
AUC from T1 to T2 Norm by SAC92314AUC from T1 to T2 Norm by SAThe area under the curve (AUC) over the interval from T1 to T2 divided by the surface area.AUC from T1 to T2 Normalized by Surface Area
AUC from T1 to T2 Norm by WTC92315AUC from T1 to T2 Norm by WTThe area under the curve (AUC) over the interval from T1 to T2 divided by the weight.AUC from T1 to T2 Normalized by Weight
AUC Infinity ObsC85761AUC Infinity ObsThe area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.Observed Area Under the Curve Infinity
AUC Infinity Obs Norm by BMIC92316AUC Infinity Obs Norm by BMIThe area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.AUC Infinity Observed Normalized by Body Mass Index
AUC Infinity Obs Norm by DoseC96695AUC Infinity Obs Norm by DoseThe area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose.AUC Infinity Observed Normalized by Dose
AUC Infinity Obs Norm by SAC92317AUC Infinity Obs Norm by SAThe area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.AUC Infinity Observed Normalized by Surface Area
AUC Infinity Obs Norm by WTC92318AUC Infinity Obs Norm by WTThe area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.AUC Infinity Observed Normalized by Weight
AUC Infinity PredC85785AUC Infinity PredThe area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.Predicted Area Under the Curve Infinity
AUC Infinity Pred Norm by BMIC92319AUC Infinity Pred Norm by BMIThe area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.AUC Infinity Predicted Normalized by Body Mass Index
AUC Infinity Pred Norm by DoseC85786AUC Infinity Pred Norm by DoseThe area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose.Predicted Area Under the Curve Infinity by Dose
AUC Infinity Pred Norm by SAC92320AUC Infinity Pred Norm by SAThe area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.AUC Infinity Predicted Normalized by Surface Area
AUC Infinity Pred Norm by WTC92321AUC Infinity Pred Norm by WTThe area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.AUC Infinity Predicted Normalized by Weight
AUC Over Dosing IntervalC85567AUC Over Dosing IntervalThe area under the curve (AUC) for the defined interval between doses (TAU).Area Under the Curve Over Dosing Interval
AUC Over Dosing Interval Norm by BMIC92322AUC Over Dosing Interval Norm by BMIThe area under the curve (AUC) for the defined interval between doses (TAU) divided by the body mass index.AUC Over Dosing Interval Normalized by Body Mass Index
AUC Over Dosing Interval Norm by DoseC92323AUC Over Dosing Interval Norm by DoseThe area under the curve (AUC) for the defined interval between doses (TAU) divided by the dose.AUC Over Dosing Interval Normalized by Dose
AUC Over Dosing Interval Norm by SAC92324AUC Over Dosing Interval Norm by SAThe area under the curve (AUC) for the defined interval between doses (TAU) divided by the surface area.AUC Over Dosing Interval Normalized by Surface Area
AUC Over Dosing Interval Norm by WTC92325AUC Over Dosing Interval Norm by WTThe area under the curve (AUC) for the defined interval between doses (TAU) divided by the weight.AUC Over Dosing Interval Normalized by Weight
AUC to Last Nonzero ConcC85565AUC to Last Nonzero ConcThe area under the curve (AUC) from the time of dosing to the last measurable concentration.Area Under the Curve From Dosing to Last Concentration
AUC to Last Nonzero Conc Norm by BMIC92309AUC to Last Nonzero Conc Norm by BMIThe area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body mass index.AUC Dosing to Last Concentration Normalized by Body Mass Index
AUC to Last Nonzero Conc Norm by DoseC92310AUC to Last Nonzero Conc Norm by DoseThe area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the dose.AUC Dosing to Last Concentration Normalized by Dose
AUC to Last Nonzero Conc Norm by SAC92311AUC to Last Nonzero Conc Norm by SAThe area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the surface area.AUC Dosing to Last Concentration Normalized by Surface Area
AUC to Last Nonzero Conc Norm by WTC92305AUC to Last Nonzero Conc Norm by WTThe area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the weight.AUC Dosing to Last Concentration Normalized by Weight
AUMC % Extrapolation ObsC85766AUMC % Extrapolation ObsThe area under the moment curve (AUMC) from the last observed non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity.Observed Area Under the First Moment Curve Percent Extrapolation
AUMC % Extrapolation PredC85790AUMC % Extrapolation PredThe area under the moment curve (AUMC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity.Predicted Area Under the First Moment Curve Percent Extrapolation
AUMC Infinity ObsC85765AUMC Infinity ObsThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.Observed Area Under the First Moment Curve Infinity
AUMC Infinity Obs Norm by BMIC92330AUMC Infinity Obs Norm by BMIThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.AUMC Infinity Observed Normalized by Body Mass Index
AUMC Infinity Obs Norm by DoseC92331AUMC Infinity Obs Norm by DoseThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose.AUMC Infinity Observed Normalized by Dose
AUMC Infinity Obs Norm by SAC92332AUMC Infinity Obs Norm by SAThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.AUMC Infinity Observed Normalized by Surface Area
AUMC Infinity Obs Norm by WTC92333AUMC Infinity Obs Norm by WTThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.AUMC Infinity Observed Normalized by Weight
AUMC Infinity PredC85789AUMC Infinity PredThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.Predicted Area Under the First Moment Curve Infinity
AUMC Infinity Pred Norm by BMIC92334AUMC Infinity Pred Norm by BMIThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.AUMC Infinity Predicted Normalized by Body Mass Index
AUMC Infinity Pred Norm by DoseC92335AUMC Infinity Pred Norm by DoseThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose.AUMC Infinity Predicted Normalized by Dose
AUMC Infinity Pred Norm by SAC92336AUMC Infinity Pred Norm by SAThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.AUMC Infinity Predicted Normalized by Surface Area
AUMC Infinity Pred Norm by WTC92337AUMC Infinity Pred Norm by WTThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.AUMC Infinity Predicted Normalized by Weight
AUMC Over Dosing IntervalC85570AUMC Over Dosing IntervalThe area under the first moment curve (AUMC) for the defined interval between doses (TAU).Area Under the First Moment Curve Over Dosing Interval
AUMC Over Dosing Interval Norm by BMIC92338AUMC Over Dosing Interval Norm by BMIThe area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the body mass index.AUMC Over Dosing Interval Normalized by Body Mass Index
AUMC Over Dosing Interval Norm by DoseC92339AUMC Over Dosing Interval Norm by DoseThe area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the dose.AUMC Over Dosing Interval Normalized by Dose
AUMC Over Dosing Interval Norm by SAC92340AUMC Over Dosing Interval Norm by SAThe area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the surface area.AUMC Over Dosing Interval Normalized by Surface Area
AUMC Over Dosing Interval Norm by WTC92341AUMC Over Dosing Interval Norm by WTThe area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the weight.AUMC Over Dosing Interval Normalized by Weight
AUMC to Last Nonzero ConcC85569AUMC to Last Nonzero ConcThe area under the moment curve (AUMC) from the time of dosing to the last measurable concentration.Area Under the First Moment Curve From Dosing to Last Concentration
AUMC to Last Nonzero Conc Norm by BMIC92326AUMC to Last Nonzero Conc Norm by BMIThe area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the body mass index.AUMC Dosing to Last Concentration Normalized by Body Mass Index
AUMC to Last Nonzero Conc Norm by DoseC92327AUMC to Last Nonzero Conc Norm by DoseThe area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the dose.AUMC Dosing to Last Concentration Normalized by Dose
AUMC to Last Nonzero Conc Norm by SAC92328AUMC to Last Nonzero Conc Norm by SAThe area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the surface area.AUMC Dosing to Last Concentration Normalized by Surface Area
AUMC to Last Nonzero Conc Norm by WTC92329AUMC to Last Nonzero Conc Norm by WTThe area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the weight.AUMC Dosing to Last Concentration Normalized by Weight
AURC % Extrapolation ObsC85768AURC % Extrapolation ObsThe area under the urinary excretion rate curve (AURC) from the last observed non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity.Observed Area Under the Urinary Excretion Rate Curve Percent Extrapolation
AURC % Extrapolation PredC85792AURC % Extrapolation PredThe area under the urinary excretion rate curve (AURC) from the last predicted non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity.Predicted Area Under the Urinary Excretion Rate Curve Percent Extrapolation
AURC AllC85841AURC AllThe area under the urinary excretion rate curve (AURC) from time zero to the time of the last observation, regardless of whether the last observation is a measurable concentration or not.Area Under Urinary Excretion Rate Curve All
AURC All Norm by BMIC92342AURC All Norm by BMIThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the body mass index.AURC All Normalized by Body Mass Index
AURC All Norm by DoseC92343AURC All Norm by DoseThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the dose.AURC All Normalized by Dose
AURC All Norm by SAC92344AURC All Norm by SAThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the surface area.AURC All Normalized by Surface Area
AURC All Norm by WTC92345AURC All Norm by WTThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the weight.AURC All Normalized by Weight
AURC Dosing to Last Conc Norm by BMIC92346AURC to Last Nonzero Rate Norm by BMIThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the body mass index.AURC Dosing to Last Concentration Normalized by Body Mass Index
AURC Dosing to Last Conc Norm by DoseC92347AURC to Last Nonzero Rate Norm by DoseThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the dose.AURC Dosing to Last Concentration Normalized by Dose
AURC Dosing to Last Conc Norm by SAC92348AURC to Last Nonzero Rate Norm by SAThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the surface area.AURC Dosing to Last Concentration Normalized by Surface Area
AURC Dosing to Last Conc Norm by WTC92349AURC to Last Nonzero Rate Norm by WTThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the weight.AURC Dosing to Last Concentration Normalized by Weight
AURC from T1 to T2C85572AURC from T1 to T2The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2.Area Under the Urinary Excretion Rate Curve from T1 to T2
AURC from T1 to T2 Norm by BMIC92350AURC from T1 to T2 Norm by BMIThe area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the body mass index.AURC from T1 to T2 Normalized by Body Mass Index
AURC from T1 to T2 Norm by DoseC92351AURC from T1 to T2 Norm by DoseThe area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the dose.AURC from T1 to T2 Normalized by Dose
AURC from T1 to T2 Norm by SAC92352AURC from T1 to T2 Norm by SAThe area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the surface area.AURC from T1 to T2 Normalized by Surface Area
AURC from T1 to T2 Norm by WTC92353AURC from T1 to T2 Norm by WTThe area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the weight.AURC from T1 to T2 Normalized by Weight
AURC Infinity ObsC85767AURC Infinity ObsThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate.Observed Area Under the Urinary Excretion Rate Curve infinity
AURC Infinity Obs Norm by BMIC92354AURC Infinity Obs Norm by BMIThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the body mass index.AURC Infinity Observed Normalized by Body Mass Index
AURC Infinity Obs Norm by DoseC92355AURC Infinity Obs Norm by DoseThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the dose.AURC Infinity Observed Normalized by Dose
AURC Infinity Obs Norm by SAC92356AURC Infinity Obs Norm by SAThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the surface area.AURC Infinity Observed Normalized by Surface Area
AURC Infinity Obs Norm by WTC92357AURC Infinity Obs Norm by WTThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the weight.AURC Infinity Observed Normalized by Weight
AURC Infinity PredC85791AURC Infinity PredThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate.Predicted Area Under the Urinary Excretion Rate Curve Infinity
AURC Infinity Pred Norm by BMIC92358AURC Infinity Pred Norm by BMIThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the body mass index.AURC Infinity Predicted Normalized by Body Mass Index
AURC Infinity Pred Norm by DoseC92359AURC Infinity Pred Norm by DoseThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the dose.AURC Infinity Predicted Normalized by Dose
AURC Infinity Pred Norm by SAC92360AURC Infinity Pred Norm by SAThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the surface area.AURC Infinity Predicted Normalized by Surface Area
AURC Infinity Pred Norm by WTC92361AURC Infinity Pred Norm by WTThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the weight.AURC Infinity Predicted Normalized by Weight
AURC to Last Nonzero RateC85571AURC to Last Nonzero RateThe area under the urinary excretion rate curve (AURC) from time zero to the time of the last measurable concentration.Area Under the Urinary Excretion Rate Curve From Dosing to Last Concentration
Average Conc Norm by BMIC92367Average Conc Norm by BMIAUCTAU divided by TAU and then divided by the body mass index.Average Concentration Normalized by Body Mass Index
Average Conc Norm by DoseC92368Average Conc Norm by DoseAUCTAU divided by TAU and then divided by the dose.Average Concentration Normalized by Dose
Average Conc Norm by SAC92369Average Conc Norm by SAAUCTAU divided by TAU and then divided by the surface area.Average Concentration Normalized by Surface Area
Average Conc Norm by WTC92370Average Conc Norm by WTAUCTAU divided by TAU and then divided by the weight.Average Concentration Normalized by Weight
Average ConcentrationC85575Average ConcentrationAUCTAU divided by TAU.Average Concentration
Conc by BMIC102367Conc by BMIThe concentration divided by body mass index.Concentration Divided by Body Mass Index
Conc by DoseC102368Conc by DoseThe concentration divided by dose.Concentration Divided by Dose
Conc by SAC102369Conc by SAThe concentration divided by surface area.Concentration Divided by Surface Area
Conc by WTC102370Conc by WTThe concentration divided by weight.Concentration Divided by Weight
Conc TroughC102394Conc TroughConcentration at end of dosing interval.Trough Concentration
Conc Trough by BMIC102395Conc Trough by BMIThe trough concentration divided by body mass index.Trough Concentration Divided by Body Mass Index
Conc Trough by DoseC102396Conc Trough by DoseThe trough concentration divided by dose.Trough Concentration Divided by Dose
Conc Trough by SAC102397Conc Trough by SAThe trough concentration divided by surface area.Trough Concentration Divided by Surface Area
Conc Trough by WTC102398Conc Trough by WTThe trough concentration divided by weight.Trough Concentration Divided by Weight
ConcentrationC41185ConcentrationThe quantity of a specified substance in a unit volume or weight of another substance.Concentration
Correlation Between TimeX and Log ConcYC85821Correlation Between TimeX and Log ConcYThe correlation between time (X) and log concentration (Y) for the points used in the estimation of lambda z.Time and Log Concentration Correlation
Effective Half-LifeC95007Effective Half-LifeThe drug half-life that quantifies the accumulation ratio of a drug following multiple dosing.Effective Half-life
Excret Rate from T1 to T2C105449Excret Rate from T1 to T2The excretion rate over the interval from T1 to T2, determined for the specimen type specified in PPSPEC.Excretion Rate From T1 to T2
Excret Rate from T1 to T2 Norm by BMIC105450Excret Rate from T1 to T2 Norm by BMIThe excretion rate over the interval from T1 to T2 divided by the body mass index, determined for the specimen type specified in PPSPEC.Excretion Rate From T1 to T2 Normalized by BMI
Excret Rate from T1 to T2 Norm by DoseC105451Excret Rate from T1 to T2 Norm by DoseThe excretion rate over the interval from T1 to T2 divided by the dose, determined for the specimen type specified in PPSPEC.Excretion Rate From T1 to T2 Normalized by Dose
Excret Rate from T1 to T2 Norm by SAC105452Excret Rate from T1 to T2 Norm by SAThe excretion rate over the interval from T1 to T2 divided by the surface area, determined for the specimen type specified in PPSPEC.Excretion Rate From T1 to T2 Normalized by SA
Excret Rate from T1 to T2 Norm by WTC105453Excret Rate from T1 to T2 Norm by WTThe excretion rate over the interval from T1 to T2 divided by the weight, determined for the specimen type specified in PPSPEC.Excretion Rate From T1 to T2 Normalized by WT
Fluctuation%C85581Fluctuation%The difference between Cmin and Cmax standardized to Cavg, between dose time and Tau.Concentration Variability Between Dose Time and Tau
Half-Life Lambda zC85818Half-Life Lambda zTerminal half-life.Terminal Half Life
Hemodialysis ClearanceC112287Hemodialysis ClearanceThe clearance of a substance from the blood during a hemodialysis session.Hemodialysis Clearance
Hemodialysis Extraction RatioC116213Hemodialysis Extraction RatioThe fractional content of a substance removed from the blood during a hemodialysis session.Hemodialysis Extraction Ratio
Initial ConcC85644Initial ConcInitial concentration. Given only for bolus IV models.Initial Concentration
Initial Conc Norm by BMIC92383Initial Conc Norm by BMIInitial concentration divided by the body mass index. Given only for bolus IV models.Initial Concentration Normalized by Body Mass Index
Initial Conc Norm by DoseC92384Initial Conc Norm by DoseInitial concentration divided by the dose. Given only for bolus IV models.Initial Concentration Normalized by Dose
Initial Conc Norm by SAC92385Initial Conc Norm by SAInitial concentration divided by the surface area. Given only for bolus IV models.Initial Concentration Normalized by Surface Area
Initial Conc Norm by WTC92386Initial Conc Norm by WTInitial concentration divided by the weight. Given only for bolus IV models.Initial Concentration Normalized by Weight
Lambda zC85652Lambda zThe first order rate constant associated with the terminal (log-linear) portion of the curve.Lambda Z
Lambda z Lower LimitC85653Lambda z Lower LimitThe lower limit on time for values to be included in the calculation of Lambda z.Lambda Z Time Lower Limit
Lambda z Upper LimitC85654Lambda z Upper LimitThe upper limit on time for values to be included in the calculation of Lambda z.Lambda Z Time Upper Limit
Last Meas Excretion RateC85656Last Meas Excretion RateThe last measurable (positive) excretion rate determined for the specimen type specified in PPSPEC.Last Measurable Observed Excretion Rate
Last Meas Excretion Rate Norm by BMIC92391Last Meas Excretion Rate Norm by BMIThe last measurable (positive) excretion rate divided by the body mass index.Last Measurable Excretion Rate Normalized by Body Mass Index
Last Meas Excretion Rate Norm by DoseC92392Last Meas Excretion Rate Norm by DoseThe last measurable (positive) excretion rate divided by the dose.Last Measurable Excretion Rate Normalized by Dose
Last Meas Excretion Rate Norm by SAC92393Last Meas Excretion Rate Norm by SAThe last measurable (positive) excretion rate divided by the surface area.Last Measurable Excretion Rate Normalized by Surface Area
Last Meas Excretion Rate Norm by WTC92394Last Meas Excretion Rate Norm by WTThe last measurable (positive) excretion rate divided by the weight.Last Measurable Excretion Rate Normalized by Weight
Last Nonzero ConcC85655Last Nonzero ConcThe concentration corresponding to Tlast.Last Concentration
Last Nonzero Conc Norm by BMIC92387Last Nonzero Conc Norm by BMIThe concentration corresponding to Tlast divided by the body mass index.Last Concentration Normalized by Body Mass Index
Last Nonzero Conc Norm by DoseC92388Last Nonzero Conc Norm by DoseThe concentration corresponding to Tlast divided by the dose.Last Concentration Normalized by Dose
Last Nonzero Conc Norm by SAC92389Last Nonzero Conc Norm by SAThe concentration corresponding to Tlast divided by the surface area.Last Concentration Normalized by Surface Area
Last Nonzero Conc Norm by WTC92390Last Nonzero Conc Norm by WTThe concentration corresponding to Tlast divided by the weight.Last Concentration Normalized by Weight
Max ConcC70918Max ConcThe maximum concentration occurring at Tmax.Cmax
Max Conc Norm by BMIC92371Max Conc Norm by BMIThe maximum concentration occurring at Tmax, divided by the body mass index.Maximum Concentration Normalized by Body Mass Index
Max Conc Norm by DoseC85698Max Conc Norm by DoseThe maximum concentration occurring at Tmax, divided by the dose.Maximum Concentration Dose Normalized
Max Conc Norm by SAC92372Max Conc Norm by SAThe maximum concentration occurring at Tmax, divided by the surface area.Maximum Concentration Normalized by Surface Area
Max Conc Norm by WTC92373Max Conc Norm by WTThe maximum concentration occurring at Tmax, divided by the weight.Maximum Concentration Normalized by Weight
Max Excretion RateC85699Max Excretion RateThe maximum excretion rate determined for the specimen type specified in PPSPEC.Maximum Observed Excretion Rate
Max Excretion Rate Norm by BMIC92395Max Excretion Rate Norm by BMIThe maximum excretion rate divided by the body mass index.Maximum Observed Excretion Rate Normalized by Body Mass Index
Max Excretion Rate Norm by DoseC92396Max Excretion Rate Norm by DoseThe maximum excretion rate divided by the dose.Maximum Observed Excretion Rate Normalized by Dose
Max Excretion Rate Norm by SAC92397Max Excretion Rate Norm by SAThe maximum excretion rate divided by the surface area.Maximum Observed Excretion Rate Normalized by Surface Area
Max Excretion Rate Norm by WTC92398Max Excretion Rate Norm by WTThe maximum excretion rate divided by the weight.Maximum Observed Excretion Rate Normalized by Weight
Midpoint of Collection IntervalC85580Midpoint of Collection IntervalThe midpoint of collection interval, which is associated with last Measurable rate.Collection Interval Midpoint
Min ConcC85579Min ConcThe minimum concentration between dose time and dose time plus Tau (at Tmin).Cmin
Min Conc Norm by BMIC92374Min Conc Norm by BMIThe minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body mass index.Minimum Concentration Normalized by Body Mass Index
Min Conc Norm by DoseC92375Min Conc Norm by DoseThe minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the dose.Minimum Concentration Normalized by Dose
Min Conc Norm by SAC92376Min Conc Norm by SAThe minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the surface area.Minimum Concentration Normalized by Surface Area
Min Conc Norm by WTC92377Min Conc Norm by WTThe minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the weight.Minimum Concentration Normalized by Weight
MRT Infinity ObsC85769MRT Infinity ObsThe mean residence time (MRT) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.Observed Mean Residence Time Infinity
MRT Infinity PredC85793MRT Infinity PredThe mean residence time (MRT) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.Predicted Mean Residence Time Infinity
MRT to Last Nonzero ConcC85700MRT to Last Nonzero ConcMean residence time (MRT) from the time of dosing to the time of the last measurable concentration.Mean Residence Time Last
Nonrenal CLC102376Nonrenal CLThe total clearance of a substance from the blood less the renal clearance.Nonrenal Clearance
Nonrenal CL Norm by BMIC105454Nonrenal CL Norm by BMIThe total clearance of a substance from the blood minus the renal clearance divided by the body mass index.Nonrenal Clearance Normalized by BMI
Nonrenal CL Norm by DoseC105455Nonrenal CL Norm by DoseThe total clearance of a substance from the blood minus the renal clearance divided by the dose.Nonrenal Clearance Normalized by Dose
Nonrenal CL Norm by SAC105456Nonrenal CL Norm by SAThe total clearance of a substance from the blood minus the renal clearance divided by the surface area.Nonrenal Clearance Normalized by SA
Nonrenal CL Norm by WTC105457Nonrenal CL Norm by WTThe total clearance of a substance from the blood minus the renal clearance divided by the weight.Nonrenal Clearance Normalized by WT
Number of Points for Lambda zC85816Number of Points for Lambda zThe number of time points used in computing Lambda z.Sum of Lambda Z Timepoints
Pct Rec from T1 to T2C102382Pct Rec from T1 to T2The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2.Percent Recovered from T1 to T2
Pct Rec from T1 to T2 Norm by BMIC102383Pct Rec from T1 to T2 Norm by BMIThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by body mass index.Percent Recovered from T1 to T2 Normalized by Body Mass Index
Pct Rec from T1 to T2 Norm by SAC102384Pct Rec from T1 to T2 Norm by SAThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by surface area.Percent Recovered from T1 to T2 Normalized by Surface Area
Pct Rec from T1 to T2 Norm by WTC102385Pct Rec from T1 to T2 Norm by WTThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by weight.Percent Recovered from T1 to T2 Normalized by Weight
Pct Rec Infinity ObsC112034Pct Rec Infinity ObsThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration.Percent Recovered Infinity Observed
Pct Rec Infinity Obs Norm by BMIC112389Pct Rec Infinity Obs Norm by BMIThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Percent Recovered Infinity Observed Normalized by Body Mass Index
Pct Rec Infinity Obs Norm by SAC112390Pct Rec Infinity Obs Norm by SAThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.Percent Recovered Infinity Observed Normalized by Surface Area
Pct Rec Infinity Obs Norm by WTC112391Pct Rec Infinity Obs Norm by WTThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.Percent Recovered Infinity Observed Normalized by Weight
Pct Rec Infinity PredC112035Pct Rec Infinity PredThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.Percent Recovered Infinity Predicted
Pct Rec Infinity Pred Norm by BMIC112392Pct Rec Infinity Pred Norm by BMIThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.Percent Recovered Infinity Predicted Normalized by Body Mass Index
Pct Rec Infinity Pred Norm by SAC112393Pct Rec Infinity Pred Norm by SAThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Percent Recovered Infinity Predicted Normalized by Surface Area
Pct Rec Infinity Pred Norm by WTC112394Pct Rec Infinity Pred Norm by WTThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.Percent Recovered Infinity Predicted Normalized by Weight
Pct Rec Over Dosing IntervalC102386Pct Rec Over Dosing IntervalThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU).Percent Recovered Over Dosing Interval
Pct Rec Over Dosing Interval Norm by BMIC102387Pct Rec Over Dosing Interval Norm by BMIThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by the body mass index.Percent Recovered Over Dosing Interval Normalized by Body Mass Index
Pct Rec Over Dosing Interval Norm by SAC102388Pct Rec Over Dosing Interval Norm by SAThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by surface area.Percent Recovered Over Dosing Interval Normalized by Surface Area
Pct Rec Over Dosing Interval Norm by WTC102389Pct Rec Over Dosing Interval Norm by WTThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by weight.Percent Recovered Over Dosing Interval Normalized by Weight
Peak Trough RatioC102381Peak Trough RatioThe ratio of Cmax to Ctrough during a dosing interval.Peak Trough Ratio
R SquaredC85542R SquaredThe goodness of fit statistic for the terminal elimination phase.R Squared
R Squared AdjustedC85553R Squared AdjustedThe goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of Lambda z.Adjusted R Squared
Renal CLC75913Renal CLThe clearance of a substance from the blood by the kidneys.Renal Clearance
Renal CL Norm by BMIC105458Renal CL Norm by BMIThe clearance of a substance from the blood by the kidneys divided by the body mass index.Renal Clearance Normalized by BMI
Renal CL Norm by DoseC105459Renal CL Norm by DoseThe clearance of a substance from the blood by the kidneys divided by the dose.Renal Clearance Normalized by Dose
Renal CL Norm by SAC105460Renal CL Norm by SAThe clearance of a substance from the blood by the kidneys divided by the surface area.Renal Clearance Normalized by SA
Renal CL Norm by WTC105461Renal CL Norm by WTThe clearance of a substance from the blood by the kidneys divided by the weight.Renal Clearance Normalized by WT
Sum of Urine VolC85817Sum of Urine VolThe sum of urine volumes that are used for PK parameters.Sum Urine Volume
Time of CMAXC70919Time of CMAXThe time of maximum observed concentration sampled during a dosing interval.Tmax
Time of CMIN ObservationC85825Time of CMIN ObservationThe time of minimum concentration sampled during a dosing interval.Tmin
Time of Last Nonzero ConcC85822Time of Last Nonzero ConcThe time of the last measurable (positive) concentration.Time of Last Nonzero Concentration
Time of Max Excretion RateC85823Time of Max Excretion RateThe midpoint of collection interval associated with the maximum excretion rate.Time of Maximum Observed Excretion Rate
Time Until First Nonzero ConcC85824Time Until First Nonzero ConcThe time prior to the first measurable (non-zero) concentration.Time until First Nonzero Concentration
Total CL by F for Dose IntC114121Total CL by F for Dose IntThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU.Total Body Clearance by Fraction of Dose for Dose Interval
Total CL by F for Dose Int Norm by BMIC114227Total CL by F for Dose Int Norm by BMIThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index.Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Body Mass Index
Total CL by F for Dose Int Norm by DoseC114226Total CL by F for Dose Int Norm by DoseThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose.Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Dose
Total CL by F for Dose Int Norm by SAC114228Total CL by F for Dose Int Norm by SAThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area.Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Surface Area
Total CL by F for Dose Int Norm by WTC114229Total CL by F for Dose Int Norm by WTThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight.Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Weight
Total CL for Dose IntC114122Total CL for Dose IntThe total body clearance for intravascular administration, calculated using AUCTAU.Total Body Clearance for Dose Interval
Total CL for Dose Int Norm by BMIC114231Total CL for Dose Int Norm by BMIThe total body clearance for intravascular administration, calculated using AUCTAU, divided by the body mass index.Total Body Clearance for Dose Interval Normalized by Body Mass Index
Total CL for Dose Int Norm by DoseC114230Total CL for Dose Int Norm by DoseThe total body clearance for intravascular administration, calculated using AUCTAU, divided by the dose.Total Body Clearance for Dose Interval Normalized by Dose
Total CL for Dose Int Norm by SAC114232Total CL for Dose Int Norm by SAThe total body clearance for intravascular administration, calculated using AUCTAU, divided by the surface area.Total Body Clearance for Dose Interval Normalized by Surface Area
Total CL for Dose Int Norm by WTC114233Total CL for Dose Int Norm by WTThe total body clearance for intravascular administration, calculated using AUCTAU, divided by the weight.Total Body Clearance for Dose Interval Normalized by Weight
Total CL ObsC85773Total CL ObsThe total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration.Observed Total Body Clearance Rate
Total CL Obs by FC85772Total CL Obs by FThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration.Observed Total Body Clearance by Fraction of Dose Absorbed
Total CL Obs by F Norm by BMIC92399Total CL Obs by F Norm by BMIThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Total Clearance Observed by Fraction Dose Normalized by Body Mass Index
Total CL Obs by F Norm by DoseC92400Total CL Obs by F Norm by DoseThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose.Total Clearance Observed by Fraction Dose Normalized by Dose
Total CL Obs by F Norm by SAC92401Total CL Obs by F Norm by SAThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area.Total Clearance Observed by Fraction Dose Normalized by Surface Area
Total CL Obs by F Norm by WTC92402Total CL Obs by F Norm by WTThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight.Total Clearance Observed by Fraction Dose Normalized by Weight
Total CL Obs Norm by BMIC92403Total CL Obs Norm by BMIThe total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Total Clearance Observed Normalized by Body Mass Index
Total CL Obs Norm by DoseC92404Total CL Obs Norm by DoseThe total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose.Total Clearance Observed Normalized by Dose
Total CL Obs Norm by SAC92405Total CL Obs Norm by SAThe total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area.Total Clearance Observed Normalized by Surface Area
Total CL Obs Norm by WTC92406Total CL Obs Norm by WTThe total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight.Total Clearance Observed Normalized by Weight
Total CL PredC85797Total CL PredThe total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration.Predicted Total Body Clearance Rate
Total CL Pred by FC85796Total CL Pred by FThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration.Predicted Total Body Clearance by Fraction of Dose Absorbed
Total CL Pred by F Norm by BMIC92417Total CL Pred by F Norm by BMIThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by body mass index.Total Clearance Predicted by Fraction Dose Normalized by Body Mass Index
Total CL Pred by F Norm by DoseC92418Total CL Pred by F Norm by DoseThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose.Total Clearance Predicted by Fraction Dose Normalized by Dose
Total CL Pred by F Norm by SAC92419Total CL Pred by F Norm by SAThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Total Clearance Predicted by Fraction Dose Normalized by Surface Area
Total CL Pred by F Norm by WTC92420Total CL Pred by F Norm by WTThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight.Total Clearance Predicted by Fraction Dose Normalized by Weight
Total CL Pred Norm by BMIC92421Total CL Pred Norm by BMIThe total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.Total Clearance Predicted Normalized by Body Mass Index
Total CL Pred Norm by DoseC92422Total CL Pred Norm by DoseThe total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose.Total Clearance Predicted Normalized by Dose
Total CL Pred Norm by SAC92423Total CL Pred Norm by SAThe total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Total Clearance Predicted Normalized by Surface Area
Total CL Pred Norm by WTC92424Total CL Pred Norm by WTThe total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight.Total Clearance Predicted Normalized by Weight
Vol Dist InitialC102371Vol Dist InitialThe initial volume of distribution for a substance administered by bolus intravascular dosing.Initial Volume of Distribution
Vol Dist Initial Norm by BMIC102372Vol Dist Initial Norm by BMIThe initial volume of distribution for a substance administered by bolus intravascular dosing divided by the body mass index.Initial Volume of Distribution Normalized by Body Mass Index
Vol Dist Initial Norm by DoseC102373Vol Dist Initial Norm by DoseThe initial volume of distribution for a substance administered by bolus intravascular dosing divided by the dose.Initial Volume of Distribution Normalized by Dose
Vol Dist Initial Norm by SAC102374Vol Dist Initial Norm by SAThe initial volume of distribution for a substance administered by bolus intravascular dosing divided by the surface area.Initial Volume of Distribution Normalized by Surface Area
Vol Dist Initial Norm by WTC102375Vol Dist Initial Norm by WTThe initial volume of distribution for a substance administered by bolus intravascular dosing divided by the weight.Initial Volume of Distribution Normalized by Weight
Vol Dist Steady State ObsC85770Vol Dist Steady State ObsThe volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing.Observed Steady State Volume of Distribution
Vol Dist Steady State Obs Norm by BMIC102377Vol Dist Steady State Obs Norm by BMIThe volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the body mass index.Observed Steady State Volume of Distribution Normalized by Body Mass Index
Vol Dist Steady State Obs Norm by DoseC102378Vol Dist Steady State Obs Norm by DoseThe volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the dose.Observed Steady State Volume of Distribution Normalized by Dose
Vol Dist Steady State Obs Norm by SAC102379Vol Dist Steady State Obs Norm by SAThe volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the surface area.Observed Steady State Volume of Distribution Normalized by Surface Area
Vol Dist Steady State Obs Norm by WTC102380Vol Dist Steady State Obs Norm by WTThe volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the weight.Observed Steady State Volume of Distribution Normalized by Weight
Vol Dist Steady State PredC85794Vol Dist Steady State PredThe volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing.Predicted Steady State Volume of Distribution
Vol Dist Steady State Pred Norm by BMIC102390Vol Dist Steady State Pred Norm by BMIThe volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the body mass index.Predicted Steady State Volume of Distribution Normalized by Body Mass Index
Vol Dist Steady State Pred Norm by DoseC102391Vol Dist Steady State Pred Norm by DoseThe volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the dose.Predicted Steady State Volume of Distribution Normalized by Dose
Vol Dist Steady State Pred Norm by SAC102392Vol Dist Steady State Pred Norm by SAThe volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the surface area.Predicted Steady State Volume of Distribution Normalized by Surface Area
Vol Dist Steady State Pred Norm by WTC102393Vol Dist Steady State Pred Norm by WTThe volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the weight.Predicted Steady State Volume of Distribution Normalized by Weight
Vz for Dose IntC111333Vz for Dose IntThe volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU.Volume of Distribution for Dosing Interval
Vz for Dose Int by FC111364Vz for Dose Int by FThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU.Volume of Distribution for Dosing Interval by Fraction
Vz for Dose Int by F Norm by BMIC111365Vz for Dose Int by F Norm by BMIThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index.Volume of Distribution for Dosing Interval by Fraction Normalized by Body Mass Index
Vz for Dose Int by F Norm by DoseC111366Vz for Dose Int by F Norm by DoseThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose.Volume of Distribution for Dosing Interval by Fraction Normalized by Dose
Vz for Dose Int by F Norm by SAC111367Vz for Dose Int by F Norm by SAThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area.Volume of Distribution for Dosing Interval by Fraction Normalized by Surface Area
Vz for Dose Int by F Norm by WTC111368Vz for Dose Int by F Norm by WTThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight.Volume of Distribution for Dosing Interval by Fraction Normalized by Weight
Vz for Dose Int Norm by BMIC111369Vz for Dose Int Norm by BMIThe volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the body mass index.Volume of Distribution for Dosing Interval Normalized by Body Mass Index
Vz for Dose Int Norm by DoseC111370Vz for Dose Int Norm by DoseThe volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the dose.Volume of Distribution for Dosing Interval Normalized by Dose
Vz for Dose Int Norm by SAC111371Vz for Dose Int Norm by SAThe volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the surface area.Volume of Distribution for Dosing Interval Normalized by Surface Area
Vz for Dose Int Norm by WTC111372Vz for Dose Int Norm by WTThe volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the weight.Volume of Distribution for Dosing Interval Normalized by Weight
Vz ObsC85774Vz ObsThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration.Observed Volume of Distribution
Vz Obs by FC85775Vz Obs by FThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration.Observed Volume of Distribution of Absorbed Fraction
Vz Obs by F Norm by BMIC92410Vz Obs by F Norm by BMIThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Volume of Distribution of Fraction Dose Observed Normalized by Body Mass Index
Vz Obs by F Norm by DoseC102729Vz Obs by F Norm by DoseThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose.Volume of Distribution of Fraction Dose Observed Normalized by Dose
Vz Obs by F Norm by SAC92411Vz Obs by F Norm by SAThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area.Volume of Distribution of Fraction Dose Observed Normalized by Surface Area
Vz Obs by F Norm by WTC92412Vz Obs by F Norm by WTThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight.Volume of Distribution of Fraction Dose Observed Normalized by Weight
Vz Obs Norm by BMIC92407Vz Obs Norm by BMIThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Volume of Distribution Observed Normalized by Body Mass Index
Vz Obs Norm by DoseC102683Vz Obs Norm by DoseThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose.Observed Volume of Distribution Normalized by Dose
Vz Obs Norm by SAC92408Vz Obs Norm by SAThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area.Volume of Distribution Observed Normalized by Surface Area
Vz Obs Norm by WTC92409Vz Obs Norm by WTThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight.Volume of Distribution Observed Normalized by Weight
Vz PredC85798Vz PredThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration.Predicted Volume of Distribution
Vz Pred by FC85799Vz Pred by FThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration.Predicted Volume of Distribution of Absorbed Fraction
Vz Pred by F Norm by BMIC92428Vz Pred by F Norm by BMIThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.Volume of Distribution of Fraction Dose Predicted Normalized by Body Mass Index
Vz Pred by F Norm by DoseC102730Vz Pred by F Norm by DoseThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose.Volume of Distribution of Fraction Dose Predicted Normalized by Dose
Vz Pred by F Norm by SAC92429Vz Pred by F Norm by SAThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Volume of Distribution of Fraction Dose Predicted Normalized by Surface Area
Vz Pred by F Norm by WTC92430Vz Pred by F Norm by WTThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight.Volume of Distribution of Fraction Dose Predicted Normalized by Weight
Vz Pred Norm by BMIC92425Vz Pred Norm by BMIThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.Volume of Distribution Predicted Normalized by Body Mass Index
Vz Pred Norm by DoseC102696Vz Pred Norm by DoseThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose.Predicted Volume of Distribution Normalized by Dose
Vz Pred Norm by SAC92426Vz Pred Norm by SAThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Volume of Distribution Predicted Normalized by Surface Area
Vz Pred Norm by WTC92427Vz Pred Norm by WTThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight.Volume of Distribution Predicted Normalized by Weight
Back to top
CL.C85839.PKPARMCDPK Parameters Code
(PKPARMCD)
text
Extensible: Yes
C85839PK Parameters CodeParameter codes used to describe the time-concentration curve.CDISC SDTM Pharmacokinetic Parameter Terminology by Code
AILAMZC114234Accumulation Index using Lambda zPredicted accumulation ratio for area under the curve (AUC) calculated using the Lambda z estimated from single dose data.Accumulation Index using Lambda z
ARAUCC102356Accumulation Ratio AUCThe area under the curve (AUCTAU) at steady state divided by the area under the curve over the initial dosing interval.Accumulation Ratio Area Under the Curve
ARCMAXC102357Accumulation Ratio CmaxThe maximum concentration at steady state divided by the maximum concentration during the initial dosing interval.Accumulation Ratio Cmax
ARCMINC102358Accumulation Ratio CminThe minimum concentration at steady state divided by the minimum concentration during the initial dosing interval.Accumulation Ratio Cmin
ARCTROUGC102426Accumulation Ratio CtroughThe trough concentration at steady state divided by the trough concentration during the initial dosing interval.Accumulation Ratio Ctrough
AUCALLC85564AUC AllThe area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not.Area Under the Curve All
AUCALLBC92362AUC All Norm by BMIThe area under the curve (AUC) from the time of dosing to the time of the last observation divided by the body mass index, regardless of whether the last concentration is measurable or not.AUC All Normalized by Body Mass Index
AUCALLDC92306AUC All Norm by DoseThe area under the curve (AUC) from the time of dosing to the time of the last observation divided by the dose, regardless of whether the last concentration is measurable or not.AUC All Normalized by Dose
AUCALLSC92307AUC All Norm by SAThe area under the curve (AUC) from the time of dosing to the time of the last observation divided by the surface area, regardless of whether the last concentration is measurable or not.AUC All Normalized by Surface Area
AUCALLWC92308AUC All Norm by WTThe area under the curve (AUC) from the time of dosing to the time of the last observation divided by the weight, regardless of whether the last concentration is measurable or not.AUC All Normalized by Weight
AUCIFOC85761AUC Infinity ObsThe area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.Observed Area Under the Curve Infinity
AUCIFOBC92316AUC Infinity Obs Norm by BMIThe area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.AUC Infinity Observed Normalized by Body Mass Index
AUCIFODC96695AUC Infinity Obs Norm by DoseThe area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose.AUC Infinity Observed Normalized by Dose
AUCIFOSC92317AUC Infinity Obs Norm by SAThe area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.AUC Infinity Observed Normalized by Surface Area
AUCIFOWC92318AUC Infinity Obs Norm by WTThe area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.AUC Infinity Observed Normalized by Weight
AUCIFPC85785AUC Infinity PredThe area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.Predicted Area Under the Curve Infinity
AUCIFPBC92319AUC Infinity Pred Norm by BMIThe area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.AUC Infinity Predicted Normalized by Body Mass Index
AUCIFPDC85786AUC Infinity Pred Norm by DoseThe area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose.Predicted Area Under the Curve Infinity by Dose
AUCIFPSC92320AUC Infinity Pred Norm by SAThe area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.AUC Infinity Predicted Normalized by Surface Area
AUCIFPWC92321AUC Infinity Pred Norm by WTThe area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.AUC Infinity Predicted Normalized by Weight
AUCINTC85566AUC from T1 to T2The area under the curve (AUC) over the interval from T1 to T2.Area Under the Curve from T1 to T2
AUCINTBC92312AUC from T1 to T2 Norm by BMIThe area under the curve (AUC) over the interval from T1 to T2 divided by the body mass index.AUC from T1 to T2 Normalized by Body Mass Index
AUCINTDC92313AUC from T1 to T2 Norm by DoseThe area under the curve (AUC) over the interval from T1 to T2 divided by the dose.AUC from T1 to T2 Normalized by Dose
AUCINTSC92314AUC from T1 to T2 Norm by SAThe area under the curve (AUC) over the interval from T1 to T2 divided by the surface area.AUC from T1 to T2 Normalized by Surface Area
AUCINTWC92315AUC from T1 to T2 Norm by WTThe area under the curve (AUC) over the interval from T1 to T2 divided by the weight.AUC from T1 to T2 Normalized by Weight
AUCLSTC85565AUC to Last Nonzero ConcThe area under the curve (AUC) from the time of dosing to the last measurable concentration.Area Under the Curve From Dosing to Last Concentration
AUCLSTBC92309AUC to Last Nonzero Conc Norm by BMIThe area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body mass index.AUC Dosing to Last Concentration Normalized by Body Mass Index
AUCLSTDC92310AUC to Last Nonzero Conc Norm by DoseThe area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the dose.AUC Dosing to Last Concentration Normalized by Dose
AUCLSTSC92311AUC to Last Nonzero Conc Norm by SAThe area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the surface area.AUC Dosing to Last Concentration Normalized by Surface Area
AUCLSTWC92305AUC to Last Nonzero Conc Norm by WTThe area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the weight.AUC Dosing to Last Concentration Normalized by Weight
AUCPBEOC85763AUC %Back Extrapolation ObsApplies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the observed value of the last non-zero concentration.Observed Area Under the Curve Percent Back Extrapolation
AUCPBEPC85787AUC %Back Extrapolation PredApplies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the predicted value of the last non-zero concentration.Predicted Area Under the Curve Percent Back Extrapolation
AUCPEOC85764AUC %Extrapolation ObsThe area under the curve (AUC) from the last observed non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity.Observed Area Under the Curve Percent Extrapolation
AUCPEPC85788AUC %Extrapolation PredThe area under the curve (AUC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity.Predicted Area Under the Curve Percent Extrapolation
AUCTAUC85567AUC Over Dosing IntervalThe area under the curve (AUC) for the defined interval between doses (TAU).Area Under the Curve Over Dosing Interval
AUCTAUBC92322AUC Over Dosing Interval Norm by BMIThe area under the curve (AUC) for the defined interval between doses (TAU) divided by the body mass index.AUC Over Dosing Interval Normalized by Body Mass Index
AUCTAUDC92323AUC Over Dosing Interval Norm by DoseThe area under the curve (AUC) for the defined interval between doses (TAU) divided by the dose.AUC Over Dosing Interval Normalized by Dose
AUCTAUSC92324AUC Over Dosing Interval Norm by SAThe area under the curve (AUC) for the defined interval between doses (TAU) divided by the surface area.AUC Over Dosing Interval Normalized by Surface Area
AUCTAUWC92325AUC Over Dosing Interval Norm by WTThe area under the curve (AUC) for the defined interval between doses (TAU) divided by the weight.AUC Over Dosing Interval Normalized by Weight
AUMCIFOC85765AUMC Infinity ObsThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.Observed Area Under the First Moment Curve Infinity
AUMCIFOBC92330AUMC Infinity Obs Norm by BMIThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.AUMC Infinity Observed Normalized by Body Mass Index
AUMCIFODC92331AUMC Infinity Obs Norm by DoseThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose.AUMC Infinity Observed Normalized by Dose
AUMCIFOSC92332AUMC Infinity Obs Norm by SAThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.AUMC Infinity Observed Normalized by Surface Area
AUMCIFOWC92333AUMC Infinity Obs Norm by WTThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.AUMC Infinity Observed Normalized by Weight
AUMCIFPC85789AUMC Infinity PredThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.Predicted Area Under the First Moment Curve Infinity
AUMCIFPBC92334AUMC Infinity Pred Norm by BMIThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.AUMC Infinity Predicted Normalized by Body Mass Index
AUMCIFPDC92335AUMC Infinity Pred Norm by DoseThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose.AUMC Infinity Predicted Normalized by Dose
AUMCIFPSC92336AUMC Infinity Pred Norm by SAThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.AUMC Infinity Predicted Normalized by Surface Area
AUMCIFPWC92337AUMC Infinity Pred Norm by WTThe area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.AUMC Infinity Predicted Normalized by Weight
AUMCLSTC85569AUMC to Last Nonzero ConcThe area under the moment curve (AUMC) from the time of dosing to the last measurable concentration.Area Under the First Moment Curve From Dosing to Last Concentration
AUMCLSTBC92326AUMC to Last Nonzero Conc Norm by BMIThe area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the body mass index.AUMC Dosing to Last Concentration Normalized by Body Mass Index
AUMCLSTDC92327AUMC to Last Nonzero Conc Norm by DoseThe area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the dose.AUMC Dosing to Last Concentration Normalized by Dose
AUMCLSTSC92328AUMC to Last Nonzero Conc Norm by SAThe area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the surface area.AUMC Dosing to Last Concentration Normalized by Surface Area
AUMCLSTWC92329AUMC to Last Nonzero Conc Norm by WTThe area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the weight.AUMC Dosing to Last Concentration Normalized by Weight
AUMCPEOC85766AUMC % Extrapolation ObsThe area under the moment curve (AUMC) from the last observed non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity.Observed Area Under the First Moment Curve Percent Extrapolation
AUMCPEPC85790AUMC % Extrapolation PredThe area under the moment curve (AUMC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity.Predicted Area Under the First Moment Curve Percent Extrapolation
AUMCTAUC85570AUMC Over Dosing IntervalThe area under the first moment curve (AUMC) for the defined interval between doses (TAU).Area Under the First Moment Curve Over Dosing Interval
AUMCTAUBC92338AUMC Over Dosing Interval Norm by BMIThe area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the body mass index.AUMC Over Dosing Interval Normalized by Body Mass Index
AUMCTAUDC92339AUMC Over Dosing Interval Norm by DoseThe area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the dose.AUMC Over Dosing Interval Normalized by Dose
AUMCTAUSC92340AUMC Over Dosing Interval Norm by SAThe area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the surface area.AUMC Over Dosing Interval Normalized by Surface Area
AUMCTAUWC92341AUMC Over Dosing Interval Norm by WTThe area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the weight.AUMC Over Dosing Interval Normalized by Weight
AURCALLC85841AURC AllThe area under the urinary excretion rate curve (AURC) from time zero to the time of the last observation, regardless of whether the last observation is a measurable concentration or not.Area Under Urinary Excretion Rate Curve All
AURCALLBC92342AURC All Norm by BMIThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the body mass index.AURC All Normalized by Body Mass Index
AURCALLDC92343AURC All Norm by DoseThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the dose.AURC All Normalized by Dose
AURCALLSC92344AURC All Norm by SAThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the surface area.AURC All Normalized by Surface Area
AURCALLWC92345AURC All Norm by WTThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the weight.AURC All Normalized by Weight
AURCIFOC85767AURC Infinity ObsThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate.Observed Area Under the Urinary Excretion Rate Curve infinity
AURCIFOBC92354AURC Infinity Obs Norm by BMIThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the body mass index.AURC Infinity Observed Normalized by Body Mass Index
AURCIFODC92355AURC Infinity Obs Norm by DoseThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the dose.AURC Infinity Observed Normalized by Dose
AURCIFOSC92356AURC Infinity Obs Norm by SAThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the surface area.AURC Infinity Observed Normalized by Surface Area
AURCIFOWC92357AURC Infinity Obs Norm by WTThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the weight.AURC Infinity Observed Normalized by Weight
AURCIFPC85791AURC Infinity PredThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate.Predicted Area Under the Urinary Excretion Rate Curve Infinity
AURCIFPBC92358AURC Infinity Pred Norm by BMIThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the body mass index.AURC Infinity Predicted Normalized by Body Mass Index
AURCIFPDC92359AURC Infinity Pred Norm by DoseThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the dose.AURC Infinity Predicted Normalized by Dose
AURCIFPSC92360AURC Infinity Pred Norm by SAThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the surface area.AURC Infinity Predicted Normalized by Surface Area
AURCIFPWC92361AURC Infinity Pred Norm by WTThe area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the weight.AURC Infinity Predicted Normalized by Weight
AURCINTC85572AURC from T1 to T2The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2.Area Under the Urinary Excretion Rate Curve from T1 to T2
AURCINTBC92350AURC from T1 to T2 Norm by BMIThe area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the body mass index.AURC from T1 to T2 Normalized by Body Mass Index
AURCINTDC92351AURC from T1 to T2 Norm by DoseThe area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the dose.AURC from T1 to T2 Normalized by Dose
AURCINTSC92352AURC from T1 to T2 Norm by SAThe area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the surface area.AURC from T1 to T2 Normalized by Surface Area
AURCINTWC92353AURC from T1 to T2 Norm by WTThe area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the weight.AURC from T1 to T2 Normalized by Weight
AURCLSTC85571AURC to Last Nonzero RateThe area under the urinary excretion rate curve (AURC) from time zero to the time of the last measurable concentration.Area Under the Urinary Excretion Rate Curve From Dosing to Last Concentration
AURCLSTBC92346AURC to Last Nonzero Rate Norm by BMIThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the body mass index.AURC Dosing to Last Concentration Normalized by Body Mass Index
AURCLSTDC92347AURC to Last Nonzero Rate Norm by DoseThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the dose.AURC Dosing to Last Concentration Normalized by Dose
AURCLSTSC92348AURC to Last Nonzero Rate Norm by SAThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the surface area.AURC Dosing to Last Concentration Normalized by Surface Area
AURCLSTWC92349AURC to Last Nonzero Rate Norm by WTThe area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the weight.AURC Dosing to Last Concentration Normalized by Weight
AURCPEOC85768AURC % Extrapolation ObsThe area under the urinary excretion rate curve (AURC) from the last observed non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity.Observed Area Under the Urinary Excretion Rate Curve Percent Extrapolation
AURCPEPC85792AURC % Extrapolation PredThe area under the urinary excretion rate curve (AURC) from the last predicted non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity.Predicted Area Under the Urinary Excretion Rate Curve Percent Extrapolation
C0C85644Initial ConcInitial concentration. Given only for bolus IV models.Initial Concentration
C0BC92383Initial Conc Norm by BMIInitial concentration divided by the body mass index. Given only for bolus IV models.Initial Concentration Normalized by Body Mass Index
C0DC92384Initial Conc Norm by DoseInitial concentration divided by the dose. Given only for bolus IV models.Initial Concentration Normalized by Dose
C0SC92385Initial Conc Norm by SAInitial concentration divided by the surface area. Given only for bolus IV models.Initial Concentration Normalized by Surface Area
C0WC92386Initial Conc Norm by WTInitial concentration divided by the weight. Given only for bolus IV models.Initial Concentration Normalized by Weight
CAVGC85575Average ConcentrationAUCTAU divided by TAU.Average Concentration
CAVGBC92367Average Conc Norm by BMIAUCTAU divided by TAU and then divided by the body mass index.Average Concentration Normalized by Body Mass Index
CAVGDC92368Average Conc Norm by DoseAUCTAU divided by TAU and then divided by the dose.Average Concentration Normalized by Dose
CAVGSC92369Average Conc Norm by SAAUCTAU divided by TAU and then divided by the surface area.Average Concentration Normalized by Surface Area
CAVGWC92370Average Conc Norm by WTAUCTAU divided by TAU and then divided by the weight.Average Concentration Normalized by Weight
CLFOC85772Total CL Obs by FThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration.Observed Total Body Clearance by Fraction of Dose Absorbed
CLFOBC92399Total CL Obs by F Norm by BMIThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Total Clearance Observed by Fraction Dose Normalized by Body Mass Index
CLFODC92400Total CL Obs by F Norm by DoseThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose.Total Clearance Observed by Fraction Dose Normalized by Dose
CLFOSC92401Total CL Obs by F Norm by SAThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area.Total Clearance Observed by Fraction Dose Normalized by Surface Area
CLFOWC92402Total CL Obs by F Norm by WTThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight.Total Clearance Observed by Fraction Dose Normalized by Weight
CLFPC85796Total CL Pred by FThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration.Predicted Total Body Clearance by Fraction of Dose Absorbed
CLFPBC92417Total CL Pred by F Norm by BMIThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by body mass index.Total Clearance Predicted by Fraction Dose Normalized by Body Mass Index
CLFPDC92418Total CL Pred by F Norm by DoseThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose.Total Clearance Predicted by Fraction Dose Normalized by Dose
CLFPSC92419Total CL Pred by F Norm by SAThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Total Clearance Predicted by Fraction Dose Normalized by Surface Area
CLFPWC92420Total CL Pred by F Norm by WTThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight.Total Clearance Predicted by Fraction Dose Normalized by Weight
CLFTAUC114121Total CL by F for Dose IntThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU.Total Body Clearance by Fraction of Dose for Dose Interval
CLFTAUBC114227Total CL by F for Dose Int Norm by BMIThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index.Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Body Mass Index
CLFTAUDC114226Total CL by F for Dose Int Norm by DoseThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose.Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Dose
CLFTAUSC114228Total CL by F for Dose Int Norm by SAThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area.Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Surface Area
CLFTAUWC114229Total CL by F for Dose Int Norm by WTThe total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight.Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Weight
CLOC85773Total CL ObsThe total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration.Observed Total Body Clearance Rate
CLOBC92403Total CL Obs Norm by BMIThe total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Total Clearance Observed Normalized by Body Mass Index
CLODC92404Total CL Obs Norm by DoseThe total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose.Total Clearance Observed Normalized by Dose
CLOSC92405Total CL Obs Norm by SAThe total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area.Total Clearance Observed Normalized by Surface Area
CLOWC92406Total CL Obs Norm by WTThe total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight.Total Clearance Observed Normalized by Weight
CLPC85797Total CL PredThe total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration.Predicted Total Body Clearance Rate
CLPBC92421Total CL Pred Norm by BMIThe total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.Total Clearance Predicted Normalized by Body Mass Index
CLPDC92422Total CL Pred Norm by DoseThe total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose.Total Clearance Predicted Normalized by Dose
CLPSC92423Total CL Pred Norm by SAThe total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Total Clearance Predicted Normalized by Surface Area
CLPWC92424Total CL Pred Norm by WTThe total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight.Total Clearance Predicted Normalized by Weight
CLSTC85655Last Nonzero ConcThe concentration corresponding to Tlast.Last Concentration
CLSTBC92387Last Nonzero Conc Norm by BMIThe concentration corresponding to Tlast divided by the body mass index.Last Concentration Normalized by Body Mass Index
CLSTDC92388Last Nonzero Conc Norm by DoseThe concentration corresponding to Tlast divided by the dose.Last Concentration Normalized by Dose
CLSTSC92389Last Nonzero Conc Norm by SAThe concentration corresponding to Tlast divided by the surface area.Last Concentration Normalized by Surface Area
CLSTWC92390Last Nonzero Conc Norm by WTThe concentration corresponding to Tlast divided by the weight.Last Concentration Normalized by Weight
CLTAUC114122Total CL for Dose IntThe total body clearance for intravascular administration, calculated using AUCTAU.Total Body Clearance for Dose Interval
CLTAUBC114231Total CL for Dose Int Norm by BMIThe total body clearance for intravascular administration, calculated using AUCTAU, divided by the body mass index.Total Body Clearance for Dose Interval Normalized by Body Mass Index
CLTAUDC114230Total CL for Dose Int Norm by DoseThe total body clearance for intravascular administration, calculated using AUCTAU, divided by the dose.Total Body Clearance for Dose Interval Normalized by Dose
CLTAUSC114232Total CL for Dose Int Norm by SAThe total body clearance for intravascular administration, calculated using AUCTAU, divided by the surface area.Total Body Clearance for Dose Interval Normalized by Surface Area
CLTAUWC114233Total CL for Dose Int Norm by WTThe total body clearance for intravascular administration, calculated using AUCTAU, divided by the weight.Total Body Clearance for Dose Interval Normalized by Weight
CMAXC70918Max ConcThe maximum concentration occurring at Tmax.Cmax
CMAXBC92371Max Conc Norm by BMIThe maximum concentration occurring at Tmax, divided by the body mass index.Maximum Concentration Normalized by Body Mass Index
CMAXDC85698Max Conc Norm by DoseThe maximum concentration occurring at Tmax, divided by the dose.Maximum Concentration Dose Normalized
CMAXSC92372Max Conc Norm by SAThe maximum concentration occurring at Tmax, divided by the surface area.Maximum Concentration Normalized by Surface Area
CMAXWC92373Max Conc Norm by WTThe maximum concentration occurring at Tmax, divided by the weight.Maximum Concentration Normalized by Weight
CMINC85579Min ConcThe minimum concentration between dose time and dose time plus Tau (at Tmin).Cmin
CMINBC92374Min Conc Norm by BMIThe minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body mass index.Minimum Concentration Normalized by Body Mass Index
CMINDC92375Min Conc Norm by DoseThe minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the dose.Minimum Concentration Normalized by Dose
CMINSC92376Min Conc Norm by SAThe minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the surface area.Minimum Concentration Normalized by Surface Area
CMINWC92377Min Conc Norm by WTThe minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the weight.Minimum Concentration Normalized by Weight
CONCC41185ConcentrationThe quantity of a specified substance in a unit volume or weight of another substance.Concentration
CONCBC102367Conc by BMIThe concentration divided by body mass index.Concentration Divided by Body Mass Index
CONCDC102368Conc by DoseThe concentration divided by dose.Concentration Divided by Dose
CONCSC102369Conc by SAThe concentration divided by surface area.Concentration Divided by Surface Area
CONCWC102370Conc by WTThe concentration divided by weight.Concentration Divided by Weight
CORRXYC85821Correlation Between TimeX and Log ConcYThe correlation between time (X) and log concentration (Y) for the points used in the estimation of lambda z.Time and Log Concentration Correlation
CTROUGHC102394Conc TroughConcentration at end of dosing interval.Trough Concentration
CTROUGHBC102395Conc Trough by BMIThe trough concentration divided by body mass index.Trough Concentration Divided by Body Mass Index
CTROUGHDC102396Conc Trough by DoseThe trough concentration divided by dose.Trough Concentration Divided by Dose
CTROUGHSC102397Conc Trough by SAThe trough concentration divided by surface area.Trough Concentration Divided by Surface Area
CTROUGHWC102398Conc Trough by WTThe trough concentration divided by weight.Trough Concentration Divided by Weight
EFFHLC95007Effective Half-LifeThe drug half-life that quantifies the accumulation ratio of a drug following multiple dosing.Effective Half-life
ERINTC105449Excret Rate from T1 to T2The excretion rate over the interval from T1 to T2, determined for the specimen type specified in PPSPEC.Excretion Rate From T1 to T2
ERINTBC105450Excret Rate from T1 to T2 Norm by BMIThe excretion rate over the interval from T1 to T2 divided by the body mass index, determined for the specimen type specified in PPSPEC.Excretion Rate From T1 to T2 Normalized by BMI
ERINTDC105451Excret Rate from T1 to T2 Norm by DoseThe excretion rate over the interval from T1 to T2 divided by the dose, determined for the specimen type specified in PPSPEC.Excretion Rate From T1 to T2 Normalized by Dose
ERINTSC105452Excret Rate from T1 to T2 Norm by SAThe excretion rate over the interval from T1 to T2 divided by the surface area, determined for the specimen type specified in PPSPEC.Excretion Rate From T1 to T2 Normalized by SA
ERINTWC105453Excret Rate from T1 to T2 Norm by WTThe excretion rate over the interval from T1 to T2 divided by the weight, determined for the specimen type specified in PPSPEC.Excretion Rate From T1 to T2 Normalized by WT
ERLSTC85656Last Meas Excretion RateThe last measurable (positive) excretion rate determined for the specimen type specified in PPSPEC.Last Measurable Observed Excretion Rate
ERLSTBC92391Last Meas Excretion Rate Norm by BMIThe last measurable (positive) excretion rate divided by the body mass index.Last Measurable Excretion Rate Normalized by Body Mass Index
ERLSTDC92392Last Meas Excretion Rate Norm by DoseThe last measurable (positive) excretion rate divided by the dose.Last Measurable Excretion Rate Normalized by Dose
ERLSTSC92393Last Meas Excretion Rate Norm by SAThe last measurable (positive) excretion rate divided by the surface area.Last Measurable Excretion Rate Normalized by Surface Area
ERLSTWC92394Last Meas Excretion Rate Norm by WTThe last measurable (positive) excretion rate divided by the weight.Last Measurable Excretion Rate Normalized by Weight
ERMAXC85699Max Excretion RateThe maximum excretion rate determined for the specimen type specified in PPSPEC.Maximum Observed Excretion Rate
ERMAXBC92395Max Excretion Rate Norm by BMIThe maximum excretion rate divided by the body mass index.Maximum Observed Excretion Rate Normalized by Body Mass Index
ERMAXDC92396Max Excretion Rate Norm by DoseThe maximum excretion rate divided by the dose.Maximum Observed Excretion Rate Normalized by Dose
ERMAXSC92397Max Excretion Rate Norm by SAThe maximum excretion rate divided by the surface area.Maximum Observed Excretion Rate Normalized by Surface Area
ERMAXWC92398Max Excretion Rate Norm by WTThe maximum excretion rate divided by the weight.Maximum Observed Excretion Rate Normalized by Weight
ERTMAXC85823Time of Max Excretion RateThe midpoint of collection interval associated with the maximum excretion rate.Time of Maximum Observed Excretion Rate
FLUCPC85581Fluctuation%The difference between Cmin and Cmax standardized to Cavg, between dose time and Tau.Concentration Variability Between Dose Time and Tau
HDCLC112287Hemodialysis ClearanceThe clearance of a substance from the blood during a hemodialysis session.Hemodialysis Clearance
HDERC116213Hemodialysis Extraction RatioThe fractional content of a substance removed from the blood during a hemodialysis session.Hemodialysis Extraction Ratio
LAMZC85652Lambda zThe first order rate constant associated with the terminal (log-linear) portion of the curve.Lambda Z
LAMZHLC85818Half-Life Lambda zTerminal half-life.Terminal Half Life
LAMZLLC85653Lambda z Lower LimitThe lower limit on time for values to be included in the calculation of Lambda z.Lambda Z Time Lower Limit
LAMZNPTC85816Number of Points for Lambda zThe number of time points used in computing Lambda z.Sum of Lambda Z Timepoints
LAMZULC85654Lambda z Upper LimitThe upper limit on time for values to be included in the calculation of Lambda z.Lambda Z Time Upper Limit
MIDPTLSTC85580Midpoint of Collection IntervalThe midpoint of collection interval, which is associated with last Measurable rate.Collection Interval Midpoint
MRTIFOC85769MRT Infinity ObsThe mean residence time (MRT) extrapolated to infinity, calculated using the observed value of the last non-zero concentration.Observed Mean Residence Time Infinity
MRTIFPC85793MRT Infinity PredThe mean residence time (MRT) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.Predicted Mean Residence Time Infinity
MRTLSTC85700MRT to Last Nonzero ConcMean residence time (MRT) from the time of dosing to the time of the last measurable concentration.Mean Residence Time Last
NRENALCLC102376Nonrenal CLThe total clearance of a substance from the blood less the renal clearance.Nonrenal Clearance
NRENLCLBC105454Nonrenal CL Norm by BMIThe total clearance of a substance from the blood minus the renal clearance divided by the body mass index.Nonrenal Clearance Normalized by BMI
NRENLCLDC105455Nonrenal CL Norm by DoseThe total clearance of a substance from the blood minus the renal clearance divided by the dose.Nonrenal Clearance Normalized by Dose
NRENLCLSC105456Nonrenal CL Norm by SAThe total clearance of a substance from the blood minus the renal clearance divided by the surface area.Nonrenal Clearance Normalized by SA
NRENLCLWC105457Nonrenal CL Norm by WTThe total clearance of a substance from the blood minus the renal clearance divided by the weight.Nonrenal Clearance Normalized by WT
PTROUGHRC102381Peak Trough RatioThe ratio of Cmax to Ctrough during a dosing interval.Peak Trough Ratio
R2C85542R SquaredThe goodness of fit statistic for the terminal elimination phase.R Squared
R2ADJC85553R Squared AdjustedThe goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of Lambda z.Adjusted R Squared
RCAMIFOC112032Amt Rec Infinity ObsThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration.Amount Recovered Infinity Observed
RCAMIFOBC112223Amt Rec Infinity Obs Norm by BMIThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Amount Recovered Infinity Observed Normalized by Body Mass Index
RCAMIFOSC112224Amt Rec Infinity Obs Norm by SAThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.Amount Recovered Infinity Observed Normalized by Surface Area
RCAMIFOWC112225Amt Rec Infinity Obs Norm by WTThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.Amount Recovered Infinity Observed Normalized by Weight
RCAMIFPC112033Amt Rec Infinity PredThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.Amount Recovered Infinity Predicted
RCAMIFPBC112226Amt Rec Infinity Pred Norm by BMIThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.Amount Recovered Infinity Predicted Normalized by Body Mass Index
RCAMIFPSC112227Amt Rec Infinity Pred Norm by SAThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Amount Recovered Infinity Predicted Normalized by Surface Area
RCAMIFPWC112228Amt Rec Infinity Pred Norm by WTThe cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.Amount Recovered Infinity Predicted Normalized by Weight
RCAMINTC102359Amt Rec from T1 to T2The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2.Amount Recovered from T1 to T2
RCAMINTBC102360Amt Rec from T1 to T2 Norm by BMIThe cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by body mass index.Amount Recovered from T1 to T2 Normalized by Body Mass Index
RCAMINTSC102361Amt Rec from T1 to T2 Norm by SAThe cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by surface area.Amount Recovered from T1 to T2 Normalized by Surface Area
RCAMINTWC102362Amt Rec from T1 to T2 Norm by WTThe cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by weight.Amount Recovered from T1 to T2 Normalized by Weight
RCAMTAUC102363Amt Rec Over Dosing IntervalThe cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU).Amount Recovered Over Dosing Interval
RCAMTAUBC102364Amt Rec Over Dosing Interval Norm by BMIThe cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by body mass index.Amount Recovered Over Dosing Interval Normalized by Body Mass Index
RCAMTAUSC102365Amt Rec Over Dosing Interval Norm by SAThe cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by surface area.Amount Recovered Over Dosing Interval Normalized by Surface Area
RCAMTAUWC102366Amt Rec Over Dosing Interval Norm by WTThe cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by weight.Amount Recovered Over Dosing Interval Normalized by Weight
RCPCIFOC112034Pct Rec Infinity ObsThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration.Percent Recovered Infinity Observed
RCPCIFOBC112389Pct Rec Infinity Obs Norm by BMIThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Percent Recovered Infinity Observed Normalized by Body Mass Index
RCPCIFOSC112390Pct Rec Infinity Obs Norm by SAThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area.Percent Recovered Infinity Observed Normalized by Surface Area
RCPCIFOWC112391Pct Rec Infinity Obs Norm by WTThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight.Percent Recovered Infinity Observed Normalized by Weight
RCPCIFPC112035Pct Rec Infinity PredThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration.Percent Recovered Infinity Predicted
RCPCIFPBC112392Pct Rec Infinity Pred Norm by BMIThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.Percent Recovered Infinity Predicted Normalized by Body Mass Index
RCPCIFPSC112393Pct Rec Infinity Pred Norm by SAThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Percent Recovered Infinity Predicted Normalized by Surface Area
RCPCIFPWC112394Pct Rec Infinity Pred Norm by WTThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight.Percent Recovered Infinity Predicted Normalized by Weight
RCPCINTC102382Pct Rec from T1 to T2The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2.Percent Recovered from T1 to T2
RCPCINTBC102383Pct Rec from T1 to T2 Norm by BMIThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by body mass index.Percent Recovered from T1 to T2 Normalized by Body Mass Index
RCPCINTSC102384Pct Rec from T1 to T2 Norm by SAThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by surface area.Percent Recovered from T1 to T2 Normalized by Surface Area
RCPCINTWC102385Pct Rec from T1 to T2 Norm by WTThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by weight.Percent Recovered from T1 to T2 Normalized by Weight
RCPCTAUC102386Pct Rec Over Dosing IntervalThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU).Percent Recovered Over Dosing Interval
RCPCTAUBC102387Pct Rec Over Dosing Interval Norm by BMIThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by the body mass index.Percent Recovered Over Dosing Interval Normalized by Body Mass Index
RCPCTAUSC102388Pct Rec Over Dosing Interval Norm by SAThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by surface area.Percent Recovered Over Dosing Interval Normalized by Surface Area
RCPCTAUWC102389Pct Rec Over Dosing Interval Norm by WTThe percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by weight.Percent Recovered Over Dosing Interval Normalized by Weight
RENALCLC75913Renal CLThe clearance of a substance from the blood by the kidneys.Renal Clearance
RENALCLBC105458Renal CL Norm by BMIThe clearance of a substance from the blood by the kidneys divided by the body mass index.Renal Clearance Normalized by BMI
RENALCLDC105459Renal CL Norm by DoseThe clearance of a substance from the blood by the kidneys divided by the dose.Renal Clearance Normalized by Dose
RENALCLSC105460Renal CL Norm by SAThe clearance of a substance from the blood by the kidneys divided by the surface area.Renal Clearance Normalized by SA
RENALCLWC105461Renal CL Norm by WTThe clearance of a substance from the blood by the kidneys divided by the weight.Renal Clearance Normalized by WT
TLAGC85824Time Until First Nonzero ConcThe time prior to the first measurable (non-zero) concentration.Time until First Nonzero Concentration
TLSTC85822Time of Last Nonzero ConcThe time of the last measurable (positive) concentration.Time of Last Nonzero Concentration
TMAXC70919Time of CMAXThe time of maximum observed concentration sampled during a dosing interval.Tmax
TMINC85825Time of CMIN ObservationThe time of minimum concentration sampled during a dosing interval.Tmin
V0C102371Vol Dist InitialThe initial volume of distribution for a substance administered by bolus intravascular dosing.Initial Volume of Distribution
V0BC102372Vol Dist Initial Norm by BMIThe initial volume of distribution for a substance administered by bolus intravascular dosing divided by the body mass index.Initial Volume of Distribution Normalized by Body Mass Index
V0DC102373Vol Dist Initial Norm by DoseThe initial volume of distribution for a substance administered by bolus intravascular dosing divided by the dose.Initial Volume of Distribution Normalized by Dose
V0SC102374Vol Dist Initial Norm by SAThe initial volume of distribution for a substance administered by bolus intravascular dosing divided by the surface area.Initial Volume of Distribution Normalized by Surface Area
V0WC102375Vol Dist Initial Norm by WTThe initial volume of distribution for a substance administered by bolus intravascular dosing divided by the weight.Initial Volume of Distribution Normalized by Weight
VOLPKC85817Sum of Urine VolThe sum of urine volumes that are used for PK parameters.Sum Urine Volume
VSSOC85770Vol Dist Steady State ObsThe volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing.Observed Steady State Volume of Distribution
VSSOBC102377Vol Dist Steady State Obs Norm by BMIThe volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the body mass index.Observed Steady State Volume of Distribution Normalized by Body Mass Index
VSSODC102378Vol Dist Steady State Obs Norm by DoseThe volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the dose.Observed Steady State Volume of Distribution Normalized by Dose
VSSOSC102379Vol Dist Steady State Obs Norm by SAThe volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the surface area.Observed Steady State Volume of Distribution Normalized by Surface Area
VSSOWC102380Vol Dist Steady State Obs Norm by WTThe volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the weight.Observed Steady State Volume of Distribution Normalized by Weight
VSSPC85794Vol Dist Steady State PredThe volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing.Predicted Steady State Volume of Distribution
VSSPBC102390Vol Dist Steady State Pred Norm by BMIThe volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the body mass index.Predicted Steady State Volume of Distribution Normalized by Body Mass Index
VSSPDC102391Vol Dist Steady State Pred Norm by DoseThe volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the dose.Predicted Steady State Volume of Distribution Normalized by Dose
VSSPSC102392Vol Dist Steady State Pred Norm by SAThe volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the surface area.Predicted Steady State Volume of Distribution Normalized by Surface Area
VSSPWC102393Vol Dist Steady State Pred Norm by WTThe volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the weight.Predicted Steady State Volume of Distribution Normalized by Weight
VZFOC85775Vz Obs by FThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration.Observed Volume of Distribution of Absorbed Fraction
VZFOBC92410Vz Obs by F Norm by BMIThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Volume of Distribution of Fraction Dose Observed Normalized by Body Mass Index
VZFODC102729Vz Obs by F Norm by DoseThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose.Volume of Distribution of Fraction Dose Observed Normalized by Dose
VZFOSC92411Vz Obs by F Norm by SAThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area.Volume of Distribution of Fraction Dose Observed Normalized by Surface Area
VZFOWC92412Vz Obs by F Norm by WTThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight.Volume of Distribution of Fraction Dose Observed Normalized by Weight
VZFPC85799Vz Pred by FThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration.Predicted Volume of Distribution of Absorbed Fraction
VZFPBC92428Vz Pred by F Norm by BMIThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.Volume of Distribution of Fraction Dose Predicted Normalized by Body Mass Index
VZFPDC102730Vz Pred by F Norm by DoseThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose.Volume of Distribution of Fraction Dose Predicted Normalized by Dose
VZFPSC92429Vz Pred by F Norm by SAThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Volume of Distribution of Fraction Dose Predicted Normalized by Surface Area
VZFPWC92430Vz Pred by F Norm by WTThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight.Volume of Distribution of Fraction Dose Predicted Normalized by Weight
VZFTAUC111364Vz for Dose Int by FThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU.Volume of Distribution for Dosing Interval by Fraction
VZFTAUBC111365Vz for Dose Int by F Norm by BMIThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index.Volume of Distribution for Dosing Interval by Fraction Normalized by Body Mass Index
VZFTAUDC111366Vz for Dose Int by F Norm by DoseThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose.Volume of Distribution for Dosing Interval by Fraction Normalized by Dose
VZFTAUSC111367Vz for Dose Int by F Norm by SAThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area.Volume of Distribution for Dosing Interval by Fraction Normalized by Surface Area
VZFTAUWC111368Vz for Dose Int by F Norm by WTThe volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight.Volume of Distribution for Dosing Interval by Fraction Normalized by Weight
VZOC85774Vz ObsThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration.Observed Volume of Distribution
VZOBC92407Vz Obs Norm by BMIThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index.Volume of Distribution Observed Normalized by Body Mass Index
VZODC102683Vz Obs Norm by DoseThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose.Observed Volume of Distribution Normalized by Dose
VZOSC92408Vz Obs Norm by SAThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area.Volume of Distribution Observed Normalized by Surface Area
VZOWC92409Vz Obs Norm by WTThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight.Volume of Distribution Observed Normalized by Weight
VZPC85798Vz PredThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration.Predicted Volume of Distribution
VZPBC92425Vz Pred Norm by BMIThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index.Volume of Distribution Predicted Normalized by Body Mass Index
VZPDC102696Vz Pred Norm by DoseThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose.Predicted Volume of Distribution Normalized by Dose
VZPSC92426Vz Pred Norm by SAThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area.Volume of Distribution Predicted Normalized by Surface Area
VZPWC92427Vz Pred Norm by WTThe volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight.Volume of Distribution Predicted Normalized by Weight
VZTAUC111333Vz for Dose IntThe volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU.Volume of Distribution for Dosing Interval
VZTAUBC111369Vz for Dose Int Norm by BMIThe volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the body mass index.Volume of Distribution for Dosing Interval Normalized by Body Mass Index
VZTAUDC111370Vz for Dose Int Norm by DoseThe volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the dose.Volume of Distribution for Dosing Interval Normalized by Dose
VZTAUSC111371Vz for Dose Int Norm by SAThe volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the surface area.Volume of Distribution for Dosing Interval Normalized by Surface Area
VZTAUWC111372Vz for Dose Int Norm by WTThe volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the weight.Volume of Distribution for Dosing Interval Normalized by Weight
Back to top
CL.C85494.PKUNITPK Units of Measure
(PKUNIT)
text
Extensible: Yes
C85494PK Units of MeasureUnits of measure for pharmacokinetic data and parameters.CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology
%C25613PercentageA fraction or ratio with 100 understood as the denominator. (NCI)Percentage
(L/day)/gC85657L/g/d;mL/mg/day;uL/ug/dayLiters per day (flow), divided by grams (weight).Liter per Gram per Day
(L/day)/mgC85672L/day/mg;L/mg/d;mL/day/ug;mL/ug/dayLiters per day (flow), divided by milligrams (dose).Liter per Milligram per Day
(L/day)/ugC85665L/day/mcg;L/day/ug;L/mcg/day;mL/day/ng;mL/ng/dayLiters per day (flow), divided by micrograms (dose).Liter per Microgram per Day
(L/h)/gC85658L/g/h;L/h/g;mL/h/mg;mL/mg/h;uL/h/ug;uL/ug/hLiters per hour (flow), divided by grams (weight).Liter per Gram per Hour
(L/h)/mgC85673L/h/mg;L/mg/h;mL/h/ug;mL/ug/hLiters per hour (flow), divided by milligrams (dose).Liter per Milligram per Hour
(L/h)/ugC85662L/h/mcg;L/h/ug;L/mcg/h;L/ug/h;mL/h/ng;mL/ng/hLiters per hour (flow), divided by micrograms (dose).Liter per Microgram per Hour
(L/min)/gC85659L/g/min;L/min/g;mL/mg/min;uL/ug/minLiters per minute (flow), divided by grams (weight).Liter per Gram per Minute
(L/min)/mgC85674L/mg/min;L/min/mg;mL/min/ug;mL/ug/minLiters per minute (flow), divided by milligrams (dose).Liter per Milligram per Minute
(L/min)/ugC85666L/mcg/min;L/min/mcg;L/min/ug;mL/min/ng;mL/ng/minLiters per minute (flow), divided by micrograms (dose).Liter per Microgram per Minute
/hC66966Per HourA rate of occurrences of something within a period of time equal to sixty minutes.Per Hour
dayC25301DayThe time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI)Day
day*fg/mLC85583Days times femtograms per milliliter (area under the curve).Day Times Femtogram per Milliliter
day*fg/mL/(kg/m2)C111167Days times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Femtogram per Milliliter per Kilogram per Meter Squared
day*fg/mL/(mg/g)C117894Days times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times Femtogram Per Milliliter Per Milligram Per Gram
day*fg/mL/(mg/g/day)C117895Days times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times Femtogram Per Milliliter Per Milligram Per Gram Per Day
day*fg/mL/gC112244Days times femtograms per milliliter (area under the curve), divided by grams (weight).Day Times Femtogram Per Milliliter Per Gram
day*fg/mL/kgC112245Days times femtograms per milliliter (area under the curve), divided by kilograms (weight).Day Times Femtogram Per Milliliter Per Kilogram
day*fg/mL/m2C111168Days times femtograms per milliliter (area under the curve), divided by meters squared (surface area).Day Times Femtogram per Milliliter per Meter Squared
day*g/mLC85584Days times grams per milliliter (area under the curve).Day Times Gram per Milliliter
day*g/mL/(kg/m2)C111169Days times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Gram per Milliliter per Kilogram per Meter Squared
day*g/mL/(mg/g)C117896Days times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times gram Per Milliliter Per Milligram Per Gram
day*g/mL/(mg/g/day)C117897Days times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times gram Per Milliliter Per Milligram Per Gram Per Day
day*g/mL/gC112246Days times grams per milliliter (area under the curve), divided by grams (weight).Day Times Gram Per Milliliter Per Gram
day*g/mL/kgC112247Days times grams per milliliter (area under the curve), divided by kilograms (weight).Day Times Gram Per Milliliter Per Kilogram
day*g/mL/m2C111170Days times grams per milliliter (area under the curve), divided by meters squared (surface area).Day Times Gram per Milliliter per Meter Squared
day*mg/mLC85588Days times milligrams per milliliter (area under the curve).Day Times Milligram per Milliliter
day*mg/mL/(kg/m2)C111175Days times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Milligram per Milliliter per Kilogram per Meter Squared
day*mg/mL/(mg/g)C117898Days times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times Milligram Per Milliliter Per Milligram Per Gram
day*mg/mL/(mg/g/day)C117899Days times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times Milligram Per Milliliter Per Milligram Per Gram Per Day
day*mg/mL/gC112252Days times milligrams per milliliter (area under the curve), divided by grams (weight).Day Times Milligram Per Milliliter Per Gram
day*mg/mL/kgC112253Days times milligrams per milliliter (area under the curve), divided by kilograms (weight).Day Times Milligram Per Milliliter Per Kilogram
day*mg/mL/m2C111176Days times milligrams per milliliter (area under the curve), divided by meters squared (surface area).Day Times Milligram per Milliliter per Meter Squared
day*mmol/LC85587Days times millimoles per liter (area under the curve).Day Times Micromole per Milliliter
day*mmol/L/(kg/m2)C111177Days times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Millimole per Liter per Kilogram per Meter Squared
day*mmol/L/(mg/g)C117900Days times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times Millimole Per Liter Per Milligram Per Gram
day*mmol/L/(mg/g/day)C117901Days times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times Millimole Per Liter Per Milligram Per Gram Per Day
day*mmol/L/gC112254Days times millimoles per liter (area under the curve), divided by grams (weight).Day Times Millimole Per Liter Per Gram
day*mmol/L/kgC112255Days times millimoles per liter (area under the curve), divided by kilograms (weight).Day Times Millimole Per Liter Per Kilogram
day*mmol/L/m2C111178Days times millimoles per liter (area under the curve), divided by meters squared (surface area).Day Times Millimole per Liter per Meter Squared
day*mol/LC85589Days times moles per liter (area under the curve).Day Times Millimole per Milliliter
day*mol/L/(kg/m2)C111179Days times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Mole per Liter per Kilogram per Meter Squared
day*mol/L/(mg/g)C117902Days times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times mole Per Liter Per Milligram Per Gram
day*mol/L/(mg/g/day)C117903Days times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times mole Per Liter Per Milligram Per Gram Per Day
day*mol/L/gC112256Days times moles per liter (area under the curve), divided by grams (weight).Day Times Mole Per Liter Per Gram
day*mol/L/kgC112257Days times moles per liter (area under the curve), divided by kilograms (weight).Day Times Mole Per Liter Per Kilogram
day*mol/L/m2C111180Days times moles per liter (area under the curve), divided by meters squared (surface area).Day Times Mole per Liter per Meter Squared
day*ng/mLC85591Days times nanograms per milliliter (area under the curve).Day Times Nanogram per Milliliter
day*ng/mL/(kg/m2)C111181Days times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Nanogram per Milliliter per Kilogram per Meter Squared
day*ng/mL/(mg/g)C117904Days times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times Nanogram Per Milliliter Per Milligram Per Gram
day*ng/mL/(mg/g/day)C117905Days times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times Nanogram Per Milliliter Per Milligram Per Gram Per Day
day*ng/mL/gC112258Days times nanograms per milliliter (area under the curve), divided by grams (weight).Day Times Nanogram Per Milliliter Per Gram
day*ng/mL/kgC112259Days times nanograms per milliliter (area under the curve), divided by kilograms (weight).Day Times Nanogram Per Milliliter Per Kilogram
day*ng/mL/m2C111182Days times nanograms per milliliter (area under the curve), divided by meters squared (surface area).Day Times Nanogram per Milliliter per Meter Squared
day*nmol/LC85594Days times nanomoles per liter (area under the curve).Day Times Picomole per Milliliter
day*nmol/L/(kg/m2)C111183Days times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Nanomole per Liter per Kilogram per Meter Squared
day*nmol/L/(mg/g)C117906Days times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times Nanomole Per Liter Per Milligram Per Gram
day*nmol/L/(mg/g/day)C117907Days times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times Nanomole Per Liter Per Milligram Per Gram Per Day
day*nmol/L/gC112260Days times nanomoles per liter (area under the curve), divided by grams (weight).Day Times Nanomole Per Liter Per Gram
day*nmol/L/kgC112261Days times nanomoles per liter (area under the curve), divided by kilograms (weight).Day Times Nanomole Per Liter Per Kilogram
day*nmol/L/m2C111184Days times nanomoles per liter (area under the curve), divided by meters squared (surface area).Day Times Nanomole per Liter per Meter Squared
day*pg/mLC85593Days times picograms per milliliter (area under the curve).Day Times Picogram per Milliliter
day*pg/mL/(kg/m2)C111185Days times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Picogram per Milliliter per Kilogram per Meter Squared
day*pg/mL/(mg/g)C117908Days times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times Picogram Per Milliliter Per Milligram Per Gram
day*pg/mL/(mg/g/day)C117909Days times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times Picogram Per Milliliter Per Milligram Per Gram Per Day
day*pg/mL/gC112262Days times picograms per milliliter (area under the curve), divided by grams (weight).Day Times Picogram Per Milliliter Per Gram
day*pg/mL/kgC112263Days times picograms per milliliter (area under the curve), divided by kilograms (weight).Day Times Picogram Per Milliliter Per Kilogram
day*pg/mL/m2C111186Days times picograms per milliliter (area under the curve), divided by meters squared (surface area).Day Times Picogram per Milliliter per Meter Squared
day*pmol/LC111187Days times picomoles per liter (area under the curve).Day Times Picomole per Liter
day*pmol/L/(kg/m2)C111188Days times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Picomole per Liter per Kilogram per Meter Squared
day*pmol/L/(mg/g)C117910Days times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times Picomole Per Liter Per Milligram Per Gram
day*pmol/L/(mg/g/day)C117911Days times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times Picomole Per Liter Per Milligram Per Gram Per Day
day*pmol/L/gC112264Days times picomoles per liter (area under the curve), divided by grams (weight).Day Times Picomole Per Liter Per Gram
day*pmol/L/kgC112265Days times picomoles per liter (area under the curve), divided by kilograms (weight).Day Times Picomole Per Liter Per Kilogram
day*pmol/L/m2C111189Days times picomoles per liter (area under the curve), divided by meters squared (surface area).Day Times Picomole per Liter per Meter Squared
day*ug/mLC85586Days times micrograms per milliliter (area under the curve).Day Times Microgram per Milliliter
day*ug/mL/(kg/m2)C111171Days times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Microgram per Milliliter per Kilogram per Meter Squared
day*ug/mL/(mg/g)C117912Days times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times Microgram Per Milliliter Per Milligram Per Gram
day*ug/mL/(mg/g/day)C117913Days times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times Microgram Per Milliliter Per Milligram Per Gram Per Day
day*ug/mL/gC112248Days times micrograms per milliliter (area under the curve), divided by grams (weight).Day Times Microgram Per Milliliter Per Gram
day*ug/mL/kgC112249Days times micrograms per milliliter (area under the curve), divided by kilograms (weight).Day Times Microgram Per Milliliter Per Kilogram
day*ug/mL/m2C111172Days times micrograms per milliliter (area under the curve), divided by meters squared (surface area).Day Times Microgram per Milliliter per Meter Squared
day*umol/LC85592Days times micromoles per liter (area under the curve).Day Times Nanomole per Milliliter
day*umol/L/(kg/m2)C111173Days times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Day Times Micromole per Liter per Kilogram per Meter Squared
day*umol/L/(mg/g)C117914Days times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Day Times Micromole Per Liter Per Milligram Per Gram
day*umol/L/(mg/g/day)C117915Days times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Day Times Micromole Per Liter Per Milligram Per Gram Per Day
day*umol/L/gC112250Days times micromoles per liter (area under the curve), divided by grams (weight).Day Times Micromole Per Liter Per Gram
day*umol/L/kgC112251Days times micromoles per liter (area under the curve), divided by kilograms (weight).Day Times Micromole Per Liter Per Kilogram
day*umol/L/m2C111174Days times micromoles per liter (area under the curve), divided by meters squared (surface area).Day Times Micromole per Liter per Meter Squared
fg/mLC85597fg/mL;pg/LA unit of concentration or mass density equal to one femtogram of substance per milliliter of solution or one picogram of substance per liter of solution.Femtogram per Milliliter
fg/mL/(kg/m2)C119336Femtograms per milliliter (concentration), divided by kilograms per meter squared (body mass index).Femtogram per Milliliter per Kilogram per Meter Squared
fg/mL/(mg/day)C119337Femtograms per milliliter (concentration), divided by milligrams per day (daily dose).Femtogram per Milliliter per Milligram per Day
fg/mL/(mg/kg)C119338Femtograms per milliliter (concentration), divided by milligrams per kilogram.Femtogram per Milliliter per Milligram per Kilogram
fg/mL/(mg/kg/day)C119339Femtograms per milliliter (concentration), divided by milligrams per kilogram per day.Femtogram per Milliliter per Milligram per Kilogram per Day
fg/mL/(mg/m2)C119340Femtograms per milliliter (concentration), divided by milligrams per meter squared.Femtogram per Milliliter per Milligram per Meter Squared
fg/mL/(mg/m2/day)C119341Femtograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Femtogram per Milliliter per Milligram per Meter Squared per Day
fg/mL/(ug/day)C119342Femtograms per milliliter (concentration), divided by micrograms per day (daily dose).Femtogram per Milliliter per Microgram per Day
fg/mL/(ug/kg)C119343Femtograms per milliliter (concentration), divided by micrograms per kilogram.Femtogram per Milliliter per Microgram per Kilogram
fg/mL/(ug/kg/day)C119344Femtograms per milliliter (concentration), divided by micrograms per kilogram per day.Femtogram per Milliliter per Microgram per Kilogram per Day
fg/mL/(ug/m2)C119345Femtograms per milliliter (concentration), divided by micrograms per meter squared.Femtogram per Milliliter per Microgram per Meter Squared
fg/mL/(ug/m2/day)C119346Femtograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Femtogram per Milliliter per Microgram per Meter Squared per Day
fg/mL/gC119347Femtograms per milliliter (concentration), divided by grams (weight).Femtogram per Milliliter per Gram
fg/mL/kgC119348Femtograms per milliliter (concentration), divided by kilograms (weight).Femtogram per Milliliter per Kilogram
fg/mL/m2C119349Femtograms per milliliter (concentration), divided by meters squared (surface area).Femtogram per Milliliter per Meter Square
fg/mL/mgC119350Femtograms per milliliter (concentration), divided by milligrams (dose).Femtogram per Milliliter per Milligram
fg/mL/ugC119351Femtograms per milliliter (concentration), divided by micrograms (dose).Femtogram per Milliliter per Microgram
gC48155GramA metric unit of mass equal to one one thousandth of a kilogram. (NCI)Gram
g/dayC67372Gram per Day;g/24h;g/d;gram/24 Hours;gram/dayA dose calculation unit expressed in gram(s) per period of time equal to twenty-four hours.Gram per 24 Hours
g/hC85601g/h;gram/hGrams per hour.Gram per Hour
g/minC85602g/min;gram/minGrams per minute.Gram per Minute
g/mLC64566Gram per Milliliter;Kilogram per Liter;g/mL;gram/mL;kg/L;mg/uLA unit of concentration or mass density equal to one gram of substance per milliliter of solution or one kilogram of substance per liter of solution.Kilogram per Liter
g/mL/(kg/m2)C119352Grams per milliliter (concentration), divided by kilograms per meter squared (body mass index).Gram per Milliliter per Kilogram per Meter Squared
g/mL/(mg/day)C119353Grams per milliliter (concentration), divided by milligrams per day (daily dose).Gram per Milliliter per Milligram per Day
g/mL/(mg/kg)C105462Grams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight).Gram Per Milliliter Per Milligram Per Kilogram
g/mL/(mg/kg/day)C105463Grams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight).Gram Per Milliliter Per Milligram Per Kilogram Per Day
g/mL/(mg/m2)C119354Grams per milliliter (concentration), divided by milligrams per meter squared.Gram per Milliliter per Milligram per Meter Squared
g/mL/(mg/m2/day)C119355Grams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Gram per Milliliter per Milligram per Meter Squared per Day
g/mL/(ug/day)C119356Grams per milliliter (concentration), divided by micrograms per day (daily dose).Gram per Milliliter per Microgram per Day
g/mL/(ug/kg)C119357Grams per milliliter (concentration), divided by micrograms per kilogram.Gram per Milliliter per Microgram per Kilogram
g/mL/(ug/kg/day)C119358Grams per milliliter (concentration), divided by micrograms per kilogram per day.Gram per Milliliter per Microgram per Kilogram per Day
g/mL/(ug/m2)C119359Grams per milliliter (concentration), divided by micrograms per meter squared.Gram per Milliliter per Microgram per Meter Squared
g/mL/(ug/m2/day)C119360Grams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Gram per Milliliter per Microgram per Meter Squared per Day
g/mL/gC119361Grams per milliliter (concentration), divided by grams (weight).Gram per Milliliter per Gram
g/mL/kgC119362Grams per milliliter (concentration), divided by kilograms (weight).Gram per Milliliter per Kilogram
g/mL/m2C119363Grams per milliliter (concentration), divided by meters squared (surface area).Gram per Milliliter per Meter Squared
g/mL/mgC119364Grams per milliliter (concentration), divided by milligrams (dose).Gram per Milliliter per Milligram
g/mL/ugC119365Grams per milliliter (concentration), divided by micrograms (dose).Gram per Milliliter per Microgram
hC25529Hour;hrA unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)Hour
h*fg/mLC85611Hours times femtograms per milliliter (area under the curve).Hour Times Femtogram per Milliliter
h*fg/mL/(kg/m2)C111210Hours times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Femtogram per Milliliter per Kilogram per Meter Squared
h*fg/mL/(mg/g)C117916Hours times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times Femtogram Per Milliliter Per Milligram Per Gram
h*fg/mL/(mg/g/day)C117917Hours times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times Femtogram Per Milliliter Per Milligram Per Gram Per Day
h*fg/mL/gC112298Hours times femtograms per milliliter (area under the curve), divided by grams (weight).Hour Times Femtogram Per Milliliter Per Gram
h*fg/mL/kgC112299Hours times femtograms per milliliter (area under the curve), divided by kilograms (weight).Hour Times Femtogram Per Milliliter Per Kilogram
h*fg/mL/m2C111211Hours times femtograms per milliliter (area under the curve), divided by meters squared (surface area).Hour Times Femtogram per Milliliter per Meter Squared
h*g/mLC85613Hours times grams per milliliter (area under the curve).Hour Times Gram per Milliliter
h*g/mL/(kg/m2)C111212Hours times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Gram per Milliliter per Kilogram per Meter Squared
h*g/mL/(mg/g)C117918Hours times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times gram Per Milliliter Per Milligram Per Gram
h*g/mL/(mg/g/day)C117919Hours times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times gram Per Milliliter Per Milligram Per Gram Per Day
h*g/mL/(mg/kg)C105464h*g/mL/(ug/g)Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).Hour Times Gram Per Milliliter Per Milligram Per Kilogram
h*g/mL/(mg/kg/day)C105465h*g/mL/(ug/g/day)Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight).Hour Times Gram Per Milliliter Per Milligram Per Kilogram Per Day
h*g/mL/gC112300Hours times grams per milliliter (area under the curve), divided by grams (weight).Hour Times Gram Per Milliliter Per Gram
h*g/mL/kgC112301Hours times grams per milliliter (area under the curve), divided by kilograms (weight).Hour Times Gram Per Milliliter Per Kilogram
h*g/mL/m2C111213Hours times grams per milliliter (area under the curve), divided by meters squared (surface area).Hour Times Gram per Milliliter per Meter Squared
h*mg/mLC85621Hours times milligrams per milliliter (area under the curve).Hour Times Milligram per Milliliter
h*mg/mL/(kg/m2)C111218Hours times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Milligram per Milliliter per Kilogram per Meter Squared
h*mg/mL/(mg/g)C117920Hours times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times Milligram Per Milliliter Per Milligram Per Gram
h*mg/mL/(mg/g/day)C117921Hours times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times Milligram Per Milliliter Per Milligram Per Gram Per Day
h*mg/mL/(mg/kg)C105468h*mg/mL/(ug/g)Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).Hour Times Milligram Per Milliliter Per Milligram Per Kilogram
h*mg/mL/(mg/kg/day)C105469h*mg/mL/(ug/g/day)Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight).Hour Times Milligram Per Milliliter Per Milligram Per Kilogram Per Day
h*mg/mL/gC112305Hours times milligrams per milliliter (area under the curve), divided by grams (weight).Hour Times Milligram Per Milliliter Per Gram
h*mg/mL/kgC112306Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight).Hour Times Milligram Per Milliliter Per Kilogram
h*mg/mL/m2C111219Hours times milligrams per milliliter (area under the curve), divided by meters squared (surface area).Hour Times Milligram per Milliliter per Meter Squared
h*mmol/LC85618Hours times millimoles per liter (area under the curve).Hour Times Micromole per Milliliter
h*mmol/L/(kg/m2)C111220Hours times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Millimole per Liter per Kilogram per Meter Squared
h*mmol/L/(mg/g)C117922Hours times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times Millimole Per Liter Per Milligram Per Gram
h*mmol/L/(mg/g/day)C117923Hours times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times Millimole Per Liter Per Milligram Per Gram Per Day
h*mmol/L/gC106530Hours times millimoles per liter (area under the curve), divided by grams (weight).Hour times Millimole Per Liter Per Gram
h*mmol/L/kgC112307Hours times millimoles per liter (area under the curve), divided by kilograms (weight).Hour Times Millimole Per Liter Per Kilogram
h*mmol/L/m2C111221Hours times millimoles per liter (area under the curve), divided by meters squared (surface area).Hour Times Millimole per Liter per Meter Squared
h*mol/LC85622Hours times moles per liter (area under the curve).Hour Times Millimole per Milliliter
h*mol/L/(kg/m2)C111222Hours times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Mole per Liter per Kilogram per Meter Squared
h*mol/L/(mg/g)C117924Hours times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times mole Per Liter Per Milligram Per Gram
h*mol/L/(mg/g/day)C117925Hours times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times mole Per Liter Per Milligram Per Gram Per Day
h*mol/L/gC106531Hours times moles per liter (area under the curve), divided by grams (weight).Hour times Mole Per Liter Per Gram
h*mol/L/kgC112308Hours times moles per liter (area under the curve), divided by kilograms (weight).Hour Times Mole Per Liter Per Kilogram
h*mol/L/m2C111223Hours times moles per liter (area under the curve), divided by meters squared (surface area).Hour Times Mole per Liter per Meter Squared
h*ng/mLC85624Hours times nanograms per milliliter (area under the curve).Hour Times Nanogram per Milliliter
h*ng/mL/(kg/m2)C111224Hours times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Nanogram per Milliliter per Kilogram per Meter Squared
h*ng/mL/(mg/g)C117926Hours times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times Nanogram Per Milliliter Per Milligram Per Gram
h*ng/mL/(mg/g/day)C117927Hours times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times Nanogram Per Milliliter Per Milligram Per Gram Per Day
h*ng/mL/(mg/kg)C85628h*ng/mL/(ug/g)Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).Hour Times Nanogram per Milliliter per Milligram per Kilogram
h*ng/mL/(mg/kg/day)C105470h*ng/mL/(ug/g/day)Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight).Hour Times Nanogram Per Milliliter Per Milligram Per Kilogram Per Day
h*ng/mL/(mg/m2)C85629Hours times nanograms per milliliter (area under the curve), divided by milligrams per meter squared (dose normalized by surface area).Hour Times Nanogram per Milliliter per Milligram per Meter Squared
h*ng/mL/gC85625Hours times nanograms per milliliter (area under the curve), divided by grams (weight).Hour Times Nanogram per Milliliter per Gram
h*ng/mL/kgC85626Hours times nanograms per milliliter (area under the curve), divided by kilograms (weight).Hour Times Nanogram per Milliliter per Kilogram
h*ng/mL/m2C111225Hours times nanograms per milliliter (area under the curve), divided by meters squared (surface area).Hour Times Nanogram per Milliliter per Meter Squared
h*ng/mL/mgC85627h*ng/mL/mg;h*ng/mg/mL;ng*h/mL/mg;ng*h/mg/mLHours times nanograms per milliliter (area under the curve), divided by milligrams (dose).Hour Times Nanogram per Milliliter per Milligram
h*nmol/LC85640Hours times nanomoles per liter (area under the curve).Hour Times Picomole per Milliliter
h*nmol/L/(kg/m2)C111226Hours times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Nanomole per Liter per Kilogram per Meter Squared
h*nmol/L/(mg/g)C117928Hours times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times Nanomole Per Liter Per Milligram Per Gram
h*nmol/L/(mg/g/day)C117929Hours times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times Nanomole Per Liter Per Milligram Per Gram Per Day
h*nmol/L/gC116062Hours times nanomoles per liter (area under the curve), divided by grams (dose or weight).Hour Times Nanomole per Liter per Gram
h*nmol/L/kgC112309Hours times nanomoles per liter (area under the curve), divided by kilograms (weight).Hour Times Nanomole Per Liter Per Kilogram
h*nmol/L/m2C111227Hours times nanomoles per liter (area under the curve), divided by meters squared (surface area).Hour Times Nanomole per Liter per Meter Squared
h*nmol/L/umolC85631h*nmol/L/mcmol;h*nmol/umol/L;nmol*h/L/umol;nmol*h/umol/LHours times nanomoles per liter per micromole.Hour Times Nanomole per Liter per Micromole
h*pg/mLC85635Hours times picograms per milliliter (area under the curve).Hour Times Picogram per Milliliter
h*pg/mL/(kg/m2)C111228Hours times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Picogram per Milliliter per Kilogram per Meter Squared
h*pg/mL/(mg/g)C117930Hours times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times Picogram Per Milliliter Per Milligram Per Gram
h*pg/mL/(mg/g/day)C117931Hours times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times Picogram Per Milliliter Per Milligram Per Gram Per Day
h*pg/mL/(mg/kg)C105471h*pg/mL/(ug/g)Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).Hour Times Picogram Per Milliliter Per Milligram Per Kilogram
h*pg/mL/(mg/kg/day)C105472h*pg/mL/(ug/g/day)Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight).Hour Times Picogram Per Milliliter Per Milligram Per Kilogram Per Day
h*pg/mL/gC112310Hours times picograms per milliliter (area under the curve), divided by grams (weight).Hour Times Picogram Per Milliliter Per Gram
h*pg/mL/kgC85636Hours times picograms per milliliter (area under the curve), divided by kilograms (weight).Hour Times Picogram per Milliliter per Kilogram
h*pg/mL/m2C111229Hours times picograms per milliliter (area under the curve), divided by meters squared (surface area).Hour Times Picogram per Milliliter per Meter Squared
h*pg/mL/mgC85638h*pg/mL/mg;h*pg/mg/mL;pg*h/mL/mg;pg*h/mg/mLHours times picograms per milliliter (area under the curve), divided by milligrams (dose).Hour Times Picogram per Milliliter per Milligram
h*pmol/LC85612Hours times picomoles per liter (area under the curve).Hour Times Femtomole per Milliliter
h*pmol/L/(kg/m2)C111230Hours times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Picomole per Liter per Kilogram per Meter Squared
h*pmol/L/(mg/g)C117932Hours times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times Picomole Per Liter Per Milligram Per Gram
h*pmol/L/(mg/g/day)C117933Hours times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times Picomole Per Liter Per Milligram Per Gram Per Day
h*pmol/L/gC106532Hours times picomoles per liter (area under the curve), divided by grams (weight).Hour times Picomole Per Liter Per Gram
h*pmol/L/kgC112311Hours times picomoles per liter (area under the curve), divided by kilograms (weight).Hour Times Picomole Per Liter Per Kilogram
h*pmol/L/m2C111231Hours times picomoles per liter (area under the curve), divided by meters squared (surface area).Hour Times Picomole per Liter per Meter Squared
h*ug/mLC85615Hours times micrograms per milliliter (area under the curve).Hour Times Microgram per Milliliter
h*ug/mL/(kg/m2)C111214Hours times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Microgram per Milliliter per Kilogram per Meter Squared
h*ug/mL/(mg/g)C117934Hours times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times Microgram Per Milliliter Per Milligram Per Gram
h*ug/mL/(mg/g/day)C117935Hours times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times Microgram Per Milliliter Per Milligram Per Gram Per Day
h*ug/mL/(mg/kg)C105466h*ug/mL/(ug/g)Hours times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight).Hour Times Microgram Per Milliliter Per Milligram Per Kilogram
h*ug/mL/(mg/kg/day)C105467h*ug/mL/(ug/g/day)Hours times micrograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight).Hour Times Microgram Per Milliliter Per Milligram Per Kilogram Per Day
h*ug/mL/gC112302Hours times micrograms per milliliter (area under the curve), divided by grams (weight).Hour Times Microgram Per Milliliter Per Gram
h*ug/mL/kgC112303Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight).Hour Times Microgram Per Milliliter Per Kilogram
h*ug/mL/m2C111215Hours times micrograms per milliliter (area under the curve), divided by meters squared (surface area).Hour Times Microgram per Milliliter per Meter Squared
h*ug/mL/mgC85617h*mcg/mL/mg;h*ug/mg/mL;ug*h/mL/mg;ug*h/mg/mLHours times micrograms per milliliter (area under the curve), divided by milligrams (dose).Hour Times Microgram per Milliliter per Milligram
h*umol/LC85632Hours times micromoles per liter (area under the curve).Hour Times Nanomole per Milliliter
h*umol/L/(kg/m2)C111216Hours times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Hour Times Micromole per Liter per Kilogram per Meter Squared
h*umol/L/(mg/g)C117936Hours times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Hour Times Micromole Per Liter Per Milligram Per Gram
h*umol/L/(mg/g/day)C117937Hours times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Hour Times Micromole Per Liter Per Milligram Per Gram Per Day
h*umol/L/gC116063Hours times micromoles per liter (area under the curve), divided by grams (dose or weight).Hour Times Micromole per liter per Gram
h*umol/L/kgC112304Hours times micromoles per liter (area under the curve), divided by kilograms (weight).Hour Times Micromole Per Liter Per Kilogram
h*umol/L/m2C111217Hours times micromoles per liter (area under the curve), divided by meters squared (surface area).Hour Times Micromole per Liter per Meter Squared
h2*mg/mLC85606h*h*mg/mL;h2*g/L;h2*ug/uL;h^2*mg/mL;mg*h2/mLHours squared times milligrams per milliliter.Hour Squared Times Milligram per Milliliter
h2*mmol/LC85605Hours squared times millimoles per liter (area under the moment curve).Hour Squared Times Micromole per Milliliter
h2*mol/LC85607Hours squared times moles per liter (area under the moment curve).Hour Squared Times Millimole per Milliliter
h2*ng/mLC85608h*h*ng/mL;h2*ug/L;h^2*ng/mL;ng*h2/mLHours squared times nanograms per milliliter.Hour Squared Times Nanogram per Milliliter
h2*nmol/LC85610Hours squared times nanomoles per liter (area under the moment curve).Hour Squared Times Picomole per Milliliter
h2*pg/mLC85609h*h*pg/mL;h2*ng/L;h^2*pg/mL;pg*h2/mLHours squared times picogram per milliliter.Hour Squared Times Picogram per Milliliter
h2*pmol/LC106529Hours squared times picomoles per liter (area under the moment curve).Hour Squared Times Picomole Per Liter
h2*ug/mLC85604h*h*ug/mL;h2*mcg/mL;h2*mg/L;h^2*ug/mL;ug*h2/mLHours squared times micrograms per milliliter.Hour Squared Times Microgram per Milliliter
h2*umol/LC106528Hours squared times micromoles per liter (area under the moment curve).Hour Squared Times Micromole Per Liter
IU/dayC85645IU/dInternational units per day.International Unit per Day
IU/hC85646IU/hInternational units per hour.International Unit per Hour
IU/minC85647IU/minInternational units per minute.International Unit per Minute
IU/mLC67377IE/mL;International Unit per Milliliter;Kilo International Unit per Liter;kIU/LA unit of concentration (biologic activity) equal to one international unit of substance per milliliter of solution.International Unit per Milliliter
IU/mL/(kg/m2)C119366International units per milliliter (concentration), divided by kilograms per meter squared (body mass index).International Unit per Milliliter per Kilogram per Meter Squared
IU/mL/(mg/day)C119367International units per milliliter (concentration), divided by milligrams per day (daily dose).International Unit per Milliliter per Milligram per Day
IU/mL/(mg/kg)C119368International units per milliliter (concentration), divided by milligrams per kilogram.International Unit per Milliliter per Milligram per Kilogram
IU/mL/(mg/kg/day)C119369International units per milliliter (concentration), divided by milligrams per kilogram per day.International Unit per Milliliter per Milligram per Kilogram per Day
IU/mL/(mg/m2)C119370International units per milliliter (concentration), divided by milligrams per meter squared.International Unit per Milliliter per Milligram per Meter Squared
IU/mL/(mg/m2/day)C119371International units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).International Unit per Milliliter per Milligram per Meter Squared per Day
IU/mL/(ug/day)C119372International units per milliliter (concentration), divided by micrograms per day (daily dose).International Unit per Milliliter per Microgram per Day
IU/mL/(ug/kg)C119373International units per milliliter (concentration), divided by micrograms per kilogram.International Unit per Milliliter per Microgram per Kilogram
IU/mL/(ug/kg/day)C119374International units per milliliter (concentration), divided by micrograms per kilogram per day.International Unit per Milliliter per Microgram per Kilogram per Day
IU/mL/(ug/m2)C119375International units per milliliter (concentration), divided by micrograms per meter squared.International Unit per Milliliter per Microgram per Meter Squared
IU/mL/(ug/m2/day)C119376International units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).International Unit per Milliliter per Microgram per Meter Squared per Day
IU/mL/gC119377International units per milliliter (concentration), divided by grams (weight).International Unit per Milliliter per Gram
IU/mL/kgC119378International units per milliliter (concentration), divided by kilograms (weight).International Unit per Milliliter per Kilogram
IU/mL/m2C119379International units per milliliter (concentration), divided by meters squared (surface area).International Unit per Milliliter per Meter Squared
IU/mL/mgC119380International units per milliliter (concentration), divided by milligrams (dose).International Unit per Milliliter per Milligram
IU/mL/ugC119381International units per milliliter (concentration), divided by micrograms (dose).International Unit per Milliliter per Microgram
LC48505LiterA unit of volume equal to a cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.(NCI)Liter
L/dayC69110Liters per day.Liter per Day
L/hC69160L/hLiters per hour.Liter per Hour
L/kg/dayC73755L/day/kg;L/kg/d;Milliliter per Gram per Day;mL/day/g;mL/g/day;uL/day/mg;uL/mg/dayLiters per kilogram per day.Milliliter per Gram per Day
L/kg/hC73756Milliliter per Gram per HourMilliliters per gram per hour.Milliliter per Gram per Hour
L/kg/minC73757Milliliter per Gram per MinuteMilliliters per gram per minute.Milliliter per Gram per Minute
L/minC67388Liters per MinuteA unit of volumetric flow rate defined as the rate at which one liter of matter travels during the period of time equal to one minute.(NCI)Liter per Minute
L/mmol/dayC85676L/day/mmol;L/mmol/d;mL/day/umol;mL/umol/dayLiters per millimole per day.Liter per Millimole per Day
L/mmol/hC85677L/h/mmol;L/mmol/h;mL/h/umol;mL/umol/hLiters per millimole per hour.Liter per Millimole per Hour
L/mmol/minC85678L/min/mmol;L/mmol/min;mL/min/umol;mL/umol/minLiters per millimole per minute.Liter per Millimole per Minute
L/molC85680L/mol;mL/mmol;uL/umolLiters per mole.Liter per Mole
L/mol/dayC85681L/day/mol;L/mol/d;mL/day/mmol;mL/mmol/day;uL/day/umol;uL/umol/dayLiters per mole per day.Liter per Mole per Day
L/mol/hC85682L/h/mol;L/mol/h;mL/h/mmol;mL/mmol/h;uL/h/umol;uL/umol/hLiters per mole per hour.Liter per Mole per Hour
L/mol/minC85683L/min/mol;L/mol/min;mL/min/mmol;mL/mmol/min;uL/min/umol;uL/umol/minLiters per mole per minute.Liter per Mole per Minute
L/ng/dayC85685L/day/ng;L/ng/d;mL/day/pg;mL/pg/dayLiters per nanogram per day.Liter per Nanogram per Day
L/ng/hC85686L/h/ng;L/ng/h;mL/h/pg;mL/pg/hLiters per nanogram per hour.Liter per Nanogram per Hour
L/ng/minC85687L/min/ng;L/ng/min;mL/min/pg;mL/pg/minLiters per nanogram per minute.Liter per Nanogram per Minute
L/nmol/dayC85689L/day/nmol;L/nmol/d;mL/day/pmol;mL/pmol/dayLiters per nanomole per day.Liter per Nanomole per Day
L/nmol/hC85690L/h/nmol;L/nmol/h;mL/h/pmol;mL/pmol/hLiters per nanomole per hour.Liter per Nanomole per Hour
L/nmol/minC85691L/min/nmol;L/nmol/min;mL/min/pmol;mL/pmol/minLiters per nanomole per minute.Liter per Nanomole per Minute
L/pg/dayC85693L/day/pg;L/pg/dLiters per picogram per day.Liter per Picogram per Day
L/pg/hC85694L/h/pg;L/pg/hLiters per picogram per hour.Liter per Picogram per Hour
L/pg/minC85695L/min/pg;L/pg/minLiters per picogram per minute.Liter per Picogram per Minute
L/umol/dayC85668L/day/mcmol;L/day/umol;L/mcmol/day;L/umol/dLiters per micromole per day.Liter per Micromole per Day
L/umol/hC85669L/h/mcmol;L/h/umol;L/mcmol/h;L/umol/hLiters per micromole per hour.Liter per Micromole per Hour
L/umol/minC85670L/mcmol/min;L/min/mcmol;L/min/umol;L/umol/minLiters per micromole per minute.Liter per Micromole per Minute
mgC28253MilligramThe unit of mass equal to one thousandth of a gram or 1000 micrograms. One milligram equals approximately 0.015432 grain or 35.274 x 10E-6 ounce.(NCI)Milligram
mg/dayC67399Milligram per DayA unit of measure referring to the ratio between mass expressed in milligrams per day.(NCI)Milligram per 24 Hours
mg/hC66969Milligram per HourA unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI)Milligram per Hour
mg/minC73742Milligram per MinuteMilligrams per minute.Milligram per Minute
mg/mLC42576Gram per Liter;Kilogram per Cubic Meter;Microgram per Microliter;Milligram per Milliliter;g/L;kg/m3;mg/mL;ug/uLA unit of concentration or mass density equal to one milligram of substance per milliliter of solution or one gram of substance per liter of solution.Kilogram per Cubic Meter
mg/mL/(kg/m2)C119382Milligrams per milliliter (concentration), divided by kilograms per meter squared (body mass index).Milligram per Milliliter per Kilogram per Meter Squared
mg/mL/(mg/day)C119383Milligrams per milliliter (concentration), divided by milligrams per day (daily dose).Milligram per Milliliter per Milligram per Day
mg/mL/(mg/kg)C105475Milligrams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight).Milligram Per Milliliter Per Milligram Per Kilogram
mg/mL/(mg/kg/day)C105476Milligrams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight).Milligram Per Milliliter Per Milligram Per Kilogram Per Day
mg/mL/(mg/m2)C119384Milligrams per milliliter (concentration), divided by milligrams per meter squared.Milligram per Milliliter per Milligram per Meter Squared
mg/mL/(mg/m2/day)C119385Milligrams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Milligram per Milliliter per Milligram per Meter Squared per Day
mg/mL/(ug/day)C119386Milligrams per milliliter (concentration), divided by micrograms per day (daily dose).Milligram per Milliliter per Microgram per Day
mg/mL/(ug/kg)C119387Milligrams per milliliter (concentration), divided by micrograms per kilogram.Milligram per Milliliter per Microgram per Kilogram
mg/mL/(ug/kg/day)C119388Milligrams per milliliter (concentration), divided by micrograms per kilogram per day.Milligram per Milliliter per Microgram per Kilogram per Day
mg/mL/(ug/m2)C119389Milligrams per milliliter (concentration), divided by micrograms per meter squared.Milligram per Milliliter per Microgram per Meter Squared
mg/mL/(ug/m2/day)C119390Milligrams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Milligram per Milliliter per Microgram per Meter Squared per Day
mg/mL/gC119391Milligrams per milliliter (concentration), divided by grams (weight).Milligram per Milliliter per Gram
mg/mL/hC85711g/L/h;g/h/L;mg/h/mL;ug/h/uL;ug/uL/hMilligrams per milliliter per hour.Milligram per Milliliter per Hour
mg/mL/kgC119392Milligrams per milliliter (concentration), divided by kilograms (weight).Milligram per Milliliter per Kilogram
mg/mL/m2C119393Milligrams per milliliter (concentration), divided by meters squared (surface area).Milligram per Milliliter per Meter Squared
mg/mL/mgC119394Milligrams per milliliter (concentration), divided by milligrams (dose).Milligram per Milliliter per Milligram
mg/mL/ugC119395Milligrams per milliliter (concentration), divided by micrograms (dose).Milligram per Milliliter per Microgram
minC48154Minute Unit of TimeA unit measure of time equal to 60 seconds.(NCI)Minute
min*fg/mLC85724Minutes times femtograms per milliliter (area under the curve).Minute Times Femtogram per Milliliter
min*fg/mL/(kg/m2)C111254Minutes times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Femtogram per Milliliter per Kilogram per Meter Squared
min*fg/mL/(mg/g)C117938Minutes times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times Femtogram Per Milliliter Per Milligram Per Gram
min*fg/mL/(mg/g/day)C117939Minutes times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times Femtogram Per Milliliter Per Milligram Per Gram Per Day
min*fg/mL/gC112334Minutes times femtograms per milliliter (area under the curve), divided by grams (weight).Minute Times Femtogram Per Milliliter Per Gram
min*fg/mL/kgC112335Minutes times femtograms per milliliter (area under the curve), divided by kilograms (weight).Minute Times Femtogram Per Milliliter Per Kilogram
min*fg/mL/m2C111255Minutes times femtograms per milliliter (area under the curve), divided by meters squared (surface area).Minute Times Femtogram per Milliliter per Meter Squared
min*g/mLC85725Minutes times grams per milliliter (area under the curve).Minute Times Gram per Milliliter
min*g/mL/(kg/m2)C111256Minutes times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Gram per Milliliter per Kilogram per Meter Squared
min*g/mL/(mg/g)C117940Minutes times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times gram Per Milliliter Per Milligram Per Gram
min*g/mL/(mg/g/day)C117941Minutes times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times gram Per Milliliter Per Milligram Per Gram Per Day
min*g/mL/gC112336Minutes times grams per milliliter (area under the curve), divided by grams (weight).Minute Times Gram Per Milliliter Per Gram
min*g/mL/kgC112337Minutes times grams per milliliter (area under the curve), divided by kilograms (weight).Minute Times Gram Per Milliliter Per Kilogram
min*g/mL/m2C111257Minutes times grams per milliliter (area under the curve), divided by meters squared (surface area).Minute Times Gram per Milliliter per Meter Squared
min*mg/mLC85729Minutes times milligrams per milliliter (area under the curve).Minute Times Milligram per Milliliter
min*mg/mL/(kg/m2)C111262Minutes times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Milligram per Milliliter per Kilogram per Meter Squared
min*mg/mL/(mg/g)C117942Minutes times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times Milligram Per Milliliter Per Milligram Per Gram
min*mg/mL/(mg/g/day)C117943Minutes times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times Milligram Per Milliliter Per Milligram Per Gram Per Day
min*mg/mL/gC112342Minutes times milligrams per milliliter (area under the curve), divided by grams (weight).Minute Times Milligram Per Milliliter Per Gram
min*mg/mL/kgC112343Minutes times milligrams per milliliter (area under the curve), divided by kilograms (weight).Minute Times Milligram Per Milliliter Per Kilogram
min*mg/mL/m2C111263Minutes times milligrams per milliliter (area under the curve), divided by meters squared (surface area).Minute Times Milligram per Milliliter per Meter Squared
min*mmol/LC85728Minutes times millimoles per liter (area under the curve).Minute Times Micromole per Milliliter
min*mmol/L/(kg/m2)C111264Minutes times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Millimole per Liter per Kilogram per Meter Squared
min*mmol/L/(mg/g)C117944Minutes times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times Millimole Per Liter Per Milligram Per Gram
min*mmol/L/(mg/g/day)C117945Minutes times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times Millimole Per Liter Per Milligram Per Gram Per Day
min*mmol/L/gC112344Minutes times millimoles per liter (area under the curve), divided by grams (weight).Minute Times Millimole Per Liter Per Gram
min*mmol/L/kgC112345Minutes times millimoles per liter (area under the curve), divided by kilograms (weight).Minute Times Millimole Per Liter Per Kilogram
min*mmol/L/m2C111265Minutes times millimoles per liter (area under the curve), divided by meters squared (surface area).Minute Times Millimole per Liter per Meter Squared
min*mol/LC85730Minutes times moles per liter (area under the curve).Minute Times Millimole per Milliliter
min*mol/L/(kg/m2)C111266Minutes times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Mole per Liter per Kilogram per Meter Squared
min*mol/L/(mg/g)C117946Minutes times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times mole Per Liter Per Milligram Per Gram
min*mol/L/(mg/g/day)C117947Minutes times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times mole Per Liter Per Milligram Per Gram Per Day
min*mol/L/gC112346Minutes times moles per liter (area under the curve), divided by grams (weight).Minute Times Mole Per Liter Per Gram
min*mol/L/kgC112347Minutes times moles per liter (area under the curve), divided by kilograms (weight).Minute Times Mole Per Liter Per Kilogram
min*mol/L/m2C111267Minutes times moles per liter (area under the curve), divided by meters squared (surface area).Minute Times Mole per Liter per Meter Squared
min*ng/mLC85732Minutes times nanograms per milliliter (area under the curve).Minute Times Nanogram per Milliliter
min*ng/mL/(kg/m2)C111268Minutes times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Nanogram per Milliliter per Kilogram per Meter Squared
min*ng/mL/(mg/g)C117948Minutes times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times Nanogram Per Milliliter Per Milligram Per Gram
min*ng/mL/(mg/g/day)C117949Minutes times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times Nanogram Per Milliliter Per Milligram Per Gram Per Day
min*ng/mL/gC112348Minutes times nanograms per milliliter (area under the curve), divided by grams (weight).Minute Times Nanogram Per Milliliter Per Gram
min*ng/mL/kgC112349Minutes times nanograms per milliliter (area under the curve), divided by kilograms (weight).Minute Times Nanogram Per Milliliter Per Kilogram
min*ng/mL/m2C111269Minutes times nanograms per milliliter (area under the curve), divided by meters squared (surface area).Minute Times Nanogram per Milliliter per Meter Squared
min*nmol/LC85735Minutes times nanomoles per liter (area under the curve).Minute Times Picomole per Milliliter
min*nmol/L/(kg/m2)C111270Minutes times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Nanomole per Liter per Kilogram per Meter Squared
min*nmol/L/(mg/g)C117950Minutes times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times Nanomole Per Liter Per Milligram Per Gram
min*nmol/L/(mg/g/day)C117951Minutes times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times Nanomole Per Liter Per Milligram Per Gram Per Day
min*nmol/L/gC112350Minutes times nanomoles per liter (area under the curve), divided by grams (weight).Minute Times Nanomole Per Liter Per Gram
min*nmol/L/kgC112351Minutes times nanomoles per liter (area under the curve), divided by kilograms (weight).Minute Times Nanomole Per Liter Per Kilogram
min*nmol/L/m2C111271Minutes times nanomoles per liter (area under the curve), divided by meters squared (surface area).Minute Times Nanomole per Liter per Meter Squared
min*pg/mLC85734Minutes times picograms per milliliter (area under the curve).Minute Times Picogram per Milliliter
min*pg/mL/(kg/m2)C111272Minutes times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Picogram per Milliliter per Kilogram per Meter Squared
min*pg/mL/(mg/g)C117952Minutes times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times Picogram Per Milliliter Per Milligram Per Gram
min*pg/mL/(mg/g/day)C117953Minutes times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times Picogram Per Milliliter Per Milligram Per Gram Per Day
min*pg/mL/gC112352Minutes times picograms per milliliter (area under the curve), divided by grams (weight).Minute Times Picogram Per Milliliter Per Gram
min*pg/mL/kgC112353Minutes times picograms per milliliter (area under the curve), divided by kilograms (weight).Minute Times Picogram Per Milliliter Per Kilogram
min*pg/mL/m2C111273Minutes times picograms per milliliter (area under the curve), divided by meters squared (surface area).Minute Times Picogram per Milliliter per Meter Squared
min*pmol/LC106543Minutes times picomoles per liter (area under the curve).Minute Times Picomole Per Liter
min*pmol/L/(kg/m2)C111274Minutes times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Picomole per Liter per Kilogram per Meter Squared
min*pmol/L/(mg/g)C117954Minutes times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times Picomole Per Liter Per Milligram Per Gram
min*pmol/L/(mg/g/day)C117955Minutes times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times Picomole Per Liter Per Milligram Per Gram Per Day
min*pmol/L/gC112354Minutes times picomoles per liter (area under the curve), divided by grams (weight).Minute Times Picomole Per Liter Per Gram
min*pmol/L/kgC112355Minutes times picomoles per liter (area under the curve), divided by kilograms (weight).Minute Times Picomole Per Liter Per Kilogram
min*pmol/L/m2C111275Minutes times picomoles per liter (area under the curve), divided by meters squared (surface area).Minute Times Picomole per Liter per Meter Squared
min*ug/mLC85727Minutes times micrograms per milliliter (area under the curve).Minute Times Microgram per Milliliter
min*ug/mL/(kg/m2)C111258Minutes times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Microgram per Milliliter per Kilogram per Meter Squared
min*ug/mL/(mg/g)C117956Minutes times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times Microgram Per Milliliter Per Milligram Per Gram
min*ug/mL/(mg/g/day)C117957Minutes times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times Microgram Per Milliliter Per Milligram Per Gram Per Day
min*ug/mL/gC112338Minutes times micrograms per milliliter (area under the curve), divided by grams (weight).Minute Times Microgram Per Milliliter Per Gram
min*ug/mL/kgC112339Minutes times micrograms per milliliter (area under the curve), divided by kilograms (weight).Minute Times Microgram Per Milliliter Per Kilogram
min*ug/mL/m2C111259Minutes times micrograms per milliliter (area under the curve), divided by meters squared (surface area).Minute Times Microgram per Milliliter per Meter Squared
min*umol/LC85733Minutes times micromoles per liter (area under the curve).Minute Times Nanomole per Milliliter
min*umol/L/(kg/m2)C111260Minutes times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index).Minute Times Micromole per Liter per Kilogram per Meter Squared
min*umol/L/(mg/g)C117958Minutes times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight).Minute Times Micromole Per Liter Per Milligram Per Gram
min*umol/L/(mg/g/day)C117959Minutes times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight).Minute Times Micromole Per Liter Per Milligram Per Gram Per Day
min*umol/L/gC112340Minutes times micromoles per liter (area under the curve), divided by grams (weight).Minute Times Micromole Per Liter Per Gram
min*umol/L/kgC112341Minutes times micromoles per liter (area under the curve), divided by kilograms (weight).Minute Times Micromole Per Liter Per Kilogram
min*umol/L/m2C111261Minutes times micromoles per liter (area under the curve), divided by meters squared (surface area).Minute Times Micromole per Liter per Meter Squared
mIU/mLC67376IE/L;IU/L;International Unit per Liter;mIU/mLA unit of concentration (biologic activity) equal to one milli-international unit of substance per milliliter of solution or one international unit of substance per liter of solution.International Unit per Liter
mIU/mL/(kg/m2)C119396Milli-international units per milliliter (concentration), divided by kilograms per meter squared (body mass index).Milli-International Unit per Milliliter per Kilogram per Meter Squared
mIU/mL/(mg/day)C119397Milli-international units per milliliter (concentration), divided by milligrams per day (daily dose).Milli-International Unit per Milliliter per Milligram per Day
mIU/mL/(mg/kg)C119398Milli-international units per milliliter (concentration), divided by milligrams per kilogram.Milli-International Unit per Milliliter per Milligram per Kilogram
mIU/mL/(mg/kg/day)C119399Milli-international units per milliliter (concentration), divided by milligrams per kilogram per day.Milli-International Unit per Milliliter per Milligram per Kilogram per Day
mIU/mL/(mg/m2)C119400Milli-international units per milliliter (concentration), divided by milligrams per meter squared.Milli-International Unit per Milliliter per Milligram per Meter Squared
mIU/mL/(mg/m2/day)C119401Milli-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Milli-International Unit per Milliliter per Milligram per Meter Squared per Day
mIU/mL/(ug/day)C119402Milli-international units per milliliter (concentration), divided by micrograms per day (daily dose).Milli-International Unit per Milliliter per Microgram per Day
mIU/mL/(ug/kg)C119403Milli-international units per milliliter (concentration), divided by micrograms per kilogram.Milli-International Unit per Milliliter per Microgram per Kilogram
mIU/mL/(ug/kg/day)C119404Milli-international units per milliliter (concentration), divided by micrograms per kilogram per day.Milli-International Unit per Milliliter per Microgram per Kilogram per Day
mIU/mL/(ug/m2)C119405Milli-international units per milliliter (concentration), divided by micrograms per meter squared.Milli-International Unit per Milliliter per Microgram per Meter Squared
mIU/mL/(ug/m2/day)C119406Milli-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Milli-International Unit per Milliliter per Microgram per Meter Squared per Day
mIU/mL/gC119407Milli-international units per milliliter (concentration), divided by grams (weight).Milli-International Unit per Milliliter per Gram
mIU/mL/kgC119408Milli-international units per milliliter (concentration), divided by kilograms (weight).Milli-International Unit per Milliliter per Kilogram
mIU/mL/m2C119409Milli-international units per milliliter (concentration), divided by meters squared (surface area).Milli-International Unit per Milliliter per Meter Squared
mIU/mL/mgC119410Milli-international units per milliliter (concentration), divided by milligrams (dose).Milli-International Unit per Milliliter per Milligram
mIU/mL/ugC119411Milli-international units per milliliter (concentration), divided by micrograms (dose).Milli-International Unit per Milliliter per Microgram
mLC28254Milliliter;cm3The unit of volume equal to one thousandth of a liter, one cubic centimeter, 10E-6 cubic meter, or approximately to 0.061 023 7 cubic inch.(NCI)Milliliter
mL/dayC67410Milliliter per DayMilliliters per day.Milliliter per 24 Hours
mL/hC66962Milliliters per HourA unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one hour.(NCI)Milliliter per Hour
mL/kg/dayC73758Milliliter per Kilogram per DayMilliliters per kilogram per day.Milliliter per Kilogram per Day
mL/kg/hC73759Milliliter per Kilogram per HourMilliliters per kilogram per hour.Milliliter per Kilogram per Hour
mL/kg/minC73760Milliliter per Kilogram per Minute;mL/kg/min;mL/min/kg;uL/g/min;uL/min/gMilliliters per kilogram per minute.Milliliter per Kilogram per Minute
mL/minC64777Milliliters per MinuteA metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute.(NCI)Milliliter per Minute
mL/mol/dayC85716mL/day/mol;mL/mol/d;uL/day/mmol;uL/mmol/dayMilliliters per mole per day.Milliliter per Mole per Day
mL/mol/hC85717mL/h/mol;mL/mol/h;uL/h/mmol;uL/mmol/hMilliliters per mole per hour.Milliliter per Mole per Hour
mL/mol/minC85718mL/min/mol;mL/mol/min;uL/min/mmol;uL/mmol/minMilliliters per mole per minute.Milliliter per Mole per Minute
mmolC48513MillimoleA unit of amount of substance equal to 0.001 mole.(NCI)Millimole
mmol/hC85720Millimoles per hour.Millimole per Hour
mmol/LC64387Micromole per Milliliter;Millimole per Liter;Mole per Cubic Meter;mcmol/mL;mmol/L;mol/m3;nmol/uL;umol/mLA unit of concentration (molarity unit) equal to one millimole of solute per liter of solution.Millimole per Liter
mmol/L/(kg/m2)C119412Millimoles per liter (concentration), divided by kilograms per meter squared (body mass index).Millimole per Liter per Kilogram per Meter Squared
mmol/L/(mg/day)C119413Millimoles per liter (concentration), divided by milligrams per day (daily dose).Millimole per Liter per Milligram per Day
mmol/L/(mg/kg)C119414Millimoles per liter (concentration), divided by milligrams per kilogram.Millimole per Liter per Milligram per Kilogram
mmol/L/(mg/kg/day)C119415Millimoles per liter (concentration), divided by milligrams per kilogram per day.Millimole per Liter per Milligram per Kilogram per Day
mmol/L/(mg/m2)C119416Millimoles per liter (concentration), divided by milligrams per meter squared.Millimole per Liter per Milligram per Meter Squared
mmol/L/(mg/m2/day)C119417Millimoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Millimole per Liter per Milligram per Meter Squared per Day
mmol/L/(ug/day)C119418Millimoles per liter (concentration), divided by micrograms per day (daily dose).Millimole per Liter per Microgram per Day
mmol/L/(ug/kg)C119419Millimoles per liter (concentration), divided by micrograms per kilogram.Millimole per Liter per Microgram per Kilogram
mmol/L/(ug/kg/day)C119420Millimoles per liter (concentration), divided by micrograms per kilogram per day.Millimole per Liter per Microgram per Kilogram per Day
mmol/L/(ug/m2)C119421Millimoles per liter (concentration), divided by micrograms per meter squared.Millimole per Liter per Microgram per Meter Squared
mmol/L/(ug/m2/day)C119422Millimoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Millimole per Liter per Microgram per Meter Squared per Day
mmol/L/gC119423Millimoles per liter (concentration), divided by grams (weight).Millimole per Liter per Gram
mmol/L/kgC119424Millimoles per liter (concentration), divided by kilograms (weight).Millimole per Liter per Kilogram
mmol/L/m2C119425Millimoles per liter (concentration), divided by meters squared (surface area).Millimole per Liter per Meter Squared
mmol/L/mgC119426Millimoles per liter (concentration), divided by milligrams (dose).Millimole per Liter per Milligram
mmol/L/ugC119427Millimoles per liter (concentration), divided by micrograms (dose).Millimole per Liter per Microgram
mmol/minC85722Millimoles per minute.Millimole per Minute
mmol/mL/hC85721mmol/h/mL;mmol/mL/h;mol/L/h;mol/h/L;umol/h/uL;umol/uL/hMillimoles per milliliter per hour.Millimole per Milliliter per Hour
molC42539MoleA unit defined as the amount of substance that contains as many elementary units as there are atoms in 0.012 kg of carbon-12. When the mole is used, the elementary entities must be specified and may be atoms, molecules, ions, electrons, other particles, or specified groups of such particles.(NCI)Mole
mol/dayC85737mol/dMoles per day.Mole per Day
mol/hC85738Moles per hour.Mole per Hour
mol/LC48555Mole per Liter;mmol/mL;mol/LA unit of concentration (molarity unit) equal to one mole of solute in one liter of solution.(NCI)Mole per Liter
mol/L/(kg/m2)C119428Moles per liter (concentration), divided by kilograms per meter squared (body mass index).Mole per Liter per Kilogram per Meter Squared
mol/L/(mg/day)C119429Moles per liter (concentration), divided by milligrams per day (daily dose).Mole per Liter per Milligram per Day
mol/L/(mg/kg)C119430Moles per liter (concentration), divided by milligrams per kilogram.Mole per Liter per Milligram per Kilogram
mol/L/(mg/kg/day)C119431Moles per liter (concentration), divided by milligrams per kilogram per day.Mole per Liter per Milligram per Kilogram per Day
mol/L/(mg/m2)C119432Moles per liter (concentration), divided by milligrams per meter squared.Mole per Liter per Milligram per Meter Squared
mol/L/(mg/m2/day)C119433Moles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Mole per Liter per Milligram per Meter Squared per Day
mol/L/(ug/day)C119434Moles per liter (concentration), divided by micrograms per day (daily dose).Mole per Liter per Microgram per Day
mol/L/(ug/kg)C119435Moles per liter (concentration), divided by micrograms per kilogram.Mole per Liter per Microgram per Kilogram
mol/L/(ug/kg/day)C119436Moles per liter (concentration), divided by micrograms per kilogram per day.Mole per Liter per Microgram per Kilogram per Day
mol/L/(ug/m2)C119437Moles per liter (concentration), divided by micrograms per meter squared.Mole per Liter per Microgram per Meter Squared
mol/L/(ug/m2/day)C119438Moles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Mole per Liter per Microgram per Meter Squared per Day
mol/L/gC119439Moles per liter (concentration), divided by grams (weight).Mole per Liter per Gram
mol/L/kgC119440Moles per liter (concentration), divided by kilograms (weight).Mole per Liter per Kilogram
mol/L/m2C119441Moles per liter (concentration), divided by meters squared (surface area).Mole per Liter per Meter Squared
mol/L/mgC119442Moles per liter (concentration), divided by milligrams (dose).Mole per Liter per Milligram
mol/L/ugC119443Moles per liter (concentration), divided by micrograms (dose).Mole per Liter per Microgram
mol/minC85739Moles per minute.Mole per Minute
ngC48516NanogramA unit of mass equal to one billionth (10E-9) of a gram, or one millionth (10E-6) of a milligram.(NCI)Nanogram
ng/dayC85741ng/dNanograms per day.Nanogram per Day
ng/hC85742Nanograms per hour.Nanogram per Hour
ng/kg/minC85743ng/kg/min;ng/min/kg;pg/g/min;pg/min/gNanograms per kilogram per minute.Nanogram per Kilogram per Minute
ng/mg of CreatinineC85744ng/mg of Creatinine;ug/g of CreatinineNanograms per milligram of creatinine.Nanogram per Milligram of Creatinine
ng/minC85749Nanograms per minute.Nanogram per Minute
ng/mLC67306Microgram per Liter;Milligram per Cubic Meter;Nanogram per Milliliter;mcg/L;mg/m3;ng/mL;ug/LA unit of concentration or mass density equal to one nanogram of substance per milliliter of solution or one microgram of substance per liter of solution.Microgram per Liter
ng/mL/(kg/m2)C119444Nanograms per milliliter (concentration), divided by kilograms per meter squared (body mass index).Nanogram per Milliliter per Kilogram per Meter Squared
ng/mL/(mg/day)C119445Nanograms per milliliter (concentration), divided by milligrams per day (daily dose).Nanogram per Milliliter per Milligram per Day
ng/mL/(mg/kg)C105477Nanograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight).Nanogram Per Milliliter Per Milligram Per Kilogram
ng/mL/(mg/kg/day)C105478Nanograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight).Nanogram Per Milliliter Per Milligram Per Kilogram Per Day
ng/mL/(mg/m2)C119446Nanograms per milliliter (concentration), divided by milligrams per meter squared.Nanogram per Milliliter per Milligram per Meter Squared
ng/mL/(mg/m2/day)C119447Nanograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Nanogram per Milliliter per Milligram per Meter Squared per Day
ng/mL/(ug/day)C119448Nanograms per milliliter (concentration), divided by micrograms per day (daily dose).Nanogram per Milliliter per Microgram per Day
ng/mL/(ug/kg)C119449Nanograms per milliliter (concentration), divided by micrograms per kilogram.Nanogram per Milliliter per Microgram per Kilogram
ng/mL/(ug/kg/day)C119450Nanograms per milliliter (concentration), divided by micrograms per kilogram per day.Nanogram per Milliliter per Microgram per Kilogram per Day
ng/mL/(ug/m2)C119451Nanograms per milliliter (concentration), divided by micrograms per meter squared.Nanogram per Milliliter per Microgram per Meter Squared
ng/mL/(ug/m2/day)C119452Nanograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Nanogram per Milliliter per Microgram per Meter Squared per Day
ng/mL/gC119453Nanograms per milliliter (concentration), divided by grams (weight).Nanogram per Milliliter per Gram
ng/mL/hC67430ng/h/mL;ng/mL/h;ug/L/hNanograms per milliliter per hour.Nanogram per Milliliter per Hour
ng/mL/kgC85746Nanograms per milliliter (concentration), divided by kilograms (weight).Nanogram per Milliliter per Kilogram
ng/mL/m2C119454Nanograms per milliliter (concentration), divided by meters squared (surface area).Nanogram per Milliliter per Meter Squared
ng/mL/mgC85747Nanograms per milliliter (concentration), divided by milligrams (dose).Nanogram per Milliliter per Milligram
ng/mL/ugC119455Nanograms per milliliter (concentration), divided by micrograms (dose).Nanogram per Milliliter per Microgram
nLC69188NanoliterA unit of volume equal to one billionth of a liter (10E-9 liter).(NCI)Nanoliter
nmolC48517NanomoleA unit of amount of substance equal to one billionth (10E-9) of a mole.(NCI)Nanomole
nmol/dayC85751nmol/dNanomoles per day.Nanomole per Day
nmol/gC85752nmol/g;pmol/mg;umol/kgNanomoles per gram.Nanomole per Gram
nmol/hC85753Nanomoles per hour.Nanomole per Hour
nmol/kgC85754nmol/kg;pmol/gNanomoles per kilogram.Nanomole per Kilogram
nmol/LC67432Nanomole per LiterA unit of concentration (molarity unit) equal to one nanomole of solute per liter of solution.Nanomole per Liter
nmol/L/(kg/m2)C119456Nanomoles per liter (concentration), divided by kilograms per meter squared (body mass index).Nanomole per Liter per Kilogram per Meter Squared
nmol/L/(mg/day)C119457Nanomoles per liter (concentration), divided by milligrams per day (daily dose).Nanomole per Liter per Milligram per Day
nmol/L/(mg/kg)C119458Nanomoles per liter (concentration), divided by milligrams per kilogram.Nanomole per Liter per Milligram per Kilogram
nmol/L/(mg/kg/day)C119459Nanomoles per liter (concentration), divided by milligrams per kilogram per day.Nanomole per Liter per Milligram per Kilogram per Day
nmol/L/(mg/m2)C119460Nanomoles per liter (concentration), divided by milligrams per meter squared.Nanomole per Liter per Milligram per Meter Squared
nmol/L/(mg/m2/day)C119461Nanomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Nanomole per Liter per Milligram per Meter Squared per Day
nmol/L/(ug/day)C119462Nanomoles per liter (concentration), divided by micrograms per day (daily dose).Nanomole per Liter per Microgram per Day
nmol/L/(ug/kg)C119463Nanomoles per liter (concentration), divided by micrograms per kilogram.Nanomole per Liter per Microgram per Kilogram
nmol/L/(ug/kg/day)C119464Nanomoles per liter (concentration), divided by micrograms per kilogram per day.Nanomole per Liter per Microgram per Kilogram per Day
nmol/L/(ug/m2)C119465Nanomoles per liter (concentration), divided by micrograms per meter squared.Nanomole per Liter per Microgram per Meter Squared
nmol/L/(ug/m2/day)C119466Nanomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Nanomole per Liter per Microgram per Meter Squared per Day
nmol/L/gC119467Nanomoles per liter (concentration), divided by grams (weight).Nanomole per Liter per Gram
nmol/L/kgC119468Nanomoles per liter (concentration), divided by kilograms (weight).Nanomole per Liter per Kilogram
nmol/L/m2C119469Nanomoles per liter (concentration), divided by meters squared (surface area).Nanomole per Liter per Meter Squared
nmol/L/mgC119470Nanomoles per liter (concentration), divided by milligrams (dose).Nanomole per Liter per Milligram
nmol/L/ugC119471Nanomoles per liter (concentration), divided by micrograms (dose).Nanomole per Liter per Microgram
nmol/minC85758Nanomoles per minute.Nanomole per Minute
nmol/mL/hC85757nmol/h/mL;nmol/mL/h;umol/L/hNanomoles per milliliter per hour.Nanomole per Milliliter per Hour
nU/mLC85760mcU/L;nU/mL;uU/LNanounits per milliliter.Nanounit per Milliliter
pg/dayC85778pg/dPicograms per day.Picogram per Day
pg/dLC67331Picogram per DeciliterPicograms per deciliter.Picogram per Deciliter
pg/hC85779Picograms per hour.Picogram per Hour
pg/mgC67396Microgram per Kilogram;mcg/kg;ng/g;ug/kgA unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI)Microgram per Kilogram
pg/mg CreatinineC85780ng/g of Creatinine;pg/mg of CreatininePicograms per milligram creatinine.Picogram per Milligram of Creatinine
pg/minC85782Picograms per minute.Picogram per Minute
pg/mLC67327Microgram per Cubic Meter;ng/L;pg/mL;ug/m3A unit of concentration or mass density equal to one picogram of substance per milliliter of solution or one nanogram of substance per liter of solution.Nanogram per Liter
pg/mL/(kg/m2)C119472Picograms per milliliter (concentration), divided by kilograms per meter squared (body mass index).Picogram per Milliliter per Kilogram per Meter Squared
pg/mL/(mg/day)C119473Picograms per milliliter (concentration), divided by milligrams per day (daily dose).Picogram per Milliliter per Milligram per Day
pg/mL/(mg/kg)C105479Picograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight).Picogram Per Milliliter Per Milligram Per Kilogram
pg/mL/(mg/kg/day)C105480Picograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight).Picogram Per Milliliter Per Milligram Per Kilogram Per Day
pg/mL/(mg/m2)C119474Picograms per milliliter (concentration), divided by milligrams per meter squared.Picogram per Milliliter per Milligram per Meter Squared
pg/mL/(mg/m2/day)C119475Picograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Picogram per Milliliter per Milligram per Meter Squared per Day
pg/mL/(ug/day)C119476Picograms per milliliter (concentration), divided by micrograms per day (daily dose).Picogram per Milliliter per Microgram per Day
pg/mL/(ug/kg)C119477Picograms per milliliter (concentration), divided by micrograms per kilogram.Picogram per Milliliter per Microgram per Kilogram
pg/mL/(ug/kg/day)C119478Picograms per milliliter (concentration), divided by micrograms per kilogram per day.Picogram per Milliliter per Microgram per Kilogram per Day
pg/mL/(ug/m2)C119479Picograms per milliliter (concentration), divided by micrograms per meter squared.Picogram per Milliliter per Microgram per Meter Squared
pg/mL/(ug/m2/day)C119480Picograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Picogram per Milliliter per Microgram per Meter Squared per Day
pg/mL/gC119481Picograms per milliliter (concentration), divided by grams (weight).Picogram per Milliliter per Gram
pg/mL/kgC119482Picograms per milliliter (concentration), divided by kilograms (weight).Picogram per Milliliter per Kilogram
pg/mL/m2C119483Picograms per milliliter (concentration), divided by meters squared (surface area).Picogram per Milliliter per Meter Squared
pg/mL/mgC119484Picograms per milliliter (concentration), divided by milligrams (dose).Picogram per Milliliter per Milligram
pg/mL/ugC85781pg/mL/mcgPicograms per milliliter (concentration), divided by micrograms (dose).Picogram per Milliliter per Microgram
pmol/LC67434Femtomole per Milliliter;Picomole per Liter;fmol/mLA unit of concentration (molarity unit) equal to one picomole of solute per liter of solution.Picomole per Liter
pmol/L/(kg/m2)C119485Picomoles per liter (concentration), divided by kilograms per meter squared (body mass index).Picomole per Liter per Kilogram per Meter Squared
pmol/L/(mg/day)C119486Picomoles per liter (concentration), divided by milligrams per day (daily dose).Picomole per Liter per Milligram per Day
pmol/L/(mg/kg)C119487Picomoles per liter (concentration), divided by milligrams per kilogram.Picomole per Liter per Milligram per Kilogram
pmol/L/(mg/kg/day)C119488Picomoles per liter (concentration), divided by milligrams per kilogram per day.Picomole per Liter per Milligram per Kilogram per Day
pmol/L/(mg/m2)C119489Picomoles per liter (concentration), divided by milligrams per meter squared.Picomole per Liter per Milligram per Meter Squared
pmol/L/(mg/m2/day)C119490Picomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Picomole per Liter per Milligram per Meter Squared per Day
pmol/L/(ug/day)C119491Picomoles per liter (concentration), divided by micrograms per day (daily dose).Picomole per Liter per Microgram per Day
pmol/L/(ug/kg)C119492Picomoles per liter (concentration), divided by micrograms per kilogram.Picomole per Liter per Microgram per Kilogram
pmol/L/(ug/kg/day)C119493Picomoles per liter (concentration), divided by micrograms per kilogram per day.Picomole per Liter per Microgram per Kilogram per Day
pmol/L/(ug/m2)C119494Picomoles per liter (concentration), divided by micrograms per meter squared.Picomole per Liter per Microgram per Meter Squared
pmol/L/(ug/m2/day)C119495Picomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Picomole per Liter per Microgram per Meter Squared per Day
pmol/L/gC119496Picomoles per liter (concentration), divided by grams (weight).Picomole per Liter per Gram
pmol/L/kgC119497Picomoles per liter (concentration), divided by kilograms (weight).Picomole per Liter per Kilogram
pmol/L/m2C119498Picomoles per liter (concentration), divided by meters squared (surface area).Picomole per Liter per Meter Squared
pmol/L/mgC119499Picomoles per liter (concentration), divided by milligrams (dose).Picomole per Liter per Milligram
pmol/L/ugC85784Picomoles per liter (concentration), divided by micrograms (dose).Picomole per Liter per Microgram
RATIOC44256A unit of measurement for the quotient of the amount of one entity to another.Ratio
ugC48152Microgram;mcgThe unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)Microgram
ug/dayC71205Microgram per Day;mcg/dayA unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to twenty four hours. Microgram per day is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to twenty four hours.(NCI)Microgram per Day
ug/hC67394Micrograms per Hour;mcg/hA unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI)Microgram per Hour
ug/inhC85703mcg/inhMicrograms per inhalation.Microgram per Inhalation
ug/minC71211Micrograms per Minute;mcg/minA unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one minute. Microgram per minute is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to one minute.(NCI)Microgram per Minute
ug/mLC64572Gram per Cubic Meter;Microgram per Milliliter;Milligram per Liter;g/m3;mcg/mL;mg/L;ng/uL;ug/mLA unit of concentration or mass density equal to one microgram of substance per milliliter of solution or one milligram of substance per liter of solution.Microgram per Milliliter
ug/mL/(kg/m2)C119500Micrograms per milliliter (concentration), divided by kilograms per meter squared (body mass index).Microgram per Milliliter per Kilogram per Meter Squared
ug/mL/(mg/day)C119501Micrograms per milliliter (concentration), divided by milligrams per day (daily dose).Microgram per Milliliter per Milligram per Day
ug/mL/(mg/kg)C105473Micrograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight).Microgram Per Milliliter Per Milligram Per Kilogram
ug/mL/(mg/kg/day)C105474Micrograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight).Microgram Per Milliliter Per Milligram Per Kilogram Per Day
ug/mL/(mg/m2)C119502Micrograms per milliliter (concentration), divided by milligrams per meter squared.Microgram per Milliliter per Milligram per Meter Squared
ug/mL/(mg/m2/day)C119503Micrograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Microgram per Milliliter per Milligram per Meter Squared per Day
ug/mL/(ug/day)C119504Micrograms per milliliter (concentration), divided by micrograms per day (daily dose).Microgram per Milliliter per Microgram per Day
ug/mL/(ug/kg)C119505Micrograms per milliliter (concentration), divided by micrograms per kilogram.Microgram per Milliliter per Microgram per Kilogram
ug/mL/(ug/kg/day)C119506Micrograms per milliliter (concentration), divided by micrograms per kilogram per day.Microgram per Milliliter per Microgram per Kilogram per Day
ug/mL/(ug/m2)C119507Micrograms per milliliter (concentration), divided by micrograms per meter squared.Microgram per Milliliter per Microgram per Meter Squared
ug/mL/(ug/m2/day)C119508Micrograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Microgram per Milliliter per Microgram per Meter Squared per Day
ug/mL/gC119509Micrograms per milliliter (concentration), divided by grams (weight).Microgram per Milliliter per Gram
ug/mL/kgC119510Micrograms per milliliter (concentration), divided by kilograms (weight).Microgram per Milliliter per Kilogram
ug/mL/m2C119511Micrograms per milliliter (concentration), divided by meters squared (surface area).Microgram per Milliliter per Meter Squared
ug/mL/mgC85710Micrograms per milliliter (concentration), divided by milligrams (dose).Milligram per Liter per Milligram
ug/mL/ugC119512Micrograms per milliliter (concentration), divided by micrograms (dose).Microgram per Milliliter per Microgram
ug/puffC85704mcg/puffMicrograms per puff.Microgram per Puff
uIU/mLC67405Micro-International Unit per milliliter;mIE/L;mIU/L;mcIU/mL;uIU/mLA unit of concentration (biologic activity) equal to one micro-international unit of substance per milliliter of solution or one milli-international unit of substance per liter of solution.Microinternational Unit per Milliliter
uIU/mL/(kg/m2)C119513Micro-international units per milliliter (concentration), divided by kilograms per meter squared (body mass index).Micro-International Units per Milliliter per Kilogram per Meter Squared
uIU/mL/(mg/day)C119514Micro-international units per milliliter (concentration), divided by milligrams per day (daily dose).Micro-International Units per Milliliter per Milligram per Day
uIU/mL/(mg/kg)C119515Micro-international units per milliliter (concentration), divided by milligrams per kilogram.Micro-International Units per Milliliter per Milligram per Kilogram
uIU/mL/(mg/kg/day)C119516Micro-international units per milliliter (concentration), divided by milligrams per kilogram per day.Micro-International Units per Milliliter per Milligram per Kilogram per Day
uIU/mL/(mg/m2)C119517Micro-international units per milliliter (concentration), divided by milligrams per meter squared.Micro-International Units per Milliliter per Milligram per Meter Squared
uIU/mL/(mg/m2/day)C119518Micro-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Micro-International Units per Milliliter per Milligram per Meter Squared per Day
uIU/mL/(ug/day)C119519Micro-international units per milliliter (concentration), divided by micrograms per day (daily dose).Micro-International Units per Milliliter per Microgram per Day
uIU/mL/(ug/kg)C119520Micro-international units per milliliter (concentration), divided by micrograms per kilogram.Micro-International Units per Milliliter per Microgram per Kilogram
uIU/mL/(ug/kg/day)C119521Micro-international units per milliliter (concentration), divided by micrograms per kilogram per day.Micro-International Units per Milliliter per Microgram per Kilogram per Day
uIU/mL/(ug/m2)C119522Micro-international units per milliliter (concentration), divided by micrograms per meter squared.Micro-International Units per Milliliter per Microgram per Meter Squared
uIU/mL/(ug/m2/day)C119523Micro-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Micro-International Units per Milliliter per Microgram per Meter Squared per Day
uIU/mL/gC119524Micro-international units per milliliter (concentration), divided by grams (weight).Micro-International Units per Milliliter per Gram
uIU/mL/kgC119525Micro-international units per milliliter (concentration), divided by kilograms (weight).Micro-International Units per Milliliter per Kilogram
uIU/mL/m2C119526Micro-international units per milliliter (concentration), divided by meters squared (surface area).Micro-International Units per Milliliter per Meter Squared
uIU/mL/mgC119527Micro-international units per milliliter (concentration), divided by milligrams (dose).Micro-International Units per Milliliter per Milligram
uIU/mL/ugC119528Micro-international units per milliliter (concentration), divided by micrograms (dose).Micro-International Units per Milliliter per Microgram
uLC48153Microliter;mcL;mm3A unit of volume accepted for use with the SI and equal to one millionth of a liter (10E-6 liter).(NCI)Microliter
umolC48509Micromole;mcmolA unit of amount of substance equal to one millionth (10E-6) of a mole.(NCI)Micromole
umol/dayC67406Micromoles per Day;mcmol/dayA unit of amount of substance flow rate equivalent to the rate at which one millionth of a mole of substance travels to a given object or space over a period of time equal to 24 hours.(NCI)Micromole per 24 Hours
umol/hC85707mcmol/h;umol/hMicromoles per hour.Micromole per Hour
umol/LC48508Micromole per LiterA unit of concentration (molarity unit) equal to one micromole of solute per liter of solution.Micromole per Liter
umol/L/(kg/m2)C119529Micromoles per liter (concentration), divided by kilograms per meter squared (body mass index).Micromole per Liter per Kilogram per Meter Squared
umol/L/(mg/day)C119530Micromoles per liter (concentration), divided by milligrams per day (daily dose).Micromole per Liter per Milligram per Day
umol/L/(mg/kg)C119531Micromoles per liter (concentration), divided by milligrams per kilogram.Micromole per Liter per Milligram per Kilogram
umol/L/(mg/kg/day)C119532Micromoles per liter (concentration), divided by milligrams per kilogram per day.Micromole per Liter per Milligram per Kilogram per Day
umol/L/(mg/m2)C119533Micromoles per liter (concentration), divided by milligrams per meter squared.Micromole per Liter per Milligram per Meter Squared
umol/L/(mg/m2/day)C119534Micromoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area).Micromole per Liter per Milligram per Meter Squared per Day
umol/L/(ug/day)C119535Micromoles per liter (concentration), divided by micrograms per day (daily dose).Micromole per Liter per Microgram per Day
umol/L/(ug/kg)C119536Micromoles per liter (concentration), divided by micrograms per kilogram.Micromole per Liter per Microgram per Kilogram
umol/L/(ug/kg/day)C119537Micromoles per liter (concentration), divided by micrograms per kilogram per day.Micromole per Liter per Microgram per Kilogram per Day
umol/L/(ug/m2)C119538Micromoles per liter (concentration), divided by micrograms per meter squared.Micromole per Liter per Microgram per Meter Squared
umol/L/(ug/m2/day)C119539Micromoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area).Micromole per Liter per Microgram per Meter Squared per Day
umol/L/gC119540Micromoles per liter (concentration), divided by grams (weight).Micromole per Liter per Gram
umol/L/kgC119541Micromoles per liter (concentration), divided by kilograms (weight).Micromole per Liter per Kilogram
umol/L/m2C119542Micromoles per liter (concentration), divided by meters squared (surface area).Micromole per Liter per Meter Squared
umol/L/mgC119543Micromoles per liter (concentration), divided by milligrams (dose).Micromole per Liter per Milligram
umol/L/ugC119544Micromoles per liter (concentration), divided by micrograms (dose).Micromole per Liter per Microgram
umol/minC85708mcmol/min;umol/minMicromoles per minute.Micromole per Minute
Back to top
CL.C99075.PORTOTPortion/Totality
(PORTOT)
text
Extensible: Yes
C99075Portion/TotalityQualifier for anatomical location or specimen further detailing the portion or totality, which means arrangement of, or apportioning of an entity.CDISC SDTM Portion/Totality Terminology
ALLC64916Being or representing the total number of individual entities.All
ENTIREC25326WholeBeing or representing the complete extent of a single entity.Whole
MULTIPLEC78728Many;SeveralMore than one. (NCI)Many
PARTIALC25378Being or representing an incomplete extent of a single entity.Partial
SEGMENTC45312One of the parts into which something is divided.Segment
SINGLEC48440One.Single
Back to top
CL.C71148.POSITIONPosition
(POSITION)
text
Extensible: Yes
C71148PositionTerminology codelist used with Body Position within CDISC.CDISC SDTM Body Position Terminology
DECUBITUSC77532RecumbentLying down. (NCI)Recumbent Position
FOWLERSC62173FowlersA semi-sitting position whereby the head of an adjustable bed is elevated to the desired height, about 60-90 cm, to produce angulation of the body, usually 45 degrees to 60 degrees. Knees may or may not be bent. (NCI)Fowler's Position
LATERAL DECUBITUSC100758Lateral DecubitusLying down on one side.Lateral Decubitus Position
LEFT LATERAL DECUBITUSC62172Left lateral decubitusA recumbent left lateral side position. (NCI)Left Lateral Decubitus Position
PRONEC62165ProneAn anterior recumbent body position whereby the person lies on its stomach and faces downward. (NCI)Prone Position
REVERSE TRENDELENBURGC62169Reverse TrendelenburgA supine position with the person inclined at an angle of 45 degrees so that the head is higher than the pelvis. (NCI)Reverse Trendelenburg
RIGHT LATERAL DECUBITUSC62171Right lateral decubitusA recumbent right lateral side position. (NCI)Right Lateral Decubitus Position
SEMI-FOWLERSC62174Semi-FowlersA semi-sitting or semi-reclined body position whereby the head is elevated on an angle of approximately 30 degrees. (NCI)Semi-Fowler's Position
SEMI-RECUMBENTC111310A semi-sitting or semi-reclined body position in which the head is elevated above horizontal. (NCI)Semi-Recumbent
SITTINGC62122SittingThe state or act of one who sits; the posture of one who occupies a seat. (NCI)Sitting
SLINGC92604SlingA position in which the subject's body is supported by a sling.Patient in Body Sling
STANDINGC62166StandingThe act of assuming or maintaining an erect upright position. (NCI)Standing
SUPINEC62167SupineA posterior recumbent body position whereby the person lies on its back and faces upward. (NCI)Supine Position
TRENDELENBURGC62168TrendelenburgA supine position with the person inclined at an angle of 45 degrees so that the pelvis is higher than the head. (NCI)Trendelenburg
UNCONSTRAINEDC90480UnconstrainedThe ability to move body parts and limbs without physical restriction. (NCI)Unconstrained Body Movement
Back to top
CL.C102582.PRITBCONPriority of Tuberculosis Contact
(PRITBCON)
text
Extensible: Yes
C102582Priority of Tuberculosis ContactTerminology relevant to the prioritization of tuberculosis contacts.CDISC SDTM Priority of Tuberculosis Contact Terminology
HIGH-PRIORITY TUBERCULOSIS CONTACTC102644An individual that has tested positive for pulmonary, laryngeal, or pleural tuberculosis and may or may not present with cavitary disease.High-priority Tuberculosis Subject
LOW-PRIORITY TUBERCULOSIS CONTACTC102662An individual that has had limited exposure to an individual with tuberculosis and has a low probability of having had a recent infection.Low-priority Tuberculosis Subject
MEDIUM-PRIORITY TUBERCULOSIS CONTACTC102665An individual that has tested negative for pulmonary, laryngeal, or pleural tuberculosis but has had a non-cavitary chest x-ray that is consistent with tuberculosis.Medium-priority Tuberculosis Subject
Back to top
CL.C101858.PROCEDURProcedure
(PROCEDUR)
text
Extensible: Yes
C101858ProcedureA terminology codelist to describe any activity considered to be a therapeutic or diagnostic procedure.CDISC SDTM Procedure Terminology
ABLATIONC20985Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by surgery, chemical destruction, morbid process, or noxious substance. (NCI)Ablation Therapy
ABLATION, ACCESSORY PATHWAYSC99907An invasive therapeutic procedure to destroy tissue in an accessory pathways in the atrioventricular conduction system that contributes to arrhythmia.Ablation of Cardiac Accessory Pathway
ABLATION, ATRIALC80432An invasive therapeutic procedure to destroy tissue in the cardiac atria that is the source of an arrhythmia.Atrial Ablation
ABLATION, AV NODEC99908An invasive therapeutic procedure to destroy tissue in the AV-node that contributes to arrhythmia.Ablation of Cardiac Atrioventricular Node
ABLATION, CHEMICALC111157Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by chemical means. (NCI)Chemical Ablation
ABLATION, LASERC111241Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by light amplification by stimulated emission of radiation. (NCI)Laser Ablation
ABLATION, VENTRICULARC80433An invasive therapeutic procedure to destroy tissue in the cardiac ventricles that is the source of an arrhythmia.Ventricular Ablation
AORTIC BALLOON VALVOTOMYC99916Dilation of the valve between the left ventricle of the heart and the aorta by inflating a balloon.Aortic Balloon Valvotomy
AORTIC VALVE REPLACEMENTC50815Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. aortic valve with a bioprosthetic, homograft, or autograft valve.Aortic Valve Replacement
ATRIAL SEPTAL CLOSUREC99939Repair of atrial septum.Closure of Cardiac Atrial Septum
CARDIAC RESYNCHRONIZATION THERAPYC80436An invasive procedure that includes an electronic device that stimulates both right and left cardiac ventricles to improve coordination of ventricular contraction.Cardiac Resynchronization Therapy
CARDIAC STENT PLACEMENTC100080A procedure performed during a percutaneous coronary intervention in which a device is deployed into the lumen of a coronary artery to expand and support the vessel wall such that the vessel remains patent and blood flow is uninhibited.Cardiac Stent Placement
CARDIAC TRANSPLANTC15246Heart TransplantA surgical procedure in which a damaged heart is removed and replaced by another heart from a suitable donor.Heart Transplantation
CARDIOVERSION, CHEMICALC99937CHEMICAL CARDIOVERSIONThe administration of pharmacologic agents to correct abnormal heart rhythm.Chemical Cardioversion
CARDIOVERSION, ELECTRICALC99948ELECTRICAL CARDIOVERSIONThe administration of electric current to correct abnormal heart rhythm.Electric Cardioversion
CORONARY ARTERY BYPASS GRAFTC51998Aortocoronary Bypass;CAB;CABG;Coronary Artery Bypass;Coronary Artery Bypass Graft;Coronary Artery Bypass Graft Surgery;Coronary Artery Bypass Grafting;Heart BypassA procedure performed to bypass partially or completely occluded coronary arteries with veins and/or arteries harvested from elsewhere in the body, thereby improving the blood supply to the coronary circulation supplying the myocardium (heart muscle).Coronary Artery Bypass Surgery
CRYOABLATIONC15215Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by freezing. (NCI)Cryosurgery
CRYOTHERAPYC40030The therapeutic use of cold or refrigeration.Cryotherapy
ELECTROCAUTERIZATIONC111192A procedure for destroying tissue using an electrical current.Electrocauterization
ENDARTERECTOMYC52002Excision of an atheromatous plaque. (NCI)Endarterectomy
EXCISIONC15232The act of cutting out; the surgical removal of part or all of a structure or organ. (NCI)Excision
IMMUNOTHERAPYC15262A therapy designed to induce changes in a patient's immune status.Immunotherapy
IMPLANTABLE CARDIOVERTER DEFIBRILLATORC80435Implantable Cardioverter Defibrillator ProcedureA procedure involving an electronic device implanted in the body that delivers electrical stimulation to the heart to treat tachycardia. It may also have the capability to treat bradycardia.Implantable Cardioverter-Defibrillator Placement
INFRARED PHOTO COAGULATIONC62730Infrared CoagulationThe use of an intense beam of light, such as a laser, to seal off blood vessels or destroy tissue. (NCI)Infrared Photocoagulation Therapy
LEADC99934Lead ProcedureA procedure involving one or more wires used for pacemaker or implantable defibrillator devices.Cardiac Lead Procedure
LEFT ATRIAL APPENDAGE OCCLUSIONC99965The therapeutic blockage of the muscular pouch in the left atrium.Intentional Left Cardiac Atrial Appendage Occlusion Procedure
LEFT VENTRICULAR ASSIST DEVICEC80473LVADA procedure involving a mechanical cardiac pump which receives blood from the left ventricle and delivers it to the aorta.Left Ventricular Assist Device
LEFT VENTRICULAR SYSTOLIC DYSFUNCTION EVALUATIONC99975An examination and assessment of the inability of the left ventricle to effectively pump blood to the body.Left Cardiac Ventricular Systolic Dysfunction Evaluation
MITRAL BALLOON VALVOTOMYC99987Dilation of the valve between the left atrium and the left ventricle of the heart by inflating a balloon.Mitral Balloon Valvotomy
MITRAL COMMISSUROTOMYC99988Dilation of the valve between the left atrium and the left ventricle of the heart by use of a surgeon's finger or rigid instrument.Mitral Commissurotomy
MITRAL VALVE REPAIRC80449Surgery performed for the purpose of reducing regurgitation of the mitral valve.Mitral Valve Repair
MITRAL VALVE REPLACEMENTC50825Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. mitral valve with bioprosthetic, homograft or autograft valve.Mitral Valve Replacement
NON-CARDIOVASCULAR SURGERYC99995An operative procedure that does not involve the heart or the blood vessels.Non-Cardiovascular Surgery
PACEMAKERC99998Pacemaker ProcedureA procedure involving an electronic device that delivers electrical stimulation to the heart to treat bradycardia.Pacemaker Procedure
PERCUTANEOUS CORONARY INTERVENTIONC99521PCIA percutaneous coronary intervention (PCI) is the placement of an angioplasty guide wire, balloon, or other device (e.g. stent, atherectomy, brachytherapy, or thrombectomy catheter) into a native coronary artery or coronary artery bypass graft for the purpose of mechanical coronary revascularization. Examples of things not considered to be PCI procedures include intravascular ultrasound, measurements of coronary flow reserve, or measurements of fractional flow reserve.Percutaneous Coronary Intervention
PERCUTANEOUS MITRAL REPAIRC100003Invasive procedure through a puncture in the skin, performed for the purpose of reducing regurgitation of the mitral valve.Percutaneous Mitral Valve Repair
PERICARDIAL STRIPPINGC100004Removal or resection of the pericardium.Pericardial Stripping
PERICARDIAL WINDOWC51618A procedure in which an opening is made in the pericardium.Pericardial Window Procedure
PERICARDIOCENTESISC52010The aspiration of excess fluid between the pericardium and the heart.Pericardiocentesis
PERIPHERAL VASCULAR INTERVENTIONC116150PVIA peripheral vascular intervention is a catheter-based or open surgical procedure designed to improve arterial or venous blood flow or otherwise modify or revise vascular conduits. In general, the intention to perform percutaneous vascular intervention is denoted by the insertion of a guide wire into an artery or vein. For the sake of simplicity, this definition applies to the extracranial carotid artery and other non-cardiac arteries and veins, while it excludes the lymphatics and intracranial vessels.Peripheral Vascular Intervention
PULMONARY VALVE REPLACEMENTC50817Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. pulmonary valve with bioprosthetic, homograft or autograft valve.Pulmonary Valve Replacement
PULMONIC VALVULOPLASTYC100044Dilation of the valve between the right ventricle and the pulmonary artery of the heart by inflating a balloon.Pulmonic Valvuloplasty
RIGHT VENTRICULAR ASSIST DEVICEC100010RVADA procedure involving a mechanical pump which receives blood from the right ventricle and delivers it to the pulmonary artery.Right Cardiac Ventricle Assist Device Procedure
SEPTAL ABLATIONC80439A cardiac catheterization procedure to relieve symptoms in patients with severe obstructive hypertrophic cardiomyopathy. A catheter is used to inject alcohol into a septal artery supplying the heart muscle responsible for the obstruction, destroying the muscle tissue and relieving the obstruction.Septal Ablation
SURGICAL MAZEC100017Cox MazeA cardiac procedure intended to inhibit atrial fibrillation, in which a series of incisions are made in the atria to block abnormal electrical circuits that contribute to atrial fibrillation.Surgical Maze Procedure
TRANSCATHETER AORTIC VALVE IMPLANTC100022Use of a thin tube to deliver an artificial valve apparatus between the left ventricle of the heart and the aorta.Transcatheter Aortic Valve Implantation
TRICUSPID VALVE REPAIRC99935Surgery performed for the purpose of reducing regurgitation of the cardiac valve between the right atrium and right ventricle.Cardiac Tricuspid Valve Repair
TRICUSPID VALVE REPLACEMENTC50816Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. tricuspid valve with bioprosthetic, homograft or autograft valve.Tricuspid Valve Replacement
VENTRICULAR ANEURYSM RESECTIONC80451Cardiac surgical procedure performed for the removal of an aneurysm from the ventricular wall.Ventricular Aneurysm Resection
VENTRICULAR SEPTAL CLOSUREC99940Repair of ventricular septum.Closure of Cardiac Ventricle Septum
Back to top
CL.C101856.PRURGNCYProcedure Urgency Status
(PRURGNCY)
text
Extensible: No
C101856Procedure Urgency StatusA terminology codelist that describes the degree of urgency for a procedure.CDISC SDTM Procedure Urgency Status Terminology
ELECTIVEC51996Elective procedures can be deferred without increased risk of compromised outcome. Patient's clinical condition is currently stable and has been stable in the days/weeks prior. The clinical situation does not demand that the procedure take place at a specified time.Elective Surgical Procedure
EMERGENCYC62648Emergency procedures must be performed as soon as possible because of substantial concerns that delay could lead to death. Clinical situation demands that procedure should be performed immediately or in next available room, even if it means another case must be rescheduled.Emergency
SALVAGEC15359Performing a salvage procedure is the last resort. The clinical situation involves either ongoing life support measures, life support measures for more than 60 seconds during the prior 10 minutes, or unanticipated institution of extracorporeal circulatory support.Salvage Therapy
URGENTC100031Deferring an urgent procedure increases risk of adverse outcome or clinical deterioration. Clinical situation warrants performing urgent procedures during the current episode of care to avoid compromising patient safety.Urgent Procedure
Back to top
CL.C114118.PROTMLSTProtocol Milestone
(PROTMLST)
text
Extensible: Yes
C114118Protocol MilestoneA terminology codelist relevant to protocol-specified, point-in-time events during a study.CDISC SDTM Protocol Milestone Terminology
INFORMED CONSENT OBTAINEDC16735Consent by a patient for participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved.Informed Consent
RANDOMIZEDC114209Participants are assigned to arms of a clinical trial by chance.Subject is Randomized
Back to top
CL.C74457.RACERace
(RACE)
text
Extensible: No
C74457RaceTerminology codelist used to identify the race of an individual within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model.CDISC SDTM Race Terminology
AMERICAN INDIAN OR ALASKA NATIVEC41259A person having origins in any of the original peoples of North and South America (including Central America), and who maintains tribal affiliation or community attachment. (FDA)American Indian or Alaska Native
ASIANC41260A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. (FDA)Asian
BLACK OR AFRICAN AMERICANC16352A person having origins in any of the black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American." (FDA)African American
NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDERC41219Denotes a person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. The term covers particularly people who identify themselves as part-Hawaiian, Native Hawaiian, Guamanian or Chamorro, Carolinian, Samoan, Chuu. (FDA)Native Hawaiian or Other Pacific Islander
WHITEC41261Denotes a person with European, Middle Eastern, or North African ancestral origin who identifies, or is identified, as White. (FDA)White
Back to top
CL.C101864.CSLVLNIMReason CS/LV Lead Not Implanted
(CSLVLNIM)
text
Extensible: No
C101864Reason CS/LV Lead Not ImplantedThe reason that a Coronary Sinus Access or Left Ventricular (CS/LV) lead was not implanted.CDISC SDTM Reason Coronary Sinus Access or Left Ventricular Lead Not Implanted Terminology
COULD NOT OBTAIN ACCEPTABLE PACING THRESHOLDSC100025The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain acceptable pacing thresholds.Unable to Obtain Acceptable Pacing Thresholds
LEAD POSITION RESULTS IN UNDESIRABLE STIMULATION OF THE DIAPHRAGMC99933The coronary sinus/left ventricular lead was not implanted because the lead position resulted in undesirable stimulation of the diaphragm.Cardiac Lead Position Results in Undesirable Stimulation of Diaphragm
PREVIOUSLY IMPLANTEDC100007The coronary sinus/left ventricular lead was not implanted because a lead had been previously implanted.Previously Implanted Cardiac Lead
UNABLE TO OBTAIN SATISFACTORY CORONARY SINUS ACCESSC100026The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain satisfactory coronary sinus access.Unable to Obtain Satisfactory Coronary Sinus Access
UNABLE TO OBTAIN SATISFACTORY VASCULAR ACCESSC100027The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain satisfactory vascular access.Unable to Obtain Satisfactory Vascular Access
UNABLE TO POSITION LEAD DUE TO CORONARY SINUS DISSECTIONC100028The coronary sinus/left ventricular lead was not implanted because the coronary sinus was dissected.Unable to Position Lead Due to Coronary Sinus Dissection
UNABLE TO POSITION LEAD IN TRIBUTARY VEIN OF CORONARY SINUSC100029The coronary sinus/left ventricular lead was not implanted because the operator was unable to position the lead in the tributary vein of the coronary sinus.Unable to Position Lead In tributary Vein of Coronary Sinus
Back to top
CL.C102584.REASTRTReason For Treatment
(REASTRT)
text
Extensible: Yes
C102584Reason For TreatmentTerminology relevant to the reason the treatment was administered.CDISC SDTM Reason For Treatment Terminology
FAILURE AFTER FIRST TREATMENTC102635A lack of response to the first cycle of therapy.Failure After First Treatment
FAILURE AFTER MULTIPLE TREATMENTSC102636A lack of response to more than one cycle of therapy.Failure After Multiple Treatments
PREVIOUS PATIENT NONCOMPLIANCEC102698A previous episode of failure by a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment.Previous Patient Noncompliance
RECURRENT DISEASEC38155Recurrent DiseaseThe return of a disease after a period of remission.Recurrent Disease
Back to top
CL.C102583.REASTINTReason for Treatment Interruption
(REASTINT)
text
Extensible: Yes
C102583Reason for Treatment InterruptionTerminology relevant to the reason the drug or therapy was temporarily ceased.CDISC SDTM Reason for Treatment Interruption Terminology
FORGOT TO TAKE MEDICATION DOSEC102638A patient's failure to remember to take a dose of medication.Forgot to Take Medication Dose
INTOLERANCEC71437An inability to absorb or metabolize certain substances in the normal way.Intolerance
MEDICATION MISPLACEDC102664Medications that were lost because they were put in the wrong place.Medication Misplaced
PATIENT NONCOMPLIANCEC91752Failure of a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment.Patient Noncompliance
TREATMENT FAILUREC48226The lack of expected or desired effect related to a therapy. (NCI)Lack of Efficacy
VACATIONC80227Leisure time away from work devoted to rest or pleasure.Vacation
Back to top
CL.C102586.RSTRTNAReason Treatment Not Administered
(RSTRTNA)
text
Extensible: Yes
C102586Reason Treatment Not AdministeredTerminology relevant to the reason the treatment was not administered.CDISC SDTM Reason Treatment Not Administered Terminology
MEDICATION LOSTC102663The medication is no longer held or possessed by the subject and is incapable of being recovered or regained.Medication Lost
NOT OFFEREDC102682Is not an option.Not Offered
REFUSEC49161To decline to do, accept, give, or allow something.Refuse
RELOCATIONC77951The act of changing your residence or place of business.Relocation
Back to top
CL.C78736.NRINDReference Range Indicator
(NRIND)
text
Extensible: Yes
C78736Reference Range IndicatorA description of the results relative to the normal or expected range of values.CDISC SDTM Reference Range Indicator
ABNORMALC78802Reported values outside the typical or expected range. (NCI)Abnormal Reference Range
HIGHC78800Reported values above the typical or expected range. (NCI)Value Above Reference Range
LOWC78801Reported values below the typical or expected range. (NCI)Value Below Reference Range
NORMALC78727Reported values within the typical or expected range. (NCI)Normal Reference Range
Back to top
CL.C66728.STENRFRelation to Reference Period
(STENRF)
text
Extensible: No
C66728Relation to Reference PeriodThe relative relationship of a timepoint to a reference timepoint.CDISC SDTM Relation to Reference Period Terminology
AFTERC38008The time period following a point or another period of time. (NCI)Post
BEFOREC25629Earlier in time or order. (NCI)Prior
COINCIDENTC25456Occurring or operating at the same time.Concurrent
DURINGC25490At some point in a given period of time. (NCI)During
DURING/AFTERC49640Within a certain period of time or after a certain point or period in time. (NCI)During or After
ONGOINGC53279ContinuousRemain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI)Continue
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C100130.RELSUBRelationship to Subject
(RELSUB)
text
Extensible: Yes
C100130Relationship to SubjectThe relationship of a person to a study subject.CDISC SDTM Relationship to Subject Terminology
AUNT, BIOLOGICALC96569Biological AuntA female relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI)Biological Aunt
AUNT, BIOLOGICAL MATERNALC96575Biological Maternal AuntA female relative who is a sibling of the biological mother, and who both share a common ancestor. (NCI)Biological Maternal Aunt
AUNT, BIOLOGICAL PATERNALC96581Biological Paternal AuntA female relative who is a sibling of the biological father, and who both share a common ancestor. (NCI)Biological Paternal Aunt
BROTHER, BIOLOGICALC96570Biological BrotherA male who shares with his sibling the genetic makeup inherited from one or both of their shared biological parents.Biological Brother
BROTHER, BIOLOGICAL MATERNAL HALFC96656Half-brother with Mother as Common ParentA male who shares with his sibling the genetic makeup inherited from only the biological mother.Half-brother with Mother as Common Parent
BROTHER, BIOLOGICAL PATERNAL HALFC96655Half-brother with Father as Common ParentA male who shares with his sibling the genetic makeup inherited from only the biological father.Half-brother with Father as Common Parent
BROTHER, FULLC111201A male who shares with his sibling the genetic makeup inherited from both of the biological parents.Full Brother
BROTHER, HALFC71402Half BrotherA male who shares with his sibling the genetic makeup inherited from only one of the biological parents.Half Brother
CAREGIVERC17445CaregiverThe primary person in charge of the care of a patient, usually a family member or a designated health care professional. (NCI)Caregiver
CHILD, BIOLOGICALC100807Biological ChildA son or daughter with genetic makeup inherited from the parent.Biological Child
CLINICIANC85499ClinicianAn individual, such as a physician, nurse practitioner or other health care professional, who takes responsibility for a subject's care.Clinician
COUSIN, BIOLOGICALC96571Biological CousinA relative who is the offspring of a sibling of either of the biological parents, and who share a common ancestor. (NCI)Biological Cousin
COUSIN, BIOLOGICAL MATERNALC96576Biological Maternal CousinA relative who is the offspring of a sibling of the biological mother and share a common ancestor.Biological Maternal Cousin
COUSIN, BIOLOGICAL PATERNALC96582Biological Paternal CousinA relative who is the offspring of a sibling of the biological father and share a common ancestor.Biological Paternal Cousin
DOMESTIC PARTNERC53262Domestic PartnerPerson declares that a domestic partnership relationship exists. (HL7)Domestic Partnership
DONORC48284DonorOne that contributes something. (NCI)Donor
DONOR, ORGANC100810Organ DonorSomeone from whom an organ is removed for transplantation or other purpose.Organ Donor
DONOR, TISSUEC25168Tissue DonorSomeone from whom tissue is removed for transplantation or other purpose.Tissue Donor
FAMILY MEMBERC41256Family MemberAny of the individuals who are descended from a common progenitor, related by marriage or other legal tie.Family Member
FATHER, BIOLOGICALC96572Biological FatherA male who contributes to the genetic makeup of his offspring through the fertilization of an ovum by his sperm. (NCI)Biological Father
GRANDCHILD, BIOLOGICALC100805Biological GrandchildA biological child of an individual's biological child.Biological Grandchild
GRANDFATHER, BIOLOGICALC96573Biological GrandfatherA male relative who is the biological father of either the biological mother or the biological father. (NCI)Biological Grandfather
GRANDFATHER, BIOLOGICAL MATERNALC96577Biological Maternal GrandfatherA male relative who is the biological father of the biological mother. (NCI)Biological Maternal Grandfather
GRANDFATHER, BIOLOGICAL PATERNALC96583Biological Paternal GrandfatherA male relative who is the biological father of the biological father. (NCI)Biological Paternal Grandfather
GRANDMOTHER, BIOLOGICALC96574Biological GrandmotherA female relative who is the biological mother of either the biological mother or the biological father. (NCI)Biological Grandmother
GRANDMOTHER, BIOLOGICAL MATERNALC96578Biological Maternal GrandmotherA female relative who is the biological mother of the biological mother. (NCI)Biological Maternal Grandmother
GRANDMOTHER, BIOLOGICAL PATERNALC96584Biological Paternal GrandmotherA female relative who is the biological mother of the biological father. (NCI)Biological Paternal Grandmother
GRANDPARENT, BIOLOGICALC100806Biological GrandparentA biological parent of the biological father or biological mother.Biological Grandparent
GRANDPARENT, BIOLOGICAL MATERNALC111248A relative who is the biological parent of the biological mother.Maternal Biological Grandparent
GRANDPARENT, BIOLOGICAL PATERNALC111286A relative who is the biological parent of the biological father.Paternal Biological Grandparent
MOTHER, BIOLOGICALC96580Biological MotherA female who contributes to the genetic makeup of her offspring from the fertilization of her ovum. (NCI)Biological Mother
NURSEC20821NurseA professional healthcare provider who has graduated from a nursing program.Nurse
PREGNANCY PARTNERC100811Pregnancy PartnerAn individual who provides support to a pregnant individual.Pregnancy Partner
RELATIVE, FIRST DEGREEC21481First Degree RelativeAny individual related biologically or legally to another individual and considered immediate family as in the case of a spouse, parent, sibling or child.First Degree Relative
RELATIVE, SECOND DEGREEC19811Second Degree RelativeAny individual related biologically or legally to another individual and considered one degree removed from the immediate family as in the case of in-laws, grandparents, aunts and uncles.Second Degree Relative
RELATIVE, THIRD DEGREEC100808Third Degree RelativeAny individual related biologically or legally to another individual and considered two degrees removed from the immediate family as in the case of cousins.Third Degree Relative
SEXUAL PARTNERC100812Sexual PartnerA person with whom one has had sexual relations.Sexual Partner
SIBLING, BIOLOGICALC100809Biological SiblingA person's brother or sister with whom they share a genetic makeup inherited from their shared biological parents.Biological Sibling
SIBLING, FULLC71390A person's brother or sister with whom they share a genetic makeup inherited from both of their shared biological parents.Full Sibling
SIBLING, HALFC71391A person's brother or sister with whom they share a genetic makeup inherited from one of their shared biological parents.Half Sibling
SISTER, BIOLOGICALC96586Biological SisterA female who shares with her sibling the genetic makeup inherited from one or both of their shared biological parents.Biological Sister
SISTER, BIOLOGICAL MATERNAL HALFC96658Half-sister with Mother as Common ParentA female who shares with her sibling the genetic makeup inherited from only the biological mother.Half-sister with Mother as Common Parent
SISTER, BIOLOGICAL PATERNAL HALFC96657Half-sister with Father as Common ParentA female who shares with her sibling the genetic makeup inherited from only the biological father.Half-sister with Father as Common Parent
SISTER, FULLC111202A female who shares with her sibling the genetic makeup inherited from both of the biological parents.Full Sister
SISTER, HALFC71403Half SisterA female who shares with her sibling the genetic makeup inherited from only one of the biological parents.Half Sister
SPOUSEC62649SpouseA person's partner in marriage. (NCI)Spouse
TECHNICIANC63861TechnicianA person skilled in the performance of the technical or procedural aspects of a profession. (NCI)Technician
TWINC73427TwinEither of two offspring born from the same pregnancy. (NCI)Twin
TWIN, DIZYGOTICC73428Dizygotic TwinEither of the two offspring resulting from two separately fertilized ovums during the same pregnancy.Fraternal Twin
TWIN, MONOZYGOTICC73429Monozygotic TwinEither of the two offspring resulting from a shared ovum. (NCI)Identical Twin
UNCLE, BIOLOGICALC96587Biological UncleA male relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI)Biological Uncle
UNCLE, BIOLOGICAL MATERNALC96579Biological Maternal UncleA male relative who is a sibling of the biological mother, and who both share a common ancestor. (NCI)Biological Maternal Uncle
UNCLE, BIOLOGICAL PATERNALC96585Biological Paternal UncleA male relative who is a sibling of the biological father, and who both share a common ancestor. (NCI)Biological Paternal Uncle
Back to top
CL.C78737.RELTYPERelationship Type
(RELTYPE)
text
Extensible: No
C78737Relationship TypeThe description of relationship types between a record or set of records.CDISC SDTM Relationship Type Terminology
MANYC78728Many;SeveralMore than one. (NCI)Many
ONEC66832A textual representation of the numeral 1.One
Back to top
CL.C106479.RPTESTCDReproductive System Findings Test Code
(RPTESTCD)
text
Extensible: Yes
C106479Reproductive System Findings Test CodeA terminology codelist for the physiological test codes related to the male and female reproductive systems.CDISC SDTM Reproductive System Findings Test Code Terminology
ABORTNC106550Number of AbortionsA measurement of the total number of instances in which there has been a spontaneous termination of pregnancy (miscarriage) or elective termination of pregnancy.Number of Abortions
BCMETHODC106501Birth Control MethodThe method by which conception or impregnation is prevented.Birth Control Method
BRTHLVNC16955Number of Live BirthsA measurement of the total number of live-born offspring a female has delivered.Parity
CHILDPOTC106508Childbearing PotentialAn indicator as to whether the female subject has the potential to become pregnant. (NCI)Childbearing Potential
MENARAGEC19666Menarche AgeThe age at which the first menstruation event occurred. (NCI)Age at Menarche
MENOAGEC106497Menopause AgeThe age at which permanent cessation of menses occurred. (NCI)Age at Menopause
MENOSTATC106541Menopause StatusThe status of a female with respect to menopause.Menopause Status
MENSDURC119549Menstrual Cycle DurationThe length of time of the menses cycle, measured from the beginning of one menstrual period to the beginning of the next.Menstrual Cycle Duration
PREGNNC106551Number of PregnanciesA measurement of the total number of pregnancy events experienced by a female.Number of Pregnancies
PREGSTC106561Pregnant During the StudyAn indicator as to whether a female is pregnant during the study period. (NCI)Pregnant During the Study
Back to top
CL.C106478.RPTESTReproductive System Findings Test Name
(RPTEST)
text
Extensible: Yes
C106478Reproductive System Findings Test NameA terminology codelist for the physiological test names related to the male and female reproductive systems.CDISC SDTM Reproductive System Findings Test Name Terminology
Birth Control MethodC106501Birth Control MethodThe method by which conception or impregnation is prevented.Birth Control Method
Childbearing PotentialC106508Childbearing PotentialAn indicator as to whether the female subject has the potential to become pregnant. (NCI)Childbearing Potential
Menarche AgeC19666Menarche AgeThe age at which the first menstruation event occurred. (NCI)Age at Menarche
Menopause AgeC106497Menopause AgeThe age at which permanent cessation of menses occurred. (NCI)Age at Menopause
Menopause StatusC106541Menopause StatusThe status of a female with respect to menopause.Menopause Status
Menstrual Cycle DurationC119549Menstrual Cycle DurationThe length of time of the menses cycle, measured from the beginning of one menstrual period to the beginning of the next.Menstrual Cycle Duration
Number of AbortionsC106550Number of AbortionsA measurement of the total number of instances in which there has been a spontaneous termination of pregnancy (miscarriage) or elective termination of pregnancy.Number of Abortions
Number of Live BirthsC16955Number of Live BirthsA measurement of the total number of live-born offspring a female has delivered.Parity
Number of PregnanciesC106551Number of PregnanciesA measurement of the total number of pregnancy events experienced by a female.Number of Pregnancies
Pregnant During the StudyC106561Pregnant During the StudyAn indicator as to whether a female is pregnant during the study period. (NCI)Pregnant During the Study
Back to top
CL.C111106.RETESTCDRespiratory Test Code
(RETESTCD)
text
Extensible: Yes
C111106Respiratory Test CodeA terminology codelist based on the test codes for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs.CDISC SDTM Respiratory Test Code Terminology
ERVC111200Expiratory Reserve VolumeThe maximum volume of air a subject can exhale from the lungs after a tidal exhalation.Expiratory Reserve Volume
ERVPPC112375Percent Predicted ERVThe maximum volume of air a subject can exhale from the lungs after a tidal exhalation as a proportion of the predicted normal value.Percent Predicted Expiratory Reserve Volume
FEF2575C119545Forced Expiratory Flow 25-75%The mean forced expiratory flow rate at 25-75% of the forced vital capacity. (NCI)Forced Expiratory Flow at 25-75 Percent
FEF2575PC119546Percent Predicted FEF25-75The mean forced expiratory flow rate at 25-75% of the forced vital capacity as a proportion of the predicted normal value. (NCI)Percent Predicted Forced Expiratory Flow at 25-75 Percent
FEV1C38084Forced Expiratory Volume in 1 SecondThe volume of air that a subject can breathe out during the first second of exhalation after maximum inhalation.Forced Expiratory Volume in 1 Second
FEV1FVCC111359FEV1/FVCThe proportion of total forced vital capacity that is expelled during the first second of a forced exhalation.Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio Measurement
FEV1FVCPC112377Percent Predicted FEV1/FVCThe proportion of total forced vital capacity that is expelled during the first second of a forced exhalation as a proportion of the predicted normal value.Percent Predicted Forced Expiratory Volume in 1 Second Divided by Forced Vital Capacity
FEV1PPC112376Percent Predicted FEV1Forced expiratory volume in one second as a proportion of the predicted normal value.Percent Predicted Forced Expiratory Volume in 1 Second
FEV1REVC112285FEV1 ReversibilityThe change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value.Forced Expiratory Volume in 1 Second Reversibility
FEV6C47843Forced Expiratory Volume in 6 SecondsThe volume of air that a subject can breathe out during the first 6 seconds of exhalation after maximum inhalation.Forced Expiratory Volume in 6 Seconds
FEV6PPC112378Percent Predicted FEV6Forced expiratory volume in six seconds as a proportion of the predicted normal value.Percent Predicted Forced Expiratory Volume in 6 Seconds
FIFMAXC112333Maximum Forced Inspiratory FlowForced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled.Maximum Forced Inspiratory Flow
FIFMAXPPC112379Percent Predicted FIFmaxForced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled as a proportion of the predicted normal value.Percent Predicted Forced Inspiratory Flow Maximum
FIV1C111360Forced Inspiratory Volume in 1 SecondThe volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation.Forced Inspiratory Volume in 1 Second
FIV1PPC112380Percent Predicted FIV1The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation as a proportion of the predicted normal value.Percent Predicted Forced Inspiratory Volume in 1 Second
FVCC111361Forced Vital CapacityThe maximum volume of air that can be exhaled after forced maximum inhalation.Forced Vital Capacity
FVCPPC112381Percent Predicted Forced Vital CapacityForced vital capacity as a proportion of the predicted normal value.Percent Predicted Forced Vital Capacity
ICC111362Inspiratory CapacityThe maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV).Inspiratory Capacity
ICPPC112382Percent Predicted Inspiratory CapacityThe maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV) as a proportion of the predicted normal value.Percent Predicted Inspiratory Capacity
ICREVC112321IC ReversibilityThe change in IC following administration of a bronchodilator relative to the pre-treatment IC value.Inspiratory Capacity Reversibility
IRVC111237Inspiratory Reserve VolumeThe maximum volume of air a subject can inhale into the lungs after a tidal inhalation.Inspiratory Reserve Volume
IRVPPC112383Percent Predicted IRVThe maximum volume of air a subject can inhale into the lungs after a tidal inhalation as a proportion of the predicted normal value.Percent Predicted Inspiratory Reserve Volume
PEFC41372Peak Expiratory FlowThe maximal flow achieved during the maximally forced expiration initiated at maximum inhalation.Peak Expiratory Flow
PEFPPC112384Percent Predicted Peak Expiratory FlowThe maximal flow achieved during the maximally forced expiration initiated at maximum inhalation as a proportion of the predicted normal value.Percent Predicted Peak Expiratory Flow
PEFREVC112368PEF ReversibilityThe change in PEF following administration of a bronchodilator relative to the pre-treatment PEF value.Peak Expiratory Flow Reversibility
PNIFC119547Peak Nasal Inspiratory FlowThe maximal flow achieved during the maximally forced inspiration through the nose initiated at maximum exhalation. (NCI)Peak Nasal Inspiratory Flow
RVC89836Residual VolumeThe volume of air remaining in the lungs after maximum exhalation.Residual Volume
RVPPC112385Percent Predicted Residual VolumeThe volume of air remaining in the lungs after maximum exhalation as a proportion of the predicted normal value.Percent Predicted Residual Volume
SVCC111315Slow Vital CapacityThe maximum volume of air that can be exhaled after slow maximum inhalation.Slow Vital Capacity
SVCPPC112386Percent Predicted Slow Vital CapacityThe maximum volume of air that can be exhaled after slow maximum inhalation as a proportion of the predicted normal value.Percent Predicted Slow Vital Capacity
TLCC111325Total Lung CapacityThe total volume of air in the lungs after maximum inhalation.Total Lung Capacity
TLCPPC112388Percent Predicted Total Lung CapacityThe total volume of air in the lungs after maximum inhalation as a proportion of the predicted normal value.Percent Predicted Total Lung Capacity
TVC111324Tidal VolumeThe volume of air moved into and out of the lungs during breathing at rest.Tidal Volume
TVPPC112387Percent Predicted Tidal VolumeThe volume of air moved into and out of the lungs during breathing at rest as a proportion of the predicted normal value.Percent Predicted Tidal Volume
Back to top
CL.C111107.RETESTRespiratory Test Name
(RETEST)
text
Extensible: Yes
C111107Respiratory Test NameA terminology codelist based on the test names for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs.CDISC SDTM Respiratory Test Name Terminology
Expiratory Reserve VolumeC111200Expiratory Reserve VolumeThe maximum volume of air a subject can exhale from the lungs after a tidal exhalation.Expiratory Reserve Volume
FEV1 ReversibilityC112285FEV1 ReversibilityThe change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value.Forced Expiratory Volume in 1 Second Reversibility
FEV1/FVCC111359FEV1/FVCThe proportion of total forced vital capacity that is expelled during the first second of a forced exhalation.Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio Measurement
Forced Expiratory Flow 25-75%C119545Forced Expiratory Flow 25-75%The mean forced expiratory flow rate at 25-75% of the forced vital capacity. (NCI)Forced Expiratory Flow at 25-75 Percent
Forced Expiratory Volume in 1 SecondC38084Forced Expiratory Volume in 1 SecondThe volume of air that a subject can breathe out during the first second of exhalation after maximum inhalation.Forced Expiratory Volume in 1 Second
Forced Expiratory Volume in 6 SecondsC47843Forced Expiratory Volume in 6 SecondsThe volume of air that a subject can breathe out during the first 6 seconds of exhalation after maximum inhalation.Forced Expiratory Volume in 6 Seconds
Forced Inspiratory Volume in 1 SecondC111360Forced Inspiratory Volume in 1 SecondThe volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation.Forced Inspiratory Volume in 1 Second
Forced Vital CapacityC111361Forced Vital CapacityThe maximum volume of air that can be exhaled after forced maximum inhalation.Forced Vital Capacity
IC ReversibilityC112321IC ReversibilityThe change in IC following administration of a bronchodilator relative to the pre-treatment IC value.Inspiratory Capacity Reversibility
Inspiratory CapacityC111362Inspiratory CapacityThe maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV).Inspiratory Capacity
Inspiratory Reserve VolumeC111237Inspiratory Reserve VolumeThe maximum volume of air a subject can inhale into the lungs after a tidal inhalation.Inspiratory Reserve Volume
Maximum Forced Inspiratory FlowC112333Maximum Forced Inspiratory FlowForced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled.Maximum Forced Inspiratory Flow
Peak Expiratory FlowC41372Peak Expiratory FlowThe maximal flow achieved during the maximally forced expiration initiated at maximum inhalation.Peak Expiratory Flow
Peak Nasal Inspiratory FlowC119547Peak Nasal Inspiratory FlowThe maximal flow achieved during the maximally forced inspiration through the nose initiated at maximum exhalation. (NCI)Peak Nasal Inspiratory Flow
PEF ReversibilityC112368PEF ReversibilityThe change in PEF following administration of a bronchodilator relative to the pre-treatment PEF value.Peak Expiratory Flow Reversibility
Percent Predicted ERVC112375Percent Predicted ERVThe maximum volume of air a subject can exhale from the lungs after a tidal exhalation as a proportion of the predicted normal value.Percent Predicted Expiratory Reserve Volume
Percent Predicted FEF25-75C119546Percent Predicted FEF25-75The mean forced expiratory flow rate at 25-75% of the forced vital capacity as a proportion of the predicted normal value. (NCI)Percent Predicted Forced Expiratory Flow at 25-75 Percent
Percent Predicted FEV1C112376Percent Predicted FEV1Forced expiratory volume in one second as a proportion of the predicted normal value.Percent Predicted Forced Expiratory Volume in 1 Second
Percent Predicted FEV1/FVCC112377Percent Predicted FEV1/FVCThe proportion of total forced vital capacity that is expelled during the first second of a forced exhalation as a proportion of the predicted normal value.Percent Predicted Forced Expiratory Volume in 1 Second Divided by Forced Vital Capacity
Percent Predicted FEV6C112378Percent Predicted FEV6Forced expiratory volume in six seconds as a proportion of the predicted normal value.Percent Predicted Forced Expiratory Volume in 6 Seconds
Percent Predicted FIFmaxC112379Percent Predicted FIFmaxForced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled as a proportion of the predicted normal value.Percent Predicted Forced Inspiratory Flow Maximum
Percent Predicted FIV1C112380Percent Predicted FIV1The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation as a proportion of the predicted normal value.Percent Predicted Forced Inspiratory Volume in 1 Second
Percent Predicted Forced Vital CapacityC112381Percent Predicted Forced Vital CapacityForced vital capacity as a proportion of the predicted normal value.Percent Predicted Forced Vital Capacity
Percent Predicted Inspiratory CapacityC112382Percent Predicted Inspiratory CapacityThe maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV) as a proportion of the predicted normal value.Percent Predicted Inspiratory Capacity
Percent Predicted IRVC112383Percent Predicted IRVThe maximum volume of air a subject can inhale into the lungs after a tidal inhalation as a proportion of the predicted normal value.Percent Predicted Inspiratory Reserve Volume
Percent Predicted Peak Expiratory FlowC112384Percent Predicted Peak Expiratory FlowThe maximal flow achieved during the maximally forced expiration initiated at maximum inhalation as a proportion of the predicted normal value.Percent Predicted Peak Expiratory Flow
Percent Predicted Residual VolumeC112385Percent Predicted Residual VolumeThe volume of air remaining in the lungs after maximum exhalation as a proportion of the predicted normal value.Percent Predicted Residual Volume
Percent Predicted Slow Vital CapacityC112386Percent Predicted Slow Vital CapacityThe maximum volume of air that can be exhaled after slow maximum inhalation as a proportion of the predicted normal value.Percent Predicted Slow Vital Capacity
Percent Predicted Tidal VolumeC112387Percent Predicted Tidal VolumeThe volume of air moved into and out of the lungs during breathing at rest as a proportion of the predicted normal value.Percent Predicted Tidal Volume
Percent Predicted Total Lung CapacityC112388Percent Predicted Total Lung CapacityThe total volume of air in the lungs after maximum inhalation as a proportion of the predicted normal value.Percent Predicted Total Lung Capacity
Residual VolumeC89836Residual VolumeThe volume of air remaining in the lungs after maximum exhalation.Residual Volume
Slow Vital CapacityC111315Slow Vital CapacityThe maximum volume of air that can be exhaled after slow maximum inhalation.Slow Vital Capacity
Tidal VolumeC111324Tidal VolumeThe volume of air moved into and out of the lungs during breathing at rest.Tidal Volume
Total Lung CapacityC111325Total Lung CapacityThe total volume of air in the lungs after maximum inhalation.Total Lung Capacity
Back to top
CL.C101848.RSKASMTRisk Assessment
(RSKASMT)
text
Extensible: No
C101848Risk AssessmentA terminology codelist to describe the risk of a disease, disorder or abnormal condition.CDISC SDTM Risk Assessment Terminology
HIGH RISKC102401The potential future harm that may arise from some present action or attribute or condition is almost certain.High Risk
INTERMEDIATE RISKC102402The potential future harm that may arise from some present action or attribute or condition is moderate.Intermediate Risk
LOW RISKC102403The potential future harm that may arise from some present action or attribute or condition is small.Low Risk
UNKNOWNC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
Back to top
CL.C66729.ROUTERoute of Administration
(ROUTE)
text
Extensible: Yes
C66729Route of AdministrationThe course by which a substance was administered in order to reach the site of action in the body.CDISC SDTM Route of Administration Terminology
AURICULAR (OTIC)C38192Administration to or by way of the ear. (FDA)Auricular Route of Administration
BUCCALC38193Administration directed toward the cheek, generally from within the mouth. (FDA)Buccal Route of Administration
CONJUNCTIVALC38194Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball. (FDA)Conjunctival Route of Administration
CUTANEOUSC38675Administration to the skin. (FDA)Cutaneous Route of Administration
DENTALC38197Administration to a tooth or teeth. (FDA)Dental Route of Administration
DIETARYC78373Administration by way of food stuff. (NCI)Dietary Route of Administration
ELECTRO-OSMOSISC38633Administration of through the diffusion of substance through a membrane in an electric field. (FDA)Electro-osmosis Route of Administration
ENDOCERVICALC38205Intracervical Route of AdministrationAdministration within the canal of the cervix uteri. Synonymous with the term intracervical. (FDA)Endocervical Route of Administration
ENDOSINUSIALC38206Administration within the nasal sinuses of the head. (FDA)Endosinusial Route of Administration
ENDOTRACHEALC38208Intratracheal Route of AdministrationAdministration directly into the trachea. Synonymous with the term intratracheal. (FDA)Endotracheal Route of Administration
ENTERALC38209Administration directly into the intestines. (FDA)Enteral Route of Administration
EPIDURALC38210Administration upon or over the dura mater. (FDA)Epidural Route of Administration
EXTRA-AMNIOTICC38211Administration to the outside of the membrane enveloping the fetus. (FDA)Extraamniotic Route of Administration
EXTRACORPOREALC38212Administration outside of the body. (FDA)Extracorporeal Circulation Route of Administration
HEMODIALYSISC38200Administration through hemodialysate fluid. (FDA)Administration via Hemodialysis
INFILTRATIONC38215Administration that results in substances passing into tissue spaces or into cells. (FDA)Infiltration Route of Administration
INTERSTITIALC38219Administration to or in the interstices of a tissue. (FDA)Interstitial Route of Administration
INTRA-ABDOMINALC38220Administration within the abdomen. (FDA)Intraabdominal Route of Administration
INTRA-AMNIOTICC38221Administration within the amnion. (FDA)Intraamniotic Route of Administration
INTRA-ARTERIALC38222Administration within an artery or arteries. (FDA)Intraarterial Route of Administration
INTRA-ARTICULARC38223Administration within a joint. (FDA)Intraarticular Route of Administration
INTRABILIARYC38224Administration within the bile, bile ducts or gallbladder. (FDA)Intrabiliary Route of Administration
INTRABRONCHIALC38225Administration within a bronchus. (FDA)Intrabronchial Route of Administration
INTRABURSALC38226Administration within a bursa. (FDA)Intrabursal Route of Administration
INTRACAMERALC64984Administration by injection directly into the anterior chamber of the eye.Intracameral Route of Administration
INTRACARDIACC38227Administration within the heart. (FDA)Intracardiac Route of Administration
INTRACARTILAGINOUSC38228Administration within a cartilage; endochondral. (FDA)Intracartilaginous Route of Administration
INTRACAUDALC38229Administration within the cauda equina. (FDA)Intracaudal Route of Administration
INTRACAVERNOUSC38230Administration within a pathologic cavity, such as occurs in the lung in tuberculosis. (FDA)Intracavernous Route of Administration
INTRACAVITARYC38231Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound. (FDA)Intracavitary Route of Administration
INTRACEREBRALC38232Administration within the cerebrum. (FDA)Intracerebral Route of Administration
INTRACISTERNALC38233Administration within the cisterna magna cerebellomedularis. (FDA)Intracisternal Route of Administration
INTRACORNEALC38234Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye). (FDA)Intracorneal Route of Administration
INTRACORONAL, DENTALC38217Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck. (FDA)Intracoronal Dental Route of Administration
INTRACORONARYC38218Administration within the coronary arteries. (FDA)Intracoronary Route of Administration
INTRACORPORUS CAVERNOSUMC38235Administration within the dilatable spaces of the corporus cavernosa of the penis. (FDA)Intracorporus Cavernosum Route of Administration
INTRADERMALC38238Administration within the dermis. (FDA)Intradermal Route of Administration
INTRADISCALC38239Administration within a disc. (FDA)Intradiscal Route of Administration
INTRADUCTALC38240Administration within the duct of a gland. (FDA)Intraductal Route of Administration
INTRADUODENALC38241Administration within the duodenum. (FDA)Intraduodenal Route of Administration
INTRADURALC38242Administration within or beneath the dura. (FDA)Intradural Route of Administration
INTRAEPIDERMALC38243Administration within the epidermis. (FDA)Intraepidermal Route of Administration
INTRAESOPHAGEALC38245Administration within the esophagus. (FDA)Intraesophageal Route of Administration
INTRAGASTRICC38246Administration within the stomach. (FDA)Intragastric Route of Administration
INTRAGINGIVALC38247Administration within the gingivae. (FDA)Intragingival Route of Administration
INTRAHEPATICC38248Administration into the liver.Intrahepatic Route of Administration
INTRAILEALC38249Administration within the distal portion of the small intestine, from the jejunum to the cecum. (FDA)Intraileal Route of Administration
INTRAJEJUNALC102399Administration into the jejunum.Intrajejunal Route of Administration
INTRALESIONALC38250Administration within or introduced directly into a localized lesion. (FDA)Intralesional Route of Administration
INTRALUMINALC38251Administration within the lumen of a tube. (FDA)Intraluminal Route of Administration
INTRALYMPHATICC38252Administration within the lymph. (FDA)Intralymphatic Route of Administration
INTRAMEDULLARYC38253Administration within the marrow cavity of a bone. (FDA)Intramedullary Route of Administration
INTRAMENINGEALC38254Administration within the meninges (the three membranes that envelope the brain and spinal cord). (FDA)Intrameningeal Route of Administration
INTRAMUSCULARC28161Administration within a muscle. (FDA)Intramuscular Route of Administration
INTRAOCULARC38255Administration within the eye. (FDA)Intraocular Route of Administration
INTRAOVARIANC38256Administration within the ovary. (FDA)Intraovarian Route of Administration
INTRAPALATALC102400Administration into the palate.Intrapalatal Route of Administration
INTRAPARENCHYMALC119548Administration within or into the parenchyma of a targeted organ.Intraparenchymal Route of Administration
INTRAPERICARDIALC38257Administration within the pericardium. (FDA)Intrapericardial Route of Administration
INTRAPERITONEALC38258Administration within the peritoneal cavity. (FDA)Intraperitoneal Route of Administration
INTRAPLEURALC38259Administration within the pleura. (FDA)Intrapleural Route of Administration
INTRAPROSTATICC38260Administration within the prostate gland. (FDA)Intraprostatic Route of Administration
INTRAPULMONARYC38261Administration within the lungs or its bronchi. (FDA)Intrapulmonary Route of Administration
INTRASINALC38262Administration within the nasal or periorbital sinuses. (FDA)Intrasinal Route of Administration
INTRASPINALC38263Administration within the vertebral column. (FDA)Intraspinal Route of Administration
INTRASTOMALC65138Administration into a stoma.Administration via Stoma
INTRASYNOVIALC38264Administration within the synovial cavity of a joint. (FDA)Intrasynovial Route of Administration
INTRATENDINOUSC38265Administration within a tendon. (FDA)Intratendinous Route of Administration
INTRATESTICULARC38266Administration within the testicle. (FDA)Intratesticular Route of Administration
INTRATHECALC38267Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles. (FDA)Intrathecal Route of Administration
INTRATHORACICC38207Administration within the thorax (internal to the ribs); synonymous with the term endothoracic. (FDA)Endothoracic Route of Administration
INTRATUBULARC38268Administration within the tubules of an organ. (FDA)Intratubular Route of Administration
INTRATUMORC38269Intratumor Route of AdministrationAdministration within a tumor. (FDA)Intratumoral Route of Administration
INTRATYMPANICC38270Administration within the auris media. (FDA)Intratympanic Route of Administration
INTRAUTERINEC38272Administration within the uterus. (FDA)Intrauterine Route of Administration
INTRAVASCULARC38273Administration within a vessel or vessels. (FDA)Intravascular Route of Administration
INTRAVENOUSC38276Administration within or into a vein or veins. (FDA)Intravenous Route of Administration
INTRAVENOUS BOLUSC38274Administration within or into a vein or veins all at once. (FDA)Intravenous Bolus
INTRAVENOUS DRIPC38279Administration within or into a vein or veins over a sustained period of time. (FDA)Intravenous Drip
INTRAVENTRICULARC38277Administration within a ventricle. (FDA)Intraventricular Route of Administration
INTRAVESICALC38278Administration within the bladder. (FDA)Intravesical Route of Administration
INTRAVITREALC38280Administration within the vitreous body of the eye. (FDA)Intravitreal Route of Administration
IONTOPHORESISC38203Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body. (FDA)Iontophoresis Route of Administration
IRRIGATIONC38281Administration to bathe or flush open wounds or body cavities. (FDA)Irrigation-Route of Administration
LARYNGEALC38282Administration directly upon the larynx. (FDA)Laryngeal Route of Administration
NASALC38284Intranasal Route of AdministrationAdministration to the nose; administered by way of the nose. (FDA)Nasal Route of Administration
NASOGASTRICC38285Administration through the nose and into the stomach, usually by means of a tube. (FDA)Nasogastric Route of Administration
NOT APPLICABLEC48623Routes of administration are not applicable. (FDA)Route of Administration Not Applicable
OCCLUSIVE DRESSING TECHNIQUEC38286Administration by the topical route which is then covered by a dressing which occludes the area. (FDA)Occlusive Dressing Technique
OPHTHALMICC38287Administration to the external eye. (FDA)Ophthalmic Route of Administration
ORALC38288Intraoral Route of Administration;POAdministration to or by way of the mouth. (FDA)Oral Route of Administration
ORAL GAVAGEC78374Administration through the mouth and into the stomach, usually by means of a tube. (NCI)Oral Gavage Route of Administration
OROMUCOSALC64906Administration across the mucosa of the oral cavity.Oromucosal Route of Administration
OROPHARYNGEALC38289Administration directly to the mouth and pharynx. (FDA)Oropharyngeal Route of Administration
PARENTERALC38291Administration by injection, infusion, or implantation. (FDA)Parenteral Route of Administration
PERCUTANEOUSC38676Administration through the skin. (FDA)Percutaneous Route of Administration
PERIARTICULARC38292Administration around a joint. (FDA)Periarticular Route of Administration
PERIDURALC38677Administration to the outside of the dura mater of the spinal cord. (FDA)Peridural Route of Administration
PERINEURALC38293Administration surrounding a nerve or nerves. (FDA)Perineural Route of Administration
PERIODONTALC38294Administration around a tooth. (FDA)Periodontal Route of Administration
PERIVENOUSC112396Administration into the area surrounding a vein. (NCI)Perivenous Route of Administration
RECTALC38295Administration to the rectum. (FDA)Rectal Route of Administration
RESPIRATORY (INHALATION)C38216Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect. (FDA)Inhalation Route of Administration
RETROBULBARC38296Administration behind the pons or behind the eyeball. (FDA)Retrobulbar Route of Administration
SOFT TISSUEC38198Administration into any soft tissue. (FDA)Soft Tissue Route of Administration
SUBARACHNOIDC38297Administration beneath the arachnoid. (FDA)Subarachnoid Route of Administration
SUBCONJUNCTIVALC38298Administration beneath the conjunctiva. (FDA)Subconjunctival Route of Administration
SUBCUTANEOUSC38299SC;Subdermal Route of AdministrationAdministration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL. (FDA)Subcutaneous Route of Administration
SUBLINGUALC38300Administration beneath the tongue. (FDA)Sublingual Route of Administration
SUBMUCOSALC38301Administration beneath the mucous membrane. (FDA)Submucosal Route of Administration
SUBTENONC94636Administration by injection through the membrane covering the muscles and nerves at the back of the eyeball.Subtenon Route of Administration
TOPICALC38304TOPAdministration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL. (FDA)Topical Route of Administration
TRANSDERMALC38305Administration through the dermal layer of the skin to the systemic circulation by diffusion. (FDA)Transdermal Route of Administration
TRANSMAMMARYC111326Administration by ingestion of colostrum or breast milk.Transmammary Route of Administration
TRANSMUCOSALC38283Administration across the mucosa. (FDA)Mucosal Route of Administration
TRANSPLACENTALC38307Administration through or across the placenta. (FDA)Transplacental Route of Administration
TRANSTRACHEALC38308Administration through the wall of the trachea. (FDA)Transtracheal Route of Administration
TRANSTYMPANICC38309Administration across or through the tympanic cavity. (FDA)Transtympanic Route of Administration
UNASSIGNEDC38310Route of administration has not yet been assigned. (FDA)Unassigned Route of Administration
UNKNOWNC38311Route of administration is unknown. (FDA)Unknown Route of Administration
URETERALC38312Administration into the ureter. (FDA)Ureteral Route of Administration
URETHRALC38271Administration into the urethra. (FDA)Intraurethral Route of Administration
VAGINALC38313Administration into the vagina. (FDA)Vaginal Route of Administration
Back to top
CL.C66734.DOMAINSDTM Domain Abbreviation
(DOMAIN)
text
Extensible: Yes
C66734SDTM Domain AbbreviationA unique, 2-character domain code used in the regulatory submission process. The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary)CDISC SDTM Submission Domain Abbreviation Terminology
ADC49563Analysis DatasetDatasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets.Analysis Dataset Domain
AEC49562Adverse EventsAdverse events may be captured either as free text or a pre-specified list of terms.Adverse Event Domain
AGC117755Procedure AgentsA domain for the agents administered to the subject as part of a procedure or assessment as opposed to drugs, medications and therapies administered with therapeutic intent.Procedure Agents Domain
AUC49565AutopsyAdditional data about deaths, specific to findings from autopsies.Autopsy Domain
AXC111282Non-Compliant ADaM DatasetsPrefix to indicate an analysis dataset that is not compliant with a defined ADaM structure.Non-Compliant ADaM Datasets Domain
BEC111138Biospecimen EventsAn events domain that documents biospecimen collection and storage information.Biospecimen Events Domain
BMC49566Bone MeasurementsFindings resulting from evaluations of bone mineral density.Bone Measurements Domain
BRC49567BiopsyFindings resulting from biopsies.Biopsy Domain
BSC111137BiospecimenA findings domain that documents biospecimen handling information.Biospecimen Domain
CEC85441Clinical EventsA dataset used to capture clinical events of interest that would not be classified as adverse events.Clinical Events Domain
CMC49568Concomitant MedsCase report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition.Concomitant Medication Domain
COC49569CommentsThe Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments.Comment Domain
CVC102605Cardiovascular System FindingsA domain for physiological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic vessels.Cardiovascular System Findings Domain
DAC49578Drug AccountabilityData regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.Drug Accountability Domain
DDC95087Death DiagnosisThis domain captures the diagnosis of the cause of death for a subject.Death Diagnosis Domain
DEC102616Device EventsA domain for device-related events.Device Events Domain
DIC102618Device IdentifiersA domain for the submission of information that identifies a specific device unit.Device Identifiers Domain
DMC49572DemographicsThe Demographics domain includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other observations for human clinical subjects.Demographics Domain
DOC102619Device PropertiesA domain for the characteristics of the device that do not vary over the course of the study.Device Properties Domain
DPC95088Developmental MilestoneThis domain captures the outcome of developmental milestone testing during a scheduled period of observation.Developmental Milestone Domain
DRC102620Device to Subject RelationshipA domain for the linkage of each subject to the device(s) to which they may have been exposed.Device to Subject Relationship Domain
DSC49576DispositionA subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)Disposition Domain
DTC102621Device Tracking and DispositionA domain for logistics and disposition information specific to a given device.Device Tracking and Disposition Domain
DUC102622Device-In-UseA domain for the findings for the values of measurements and settings that are intentionally set on a device when it is in use. These are characteristics that exist for the device, and have a specific setting for a use instance.Device-In-Use Domain
DVC49585Protocol DeviationsThe intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.Protocol Deviations Domain
DXC102617Device ExposureA domain for a subject's exposure to a medical device under study.Device Exposure Domain
EDC102630Endocrine System FindingsA domain for physiological findings related to the endocrine system, including the glands and cells that make hormones that are released directly into the blood and travel to tissues and organs all over the body.Endocrine System Findings Domain
EGC49626ElectrocardiogramFindings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.Electrocardiogram Domain
EXC49587ExposureThe Exposure domain model records the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.Exposure Domain
FAC85442Findings About Events or InterventionsA dataset used to capture the findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier.Findings About Events or Interventions Domain
FHC49588Family HistoryA subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI)Family History Domain
FTC117756Functional TestsA domain for named, stand-alone task-based evaluations designed to provide an assessment of mobility, dexterity, or cognitive ability.Functional Tests Domain
GIC102640Gastrointestinal System FindingsA domain for physiological findings related to the gastrointestinal system, including the esophagus, stomach, small and large intestine, anus, liver, biliary tract and pancreas.Gastrointestinal System Findings Domain
HMC102641Hematopoietic System FindingsA domain for physiological findings related to the hematopoietic system, including the bone marrow and lymph nodes involved in the production of blood.Hematopoietic System Findings Domain
HOC117757Healthcare EncountersA domain for inpatient and outpatient healthcare events.Healthcare Encounters Domain
HUC49589Healthcare Resource UtilizationHealthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays.Healthcare Resource Utilization Domain
IEC61536Inclusion/ExclusionThe intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.Inclusion Exclusion Domain
IGC102651Integumentary System FindingsA domain for physiological findings related to the integumentary system, including the epidermis, dermis, all of the derivatives of the epidermis, hairs, nails, sudoriferous and sebaceous glands, and mammary glands.Integumentary System Findings Domain
IMC102649Immune System FindingsA domain for physiological findings related to the immune system, including the thymus, spleen and tonsils.Immune System Findings Domain
ISC112320Immunogenicity Specimen AssessmentsA findings domain for assessments that determine whether a therapy induced an immune response.Immunogenicity Specimen Assessments Domain
LBC49592Laboratory DataLaboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.Laboratory Data Domain
MBC49602MicrobiologyMicrobiology specimen findings, including gram stain results, and organisms found.Microbiology Specimen Domain
MHC49603Medical HistoryThe medical history dataset includes the subject's prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.Medical History Domain
MIC95095Microscopic FindingsThe histopathology findings and microscopic evaluations recorded.Microscopic Findings Domain
MKC102674Musculoskeletal Findings, Connective and Soft Tissue FindingsA domain for physiological findings related to the system of muscles, tendons, ligaments, bones, joints and associated tissues.Musculoskeletal Findings, Connective and Soft Tissue Findings Domain
MLC49604Meal DataInformation regarding the subject's meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis.Meal Data Domain
MOC102671Morphology FindingsA domain relevant to the science of the form and structure of an organism or of its parts.Morphology Findings Domain
MSC61531Microbiology SusceptibilityThis includes microbiology susceptibility test results, plus results of any other organism-related tests.Microbiology Susceptibility Domain
NVC102677Nervous System FindingsA domain for physiological findings related to the nervous system, including the brain, spinal cord, the cranial and spinal nerves, autonomic ganglia and plexuses.Nervous System Findings Domain
PBC106552Pharmacogenomics BiomarkerA special-purpose domain that relates a set of genetic variations to an inference about the medical meaning of that set of genetic variations.Pharmacogenomics Biomarker Domain
PCC49606Pharmacokinetic ConcentrationConcentrations of drugs/metabolites in fluids or tissues as a function of time.Pharmacokinetic Concentration Domain
PEC49608Physical ExamFindings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.Physical Exam Domain
PFC111289Pharmacogenomics FindingsA findings domain for gene expression and genetic variation assessments.Pharmacogenomics Findings Domain
PGC61529Pharmacogenomics/Genetics Methods and Supporting InformationPharmacogenomics findings that initially focus on genotype and gene expression data.Pharmacogenomics Domain
PPC49607Pharmacokinetic ParametersPharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.Pharmacokinetic Parameters Domain
PRC102700ProcedureA domain relevant to an interventional activity that is intended to have diagnostic, preventive, therapeutic, or palliative effects.Procedure Domain
PSC111300Protocol Summary for PGxA special purpose domain that contains the protocol summary information for pharmacogenomics assessments.Protocol Summary for Pharmacogenomic Assessments Domain
PTC111290Pharmacogenomics Trial CharacteristicsA special purpose domain that contains design parameters used in performing pharmacogenomic assessments.Pharmacogenomics Trial Characteristics Domain
QSC49609QuestionnairesQuestionnaires are named, stand-alone instruments designed to provide an assessment of a concept. Questionnaires have a defined standard structure, format, and content; consist of conceptually related items that are typically scored; and have documented methods for administration and analysis. Most often, questionnaires have as their primary purpose the generation of a quantitative statistic to assess a qualitative concept.Questionnaire Domain
REC95098Respiratory System FindingsA domain for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs.Respiratory Domain
RPC102707Reproductive System FindingsA domain for physiological findings related to the male and female reproductive systems.Reproductive System Findings Domain
RSC107097Disease ResponseThe disease response (RS) domain represents disease response evaluations determined from collected data in the tumor results (TR) domain and/or other SDTM domains.Disease Response Domain
SBC106571Subject BiomarkerA special purpose domain that associates the subject with the medical conclusions contained in the pharmacogenomics biological state (PB) domain based on the observations reported in pharmacogenomics findings (PF) domain.Subject Biomarker Domain
SCC49610Subject CharacteristicsThe subject characteristics domain is for data not collected in other domains that is subject-related.Subject Characteristics Domain
SEC49616Subject ElementThe subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.Subject Element Domain
SGC49611SurgerySurgical information.Surgery Domain
SKC49612Skin TestFindings from diagnostic skin tests.Skin Test Domain
SLC49613Sleep Polysomnography DataFindings from diagnostic sleep tests (polysomnography).Sleep Polysomnography Domain
SRC112420Skin ResponseA findings about domain for submitting dermal responses to antigens.Skin Response Domain
SUC49615Substance UseThe intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.Substance Use Domain
SVC49617Subject VisitsThe subject visits table describes the actual start and end data/time for each visit of each individual subject.Subject Visits Domain
TAC49618Trial ArmsThe trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.Trial Arms Domain
TEC49619Trial ElementsThe trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element.Trial Elements Domain
TFC95100Tumor FindingsThis domain captures the tumor findings of the nonclinical subject.Tumor Findings Domain
TIC49620Trial Inclusion/Exclusion CriteriaThe trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial.Trial Inclusion and Exclusion Criteria Domain
TPC95101Trial PathsThe trial paths domain is not subject oriented. This domain provides the complete planned non-treatment related sequences of stages for each path in a study.Trial Paths Domain
TRC106578Tumor ResultsThis domain represents quantitative measurements and/or qualitative assessments of the tumors identified in the tumor identifier (TU) domain.Tumor Results Domain
TSC53483Trial SummaryThe trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic.Trial Summary Domain
TUC106577Tumor IdentifierThis domain represents data that uniquely identifies tumors.Tumor Identifier Domain
TVC49621Trial VisitsThe trial visits table describes the planned order and number of visits in the study within each arm.Trial Visits Domain
TXC95103Trial SetsThe trial stages domain is not subject oriented. It contains one record for each trial set characteristic including experimental factors, treatment factors, inherent characteristics, or distinct sponsor designations.Trial Sets Domain
URC102726Urinary System FindingsA domain for physiological findings related to the urinary tract, including the organs involved in the creation and excretion of urine such as the kidneys, ureters, bladder and urethra.Urinary System Findings Domain
VRC106581Viral Resistance FindingsA findings domain that contains information about virus drug-resistance.Viral Resistance Domain
VSC49622Vital SignsMeasurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.Vital Signs Domain
Back to top
CL.C116111.SPCIESSDTM Species
(SPCIES)
text
Extensible: Yes
C116111SDTM SpeciesTerminology relevant to the species of the pathogen to which the subject is a host when the pathogen is the focus of the test or interpretation.CDISC SDTM Species Terminology
ACINETOBACTER LWOFFIIC86095ACINETOBACTER CALCOACETICUS SUBSP. LWOFFIIAny bacterial organism that can be assigned to the species Acinetobacter lwoffii.Acinetobacter lwoffii
ACTINOBACILLUS PLEUROPNEUMONIAEC86101HAEMOPHILUS PLEUROPNEUMONIAEAny bacterial organism that can be assigned to the species Actinobacillus pleuropneumoniae.Actinobacillus pleuropneumoniae
BACILLUS ANTHRACISC86160Any bacterial organism that can be assigned to the species Bacillus anthracis.Bacillus anthracis
BARMAH FOREST VIRUSC112232Any viral organism that can be assigned to the species Barmah Forest virus.Barmah Forest Virus
BK POLYOMAVIRUSC89820BK VirusAny viral organism that can be assigned to the species BK polyomavirus.BK Virus
BORDETELLA PERTUSSISC76205Any bacterial organism that can be assigned to the species Bordetella pertussis.Bordetella pertussis
BUTTIAUXELLA AGRESTISC86229Any bacterial organism that can be assigned to the species Buttiauxella agrestis.Buttiauxella agrestis
CHLAMYDIA TRACHOMATISC86253Any bacterial organism that can be assigned to the species Chlamydia trachomatis.Chlamydia trachomatis
CHLAMYDOPHILA PNEUMONIAEC76272CHLAMYDIA PNEUMONIAEAny bacterial organism that can be assigned to the species Chlamydophila pneumoniae.Chlamydophila pneumoniae
CLOSTRIDIUM GLYCOLICUMC86280Any bacterial organism that can be assigned to the species Clostridium glycolicum.Clostridium glycolicum
CLOSTRIDIUM HISTOLYTICUMC86282Any bacterial organism that can be assigned to the species Clostridium histolyticum.Clostridium histolyticum
CLOSTRIDIUM NOVYIC86285Any bacterial organism that can be assigned to the species Clostridium novyi.Clostridium novyi
CLOSTRIDIUM TERTIUMC86297Any bacterial organism that can be assigned to the species Clostridium tertium.Clostridium tertium
COLORADO TICK FEVER VIRUSC112240CTFVAny viral organism that can be assigned to the species Colorado tick fever virus.Colorado Tick Fever Virus
CORYNEBACTERIUM AMYCOLATUMC86308Any bacterial organism that can be assigned to the species Corynebacterium amycolatum.Corynebacterium amycolatum
CORYNEBACTERIUM DIPHTHERIAEC86312Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae.Corynebacterium diphtheriae
CORYNEBACTERIUM MACGINLEYIC86315Any bacterial organism that can be assigned to the species Corynebacterium macginleyi.Corynebacterium macginleyi
CORYNEBACTERIUM UREALYTICUMC86325CDC GROUP D2;CORYNEBACTERIUM GROUP D-2Any bacterial organism that can be assigned to the species Corynebacterium urealyticum.Corynebacterium urealyticum
CORYNEBACTERIUM XEROSISC86326Any bacterial organism that can be assigned to the species Corynebacterium xerosis.Corynebacterium xerosis
COXIELLA BURNETIIC86328Any bacterial organism that can be assigned to the species Coxiella burnetii.Coxiella burnetii
DENGUE VIRUSC112036Any viral organism that can be assigned to the species Dengue virus.Dengue Virus
ECHOVIRUSC112272Any viral organism that can be assigned to the species Echovirus.Echovirus
ENTEROBACTER AEROGENESC86356AEROBACTER AEROGENESAny bacterial organism that can be assigned to the species Enterobacter aerogenes.Enterobacter aerogenes
ENTEROBACTER ASBURIAEC86358CDC ENTERIC GROUP 17Any bacterial organism that can be assigned to the species Enterobacter asburiae.Enterobacter asburiae
ESCHERICHIA COLIC14206E. COLIAny bacterial organism that can be assigned to the species Escherichia coli.Escherichia coli
ESCHERICHIA FERGUSONIIC86380CDC ENTERIC GROUP 10Any bacterial organism that can be assigned to the species Escherichia fergusonii.Escherichia fergusonii
ESCHERICHIA VULNERISC86382CDC ENTERIC GROUP 1Any bacterial organism that can be assigned to the species Escherichia vulneris.Escherichia vulneris
EWINGELLA AMERICANAC86391CDC ENTERIC GROUP 40Any bacterial organism that can be assigned to the species Ewingella americana.Ewingella americana
EXIGUOBACTERIUM ACETYLICUMC86886BREVIBACTERIUM ACETYLICUMAny bacterial organism that can be assigned to the species Exiguobacterium acetylicum.Exiguobacterium acetylicum
GORDONIA BRONCHIALISC86416GORDONA BRONCHIALIS;RHODOCOCCUS BRONCHIALISAny bacterial organism that can be assigned to the species Gordonia bronchialis.Gordonia bronchialis
GORDONIA SPUTIC86418GORDONA SPUTIAny bacterial organism that can be assigned to the species Gordonia sputi.Gordonia sputi
HAEMOPHILUS AEGYPTIUSC86428Any bacterial organism that can be assigned to the species Haemophilus aegyptius.Haemophilus aegyptius
HAEMOPHILUS INFLUENZAEC86431H-FLUAny bacterial organism that can be assigned to the species Haemophilus influenzae.Haemophilus influenzae
HENDRA VIRUSC112289Any viral organism that can be assigned to the species Hendra virus.Hendra Virus
HEPATITIS A VIRUSC14325HAVAny viral organism that can be assigned to the species Hepatitis A virus.Hepatitis A Virus
HEPATITIS B VIRUSC14215HBVAny viral organism that can be assigned to the species Hepatitis B virus.Hepatitis B Virus
HEPATITIS C VIRUSC14312HCVAny viral organism that can be assigned to the species Hepatitis C virus.Hepatitis C Virus
HEPATITIS D VIRUSC93324HDVAny viral organism that can be assigned to the species Hepatitis D virus.Hepatitis D Virus
HEPATITIS E VIRUSC14295HEVAny viral organism that can be assigned to the species Hepatitis E virus.Hepatitis E Virus
HUMAN HERPESVIRUS 1C14311HHV-1;HSV-1;Herpes Simplex Virus type 1Any viral organism that can be assigned to the species Human Herpesvirus 1 within the genus Simplexvirus.Human Herpesvirus 1
HUMAN HERPESVIRUS 2C112313HHV-2;HSV-2;Herpes Simplex Virus type 2Any viral organism that can be assigned to the species Human Herpesvirus 2 within the genus Simplexvirus.Human Herpesvirus 2
HUMAN HERPESVIRUS 3C71091HHV-3;VZV;Varicella Zoster VirusAny viral organism that can be assigned to the species Human Herpesvirus 3.Varicella Zoster Virus
HUMAN HERPESVIRUS 4C14204EBV;Epstein-Barr Virus;HHV-4Any viral organism that can be assigned to the species Human Herpesvirus 4.Epstein-Barr Virus
HUMAN HERPESVIRUS 5C112314HCMV;HHV-5;Human CytomegalovirusAny viral organism that can be assigned to the species Human Herpesvirus 5.Human Herpesvirus 5
HUMAN HERPESVIRUS 6C14218HHV-6Any viral organism that can be assigned to the species Human Herpesvirus 6.Human Herpesvirus 6
HUMAN HERPESVIRUS 7C112315HHV-7Any viral organism that can be assigned to the species Human Herpesvirus 7.Human Herpesvirus 7
HUMAN HERPESVIRUS 8C14327HHV-8;KSHV;Kaposi's sarcoma-associated herpesvirusAny viral organism that can be assigned to the species Human herpesvirus 8.Human Herpesvirus 8
HUMAN IMMUNODEFICIENCY VIRUS 1C14220HIV-1;LAV-1Any viral organism that can be assigned to the species Human Immunodeficiency virus 1.Human Immunodeficiency Virus 1
HUMAN IMMUNODEFICIENCY VIRUS 2C14221HIV-2;LAV-2Any viral organism that can be assigned to the species Human Immunodeficiency virus 2.Human Immunodeficiency Virus 2
HUMAN PARVOVIRUS B19C89772B19 Virus;Human Erythrovirus B19;Parvovirus B19Any viral organism that can be assigned to the species Human Parvovirus B19.Parvovirus B19
HUMAN RESPIRATORY SYNCYTIAL VIRUSC14267Human RSV;RSV;hRSVAny viral organism that can be assigned to the species Human Respiratory Syncitial virus.Human Respiratory Syncytial Virus
INFLUENZA A VIRUSC53454FLUAV;Influenza Virus Type AAny viral organism that can be assigned to the species Influenza A virus.Influenza A Virus
INFLUENZA B VIRUSC53468FLUBV;Influenza Virus Type BAny viral organism that can be assigned to the species Influenza B virus.Influenza B Virus
INFLUENZA C VIRUSC97157FLUCV;Influenza Virus Type CAny viral organism that can be assigned to the species Influenza C virus.Influenza C Virus
JC VIRUSC14229Human polyomavirus (type JC);Polyomavirus hominis 2;polyomavirus JCAny viral organism that can be assigned to the species JC polyomavirus.JC Virus
KLEBSIELLA OZAENAEC86456KLEBSIELLA PNEUMONIAE SUBSP. OZAENAEAny bacterial organism that can be assigned to the species Klebsiella ozaenae.Klebsiella ozaenae
KLEBSIELLA PNEUMONIAEC86457K. PNEUMONIAEAny bacterial organism that can be assigned to the species Klebsiella pneumoniae.Klebsiella pneumoniae
KLEBSIELLA RHINOSCLEROMATISC86458KLEBSIELLA PNEUMONIAE SUBSP. RHINOSCLEROMATISAny bacterial organism that can be assigned to the species Klebsiella rhinoscleromatis.Klebsiella rhinoscleromatis
KLEBSIELLA SINGAPORENSISC86459Any bacterial organism that can be assigned to the species Klebsiella singaporensis.Klebsiella singaporensis
KLEBSIELLA VARIICOLAC86460Any bacterial organism that can be assigned to the species Klebsiella variicola.Klebsiella variicola
KLUYVERA ASCORBATAC86462CDC ENTERIC GROUP 8Any bacterial organism that can be assigned to the species Kluyvera ascorbata.Kluyvera ascorbata
KLUYVERA CRYOCRESCENSC86463Any bacterial organism that can be assigned to the species Kluyvera cryocrescens.Kluyvera cryocrescens
KOCURIA KRISTINAEC86468MICROCOCCUS KRISTINAEAny bacterial organism that can be assigned to the species Kocuria kristinae.Kocuria kristinae
KOCURIA RHIZOPHILAC86513MICROCOCCUS LUTEUS;SARCINA LUTEAAny bacterial organism that can be assigned to the species Kocuria rhizophila.Micrococcus luteus
KOCURIA ROSEAC86469Any bacterial organism that can be assigned to the species Kocuria rosea.Kocuria rosea
KOCURIA VARIANSC86470Any bacterial organism that can be assigned to the species Kocuria varians.Kocuria varians
LEGIONELLA PNEUMOPHILAC86489Any bacterial organism that can be assigned to the species Legionella pneumophila.Legionella pneumophila
MANNHEIMIA HAEMOLYTICAC86508PASTEURELLA HAEMOLYTICAAny bacterial organism that can be assigned to the species Mannheimia haemolytica.Mannheimia haemolytica
MEASLES VIRUSC14237Rubeola Virus;SSPEV;rougeole virus;subacute sclerosing panencephalitis virusAny viral organism that can be assigned to the species Measles virus.Measles Virus
MEGASPHAERA ELSDENIIC86896PEPTOSTREPTOCOCCUS ELSDENIIAny bacterial organism that can be assigned to the species Megasphaera elsdenii.Megasphaera elsdenii
METHYLOBACTERIUM MESOPHILICUMC86510PSEUDOMONAS MESOPHILICAAny bacterial organism that can be assigned to the species Methylobacterium mesophilicum.Methylobacterium mesophilicum
MICROBACTERIUM PARAOXYDANSC86512Any bacterial organism that can be assigned to the species Microbacterium paraoxydans.Microbacterium paraoxydans
MICROCOCCUS LYLAEC86514Any bacterial organism that can be assigned to the species Micrococcus lylae.Micrococcus lylae
MITSUOKELLA MULTACIDAC86516Any bacterial organism that can be assigned to the species Mitsuokella multacida.Mitsuokella multacida
MOLLUSCUM CONTAGIOSUM VIRUSC112357MCV;MOCVAny viral organism that can be assigned to the species Molluscum contagiosum virus.Molluscum Contagiosum Virus
MORAXELLA BOVISC86524Any bacterial organism that can be assigned to the species Moraxella bovis.Moraxella bovis
MORAXELLA CATARRHALISC76210BRANHAMELLA CATARRHALISAny bacterial organism that can be assigned to the species Moraxella catarrhalis.Moraxella catarrhalis
MORAXELLA LACUNATAC86526MORAXELLA LIQUEFACIENSAny bacterial organism that can be assigned to the species Moraxella lacunata.Moraxella lacunata
MYCOBACTERIUM FORTUITUMC86538Any bacterial organism that can be assigned to the species Mycobacterium fortuitum.Mycobacterium fortuitum
MYCOBACTERIUM PEREGRINUMC86546Any bacterial organism that can be assigned to the species Mycobacterium peregrinum.Mycobacterium peregrinum
MYCOBACTERIUM SMEGMATISC86590Any bacterial organism that can be assigned to the species Mycobacterium smegmatis.Mycobacterium smegmatis
MYCOPLASMA PNEUMONIAEC86599Any bacterial organism that can be assigned to the species Mycoplasma pneumoniae.Mycoplasma pneumoniae
MYROIDES ODORATUSC86954FLAVOBACTERIUM ODORATUMAny bacterial organism that can be assigned to the species Myroides odoratus.Myroides odoratus
NEISSERIA GONORRHOEAEC86603Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae.Neisseria gonorrhoeae
NEWCASTLE DISEASE VIRUSC93023Avian Paramyxovirus Type 1;NDVAny viral organism that can be assigned to the species Newcastle disease virus.Newcastle Disease Virus
NIPAH VIRUSC112359NiVAny viral organism that can be assigned to the species Nipah virus.Nipah Virus
NORWALK VIRUSC112363NV;Norwalk calicivirusAny viral organism that can be assigned to the species Norwalk virus.Norwalk Virus
POLIOVIRUSC14259Enterovirus C;Human enterovirus CAny viral organism that can be assigned to the species Poliovirus.Poliovirus
PROTEUS MIRABILISC86019Any bacterial organism that can be assigned to the species Proteus mirabilis.Proteus mirabilis
PROTEUS PENNERIC86688INDOLE NEGATIVE PROTEUS VULGARISAny bacterial organism that can be assigned to the species Proteus penneri.Proteus penneri
PSEUDOCOWPOX VIRUSC112401Paravaccinia virus;PseudocowpoxvirusAny viral organism that can be assigned to the species Pseudocowpox virus.Pseudocowpox Virus
PSEUDOMONAS AERUGINOSAC86696Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa.Pseudomonas aeruginosa
RABIES VIRUSC112405Any viral organism that can be assigned to the species Rabies virus.Rabies Virus
RHINOVIRUS AC112407Human Rhinovirus AAny viral organism that can be assigned to the species Rhinovirus A.Rhinovirus A
RHINOVIRUS BC112408Human Rhinovirus BAny viral organism that can be assigned to the species Rhinovirus B.Rhinovirus B
RHINOVIRUS CC112409Human Rhinovirus CAny viral organism that can be assigned to the species Rhinovirus C.Rhinovirus C
ROSS RIVER VIRUSC112411RRVAny viral organism that can be assigned to the species Ross River virus.Ross River Virus
RUBELLA VIRUSC77198German Measles VirusAny viral organism that can be assigned to the species Rubella virus.Rubella Virus
SAPPORO VIRUSC112415Human calicivirus SLV;Human calicivirus Sapporo-like VirusAny viral organism that can be assigned to the species Sapporo virus.Sapporo Virus
SARS CORONAVIRUSC112432HCoV-SARS;SARS;Severe Acute Respiratory Syndrome CoronavirusAny viral organism that can be assigned to the species SARS coronavirus.SARS Coronavirus
SERRATIA PLYMUTHICAC86740Any bacterial organism that can be assigned to the species Serratia plymuthica.Serratia plymuthica
STAPHYLOCOCCUS AUREUSC50921STAPH. AUREUSAny bacterial organism that can be assigned to the species Staphylococcus aureus.Staphylococcus aureus
STAPHYLOCOCCUS CAPITISC86752Any bacterial organism that can be assigned to the species Staphylococcus capitis.Staphylococcus capitis
STAPHYLOCOCCUS COHNIIC86756Any bacterial organism that can be assigned to the species Staphylococcus cohnii.Staphylococcus cohnii
STREPTOCOCCUS PNEUMONIAEC76384DIPLOCOCCUS PNEUMONIAEAny bacterial organism that can be assigned to the species Streptococcus pneumoniae.Streptococcus pneumoniae
SUTTONELLA INDOLOGENESC86816KINGELLA INDOLOGENESAny bacterial organism that can be assigned to the species Suttonella indologenes.Suttonella indologenes
TATLOCKIA MICDADEIC86817LEGIONELLA MICDADEIAny bacterial organism that can be assigned to the species Legionella micdadei.Tatlockia micdadei
TICK-BORNE ENCEPHALITIS VIRUSC112422FSME virus;TBEVAny viral organism that can be assigned to the species Tick-borne encephalitis virus.Tick-Borne Encephalitis Virus
VACCINIA VIRUSC14281VVAny viral organism that can be assigned to the species Vaccinia virus.Vaccinia Virus
VARIOLA VIRUSC96527Smallpox Virus;Variola Virus VARAny viral organism that can be assigned to the species Variola virus.Variola Virus
VIBRIO ALGINOLYTICUSC86840Any bacterial organism that can be assigned to the species Vibrio alginolyticus.Vibrio alginolyticus
VIBRIO PARAHAEMOLYTICUSC86846Any bacterial organism that can be assigned to the species Vibrio parahaemolyticus.Vibrio parahaemolyticus
VIBRIO VULNIFICUSC86847BENECKEA VULNIFICAAny bacterial organism that can be assigned to the species Vibrio vulnificus.Vibrio vulnificus
WEST NILE VIRUSC71877WNVAny viral organism that can be assigned to the species West Nile virus.West Nile Virus
YELLOW FEVER VIRUSC97156Flavivirus febricis;YFVAny viral organism that can be assigned to the species Yellow fever virus.Yellow Fever Virus
YERSINIA PESTISC86860PASTEURELLA PESTISAny bacterial organism that can be assigned to the species Yersinia pestis.Yersinia pestis
Back to top
CL.C66769.AESEVSeverity/Intensity Scale for Adverse Events
(AESEV)
text
Extensible: No
C66769Severity/Intensity Scale for Adverse EventsA scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)CDISC SDTM Severity Intensity Scale for Adverse Event Terminology
MILDC413381;Grade 1A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.Mild Adverse Event
MODERATEC413392;Grade 2A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.Moderate Adverse Event
SEVEREC413403;Grade 3A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention.Severe Adverse Event
Back to top
CL.C66731.SEXSex
(SEX)
text
Extensible: No
C66731SexThe assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI)CDISC SDTM Sex of Individual Terminology
FC16576FemaleA person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)Female
MC20197MaleA person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)Male
UC17998U;UnknownNot known, not observed, not recorded, or refused. (NCI)Unknown
UNDIFFERENTIATEDC45908A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)Intersex
Back to top
CL.C66732.SEXPOPSex of Participants
(SEXPOP)
text
Extensible: No
C66732Sex of ParticipantsThe specific sex, either male, female, or mixed of the subject group being studied. (NCI)CDISC SDTM Sex of Study Group Terminology
BOTHC49636One and the other; relating to or being two in conjunction. (NCI)Both
FC16576FemaleA person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)Female
MC20197MaleA person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)Male
Back to top
CL.C66733.SIZESize
(SIZE)
text
Extensible: Yes
C66733SizeThe physical magnitude of something. (NCI)CDISC SDTM Size Terminology
LARGEC49508Of considerable or relatively great size, extent, or capacity. (NCI)Large
MEDIUMC49507Mid-way between small and large in number, quantity, magnitude or extent. (NCI)Medium
SMALLC25376Limited in number, quantity, magnitude or extent. (NCI)Small
Back to top
CL.C76351.SKINCLASSkin Classification
(SKINCLAS)
text
Extensible: Yes
C76351Skin ClassificationA classification system used to categorize the sensitivity of a subject's skin to sunlight.CDISC Skin Classification Terminology
TYPEIC74569TYPE1Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lightly complected blondes. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871)Fitzpatrick Skin Type I
TYPEIIC74570TYPE2Individuals who frequently burn but are able to tan to a small degree after extended sun exposure. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871)Fitzpatrick Skin Type II
TYPEIIIC74571TYPE3Individuals who burn infrequently and tan readily. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871)Fitzpatrick Skin Type III
TYPEIVC74572TYPE4Individuals who rarely burn and tan heavily with moderate sun exposures, especially individuals of Asian, American Indian, Mediterranean and Latin American descent. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871)Fitzpatrick Skin Type IV
TYPEVC74573TYPE5Individuals who have dark constitutive pigmentation but become noticeably darker with sun exposure, especially light complected black individuals, those of Indian descent. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871)Fitzpatrick Skin Type V
TYPEVIC74574TYPE6Individuals who have the heaviest constitutive pigmentation, especially dark skinned black individuals. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871)Fitzpatrick Skin Type VI
Back to top
CL.C112024.SRTESTCDSkin Response Test Code
(SRTESTCD)
text
Extensible: Yes
C112024Skin Response Test CodeA terminology codelist based on the test codes for dermal responses to antigens.CDISC SDTM Skin Response Test Code Terminology
ASRINDEXC112221Allergen Skin Response IndexA relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test.Allergen Skin Response Index
ASRINTC112222Allergen Skin Response IntensityA semi-quantitative assessment of the intensity of the wheal and flare reaction.Allergen Skin Response Intensity
FLARESZC112283Flare SizeThe size of the area of redness that forms around the site of an antigenic challenge to the skin.Flare Size
FLRLDIAMC112281Flare Longest DiameterThe longest diameter of the area of redness that forms around the site of an antigenic challenge to the skin.Flare Longest Diameter
FLRMDIAMC112282Flare Mean DiameterThe mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin.Flare Mean Diameter
WHEALSZC112429Wheal SizeA semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.Wheal Size
WHLLDIAMC112427Wheal Longest DiameterThe longest diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.Wheal Longest Diameter
WHLMDIAMC112428Wheal Mean DiameterThe mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.Wheal Mean Diameter
Back to top
CL.C112023.SRTESTSkin Response Test Name
(SRTEST)
text
Extensible: Yes
C112023Skin Response Test NameA terminology codelist based on the test names for dermal responses to antigens.CDISC SDTM Skin Response Test Name Terminology
Allergen Skin Response IndexC112221Allergen Skin Response IndexA relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test.Allergen Skin Response Index
Allergen Skin Response IntensityC112222Allergen Skin Response IntensityA semi-quantitative assessment of the intensity of the wheal and flare reaction.Allergen Skin Response Intensity
Flare Longest DiameterC112281Flare Longest DiameterThe longest diameter of the area of redness that forms around the site of an antigenic challenge to the skin.Flare Longest Diameter
Flare Mean DiameterC112282Flare Mean DiameterThe mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin.Flare Mean Diameter
Flare SizeC112283Flare SizeThe size of the area of redness that forms around the site of an antigenic challenge to the skin.Flare Size
Wheal Longest DiameterC112427Wheal Longest DiameterThe longest diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.Wheal Longest Diameter
Wheal Mean DiameterC112428Wheal Mean DiameterThe mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.Wheal Mean Diameter
Wheal SizeC112429Wheal SizeA semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin.Wheal Size
Back to top
CL.C74561.SKINTYPSkin Type
(SKINTYP)
text
Extensible: Yes
C74561Skin TypeA distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands.CDISC SDTM Skin Type Terminology
DRYC74592The pores are generally fine with a papery thin texture that feels dry to the touch. Usually flaky and dull looking.Dry Skin
NORMALC74593The pores are visible but not large. The texture is neither fine or thick and it neither feels dry or oily to the touch.Normal Skin
OILYC74591The pores of the skin are generally large and visible with a coarse or thick texture. It has a tendency to look dull and greasy and feels oily to the touch.Oily Skin
Back to top
CL.C102587.RISKSOCSocial Risk Factor
(RISKSOC)
text
Extensible: Yes
C102587Social Risk FactorTerminology relevant to the social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease.CDISC SDTM Social Risk Factor Terminology
CONTACT WITH TUBERCULOSIS SOURCEC102714An individual that came into contact with a source of Tuberculosis.Subject in Contact With Tuberculosis Source
CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN HOMELESS SHELTERC102613An individual who is presently or not long ago worked or offered to assist without pay at a temporary housing facility for persons without a stable or permanent residence.Current or Recent Employee or Volunteer in Homeless Shelter
CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN JAIL OR PRISONC102614An individual who is presently or not long ago worked or offered to assist without pay at an institution where persons are confined for punishment and to protect the public.Current or Recent Employee or Volunteer in Jail or Prison
CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN NURSING HOMEC102615An individual who is presently or not long ago worked or offered to assist without pay at a residential health care facility for persons with chronic illness or disability.Current or Recent Employee or Volunteer in Nursing Home
HOMELESS DURING PAST YEARC102645An individual without a stable or permanent residence within the last 365 days.Homeless During Past Year
IMMIGRANT FROM HIGH TUBERCULOSIS PREVALENT AREAC102648An individual that has migrated from a country with a high occurrence of tuberculosis.Immigrant From High Tuberculosis Prevalent Area
INCARCERATIONC85521The state of being confined to jail or prison.Incarceration
LIVED IN REFUGEE CAMPC102657An individual that resided in a camp for those displaced from their homeland.Lived in Refugee Camp
LONG-TERM FACILITY RESIDENTC102660An individual that lives at a healthcare facility that provides rehabilitative, restorative, and/or ongoing skilled nursing care to patients or residents in need of assistance with activities of daily living.Long-term Facility Resident
MIGRATORY WORKERC102670An individual who moves from one location to another location within or outside of their homeland for work.Migratory Worker
REFUGEE FROM HIGH TUBERCULOSIS PREVALENT AREAC102705An individual that has fled a country for their own safety which has a high occurrence of tuberculosis.Refugee From High Tuberculosis Prevalent Area
TRAVEL TO HIGH BURDEN COUNTRYC102719Entry into one or more of the 22 countries that have a relatively high prevalence of tuberculosis cases.Travel To High Burden Tuberculosis Country
UNEMPLOYMENTC75563The state of not having a job.Unemployment
Back to top
CL.C78733.SPECCONDSpecimen Condition
(SPECCOND)
text
Extensible: Yes
C78733Specimen ConditionThe physical state or quality of a biological specimen.CDISC SDTM Specimen Condition Terminology
AUTOLIZEDC78725Autolized SpecimenA specimen that has undergone autolysis, or self-digestion by the specimen's own digestive enzymes. (NCI)Autolized Specimen
CALCIFIEDC78723Calcified SpecimenA specimen that has undergone calcification. (NCI)Calcified Specimen
CLOTTEDC78724Clotted SpecimenA specimen that has become coagulated. (NCI)Clotted Specimen
CONTAMINATEDC68768The presence of any substance or organism that makes a preparation impure. (NCI)Contamination
DRIEDC84516Dried SpecimenA specimen that has become dessicated or dehydrated.Dried Specimen
FRESHC84517Fresh SpecimenA specimen that is analyzed in the state that it was collected.Fresh Specimen
FROZENC70717Frozen SpecimenA specimen that has been subjected to and immobilized by severe cold. (NCI)Frozen Specimen
HEMOLYZEDC70720Hemolysis in SpecimenA specimen that has undergone the destruction of red blood cells followed by the release of the hemoglobin. (NCI)Hemolysis in Specimen
ICTERICC98744Icteric SpecimenA specimen that exhibits a yellowish pigmentation due to jaundice. (NCI)Icteric Specimen
LIPEMICC70715Lipemic SpecimenA specimen that consists of or contains excessive amounts of fat and fatty substances. (NCI)Lipemic Specimen
PARAFFIN-EMBEDDEDC19597Paraffin Block;Paraffin-Embedded SpecimenA specimen that has been fixed and preserved in paraffin.Paraffin Embedded Tissue
REFRIGERATEDC70718Refrigerated SpecimenA specimen that has been kept or preserved at a low temperature in a refrigerator. (NCI)Refrigerated Specimen
ROOM TEMPERATUREC70719Ambient Temperature;Specimen at Room TemperatureA specimen that has been subjected to and adjusted to the average ambient temperature of a room, usually considered to be around 20 degrees C (68 degrees F). (NCI)Specimen at Room Temperature
Back to top
CL.C78734.SPECTYPESpecimen Type
(SPECTYPE)
text
Extensible: Yes
C78734Specimen TypeThe name and description of a biological specimen.CDISC SDTM Specimen Type Terminology
ADIPOSE TISSUEC12472Adipose Tissue;Body Fat;Fat TissueA specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers. (NCI)Adipose Tissue
AMNIOTIC FLUIDC13188Aqua AmniiThe fluid within the amniotic cavity which surrounds and protects the developing embryo. (NCI)Amniotic Fluid
AQUEOUS HUMORC13190Aqueous HumourThe watery fluid which is present in the anterior and posterior chambers of the eye. (NCI)Aqueous Humor
ARTERIAL BLOODC78729Oxygenated blood which is transported with nutrients to body tissues through the arterial system. The exception is blood within the pulmonary artery which carries deoxygenated blood to the lungs. (NCI)Arterial Blood
ATHEROSCLEROTIC PLAQUEC78739Fatty tissue which is deposited in the inner lining of the arterial wall. (NCI)Atherosclerotic Plaque
BILEC13192Fluid composed of waste products, bile acids, salts, cholesterol, and electrolytes. It is secreted by the liver parenchyma and stored in the gallbladder. (NCI)Bile
BLOODC12434Blood;Peripheral BloodA liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.Blood
BONEC12366BoneCalcified connective tissue that forms the skeletal components of the body. (NCI)Bone
BONE MARROWC12431Bone MarrowThe tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. (NCI)Bone Marrow
BREAST MILKC13257Milk produced by females for the purpose of feeding their young. (NCI)Breast Milk
BUFFY COATC84507The middle fraction of an anticoagulated blood specimen following separation by centrifugation. It contains most of the white blood cells and platelets.Buffy Coat
CALCULUSC35708Accumulated material from the secretions of an organ. It is solid and representative examples include gallbladder stones, kidney stones, and salivary gland stones. (NCI)Stone
CAPILLARY BLOODC112235A mixture of arterial blood, venous blood and interstitial fluid, which is found in the capillaries.Capillary Blood
CARDIAC MUSCLE TISSUEC12371MyocardiumThe striated muscle tissue of the heart enveloped by the epicardium and the endocardium. (NCI)Myocardium
CEREBROSPINAL FLUIDC12692CSFThe fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (NCI)Cerebrospinal Fluid
CERUMENC32293A wax secreted by glands in the ear canal.Cerumen
CIRCULATING TUMOR CELLC63797CTCA metastatic cancer cell found in the peripheral blood. (NCI)Circulating Tumor Cell
COLOSTRUMC32348A thick, protein-rich substance secreted by the breasts during the second half of pregnancy and for a few days after birth before the breast milk comes in.Human Colostrum
CORD BLOODC13300Umbilical Cord BloodBlood present in the umbilical vessels at the time of delivery.Umbilical Cord Blood
CORD SERUMC119550The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins from the cord blood of a newborn baby.Umbilical Cord Serum
DIALYSIS FLUIDC106515DialysateThe fluid which runs through a dialysis machine and captures, for discard or analysis, the excess water and waste from the blood stream through diffusion and ultrafiltration. (NCI)Dialysis Fluid
EMESISC77666Emesis;VomitStomach contents that have returned to the mouth or are ejected beyond the mouth. (NCI)Vomitus
ERYTHROCYTESC12521RBC;Red Blood CellsCell specialized for oxygen transport, having a high concentration of hemoglobin in the cytoplasm and little else; biconcave, anucleate discs, 7nm diameter in mammals.Erythrocyte
EXPIRED AIRC78741The air that moves out of the chest during expiration. It contains a higher percentage of carbon dioxide and a lower percentage of oxygen compared to the inhaled air. (NCI)Expired Air
EXUDATEC13233Fluid, cells or cellular debris that escapes from the blood vessels and accumulates in nearby tissues. It is the result of inflammation and is rich in proteins.Exudate
FLUIDC13236Liquid substances produced by the body.Body Fluid or Substance
GASTRIC CONTENTSC77614Digestive Contents;IngestaThe contents of the stomach that may include undigested food mixed with juices secreted by the gastric mucosal glands. (NCI)Gastric Content
HAIRC32705HairThe filamentous outgrowth of the epidermis. (NCI)Hair
HAIR FOLLICLEC13317A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (NCI)Hair Follicle
INFRANATANT, PLASMAC106554The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a plasma sample. (NCI)Plasma Infranatant
INFRANATANT, PLEURAL FLUIDC106558The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a pleural fluid sample. (NCI)Pleural Fluid Infranatant
INFRANATANT, SERUMC106565The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a serum sample. (NCI)Serum Infranatant
ISOLATEC53471Microbial IsolateA specific individual microbe and its genetically identical progeny separated on a single occasion from a sample taken from a host or culture system.Isolate
LAVAGE FLUIDC103411Fluid introduced into, and collected from, a body cavity by lavage procedure. (NCI)Lavage Fluid
LOCHIAC78742Vaginal discharge occurring during the post-partum period. It consists of a mixture of blood, mucus, and placental remnants. (NCI)Lochia
LUNG SURFACTANTC13273SurfactantPulmonary surfactant lines the lung epithelium and lowers surface tension to prevent collapse at end-expiration. Deficiency of pulmonary surfactant results in respiratory distress syndrome (RDS) in premature infants. Lung surfactant is synthesized in alveolar type II cells, stored in lamellar bodies and secreted via exocytosis. (NCI)Lung Surfactant
LYMPHC13252A clear, transparent, sometimes faintly yellow and slightly opalescent fluid that is collected from the tissues throughout the body, flows in the lymphatic vessels (through the lymph nodes), and is eventually added to the venous blood circulation. Lymph consists of a clear liquid portion, varying numbers of white blood cells (chiefly lymphocytes), and a few red blood cells. (NCI)Lymph
LYSATEC62004The cellular debris and fluid produced by lysis of cells.Lysate
MECONIUMC78743The newborn's first intestinal discharge. It is a dark-green, thick substance composed of mucus, intestinal secretions, hair, and intestinal mucosa cells. (NCI)Meconium
MENSTRUAL BLOODC78740The discharged blood from the uterus during the reproductive years. The discharge occurs approximately once a month. (NCI)Menstrual Blood
MUCUSC13259The thick fluid secreted by the mucus glands in the aerodigestive tract and the vagina. (NCI)Mucus
NAILC33156NailThe cutaneous plate on the dorsal surface of the distal end of a finger or toe. (NCI)Nail
PERIPHERAL BLOOD MONONUCLEAR CELLC12954PBMCA peripheral blood cell with a single nucleus, for example lymphocytes and monocytes.Peripheral Blood Mononuclear Cell
PERSPIRATIONC13280SweatThe liquid secreted by the sweat glands. (NCI)Sweat
PLASMAC13356Plasma is the fluid (acellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.Plasma
PLATELETC12520ThrombocyteAn irregular, disc-shaped structure in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes. (NCI)Platelet
PLATELET POOR PLASMAC106556PPPA plasma sample that is prepared from whole blood, which has undergone a number of centrifugation steps to decrease the amount of platelets. (NCI)Platelet-poor Plasma
PLATELET RICH PLASMAC106557PRPA plasma sample that is prepared from whole blood, which has undergone a number of centrifugation steps to concentrate the amount of platelets. (NCI)Platelet-rich Plasma
PLEURAL FLUIDC77613Pleural FluidThe fluid that is abnormally collected in the pleural cavity. (NCI)Pleural Fluid
PROSTATIC FLUIDC100896A slightly alkaline, white fluid secreted from the prostate and is a constituent of semen.Prostatic Fluid
PUSC50718A yellowish substance produced during bacterial inflammation. It contains necrotic cells and cells fighting the infection. (NCI)Pus
SALIVAC13275A clear liquid secreted into the mouth by the salivary glands and mucous glands of the mouth; moistens the mouth and starts the digestion of starches. (NCI)Saliva
SEBUMC13276A thick, oily substance produced by the sebaceous glands located in the dermis. (NCI)Sebum
SEMENC13277Seminal PlasmaThe thick, whitish secretion of the male reproductive organs. It is composed of spermatozoa in their nutrient plasma, secretions from the prostate, seminal vesicles, and various other glands, epithelial cells, and minor constituents. (NCI)Semen
SEMINAL FLUIDC33529Part of the ejaculated fluid. It contains secretions from the seminal vesicles, Cowper gland, and prostate gland.Seminal Fluid
SERUMC13325SeraThe clear portion of the blood that remains after the removal of the blood cells and the clotting proteins. (NCI)Serum
SKELETAL MUSCLE TISSUEC13050Skeletal Muscle TissueStriated muscles that are under voluntary control of the organism. They are connected at either or both ends to a bone and are utilized for locomotion and other movements. (NCI)Skeletal Muscle Tissue
SMEGMAC33574A white secretion of the sebaceous glands of the foreskin. (NCI)Smegma
SMOOTH MUSCLE TISSUEC12437Involuntary muscle tissue of the internal organs. It is composed of elongated muscle cells or fibers that are not arranged in a striated pattern and form layers of muscle tissue. The smooth muscle cells contain a contractile apparatus composed of thin and thick filaments and a cytoskeleton composed of intermediate filaments. (NCI)Smooth Muscle Tissue
SOFT TISSUEC12471Soft TissueRefers to muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body.Soft Tissue
SPUTUMC13278Material containing mucus, cellular debris, microorganisms and sometimes blood or pus. It is ejected through the mouth from the lungs, bronchi, and trachea. (NCI)Sputum
STOOLC13234FecesThe material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria. (NCI)Feces
STRIATED MUSCLE TISSUEC12436Striated muscles are appendicular and axial muscles typically connected at either or both ends to the bony skeleton of the body. Striated muscle fibers contain a highly organized, contractile cytoskeletal apparatus with a striated microscopic appearance; muscle contraction is typically under voluntary control. (NCI)Striated Muscle Tissue
SUPERNATANT, PLASMAC106555The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a plasma sample. (NCI)Plasma Supernatant
SUPERNATANT, PLEURAL FLUIDC106559The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a pleural fluid sample. (NCI)Pleural Fluid Supernatant
SUPERNATANT, SERUMC106566The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a serum sample. (NCI)Serum Supernatant
SYNOVIAL FLUIDC33718Synovia;Synovial FluidA viscid fluid secreted by the synovial membrane, serving as a lubricant. (NCI)Synovial Fluid
TISSUEC12801An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function. (NCI)Tissue
TRANSUDATEC78744The fluid that passes through the wall of the veins and capillaries to the surrounding tissues because of increased intravascular pressure. It has low protein content. (NCI)Transudate
TUMOR TISSUEC18009A tumor sample, or entire tumor that is removed for examination.Tumor Tissue
URINEC13283The fluid that is excreted by the kidneys. It is stored in the bladder and discharged through the urethra. (NCI)Urine
VENOUS BLOODC78730Deoxygenated blood containing urea and other waste products which is transported through the venous system to the heart and lungs. The exception is blood within the pulmonary vein which is oxygenated and travels from the lungs to the left atrium of the heart. (NCI)Venous Blood
VITREOUS HUMORC13323The clear colorless transparent jelly that fills the posterior chamber of the eyeball. (NCI)Vitreous Humor
Back to top
CL.C119020.STCARCRSStent Thrombosis, Coronary ARC Grade Responses
(STCARCRS)
text
Extensible: No
C119020Stent Thrombosis, Coronary ARC Grade ResponsesA terminology codelist relevant to the Academic Research Council grade for the probability that coronary artery stent thrombosis has occurred.CDISC SDTM ARC Coronary Stent Thrombosis Grade Responses Terminology
STENT THROMBOSIS ARC GRADE DEFINITEC119598Includes acute ischemic symptoms at rest, acute post ischemic ECG, positive biomarkers and pathological evidence. Definite stent thrombosis is considered to have occurred when there is either angiographic or pathological confirmation. Angiographic confirmation is the presence of a thrombus at coronary angiography that originates in the stent or in the segment 5 mm proximal or distal to the stent, with the presence of at least 1 of 3 clinical criteria within a 48-hour time window: 1) acute onset of ischemic symptoms at rest; 2) new ischemic ECG changes that suggest acute ischemia; or 3) typical rise and fall in cardiac biomarkers. Pathological confirmation is evidence of recent thrombus within the stent determined at autopsy or via examination of tissue retrieved following thrombectomy. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351)ARC Definite Stent Thrombosis
STENT THROMBOSIS ARC GRADE POSSIBLEC119600Possible stent thrombosis is considered to have occurred with any unexplained death more than 30 days after intracoronary stenting. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351)ARC Possible Stent Thrombosis
STENT THROMBOSIS ARC GRADE PROBABLEC119599Includes death within 30 days and myocardial infarction of stent territory. Probable stent thrombosis is considered to have occurred after intracoronary stenting in the following situations: 1) any unexplained death within the first 30 days; or 2) irrespective of the time after the index procedure, any MI that is related to documented acute ischemia in the territory of the implanted stent without angiographic confirmation of stent thrombosis and in the absence of any other obvious cause. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351)ARC Probable Stent Thrombosis
Back to top
CL.C119019.STCTIMRSStent Thrombosis, Coronary, ARC Timing Responses
(STCTIMRS)
text
Extensible: No
C119019Stent Thrombosis, Coronary, ARC Timing ResponsesA terminology codelist relevant to the Academic Research Council grade for the timing of the stent thrombosis after stent implantation.CDISC SDTM ARC Coronary Stent Thrombosis Timing Terminology
STENT THROMBOSIS ARC ACUTEC1195940 to 24 hours after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351)ARC Stent Thrombosis Timing Acute
STENT THROMBOSIS ARC LATEC119596Greater than 30 days to 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351)ARC Stent Thrombosis Timing Late
STENT THROMBOSIS ARC SUBACUTEC119595Greater than 24 hours to 30 days after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351)ARC Stent Thrombosis Timing Subacute
STENT THROMBOSIS ARC VERY LATEC119597Greater than 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351)ARC Stent Thrombosis Timing Very Late
Back to top
CL.C99077.STYPEStudy Type
(STYPE)
text
Extensible: No
C99077Study TypeDescribes the role the study plays in determining the interventions a subject receives.CDISC SDTM Study Type Terminology
EXPANDED ACCESSC98722Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in another clinical study. Expanded Access studies include individual-patient IND, treatment IND, compassionate use, emergency use or continued access.Expanded Access Study
INTERVENTIONALC98388Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. The individuals are then followed and biomedical and/or health outcomes are assessed.Interventional Study
OBSERVATIONALC16084Studies in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study.Observational Study
Back to top
CL.C74559.SCTESTCDSubject Characteristic Test Code
(SCTESTCD)
text
Extensible: Yes
C74559Subject Characteristic Test CodeThe test code representing each subject characteristic.CDISC SDTM Subject Characteristic Test Code Terminology
BRFEDINDC112233Breast Fed IndicatorAn indication as to whether the subject was breast fed (received mother's milk) as an infant.Breast Fed Indicator
CNTCINVC102625Contact InvestigationA public health activity whereby individuals who have been exposed to a person with a suspected or confirmed contagious illness are identified, usually for the purpose of identifying additional cases of the illness, or to offer some form of prophylactic intervention to either prevent or ameliorate disease in the exposed individual.Disease Contact Investigation
CTRYDDTCC102631Entry Date from Ptntl Cntry Disease ExpThe date on which the subject arrived in the reporting country from the country of potential disease exposure.Entry Date from Country of Potential Disease Exposure
CTRYDEXPC102612Country of Potential Disease ExposureSystem of classification based on the nation in which an individual was exposed to a disease, regardless of the nation in which he/she currently resides.Country of Potential Disease Exposure
EDLEVELC17953Education LevelYears of education that a person has completed.Education Level
EMPJOBC25193Employee JobA code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc.Occupation
HANDDOMC114182Dominant HandThe preferred hand of use for controlled and efficient performance of motor tasks.Dominant Hand
JOBCLASC74565Employee Job ClassA code qualifying the employment in various ways, such as, full-time vs. part time, etc.Employee Job Class
MARISTATC25188Marital StatusA demographic parameter indicating a person's current conjugal status.Marital Status
NATORIGC28407National OriginSystem of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides.National Origin
PREMBRTHC112400Premature Birth IndicatorAn indication as to whether the subject was born prior to 38 weeks gestation.Premature Birth Indicator
PRICONC102699Priority of Disease ContactThe categorization of individuals with or without the potential for having a particular disease.Priority of Disease Contact
RISKPOPC102666Member of High Risk PopulationAn indication that a subject is part of a population group that has a greater chance of contracting a disease or disorder.Member Of High Risk Population
RISKSOCC102711Social Risk FactorSocial factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease.Social Risk Factor
SALTYPC74566Employee Salary TypeA code specifying the method used by the employer to compute the employee's salary or wages. For example, hourly, annual, or commission.Employee Salary Type
SETCONC102708Setting of ContactThe environment within which the person may have come into contact with a disease carrier, or played the role of a disease carrier.Setting of Disease Contact
SKINCLASC74563Skin ClassificationA classification system used to categorize the sensitivity of a subject's skin to sunlight.Fitzpatrick Classification Scale
SKINTYPC74580Skin TypeA distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands.Skin Type
SRCCSINVC102713Source Case InvestigationA public health activity for the determination of who transmitted a disease to another subject and whether this person: is still infectious; was reported to the health department as a disease case or suspect; or has infected others.Source Case Investigation
SYMPTOMC4876SymptomSubjective evidence of disease perceived by the patient.Symptom
TWINTYPC112424Twin TypeThe classification of the two offspring born from the same pregnancy.Twin Type
TYPCONC102723Type of ContactIdentification and clinical investigation of disease contacts.Type of Contagion Contact
Back to top
CL.C103330.SCTESTSubject Characteristic Test Name
(SCTEST)
text
Extensible: Yes
C103330Subject Characteristic Test NameThe test name representing each subject characteristic.CDISC SDTM Subject Characteristic Test Name Terminology
Breast Fed IndicatorC112233Breast Fed IndicatorAn indication as to whether the subject was breast fed (received mother's milk) as an infant.Breast Fed Indicator
Contact InvestigationC102625Contact InvestigationA public health activity whereby individuals who have been exposed to a person with a suspected or confirmed contagious illness are identified, usually for the purpose of identifying additional cases of the illness, or to offer some form of prophylactic intervention to either prevent or ameliorate disease in the exposed individual.Disease Contact Investigation
Country of Potential Disease ExposureC102612Country of Potential Disease ExposureSystem of classification based on the nation in which an individual was exposed to a disease, regardless of the nation in which he/she currently resides.Country of Potential Disease Exposure
Dominant HandC114182Dominant HandThe preferred hand of use for controlled and efficient performance of motor tasks.Dominant Hand
Education LevelC17953Education LevelYears of education that a person has completed.Education Level
Employee JobC25193Employee JobA code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc.Occupation
Employee Job ClassC74565Employee Job ClassA code qualifying the employment in various ways, such as, full-time vs. part time, etc.Employee Job Class
Employee Salary TypeC74566Employee Salary TypeA code specifying the method used by the employer to compute the employee's salary or wages. For example, hourly, annual, or commission.Employee Salary Type
Entry Date from Ptntl Cntry Disease ExpC102631Entry Date from Ptntl Cntry Disease ExpThe date on which the subject arrived in the reporting country from the country of potential disease exposure.Entry Date from Country of Potential Disease Exposure
Marital StatusC25188Marital StatusA demographic parameter indicating a person's current conjugal status.Marital Status
Member of High Risk PopulationC102666Member of High Risk PopulationAn indication that a subject is part of a population group that has a greater chance of contracting a disease or disorder.Member Of High Risk Population
National OriginC28407National OriginSystem of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides.National Origin
Premature Birth IndicatorC112400Premature Birth IndicatorAn indication as to whether the subject was born prior to 38 weeks gestation.Premature Birth Indicator
Priority of Disease ContactC102699Priority of Disease ContactThe categorization of individuals with or without the potential for having a particular disease.Priority of Disease Contact
Setting of ContactC102708Setting of ContactThe environment within which the person may have come into contact with a disease carrier, or played the role of a disease carrier.Setting of Disease Contact
Skin ClassificationC74563Skin ClassificationA classification system used to categorize the sensitivity of a subject's skin to sunlight.Fitzpatrick Classification Scale
Skin TypeC74580Skin TypeA distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands.Skin Type
Social Risk FactorC102711Social Risk FactorSocial factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease.Social Risk Factor
Source Case InvestigationC102713Source Case InvestigationA public health activity for the determination of who transmitted a disease to another subject and whether this person: is still infectious; was reported to the health department as a disease case or suspect; or has infected others.Source Case Investigation
SymptomC4876SymptomSubjective evidence of disease perceived by the patient.Symptom
Twin TypeC112424Twin TypeThe classification of the two offspring born from the same pregnancy.Twin Type
Type of ContactC102723Type of ContactIdentification and clinical investigation of disease contacts.Type of Contagion Contact
Back to top
CL.C101852.SDTHSDTPSudden Death Syndrome Type
(SDTHSDTP)
text
Extensible: No
C101852Sudden Death Syndrome TypeA terminology codelist that describes syndromes or conditions that put a subject at risk for sudden death.CDISC SDTM Sudden Death Syndrome Type Terminology
BRUGADA SYNDROMEC71059Ventricular arrhythmia associated with Brugada syndromePolymorphic ventricular tachycardia in the absence of structural heart disease, associated with a baseline ECG pattern during sinus rhythm showing right bundle branch block with ST segment elevation in leads V1 through V3. It can also be characterized by documentation of ECG patterns associated with Brugada Syndrome, some of which may be unmasked when provoked with drugs. The most common genetic mutations identified for Brugada syndrome are in the sodium channel gene SCN5A.Brugada Syndrome Ventricular Arrhythmia by ECG Finding
CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIAC99936Ventricular Tachycardia associated with syncope and/or cardiac arrest triggered by emotion or exercise in patients whose baseline ECG is normal.Catecholaminergic Polymorphic Ventricular Tachycardia by ECG Finding
IDIOPATHIC PRIMARY VENTRICULAR TACHYCARDIA/VENTRICULAR FLUTTERC100036Ventricular tachycardia or ventricular fibrillation whose cause is unknown.Idiopathic Primary Ventricular Tachycardia/Ventricular Flutter by ECG Finding
LONG QT SYNDROMEC34786Ventricular arrhythmia associated with long QT syndromeLong QT Syndrome includes prolongation of the corrected QT interval beyond 440 ms for adult males, 460 ms for adult females and 50 ms in the presence of ventricular depolarization abnormalities (i.e., bundle branch blocks or IVCB more than 120 ms. A normal QT interval in a resting ECG with a failure to shorten with an increase in heart rate qualifies as Long QT Syndrome.Long QT Syndrome
OTHERC17649OtherDifferent than the one(s) previously specified or mentioned. (NCI)Other
SHORT QT SYNDROMEC71060Ventricular arrhythmia associated with short QT syndromeShort QT Syndrome is characterized by a QT interval of less than or equal to 300 ms.Short QT Syndrome
Back to top
CL.C102579.EVDRETRTSupporting Evidence for Re-Treatment
(EVDRETRT)
text
Extensible: Yes
C102579Supporting Evidence for Re-TreatmentTerminology relevant to the clinical evidence to support reason for re-treatment of disease.CDISC SDTM Supporting Evidence for Re-Treatment Terminology
BACTERIOLOGICAL FINDINGC102602Objective evidence of bacterial infection perceptible to the examiner by laboratory procedure.Bacteriological Finding
CLINICAL FINDINGC100104Clinical SignsObjective evidence of disease perceptible to the examiner (sign) and subjective evidence of disease perceived by the subject (symptom).Sign or Symptom
RADIOLOGIC FINDINGC35869Objective evidence of disease perceptible to the examiner by radiological procedure.Radiologic Finding
Back to top
CL.C101841.TIMIFLRSTIMI Flow Responses
(TIMIFLRS)
text
Extensible: No
C101841TIMI Flow ResponsesA terminology codelist of acceptable values to describe TIMI Flow.CDISC SDTM Thrombolysis in Myocardial Infarction Flow Responses Terminology
TIMI GRADE 0C100040Thrombolysis in Myocardial Infarction Flow - 0No perfusion. There is no antegrade flow beyond the point of occlusion. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987)Thrombolysis in Myocardial Infarction Flow-0
TIMI GRADE 1C100041Thrombolysis in Myocardial Infarction Flow - 1Penetration without perfusion. Contrast material passes beyond the area of obstruction but "hangs up" and fails to opacify the entire coronary bed distal to the obstruction for the duration of the cineangiographic filming sequence. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987)Thrombolysis in Myocardial Infarction Flow-1
TIMI GRADE 2C100042Thrombolysis in Myocardial Infarction Flow - 2Partial perfusion. The contrast material passes across the obstruction and opacifies the coronary bed distal to the obstruction. However, the rate of entry of contrast material into the vessel distal to the obstruction or its rate of clearance from the distal bed (or both) is perceptibly slower than its entry into or clearance from comparable areas not perfused by the previously occluded vessel (e.g., the opposite coronary artery or the coronary bed proximal to the obstruction). (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987)Thrombolysis in Myocardial Infarction Flow-2
TIMI GRADE 3C100043Thrombolysis in Myocardial Infarction Flow - 3Complete perfusion. Antegrade flow into the bed distal to the obstruction occurs as promptly as into the bed from the involved bed and is as rapid as clearance from an uninvolved bed in the same vessel or the opposite artery. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987)Thrombolysis in Myocardial Infarction Flow-3
Back to top
CL.C102589.TRTEPSDTreatment Episode
(TRTEPSD)
text
Extensible: No
C102589Treatment EpisodeTerminology relevant to whether an individual is being treated for a disease for the first time.CDISC SDTM Treatment Episode Terminology
NEWC25586Having no previous example or precedent or parallel; of a kind not seen before.New
RETREATMENTC54055The repeated act of the dispensing, applying, or tendering of something to another after an initial treatment.Retreatment
Back to top
CL.C102585.REASTRTFTreatment Failure Reason
(REASTRTF)
text
Extensible: Yes
C102585Treatment Failure ReasonTerminology relevant to the reason the drug or therapy was unsuccessful in treating the condition.CDISC SDTM Treatment Failure Reason Terminology
ANTIBIOTIC RESISTANCEC17449The mechanisms, functions, activities, or processes exhibited by microorganisms, especially bacteria, to resist or to become tolerant to antibiotics.Antibiotic Resistance
DRUG INTERRUPTEDC49501An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)Drug Interrupted
PATIENT NONCOMPLIANCEC91752Failure of a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment.Patient Noncompliance
SUB-THERAPEUTIC DRUG LEVELC102715A drug serum concentration below therapeutic levels.Sub-therapeutic Drug Level
Back to top
CL.C66735.TBLINDTrial Blinding Schema
(TBLIND)
text
Extensible: Yes
C66735Trial Blinding SchemaThe name of a code list that contains terms to define the type of blinding for the trial. (NCI)CDISC SDTM Trial Blinding Schema Terminology
DOUBLE BLINDC15228A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary)Double Blind Study
OPEN LABELC49659A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary)Open Label Study
SINGLE BLINDC28233A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary)Single Blind Study
Back to top
CL.C66736.TINDTPTrial Indication Type
(TINDTP)
text
Extensible: Yes
C66736Trial Indication TypeThe name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)CDISC SDTM Trial Indication Type Terminology
CUREC49654A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition. (NCI)Cure Study
DIAGNOSISC49653A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition. (NCI)Diagnosis Study
MITIGATIONC49655A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen. (NCI)Adverse Effect Mitigation Study
PREVENTIONC49657A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.Prevention Study
TREATMENTC49656A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition.Treatment Study
Back to top
CL.C66737.TPHASETrial Phase
(TPHASE)
text
Extensible: Yes
C66737Trial PhaseClinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)CDISC SDTM Trial Phase Terminology
NOT APPLICABLEC48660NA;Not ApplicableDetermination of a value is not relevant in the current context. (NCI)Not Applicable
PHASE I TRIALC156001;Trial Phase 1The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary)Phase I Trial
PHASE I/II TRIALC156931-2;Trial Phase 1-2A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.Phase I/II Trial
PHASE II TRIALC156012;Trial Phase 2Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary)Phase II Trial
PHASE II/III TRIALC156942-3;Trial Phase 2-3A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.Phase II/III Trial
PHASE IIA TRIALC496862A;Trial Phase 2AA clinical research protocol generally referred to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)Phase IIa Trial
PHASE IIB TRIALC496882B;Trial Phase 2BA clinical research protocol generally referred to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI)Phase IIb Trial
PHASE III TRIALC156023;Trial Phase 3Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary)Phase III Trial
PHASE IIIA TRIALC496873A;Trial Phase 3AA classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial. (NCI)Phase IIIa Trial
PHASE IIIB TRIALC496893B;Trial Phase 3BA subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval.Phase IIIb Trial
PHASE IV TRIALC156034;Trial Phase 4Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8] (CDISC glossary)Phase IV Trial
PHASE V TRIALC478655;Trial Phase 5Postmarketing surveillance is sometimes referred to as Phase V.Phase V Trial
Back to top
CL.C66738.TSPARMCDTrial Summary Parameter Test Code
(TSPARMCD)
text
Extensible: Yes
C66738Trial Summary Parameter Test CodeThe test code for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial.CDISC SDTM Trial Summary Parameter Terminology by Code
ACTSUBC98703Actual Number of SubjectsActual number of subjects enrolled; may include subjects who were not randomized.Actual Subject Number
ADAPTC98704Adaptive DesignIndicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study.Adaptive Design
ADDONC49703Added on to Existing TreatmentsThe addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.Test Product Added to Existing Treatment
AGEMAXC49694Planned Maximum Age of SubjectsThe anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)Planned Maximum Age of Subjects
AGEMINC49693Planned Minimum Age of SubjectsThe anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)Planned Minimum Age of Subjects
COMPTRTC68612Comparative Treatment NameA therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial.Active Comparator Drug
CRMDURC98715Confirmed Response Minimum DurationThe protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment.Confirmed Response Minimum Duration
CURTRTC85582Current Therapy or TreatmentThe literal identifier of the therapy or medication that is currently being given per protocol.Current Therapy
DCUTDESCC98718Data Cutoff DescriptionText that describes the cutoff date.Data Cutoff Date Description
DCUTDTCC98717Data Cutoff DateA date which indicates any data collected by this date will be used for analysis.Data Cutoff Date
DOSEC25488Dose Level;Dose per AdministrationThe amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)Dose
DOSFRQC89081Dosing FrequencyThe number of doses administered per a specific interval.Dose Frequency
DOSUC73558Dose UnitsThe unit of measure for the dosage form.Dosage Form Unit
DXCRITC117960Diagnostic CriteriaA standard from which a judgment concerning a medical diagnosis can be established.Diagnostic Criteria
EGBLINDC119560ECG Reading BlindedIndicates whether assessors of ECGs for this study were blinded to subject identity, timing and treatment.ECG Evaluator Blinding Parameters
EGCTMONC119561ECG Continuous MonitoringIndicates whether the 10-second ECGs for this study were extracted from a continuous recording.ECG Continuous Monitoring Indicator
EGLEADPRC119562ECG Planned Primary LeadThe ECG lead which was planned to be used for ECG interval measurements for this study.ECG Planned Primary Lead for Study
EGLEADSMC119563ECG Used Same LeadIndicates whether all ECG interval measurements for the study were based on the same lead.ECG Used Same Lead Indicator
EGRDMETHC119564ECG Read MethodThe degree of automation involved in assessing the ECGs for this study.ECG Read Method Degree of Automation
EGREPLBLC119565ECG Replicates at BaselineIndicates whether this study includes replicate ECGs for time points during the baseline portion of the study.ECG Replicates at Baseline Indicator
EGREPLTRC119566ECG Replicates On-TreatmentIndicates whether this study includes replicate ECGs for time points during the on-treatment portion of the study.ECG Replicates On-Treatment Indicator
EGTWVALGC119582ECG Twave AlgorithmThe algorithm used to identify the end of the T wave for ECGs for this study.ECG T Wave Algorithm
FCNTRYC98770Planned Country of Investigational SitesThe country name of planned study facility which has received IRB approval.Planned Country of Investigational Site
HLTSUBJIC98737Healthy Subject IndicatorIndicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study.Healthy Subject Indicator
INDICC112038Trial IndicationThe condition, disease or disorder that the clinical trial is intended to investigate or address.Trial Indication
INTMODELC98746Intervention ModelThe trial design developed to compare treatment groups.Intervention Model
INTTYPEC98747Intervention TypeThe kind of product or procedure studied in a trial.Intervention Type
LENGTHC49697Trial LengthPlanned length of observation for a single subject.Trial Length
NARMSC98771Planned Number of ArmsThe planned number of intervention groups.Planned Number of Arms
OBJPRIMC85826Trial Primary ObjectiveThe principal purpose of the trial.Trial Primary Objective
OBJSECC85827Trial Secondary ObjectiveThe auxiliary purpose of the trial.Trial Secondary Objective
OUTMSEXPC98724Exploratory Outcome MeasureExploratory measures that will be used to evaluate the intervention(s) or, for observational studies, that are exploratory of the study.Exploratory Outcome Measure
OUTMSPRIC98772Primary Outcome MeasureThe primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the outcome measures used to assess the primary objective(s).Primary Outcome Measure
OUTMSSECC98781Secondary Outcome MeasureOther key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s).Secondary Outcome Measure
PCLASC98768Pharmacological Class of Invest. TherapyThe pharmacological class of the investigational product.Pharmacological Class of Investigational Therapy
PLANSUBC49692Anticipated Enrollment;Planned Enrollment;Planned Number of Subjects;Target EnrollmentThe planned number of subjects to be entered in a clinical trial. (NCI)Planned Subject Number
RANDOMC25196Trial is RandomizedThe process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)Randomization
RANDQTC98775Randomization QuotientThe randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects.Randomization Quotient
REGIDC98714Registry IdentifierIdentification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries.Clinical Trial Registry Identifier
RLPSCRITC117961Relapse CriteriaA standard from which a judgment concerning a disease relapse can be established.Relapse Criteria
ROUTEC38114Route of AdministrationThe course by which a substance was administered in order to reach the site of action in the body.Route of Administration
SDMDURC98783Stable Disease Minimum DurationThe protocol specified minimum amount of time needed to meet the definition of stable disease.Stable Disease Minimum Duration
SENDTCC90462Study End DateFinal date on which data was collected for any subject (Date/Time of End of Participation, RFPENDTC) based on the protocol.Study End Date
SEVCRITC117962Severity CriteriaA standard from which a judgment concerning the severity of an event, disease or condition can be established.Severity Criteria
SEXPOPC49696Sex Of Participants;Sex of ParticipantsThe specific sex, either male, female, or mixed of the subject group being studied. (NCI)Sex of Study Group
SPONSORC70793Clinical Study Sponsor;Sponsor;Study SponsorAn entity that is responsible for the initiation, management, and/or financing of a clinical study.Clinical Study Sponsor
SSTDTCC69208Study Start DateThe earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen failures are not included.Study Start Date
STOPRULEC49698Study Stop RulesThe rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)Study Stop Rule
STRATFCTC16153Stratification FactorSelected pre-treatment factors by which patients are segregated to assure balance of these factors before randomization to the intervention arms of a clinical protocol.Stratification Factors
STYPEC15320Study TypeDescribes the role the study plays in determining the interventions a subject receives.Study Design
TBLINDC49658Trial Blinding SchemaThe name of a code list that contains terms to define the type of blinding for the trial. (NCI)Trial Blinding Schema
TCNTRLC49647Control TypeComparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).Control Type
TDIGRPC49650Diagnosis GroupA grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)Diagnosis Group
TINDTPC49652Trial Indication TypeThe name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)Clinical Study by Intent
TITLEC49802Trial TitleThe name of a clinical trial. (NCI)Trial Title
TPHASEC48281Trial Phase ClassificationClinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)Trial Phase
TRTC41161Investigational Therapy or TreatmentThe investigational product under study.Protocol Agent
TTYPEC49660Trial TypeThe type of clinical trial performed e.g. efficacy, safety. (NCI)Trial Type
Back to top
CL.C67152.TSPARMTrial Summary Parameter Test Name
(TSPARM)
text
Extensible: Yes
C67152Trial Summary Parameter Test NameThe test name for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial.CDISC SDTM Trial Summary Parameter Terminology by Name
Actual Number of SubjectsC98703Actual Number of SubjectsActual number of subjects enrolled; may include subjects who were not randomized.Actual Subject Number
Adaptive DesignC98704Adaptive DesignIndicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study.Adaptive Design
Added on to Existing TreatmentsC49703Added on to Existing TreatmentsThe addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.Test Product Added to Existing Treatment
Clinical Study SponsorC70793Clinical Study Sponsor;Sponsor;Study SponsorAn entity that is responsible for the initiation, management, and/or financing of a clinical study.Clinical Study Sponsor
Comparative Treatment NameC68612Comparative Treatment NameA therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial.Active Comparator Drug
Confirmed Response Minimum DurationC98715Confirmed Response Minimum DurationThe protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment.Confirmed Response Minimum Duration
Control TypeC49647Control TypeComparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).Control Type
Current Therapy or TreatmentC85582Current Therapy or TreatmentThe literal identifier of the therapy or medication that is currently being given per protocol.Current Therapy
Data Cutoff DateC98717Data Cutoff DateA date which indicates any data collected by this date will be used for analysis.Data Cutoff Date
Data Cutoff DescriptionC98718Data Cutoff DescriptionText that describes the cutoff date.Data Cutoff Date Description
Diagnosis GroupC49650Diagnosis GroupA grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)Diagnosis Group
Diagnostic CriteriaC117960Diagnostic CriteriaA standard from which a judgment concerning a medical diagnosis can be established.Diagnostic Criteria
Dose per AdministrationC25488Dose Level;Dose per AdministrationThe amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)Dose
Dose UnitsC73558Dose UnitsThe unit of measure for the dosage form.Dosage Form Unit
Dosing FrequencyC89081Dosing FrequencyThe number of doses administered per a specific interval.Dose Frequency
ECG Continuous MonitoringC119561ECG Continuous MonitoringIndicates whether the 10-second ECGs for this study were extracted from a continuous recording.ECG Continuous Monitoring Indicator
ECG Planned Primary LeadC119562ECG Planned Primary LeadThe ECG lead which was planned to be used for ECG interval measurements for this study.ECG Planned Primary Lead for Study
ECG Read MethodC119564ECG Read MethodThe degree of automation involved in assessing the ECGs for this study.ECG Read Method Degree of Automation
ECG Reading BlindedC119560ECG Reading BlindedIndicates whether assessors of ECGs for this study were blinded to subject identity, timing and treatment.ECG Evaluator Blinding Parameters
ECG Replicates at BaselineC119565ECG Replicates at BaselineIndicates whether this study includes replicate ECGs for time points during the baseline portion of the study.ECG Replicates at Baseline Indicator
ECG Replicates On-TreatmentC119566ECG Replicates On-TreatmentIndicates whether this study includes replicate ECGs for time points during the on-treatment portion of the study.ECG Replicates On-Treatment Indicator
ECG Twave AlgorithmC119582ECG Twave AlgorithmThe algorithm used to identify the end of the T wave for ECGs for this study.ECG T Wave Algorithm
ECG Used Same LeadC119563ECG Used Same LeadIndicates whether all ECG interval measurements for the study were based on the same lead.ECG Used Same Lead Indicator
Exploratory Outcome MeasureC98724Exploratory Outcome MeasureExploratory measures that will be used to evaluate the intervention(s) or, for observational studies, that are exploratory of the study.Exploratory Outcome Measure
Healthy Subject IndicatorC98737Healthy Subject IndicatorIndicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study.Healthy Subject Indicator
Intervention ModelC98746Intervention ModelThe trial design developed to compare treatment groups.Intervention Model
Intervention TypeC98747Intervention TypeThe kind of product or procedure studied in a trial.Intervention Type
Investigational Therapy or TreatmentC41161Investigational Therapy or TreatmentThe investigational product under study.Protocol Agent
Pharmacological Class of Invest. TherapyC98768Pharmacological Class of Invest. TherapyThe pharmacological class of the investigational product.Pharmacological Class of Investigational Therapy
Planned Country of Investigational SitesC98770Planned Country of Investigational SitesThe country name of planned study facility which has received IRB approval.Planned Country of Investigational Site
Planned Maximum Age of SubjectsC49694Planned Maximum Age of SubjectsThe anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)Planned Maximum Age of Subjects
Planned Minimum Age of SubjectsC49693Planned Minimum Age of SubjectsThe anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)Planned Minimum Age of Subjects
Planned Number of ArmsC98771Planned Number of ArmsThe planned number of intervention groups.Planned Number of Arms
Planned Number of SubjectsC49692Anticipated Enrollment;Planned Enrollment;Planned Number of Subjects;Target EnrollmentThe planned number of subjects to be entered in a clinical trial. (NCI)Planned Subject Number
Primary Outcome MeasureC98772Primary Outcome MeasureThe primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the outcome measures used to assess the primary objective(s).Primary Outcome Measure
Randomization QuotientC98775Randomization QuotientThe randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects.Randomization Quotient
Registry IdentifierC98714Registry IdentifierIdentification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries.Clinical Trial Registry Identifier
Relapse CriteriaC117961Relapse CriteriaA standard from which a judgment concerning a disease relapse can be established.Relapse Criteria
Route of AdministrationC38114Route of AdministrationThe course by which a substance was administered in order to reach the site of action in the body.Route of Administration
Secondary Outcome MeasureC98781Secondary Outcome MeasureOther key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s).Secondary Outcome Measure
Severity CriteriaC117962Severity CriteriaA standard from which a judgment concerning the severity of an event, disease or condition can be established.Severity Criteria
Sex of ParticipantsC49696Sex Of Participants;Sex of ParticipantsThe specific sex, either male, female, or mixed of the subject group being studied. (NCI)Sex of Study Group
Stable Disease Minimum DurationC98783Stable Disease Minimum DurationThe protocol specified minimum amount of time needed to meet the definition of stable disease.Stable Disease Minimum Duration
Stratification FactorC16153Stratification FactorSelected pre-treatment factors by which patients are segregated to assure balance of these factors before randomization to the intervention arms of a clinical protocol.Stratification Factors
Study End DateC90462Study End DateFinal date on which data was collected for any subject (Date/Time of End of Participation, RFPENDTC) based on the protocol.Study End Date
Study Start DateC69208Study Start DateThe earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen failures are not included.Study Start Date
Study Stop RulesC49698Study Stop RulesThe rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)Study Stop Rule
Study TypeC15320Study TypeDescribes the role the study plays in determining the interventions a subject receives.Study Design
Trial Blinding SchemaC49658Trial Blinding SchemaThe name of a code list that contains terms to define the type of blinding for the trial. (NCI)Trial Blinding Schema
Trial IndicationC112038Trial IndicationThe condition, disease or disorder that the clinical trial is intended to investigate or address.Trial Indication
Trial Indication TypeC49652Trial Indication TypeThe name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)Clinical Study by Intent
Trial is RandomizedC25196Trial is RandomizedThe process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)Randomization
Trial LengthC49697Trial LengthPlanned length of observation for a single subject.Trial Length
Trial Phase ClassificationC48281Trial Phase ClassificationClinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)Trial Phase
Trial Primary ObjectiveC85826Trial Primary ObjectiveThe principal purpose of the trial.Trial Primary Objective
Trial Secondary ObjectiveC85827Trial Secondary ObjectiveThe auxiliary purpose of the trial.Trial Secondary Objective
Trial TitleC49802Trial TitleThe name of a clinical trial. (NCI)Trial Title
Trial TypeC49660Trial TypeThe type of clinical trial performed e.g. efficacy, safety. (NCI)Trial Type
Back to top
CL.C66739.TTYPETrial Type
(TTYPE)
text
Extensible: Yes
C66739Trial TypeThe type of clinical trial performed e.g. efficacy, safety. (NCI)CDISC SDTM Trial Type Terminology
BIO-AVAILABILITYC49664A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)Bioavailability Study
BIO-EQUIVALENCEC49665A study most often used to compare the efficacy of different formulations to treat a given disease. It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)Therapeutic Equivalency Study
EFFICACYC49666A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)Efficacy Study
FOOD EFFECTC98729Studies that are conducted to assess the effect of food on the rate and extent of absorption of a drug, either compared to a fasted state or to a reference drug.Food Effect Study
PHARMACODYNAMICC49662A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)Pharmacodynamic Study
PHARMACOECONOMICC39493A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)Pharmacoeconomic Study
PHARMACOGENOMICC49661A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual's drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may also reveal new targets that can help in the design of new drugs. (NCI)Pharmacogenomic Study
PHARMACOKINETICC49663A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)Pharmacokinetic Study
SAFETYC49667A study that assesses the medical risks to a subject. Safety is usually assessed by examining a wide range of clinical parameters, including adverse events, vital signs, physical exam, laboratory tests.Safety Study
TOLERABILITYC98791A type of safety study that assesses the degree to which overt adverse effects can be tolerated by the subject.Tolerability Study
Back to top
CL.C96780.TUMIDENTTumor and Lesion Identification Results
(TUMIDENT)
text
Extensible: Yes
C96780Tumor and Lesion Identification ResultsTerminology relevant to tumor and lesion identification results.CDISC SDTM Tumor and Lesion Identification Result Terminology
BENIGNC14172BenignFor neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health. (NCI)Benign
MEASUREDC103416The identification of a tumor, lesion, or site of disease that is present at baseline and will be quantifiably measured.Measured Tumor Identification
NEWC94522The identification of a tumor, lesion, or site of disease which has not been previously seen or characterized.New Lesion Identification
NON-MEASURABLEC103423The identification of a tumor, lesion, or site of disease that is incapable of being measured at baseline.Non-Measurable Tumor Identification
NON-TARGETC94521The identification of a tumor, lesion or site of disease that is present at baseline and not considered a target, but may be part of the objective assessment of the response to the therapeutic intervention.Non-Target Lesion Identification
NOT MEASUREDC103425The identification of a tumor, lesion, or site of disease that is present at baseline and will not be quantifiably measured.Not Measured Tumor Identification
TARGETC94520The identification of a tumor, lesion, or site of disease that is present at baseline and is the target of the therapeutic intervention.Target Lesion Identification
TARGET EXTRA NODALC103442The identification of a tumor or lesion that is present at baseline, located outside of or independent of any lymph nodes, and is the target of the therapeutic intervention.Target Extra Nodal Tumor Identification
TARGET NODALC103443The identification of a tumor or lesion located at or near the lymph node that is present at baseline and is the target of the therapeutic intervention.Target Nodal Tumor Identification
TARGET NODULEC103444The identification of a nodule that is the target of the therapeutic intervention.Target Nodule Tumor Identification
Back to top
CL.C96784.TUTESTCDTumor Identification Test Code
(TUTESTCD)
text
Extensible: Yes
C96784Tumor Identification Test CodeTerminology relevant to the test codes that describe tumor assessments for identification purposes.CDISC SDTM Tumor Identification Test Code Terminology
GRLIDENTC119567Graft Lesion IdentificationAn indication that a graft with a lesion has been located and characterized.Graft Lesion Identification
LESIDENTC94189Lesion IdentificationAn indication that a lesion has been located and characterized.Lesion Identification
LMLIDENTC119568Limb Lesion IdentificationAn indication that a limb containing a lesion has been selected and characterized.Limb Associated Lesion Identification
TUMERGEC94525Tumor MergedAn indication that multiple tumors have coalesced into one tumor.Matted Tumor Mass Present
TUMIDENTC94523Tumor IdentificationAn indication that a tumor has been located and characterized.Tumor Identification
TUSPLITC96642Tumor SplitAn indication that a single tumor has divided into two or more tumors.Tumor Split
VSLIDENTC119569Vessel Lesion IdentificationAn indication that a vessel with a lesion has been located and characterized.Vessel Lesion Identification
Back to top
CL.C96783.TUTESTTumor Identification Test Name
(TUTEST)
text
Extensible: Yes
C96783Tumor Identification Test NameTerminology relevant to the test names that describe tumor assessments for identification purposes.CDISC SDTM Tumor Identification Test Name Terminology
Graft Lesion IdentificationC119567Graft Lesion IdentificationAn indication that a graft with a lesion has been located and characterized.Graft Lesion Identification
Lesion IdentificationC94189Lesion IdentificationAn indication that a lesion has been located and characterized.Lesion Identification
Limb Lesion IdentificationC119568Limb Lesion IdentificationAn indication that a limb containing a lesion has been selected and characterized.Limb Associated Lesion Identification
Tumor IdentificationC94523Tumor IdentificationAn indication that a tumor has been located and characterized.Tumor Identification
Tumor MergedC94525Tumor MergedAn indication that multiple tumors have coalesced into one tumor.Matted Tumor Mass Present
Tumor SplitC96642Tumor SplitAn indication that a single tumor has divided into two or more tumors.Tumor Split
Vessel Lesion IdentificationC119569Vessel Lesion IdentificationAn indication that a vessel with a lesion has been located and characterized.Vessel Lesion Identification
Back to top
CL.C96779.TRTESTCDTumor or Lesion Properties Test Code
(TRTESTCD)
text
Extensible: Yes
C96779Tumor or Lesion Properties Test CodeTerminology relevant to the test codes that describe the assessment or measurement of a tumor, lesion or site of disease.CDISC SDTM Tumor or Lesion Properties Test Code Terminology
ACHNADC103347Absolute Change From NadirThe current value minus the lowest value previously recorded.Absolute Change From Nadir
ACNSDC112218Absolute Change Nadir in Sum of DiamThe current sum of diameters minus the lowest sum of diameters previously recorded.Absolute Change From Nadir in Sum of Diameter
AREAC25244AreaThe extent of a 2-dimensional surface enclosed within a boundary. (NCI)Area
AVMETSUVC96566Average Metabolic Standard Uptake ValueA semiquantitative analysis of the average uptake of analyte by body tissue in relation to the total administered dose of the analyte.Average Metabolic Standard Uptake Value
DIAMETERC25285DiameterThe length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI)Diameter
LDIAMC96684Longest DiameterThe longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference.Longest Diameter
LESFLINDC119551Lesion Failure IndicatorAn indication as to whether lesion failure occurred.Lesion Failure Indicator
LESRVINDC119552Lesion Revascularization IndicatorAn indication as to whether repeat revascularization of a lesion occurred.Lesion Revascularization Indicator
LESSCINDC119553Lesion Success IndicatorAn indication as to whether a performed procedure of a target lesion is considered successful.Lesion Success Indicator
LMBFLINDC119554Limb Failure IndicatorAn indication as to whether limb failure occurred.Limb Failure Indicator
LPERPC96685Longest PerpendicularThe longest possible straight line or plane through a body or figure that is at a right angle to a given line or plane.Longest Perpendicular
LRISCINDC119555Lesion Revas Ischemia IndicatorAn indication as to whether clinical or functional ischemia is present before lesion revascularization occurred.Lesion Revascularization Ischemia Indicator
LRVCLINDC119556Lesion Revas Clinical IndicatorAn indication as to whether an appropriate clinical context was present before lesion revascularization occurred.Lesion Revascularization Clinical Indicator
NEWCONFC103421New Tumor ConfirmedThe verification/confirmation by other methods or modalities that a tumor, which has not been previously seen or characterized, is present in the subject.New Tumor Confirmation
PCBSAC112369Percent Change Baseline in Sum of AreaThe (current sum of areas minus the baseline sum of areas) divided by the baseline sum of areas, multiplied by 100.Percent Change From Baseline in Sum of Area
PCBSDC112370Percent Change Baseline in Sum of DiamThe (current sum of diameters minus the baseline sum of diameters) divided by the baseline sum of diameters, multiplied by 100.Percent Change From Baseline in Sum of Diameter
PCBSLDC112371Percent Change Baseline Sum Longest DiamThe (current sum of longest diameters minus the baseline sum of longest diameters) divided by the baseline sum of longest diameters, multiplied by 100.Percent Change From Baseline in Sum of Longest Diameter
PCBSVC112372Percent Change Baseline in Sum of VolumeThe (current sum of volumes minus the baseline sum of volumes) divided by the baseline sum of volumes, multiplied by 100.Percent Change From Baseline in Sum of Volume
PCHGBLC96621Percent Change From BaselineThe (current value minus the baseline value) divided by the baseline value, multiplied by 100.Percent Change From Baseline
PCHGNADC96622Percent Change From NadirThe (current value minus the lowest value previously recorded) divided by the lowest value previously recorded, multiplied by 100.Percent Change From Nadir
PCNSDC112373Percent Change Nadir in Sum of DiamThe (current sum of diameters minus the lowest sum of diameters previously recorded) divided by the lowest sum of diameters previously recorded, multiplied by 100.Percent Change From Nadir in Sum of Diameter
PCNSLDC112374Percent Change Nadir in Sum Longest DiamThe (current sum of longest diameters minus the lowest sum of longest diameters previously recorded) divided by the lowest sum of longest diameters previously recorded, multiplied by 100.Percent Change From Nadir in Sum of Longest Diameter
RADIODENC96627RadiodensityThe transparency of a material to the passage of X-rays and other forms of radiation.Radiodensity
SAXISC94982Short AxisThe plane through a body or figure that is at the shortest width of that body or figure.Short Axis
SUMAREAC96630Sum of Area;Sum of Products of Perpendicular DiametersA calculation of the aggregated area values.Sum of Areas
SUMDIAMC96631Sum of DiameterA calculation of the aggregated diameter values.Sum of Diameters
SUMLDIAMC96632Sum of Longest DiameterA calculation of the aggregated longest diameter values.Sum of Longest Diameters
SUMLPERPC96633Sum of Longest PerpendicularA calculation of the aggregated longest perpendicular values.Sum of Longest Perpendiculars
SUMNLNLDC103441Sum Diameters of Non Lymph Node TumorsA calculation of the aggregated diameter values for tumors other than the lymph nodes.Sum of Diameters of Non Lymph Node Tumors
SUMVDIAMC96634Sum of Viable DiameterA calculation of the aggregated diameter values taken from the viable portion of the tumor mass.Sum of Viable Diameters
SUMVOLC96635Sum of VolumeA calculation of the aggregated volume values.Sum of Volumes
TUMSTATEC96643Tumor StateA condition or state of a tumor at a particular time.Tumor Status
VDIAMC96646Viable DiameterThe diameter of the portion of the tumor mass that is capable of growth, proliferation and metastasis.Viable Tumor Diameter
VOLUMEC25335VolumeThe amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI)Volume
VSLFLINDC119557Vessel Failure IndicatorAn indication as to whether vessel failure occurred.Vessel Failure Indicator
VSLPINDC119558Vessel Patency IndicatorAn indication as to whether an artery is patent (free of TLR or restenosis) following intervention.Vessel Patency Indicator
VSLRVINDC119559Vessel Revascularization IndicatorAn indication as to whether repeat revascularization of an artery containing a lesion occurred.Vessel Revascularization Indicator
Back to top
CL.C96778.TRTESTTumor or Lesion Properties Test Name
(TRTEST)
text
Extensible: Yes
C96778Tumor or Lesion Properties Test NameTerminology relevant to the test codes that describe the assessment or measurement of a tumor, lesion or site of disease.CDISC SDTM Tumor or Lesion Properties Test Name Terminology
Absolute Change From NadirC103347Absolute Change From NadirThe current value minus the lowest value previously recorded.Absolute Change From Nadir
Absolute Change Nadir in Sum of DiamC112218Absolute Change Nadir in Sum of DiamThe current sum of diameters minus the lowest sum of diameters previously recorded.Absolute Change From Nadir in Sum of Diameter
AreaC25244AreaThe extent of a 2-dimensional surface enclosed within a boundary. (NCI)Area
Average Metabolic Standard Uptake ValueC96566Average Metabolic Standard Uptake ValueA semiquantitative analysis of the average uptake of analyte by body tissue in relation to the total administered dose of the analyte.Average Metabolic Standard Uptake Value
DiameterC25285DiameterThe length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI)Diameter
Lesion Failure IndicatorC119551Lesion Failure IndicatorAn indication as to whether lesion failure occurred.Lesion Failure Indicator
Lesion Revas Clinical IndicatorC119556Lesion Revas Clinical IndicatorAn indication as to whether an appropriate clinical context was present before lesion revascularization occurred.Lesion Revascularization Clinical Indicator
Lesion Revas Ischemia IndicatorC119555Lesion Revas Ischemia IndicatorAn indication as to whether clinical or functional ischemia is present before lesion revascularization occurred.Lesion Revascularization Ischemia Indicator
Lesion Revascularization IndicatorC119552Lesion Revascularization IndicatorAn indication as to whether repeat revascularization of a lesion occurred.Lesion Revascularization Indicator
Lesion Success IndicatorC119553Lesion Success IndicatorAn indication as to whether a performed procedure of a target lesion is considered successful.Lesion Success Indicator
Limb Failure IndicatorC119554Limb Failure IndicatorAn indication as to whether limb failure occurred.Limb Failure Indicator
Longest DiameterC96684Longest DiameterThe longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference.Longest Diameter
Longest PerpendicularC96685Longest PerpendicularThe longest possible straight line or plane through a body or figure that is at a right angle to a given line or plane.Longest Perpendicular
New Tumor ConfirmedC103421New Tumor ConfirmedThe verification/confirmation by other methods or modalities that a tumor, which has not been previously seen or characterized, is present in the subject.New Tumor Confirmation
Percent Change Baseline in Sum of AreaC112369Percent Change Baseline in Sum of AreaThe (current sum of areas minus the baseline sum of areas) divided by the baseline sum of areas, multiplied by 100.Percent Change From Baseline in Sum of Area
Percent Change Baseline in Sum of DiamC112370Percent Change Baseline in Sum of DiamThe (current sum of diameters minus the baseline sum of diameters) divided by the baseline sum of diameters, multiplied by 100.Percent Change From Baseline in Sum of Diameter
Percent Change Baseline in Sum of VolumeC112372Percent Change Baseline in Sum of VolumeThe (current sum of volumes minus the baseline sum of volumes) divided by the baseline sum of volumes, multiplied by 100.Percent Change From Baseline in Sum of Volume
Percent Change Baseline Sum Longest DiamC112371Percent Change Baseline Sum Longest DiamThe (current sum of longest diameters minus the baseline sum of longest diameters) divided by the baseline sum of longest diameters, multiplied by 100.Percent Change From Baseline in Sum of Longest Diameter
Percent Change From BaselineC96621Percent Change From BaselineThe (current value minus the baseline value) divided by the baseline value, multiplied by 100.Percent Change From Baseline
Percent Change From NadirC96622Percent Change From NadirThe (current value minus the lowest value previously recorded) divided by the lowest value previously recorded, multiplied by 100.Percent Change From Nadir
Percent Change Nadir in Sum Longest DiamC112374Percent Change Nadir in Sum Longest DiamThe (current sum of longest diameters minus the lowest sum of longest diameters previously recorded) divided by the lowest sum of longest diameters previously recorded, multiplied by 100.Percent Change From Nadir in Sum of Longest Diameter
Percent Change Nadir in Sum of DiamC112373Percent Change Nadir in Sum of DiamThe (current sum of diameters minus the lowest sum of diameters previously recorded) divided by the lowest sum of diameters previously recorded, multiplied by 100.Percent Change From Nadir in Sum of Diameter
RadiodensityC96627RadiodensityThe transparency of a material to the passage of X-rays and other forms of radiation.Radiodensity
Short AxisC94982Short AxisThe plane through a body or figure that is at the shortest width of that body or figure.Short Axis
Sum Diameters of Non Lymph Node TumorsC103441Sum Diameters of Non Lymph Node TumorsA calculation of the aggregated diameter values for tumors other than the lymph nodes.Sum of Diameters of Non Lymph Node Tumors
Sum of AreaC96630Sum of Area;Sum of Products of Perpendicular DiametersA calculation of the aggregated area values.Sum of Areas
Sum of DiameterC96631Sum of DiameterA calculation of the aggregated diameter values.Sum of Diameters
Sum of Longest DiameterC96632Sum of Longest DiameterA calculation of the aggregated longest diameter values.Sum of Longest Diameters
Sum of Longest PerpendicularC96633Sum of Longest PerpendicularA calculation of the aggregated longest perpendicular values.Sum of Longest Perpendiculars
Sum of Viable DiameterC96634Sum of Viable DiameterA calculation of the aggregated diameter values taken from the viable portion of the tumor mass.Sum of Viable Diameters
Sum of VolumeC96635Sum of VolumeA calculation of the aggregated volume values.Sum of Volumes
Tumor StateC96643Tumor StateA condition or state of a tumor at a particular time.Tumor Status
Vessel Failure IndicatorC119557Vessel Failure IndicatorAn indication as to whether vessel failure occurred.Vessel Failure Indicator
Vessel Patency IndicatorC119558Vessel Patency IndicatorAn indication as to whether an artery is patent (free of TLR or restenosis) following intervention.Vessel Patency Indicator
Vessel Revascularization IndicatorC119559Vessel Revascularization IndicatorAn indication as to whether repeat revascularization of an artery containing a lesion occurred.Vessel Revascularization Indicator
Viable DiameterC96646Viable DiameterThe diameter of the portion of the tumor mass that is capable of growth, proliferation and metastasis.Viable Tumor Diameter
VolumeC25335VolumeThe amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI)Volume
Back to top
CL.C96782.RSTESTCDTumor Response Assessment Test Code
(RSTESTCD)
text
Extensible: Yes
C96782Tumor Response Assessment Test CodeTerminology relevant to the test codes that describe an assessment of tumor response to treatment or therapy.CDISC SDTM Tumor Response Assessment Test Code Terminology
BESTRESPC94536Best Overall Response;Best ResponseAn assessment of the most clinically favorable overall response of the disease to the therapy.Best Overall Response
NEWLPROGC103420New Lesion ProgressionAn assessment of the equivocality of disease progression based on a newly identified lesion.New Lesion Progression
NRADPROGC96608Non-Radiological ProgressionA non-radiological determination of disease progression based on symptoms or other findings.Non-Radiological Progression
NTRGRESPC94535Non-target ResponseAn assessment of the response of a non-target tumor(s) to the therapy.Response in Non-Target Lesion
OVRLRESPC96613Overall ResponseAn assessment of the overall response of the disease to the therapy. (NCI)Overall Response
TRGRESPC94534Target ResponseAn assessment of the response of a target tumor(s) to the therapy.Response in Target Lesion
Back to top
CL.C96781.RSTESTTumor Response Assessment Test Name
(RSTEST)
text
Extensible: Yes
C96781Tumor Response Assessment Test NameTerminology relevant to the test names that describe an assessment of tumor response to treatment or therapy.CDISC SDTM Tumor Response Assessment Test Name Terminology
Best Overall ResponseC94536Best Overall Response;Best ResponseAn assessment of the most clinically favorable overall response of the disease to the therapy.Best Overall Response
New Lesion ProgressionC103420New Lesion ProgressionAn assessment of the equivocality of disease progression based on a newly identified lesion.New Lesion Progression
Non-Radiological ProgressionC96608Non-Radiological ProgressionA non-radiological determination of disease progression based on symptoms or other findings.Non-Radiological Progression
Non-target ResponseC94535Non-target ResponseAn assessment of the response of a non-target tumor(s) to the therapy.Response in Non-Target Lesion
Overall ResponseC96613Overall ResponseAn assessment of the overall response of the disease to the therapy. (NCI)Overall Response
Target ResponseC94534Target ResponseAn assessment of the response of a target tumor(s) to the therapy.Response in Target Lesion
Back to top
CL.C96785.RSSTRESCTumor Response Result
(RSSTRESC)
text
Extensible: Yes
C96785Tumor Response ResultThe result of an assessment of tumor response to treatment or therapy.CDISC SDTM Tumor Response Result Terminology
CRC4870Complete Remission;Complete ResponseThe disappearance of all signs of cancer in response to treatment. (NCI)Complete Remission
CRiC103385Complete Remission with Incomplete Blood Count Recovery;Complete Response with Incomplete Bone Marrow RecoveryThe disappearance of all signs of cancer in response to treatment accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia.Complete Response with Incomplete Bone Marrow Recovery
EQUIVOCALC86071EQUIVOCALOpen to question.Equivocal
NEC62222Not EvaluableUnable to be evaluated. (NCI)Unevaluable
Non-CR/Non-PDC96700Non Complete Response/Non Progressive DiseasePersistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)Non Complete Response/Non Progressive Disease
NOT ALL EVALUATEDC103424Not All EvaluatedNot all target tumors were assessed. Or not all non-target tumors were assessed.Not All Tumors Evaluated
nPRC103422Nodular Partial ResponseRemission with remaining lymphoid nodules reflecting residual disease.Nodular Partial Response
PDC35571Progressive DiseaseA disease process that is increasing in scope or severity. (NCI)Progressive Disease
PRC18058Partial Remission;Partial ResponseA finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient. (NCI)Partial Remission
SDC18213Stable DiseaseCancer that is neither decreasing nor increasing in extent or severity. (NCI)Stable Disease
UPDC96644Unequivocal ProgressionAn overall level of substantial worsening in non-target disease that is of a magnitude that, even in the presence of SD or PR in target disease, the treating physician would feel it important to change therapy. (RECIST)Unequivocal Progression
Back to top
CL.C71620.UNITUnit
(UNIT)
text
Extensible: Yes
C71620UnitTerminology codelist used for units within CDISC.CDISC SDTM Unit of Measure Terminology
%C25613PercentageA fraction or ratio with 100 understood as the denominator. (NCI)Percentage
% INHIBITIONC117963Percent InhibitionThe rate of measured normal activity minus inhibited activity, divided by the rate of normal activity of a given object. It is expressed as a percentage.Percent Inhibition
%(v/v)C48571Percent Volume per Volume;vol%A percent ratio of volume to volume, defined by the equation: [volume of solute (in ml)/ volume of solution (in ml)](100), typically used for admixtures of solutions.(NCI)Percent Volume per Volume
%(w/v)C48527Percent Weight per VolumeA percent ratio of weight to volume, defined by the equation: [weight of solute (in gm)/volume of solution (in dl)](100). Since the numerator and denominator of this ratio have different units, it is not a true percentage. A 1% w/v solution is defined as being 1 gram of solute dissolved in 100 milliliters of solvent.(NCI)Percent Mass per Volume
%(w/w)C48528Percent Weight per WeightA percent ratio of weight to weight, defined by the equation: [weight of solute (in gm)/weight of solution (in gm)](100).(NCI)Percent Mass per Mass
%/minC114240Percent per MinuteA unit of frequency expressed as the percentage of entities or events per minute.Percent per Minute
/100 HPFsC102695per 100 High Powered FieldsA unit of measurement of the number of entities per unit of area equal to one hundred high powered fields.Per 100 High Powered Fields
/100 WBCC67219Per 100 White Blood CellsNatural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 100 white blood cells.Per 100 White Blood Cells
/10^3 cellsC116240A unit of measure equal to the instances of an entity per 1000 cells.Per Thousand Cells
/dayC25473Daily;Per DayOccurring or done each day. (NCI)Daily
/dLC105514Per DeciliterA volume unit equal to one deciliter used as a denominator to build a derived unit expressed as a ratio. (NCI)Per Deciliter
/hC66966Per HourA rate of occurrences of something within a period of time equal to sixty minutes.Per Hour
/HPFC96619per High Powered FieldA unit of measure equal to the instances of an entity per visual field of a microscope set to its maximum magnification power.Per High Powered Field
/LC105515Per LiterA volume unit equal to one liter used as a denominator to build a derived unit expressed as a ratio. (NCI)Per Liter
/LPFC96620per Low Powered FieldA unit of measure equal to the instances of an entity per visual field of a microscope set to its minimum magnification power.Per Low Powered Field
/mLC103452Per MilliliterA volume unit equal to one milliliter used as a denominator to build a derived unit expressed as a ratio. (NCI)Per Milliliter
/monthC64498Every Month;Per MonthEvery month. (NCI)Monthly
/nLC116243Per NanoliterA volume unit equal to one nanoliter used as a denominator and a unitless measure used as the numerator.Per Nanoliter
/pLC117964Per PicoliterA volume unit equal to one picoliter used as a denominator to build a derived unit expressed as a ratio.Per Picoliter
/uLC67254Per MicroliterA volume unit equal to one microliter used as a denominator to build a derived unit expressed as a ratio. (NCI)Per Microliter
/VFC105516per Visual FieldA unit of measure equal to the instances of an entity per visual field of a microscope. (NCI)Per Visual Field
/wkC67069Every week;Per Week;QSEvery week. (NCI)Weekly
100 IU/mLC71185100 International units/MilliliterA unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one hundred international units per one milliliter of system volume.(NCI)100 International Units per Milliliter
10^10/LC10551710^4/mm3;10^4/uL;10^7/mLA unit of measurement equal to 10 to the tenth power of entities per unit of volume equal to one liter. (NCI)Ten Billion Per Liter
10^11/LC10548810^5/mm3;10^5/uL;10^8/mLA unit of measurement equal to 10 to the eleventh power of entities per unit of volume equal to one liter.Hundred Billion Per Liter
10^12 IU/LC105518TIU/L;Tera International Unit per LiterUnit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of 10^12 international unit per one liter of system volume.(NCI)Tera International Unit Per Liter
10^12/LC6730810^6/mm3;10^6/uL;T/L;TI/L;Tera/LA unit of measurement equal to 10 to the twelfth power of the number of entities per unit of volume equal to one liter.Million per Microliter
10^3 CFUC68895Thousand CFU;Thousand Colony Forming UnitsA unit of measurement of viable bacterial numbers equal to 10 to the third power colony forming units.Thousand Colony Forming Units
10^3 CFU/gC68899Thousand CFU/g;Thousand Colony Forming Units per GramA unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of 10 to the third power colony forming units in one gram of substance.Thousand Colony Forming Units per Gram
10^3 CFU/mLC68903Thousand CFU/mL;Thousand Colony Forming Units per MilliliterA unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the third power colony forming units in one milliliter of substance.Thousand Colony Forming Units per Milliliter
10^3 copies/mLC100897The unit of concentration expressed as the number of 10 to the third power copies in unit volume equal to one milliliter. (NCI)Thousand Copies per Milliliter
10^3 DNA copies/mLC98788A unit of measurement equal to 10 to the third power of the number of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter.Thousand DNA Copies per Milliliter
10^3 organismsC71187Thousand OrganismsA unit of measure of quantity of organisms expressed in 10 to the third power of organisms.Thousand Organisms
10^3 organisms/gC71190Thousand Organisms per Gram;Thousand Organisms/gA unit of measure of organism content expressed in 10 to the third power of organisms per unit of mass equal to one gram.Thousand Organisms per Gram
10^3 organisms/mLC71195Thousand Organisms per Milliliter;Thousand Organisms/mLA unit of measure of organism concentration expressed in 10 to the third power of organisms per unit of volume equal to one milliliter.Thousand Organisms per Milliliter
10^3 RNA copies/mLC98790A unit of measurement equal to 10 to the third power of the number of ribonucleic acid (RNA) copies per unit of volume equal to one milliliter.Thousand RNA Copies per Milliliter
10^3/hpfC98789A unit of measurement equal to 10 to the third power of the number of entities per unit of area equal to one high powered field.Thousand per High Powered Field
10^3/LC105519A unit of measurement equal to 10 to the third power of entities per unit of volume equal to one liter.Thousand Per Liter
10^4/hpfC98787A unit of measurement equal to 10 to the fourth power of the number of entities per unit of area equal to one high powered field.Ten Thousand per High Powered Field
10^4/LC73771A unit of measurement equal to 10 to the fourth power of entities per unit of volume equal to one liter.Thousand per Deciliter
10^5/hpfC98743A unit of measurement equal to 10 to the fifth power of the number of entities per unit of area equal to one high powered field.Hundred Thousand per High Powered Field
10^5/LC10549010^2/mLA unit of measurement equal to 10 to the fifth power of entities per unit of volume equal to one liter.Hundred Thousand Per Liter
10^6 CFUC68896Million CFU;Million Colony Forming UnitsA unit of measurement of viable bacterial numbers equal to 10 to the sixth power colony forming units.Million Colony Forming Units
10^6 CFU/gC68900Million CFU/g;Million Colony Forming Units per GramA unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of 10 to the sixth power colony forming units in one gram of substance.Million Colony Forming Units per Gram
10^6 CFU/mLC68904Million CFU/mL;Million Colony Forming Units per MilliliterA unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the sixth power colony forming units in one milliliter of substance.Million Colony Forming Units per Milliliter
10^6 copies/mLC100898The unit of concentration expressed as the number of 10 to the sixth power copies in unit volume equal to one milliliter. (NCI)Million Copies per Milliliter
10^6 DNA copies/mLC98756A unit of measurement equal to 10 to the sixth power of the number of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter.Million DNA Copies per Milliliter
10^6 IUC67335Million IU;Million International UnitsA unit of biological activity equal to 10 to the sixth power international units.Million International Units
10^6 IU/mLC98757A unit of measurement equal to 10 to the sixth power of the number of international units of an entity per unit of volume equal to one milliliter.Million International Units per Milliliter
10^6 organismsC71188Million OrganismsA unit of measure of quantity of organisms expressed in 10 to the sixth power of organisms.Million Organisms
10^6 organisms/gC71191Million Organisms per Gram;Million Organisms/gA unit of measure of organism content expressed in 10 to the sixth power of organisms per unit of mass equal to one gram.Million Organisms per Gram
10^6 organisms/mgC71193Million Organisms per Milligram;Million Organisms/mgA unit of measure of organism content expressed in 10 to the sixth power of organisms per unit of mass equal to one milligram.Million Organisms per Milligram
10^6 organisms/mLC71196Million Organisms per Milliliter;Million Organisms/mLA unit of measure of organism concentration expressed in 10 to the sixth power of organisms per unit of volume equal to one milliliter.Million Organisms per Milliliter
10^6 RNA copies/mLC98760A unit of measurement equal to 10 to the sixth power of the number of ribonucleic acid (RNA) copies per unit of volume equal to one milliliter.Million RNA Copies per Milliliter
10^6/gC98758A unit of measurement equal to 10 to the sixth power of the number of entities per unit of mass equal to one gram.Million per Gram
10^6/hpfC98759A unit of measurement equal to 10 to the sixth power of the number of entities per unit of area equal to one high powered field.Million per High Powered Field
10^6/LC6745210^3/mL;M/L;Mega/LA unit of measurement equal to 10 to the sixth power of the number of entities per unit of volume equal to one liter.Thousand per Milliliter
10^7/LC9878610^6/dLA unit of measurement equal to 10 to the seventh power of the number of entities per unit of volume equal to one liter.Ten Million per Liter
10^8/LC10548910^2/mm3;10^2/uL;10^5/mLA unit of measurement equal to 10 to the eighth power of entities per unit of volume equal to one liter.Hundred Million Per Liter
10^9 CFUC68897Billion CFU;Billion Colony Forming UnitsA unit of measurement of viable bacterial numbers equal to 10 to the ninth power colony forming units.Billion Colony Forming Units
10^9 CFU/gC68901Billion CFU/g;Billion Colony Forming Units per GramA unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of 10 to the ninth power colony forming units in one gram of substance.Billion Colony Forming Units per Gram
10^9 CFU/mLC68905Billion CFU/mL;Billion Colony Forming Units per MilliliterA unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the ninth power colony forming units in one milliliter of substance.Billion Colony Forming Units per Milliliter
10^9 organismsC71189Billion OrganismsA unit of measure of quantity of organisms expressed in 10 to the ninth power of organisms.Billion Organisms
10^9 organisms/gC71192Billion Organisms per Gram;Billion Organisms/gA unit of measure of organism content expressed in 10 to the ninth power of organisms per unit of mass equal to one gram.Billion Organisms per Gram
10^9 organisms/mgC71194Billion Organisms per Milligram;Billion Organisms/mgA unit of measure of organism content expressed in 10 to the ninth power of organisms per unit of mass equal to one milligram.Billion Organisms per Milligram
10^9 organisms/mLC71197Billion Organisms per Milliliter;Billion Organisms/mLA unit of measure of organism concentration expressed in 10 to the ninth power of organisms per unit of volume equal to one milliliter.Billion Organisms per Milliliter
10^9/LC6725510^3/mm3;10^3/uL;10^6/mL;G/L;GI/L;Giga per LiterA unit of measurement equal to 10 to the ninth power of the number of entities per unit of volume equal to one liter.Billion per Liter
AFUC77534Arbitrary Fluorescence UnitArbitrary unit(s) of fluorescent luminescence. (NCI)Arbitrary Fluorescence Units
agC64553AttogramA unit of mass equal to one quintillionth of a gram (10E-18 gram).(NCI)Attogram
AgU/mLC70500Antigen Unit per MilliliterA measure of an antigen potency defined as a number of antigen units per one milliliter of product.(NCI)Antigen Unit per Milliliter
amolC68855AttomoleA unit of amount of substance equal to one quintillionth of a mole (10E-18 mole).(NCI)Attomole
ampC42536AmpereA unit of electric current, named after the French physicist Andre Ampere. It is that constant current which, if maintained in two straight parallel conductors of infinite length and zero diameter separated by one meter in a vacuum, would produce between these conductors a force equal to 2(10E7) Newton per meter of length. This is dependent upon the definitions of the meter, kilogram, and second. One Ampere represents 6.24 x 10(E18) unit electric charge carriers, such as electrons, passing a specified fixed point in one second.(NCI)Ampere
AMPULEC48473Ampule Dosing UnitA dosing measurement based on the ampule unit.(NCI)Ampule Dosing Unit
amuC64559Atomic Mass UnitA small unit of mass used to express atomic and molecular masses. (NCI)Atomic Mass Unit
anti-Xa IUC70497Anti-Xa Activity International UnitA unit of unfractionated or low molecular weight heparin anticoagulation potency determined as the amount that neutralizes one unit of coagulation factor Xa preparation defined as an international biological standard by WHO (World Health Organization) First International Low Molecular Weight Heparin Reference Standard.(NCI)Anti-Xa Activity International Unit
anti-Xa IU/mLC70498Anti-Xa Activity International Unit per MilliliterA specific anticoagulation activity of unfractionated or low molecular weight heparin on factor Xa, expressed as a number of international anti-Xa heparin units per one milliliter of plasma.(NCI)Anti-Xa Activity International Unit per Milliliter
Antibody UnitC111129A unit of antibody concentration measured by comparison against a known concentration of antibodies in a standard reference specimen.Antibody Unit
APL U/mLC117965Immunoglobin A Phospholipid Units per MilliliterA unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter.Immunoglobin A Phospholipid Unit per Milliliter
APPLICATIONC25397Application Dosing UnitA dosing measurement based on the amount of substance applied.Application Unit
atmC54711AtmosphereA unit of pressure, equal to a barometer reading of 760 mm Hg. 1 atmosphere is 101325 Pascals and 1.01325 bar. This unit of pressure is roughly equal to the average atmospheric pressure at sea level on the earth.(NCI)Atmosphere
AUC73686Absorbance UnitA unit of optical density expressed as the absorbance of light transmitted through the medium on the logarithmic scale. (NCI)Absorbance Unit
AU/minC73687Absorbance Unit per MinuteA unit of a speed of optical density change expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance per minute. (NCI)Absorbance Unit per Minute
AU/mLC70504Allergy Unit per MilliliterUnit of measure of potency of allergenic product expressed as a number of allergy units per one milliliter of formulation.(NCI)Allergy Unit per Milliliter
BAGC48474Bag Dosing UnitA dosing measurement based on the bag unit.(NCI)Bag Dosing Unit
BARC48475Bar Dosing UnitA dosing measurement based on the bar unit.(NCI)Bar Dosing Unit
BAUC70505Bioequivalent Allergy UnitA unit used for standardization of an allergenic product based on evaluation of product potency against reference standard in combined in vivo (skin test) and in vitro (IgE-based ELISA) testing.(NCI)Bioequivalent Allergy Unit
BAU/mLC116235Bioequivalent Allergy Unit per MilliliterUnit of measure of potency of allergenic product expressed as a number of bioequivalent allergy units per one milliliter of formulation.Bioequivalent Allergy Unit per Milliliter
BE/mLC116231Biological Unit per MilliliterUnit of measure of potency of allergenic product expressed as a number of biological units per one milliliter of formulation.Biological Allergy Unit per Milliliter
BEATS/MINC49673Beats per MinuteThe number of heartbeats measured per minute time. (NCI)Beats per Minute
belC71200BelA logarithmic ratio unit (base-10 logarithms) used to express relative magnitude of a physical quantity (usually power or intensity) in comparison with a specified or implied reference level. Particularly, Bel is used as a unit of relative sound intensity. In the latter context it is equal to ten decibels or to approximately 1.151293 nepers.(NCI)Bel
BISCUITC111139A measurement based on the biscuit unit.Biscuit Dosing Unit
BLOCKSC111140A unit of measure to quantify the number of rectangular areas in a city surrounded by streets.Block Unit of Distance
BOLUSC48476Bolus Dosing UnitA dosing measurement based on the bolus unit.(NCI)Bolus Dosing Unit
BOTTLEC48477Bottle Dosing UnitA dosing measurement based on the bottle unit.(NCI)Bottle Dosing Unit
BOXC48478Box Dosing UnitA dosing measurement based on the box unit.(NCI)Box Dosing Unit
BqC42562BecquerelA unit of activity of a radionuclide, equal to one nuclear disintegration or other nuclear transition from a particular energy state occurring in an amount of a radionuclide during one second-long time interval.(NCI)Becquerel
Bq/gC70522Becquerel per GramA unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one gram.(NCI)Becquerel per Gram
Bq/kgC70521Becquerel per KilogramA unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one kilogram.(NCI)Becquerel per Kilogram
Bq/LC71165Becquerel per LiterA unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one liter.(NCI)Becquerel per Liter
Bq/mgC70524Becquerel per Milligram;Kilobecquerel per Gram;kBq/gA unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one milligram.(NCI)Becquerel per Milligram
Bq/mLC71167Becquerel per Milliliter;Kilobecquerel per Liter;kBq/LA unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one milliliter or one kilobecquerel per liter.(NCI)Becquerel per Milliliter
Bq/ugC70523Becquerel per Microgram;Bq/mcg;Kilobecquerel per Milligram;MBq/g;Megabecquerel per Gram;kBq/mgA unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one microgram.(NCI)Becquerel per Microgram
Bq/uLC71166Becquerel per Microliter;Kilobecquerel per Milliliter;MBq/L;Megabecquerel per Liter;kBq/mLA unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one millionth of a liter.(NCI)Becquerel per Microliter
BREATHS/MINC49674Breaths per MinuteThe number of breaths (inhalation and exhalation) taken per minute time. (NCI)Breaths per Minute
BUC117966Bethesda UnitA unit of measurement for blood coagulation inhibitor activity, expressed in the amount of an inhibitor neutralizing 50% of a coagulant during the incubation period.Bethesda Unit
BU/mLC117967Bethesda Unit per MilliliterA unit of measurement for blood coagulation inhibitor activity, expressed as a Bethesda Unit per unit of volume equal to one milliliter. (NCI)Bethesda Unit per Milliliter
CC42559Degree CelsiusA unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)Degree Celsius
calC67193CalorieA measurement of nutritional energy. The quantity of thermal energy required to raise one gram of water one degree Centigrade under standard conditions. 1 calorie equals 4.186 joules. (NCI)calorie
CANC48479Can Dosing UnitA dosing measurement based on the can unit.(NCI)Can Dosing Unit
CAPFULC102405Capful Dosing UnitA unit of measure equal to the amount that the cap on the bottle can contain.Capful Dosing Unit
CAPLETC64696Caplet Dosing UnitA dosing measurement based on the caplet unit.Caplet Dosing Unit
CAPSULEC48480Capsule Dosing Unit;capA dosing measurement based on the capsule unit.(NCI)Capsule Dosing Unit
CARTRIDGEC48481Cartridge Dosing UnitA dosing measurement based on the cartridge unit.(NCI)Cartridge Dosing Unit
CCID 50C7053450 Percent Cell Culture Infective DoseA potency unit defined as a minimal dose of infectious material at which preparation causes cytopathic effects (changes in the morphology and metabolism of cell culture cells, indicating cell death, due to suspected infection) in the 50% of the cell culture-containing vessels inoculated with that dilution of infectious material.(NCI)50 Percent Cell Culture Infective Dose
CCID 50/doseC7053550 Percent Cell Culture Infective Dose per DoseA potency unit equal to the potency at which one dose of preparation contains one 50 percent cell culture infective dose.(NCI)50 Percent Cell Culture Infective Dose per Dose
cdC42538CandelaThe candela is the basic unit of luminous intensity. It is the luminous intensity in a given direction of a small monochromatic light source at 540 terahertz emitting 1/683 watt per steradian in that direction. This is dependent upon the definitions of the meter, kilogram, and second.(NCI)Candela
cells/kgC116239A unit of cell concentration expressed in cells per unit of mass equal to one kilogram.Cells per Kilogram
cells/uLC67242cells/mm3A unit of cell concentration expressed in cells per unit of area equal to one cubic millimeter.Cells per Microliter
CFU/gC68898Colony Forming Unit per GramA unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of colony forming units in one gram of substance.(NCI)Colony Forming Unit per Gram
CFU/mLC68902Colony Forming Unit per MilliliterA unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of colony forming units in one milliliter of substance.(NCI)Colony Forming Unit per Milliliter
cgC64554CentigramA unit of mass equal to one hundredth of a gram.(NCI)Centigram
cGyC64693CentigrayThe metric unit of absorbed radiation dose equal to the absorption of one hundredth of joule of radiation energy per kilogram of matter.Centigray
CiC48466CurieA unit of radioactivity defined as 3.7 E10 atomic disintegrations or other nuclear transformations per second. One Curie is equal to 37 gigabecquerels.(NCI)Curie
Ci/gC70528Curie per Gram;Microcurie per Microgram;Millicurie per Milligram;mCi/mg;uCi/ugA unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one gram.(NCI)Curie per Gram
Ci/kgC70529Curie per Kilogram;Microcurie per Milligram;Millicurie per Gram;mCi/g;uCi/mgA unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one kilogram.(NCI)Curie per Kilogram
Ci/LC71170Curie per Liter;Microcurie per Microliter;uCi/uLA unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one liter.(NCI)Curie per Liter
Ci/mgC70531Curie per Milligram;Millicurie per Microgram;mCi/ugA unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one milligram.(NCI)Curie per Milligram
Ci/mLC71172Curie per MilliliterA unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one milliliter.(NCI)Curie per Milliliter
Ci/ugC70530Ci/mcg;Curie per MicrogramA unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one microgram.(NCI)Curie per Microgram
Ci/uLC71171Ci/mcL;Curie per MicroliterA unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one millionth of a liter.(NCI)Curie per Microliter
CIGARC116244Cigar Dosing UnitA dosing measurement based on the cigar unit.Cigar Dosing Unit
CIGARETTEC116245Cigarette Dosing UnitA dosing measurement based on the cigarette unit.Cigarette Dosing Unit
cLC69087CentiliterThe unit of volume equal to one hundredth of a liter or 10 milliliters or 10 cubic centimeters or 0.6102 cubic inch.Centiliter
cmC49668CentimeterA basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch.Centimeter
cm H2OC91060A unit of pressure defined by a column of water with a height of one centimeter, frequently used to measure central venous pressure, intracranial pressure, and for pressures during mechanical ventilation.Centimeters of Water
cm/minC105481Centimeters per MinuteA unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one minute. (NCI)Centimeter Per Minute
cm/sC102406cm/secA unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one second. (NCI)Centimeter per Second
cm2C48460Square CentimeterA unit of area measurement equal to a square measuring one centimeter on each side. One square centimeter is equal to 10E-4 square meter.(NCI)Square Centimeter
cmolC68687CentimoleA unit of amount of substance equal to one hundredth of a mole (10E-2 mole).(NCI)Centimole
cmol/LC68886Millimoles per Deciliter;mmol/dLA unit of concentration (molarity unit) equal to one centimole of solute in one liter of solution. (NCI)Centimole per Liter
COATC48483Coat Dosing UnitA dosing measurement based on the coat unit.(NCI)Coat Dosing Unit
CONTAINERC48484Container Dosing UnitA dosing measurement based on the container unit.(NCI)Container Dosing Unit
copies/mLC100900A unit of concentration expressed as a number of copies per unit volume equal to one milliliter.Copies per Milliliter
copies/uLC116237A unit of concentration expressed as a number of copies per unit volume equal to one microliter.Copies per Microliter
CoulombC42550CoulombA unit of quantity of electricity, equal to the quantity of charge transferred in one second across a conductor in which there is a constant current of one Ampere.(NCI)Coulomb
cpmC73688Counts per MinuteA unit of frequency expressed as the detection rate of ionization events per minute.Count per Minute
csC10548210^-2 sec;Centisecond;csecA unit of time equal to one hundredth of a second (10E-2 seconds). (NCI)Centisecond
CUPC54703Cup Dosing UnitA dosing measurement based on the cup unit.(NCI)Cup Dosing Unit
cy/cmC114242Grating Cycles per Centimeter;cpcmA unit of measure for the number of repeating vertical or horizontal bars per unit of length equal to one centimeter on a visual acuity testing card.Grating Cycles per Centimeter
cycle/minC71176Cycle per MinuteA unit of frequency equal to the frequency at which one complete execution of a periodically repeated phenomenon, alternation, event, or sequence of events occurs per unit of time equal to one minute.(NCI)Cycle per Minute
cycle/secC71480Cycle per SecondA unit of frequency equal to the frequency at which one complete execution of a periodically repeated phenomenon, alternation, event, or sequence of events occurs per unit of time equal to one second.(NCI)Cycle per Second
CYLINDERC48489Cylinder Dosing UnitA dosing measurement based on the cylinder unit.(NCI)Cylinder Dosing Unit
DAgUC70501D Antigen UnitA unit of potency of poliovirus vaccine used for poliomyelitis prevention. The unit is poliovirus type-specific.(NCI)D Antigen Unit
DAgU/mLC70502D Antigen Unit per MilliliterA unit of potency of poliovirus vaccine expressed as a number of D antigen units per one milliliter of vaccine formulation.(NCI)D Antigen Unit per Milliliter
damol/LC105483Decamole per Liter;Moles per Deciliter;mol/dLA unit of concentration (molarity unit) equal to one decamole of solute in one liter of solution. (NCI)Decamole Per Liter
DAYSC25301DayThe time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI)Day
dBC102407DecibelA unit of measure representing the intensity of an electrical signal or sound which is equal to ten times the logarithm of the ratio of two signals.Decibel
degC68667Degree Unit of Plane AngleA unit of plane angle measurement equal to the length of the arc cut out by the angle, divided by the circumference of the circle, and multiplied by 360. The symbol for degrees is a small superscript circle. One radian is about 57 degrees and one degree is pi/180 radians.(NCI)Degree Unit of Plane Angle
DIOPTERC100899DiopterA unit of measurement of the optical power of a curved mirror or lens represented by the inverse of the focal length in meters.Diopter
DISKC48490Disk Dosing UnitA dosing measurement based on the disk unit.(NCI)Disk Dosing Unit
dLC64697DeciliterThe unit of volume equal to one tenth of a liter. Accepted for use with the SI. (NCI)Deciliter
dmolC68685DecimoleA unit of amount of substance equal to one tenth of a mole (10E-1 mole).(NCI)Decimole
DNA copies/mLC98719DNA Copies per MilliliterThe unit of concentration of deoxyribonucleic acid (DNA) copies expressed as a number of copies in unit volume equal to one milliliter.DNA Copies per Milliliter
DPMC73710Disintegrations per MinuteA unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds. (NCI)Disintegration per Minute
dpm/100mgC117968Disintegrations per Minute per 100 milligrams;dpm/cgA unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one hundred milligrams.Disintegration per Minute per 100 milligrams
dpm/mgC117969Disintegrations per Minute per MilligramA unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one milligram.Disintegration per Minute per Milligram
dpm/mLC117970Disintegrations per Minute per MilliliterA unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to one milliliter.Disintegration per Minute per Milliliter
dramC64564DramA unit of mass equal to 1/16 Avoirdupois ounce or 1/256 Avoirdupois pound. One dram equals approximately 1.7718451953125 grams.(NCI)Dram Mass Unit
DRUMC48492Drum Dosing UnitA dosing measurement based on the drum unit.(NCI)Drum Dosing Unit
dynC70470DyneA unit of force defined as the force that accelerates a mass of one gram at the rate of one centimeter per second squared. One dyne is equal to 10E-5 Newton and 2.248E-6 pounds of force.(NCI)Dyne
EID 50C7053250 Percent Embryo Infective DoseAmount of infectious agent or biological product that causes infection in the 50% of embryos such as chicken embryos used in the product potency assay or pathogen activity assay.(NCI)50 Percent Embryo Infective Dose
EID 50/doseC7053350 Percent Embryo Infective Dose per DoseA potency unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI)50 Percent Embryo Infective Dose per Dose
ELISA unitC68875Enzyme-Linked Immunosorbent Assay UnitA unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme-linked immunosorbent assay method. The enzyme-linked immunosorbent assay unit is used to express potency of immunologically active substances and products, e.g. vaccines.(NCI)Enzyme-Linked Immunosorbent Assay Unit
ELISA unit/doseC68876Enzyme-Linked Immunosorbent Assay Unit per DoseA unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.(NCI)Enzyme-Linked Immunosorbent Assay Unit per Dose
ELISA unit/mLC68877Enzyme-Linked Immunosorbent Assay Unit per MilliliterA unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per unit volume equal to one milliliter.(NCI)Enzyme-Linked Immunosorbent Assay Unit per Milliliter
Enzyme UC64778Enzyme UnitA unit of catalytic activity measurement defined as the quantity of a particular enzyme that catalyzes the transformation of one micromole of the substrate per minute under standard conditions for specified assay system.Enzyme Unit
eqC67273Equivalent WeightA unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox reaction, or to the amount of substances that releases or accepts one mole of hydrogen ions in a neutralization reaction; or to the amount of electrolyte that carries one mole of positive or negative charge. This is a large unit and measurements are more often done in its derivatives, e.g. in milliequivalents.(NCI)Equivalent Weight
EUC96599EU/dL;Ehrlich UnitsA unit of measure equal to one milligram of urobilinogen per deciliter.Ehrlich Unit
FC44277Degree FahrenheitThe Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)Degree Fahrenheit
FaradC42552FaradA unit of capacitance equal to the capacitance of a capacitor having an equal and opposite charge of one coulomb on each plate and a potential difference of one volt between the plates.(NCI)Farad
FEUC96649Fibrinogen Equivalent UnitsA unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of fibrinogen contained within that sample.Fibrinogen Equivalent Unit
fgC64552FemtogramA unit of mass equal to one quadrillionth of a gram (10E-15 gram).(NCI)Femtogram
FINGERTIP UNITC71321Fingertip UnitAn arbitrary dosing unit used predominantly for semisolid topical formulations such as cream, ointment, paste, etc. One fingertip unit is the amount of a product that is squeezed out from a standard tube with 5-millimeter diameter nozzle along an adult's fingertip. A fingertip length is defined from the tip of the index finger to the first finger crease. A fingertip dosing unit varies with age and size of the body. The average fingertip unit is equal to approximately 0.5 gram for an adult male and 0.4 gram for an adult female.(NCI)Fingertip Dosing Unit
fLC64780Cubic Micrometer;Cubic Micron;Femtoliter;um3The unit of volume equal 10E-15 liter.Femtoliter
fmolC68854FemtomoleA unit of amount of substance equal to one quadrillionth of a mole (10E-15 mole).(NCI)Femtomole
fmol/gC73711Femtomole per GramA molality unit that describes the amount of substance, expressed in femtomole(s) per gram. (NCI)Femtomole per Gram
fmol/LC68887Femtomole per LiterA unit of concentration (molarity unit) equal to one quadrillionth of a mole (10E-15 mole) of solute in one liter of solution. (NCI)Femtomole per Liter
foz_brC48577Fluid Ounce ImperialA traditional unit of liquid volume equal in the British Imperial system to 1/20 pint, or 1.733871 cubic inches or 28.413063 milliliters.Fluid Ounce British
foz_usC48494Fluid Ounce USA traditional unit of liquid volume equal in the US customary system to 1/16 pint, or 1.804687 cubic inches or 29.573531 milliliters.Fluid Ounce US
fraction of 1C105484A unit for expressing a percentage as a decimal whereby the total value is measured as a fraction of the numeric 1.Fraction of 1
Frames/sC106524F/s;FPS;Frames per Second;Frames/secA unit of measure equal to the number of visual frames per unit of time equal to one second. (NCI)Frames Per Second
ftC71253FootA unit of length defined by the U.S. National Bureau of Standards as 30.48 centimeters. It is equal to 0.3048 meter, 12 inches, or to approximately 0.999998 survey foot.(NCI)International Foot
ft2C48461Square FootA unit of area equal to 144 square inches, 929.0304 square centimeters, or 9.290304E-2 square meters.(NCI)Square Foot
ft3C68859Standard Cubic FootA unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic foot at 60 degrees Fahrenheit and pressure of one atmosphere.(NCI)Standard Cubic Foot
gC48155GramA metric unit of mass equal to one one thousandth of a kilogram. (NCI)Gram
g/animalC73713Gram per AnimalA unit of measure expressed in gram(s) per animal.Gram per Animal
g/animal/dayC73714Gram per Animal per DayA unit of measure expressed in gram(s) per animal per period of time equal to twenty-four hours.Gram per Animal per Day
g/animal/wkC73715Gram per Animal per WeekA unit of measure expressed in gram(s) per animal per period of time equal to seven days.Gram per Animal per Week
g/cageC73716Gram per CageA unit of measure expressed in gram(s) per cage.Gram per Cage
g/cage/dayC73717Gram per Cage per DayA unit of measure expressed in gram(s) per cage per period of time equal to twenty-four hours.Gram per Cage per Day
g/cage/wkC73718Gram per Cage per WeekA unit of measure expressed in gram(s) per cage per period of time equal to seven days.Gram per Cage per Week
g/cm2C71201Gram per Square CentimeterA unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit.(NCI)Gram per Square Centimeter
g/dayC67372Gram per Day;g/24h;g/d;gram/24 Hours;gram/dayA dose calculation unit expressed in gram(s) per period of time equal to twenty-four hours.Gram per 24 Hours
g/dLC64783Gram per Deciliter;g%A unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which mass equal to one gram occupies the volume one deciliter.(NCI)Gram per Deciliter
g/gC70453Gram per GramA unit of a mass fraction expressed as a number of grams of substance per gram of mixture.Gram per Gram
g/g/dayC73720Gram per Gram per DayA unit of measure expressed in gram(s) per gram per period of time equal to twenty-four hours.Gram per Gram per Day
g/kgC69104Gram per Kilogram;Milligram per Gram;mg/gA unit of a mass fraction expressed as a number of grams of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI)Gram per Kilogram
g/kg/dayC66975Gram per Kilogram per Day;Milligram per Gram per Day;mg/g/dayA dose administration rate unit equal to the rate at which one gram of a product per kilogram of body mass is delivered or administered over the period of one day. (NCI)Gram per Kilogram per Day
g/LC42576Gram per Liter;Kilogram per Cubic Meter;Microgram per Microliter;Milligram per Milliliter;g/L;kg/m3;mg/mL;ug/uLA unit of concentration or mass density equal to one milligram of substance per milliliter of solution or one gram of substance per liter of solution.Kilogram per Cubic Meter
g/m2C67282Gram per Square MeterA unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one square meter. It is equal to approximately 0.029 4935 ounce per square yard. Also used as a dose calculation unit.(NCI)Gram per Square Meter
g/m2/dayC73722Gram per Square Meter per DayA dose calculation unit expressed in gram(s) per square meter per period of time equal to twenty-four hours.Gram per Square Meter per Day
g/molC73721Gram per MoleA unit of mass commonly used to express the molar mass of a substance in gram(s) per mole. (NCI)Gram per Mole
GaussC68915GaussThe unit of magnetic flux density. A field of one Gauss exerts a force on a conductor, placed in the field of 0.1 dyne per Ampere of current per centimeter of conductor. One Gauss represents a magnetic flux of one Maxwell per square centimeter of cross-section perpendicular to the field. One Gauss equals 10-4 Tesla.(NCI)Gauss
GBqC70513GigabecquerelA unit of radioactivity equal to one billion nuclear disintegrations or other nuclear transformations per second, or to 10E9 Becquerels.(NCI)Gigabecquerel
GBq/gC70525Gigabecquerel per Gram;Kilobecquerel per Microgram;kBq/ugA unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one gram.(NCI)Gigabecquerel per Gram
GBq/mgC70527Gigabecquerel per Milligram;MBq/mcg;MBq/ug;Megabecquerel per MicrogramA unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one milligram.(NCI)Gigabecquerel per Milligram
GBq/ugC70526GBq/mcg;Gigabecquerel per Microgram;MBq/ng;Megabecquerel per nanogramA unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one microgram.(NCI)Gigabecquerel per Microgram
GPL U/mLC117971Immunoglobin G Phospholipid Units per MilliliterA unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter.Immunoglobin G Phospholipid Unit per Milliliter
grainC48497GrainA unit of mass derived from the weight of a grain and equal to one seven-thousandth of a pound, or 1/480 troy ounce, or 64.79891 milligrams. The original English grain unit based on the mass of a ripe grain barleycorn was larger the corresponding grain units of France and other European nations which were based on the weight of the smaller wheat grain.(NCI)Grain
gttC69442DropA unit of volume equal to 0.05 milliliter (20 drops/ml).(NCI)Medical Drop
GyC18063GrayA unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.(NCI)Gray
HenryC42558HenryA unit of electric inductance. A coil with an inductance of one Henry requires a flux of one Weber for each Ampere of induced current. If it is the current which changes, then the induced field will generate a potential difference within the coil: if the inductance is one Henry a current change of one Ampere per second generates a potential difference of one volt. The Henry is a large unit; inductances in practical circuits are measured in millihenrys or microhenrys.(NCI)Henry
HEPC116232Histamine Equivalent Prick UnitUnit of measure of potency of allergenic product expressed as a number of histamine equivalent prick units.Histamine Equivalent Prick Unit
HOMEOPATHIC DILUTIONC48498Homeopathic Dilution UnitA dosing measurement based on the homeopathic dilution unit.(NCI)Homeopathic Dilution Unit
Hounsfield UnitC94908HUThe unit of measure for the radiodensity of a substance. The radiodensity of distilled water at standard temperature and pressure is zero on the Hounsfield scale.Hounsfield Unit
HOURSC25529Hour;hrA unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)Hour
hPaC105487HectopascalA SI derived unit of pressure equivalent to one hundred pascals, 1 millibar or 0.0145 pounds per square inch.Hectopascal
HPFC67274High Power FieldThe area visible under the maximum magnification power of the objective being used in microscopy.(NCI)High Power Field
HzC42545HertzA unit of frequency equal to one cycle per second.(NCI)Hertz
IMPLANTC48499Implant Dosing UnitA dosing measurement based on the implant unit.(NCI)Implant Dosing Unit
inC48500InchA traditional unit of length equal to 2.54 centimeters. (NCI)Inch
in2C68871Square InchA unit of area equal to the area of a square with sides of one inch. It is equal to 6.4516 square centimeters.(NCI)Square Inch
INHALATIONC48501Inhalation Dosing UnitA dosing measurement based on the inhalation unit.(NCI)Inhalation Dosing Unit
IUC48579IE;International UnitThe unitage assigned by the WHO (World Health Organization) to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization, to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.(NCI)International Unit
IU/gC70493International Unit per GramA unit of measure of quantity of substance per unit mass, expressed in terms of the International Unit per grams.(NCI)International Unit per Gram
IU/kgC67379International Unit per KilogramAn arbitrary unit of substance content expressed in international units of biological activity per one kilogram of mass of the system. It is also used as a dose calculation unit expressed in international units of biological activity per one kilogram of body mass.(NCI)International Unit per Kilogram
IU/kg/hC71209International units per Kilogram per HourA dose calculation unit equal to one international unit (an arbitrary unit of biological activity) of a product per one kilogram of body mass administered per unit of time equal to one hour.(NCI)International Unit per Kilogram per Hour
IU/LC67376IE/L;IU/L;International Unit per Liter;mIU/mLA unit of concentration (biologic activity) equal to one milli-international unit of substance per milliliter of solution or one international unit of substance per liter of solution.International Unit per Liter
IU/mgC67380International Unit per MilligramA unit of measure of quantity of substance per unit mass, expressed in terms of international units per milligram.International Unit per Milligram
IU/mLC67377IE/mL;International Unit per Milliliter;Kilo International Unit per Liter;kIU/LA unit of concentration (biologic activity) equal to one international unit of substance per milliliter of solution.International Unit per Milliliter
JARC48502Jar Dosing UnitA dosing measurement based on the jar unit.(NCI)Jar Dosing Unit
JouleC42548JouleA unit of electrical, mechanical, and thermal energy (as well as work and quantity of heat), equal to the work done when the point of application of a force of one Newton is displaced through a distance of one meter in the direction of the force or the work done when a current of one Ampere passes through a resistance of one ohm for one second. One joule is equal to 0.23889 gram-calorie (mean).(NCI)Joule
KALLIKREIN INHIBITOR UNITC48503Kallikrein Inhibitor UnitA dosing measurement based on the Kallikrein inhibitor unit.(NCI)Kallikrein Inhibitor Unit
katC42566KatalA unit for measuring catalytic (e.g. enzymatic) activity, the ability of the compound to accelerate the chemical reaction by providing a lower energy pathway between the reactants and the products. One katal is that catalytic activity which will raise the rate of reaction by one mole per second in a specified assay system. When the katal is used, the measurand should be specified by reference to the measurement procedure; the measurement procedure must identify the indicator reaction. The katal is not used to express a rate of reaction itself, which should be expressed in moles per second.(NCI)Katal
kBqC70511KilobecquerelA unit of radioactivity equal to one thousand nuclear disintegrations or other nuclear transformations per second, or to 10E3 Becquerels.(NCI)Kilobecquerel
kBq/uLC71168GBq/L;Gigabecquerel per Liter;Kilobecquerel per Microliter;MBq/mL;Megabecquerel per MilliliterA unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousand Becquerels per unit volume equal to one millionth of a liter.(NCI)Kilobecquerel per Microliter
kcalC67194Kilogram-CalorieA unit of energy defined as the amount of heat required to raise the temperature of one kilogram of pure water by one degree Centigrade under standard conditions (the specific heat of the water at 15 degrees Celsius and the constant pressure of 101.325 kilopascals or one atm being defined as unity), equal to approximately 4.1855 kJ. It is also is used by nutritionists in measuring the energy-producing potential of food as a unit of potential energy contained by a substance, which can be liberated when the material is oxidized, usually by combustion in the presence of oxygen.(NCI)Calorie
kDaC105491Kilodalton;Kilounified Atomic Mass Unit;kuA mass unit equal to one thousand daltons.Kilodalton
kgC28252KilogramThe basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI)Kilogram
kg/cm2C69094Kilogram per Square CentimeterA unit of spread rate of a substance by mass expressed in kilograms per area unit equal to one square centimeter, used also as a measure of area density and as a dose calculation unit.(NCI)Kilogram per Square Centimeter
kg/LC64566Gram per Milliliter;Kilogram per Liter;g/mL;gram/mL;kg/L;mg/uLA unit of concentration or mass density equal to one gram of substance per milliliter of solution or one kilogram of substance per liter of solution.Kilogram per Liter
kg/m2C49671Kilogram per Square MeterA unit expressed as kilogram of mass per square meter of area.(NCI)Kilogram per Square Meter
kHzC67279kilohertzA unit of measure denoting the frequency equal to 1000 cycles per second meaning e.g. that the cylical waveform changes from one state to the other (from one polarity to the other) 1000 times per second. (NCI)Kilohertz
KITC48504Kit Dosing UnitA dosing measurement based on the kit unit.(NCI)Kit Dosing Unit
kIUC70492Kilo International UnitA unit equal to one thousand international units.(NCI)Kilointernational Unit
kmC71177KilometerA unit of distance equal to 1000 meters, 0.621 miles, 1094 yards, or 3281 feet.(NCI)Kilometer
km/hC71203Kilometer Per HourA unit of both speed (scalar) and velocity (vector), defined as the distance of one thousand meters travelled per unit time equal to one hour.(NCI)Kilometer per Hour
kN/cm2C92615Kilonewton per Centimeter Squared;kdyn/cm2The kilonewton per centimeter squared is an SI derived unit of pressure; one newton is computed as the force necessary to accelerate a mass of one gram at the rate of one centimeter per second squared. One kilonewton per centimeter squared is descriptive of the amount of force exerted in a particular area. This measurement is frequently used when describing conditions of cellular movement. (NCI)Kilonewton per Centimeter Squared
kPaC67284KilopascalA SI derived unit of pressure equivalent to 1000 newtons per square meter or 10000 bars or to 0.145 pound per square inch. (NCI)Kilopascal
kPa/L/secC105492Pa/mL/secA unit of resistance equal to the number of kilopascals per unit of volume equal to one liter per unit of time equal to one second. (NCI)Kilopascal Per Liter Per Second
ksC10549310^3 sec;Kilosecond;ksecA unit of time equal to one thousand seconds (10E3 seconds). (NCI)Kilosecond
kUSPC71202Kilo United States Pharmacopoeia UnitA unit of potency equal to one thousand US Pharmacopoeia Units.(NCI)Kilo United States Pharmacopeia Unit
LC48505LiterA unit of volume equal to a cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.(NCI)Liter
L/hC69160L/hLiters per hour.Liter per Hour
L/h/m2C105494Liters per Hour per Square MeterA unit expressed as one liter of volume per unit of time equal to one hour per square meter of area. (NCI)Liter Per Hour Per Square Meter
L/kgC73725Liter per KilogramA dose calculation unit expressed in liter(s) per kilogram. (NCI)Liter per Kilogram
L/LC105495Liter per Liter;dL/dL;mL/mL;uL/uLA unit of volume concentration equal to the number of liters per unit of volume equal to one liter.Liter Per Liter
L/minC67388Liters per MinuteA unit of volumetric flow rate defined as the rate at which one liter of matter travels during the period of time equal to one minute.(NCI)Liter per Minute
L/min/m2C105496Liters per Minute per Square MeterA unit expressed as one liter of volume per unit of time equal to one minute per square meter of area. (NCI)Liter Per Minute Per Square Meter
L/sC67390L/secLiters per second.Liter per Second
LBC48531PoundA traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)Pound
lmC42560LumenA unit of luminous flux. It is the amount of light that falls on a unit area at unit distance from a source of one candela.(NCI)Lumen
log EID 50/doseC70480Log10 50 Percent Embryo Infective Dose per DoseA logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI)Log10 50 Percent Embryo Infective Dose per Dose
log10 CCID 50C70484Log10 50 Percent Cell Culture Infective DoseA potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of the cell culture-containing vessels inoculated with that dilution of infectious material in the product potency assay or pathogen activity assay.(NCI)Log10 50 Percent Cell Culture Infective Dose
log10 CCID 50/doseC70485Log10 50 Percent Cell Culture Infective Dose per DoseA logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent cell culture infective dose.(NCI)Log10 50 Percent Cell Culture Infective Dose per Dose
log10 CFU/gC102658A logarithmic-scale (base 10) unit for measuring colony forming units per unit of mass equal to one gram.Log10 Colony Forming Units per Gram
log10 CFU/mLC102659A logarithmic-scale (base 10) unit for measuring colony forming units per unit of volume equal to one milliliter.Log10 Colony Forming Units per Milliliter
log10 copies/mLC117972A logarithmic-scale (base 10) unit for measuring copies per unit of volume equal to one milliliter.Log10 Copies per Milliliter
log10 EID 50C70479Log10 50 Percent Embryo Infective DoseA potency unit for measuring infectious activity of a biologic product or infectious agent equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of embryos (such as chicken embryos) used in the product potency assay or pathogen activity assay.(NCI)Log10 50 Percent Embryo Infective Dose
Log10 ELISA unitC68878Log10 Enzyme-Linked Immunosorbent Assay UnitA logarithmic-scale (base 10) unit for measuring concentration and/or reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference for the particular quantitative enzyme-linked immunosorbent assay method.(NCI)Log10 Enzyme-Linked Immunosorbent Assay Unit
Log10 ELISA unit/doseC68879Log10 Enzyme-Linked Immunosorbent Assay Unit per DoseA logarithmic-scale (base 10) unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.(NCI)Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose
log10 IU/mLC116238A logarithmic-scale (base 10) unit for measuring international units per unit of volume equal to one milliliter.Log10 International Units per Milliliter
log10 TCID 50C70488Log10 50 Percent Tissue Culture Infective DoseA potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of the tissue culture-containing flasks inoculated with that dilution of infectious material in the product potency assay or pathogen activity assay.(NCI)Log10 50 Percent Tissue Culture Infective Dose
log10 TCID 50/doseC70489Log10 50 Percent Tissue Culture Infective Dose per DoseA logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent tissue culture infective dose.(NCI)Log10 50 Percent Tissue Culture Infective Dose per Dose
LOZENGEC48506Lozenge Dosing UnitA dosing measurement based on the lozenge unit.(NCI)Lozenge Dosing Unit
LPFC67307Low Power FieldThe area visible in one view field of the microscope under the low magnification of the objective being used in microscopy.(NCI)Low Power Field
lxC42561LuxA unit of illuminance equal to the direct illumination on a surface that is everywhere one meter from a uniform point source of one candela; a unit of illuminance that is equal to one lumen per square meter.(NCI)Lux
mC41139MeterA meter is defined as the length of the path traveled by light in a vacuum during a time interval of 1/299 792 458 of a second and is equal to 1.093 61 yards.(NCI)Meter
m/secC42571Meter Per SecondA unit of both speed (scalar) and velocity (vector), defined as the distance of one meter travelled per unit time equal to one second.(NCI)Meter per Second
m2C42569Square MeterThe SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)Square Meter
m3C42570Cubic MeterA unit of volume or capacity equal to the volume of a cube with edges one meter in length. It is equal to 1,000 liters; 1,000 cubic decimeters; 10(E6) cubic centimeters; 25.3 cubic feet; 6.29 barrels.(NCI)Cubic Meter
MBqC70512MegabecquerelA unit of radioactivity equal to one million nuclear disintegrations or other nuclear transformations per second, or to 10E6 Becquerels.(NCI)Megabecquerel
MBq/uLC71169GBq/mL;Gigabecquerel per Milliliter;Megabecquerel per MicroliterA unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one million Becquerels per unit volume equal to one millionth of a liter.(NCI)Megabecquerel per Microliter
mCiC48511MillicurieA unit of radioactivity equal to one thousandth of a Curie or 37 megabecquerels, and corresponding to a radioactivity of 37 millions of atomic disintegrations per second.(NCI)Millicurie
mCi/kgC70570Microcurie per Gram;Millicurie per Kilogram;uCi/gA unit of specific radioactivity (massic activity) equal to activity of one millicurie of the sample with total mass of one kilogram.(NCI)Millicurie per Kilogram
mCi/LC71174Microcurie per Milliliter;Millicurie per Liter;uCi/mLA unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousandth of a Curie per unit volume equal to one liter.(NCI)Millicurie per Liter
mEqC48512MilliequivalentA unit of relative amount of a substance equal to one thousandth of an equivalent weight.(NCI)Milliequivalent
mEq/dayC67471Milliequivalents per DayA unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance travels to a given object or space over a period of time equal to twenty four hours.(NCI)Milliequivalent per 24 Hours
mEq/dLC67473Milliequivalent per DeciliterA concentration unit measured as a number of milliequivalents of solute per deciliter of solution. (NCI)Milliequivalent per Deciliter
mEq/gC70580Milliequivalent Per GramA unit of relative amount of substance content equivalent to the content at which one gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI)Milliequivalent per Gram
mEq/g CreatinineC105501A unit of relative amount of substance concentration defined as the concentration of milliequivalents per gram of creatinine.Milliequivalent Per Gram of Creatinine
mEq/kgC67475Milliequivalent Per KilogramA unit of relative amount of substance content equivalent to the content at which one kilogram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI)Milliequivalent per Kilogram
mEq/LC67474Milliequivalent Per Liter;Millivalent per Liter;mval/LA concentration unit measured as a number of milliequivalents of solute per liter of solution.(NCI)Milliequivalent per Liter
mEq/mLC73737Milliequivalent per MilliliterA concentration unit expressed in milliequivalent(s) of solute per milliliter of solution. (NCI)Milliequivalent per Milliliter
mEq/mmolC92616Milliequivalent per MillimoleA concentration unit measured as a number of one thousandth of an equivalent weight per millimole of substance. (NCI)Milliequivalent per Milliimole
mEq/ugC70581Milliequivalent Per Microgram;mEq/mcgA unit of relative amount of substance content equivalent to the content at which one millionth of a gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI)Milliequivalent per Microgram
mEq/uLC70578Milliequivalent Per MicroliterA concentration unit measured as a number of milliequivalents of solute per microliter of solution.(NCI)Milliequivalent per Microliter
MESFC96691Molecules of Equivalent Soluble FluorochromesA unit of measure of the fluorescence intensity of a fluorochrome-labeled sample, which is equivalent to the fluorescence intensity of a solution containing an equivalent number of molecules of free fluorochrome in solution, under identical experimental conditions.Molecule of Equivalent Soluble Fluorochrome
MFIC96687Median Fluorescence IntensityA unit of measure equal to the geometric mean fluorescence intensity of a log-normal distribution of fluorescence signals.Median Fluorescence Intensity
mgC28253MilligramThe unit of mass equal to one thousandth of a gram or 1000 micrograms. One milligram equals approximately 0.015432 grain or 35.274 x 10E-6 ounce.(NCI)Milligram
mg/animalC73738Milligram per AnimalA unit of measure expressed in milligram(s) per animal.Milligram per Animal
mg/dayC67399Milligram per DayA unit of measure referring to the ratio between mass expressed in milligrams per day.(NCI)Milligram per 24 Hours
mg/dLC67015Milligram per Deciliter;mg%A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.(NCI)Milligram per Deciliter
mg/g CreatinineC105502A unit of substance concentration defined as the number of milligrams per gram of creatinine.Milligram Per Gram of Creatinine
mg/g/hC73740Milligram per Gram per HourA dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty minutes. (NCI)Milligram per Gram per Hour
mg/g/minC73741Milligram per Gram per MinuteA dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty seconds. (NCI)Milligram per Gram per Minute
mg/hC66969Milligram per HourA unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI)Milligram per Hour
mg/kgC67401Milligram per Kilogram;ug/gA unit of a mass fraction expressed as a number of milligrams of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI)Milligram per Kilogram
mg/kg/dayC66976Milligram per Kilogram per DayA dose calculation unit expressed in milligram(s) per kilogram per period of time equal to twenty-four hours. (NCI)Milligram per Kilogram per Day
mg/kg/hC71362Milligram per Kilogram per HourA dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one hour.(NCI)Milligram per Kilogram per Hour
mg/kg/minC71207Milligram per Kilogram per MinuteA dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.(NCI)Milligram per Kilogram per Minute
mg/LC64572Gram per Cubic Meter;Microgram per Milliliter;Milligram per Liter;g/m3;mcg/mL;mg/L;ng/uL;ug/mLA unit of concentration or mass density equal to one microgram of substance per milliliter of solution or one milligram of substance per liter of solution.Microgram per Milliliter
mg/m2C67402Milligram per Square MeterA unit of area density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit.(NCI)Milligram per Square Meter
mg/m2/dayC66974Milligram per Square Meter per DayA dose calculation unit expressed in milligram(s) per square meter per period of time equal to twenty-four hours. (NCI)Milligram per Square Meter per Day
mg/m2/hC73743Milligram per Square Meter per HourA dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty minutes. (NCI)Milligram per Square Meter per Hour
mg/m2/minC73744Milligram per Square Meter per MinuteA dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty seconds. (NCI)Milligram per Square Meter per Minute
mg/minC73742Milligram per MinuteMilligrams per minute.Milligram per Minute
mg/mL/minC67403Milligram per Milliliter per MinuteA unit expressed in milligrams per milliliter per period of time equal to sixty seconds.Milligram per Milliliter per Minute
MHzC67314MegahertzThe SI derived unit of frequency; equal to one million oscillations per second or to 10E6 hertz. (NCI)Megahertz
MileC71183International MileA unit of distance equal to 5280 international feet, 1760 international yards, or 1609.344 meters.(NCI)Mile
minC48154Minute Unit of TimeA unit measure of time equal to 60 seconds.(NCI)Minute
mIU/LC67405Micro-International Unit per milliliter;mIE/L;mIU/L;mcIU/mL;uIU/mLA unit of concentration (biologic activity) equal to one micro-international unit of substance per milliliter of solution or one milli-international unit of substance per liter of solution.Microinternational Unit per Milliliter
mJoule/cm2C116241A unit of radiant exposure defined as a unit of energy equal to one millijoule applied to a unit of area equal to one square centimeter.Millijoules per Square Centimeter
mkatC70507MillikatalA unit of catalytic activity measurement equal to one thousandth of one katal (10E-3 katal).(NCI)Millikatal
mLC28254Milliliter;cm3The unit of volume equal to one thousandth of a liter, one cubic centimeter, 10E-6 cubic meter, or approximately to 0.061 023 7 cubic inch.(NCI)Milliliter
mL/animalC73746Milliliter per AnimalA unit of measure expressed in milliliter(s) per animal.Milliliter per Animal
mL/animal/dayC73747Milliliter per Animal per DayA unit of measure expressed in milliliter(s) per animal per period of time equal to twenty-four hours.Milliliter per Animal per Day
mL/animal/wkC73748Milliliter per Animal per WeekA unit of measure expressed in milliliter(s) per animal per period of time equal to seven days.Milliliter per Animal per Week
mL/breathC73749Milliliter per BreathA unit of measure expressed in milliliter(s) per inspiration or expiration of breath.Milliliter per Breath
mL/cageC73750Milliliter per CageA unit of measure expressed in milliliter(s) per cage.Milliliter per Cage
mL/cage/dayC73751Milliliter per Cage per DayA unit of measure expressed in milliliter(s) per cage per period of time equal to twenty-four hours.Milliliter per Cage per Day
mL/cage/wkC73752Milliliter per Cage per WeekA unit of measure expressed in milliliter(s) per cage expressed per period of time equal to seven days.Milliliter per Cage per Week
mL/cmC105503Milliliter per Centimeter;dL/mA unit of measure equal to the number of milliliters per unit of length equal to one centimeter. (NCI)Milliliter per Centimeter
mL/cm H2OC98755A unit of pressure expressed in milliliter(s) per centimeter of water. (NCI)Milliliter per Centimeter of Water
mL/dayC67410Milliliter per DayMilliliters per day.Milliliter per 24 Hours
mL/dLC105504Milliliters per DeciliterA unit of volume concentration equal to the number of milliliters per unit of volume equal to one deciliter.Milliliter per Deciliter
mL/gC73754Milliliter per GramA unit of measure expressed in milliliter(s) per gram.Milliliter per Gram
mL/g/dayC73755L/day/kg;L/kg/d;Milliliter per Gram per Day;mL/day/g;mL/g/day;uL/day/mg;uL/mg/dayLiters per kilogram per day.Milliliter per Gram per Day
mL/g/hC73756Milliliter per Gram per HourMilliliters per gram per hour.Milliliter per Gram per Hour
mL/g/minC73757Milliliter per Gram per MinuteMilliliters per gram per minute.Milliliter per Gram per Minute
mL/hC66962Milliliters per HourA unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one hour.(NCI)Milliliter per Hour
mL/kgC67411Milliliter per KilogramA dose calculation unit equal to one milliliter of preparation per one kilogram of body mass. (NCI)Milliliter per Kilogram
mL/kg/dayC73758Milliliter per Kilogram per DayMilliliters per kilogram per day.Milliliter per Kilogram per Day
mL/kg/hC73759Milliliter per Kilogram per HourMilliliters per kilogram per hour.Milliliter per Kilogram per Hour
mL/kg/minC73760Milliliter per Kilogram per Minute;mL/kg/min;mL/min/kg;uL/g/min;uL/min/gMilliliters per kilogram per minute.Milliliter per Kilogram per Minute
mL/m2C73761Milliliter per Square MeterA unit of measure expressed in milliliter(s) per square meter.Milliliter per Square Meter
mL/m2/dayC66977Milliliter per Square Meter per DayA dose calculation unit expressed in milliliter(s) per square meter per period of time equal to twenty-four hours. (NCI)Milliliter per Square Meter per Day
mL/m2/hC73762Milliliter per Square Meter per HourA dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty minutes. (NCI)Milliliter per Square Meter per Hour
mL/m2/minC73763Milliliter per Square Meter per MinuteA dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty seconds. (NCI)Milliliter per Square Meter per Minute
mL/minC64777Milliliters per MinuteA metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute.(NCI)Milliliter per Minute
mL/min/1.73m2C67412A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute per 1.73 meters squared of body surface area.Milliliter per Minute per 1.73 m2 of Body Surface Area
mL/min/mmHgC67417Milliliter per Minute per TorrA unit of measure equal to the number of milliliters per unit of time equal to one minute per unit of pressure equal to one milliter of mercury (mmHg).Milliliter per Minute per Millimeters of Mercury
mL/mmHgC106542Milliliters per Millimeter of MercuryA unit equal to the volume in milliliters per one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)Milliliters Per Millimeter of Mercury
mL/mmHg/min/LC67418A unit of gas diffusion capacity equal to one milliliter per millimeter of mercury per minute per liter of volume.Milliliter per Minute per Millimeters of Mercury per Liter
mL/sC69073mL/secMilliliters per second.Milliliter per Second
mL/sec/1.73m2C105505A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per 1.73 meters squared of body surface area.Milliliter Per Second Per 1.73 Meter Squared
mmC28251MillimeterA unit of measure equal to one thousandth of a meter. (NCI)Millimeter
mm/2hC105509Millimeters per Two HoursA unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to two hours. (NCI)Millimeter per Two Hours
mm/hC67419Millimeter per HourA unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travels per unit time equal to one hour.(NCI)Millimeter per Hour
mm/minC105507Millimeters per MinuteA unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one minute. (NCI)Millimeter Per Minute
mm/secC105508Millimeters per SecondA unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one second. (NCI)Millimeter Per Second
mm2C65104Square MillimeterA unit of area measurement equal to a square measuring one millimeter on each side. One square millimeter is equal to 10(E-2) square centimeter and 10(E-6) square meter.(NCI)Square Millimeter
mmHgC49670Millimeter of MercuryA unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)Millimeter of Mercury
mmHg/L/minC105506A unit of resistance equal to the number of millimeters of mercury per unit of volume equal to one liter per unit of time equal to one minute.Millimeter Mercury Per Liter Per Minute
mmHg/secC73764Millimeter of Mercury per SecondA rate of inflation or deflation of a manometric device based on the unit of pressure equal to 133,332 Pa or 1.316E10-3 standard atmosphere during period of time equal to one sixtieth of a minute. (NCI)Millimeter of Mercury per Second
mmolC48513MillimoleA unit of amount of substance equal to 0.001 mole.(NCI)Millimole
mmol/dayC67420Millimole per 24 HoursA unit of amount of substance flow rate equivalent to the rate at which one thousandth of a mole of substance travels or is delivered to a given object or space over a period of time equal to 24 hours.(NCI)Millimole per 24 Hours
mmol/gC68740Millimole per GramA unit amount of substance content (molality unit) defined as one mole of solute per one kilogram of solvent.(NCI)Mole per Kilogram
mmol/g CreatinineC105510A unit of substance concentration defined as the concentration of millimoles of solute per gram of creatinine.Millimole Per Gram of Creatinine
mmol/kgC68892Millimole per KilogramA unit of amount of substance content (molality unit) defined as one thousandth of mole (10E-3 mole) of solute per one kilogram of solvent.(NCI)Millimole per Kilogram
mmol/LC64387Micromole per Milliliter;Millimole per Liter;Mole per Cubic Meter;mcmol/mL;mmol/L;mol/m3;nmol/uL;umol/mLA unit of concentration (molarity unit) equal to one millimole of solute per liter of solution.Millimole per Liter
mmol/min/kPaC116242A unit of gas diffusion capacity equal to one millimole per minute per kilopascal.Millimoles per Minute per Kilopascal
mmol/min/kPa/LC67423A unit of gas diffusion capacity equal to one millimole per minute per kilopascal per liter of volume.Millimole per Minute per Thousand Pascal per Liter
mmol/molC111253A unit of fraction expressed as the ratio of the amount of a substance in solution, in millimoles, to the amount of a different substance in the mixture, in moles.Millimole per Mole
mmol/mol CreatinineC105511A unit of substance concentration defined as the concentration of millimoles of solute per mole of creatinine.Millimole Per Mole of Creatinine
molC42539MoleA unit defined as the amount of substance that contains as many elementary units as there are atoms in 0.012 kg of carbon-12. When the mole is used, the elementary entities must be specified and may be atoms, molecules, ions, electrons, other particles, or specified groups of such particles.(NCI)Mole
mol/gC68893Mole per GramA unit of amount of substance content (molality unit) defined as one mole of solute per one gram of solvent.(NCI)Mole per Gram
mol/LC48555Mole per Liter;mmol/mL;mol/LA unit of concentration (molarity unit) equal to one mole of solute in one liter of solution.(NCI)Mole per Liter
mol/mgC68894Mole per MilligramA unit of amount of substance content (molality unit) defined as one mole of solute per one milligram of solvent.(NCI)Mole per Milligram
mol/mLC68891Mole per MilliliterA unit of concentration (molarity unit) equal to one mole of solute in one milliliter of solution.(NCI)Mole per Milliliter
mol/molC70455Mole per Mole;mmol/mmolA unit of fraction expressed as the ratio of the amount of substance of solute in moles to the amount of substance of the mixture in moles.(NCI)Mole per Mole
MONTHSC29846MonthOne of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)Month
mOsmC67318MilliosmoleA unit of osmotic pressure equal to one thousandth of an osmole or osmotic pressure of 0.001 molar solution of a substance that does not dissociate. (NCI)Milliosmole
mOsm/kgC67427Milliosmole per KilogramA unit of osmotic pressure equal to one thousandth of an osmole per kilogram substance.Milliosmole per Kilogram
mPaC73765MillipascalA SI derived unit of pressure equivalent to one thousandth of one pascal. (NCI)Millipascal
mphC105500Miles per HourA unit of both speed (scalar) and velocity (vector), defined as the distance of one mile travelled per unit time equal to one hour. (NCI)Mile Per Hour
MPL U/mLC117973Immunoglobin M Phospholipid Units per MilliliterA unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter.Immunoglobin M Phospholipid Unit per Milliliter
msecC41140MillisecondA unit of time, which is equal to one thousandth of a second.(NCI)Millisecond
mU/LC67408An arbitrary unit of substance concentration equal to the concentration at which one liter of mixture contains one thousandth of a unit of a substance.Microunit per Milliliter
mVC67324MillivoltA unit of electric potential and electromotive force equal to one thousandth of a volt.(NCI)Millivolt
mV*minC105512Millivolt * MinutesA SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one millivolt, when the flux is uniformly reduced to zero within one minute. (NCI)Millivolt Minute
mV2/HzC114241Millivolt Squared per Hertz;Millivolt^2/HertzA unit equal to one thousandth of a volt squared per unit of frequency equal to one Hertz.Millivolt Squared per Hertz
nCiC67352NanocurieA unit of radioactivity equal to one billionth of Curie or 37 Becquerels, and corresponding to a radioactivity of 37 atomic disintegrations per second.(NCI)Nanocurie
NEBULEC71204NebuleA unit of measurement based on the nebule dosing unit.(NCI)Nebule Dosing Unit
NEEDLE GAUGEC101687A number representing the outer diameter of a needle. (NCI)Needle Gauge
NewtonC42546NewtonA unit of force which, when applied in a vacuum to a body having a mass of one kilogram, causes an acceleration of one meter per second squared. It is equal to 10E5 dynes.(NCI)Newton
ngC48516NanogramA unit of mass equal to one billionth (10E-9) of a gram, or one millionth (10E-6) of a milligram.(NCI)Nanogram
ng/dLC67326Nanogram per DeciliterA unit of mass concentration defined as the concentration of one nanogram of a substance in unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume one deciliter.(NCI)Nanogram per Deciliter
ng/LC67327Microgram per Cubic Meter;ng/L;pg/mL;ug/m3A unit of concentration or mass density equal to one picogram of substance per milliliter of solution or one nanogram of substance per liter of solution.Nanogram per Liter
NIUC77535Normalized Fluorescence Intensity Unit;Normalized Intensity Unit;Relative Fluorescence Intensity Unit;Relative Intensity UnitA unit of measurement that estimates the size or amount of material in a sample by normalizing its luminescence to that of a reference standard. (NCI)Relative Fluorescence Unit
nkatC70508NanokatalA unit of catalytic activity measurement equal to one billionth of one katal (10E-9 katal).(NCI)Nanokatal
nkat/LC70510Nanokatal per LiterA unit of catalytic activity concentration defined as the catalytic activity of the component equal to one billionth of one katal (10E-9 katal) in the unit volume of the system equal to one liter.(NCI)Nanokatal per Liter
nLC69188NanoliterA unit of volume equal to one billionth of a liter (10E-9 liter).(NCI)Nanoliter
nmC67328NanometerA unit of length equal to one billionth of a meter (10E-9 meter). Nanometer is used as a unit for light wavelength measurement.(NCI)Nanometer
nmolC48517NanomoleA unit of amount of substance equal to one billionth (10E-9) of a mole.(NCI)Nanomole
nmol BCE/LC117974Nanomoles Bone Collagen Equivalents per LiterA unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of volume equal to one liter.Nanomole Bone Collagen Equivalent per Liter
nmol BCE/mmolC118137Nanomoles Bone Collagen Equivalents per MillimoleA unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one millimole.Nanomole Bone Collagen Equivalent per Millimole
nmol/LC67432Nanomole per LiterA unit of concentration (molarity unit) equal to one nanomole of solute per liter of solution.Nanomole per Liter
nmol/mL/minC92613Nanomole per Milliliter per MinuteA unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute in one milliliter of solution to be administered per minute of time.Nanomole per Minute per Milliliter
nsecC73767NanosecondA unit of time equal to one billionth of a second. (NCI)Nanosecond
nU/cLC105513Nanounit per CentiliterAn arbitrary unit of substance content expressed in nanounit(s) per centiliter. (NCI)Nanounit Per Centiliter
ohmC42554OhmA unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one Ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in Siemens. (NCI)Ohm
osmC67330OsmoleA unit of osmotic pressure equal to that of an ideal solution of a nondissociating substance that has a concentration of one mole of solute per liter of solution.(NCI)Osmole
ozC48519OunceA unit of mass, the avoirdupois ounce is equal to 1/16 pound, or 28.3495 grams, or 0.911 457 troy ounce.(NCI)Ounce
PAC74924/Year;Every Year;Per Annum;Per YearA frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days.Per Year
PaC42547PascalA unit of pressure equivalent to one Newton per square meter or 10 bars or to 1.45x10(E-4) pounds per square inch.(NCI)Pascal
PACKC62653A number of individual items packaged as a unit.Pack
Pack YearC73993A quantification of lifetime tobacco exposure defined as (number of cigarettes smoked per day x number of years smoked)/20. One pack-year is smoking 20 cigarettes a day for one year.Pack Year
PACKAGEC48520Pack Dosing Unit;Package Dosing UnitA dosing measurement based on the package unit.(NCI)Package Dosing Unit
PACKETC48521Packet Dosing UnitA dosing measurement based on the packet unit.(NCI)Packet Dosing Unit
PATCHC48524Patch Dosing UnitA dosing measurement based on the patch unit.(NCI)Patch Dosing Unit
PELLETC48525Pellet Dosing UnitA dosing measurement based on the pellet unit.(NCI)Pellet Dosing Unit
per minC66967Per MinuteThe number of occurrences of something within a minute of time.(NCI)Per Minute
per secC66965Per SecondThe number of occurrences of something within a second of time.(NCI)Per Second
PFUC67264Plaque Forming UnitA measure of viable infectious entities (e.g. viral particle or group of particles) in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque. A number of plaque forming units (PFU) per unit volume is a conventional way to refer the titer of an infective entity in a specimen or preparation.(NCI)Plaque Forming Unit
PFU/doseC71198Plaque Forming Unit per DoseA unit of potency of a biological product expressed as a quantity of viable infectious entities capable to produce a cytopathic effect in the appropriate cell culture per a single dose of the preparation.(NCI)Plaque Forming Unit per Dose
PFU/mLC71199Plaque Forming Unit per MilliliterA unit of potency of a biological product expressed as a quantity of viable infectious entities capable to produce a cytopathic effect in the appropriate cell culture per one milliliter of the preparation.(NCI)Plaque Forming Unit per Milliliter
pgC64551PicogramA unit of mass equal to one trillionth of a gram (10E-12 gram).(NCI)Picogram
pg/dLC67331Picogram per DeciliterPicograms per deciliter.Picogram per Deciliter
pg/LC85597fg/mL;pg/LA unit of concentration or mass density equal to one femtogram of substance per milliliter of solution or one picogram of substance per liter of solution.Femtogram per Milliliter
PIPEC116246Pipe Dosing UnitA dosing measurement based on the pipe unit.Pipe Dosing Unit
PIXELC48367The smallest resolvable rectangular area of an image, either on a screen or stored in memory. (NCI)Pixel
PIXELS/cmC114238PPCM;Pixels per CentimeterA unit of image resolution expressed in the numbers of pixels per centimeter in the horizontal or vertical direction.Pixels per Centimeter
PIXELS/inC114239PPI;Pixels per InchA unit of image resolution expressed in the numbers of pixels per inch in the horizontal or vertical direction.Pixels per Inch
pkatC70509PicokatalA unit of catalytic activity measurement equal to trillionth of one katal (10E-12 katal).(NCI)Picokatal
pLC69189PicoliterA unit of volume equal to one trillionth of a liter (10E-12 liter). (NCI)Picoliter
pmC69148PicometerA unit of length equal to one trillionth of a meter (10E-12 meter).(NCI)Picometer
pmolC65045PicomoleA unit of amount of substance equal to a trillionth (10E-12) of a mole.(NCI)Picomole
pmol/LC67434Femtomole per Milliliter;Picomole per Liter;fmol/mLA unit of concentration (molarity unit) equal to one picomole of solute per liter of solution.Picomole per Liter
PNU/mLC116236Protein Nitrogen Unit per MilliliterUnit of measure of potency of an allergenic product expressed as a number of protein nitrogen units per one milliliter of formulation.Allergenic Protein Nitrogen Unit per Milliliter
POUCHC48530Pouch Dosing UnitA dosing measurement based on the pouch unit.(NCI)Pouch Dosing Unit
ppbC70565Part per BillionA unit of measure referring to one entity counted per one billion entities.(NCI)Part Per Billion
ppmC48523Part per MillionA unit of measurement referring to one entity counted per one million entities.(NCI)Part Per Million
ppthC69112Part per ThousandA unit of proportion equal to 10E-3.(NCI)Part per Thousand
pptrC70566Parts per TrillionA unit of measure referring to one entity counted per one trillion entities.(NCI)Part Per Trillion
PRESSOR UNITSC48532Pressor UnitA dosing measurement based on the pressor unit.(NCI)Pressor Unit
psecC73768PicosecondA unit of time equal to one trillionth of a second. (NCI)Picosecond
psiC67334Pounds per Square InchA unit of pressure equivalent to 6.894757 kilopascals, or 703.0696 kilograms per square meter, or 51.71507 millimeters of mercury.(NCI)Pound per Square Inch
pt_brC69114British Pint;Imperial PintA traditional unit of volume equal to 20 British fluid ounces, 34.678 cubic inches or approximately 568.261 milliliters.Pint British
pt_usC48529US PintA United States liquid unit equal to 16 US fluid ounces or 28.875 cubic inches or approximately 473.177 milliliters.Pint
PUFFC65060PuffA means of delivering a defined dose of a therapeutic aerolized solution into either the upper or lower respiratory tract. Metered-dose inhalers or spray pumps are devices that provide a puff dose for delivery into either the oral or the nasal cavity.(NCI)Puff Dosing Unit
QUANTITY SUFFICIENTC48590Quantity SufficientA quantity of an ingredient or product needed to bring up a volume or weight of the preparation to a final amount as it is indicated in the prescription; also refers to a determination of an adequate supply of medicine to fulfill either a prescribed amount or a sufficient quantity to provide treatment over a specified time frame.(NCI)Quantity Sufficient
RadC18064RadThe special unit for absorbed radiation dose, which is the amount of energy from any type of ionizing radiation (e.g., alpha, beta, gamma, neutrons, etc.) deposited in any medium (e.g., water, tissue, air). A dose of one rad means the absorption of 100 ergs per gram of absorbing tissue. One rad is equal to 0.01 gray.(NCI)Rad
RATIOC44256A unit of measurement for the quotient of the amount of one entity to another.Ratio
RINGC62609Ring Dosing UnitA dosing measurement based on the ring unit.(NCI)Ring Dosing Unit
RNA copies/mLC67441RNA Copies per MilliliterThe unit of concentration of Ribonucleic Acid (RNA) copies expressed as a number of copies in unit volume equal to one milliliter.(NCI)RNA Copy per Milliliter
RoentgenC70575RoentgenA unit of exposure to ionizing radiation. One Roentgen is the amount of gamma or x-rays required to produce ions resulting in a charge of 2.58E-4 Coulombs/kilogram of air under standard conditions.(NCI)Roentgen
rpmC70469Revolution per MinuteA unit of frequency equal to one revolution per unit of time equal to one minute.(NCI)Revolution per Minute
SACHETC71324Sachet dosing unitA dosing unit that contains a solid pharmaceutical preparation in the form of a small packet or bag made from a flexible, often porous material.(NCI)Sachet Dosing Unit
SBE/mLC116233Standardized Biological Unit per MilliliterUnit of measure of potency of allergenic product expressed as a number of standardized biological units per one milliliter of formulation.Standardized Allergy Biological Unit per Milliliter
scmC68858Standard Cubic MeterA unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic meter at standard conditions: temperature 273.15 K and pressure of one atmosphere (101.325 kilopascals).(NCI)Standard Cubic Meter
SCOOPFULC48536Scoopful Dosing UnitA dosing measurement based on the scoopful unit.(NCI)Scoopful Dosing Unit
secC42535SecondThe second is a unit of time with a duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the cesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour. Abbreviation Sec. is acceptable in non-scientific usage only.(NCI)Second
Shock WaveC112433Shock WaveA dosing measurement based on the shock wave unit.Shockwave Dosing Unit
SiemensC42555SiemensA unit of electrical conductance, admittance, and susceptance. A conductor has a conductance of one Siemens if an electrical potential difference of one volt produces a one Ampere current in it. The conductance in Siemens is the reciprocal of its resistance in ohms.(NCI)Siemens
SPRAYC48537Spray Dosing UnitA dosing measurement based on the spray unit.(NCI)Spray Dosing Unit
SQU/mLC116234Standardized Quality Unit per MilliliterUnit of measure of potency of allergenic product expressed as a number of standardized quality units per one milliliter of formulation.Standardized Allergy Quality Unit per Milliliter
STEPSC111318A unit of measure to quantify the number of strides taken during a normal walking gait.Step Unit of Distance
STRIPC48538Strip Dosing UnitA dosing measurement based on the strip unit.(NCI)Strip Dosing Unit
SUPPOSITORYC48539Suppository Dosing UnitA dosing measurement based on the suppository unit.(NCI)Suppository Dosing Unit
SvC42553SievertA unit of equivalent radiation dose. One Sv is received when the actual absorbed dose of ionizing radiation, after being multiplied by the dimensionless factors Q (the relative biological efficiency or quality factor) and N (the product of any other multiplying factors that takes into account the distribution of energy throughout the dose), is one joule per kilogram. In this scheme, the relationship between the absorbed dose of radiation D and the dose equivalent H is, therefore, given by H = QND. Both Q and N are stipulated by the International Commission on Radiological Protection. One Sv is equal to 100 rem.(NCI)Sievert
SYRINGEC48540Syringe Dosing UnitA dosing measurement based on the syringe unit.(NCI)Syringe Dosing Unit
TABLETC48542Tablet Dosing Unit;tabA dosing measurement based on the tablet unit.(NCI)Tablet Dosing Unit
TAMPONC48543Tampon Dosing UnitA dosing measurement based on the tampon unit.(NCI)Tampon Dosing Unit
TbspC48541Tablespoon Dosing UnitA unit of volume informally used in pharmacy. The tablespoon has been standardized at 15 milliliters in US, Britain, Canada, and New Zealand, and at 20 milliliters in Australia and some European countries.(NCI)Tablespoon Dosing Unit
TCID 50/doseC7053750 Percent Tissue Culture Infective Dose per DoseA potency unit equal to the potency at which one dose of preparation contains one 50 percent tissue culture infective dose.(NCI)50 Percent Tissue Culture Infective Dose per Dose
TeslaC42557TeslaA unit of magnetic flux density equal to the magnitude of the magnetic field vector necessary to produce a force of one Newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one Weber per square meter.(NCI)Tesla
titerC67454Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent.Titer
TorrC112423TorrA non-SI manometric unit of pressure equal to 1/760 of a standard atmosphere (a standard atmosphere being defined as equal to 101325 pascals). One Torr is equal to 133.3223684 pascals.Torr
TRACEC48547Trace Dosing UnitAn extremely small amount.(NCI)Trace Dosing Unit
TROCHEC48548Troche Dosing UnitA dosing measurement based on the troche unit.(NCI)Troche Dosing Unit
tspC48544Teaspoon Dosing UnitA unit of volume used in pharmacy equal to 5 milliliters.(NCI)Teaspoon Dosing Unit
TUBEC48549Tube Dosing UnitA dosing measurement based on the tube unit.(NCI)Tube Dosing Unit
tuberculin unitC65132Tuberculin UnitAn arbitrary unit of tuberculin dosage defined by comparison of clinical response with a preparation of the purified protein derivative standardized for use in humans for tuberculin skin test reaction.(NCI)Tuberculin Unit
tuberculin unit/mLC70506Tuberculin Unit per MilliliterA unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in one milliliter of preparation.(NCI)Tuberculin Unit per Milliliter
UC44278UnitA single undivided thing occurring in the composition of something else.Unit
U/animalC73773Unit per AnimalAn arbitrary dosing unit expressed in unit(s) per animal. (NCI)Unit per Animal
U/cLC105520Unit per CentiliterAn arbitrary unit of substance content expressed in unit(s) per centiliter.Unit Per Centiliter
U/dLC105521Unit per DeciliterAn arbitrary unit of substance content expressed in unit(s) per deciliter.Unit Per Deciliter
U/gC77606Unit per GramAn arbitrary unit of substance content expressed in unit(s) per gram. (NCI)Unit per Gram
U/g CreatinineC105523A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one unit per gram of creatinine.Unit Per Gram of Creatinine
U/g HGBC105522Units per Gram HemoglobinUnit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one unit per gram of hemoglobin. (NCI)Unit Per Gram Hemoglobin
U/g/dayC73774Unit per Gram per DayAn arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to twenty-four hours. (NCI)Unit per Gram per Day
U/g/hC73775Unit per Gram per HourAn arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to sixty minutes. (NCI)Unit per Gram per Hour
U/g/minC73776Unit per Gram per MinuteAn arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to sixty seconds. (NCI)Unit per Gram per Minute
U/kgC67465Unit per KilogramAn arbitrary unit of substance content expressed in units of biological activity per unit of mass equal to one kilogram. Unit per kilogram is also used as a dose calculation unit expressed in arbitrary units per one kilogram of body mass. (NCI)Unit per Kilogram
U/kg/dayC73777Unit per kilogram per DayAn arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to twenty-four hours. (NCI)Unit per Kilogram per Day
U/kg/hC73778Unit per Kilogram per HourAn arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty minutes. (NCI)Unit per Kilogram per Hour
U/kg/minC73779Unit per Kilogram per MinuteAn arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty seconds. (NCI)Unit per Kilogram per Minute
U/LC67456Unit per Liter;mU/mLAn arbitrary unit of substance concentration equal to the concentration at which one liter of mixture contains one unit of a substance. (NCI)Unit per Liter
U/m2C67467Unit per Square MeterA unit expressed as a number of arbitrary units of substance per one square meter of a body surface area.Unit per Square Meter
U/m2/dayC73783Unit per Square Meter per DayAn arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to twenty-four hours. (NCI)Unit per Square Meter per Day
U/m2/hC73784Unit per Square Meter per HourAn arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty minutes. (NCI)Unit per Square Meter per Hour
U/m2/minC73785Unit per Square Meter per MinuteAn arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty seconds. (NCI)Unit per Square Meter per Minute
U/mgC73780Unit per MilligramAn arbitrary unit of substance content expressed in unit(s) per milligram. (NCI)Unit per Milligram
U/mLC77607Unit per MilliliterAn arbitrary unit of substance content expressed in unit(s) per milliliter. (NCI)Unit per Milliliter
U/mmolC92618Unit per MillimoleAn arbitrary unit of substance concentration equal to the concentration at which one millimole of a mixture contains one unit of a substance. (NCI)Unit per Millimole
uCiC48507Microcurie;mcCiA unit of radioactivity equal to one millionth of a Curie or 37 kilobecquerels, and corresponding to a radioactivity of 37 000 atomic disintegrations per second.(NCI)Microcurie
uCi/kgC70571Microcurie per Kilogram;mcCi/kgA unit of specific radioactivity (massic activity) equal to activity of one microcurie of the sample with total mass of one kilogram.(NCI)Microcurie per Kilogram
uCi/LC71173Microcurie per Liter;mcCi/LA unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one millionth of a Curie per unit volume equal to one liter.(NCI)Microcurie per Liter
uEqC73726MicroequivalentA unit of relative amount of a substance equal to one millionth of an equivalent weight.(NCI)Microequivalent
uEq/LC117975Microequivalent per Liter;Nanoequivalent per Milliliter;nEq/mLA concentration unit measured as a number of microequivalents of solute per liter of solution.Microequivalent per Liter
ugC48152Microgram;mcgThe unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI)Microgram
ug/animalC73728Microgram per AnimalA unit of measure expressed in microgram(s) per animal.Microgram per Animal
ug/dayC71205Microgram per Day;mcg/dayA unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to twenty four hours. Microgram per day is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to twenty four hours.(NCI)Microgram per Day
ug/dLC67305Microgram per DeciliterA unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one microgram occupies the volume one deciliter. (NCI)Microgram per Deciliter
ug/g/dayC74921Microgram per Gram per DayA dose calculation unit expressed in microgram(s) per gram per period of time equal to twenty-four hours. (NCI)Microgram per Gram per Day
ug/g/hC74922Microgram per Gram per HourA dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty minutes. (NCI)Microgram per Gram per Hour
ug/g/minC74923Microgram per Gram per MinuteA dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty seconds. (NCI)Microgram per Gram per Minute
ug/hC67394Micrograms per Hour;mcg/hA unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI)Microgram per Hour
ug/kgC67396Microgram per Kilogram;mcg/kg;ng/g;ug/kgA unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI)Microgram per Kilogram
ug/kg/dayC73729Microgram per Kilogram per DayA dose calculation unit expressed in microgram(s) per kilogram per period of time equal to twenty-four hours. (NCI)Microgram per Kilogram per Day
ug/kg/hC73730Microgram per Kilogram per HourA dose calculation unit expressed in microgram(s) per kilogram per period of time equal to sixty minutes. (NCI)Microgram per Kilogram per Hour
ug/kg/minC71210Gamma per Kilogram per Minute;Microgram per Kilogram per Minute;gamma/kg/min;mcg/kg/minA dose calculation unit equal to one millionth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.(NCI)Microgram per Kilogram per Minute
ug/LC67306Microgram per Liter;Milligram per Cubic Meter;Nanogram per Milliliter;mcg/L;mg/m3;ng/mL;ug/LA unit of concentration or mass density equal to one nanogram of substance per milliliter of solution or one microgram of substance per liter of solution.Microgram per Liter
ug/m2C67312Microgram per Square MeterA dose calculation unit expressed in microgram(s) per square meter.Microgram per Square Meter
ug/m2/dayC73787Microgram per Square Meter per DayA dose calculation unit expressed in microgram(s) per square meter per period of time equal to twenty-four hours. (NCI)Microgram per Square Meter per Day
ug/m2/hC73727Microgram per Square Meter per HourA dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty minutes. (NCI)Microgram per Square Meter per Hour
ug/m2/minC73733Microgram per Square Meter per MinuteA dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty seconds. (NCI)Microgram per Square Meter per Minute
ug/minC71211Micrograms per Minute;mcg/minA unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one minute. Microgram per minute is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to one minute.(NCI)Microgram per Minute
ug/mL/hC75905Microgram per Milliliter per HourA dose calculation unit expressed in microgram(s) per milliliter of solution per period of time equal to sixty minutes. (NCI)Microgram per Milliliter per Hour
ugEqC105497Microgram EquivalentA unit of relative amount of substance concentration equal to one millionth of a gram of an equivalent weight. (NCI)Microgram Equivalent
ukatC70562Microkatal;mckatA unit of catalytic activity measurement equal to one millionth of katal (10E-6 katal).(NCI)Microkatal
ukat/LC67397Microkatal per Liter;mckat/LUnit of catalytic activity concentration defined as activity equal to one millionth of katal per one liter of the system volume.(NCI)Microkatal per Liter
uLC48153Microliter;mcL;mm3A unit of volume accepted for use with the SI and equal to one millionth of a liter (10E-6 liter).(NCI)Microliter
uL/mLC69175Microliter per Milliliter;mcL/mLA unit of volume fraction expressed as a number of microliters of the constituent per the volume of the system represented in milliliters.(NCI)Microliter per Milliliter
umC48510Micron;mcmA unit of length in metric system equal to 10E-6 meter, or micrometer.(NCI)Micron
um2C73770MicroSquare MeterA SI unit of area measurement equal to a square whose sides are one micrometer long. (NCI)Square Micrometer
umolC48509Micromole;mcmolA unit of amount of substance equal to one millionth (10E-6) of a mole.(NCI)Micromole
umol/dayC67406Micromoles per Day;mcmol/dayA unit of amount of substance flow rate equivalent to the rate at which one millionth of a mole of substance travels to a given object or space over a period of time equal to 24 hours.(NCI)Micromole per 24 Hours
umol/LC48508Micromole per LiterA unit of concentration (molarity unit) equal to one micromole of solute per liter of solution.Micromole per Liter
umol/L/secC105498Micromoles per Liter per SecondA concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one second. (NCI)Micromole Per Liter Per Second
umol/mg/minC73735Micromole per Milligram per MinuteA unit of concentration (molarity unit) equal to one millionth of a mole (10E-6 mole) per milligram of a substance per period of time equal to sixty seconds. (NCI)Micromole per Milligram per Minute
umol/minC85708mcmol/min;umol/minMicromoles per minute.Micromole per Minute
uOsMC73736MicroosmoleA unit of osmotic pressure equal to one millionth of an osmole or the osmotic pressure of a 10E-6 molar solution of a substance that does not dissociate. (NCI)Microosmole
usecC69149MicrosecondA unit of time equal to one millionth of a second. (NCI)Microsecond
uVC71175Microvolt;mcVA unit of an electric potential and electromotive force equal to one millionth of a volt.(NCI)Microvolt
uV*secC105499Microvolt * SecondsA SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one microvolt, when the flux is uniformly reduced to zero within one second. (NCI)Microvolt Second
VC42551VoltA unit of electric potential and electromotive force, equal to the difference of electric potential between two points on a conducting wire carrying a constant current of one Ampere when the power dissipated between the points is one watt. This is equivalent to the potential difference across a resistance of one ohm when one Ampere of current flows through it.(NCI)Volt
V/secC105524V/s;Volt per SecondA SI derived rate unit equal to one volt per unit of time equal to one second.Volt Per Second
v/vC67469volume fractionQuotient of the volume of a substance and the total volume of the sample containing the substance.Volume Fraction
VIALC48551Vial Dosing UnitA dosing measurement based on the vial unit.(NCI)Vial Dosing Unit
VIRTUAL PIXELC114237A type of pixel created from overlying two adjacent real pixels to create an additional virtual image of a pixel that is visible to the human eye.Virtual Pixel
WAFERC48552Wafer Dosing UnitA dosing measurement based on the wafer unit.(NCI)Wafer Dosing Unit
WattC42549WattA unit of power equal to the power which in one second produces or transfers the energy of one joule. The unit is used in measurements of power emitted, transferred or received as radiation, sound waves, heat flow rate, and rate of energy transfer. Equal to 1/746 of horsepower.(NCI)Watt
WeberC42556V*sec;Volt Second;Volt-second;WeberA unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one volt, when the flux is uniformly reduced to zero within one second.(NCI)Weber
WEEKSC29844WeekAny period of seven consecutive days. (NCI)Week
ydC48553YardA unit of length equal to 3 feet, or 36 inches, or 0.9144 meter.(NCI)Yard
YEARSC29848YearThe period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)Year
Back to top
CL.C66770.VSRESUUnits for Vital Signs Results
(VSRESU)
text
Extensible: Yes
C66770Units for Vital Signs ResultsThe unit used to record and describe the result of a test investigating a vital sign. (NCI)CDISC SDTM Unit for Vital Sign Result Terminology
%C25613PercentageA fraction or ratio with 100 understood as the denominator. (NCI)Percentage
BEATS/MINC49673Beats per MinuteThe number of heartbeats measured per minute time. (NCI)Beats per Minute
BREATHS/MINC49674Breaths per MinuteThe number of breaths (inhalation and exhalation) taken per minute time. (NCI)Breaths per Minute
CC42559Degree CelsiusA unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)Degree Celsius
cmC49668CentimeterA basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch.Centimeter
FC44277Degree FahrenheitThe Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)Degree Fahrenheit
gC48155GramA metric unit of mass equal to one one thousandth of a kilogram. (NCI)Gram
inC48500InchA traditional unit of length equal to 2.54 centimeters. (NCI)Inch
kgC28252KilogramThe basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI)Kilogram
kg/m2C49671Kilogram per Square MeterA unit expressed as kilogram of mass per square meter of area.(NCI)Kilogram per Square Meter
LBC48531PoundA traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)Pound
m2C42569Square MeterThe SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)Square Meter
mmC28251MillimeterA unit of measure equal to one thousandth of a meter. (NCI)Millimeter
mmHgC49670Millimeter of MercuryA unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)Millimeter of Mercury
Back to top
CL.C102590.VCNEVDVaccination Evidence Source
(VCNEVD)
text
Extensible: Yes
C102590Vaccination Evidence SourceTerminology relevant to the source of information regarding the subject's vaccination status.CDISC SDTM Vaccination Evidence Source Terminology
SCARC34483A mark left (usually on the skin) by the healing of injured tissue.Scar
SELF-REPORTC74528An individual's perspective or subjective interpretation of an event or information.Self-Report
WRITTEN DOCUMENTATIONC86042The collecting, abstracting, and coding of printed or written information for future reference.Written Documentation
Back to top
CL.C116110.VRTESTCDViral Resistance Findings Test Code
(VRTESTCD)
text
Extensible: Yes
C116110Viral Resistance Findings Test CodeTerminology used for virology test codes of the CDISC Standard Data Tabulation Model.CDISC SDTM Viral Resistance Findings Test Code Terminology
IC50FCBC116250IC50 Fold Change from BaselineA fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC50 Treatment Result divided by the IC50 Treatment Result from the baseline visit.Half Maximal Inhibitory Concentration Fold Change from Baseline Measurement
IC50FCRC116249IC50 Fold Change from ReferenceA fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC50 Treatment Result divided by the IC50 Reference Control Result.Half Maximal Inhibitory Concentration Fold Change from Reference Measurement
IC50RC116248IC50 Reference Control ResultA reference control sample response based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction.Half Maximal Inhibitory Concentration Reference Control Result Measurement
IC50TC116247IC50 Treatment ResultA measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 50% inhibition of the standard growth of the viral organism, or of a reaction.Half Maximal Inhibitory Concentration Treatment Result Measurement
IC95FCBC116254IC95 Fold Change from BaselineA fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC95 Treatment Result divided by the IC95 Treatment Result from the baseline visit.95 Percent Maximal Inhibitory Concentration Fold Change from Baseline Measurement
IC95FCRC116253IC95 Fold Change from ReferenceA fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC95 Treatment Result divided by the IC95 Reference Control Result.95 Percent Maximal Inhibitory Concentration Fold Change from Reference Measurement
IC95RC116252IC95 Reference Control ResultA reference control sample response based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction.95 Percent Maximal Inhibitory Concentration Reference Control Result Measurement
IC95TC116251IC95 Treatment ResultA measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 95% inhibition of the standard growth of the viral organism, or of a reaction.95 Percent Maximal Inhibitory Concentration Treatment Result Measurement
ICNETASC116255Inhibitory Concentration Net AssessmentAn indication of reduced or increased susceptibility of a viral organism, or activity of a biological/biochemical reaction in response to the inhibitory concentration (IC50 and/or IC95) of a specific drug.Inhibitory Concentration Net Assessment Measurement
Back to top
CL.C116109.VRTESTViral Resistance Findings Test Name
(VRTEST)
text
Extensible: Yes
C116109Viral Resistance Findings Test NameTerminology used for virology test names of the CDISC Standard Data Tabulation Model.CDISC SDTM Viral Resistance Findings Test Name Terminology
IC50 Fold Change from BaselineC116250IC50 Fold Change from BaselineA fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC50 Treatment Result divided by the IC50 Treatment Result from the baseline visit.Half Maximal Inhibitory Concentration Fold Change from Baseline Measurement
IC50 Fold Change from ReferenceC116249IC50 Fold Change from ReferenceA fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC50 Treatment Result divided by the IC50 Reference Control Result.Half Maximal Inhibitory Concentration Fold Change from Reference Measurement
IC50 Reference Control ResultC116248IC50 Reference Control ResultA reference control sample response based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction.Half Maximal Inhibitory Concentration Reference Control Result Measurement
IC50 Treatment ResultC116247IC50 Treatment ResultA measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 50% inhibition of the standard growth of the viral organism, or of a reaction.Half Maximal Inhibitory Concentration Treatment Result Measurement
IC95 Fold Change from BaselineC116254IC95 Fold Change from BaselineA fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC95 Treatment Result divided by the IC95 Treatment Result from the baseline visit.95 Percent Maximal Inhibitory Concentration Fold Change from Baseline Measurement
IC95 Fold Change from ReferenceC116253IC95 Fold Change from ReferenceA fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC95 Treatment Result divided by the IC95 Reference Control Result.95 Percent Maximal Inhibitory Concentration Fold Change from Reference Measurement
IC95 Reference Control ResultC116252IC95 Reference Control ResultA reference control sample response based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction.95 Percent Maximal Inhibitory Concentration Reference Control Result Measurement
IC95 Treatment ResultC116251IC95 Treatment ResultA measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 95% inhibition of the standard growth of the viral organism, or of a reaction.95 Percent Maximal Inhibitory Concentration Treatment Result Measurement
Inhibitory Concentration Net AssessmentC116255Inhibitory Concentration Net AssessmentAn indication of reduced or increased susceptibility of a viral organism, or activity of a biological/biochemical reaction in response to the inhibitory concentration (IC50 and/or IC95) of a specific drug.Inhibitory Concentration Net Assessment Measurement
Back to top
CL.C66741.VSTESTCDVital Signs Test Code
(VSTESTCD)
text
Extensible: Yes
C66741Vital Signs Test CodeThe test code given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure.CDISC SDTM Vital Sign Terminology by Code
ABSKNFC103346Abdominal Skinfold ThicknessA measurement for determining the subcutaneous fat layer thickness whereby a pinch of skin approximately five centimeters to the right of the umbilicus is measured using calipers. (NCI)Abdominal Skinfold Thickness
BMIC16358Body Mass IndexA general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)Body Mass Index
BODLNGTHC81298Body LengthThe linear extent in space from one end of the body to the other end, or the extent of the body from beginning to end.Total Body Length
BODYFATC12472Adipose Tissue;Body Fat;Fat TissueA specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers. (NCI)Adipose Tissue
BSAC25157Body Surface AreaA measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI)Body Surface Area
DIABPC25299Diastolic Blood PressureThe blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)Diastolic Blood Pressure
FARMCIRC100946Forearm CircumferenceThe distance around an individual's forearm.Forearm Circumference
FRMSIZEC49680Body Frame SizeThe categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)Body Frame Size
HDCIRCC81255Head CircumferenceA circumferential measurement of the head at the widest point.Head Circumference
HEIGHTC25347HeightThe vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)Height
HIPCIRC100947Hip CircumferenceThe distance around an individual's pelvic area or hips.Hip Circumference
HRC49677Heart RateThe number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)Heart Rate
IDEALWTC117976Ideal Body WeightA person's optimum weight as calculated by a standard methodology.Ideal Body Weight
KNEEHEELC84372Knee to Heel Length;Lower Leg LengthA measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI)Knee to Heel Length Measurement
LBMC71258Lean Body MassThe weight of all organs and tissue in an individual less the weight of the individual's body fat.Lean Body Mass
MAPC49679Mean Arterial PressureThe mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)Mean Arterial Pressure
OXYSATC60832Oxygen SaturationA measurement of the oxygen-hemoglobin saturation of a volume of blood.Oxygen Saturation Measurement
PULSEC49676Pulse RateThe rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)Pulse Rate
PULSEPRC100945Pulse PressureThe change in systolic to diastolic pressure which produces a pulse.Pulse Pressure
RESPC49678Respiratory RateThe rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)Respiratory Rate
SADC87054Sagittal Abdominal DiameterA standard measure of visceral obesity, or abdominal fat, which is measured from the patient's back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supine position. (NCI)Sagittal Abdominal Diameter
SSSKNFC98785Subscapular Skinfold ThicknessA measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI)Subscapular Skinfold Thickness
SYSBPC25298Systolic Blood PressureThe blood pressure during the contraction of the left ventricle of the heart. (NCI)Systolic Blood Pressure
TBWC104622Total Body WaterA measurement of the quantity of water within the body, including both the intracellular and extracellular compartments.Total Body Water Measurement
TEMPC25206TemperatureThe property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)Temperature
TRSKNFC98793Triceps Skinfold ThicknessA measurement of the thickness of a pinch of skin on the triceps. (NCI)Triceps Skinfold Thickness
WEIGHTC25208WeightThe vertical force exerted by a mass as a result of gravity. (NCI)Weight
WSTCIRC100948Waist CircumferenceThe distance around an individual's midsection or waist.Waist Circumference
Back to top
CL.C67153.VSTESTVital Signs Test Name
(VSTEST)
text
Extensible: Yes
C67153Vital Signs Test NameThe test name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure.CDISC SDTM Vital Sign Terminology by Name
Abdominal Skinfold ThicknessC103346Abdominal Skinfold ThicknessA measurement for determining the subcutaneous fat layer thickness whereby a pinch of skin approximately five centimeters to the right of the umbilicus is measured using calipers. (NCI)Abdominal Skinfold Thickness
Adipose TissueC12472Adipose Tissue;Body Fat;Fat TissueA specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers. (NCI)Adipose Tissue
Body Frame SizeC49680Body Frame SizeThe categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)Body Frame Size
Body LengthC81298Body LengthThe linear extent in space from one end of the body to the other end, or the extent of the body from beginning to end.Total Body Length
Body Mass IndexC16358Body Mass IndexA general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)Body Mass Index
Body Surface AreaC25157Body Surface AreaA measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI)Body Surface Area
Diastolic Blood PressureC25299Diastolic Blood PressureThe blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)Diastolic Blood Pressure
Forearm CircumferenceC100946Forearm CircumferenceThe distance around an individual's forearm.Forearm Circumference
Head CircumferenceC81255Head CircumferenceA circumferential measurement of the head at the widest point.Head Circumference
Heart RateC49677Heart RateThe number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)Heart Rate
HeightC25347HeightThe vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)Height
Hip CircumferenceC100947Hip CircumferenceThe distance around an individual's pelvic area or hips.Hip Circumference
Ideal Body WeightC117976Ideal Body WeightA person's optimum weight as calculated by a standard methodology.Ideal Body Weight
Knee to Heel LengthC84372Knee to Heel Length;Lower Leg LengthA measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI)Knee to Heel Length Measurement
Lean Body MassC71258Lean Body MassThe weight of all organs and tissue in an individual less the weight of the individual's body fat.Lean Body Mass
Mean Arterial PressureC49679Mean Arterial PressureThe mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)Mean Arterial Pressure
Oxygen SaturationC60832Oxygen SaturationA measurement of the oxygen-hemoglobin saturation of a volume of blood.Oxygen Saturation Measurement
Pulse PressureC100945Pulse PressureThe change in systolic to diastolic pressure which produces a pulse.Pulse Pressure
Pulse RateC49676Pulse RateThe rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)Pulse Rate
Respiratory RateC49678Respiratory RateThe rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)Respiratory Rate
Sagittal Abdominal DiameterC87054Sagittal Abdominal DiameterA standard measure of visceral obesity, or abdominal fat, which is measured from the patient's back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supine position. (NCI)Sagittal Abdominal Diameter
Subscapular Skinfold ThicknessC98785Subscapular Skinfold ThicknessA measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI)Subscapular Skinfold Thickness
Systolic Blood PressureC25298Systolic Blood PressureThe blood pressure during the contraction of the left ventricle of the heart. (NCI)Systolic Blood Pressure
TemperatureC25206TemperatureThe property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)Temperature
Total Body WaterC104622Total Body WaterA measurement of the quantity of water within the body, including both the intracellular and extracellular compartments.Total Body Water Measurement
Triceps Skinfold ThicknessC98793Triceps Skinfold ThicknessA measurement of the thickness of a pinch of skin on the triceps. (NCI)Triceps Skinfold Thickness
Waist CircumferenceC100948Waist CircumferenceThe distance around an individual's midsection or waist.Waist Circumference
WeightC25208WeightThe vertical force exerted by a mass as a result of gravity. (NCI)Weight
Back to top
CL.C117746.HEPENCGRWest Haven Hepatic Encephalopathy Grade
(HEPENCGR)
text
Extensible: No
C117746West Haven Hepatic Encephalopathy GradeA grading system to describe the severity of hepatic encephalopathy based on the level of mental status by the West Haven Hepatic Encephalopathy Grade.CDISC SDTM West Haven Hepatic Encephalopathy Grade Terminology
GRADE 0C117824Minimal - symptoms or pathological characteristics include minimal hepatic encephalopathy, lack of detectable changes in personality or behavior, minimal changes in memory, concentration and intellectual function, and absence of coordination asterixis. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview)West Haven Hepatic Encephalopathy Grade 0
GRADE 1C117825Mild - symptoms or pathological characteristics include trivial lack of awareness, shortened attention span, impaired ability to perform addition or subtraction, hypersomnia, insomnia, or inversion of sleep pattern, euphoria, depression or irritability, mild confusion, slowing of ability to perform mental tasks. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.)West Haven Hepatic Encephalopathy Grade 1
GRADE 2C117826Moderate - symptoms or pathological characteristics include lethargy or apathy, disorientation, inappropriate behavior, slurred speech, obvious asterixis, drowsiness, lethargy, gross deficits in ability to perform mental tasks, obvious personality changes, inappropriate behavior, and intermittent disorientation, unsurely regarding time. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.)West Haven Hepatic Encephalopathy Grade 2
GRADE 3C117827Severe - symptoms or pathological characteristics include somnolence with some arousability, inability to perform mental tasks, disorientation about time and place, marked confusion, amnesia, occasional fits of rage, present but incomprehensible speech. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.)West Haven Hepatic Encephalopathy Grade 3
GRADE 4C117828Coma - symptoms or pathological characteristics include coma with or without response to painful stimuli. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.)West Haven Hepatic Encephalopathy Grade 4
Back to top